Citrus Sinensis ID: 047716
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.929 | 0.362 | 0.485 | 3e-83 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.864 | 0.342 | 0.442 | 3e-68 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.861 | 0.337 | 0.449 | 5e-66 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.873 | 0.325 | 0.437 | 6e-66 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.876 | 0.344 | 0.453 | 2e-65 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.916 | 0.341 | 0.427 | 1e-61 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.889 | 0.362 | 0.421 | 2e-60 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.876 | 0.299 | 0.436 | 1e-57 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.883 | 0.277 | 0.417 | 2e-57 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.913 | 0.292 | 0.413 | 6e-57 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 308 bits (790), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 154/317 (48%), Positives = 220/317 (69%), Gaps = 15/317 (4%)
Query: 19 EIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGC--INGGKEI--AVKKLIKIVEEGES 74
E+ LR F+Y ++ A+ +F EE+GRG G VYKG + GG E+ AVKKL ++ + E
Sbjct: 515 ELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEK 574
Query: 75 EFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRR 134
EF+NE+K+IG+IHHKNLV L+GFC+EG ++++VYEF+ G+L N LFR R SW +R+
Sbjct: 575 EFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFR-RPRPSWEDRKN 633
Query: 135 IALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL 194
IA+ I G+ YLH+EC +IIHCDIKP NIL+DE + +ISDFGL+KLL +QT T T +
Sbjct: 634 IAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNI 693
Query: 195 RGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY 254
RGT+GY APE RN+ IT K DVYS+GVMLLEIVCC+K VD +D ++LI+WA+ C+
Sbjct: 694 RGTKGYVAPEWF-RNSPITSKVDVYSYGVMLLEIVCCKKAVD---LEDNVILINWAYDCF 749
Query: 255 EAGELQNLVSDQEDV--NIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV----PP 308
G L++L D + ++E E VKI +WC++ E +RP M+ V M+EG++ PP
Sbjct: 750 RQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPP 809
Query: 309 HQNMLTHPTSTNQEKST 325
+ + + T +++ S+
Sbjct: 810 NPSPYSTFTWSDESLSS 826
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 128/289 (44%), Positives = 193/289 (66%), Gaps = 8/289 (2%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIG 84
F+Y+ + A+ NF ++G+GG G VY+G + G +AVKKL + + +G+ EFR E+ IIG
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKL-EGIGQGKKEFRAEVSIIG 541
Query: 85 RIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIME 141
IHH +LV L GFC+EG++RLL YEF+ GSL +FR + L W R IAL +
Sbjct: 542 SIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAK 601
Query: 142 GLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYT 201
GL YLH++C+ RI+HCDIKP NIL+D+++ AK+SDFGL+KL+ +Q+ +T +RGTRGY
Sbjct: 602 GLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYL 661
Query: 202 APELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261
APE + N I+ K+DVYS+G++LLE++ RKN D S ++ +A + E G+L +
Sbjct: 662 APEWIT-NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMD 720
Query: 262 LVSDQE---DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307
+V + DV E + +K LWC++ ++ RP+M +V+ M+EG+ P
Sbjct: 721 IVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFP 769
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 130/289 (44%), Positives = 191/289 (66%), Gaps = 9/289 (3%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIG 84
F+Y+++ +++FKE++G GG G VY+G + +AVK+L + +E+GE +FR E+ I
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQL-EGIEQGEKQFRMEVATIS 532
Query: 85 RIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSERRRIALEIMEG 142
HH NLV L+GFCS+G +RLLVYEFMRNGSL N LF + L+W R IAL +G
Sbjct: 533 STHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKG 592
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYT 201
+ YLH+EC I+HCDIKP NIL+D+++ AK+SDFGL+KLL R + +RGTRGY
Sbjct: 593 ITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYL 652
Query: 202 APELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE--- 258
APE + N IT K+DVYS+G++LLE+V ++N D S + + WA++ +E G
Sbjct: 653 APEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKA 711
Query: 259 -LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306
L +S+ + V++E+ +VK WC++ + RPTM +V+ M+EGI
Sbjct: 712 ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGIT 760
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 129/295 (43%), Positives = 185/295 (62%), Gaps = 11/295 (3%)
Query: 24 SFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKII 83
SF+Y + + NF + +G GG G VYKG + G +AVK+L + + GE EF E+ I
Sbjct: 519 SFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTI 578
Query: 84 GRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR---LSWSERRRIALEIM 140
G +HH NLV L G+CSE S+RLLVYE+M NGSL +F +EQ L W R IA+
Sbjct: 579 GSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATA 638
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
+G+ Y H++C RIIHCDIKP NIL+D+++ K+SDFGL+K++ + + T++RGTRGY
Sbjct: 639 QGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGY 698
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260
APE S N ITVKADVYS+G++LLEIV R+N+D S ++ WA++ G
Sbjct: 699 LAPEWVS-NRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTSL 757
Query: 261 NLVSD--QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI-----VPP 308
V Q EE +K+ WC++ E+++RP+M +V+ ++EG +PP
Sbjct: 758 KAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 135/298 (45%), Positives = 192/298 (64%), Gaps = 13/298 (4%)
Query: 22 LRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMK 81
L +FSY ++ A++NF +++G GG G V+KG + +IAVK+L + + +GE +FR E+
Sbjct: 480 LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGISQGEKQFRTEVV 538
Query: 82 IIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF--RAEQR--LSWSERRRIAL 137
IG I H NLV L GFCSEGS +LLVY++M NGSL + LF + E++ L W R +IAL
Sbjct: 539 TIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIAL 598
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGT 197
GL YLHDEC IIHCDIKP NIL+D + K++DFGL+KL+ D +R T +RGT
Sbjct: 599 GTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGT 658
Query: 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY-EA 256
RGY APE S IT KADVYS+G+ML E+V R+N ++S + WA +
Sbjct: 659 RGYLAPEWIS-GVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKD 717
Query: 257 GELQNLVSDQ---EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV---PP 308
G++++LV + + V+IEE K+ WC++ E + RP M QV+ ++EG++ PP
Sbjct: 718 GDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPP 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 236 bits (603), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 141/330 (42%), Positives = 182/330 (55%), Gaps = 32/330 (9%)
Query: 9 RQVSSPDVFEEIKLRSF---------SYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE 59
+QV+ P FE L SF +E++ A+ENFK +IG GG G VYKG +
Sbjct: 480 KQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETL 539
Query: 60 IAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNL 119
IAVKK+ G EF E+ IIG I H NLV L GFC+ G LLVYE+M +GSL
Sbjct: 540 IAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKT 599
Query: 120 LFRAEQR-LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFG 178
LF L W ER IAL GL YLH C+ +IIHCD+KP NIL+ + ++ KISDFG
Sbjct: 600 LFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFG 659
Query: 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDES 238
LSKLL +++ +T +RGTRGY APE + N I+ KADVYS+G++LLE+V RKN
Sbjct: 660 LSKLLNQEESSLFTTMRGTRGYLAPEWIT-NAAISEKADVYSYGMVLLELVSGRKNCSFR 718
Query: 239 LRDDEIV-------------------LIDWAHQCYEAGELQNLVSDQED--VNIEEFENL 277
R + + +A +E G L + + V +E E L
Sbjct: 719 SRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKL 778
Query: 278 VKIGLWCVECELNLRPTMKQVIWMMEGIVP 307
V+I L CV E LRPTM V+ M EG +P
Sbjct: 779 VRIALCCVHEEPALRPTMAAVVGMFEGSIP 808
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 232 bits (592), Expect = 2e-60, Method: Compositional matrix adjust.
Identities = 127/301 (42%), Positives = 177/301 (58%), Gaps = 12/301 (3%)
Query: 15 DVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGES 74
D F + L+ FS++++ A+ F +++G GG G V+KG + G K ++ GES
Sbjct: 441 DGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGES 500
Query: 75 EFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRL-SWSERR 133
EFR E+ IG I H NLV L GFCSE +RLLVY++M GSL + L R +L SW R
Sbjct: 501 EFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRF 560
Query: 134 RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193
RIAL +G+ YLH+ C IIHCDIKP NIL+D + AK+SDFGL+KLL D +R
Sbjct: 561 RIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLAT 620
Query: 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV---DESLRDDEIVLIDWA 250
+RGT GY APE S IT KADVYSFG+ LLE++ R+NV ++L + E W
Sbjct: 621 MRGTWGYVAPEWIS-GLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWF 679
Query: 251 HQCYEA-----GELQNLVSDQ--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303
+ A G + ++V + + N EE + + +WC++ +RP M V+ M+E
Sbjct: 680 FPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLE 739
Query: 304 G 304
G
Sbjct: 740 G 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 223 bits (569), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 128/293 (43%), Positives = 171/293 (58%), Gaps = 8/293 (2%)
Query: 19 EIKLRSFSYEQIVLASENF--KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEF 76
E+ + SFS QI +A+ NF IG GG G VYKG + G IAVK+L ++G EF
Sbjct: 606 ELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREF 665
Query: 77 RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQ---RLSWSERR 133
NE+ +I +HH NLV L G C EG LLVYEF+ N SL LF ++ RL W RR
Sbjct: 666 LNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRR 725
Query: 134 RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193
+I + + GL YLH+E +I+H DIK N+L+D+ KISDFGL+KL + D T T
Sbjct: 726 KICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTR 785
Query: 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253
+ GT GY APE R + +T KADVYSFG++ LEIV R N E +++ LIDW
Sbjct: 786 IAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVL 844
Query: 254 YEAGELQNLVSDQ--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304
E L LV + + N EE +++I + C E RP+M +V+ M+EG
Sbjct: 845 REKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEG 897
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 122/292 (41%), Positives = 176/292 (60%), Gaps = 5/292 (1%)
Query: 19 EIKLRSFSYEQIVLASENF--KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEF 76
++K +F+Y ++ A+++F ++G GG G VYKG +N G+E+AVK L +G+ +F
Sbjct: 675 DVKPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQF 734
Query: 77 RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQ-RLSWSERRRI 135
E+ I + H+NLV L G C EG +RLLVYE++ NGSL LF + L WS R I
Sbjct: 735 VAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEI 794
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195
L + GL YLH+E RI+H D+K NIL+D K+SDFGL+KL +T T +
Sbjct: 795 CLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVA 854
Query: 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255
GT GY APE R + +T K DVY+FGV+ LE+V R N DE+L D++ L++WA +E
Sbjct: 855 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHE 913
Query: 256 AGELQNLVSDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306
G L+ Q + N+EE + ++ I L C + LRP M +V+ M+ G V
Sbjct: 914 KGREVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDV 965
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 127/307 (41%), Positives = 179/307 (58%), Gaps = 10/307 (3%)
Query: 19 EIKLRSFSYEQIVLASENF--KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEF 76
+++ +F+ QI A++NF +IG GG G VYKG ++ GK IAVK+L +G EF
Sbjct: 660 DLQTGTFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREF 719
Query: 77 RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQ----RLSWSER 132
NE+ +I + H NLV L G C EG+ +LVYE++ N L LF ++ +L WS R
Sbjct: 720 VNEIGMISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTR 779
Query: 133 RRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192
++I L I +GL +LH+E +I+H DIK N+L+D+ AKISDFGL+KL T T
Sbjct: 780 KKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHIST 839
Query: 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQ 252
+ GT GY APE R +T KADVYSFGV+ LEIV + N + +D + L+DWA+
Sbjct: 840 RIAGTIGYMAPEYAMR-GYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYV 898
Query: 253 CYEAGELQNLVSD--QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQ 310
E G L LV D + EE ++ + L C LRPTM QV+ ++EG Q
Sbjct: 899 LQERGSLLELVDPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKT-AMQ 957
Query: 311 NMLTHPT 317
+L+ P+
Sbjct: 958 ELLSDPS 964
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | ||||||
| 255585429 | 787 | serine-threonine protein kinase, plant-t | 0.947 | 0.391 | 0.651 | 1e-119 | |
| 359493028 | 815 | PREDICTED: G-type lectin S-receptor-like | 0.907 | 0.361 | 0.554 | 3e-96 | |
| 359477044 | 768 | PREDICTED: G-type lectin S-receptor-like | 0.938 | 0.397 | 0.565 | 7e-96 | |
| 359477040 | 774 | PREDICTED: G-type lectin S-receptor-like | 0.938 | 0.394 | 0.559 | 4e-95 | |
| 225431565 | 791 | PREDICTED: G-type lectin S-receptor-like | 0.913 | 0.375 | 0.553 | 5e-94 | |
| 359477052 | 767 | PREDICTED: G-type lectin S-receptor-like | 0.907 | 0.384 | 0.556 | 8e-94 | |
| 357478045 | 928 | Kinase-like protein [Medicago truncatula | 0.932 | 0.326 | 0.549 | 2e-92 | |
| 356546166 | 810 | PREDICTED: G-type lectin S-receptor-like | 0.904 | 0.362 | 0.562 | 7e-92 | |
| 224078930 | 488 | predicted protein [Populus trichocarpa] | 0.941 | 0.627 | 0.548 | 7e-92 | |
| 359477048 | 792 | PREDICTED: G-type lectin S-receptor-like | 0.953 | 0.391 | 0.548 | 9e-92 |
| >gi|255585429|ref|XP_002533409.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526754|gb|EEF28982.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1116), Expect = e-119, Method: Compositional matrix adjust.
Identities = 206/316 (65%), Positives = 251/316 (79%), Gaps = 8/316 (2%)
Query: 1 MWSYKIISRQVS-SPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN---G 56
+W YKI + Q + E+I LRSFSY+Q+V A+++F++EIG+G SG+VYKG + G
Sbjct: 465 IWRYKINTGQACHDQSIAEDINLRSFSYDQLVAATDDFRDEIGKGASGKVYKGSLGENGG 524
Query: 57 GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116
GKEIAVK+L K+VE+GE EFRNEMKIIGR HHKNLV L+GFCSEGSNRLLVYEFM+NGSL
Sbjct: 525 GKEIAVKRLEKMVEDGEREFRNEMKIIGRTHHKNLVHLIGFCSEGSNRLLVYEFMKNGSL 584
Query: 117 GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISD 176
NLLF + R SW ER RI L+I +GLHYLH+ECET+IIHCDIKPHN+LMDES AKISD
Sbjct: 585 ENLLFNTQNRPSWKERMRIVLDIAKGLHYLHEECETKIIHCDIKPHNVLMDESHSAKISD 644
Query: 177 FGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVD 236
FGLSKLLK DQTRTYT+ RGTRGY APE H N IT KADVYSFG++LLE +CCRKN D
Sbjct: 645 FGLSKLLKPDQTRTYTIPRGTRGYGAPEWHKNNTPITTKADVYSFGILLLETICCRKNFD 704
Query: 237 ESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMK 296
+ + I+L+DW ++CYE GEL N+V DQ ++++ E E +VKIGLWCV+ E+N RPTMK
Sbjct: 705 LTAPSEAIILMDWVYRCYEDGELGNVVGDQAELDLGELEKMVKIGLWCVQTEVNSRPTMK 764
Query: 297 QVIWMMEGIV----PP 308
+VI MMEG + PP
Sbjct: 765 EVILMMEGTIVTASPP 780
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493028|ref|XP_002264274.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 357 bits (917), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 167/301 (55%), Positives = 230/301 (76%), Gaps = 6/301 (1%)
Query: 18 EEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFR 77
E++ LR F+Y ++ A+ F++E+G+G G V+KG I+ GK +A+K+L K++ EGE EF+
Sbjct: 509 EDVALRPFTYHELEKATNGFRDEVGKGAFGTVFKGAISNGKTVAIKRLEKMMAEGEWEFQ 568
Query: 78 NEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIAL 137
NEMK IGR HHKNLV L+G+C +GSNRLLVYE+M NGSL + LF++E++ W ER IAL
Sbjct: 569 NEMKSIGRTHHKNLVRLLGYCHDGSNRLLVYEYMTNGSLADFLFKSERKPIWEERIEIAL 628
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGT 197
+ G+ YLH+ECET+IIHCDIKP NILMDE AKI+DFGL+KLL +QTRTYT +RGT
Sbjct: 629 SVARGILYLHEECETQIIHCDIKPENILMDEKGCAKIADFGLAKLLMPNQTRTYTGIRGT 688
Query: 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257
RGY APE H RN ITVKADVYSFG+ML+EI+CCR+++D + ++E+VL+D+ + C+EA
Sbjct: 689 RGYVAPEWH-RNLPITVKADVYSFGIMLMEIICCRRSLDMDVSENEVVLVDYVYDCFEAR 747
Query: 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV----PPHQNML 313
EL LV D+E V+ + + +VK+GLWC++ E ++RP MK+V+ MMEG V PP +
Sbjct: 748 ELDKLVRDEE-VDGMKLQRMVKVGLWCIQDEPSVRPLMKKVVLMMEGTVDIPAPPRASFA 806
Query: 314 T 314
+
Sbjct: 807 S 807
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477044|ref|XP_002275760.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 356 bits (914), Expect = 7e-96, Method: Compositional matrix adjust.
Identities = 177/313 (56%), Positives = 233/313 (74%), Gaps = 8/313 (2%)
Query: 1 MWSYKIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEI 60
+W+YK IS + + + E + LRSF+Y ++ + FKEEIG+G SG VYKG I+ + I
Sbjct: 450 LWAYKKIS-ETGNVGLTEGVALRSFTYMELEKVTNGFKEEIGKGASGTVYKGAISNSQRI 508
Query: 61 -AVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNL 119
AVKKL K++ EG+ EF+NE+K+IGR HH+NLV L+G+C EG NRLLVYE+M NGSL +L
Sbjct: 509 VAVKKLEKVLAEGQREFQNELKVIGRTHHRNLVRLLGYCLEGPNRLLVYEYMSNGSLADL 568
Query: 120 LFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
LF ++ W ER IAL + G+ YLH+ECET+IIHCDIKP NILMDE +AKISDFGL
Sbjct: 569 LFTPGKQPCWIERMGIALNVARGVLYLHEECETQIIHCDIKPQNILMDEYKRAKISDFGL 628
Query: 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESL 239
+KLL DQT T+T +RGTRGY APE H R +TVKADVYS+G++LLE +CCRKNVD SL
Sbjct: 629 AKLLMHDQTNTFTGIRGTRGYVAPEWH-RKLPVTVKADVYSYGIVLLETICCRKNVDWSL 687
Query: 240 RDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
++E +L +W + C+EAGEL LV D+E V+ + E +VK+GLWC+ E +LRP+MK+V+
Sbjct: 688 PEEEAILEEWVYHCFEAGELGKLVGDEE-VDKRQLERMVKVGLWCILDEPSLRPSMKKVL 746
Query: 300 WMMEGI----VPP 308
M+EG VPP
Sbjct: 747 LMLEGTVDIPVPP 759
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477040|ref|XP_002275651.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 353 bits (907), Expect = 4e-95, Method: Compositional matrix adjust.
Identities = 175/313 (55%), Positives = 233/313 (74%), Gaps = 8/313 (2%)
Query: 1 MWSYKIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEI 60
+W+YK IS V+ ++ E++ LRSF+Y ++ + F EEIG+G SG VYKG + G+ I
Sbjct: 456 LWAYKKISETVNV-ELTEDVALRSFTYMELEKVTNGFMEEIGKGASGTVYKGATSNGQRI 514
Query: 61 -AVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNL 119
AVKKL K++ EGE EF+NE+K+IGR HH+NLV L+G+C +G NRLLVYE+M NGSL +
Sbjct: 515 VAVKKLEKVLAEGEIEFQNELKVIGRTHHRNLVRLLGYCLDGPNRLLVYEYMSNGSLADW 574
Query: 120 LFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
LF ++ WSER IAL + G+ YLH+ECET IIHCDIKP NILMDE AKISDFGL
Sbjct: 575 LFTPGKQPRWSERMGIALNVARGILYLHEECETCIIHCDIKPQNILMDEYRCAKISDFGL 634
Query: 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESL 239
+KLL DQT T T +RGTRGY APE H R ++VKADVYS+G++LLE +CCR+NVD SL
Sbjct: 635 AKLLMHDQTNTSTGIRGTRGYVAPEWH-RKQPVSVKADVYSYGIVLLETICCRRNVDWSL 693
Query: 240 RDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
D+E++L +W +QC+EAGEL LV D+E V+ + + +VK+GLWC+ + +LRP+MK+V+
Sbjct: 694 PDEEVILEEWVYQCFEAGELGKLVGDEE-VDRRQLDMMVKVGLWCILDDPSLRPSMKKVL 752
Query: 300 WMMEGI----VPP 308
M+EG VPP
Sbjct: 753 LMLEGTVDIPVPP 765
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431565|ref|XP_002276127.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 350 bits (898), Expect = 5e-94, Method: Compositional matrix adjust.
Identities = 172/311 (55%), Positives = 237/311 (76%), Gaps = 14/311 (4%)
Query: 16 VFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE-IAVKKLIKIVEEGES 74
+ EE+K++SFSY+++ AS NFKEE+G+G G VY G ++ GK+ +A+K+L K+VEEGE
Sbjct: 488 LMEELKMQSFSYKELQKASRNFKEELGKGAFGTVYLGVLHKGKKLVAIKRLEKMVEEGER 547
Query: 75 EFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRR 134
EFR EM+ IGR HHKNLV L+G+C+EGS RLLVYE+M N SL ++LF+++ R W ER R
Sbjct: 548 EFRAEMRAIGRTHHKNLVRLLGYCTEGSKRLLVYEYMSNRSLADILFKSKTRPPWDERVR 607
Query: 135 IALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL 194
IAL++ G+ YLH+ECE IIHCDIKP NILMD+ W AKISDFGL+KLL DQTRT+T +
Sbjct: 608 IALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKISDFGLAKLLMPDQTRTFTGV 667
Query: 195 RGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESL-RDDEIVLIDWAHQC 253
RGTRGY APE +N I+VKADVYS+G++LLE+VCCR+N++ ++ + +EIVL +WA++C
Sbjct: 668 RGTRGYLAPEWQ-QNIPISVKADVYSYGIVLLELVCCRRNLEVNVSKPEEIVLSNWAYKC 726
Query: 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI----VPPH 309
+ AGEL L+ +E V + E +VK+GLWC++ E LRP++K ++ M+EGI VPP
Sbjct: 727 FVAGELYKLLGGEE-VERKSLEEMVKLGLWCIQDEPALRPSIKSIVLMLEGITEIAVPP- 784
Query: 310 QNMLTHPTSTN 320
PT+T+
Sbjct: 785 -----CPTTTS 790
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477052|ref|XP_002276297.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 349 bits (896), Expect = 8e-94, Method: Compositional matrix adjust.
Identities = 172/309 (55%), Positives = 235/309 (76%), Gaps = 14/309 (4%)
Query: 18 EEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE-IAVKKLIKIVEEGESEF 76
EE+K++SFSY+++ AS NFKEE+G+G G VY G + GK+ +A+K+L K+VEEGE EF
Sbjct: 466 EELKMQSFSYKELQKASRNFKEELGKGAFGTVYLGVLQQGKKLVAIKRLEKMVEEGEREF 525
Query: 77 RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIA 136
R EM+ IGR HHKNLV L+G+C+EGS RLLVYE+M N SL ++LF+++ R W ER RIA
Sbjct: 526 RAEMRAIGRTHHKNLVRLLGYCTEGSRRLLVYEYMSNRSLADILFKSKTRPPWDERVRIA 585
Query: 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG 196
L++ G+ YLH+ECE IIHCDIKP NILMD+ W AKISDFGL+KLL DQTRT+T +RG
Sbjct: 586 LDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKISDFGLAKLLMPDQTRTFTGVRG 645
Query: 197 TRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD-DEIVLIDWAHQCYE 255
TRGY APE +N I+VKADVYS+G++LLE+VCCR+N++ ++ + +EIVL +WA++C+
Sbjct: 646 TRGYLAPEWQ-QNIPISVKADVYSYGIVLLELVCCRRNLEVNVSEPEEIVLSNWAYKCFV 704
Query: 256 AGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI----VPPHQN 311
AGEL L+ +E V + E +VK+GLWC++ E LRP++K ++ M+EGI VPP
Sbjct: 705 AGELHKLLGGEE-VERKSLEQMVKLGLWCIQDEPALRPSIKSIVLMLEGITEIAVPP--- 760
Query: 312 MLTHPTSTN 320
PT+T+
Sbjct: 761 ---CPTTTS 766
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357478045|ref|XP_003609308.1| Kinase-like protein [Medicago truncatula] gi|357478091|ref|XP_003609331.1| Kinase-like protein [Medicago truncatula] gi|355510363|gb|AES91505.1| Kinase-like protein [Medicago truncatula] gi|355510386|gb|AES91528.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 345 bits (884), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 171/311 (54%), Positives = 229/311 (73%), Gaps = 8/311 (2%)
Query: 4 YKIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE-IAV 62
YK ++ V+ ++ LR F+Y ++ A+ NFKEE+G+G G+VYKG +N GK IAV
Sbjct: 495 YKRLTETVNFGGQNADLALRRFTYNELRRATNNFKEELGKGAFGKVYKGALNKGKRLIAV 554
Query: 63 KKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR 122
K+L K+VE+GE EF+ E++ IG+ HH+NLV L+GFC EGS RLLVYE+M NGSL LLF
Sbjct: 555 KRLEKVVEDGEREFQAEVRSIGKTHHRNLVRLLGFCHEGSKRLLVYEYMSNGSLEKLLFG 614
Query: 123 AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182
++R W ER R+AL+I G+ YLH+ECE IIHCDIKP NILMDE W AKISDFGL+KL
Sbjct: 615 DQRRPDWDERVRMALDIARGISYLHEECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 674
Query: 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDES-LRD 241
L DQTRT+TV+RGTRGY APE + N I++KADVYS+G+ML EI+CCR+N+D + L
Sbjct: 675 LMPDQTRTFTVVRGTRGYMAPEWN-MNVPISLKADVYSYGIMLFEILCCRRNLDVNVLEP 733
Query: 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301
+EI+L WA++C AG++ NLV E ++ EN+VK+ LWC++ + LRPTMK V+ M
Sbjct: 734 EEILLSGWAYKCLVAGQVNNLVP-WEVIDNNVMENMVKVALWCIQDDPFLRPTMKGVVLM 792
Query: 302 MEGI----VPP 308
+EG+ +PP
Sbjct: 793 LEGVTDIAIPP 803
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546166|ref|XP_003541502.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 343 bits (880), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 170/302 (56%), Positives = 221/302 (73%), Gaps = 8/302 (2%)
Query: 18 EEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE-IAVKKLIKIVEEGESEF 76
EE+ L+ FSY ++ A+ NFK+++GRG G VYKG +N G+ IAVK+L K+VEEGE EF
Sbjct: 505 EELTLKRFSYSELKRATNNFKQKLGRGSFGAVYKGGLNKGRRLIAVKRLEKLVEEGEREF 564
Query: 77 RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE--QRLSWSERRR 134
+ EM+ IG+ HH+NLV L+GFC+EGS RLLVYE+M NGSL NL+F A+ +R W ER R
Sbjct: 565 QAEMRAIGKTHHRNLVRLLGFCAEGSKRLLVYEYMPNGSLENLIFGAQSQRRPGWDERVR 624
Query: 135 IALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL 194
IALEI +G+ YLH+ECE IIHCDIKP NILMDE W AKISDFGL+KLL DQTRT T
Sbjct: 625 IALEIAKGILYLHEECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTITGA 684
Query: 195 RGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI-DWAHQC 253
RGTRGY APE N I+VK DVYS+G++LLEI+CCR+N++ + + E L+ +WA++C
Sbjct: 685 RGTRGYVAPEWDKLNIPISVKVDVYSYGIVLLEILCCRRNIEVHVSEPEAALLSNWAYKC 744
Query: 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI----VPPH 309
+ +G+L L + N EN+VK+ LWC++ E LRPTMK V+ M+EGI +PP
Sbjct: 745 FVSGQLNKLFLWESVDNKTSVENIVKVALWCIQDEPFLRPTMKSVVLMLEGITDIAIPPC 804
Query: 310 QN 311
N
Sbjct: 805 PN 806
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224078930|ref|XP_002335729.1| predicted protein [Populus trichocarpa] gi|222834660|gb|EEE73123.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 343 bits (879), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 174/317 (54%), Positives = 233/317 (73%), Gaps = 11/317 (3%)
Query: 1 MWSYKIIS-RQVSSPD---VFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCING 56
++ Y +++ ++V S D + EE R+F+Y ++ + FKEEIGRG G VYKG I+
Sbjct: 165 IYRYHVLAYKKVPSNDSTGLNEEFAPRAFTYAELENVTGGFKEEIGRGSFGTVYKGIISS 224
Query: 57 G-KEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGS 115
K +AVK+L K++ EGE EF+NEMK+IG+ HH+NLV L+G+C +G +RLLVYE+M NGS
Sbjct: 225 NQKVVAVKRLEKVLAEGEREFQNEMKVIGKTHHRNLVRLLGYCHDGHHRLLVYEYMSNGS 284
Query: 116 LGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175
L ++LF E+R + ER IA I G+ YLH+ECET+IIHCDIKP NIL+DES K+S
Sbjct: 285 LADILFSLEKRPCFPERLEIARNIARGIVYLHEECETQIIHCDIKPQNILIDESRCPKVS 344
Query: 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV 235
DFGL+KLLK+DQT+T+T +RGTRGY APE H RN +TVKADVYSFGVMLLEI CCRKNV
Sbjct: 345 DFGLAKLLKSDQTKTFTGIRGTRGYVAPEWH-RNMPVTVKADVYSFGVMLLEITCCRKNV 403
Query: 236 DESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTM 295
D SL +DE VL W +QC++ G++ LV D E V ++ + +VK+G+WC E +LRP+M
Sbjct: 404 DWSLPEDEAVLEQWVYQCFQDGDMDKLVGD-EIVEKKQLDRMVKVGIWCTLDEPSLRPSM 462
Query: 296 KQVIWMMEGIV----PP 308
K+V+ M+EG V PP
Sbjct: 463 KKVLLMLEGTVEIPIPP 479
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477048|ref|XP_002275811.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 343 bits (879), Expect = 9e-92, Method: Compositional matrix adjust.
Identities = 175/319 (54%), Positives = 228/319 (71%), Gaps = 9/319 (2%)
Query: 1 MWSYKIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCI-NGGKE 59
+WSY+ +S +V+ EE L+SFSY+++ A++ F+EE+GRG G VYKG I K
Sbjct: 477 VWSYRQLSEEVNLGST-EEFTLQSFSYDELEKATDGFREELGRGCYGAVYKGTIERDNKV 535
Query: 60 IAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNL 119
+AVK+L K+VE+GE EF+ EM IG+ HH+NLV L+GFC EGS +LLVYEFMRNGSL +L
Sbjct: 536 VAVKRLEKVVEQGEKEFQAEMTAIGQTHHRNLVRLLGFCIEGSKKLLVYEFMRNGSLADL 595
Query: 120 LFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
LF AE+R W R RIALE+ G+ YLH+ECE++I+HCDIKP NILMD++W AKISDFG
Sbjct: 596 LFNAEKRSIWKVRVRIALELARGILYLHEECESQIVHCDIKPQNILMDDAWTAKISDFGF 655
Query: 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESL 239
SKLL +Q T +RGT GY+APE H +N I+VKAD+YSFGV+LLEIVCCR++++ +
Sbjct: 656 SKLLMPNQEGIVTGIRGTAGYSAPEWH-KNTLISVKADIYSFGVVLLEIVCCRRSIEVKV 714
Query: 240 RD-DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQV 298
DEI+L W + C A EL LV D E V + E +VK+GLWCV+ + LRP+MK V
Sbjct: 715 STADEIILSSWVYGCLVARELDKLVGD-EQVEFKSLERMVKVGLWCVQDDPALRPSMKNV 773
Query: 299 IWMMEGIV----PPHQNML 313
I M+EG V PP L
Sbjct: 774 ILMLEGTVDIPFPPSPTPL 792
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | ||||||
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.864 | 0.342 | 0.442 | 4.7e-64 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.858 | 0.336 | 0.451 | 1.1e-62 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.876 | 0.344 | 0.453 | 6.2e-62 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.732 | 0.272 | 0.473 | 1.5e-57 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.876 | 0.299 | 0.436 | 4.6e-56 | |
| TAIR|locus:2137154 | 648 | CRK38 "cysteine-rich RLK (RECE | 0.870 | 0.436 | 0.435 | 6.1e-55 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.876 | 0.272 | 0.417 | 1.1e-54 | |
| TAIR|locus:2033577 | 425 | AT1G70740 [Arabidopsis thalian | 0.889 | 0.68 | 0.384 | 2.1e-54 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.929 | 0.453 | 0.383 | 1.9e-53 | |
| TAIR|locus:2017647 | 885 | AT1G51820 [Arabidopsis thalian | 0.849 | 0.311 | 0.404 | 3.5e-53 |
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 128/289 (44%), Positives = 193/289 (66%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIG 84
F+Y+ + A+ NF ++G+GG G VY+G + G +AVKKL + + +G+ EFR E+ IIG
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKL-EGIGQGKKEFRAEVSIIG 541
Query: 85 RIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR---LSWSERRRIALEIME 141
IHH +LV L GFC+EG++RLL YEF+ GSL +FR + L W R IAL +
Sbjct: 542 SIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAK 601
Query: 142 GLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYT 201
GL YLH++C+ RI+HCDIKP NIL+D+++ AK+SDFGL+KL+ +Q+ +T +RGTRGY
Sbjct: 602 GLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYL 661
Query: 202 APELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261
APE + N I+ K+DVYS+G++LLE++ RKN D S ++ +A + E G+L +
Sbjct: 662 APEWIT-NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMD 720
Query: 262 LVSDQE---DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307
+V + DV E + +K LWC++ ++ RP+M +V+ M+EG+ P
Sbjct: 721 IVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFP 769
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 1.1e-62, P = 1.1e-62
Identities = 130/288 (45%), Positives = 191/288 (66%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIG 84
F+Y+++ +++FKE++G GG G VY+G + +AVK+L + +E+GE +FR E+ I
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQL-EGIEQGEKQFRMEVATIS 532
Query: 85 RIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSERRRIALEIMEG 142
HH NLV L+GFCS+G +RLLVYEFMRNGSL N LF + L+W R IAL +G
Sbjct: 533 STHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKG 592
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYT 201
+ YLH+EC I+HCDIKP NIL+D+++ AK+SDFGL+KLL R + +RGTRGY
Sbjct: 593 ITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYL 652
Query: 202 APELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE--- 258
APE + N IT K+DVYS+G++LLE+V ++N D S + + WA++ +E G
Sbjct: 653 APEWLA-NLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGNTKA 711
Query: 259 -LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
L +S+ + V++E+ +VK WC++ + RPTM +V+ M+EGI
Sbjct: 712 ILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGI 759
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 6.2e-62, P = 6.2e-62
Identities = 135/298 (45%), Positives = 192/298 (64%)
Query: 22 LRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMK 81
L +FSY ++ A++NF +++G GG G V+KG + +IAVK+L + + +GE +FR E+
Sbjct: 480 LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRL-EGISQGEKQFRTEVV 538
Query: 82 IIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF--RAEQR--LSWSERRRIAL 137
IG I H NLV L GFCSEGS +LLVY++M NGSL + LF + E++ L W R +IAL
Sbjct: 539 TIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIAL 598
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGT 197
GL YLHDEC IIHCDIKP NIL+D + K++DFGL+KL+ D +R T +RGT
Sbjct: 599 GTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGT 658
Query: 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY-EA 256
RGY APE S IT KADVYS+G+ML E+V R+N ++S + WA +
Sbjct: 659 RGYLAPEWIS-GVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKD 717
Query: 257 GELQNLVSDQ---EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV---PP 308
G++++LV + + V+IEE K+ WC++ E + RP M QV+ ++EG++ PP
Sbjct: 718 GDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPP 775
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 527 (190.6 bits), Expect = 1.5e-57, Sum P(2) = 1.5e-57
Identities = 118/249 (47%), Positives = 151/249 (60%)
Query: 6 IISRQVSSPDVFEEIKLRSF---------SYEQIVLASENFKEEIGRGGSGRVYKGCING 56
I +QV+ P FE L SF +E++ A+ENFK +IG GG G VYKG +
Sbjct: 477 IREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPD 536
Query: 57 GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116
IAVKK+ G EF E+ IIG I H NLV L GFC+ G LLVYE+M +GSL
Sbjct: 537 ETLIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSL 596
Query: 117 GNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175
LF L W ER IAL GL YLH C+ +IIHCD+KP NIL+ + ++ KIS
Sbjct: 597 EKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKIS 656
Query: 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV 235
DFGLSKLL +++ +T +RGTRGY APE + N I+ KADVYS+G++LLE+V RKN
Sbjct: 657 DFGLSKLLNQEESSLFTTMRGTRGYLAPEWIT-NAAISEKADVYSYGMVLLELVSGRKNC 715
Query: 236 DESLRDDEI 244
R + +
Sbjct: 716 SFRSRSNSV 724
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 4.6e-56, Sum P(2) = 4.6e-56
Identities = 128/293 (43%), Positives = 171/293 (58%)
Query: 19 EIKLRSFSYEQIVLASENFKE--EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEF 76
E+ + SFS QI +A+ NF IG GG G VYKG + G IAVK+L ++G EF
Sbjct: 606 ELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREF 665
Query: 77 RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQ---RLSWSERR 133
NE+ +I +HH NLV L G C EG LLVYEF+ N SL LF ++ RL W RR
Sbjct: 666 LNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRR 725
Query: 134 RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193
+I + + GL YLH+E +I+H DIK N+L+D+ KISDFGL+KL + D T T
Sbjct: 726 KICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTR 785
Query: 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253
+ GT GY APE R + +T KADVYSFG++ LEIV R N E +++ LIDW
Sbjct: 786 IAGTFGYMAPEYAMRGH-LTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVL 844
Query: 254 YEAGELQNLVSDQ--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304
E L LV + + N EE +++I + C E RP+M +V+ M+EG
Sbjct: 845 REKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEG 897
|
|
| TAIR|locus:2137154 CRK38 "cysteine-rich RLK (RECEPTOR-like protein kinase) 38" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 6.1e-55, P = 6.1e-55
Identities = 129/296 (43%), Positives = 184/296 (62%)
Query: 21 KLRSFSYEQIVLASENFKEE--IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN 78
KLR F + I+ A+++F E IG+GG G VYKG + GG+EIAVK+L + +GE EFRN
Sbjct: 324 KLR-FDFRMILTATDDFSFENKIGQGGFGSVYKGKLPGGEEIAVKRLTRGSGQGEIEFRN 382
Query: 79 EMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRL--SWSERRRIA 136
E+ ++ R+ H+NLV L+GFC+EG +LVYEF+ N SL + +F E+RL +W R RI
Sbjct: 383 EVLLLTRLQHRNLVKLLGFCNEGDEEILVYEFVPNSSLDHFIFDEEKRLLLTWDMRARII 442
Query: 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT-VLR 195
+ GL YLH++ + RIIH D+K NIL+D K++DFG+++L DQTR T +
Sbjct: 443 EGVARGLVYLHEDSQLRIIHRDLKASNILLDAYMNPKVADFGMARLFNMDQTRAVTRKVV 502
Query: 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255
GT GY APE + RN +VK DVYSFGV+LLE++ R N + + + L +A +C+
Sbjct: 503 GTFGYMAPE-YVRNRTFSVKTDVYSFGVVLLEMITGRSNKNYF---EALGLPAYAWKCWV 558
Query: 256 AGELQNLVSDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI-WM-MEGIVPP 308
AGE +++ E + IGL CV+ ++ RPTM VI W+ E I P
Sbjct: 559 AGEAASIIDHVLSRSRSNEIMRFIHIGLLCVQENVSKRPTMSLVIQWLGSETIAIP 614
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 1.1e-54, P = 1.1e-54
Identities = 121/290 (41%), Positives = 176/290 (60%)
Query: 19 EIKLRSFSYEQIVLASENF--KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEF 76
++K +F+Y ++ A+++F ++G GG G VYKG +N G+E+AVK+L +G+ +F
Sbjct: 692 DVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQF 751
Query: 77 RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQ-RLSWSERRRI 135
E+ I + H+NLV L G C EG +RLLVYE++ NGSL LF + L WS R I
Sbjct: 752 VAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHLDWSTRYEI 811
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195
L + GL YLH+E RIIH D+K NIL+D K+SDFGL+KL +T T +
Sbjct: 812 CLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVA 871
Query: 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255
GT GY APE R + +T K DVY+FGV+ LE+V RKN DE+L + + L++WA +E
Sbjct: 872 GTIGYLAPEYAMRGH-LTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHE 930
Query: 256 AGELQNLVSDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304
L+ D+ + N+EE + ++ I L C + LRP M +V+ M+ G
Sbjct: 931 KNRDVELIDDELSEYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAMLSG 980
|
|
| TAIR|locus:2033577 AT1G70740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 2.1e-54, P = 2.1e-54
Identities = 115/299 (38%), Positives = 192/299 (64%)
Query: 25 FSYEQIVLASENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKI 82
F ++ +V A+++F ++G GG G V+KG + G++IAVKKL ++ +G++EF NE K+
Sbjct: 50 FPFQVLVSATKDFHPTHKLGEGGFGPVFKGRLPDGRDIAVKKLSQVSRQGKNEFVNEAKL 109
Query: 83 IGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSERRRIALEIM 140
+ ++ H+N+V+L G+C+ G ++LLVYE++ N SL +LF++ ++ + W +R I I
Sbjct: 110 LAKVQHRNVVNLWGYCTHGDDKLLVYEYVVNESLDKVLFKSNRKSEIDWKQRFEIITGIA 169
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
GL YLH++ IIH DIK NIL+DE W KI+DFG+++L + D T T + GT GY
Sbjct: 170 RGLLYLHEDAPNCIIHRDIKAGNILLDEKWVPKIADFGMARLYQEDVTHVNTRVAGTNGY 229
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260
APE + + ++VKADV+SFGV++LE+V +KN S+R + L++WA + Y+ G
Sbjct: 230 MAPE-YVMHGVLSVKADVFSFGVLVLELVSGQKNSSFSMRHPDQTLLEWAFKLYKKGRTM 288
Query: 261 NLVSDQE---DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQNMLTHP 316
++ DQ+ + ++ + V+IGL CV+ + + RP+M++V ++ P H HP
Sbjct: 289 EIL-DQDIAASADPDQVKLCVQIGLLCVQGDPHQRPSMRRVSLLLSR-KPGHLEEPDHP 345
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 1.9e-53, P = 1.9e-53
Identities = 123/321 (38%), Positives = 187/321 (58%)
Query: 20 IKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNE 79
I L+ +SY Q+ +++F E IG+GG G VY+G + G+ +AVK L + GE +F NE
Sbjct: 333 IPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGE-DFINE 391
Query: 80 MKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSERRRIALE 138
+ + + H N+V L+GFCSEG R ++YEFM NGSL + + + W E IAL
Sbjct: 392 VASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKKSSTMDWRELYGIALG 451
Query: 139 IMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV-LRGT 197
+ GL YLH C TRI+H DIKP N+L+D++ K+SDFGL+KL + ++ + RGT
Sbjct: 452 VARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILSLMDTRGT 511
Query: 198 RGYTAPELHSR-NNRITVKADVYSFGVMLLEIVCCRKNV---DESLRDDEIVLIDWAHQC 253
GY APE+ SR R++ K+DVYS+G+++L+I+ R D + + +W ++
Sbjct: 512 IGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPEWIYRD 571
Query: 254 YEAGE----LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI---- 305
E ++ +S++ED E + + +GLWC++ RP M +V+ MMEG
Sbjct: 572 LEKAHNGKSIETAISNEED---EIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLDAL 628
Query: 306 -VPPHQNMLTHPTSTNQEKST 325
VPP + PT+T QE ST
Sbjct: 629 EVPPRPVLQQIPTATLQESST 649
|
|
| TAIR|locus:2017647 AT1G51820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 3.5e-53, P = 3.5e-53
Identities = 115/284 (40%), Positives = 174/284 (61%)
Query: 21 KLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEM 80
K R FSY Q+V+ + NF+ +G+GG G VY G +NG +++AVK L +G +F+ E+
Sbjct: 564 KNRRFSYSQVVIMTNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKQFKAEV 623
Query: 81 KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSERRRIALE 138
+++ R+HHKNLV LVG+C EG N L+YE+M NG L + R L+W R +I +E
Sbjct: 624 ELLLRVHHKNLVGLVGYCDEGDNLALIYEYMANGDLKEHMSGTRNRFILNWGTRLKIVIE 683
Query: 139 IMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQTRTYTVLRGT 197
+GL YLH+ C+ ++H D+K NIL++E ++AK++DFGLS+ L +T TV+ GT
Sbjct: 684 SAQGLEYLHNGCKPPMVHRDVKTTNILLNEHFEAKLADFGLSRSFLIEGETHVSTVVAGT 743
Query: 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257
GY PE H R N +T K+DVYSFG++LLEI+ R +D+S I +W G
Sbjct: 744 PGYLDPEYH-RTNWLTEKSDVYSFGILLLEIITNRHVIDQSREKPHIG--EWVGVMLTKG 800
Query: 258 ELQNLV--SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
++Q+++ S ED + V++ + C+ RPTM QV+
Sbjct: 801 DIQSIMDPSLNEDYDSGSVWKAVELAMSCLNHSSARRPTMSQVV 844
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 325 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-29 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-56
Identities = 75/196 (38%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNLVDLVGFC 98
+G GG G VY GK++A+K + K E E++I+ +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 99 SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158
+ ++ LV E+ GSL +LL E +LS E RI L+I+EGL YLH IIH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117
Query: 159 IKPHNILMDE-SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
+KP NIL+D + K K++DFGLSKLL T + GT Y APE+ + K+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 218 VYSFGVMLLEIVCCRK 233
++S GV+L E+ +
Sbjct: 177 IWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 2e-55
Identities = 85/265 (32%), Positives = 126/265 (47%), Gaps = 16/265 (6%)
Query: 37 FKEEIGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVD 93
++G G G VYK GK +AVK L K + + R E++I+ R+ H N+V
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L+ + + LV E+ G L + L LS E ++IAL+I+ GL YLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
IIH D+KP NIL+DE+ KI+DFGL+K L + T GT Y APE+ N
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFVGTPWYMAPEVLLGGNGYG 177
Query: 214 VKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273
K DV+S GV+L E++ + D++ LI G + EE
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLI-----RRILGPPLEFDEPKWSSGSEE 232
Query: 274 FENLVKIGLWCVECELNLRPTMKQV 298
++L+K + RPT +++
Sbjct: 233 AKDLIK-KCLNKDPS--KRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 1e-51
Identities = 66/198 (33%), Positives = 101/198 (51%), Gaps = 9/198 (4%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNLVDL 94
E++G G G+VY GK +A+K + K + + E E+KI+ ++ H N+V L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ LV E+ G L +LL + RLS E R +I+ L YLH + I
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSK---GI 118
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
+H D+KP NIL+DE K++DFGL++ L + T V GT Y APE+
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLG-KGYGK 175
Query: 215 KADVYSFGVMLLEIVCCR 232
D++S GV+L E++ +
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 7e-45
Identities = 74/202 (36%), Positives = 106/202 (52%), Gaps = 18/202 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGK-----EIAVKKLIKIVEEGE-SEFRNEMKIIGRIHHKN 90
+++G G G VYKG + G E+AVK L + E + EF E +I+ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V L+G C+E +V E+M G L + L + +LS S+ AL+I G+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPELHS 207
IH D+ N L+ E+ KISDFGLS+ L D Y RG + + APE S
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWMAPE--S 174
Query: 208 RNNRI-TVKADVYSFGVMLLEI 228
T K+DV+SFGV+L EI
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-44
Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKE-----IAVKKL-IKIVEEGESEFRNEMKIIGRIHHKN 90
+++G G G VYKG + G E +AVK L EE EF E I+ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V L+G C++G +V E+M G L + L + ++L+ + ++AL+I +G+ YL +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPELHS 207
+H D+ N L+ E+ KISDFGLS+ + D Y G + + APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD--YYRKRGGGKLPIKWMAPES-L 176
Query: 208 RNNRITVKADVYSFGVMLLEIVC 230
++ + T K+DV+SFGV+L EI
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 73/203 (35%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 37 FKEEIGRGGSGRVYKGCINGGK-----EIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKN 90
+++G G G VYKG + G E+AVK L + E+ EF E +I+ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGN-LLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
+V L+G C+E ++V E+M G L + L + LS S+ AL+I G+ YL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPELH 206
IH D+ N L+ E+ KISDFGLS+ L D Y ++G + + APE
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWMAPE-- 174
Query: 207 SRNNRI-TVKADVYSFGVMLLEI 228
S T K+DV+SFGV+L EI
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 67/195 (34%), Positives = 98/195 (50%), Gaps = 11/195 (5%)
Query: 39 EEIGRGGSGRVYKGCING-GKEIAVKK--LIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
E +GRG G VY G+ +AVK L EE E++I+ + H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 96 GFC-SEGSNRLLVY-EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
G E N L ++ E++ GSL +LL + +L R+ +I+EGL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQILEGLAYLHSN---G 121
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV-LRGTRGYTAPELHSRNNRI 212
I+H DIK NIL+D K++DFG +K L +T T +RGT + APE+ R
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRGEEY 180
Query: 213 TVKADVYSFGVMLLE 227
AD++S G ++E
Sbjct: 181 GRAADIWSLGCTVIE 195
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 39 EEIGRGGSGRVYKGCINGGK----EIAVKKLIKIVEEGE-SEFRNEMKIIGRIHHKNLVD 93
+++G G G VYKG + G E+AVK L + E E +F E +++ ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 94 LVGFCSEGSNRLLVYEFMRNGSL--------GNLLFRAEQRLSWSERRRIALEIMEGLHY 145
L+G C+E LV E+M G L + LS + A++I +G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTA 202
L + +H D+ N L+ E KISDFGLS+ Y G + + A
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR--DVYDDDYYRKKTGGKLPIRWMA 175
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PE ++ T K+DV+SFGV+L EI
Sbjct: 176 PES-LKDGIFTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 70/192 (36%), Positives = 101/192 (52%), Gaps = 9/192 (4%)
Query: 38 KEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEF-RNEMKIIGRIHHKNLVDLV 95
E+IG+GG G VYK GKE+A+K IK+ + + E NE++I+ + H N+V
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKV-IKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G + +V EF GSL +LL Q L+ S+ + E+++GL YLH II
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H DIK NIL+ + K+ DFGLS L + R V GT + APE+ K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEV-INGKPYDYK 177
Query: 216 ADVYSFGVMLLE 227
AD++S G+ +E
Sbjct: 178 ADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 73/201 (36%), Positives = 104/201 (51%), Gaps = 29/201 (14%)
Query: 40 EIGRGGSGRVYKGC-INGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVG 96
+G+G SG VYK GK A+KK I + EE + E+K + +V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKK-IHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 97 -FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDECETR 153
F EG + V E+M GSL +LL + + E IA +I++GL YLH +
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGK---IPEPVLAYIARQILKGLDYLHTK--RH 120
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKT--DQTRTYTVLRGTRGYTAPELHSRNNR 211
IIH DIKP N+L++ + KI+DFG+SK+L+ DQ T+ GT Y +PE R
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSPE------R 171
Query: 212 I-----TVKADVYSFGVMLLE 227
I + AD++S G+ LLE
Sbjct: 172 IQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (315), Expect = 3e-33
Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 23/279 (8%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE---FRNEMKIIGRI-HHKNL 91
++G G G VY K +A+K L K +E E F E++I+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQRLSWSERRRIALEIMEGLHYLHDE 149
V L F + + LV E++ GSL +LL + LS SE I +I+ L YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-- 118
Query: 150 CETRIIHCDIKPHNILMDE-SWKAKISDFGLSKLLKTDQTRT-----YTVLRGTRGYTAP 203
IIH DIKP NIL+D K+ DFGL+KLL + + + GT GY AP
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 204 ELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVD-ESLRDDEIVLIDWAHQCYEAGELQ 260
E+ + +D++S G+ L E++ + E + +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
L ++ + +L+K + + R + +
Sbjct: 238 PLSPSNPELISKAASDLLK---KLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 56/194 (28%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 37 FKEEIGRGGSGRVYKGC-INGGKEIAVKK--LIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
+ IGRG G VYKG + G +A+K+ L KI EE E+ ++ + H N+V
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
+G + ++ E+ NGSL ++ + S ++++GL YLH++
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQ---G 119
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
+IH DIK NIL + K++DFG++ L +V+ GT + APE+ + +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEV-IEMSGAS 177
Query: 214 VKADVYSFGVMLLE 227
+D++S G ++E
Sbjct: 178 TASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHK 89
I IG+G G V G G+++AVK L K F E ++ + H
Sbjct: 3 INSKELKLGATIGKGEFGDVMLG-DYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHP 60
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHD 148
NLV L+G +G+ +V E+M GSL + L R ++ +++ AL++ EG+ YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE- 119
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
E +H D+ N+L+ E AK+SDFGL+K + ++ + +TAPE R
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEA-LR 172
Query: 209 NNRITVKADVYSFGVMLLEI 228
+ + K+DV+SFG++L EI
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 62/195 (31%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 36 NFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDL 94
E+IG G SG VYK GKE+A+KK +++ ++ + NE+ I+ H N+VD
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKK-MRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
G +V E+M GSL +++ + R++ + + E+++GL YLH +
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNV 137
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
IH DIK NIL+ + K++DFG + L ++++ +V+ GT + APE+ R +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKD-YGP 195
Query: 215 KADVYSFGVMLLEIV 229
K D++S G+M +E+
Sbjct: 196 KVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 37 FKEEIGRGGSGRVYKGCI-----NGGKEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHKN 90
F +++G G G+V N G+++AVK L E+ S+F E++I+ + H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 91 LVDLVGFCSE--GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
+V G C + G + L+ E++ +GSL + L R +++ + +I +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG----YTAPE 204
+ R IH D+ NIL++ KISDFGL+K+L D + Y ++ + APE
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED--KDYYYVKEPGESPIFWYAPE 182
Query: 205 LHSRNNRITVKADVYSFGVMLLEIVC-CRKN 234
R ++ + +DV+SFGV L E+ +
Sbjct: 183 C-LRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 34 SENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
S ++G G G V++G N +AVK L K +F E +I+ ++ H L+
Sbjct: 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQ 65
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECET 152
L C+ +V E M+ GSL L R L + +A ++ G+ YL
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQ 122
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRN 209
IH D+ N+L+ E+ K++DFGL++++K D Y G + +TAPE +
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEA-ALY 178
Query: 210 NRITVKADVYSFGVMLLEIV 229
NR ++K+DV+SFG++L EIV
Sbjct: 179 NRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 71/199 (35%), Positives = 107/199 (53%), Gaps = 18/199 (9%)
Query: 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE---SEFRNEMKIIGRIHHKNLVDL 94
+ ++G G G V+ G NG ++AVK L + G F E +I+ ++ H LV L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETR 153
CSE +V E+M GSL + L E + L + +A +I EG+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRN 123
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNN 210
IH D+ NIL+ E+ KI+DFGL++L++ D+ YT G + +TAPE +
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEA-ANYG 179
Query: 211 RITVKADVYSFGVMLLEIV 229
R T+K+DV+SFG++L EIV
Sbjct: 180 RFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 7e-29
Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 9/169 (5%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKL-IKIVEEG--ESEFRNEMKIIGRIHHKNLVDLVG 96
IG G G V+K G+ +A+KK+ ++ +E G R E+K + H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
GS +LV E+M L +L E+ L ++ + +++G+ Y+H I+H
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
D+KP N+L+ KI+DFGL++L ++ R Y+ TR Y APEL
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 2e-28
Identities = 71/196 (36%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIK--IVEEGESEF-RNEMKIIGRIHHKNLVDLV- 95
+G+G G+V GK A+K L K I++ E E E I+ RI+H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
F +E +L LV E+ G L + L E R S R A EI+ L YLH I
Sbjct: 61 AFQTE--EKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLALEYLHSL---GI 114
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
I+ D+KP NIL+D K++DFGL+K L ++ +RT T GT Y APE+
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLG-KGYGK 172
Query: 215 KADVYSFGVMLLEIVC 230
D +S GV+L E++
Sbjct: 173 AVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 69/215 (32%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG---ESEFRNEMKIIGRIHHKNLVD 93
F +E+G G G V+ G G ++A IK++ EG E +F E K++ ++ H NLV
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVA----IKMIREGAMSEDDFIEEAKVMMKLSHPNLVQ 63
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L G C++ +V E+M NG L N L + +L + ++ E + YL
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--- 120
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNN 210
IH D+ N L+ E K+SDFGL++ + DQ YT +GT+ + PE+ +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDY-S 176
Query: 211 RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245
R + K+DV+SFGV++ E+ K E + E+V
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-28
Identities = 69/215 (32%), Positives = 114/215 (53%), Gaps = 17/215 (7%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG---ESEFRNEMKIIGRIHHKNLVD 93
+EIG G G V+ G +++A IK + EG E +F E +++ ++ H LV
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVA----IKTIREGAMSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L G C+E S LV+EFM +G L + L + S + L++ EG+ YL
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNN 210
+IH D+ N L+ E+ K+SDFG+++ + DQ YT GT+ +++PE+ S +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWSSPEVFSFSK 177
Query: 211 RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245
+ K+DV+SFGV++ E+ K E+ + E+V
Sbjct: 178 YSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 59/192 (30%), Positives = 100/192 (52%), Gaps = 6/192 (3%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFC 98
++G G G V++G +A+K L + +F+ E++ + R+ HK+L+ L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 99 SEGSNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETRIIHC 157
S G ++ E M GSL L E + L + +A ++ EG+ YL ++ IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHR 128
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
D+ NIL+ E K++DFGL++L+K D + + +TAPE S + K+D
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-WTAPEAASH-GTFSTKSD 186
Query: 218 VYSFGVMLLEIV 229
V+SFG++L E+
Sbjct: 187 VWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 1e-27
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFR---NEMKIIGRIHHKNLVDL 94
++IG+G G+VY ++ V K I + E E NE+KI+ +++H N++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 95 VGFCSEGSNRLLVYEFMRNGSLG---------NLLFRAEQRLSWSERRRIALEIMEGLHY 145
E +V E+ G L F EQ L W +++ L Y
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF------VQLCLALKY 118
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
LH +I+H DIKP NI + + K+ DFG+SK+L + TV+ GT Y +PEL
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPEL 174
Query: 206 HSRNNRITVKADVYSFGVMLLEIVCCRK 233
+N K+D++S G +L E+ +
Sbjct: 175 -CQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN----EMKIIGRIHHKNLVDLV 95
E+G G SG V K +I K I++ E + E+ I+ + + +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G + + E+M GSL +L + R+ +IA+ +++GL YLH++ +II
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKII 123
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI--- 212
H D+KP NIL++ + K+ DFG+S L +T+ GT Y APE RI
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPE------RIQGN 174
Query: 213 --TVKADVYSFGVMLLEIV 229
+VK+D++S G+ L+E+
Sbjct: 175 DYSVKSDIWSLGLSLIELA 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 22/292 (7%)
Query: 17 FEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE 75
F+ +S + I L+S + I RG G YKG I G + VK++ + SE
Sbjct: 675 FDSKVSKSITINDI-LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 76 FRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI 135
+ +G++ H N+V L+G C L++E++ +L +L + LSW RR+I
Sbjct: 734 IAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKI 785
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195
A+ I + L +LH C ++ ++ P I++D + + L LL TD
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI---- 840
Query: 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255
+ Y APE + IT K+D+Y FG++L+E++ + D +++WA CY
Sbjct: 841 -SSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYS 897
Query: 256 AGEL----QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303
L + VN E ++ + L C + RP V+ +E
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 64/195 (32%), Positives = 105/195 (53%), Gaps = 12/195 (6%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E+IG+G G VYKG + G E+AVK + + + +F E +I+ + H N+V L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
C + +V E + GSL L + + RL+ + +++L+ G+ YL + IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR----GYTAPELHSRNNRIT 213
D+ N L+ E+ KISDFG+S + ++ YTV G + +TAPE R T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPEA-LNYGRYT 173
Query: 214 VKADVYSFGVMLLEI 228
++DV+S+G++L E
Sbjct: 174 SESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 38 KEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIHHKNLV 92
E++G G G VYK G+ +A+KK I++ E E + R E+ ++ + H N+V
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKK-IRLDNEEEGIPSTALR-EISLLKELKHPNIV 61
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
L+ LV+E+ L L + LS + + I +++ GL Y H
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH--- 117
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT--VLRGTRGYTAPE--LHSR 208
RI+H D+KP NIL++ K++DFGL++ RTYT V+ T Y APE L S+
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV--TLWYRAPEILLGSK 174
Query: 209 NNRITVKADVYSFGVMLLEIV 229
+ V D++S G + E++
Sbjct: 175 HYSTAV--DIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 24/203 (11%)
Query: 39 EEIGRGGSGRVYKGC--INGGKEIAVKKLIKIVEEGESE-----FRNEMKIIGRIHHKNL 91
+ IG G G V +G + G KEI V IK ++ G S+ F E I+G+ H N+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVA--IKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
+ L G ++ +++ E+M NGSL L + + + + + I G+ YL +
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG------YTAPEL 205
+H D+ NIL++ + K+SDFGLS+ L+ D TYT T+G +TAPE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLE-DSEATYT----TKGGKIPIRWTAPEA 179
Query: 206 HSRNNRITVKADVYSFGVMLLEI 228
+ + T +DV+SFG+++ E+
Sbjct: 180 IA-YRKFTSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGE-------SEFRNEMKIIGRIHHKNLV 92
+G G VYK G+ +A+KK IK+ E E + R E+K++ + H N++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKK-IKLGERKEAKDGINFTALR-EIKLLQELKHPNII 65
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
L+ SN LV+EFM L ++ L+ ++ + L + GL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN--- 121
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNR 211
I+H D+KP+N+L+ K++DFGL++ + + T+ V+ TR Y APEL
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELLFGARH 179
Query: 212 ITVKADVYSFGVMLLE 227
V D++S G + E
Sbjct: 180 YGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 36 NFKEEIGRGGSGRVYKG-CINGGKEIAVKK--LIKIVEEGESEFRNEMKIIGRIHHKNLV 92
E IG G + VY C+ +++A+K+ L K + E R E++ + + +H N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVV 62
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIAL---EIMEGLHYLHDE 149
G LV ++ GSL +++ ++ + IA E+++GL YLH
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIM-KSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPELH 206
IH DIK NIL+ E KI+DFG+S L RT V + GT + APE+
Sbjct: 122 ---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 207 SRNNRITVKADVYSFGVMLLEI 228
+ + KAD++SFG+ +E+
Sbjct: 179 EQVHGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEF-----RNEMKIIGRIHHKNLV 92
+IG G G+VYK G+ +A+KK+ +E + F R E+K++ ++ H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIR-EIKLLQKLRHPNIV 61
Query: 93 DLVGFC-SEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
L S+G + +V+E+M + L LL E + + S+ + +++EGL YLH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
I+H DIK NIL++ K++DFGL++ + YT T Y PEL
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 211 RITVKADVYSFGVMLLEI 228
R + D++S G +L E+
Sbjct: 178 RYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE-SEFRNEMKIIGRIHHKNLVDLVGFC 98
E+G G G+VYK A K+I+I E E +F E+ I+ H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 99 SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158
+ ++ EF G+L +++ E+ L+ + R + +++E L++LH ++IH D
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 159 IKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAPEL----HSRNNRIT 213
+K NIL+ K++DFG+S K T Q R + GT + APE+ ++N
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFKDNPYD 186
Query: 214 VKADVYSFGVMLLEI 228
KAD++S G+ L+E+
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-23
Identities = 68/214 (31%), Positives = 112/214 (52%), Gaps = 13/214 (6%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
F +E+G G G V G G ++A+K +IK E EF E K++ ++ H+ LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
C++ +V E+M NG L N L +R S+ + ++ EG+ YL + + IH
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRNNRI 212
D+ N L+D+ K+SDFGLS+ + D+ YT G++ ++ PE L ++
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLY--SKF 178
Query: 213 TVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVL 246
+ K+DV++FGV++ E+ K E + E V
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
E++G G G VYK G+ +A+K + VEE E E+ I+ + +V
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G + ++ +V E+ GS+ +++ + L+ E I + ++GL YLH + I
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKI 121
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSRNNRIT 213
H DIK NIL++E +AK++DFG+S L + TV+ GT + APE N
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN-- 178
Query: 214 VKADVYSFGVMLLEI 228
KAD++S G+ +E+
Sbjct: 179 -KADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-23
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKE-----IAVKKLIKI-VEEGESEFRNEMKIIGRIHHK 89
K E+G G G+V+ G C + E +AVK L + + +F E +++ H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR-------------AEQRLSWSERRRIA 136
N+V G C+EG ++V+E+M +G L L L+ S+ +IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQTRTYTVLR 195
++I G+ YL + +H D+ N L+ KI DFG+S+ + TD Y +
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD----YYRVG 181
Query: 196 GTR----GYTAPELHSRNNRITVKADVYSFGVMLLEI 228
G + PE + T ++DV+SFGV+L EI
Sbjct: 182 GHTMLPIRWMPPE-SIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-23
Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 15/197 (7%)
Query: 38 KEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
K ++G G G VY+G +AVK L + E E EF E ++ I H NLV L+G
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETR-I 154
C+ ++ EFM G+L + L Q ++ +A +I + YL E +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL----EKKNF 125
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNR 211
IH D+ N L+ E+ K++DFGLS+L+ D TYT G + +TAPE + N+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAY-NK 181
Query: 212 ITVKADVYSFGVMLLEI 228
++K+DV++FGV+L EI
Sbjct: 182 FSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-23
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 39 EEIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGE------SEFRNEMKIIGRIHHKN 90
E +G G G VY+G +N G AVK+ + + ++G+ + E+ ++ ++ H N
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKE-VSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V +G E N + E + GSL LL + R +I+ GL YLHD
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR- 121
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
+H DIK NIL+D + K++DFG++K + +G+ + APE+ ++
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE--FSFAKSFKGSPYWMAPEVIAQQG 177
Query: 211 RITVKADVYSFGVMLLEIV 229
+ AD++S G +LE+
Sbjct: 178 GYGLAADIWSLGCTVLEMA 196
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE---FRNEMKIIGRIHHKNLVDLV 95
+G G G V K + I K I + + R E++I +V
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYY 65
Query: 96 G-FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR---RIALEIMEGLHYLHDEC 150
G F E S+ + + E+ GSL ++ + ++R + +IA +++GL YLH
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR- 124
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
+IIH DIKP NIL+ + K+ DFG+S L T+T GT Y APE +
Sbjct: 125 --KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPE-RIQGK 178
Query: 211 RITVKADVYSFGVMLLEIV 229
++ +DV+S G+ LLE+
Sbjct: 179 PYSITSDVWSLGLTLLEVA 197
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEFR---NEMKIIGRIHHKNLVDLVG 96
IG G G+VY ++ G+ +AVK+ I+I + + +EMK++ + H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKE-IRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ E+ G+L LL + L R L+++EGL YLH I+H
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVH 122
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPELHSRNNRIT 213
DIKP NI +D + K+ DFG + LK + T ++ G Y APE+ +
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 214 V--KADVYSFGVMLLEIV 229
AD++S G ++LE+
Sbjct: 183 HGRAADIWSLGCVVLEMA 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 39 EEIGRGGSGRVYKGCINGGKEI-AVKKLIKIVEEGESEFRN---EMKIIGRIHHKNLVDL 94
+IG G G VYK EI A+KK IK+ E E + E+K++ ++H N++ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKK-IKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ + LV+EFM L L+ ++ L S + ++++GL + H I
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
+H D+KP N+L++ K++DFGL++ + R YT TR Y APEL + +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 215 KADVYSFGVMLLEIV 229
D++S G + E++
Sbjct: 179 PVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 37 FKEEIGRGGSGRVYKGCI-----NGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL 91
F +++G+G G V N G+ +AVKKL E +F E++I+ + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 92 VDLVGFC-SEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
V G C S G L LV E++ GSL + L + +RL + A +I +G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPELH 206
R +H D+ NIL++ + KI DFGL+K+L D+ Y V + APE
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWYAPESL 183
Query: 207 SRNNRITVKADVYSFGVMLLEI 228
+ ++ +V +DV+SFGV+L E+
Sbjct: 184 T-ESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 15/198 (7%)
Query: 41 IGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESE-----FRNEMKIIGRIHHKNLVD 93
IG G G V++G + G KE+AV IK ++ G +E F +E I+G+ H N++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVA--IKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L G ++ +++ E+M NG+L L + S + + I G+ YL D
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MN 127
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG--YTAPELHSRNNR 211
+H D+ NIL++ + + K+SDFGLS++L+ D TYT G +TAPE + +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RK 186
Query: 212 ITVKADVYSFGVMLLEIV 229
T +DV+SFG+++ E++
Sbjct: 187 FTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 9e-22
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 39/225 (17%)
Query: 37 FKEEIGRGGSGRVYKGC-INGGKEIAVKKL--IKIVEEGESEF-RNEMKIIGRI-HHKNL 91
F + IG G V KE A+K L ++++E + ++ + E +++ R+ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 92 VDLVG-FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHD 148
+ L F E N V E+ NG L + + S E+ R A EI+ L YLH
Sbjct: 65 IKLYYTFQDE-ENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ--------------------- 187
+ IIH D+KP NIL+D+ KI+DFG +K+L +
Sbjct: 121 K---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
V GT Y +PEL +D+++ G ++ +++ +
Sbjct: 178 RFASFV--GTAEYVSPEL-LNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 29 QIVLASENFKEEIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGES-----EFRNEMK 81
+I L++ F EE+G G G+VYKG + G + A IK ++E EFR E +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 82 IIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR---------------AEQR 126
++ + H N+V L+G C++ +++E++ +G L L R +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
L S+ IA++I G+ YL +H D+ N L+ E KISDFGLS+ + +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 187 -----QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
Q+++ +R + PE + T ++D++SFGV+L EI
Sbjct: 178 DYYRVQSKSLLPVR----WMPPE-AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 66/195 (33%), Positives = 105/195 (53%), Gaps = 13/195 (6%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFC 98
+++G G G V+ G NG ++AVK L ES F E +I+ ++ H LV L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVV 70
Query: 99 SEGSNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETRIIHC 157
SE +V E+M GSL + L E R L +A ++ G+ Y+ IH
Sbjct: 71 SE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRITV 214
D++ NIL+ + KI+DFGL++L++ ++ YT +G + +TAPE + R T+
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEA-ALYGRFTI 182
Query: 215 KADVYSFGVMLLEIV 229
K+DV+SFG++L E+V
Sbjct: 183 KSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 67/194 (34%), Positives = 95/194 (48%), Gaps = 17/194 (8%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLI---KIVEEGE-SEFRNEMKIIGRIHHKNLVDL-V 95
IG+G G+V K++ K + K VE+G NE +I+ ++H LV+L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDECETR 153
F E N LV + + G G+L + Q++ +SE + EI+ L YLH
Sbjct: 68 SFQDE-ENMYLVVDLL-LG--GDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKG 120
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
IIH DIKP NIL+DE I+DF ++ + D T T GT GY APE+ R +
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQGY-S 177
Query: 214 VKADVYSFGVMLLE 227
V D +S GV E
Sbjct: 178 VAVDWWSLGVTAYE 191
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 70/204 (34%), Positives = 102/204 (50%), Gaps = 23/204 (11%)
Query: 36 NFKEEIGRGGSGRV----YKGCINGGKEIAVKKLIK--IVEEGESE-FRNEMKIIGRIHH 88
F + +G G GRV +K GK A+K L K IV+ + E NE +I+ I H
Sbjct: 4 EFIKTLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
LV+L G + SN LV E++ G L + L R R R A +++ L YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LH 206
I++ D+KP N+L+D KI+DFG +K +K RTYT L GT Y APE L
Sbjct: 120 L---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---GRTYT-LCGTPEYLAPEIILS 172
Query: 207 SRNNRITVKADVYSFGVMLLEIVC 230
+ D ++ G+++ E++
Sbjct: 173 KGYGK---AVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-21
Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 17/198 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG---ESEFRNEMKIIGRIHHKNLVD 93
F +E+G G G V+ G ++A+K + EG E +F E K++ ++ H LV
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKA----INEGAMSEEDFIEEAKVMMKLSHPKLVQ 63
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L G C++ +V EFM NG L N L + + +LS + ++ EG+ YL
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNS 120
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNN 210
IH D+ N L+ + K+SDFG+++ + D+ YT G + ++ PE+ + +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNF-S 176
Query: 211 RITVKADVYSFGVMLLEI 228
+ + K+DV+SFGV++ E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 63/191 (32%), Positives = 105/191 (54%), Gaps = 13/191 (6%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFC 98
E IG G G V +G G K +AVK IK ++ F E ++ ++HHKNLV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK-VAVK-NIKCDVTAQA-FLEETAVMTKLHHKNLVRLLGVI 68
Query: 99 SEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
+ +V E M G+L N L R +S + + +L++ EG+ YL + +++H
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
D+ NIL+ E AK+SDFGL+++ + ++ +TAPE ++ + + K+D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEA-LKHKKFSSKSD 179
Query: 218 VYSFGVMLLEI 228
V+S+GV+L E+
Sbjct: 180 VWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-20
Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 19/198 (9%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE---FRNEMKIIGRIHHKNLVDLV 95
+++G G G V+ G NG ++A+K L ++G F E ++ ++ H LV L
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRI 154
++ ++ E+M NGSL + L E +L+ ++ +A +I EG+ ++
Sbjct: 68 AVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNY 123
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNR 211
IH D++ NIL+ E+ KI+DFGL++L++ ++ YT G + +TAPE +
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT- 179
Query: 212 ITVKADVYSFGVMLLEIV 229
T+K+DV+SFG++L EIV
Sbjct: 180 FTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-20
Identities = 64/194 (32%), Positives = 108/194 (55%), Gaps = 13/194 (6%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS 99
++G+G G V+ G NG ++A+K L E+ F E +I+ ++ H LV L S
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 100 EGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158
E +V EFM GSL + L + + L + +A +I +G+ Y+ IH D
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 159 IKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRITVK 215
++ NIL+ ++ KI+DFGL++L++ ++ YT +G + +TAPE + R T+K
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEA-ALYGRFTIK 183
Query: 216 ADVYSFGVMLLEIV 229
+DV+SFG++L E+V
Sbjct: 184 SDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIK--IVEEG-ESEFRNEMKIIGRIHHKNLVDLV- 95
+G GG GRV + + A+K + K IVE G + +E +I+ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 96 GFCSEGSNRLLVY---EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
F ++ +Y E+ G L +L R R ++ YLH+
Sbjct: 61 TF----KDKKYIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIACVVLAFEYLHNR--- 112
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-----HS 207
II+ D+KP N+L+D + K+ DFG +K LK+ Q +T+T GT Y APE+ +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWT-FCGTPEYVAPEIILNKGYD 170
Query: 208 RNNRITVKADVYSFGVMLLEIVC 230
+ D +S G++L E++
Sbjct: 171 FS------VDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 29/205 (14%)
Query: 41 IGRGGSGRVYKGC--INGGKEIAVKKLIKIVEEGE-----SEFRNEMKIIGRIHHKNLVD 93
+G+G GRVY C ++ G+E+AVK++ + E + E++++ + H+ +V
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 94 LVGFCSEGSNRLLVY-EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
G C L ++ E+M GS+ + L +A L+ + R+ +I+EG+ YLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSN--- 123
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKT---DQTRTYTVLRGTRGYTAPEL---- 205
I+H DIK NIL D + K+ DFG SK L+T T +V GT + +PE+
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVISGE 182
Query: 206 -HSRNNRITVKADVYSFGVMLLEIV 229
+ R KADV+S G ++E++
Sbjct: 183 GYGR------KADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 25/212 (11%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKK--LIKIVEEGESE--------FRNEMKIIGRIH 87
E IG+G GRVY + G+ +AVK+ L + R+E++ + +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 88 HKNLVDLVGFCSEGSNRLLVY-EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYL 146
H N+V +GF L ++ E++ GS+G+ L R R R +++EGL YL
Sbjct: 67 HLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 147 HDECETRIIHCDIKPHNILMDESWKAKISDFGLSK----LLKTDQTRTYTVLRGTRGYTA 202
H + I+H D+K N+L+D KISDFG+SK + DQ + ++G+ + A
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS---MQGSVFWMA 178
Query: 203 PE-LHSRNNRITVKADVYSFGVMLLEIVCCRK 233
PE +HS + + K D++S G ++LE+ R+
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 39/216 (18%)
Query: 40 EIGRGGSGRVYKGCING------GKEIAVKKLIKIVEEGES-----EFRNEMKIIGRIHH 88
E+G+G G VY+G G +A IK V E S EF NE ++ +
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVA----IKTVNENASMRERIEFLNEASVMKEFNC 68
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQR-------LSWSERRRIALEI 139
++V L+G S G L+V E M G L + L R E + + ++A EI
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 140 MEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL-KTDQTRTYTVLRGTR 198
+G+ YL + +H D+ N ++ E KI DFG+++ + +TD R +G +
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGK 180
Query: 199 G-----YTAPELHSRNNRITVKADVYSFGVMLLEIV 229
G + APE ++ T K+DV+SFGV+L E+
Sbjct: 181 GLLPVRWMAPE-SLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVG 96
E IG G G+VYK ++ K++ I+E+ E E + E I+ + +H N+ G
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 97 -FCSEGSNRL-----LVYEFMRNGSLGNL---LFRAEQRLSWSERRRIALEIMEGLHYLH 147
F + LV E GS+ +L L + +RL I E + GL YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-- 205
+ ++IH DIK NIL+ ++ + K+ DFG+S L + R T + GT + APE+
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIA 186
Query: 206 --HSRNNRITVKADVYSFGVMLLE 227
+ ++DV+S G+ +E
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-20
Identities = 63/203 (31%), Positives = 110/203 (54%), Gaps = 17/203 (8%)
Query: 38 KEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESE-----FRNEMKIIGRIHHKN 90
+E IG G G V +G + G +EI V IK ++ G +E F +E I+G+ H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVA--IKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
++ L G ++ +++ EFM NG+L + L + + + + + + I G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---S 123
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTR---GYTAPELH 206
E +H D+ NIL++ + K+SDFGLS+ L+ D + TYT G + +TAPE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 207 SRNNRITVKADVYSFGVMLLEIV 229
+ + T +DV+S+G+++ E++
Sbjct: 184 AY-RKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 7e-20
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 38/208 (18%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGES-----EFRNEMKIIGRIHHKNLVDL 94
+G G G VYKG I G+++ + IK++ E S E +E ++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 95 VGFCSEGSNRLLVYEFMRNGSL--------GNLLFRAEQRLSWSERRRIALEIMEGLHYL 146
+G C S L+ + M G L N+ ++ L+W +I +G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNI--GSQYLLNWCV------QIAKGMSYL 125
Query: 147 HDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG-----YT 201
E R++H D+ N+L+ KI+DFGL+KLL D+ G +
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE----KEYHAEGGKVPIKWM 178
Query: 202 APE-LHSRNNRITVKADVYSFGVMLLEI 228
A E + R T K+DV+S+GV + E+
Sbjct: 179 ALESILHR--IYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 59/185 (31%), Positives = 93/185 (50%), Gaps = 20/185 (10%)
Query: 57 GKEIAVKKLIKIVEEGESE---FRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL-VYEFMR 112
G E+A+K L E E + FR E + R++H N+V L+ L V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DES 169
+L +L A+ L E R+ L++++ L H++ I+H D+KP NI++
Sbjct: 63 GRTLREVL-AADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVR 118
Query: 170 WKAKISDFGLSKLL-------KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFG 222
AK+ DFG+ LL TRT VL GT Y APE R +T +D+Y++G
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPE-QLRGEPVTPNSDLYAWG 176
Query: 223 VMLLE 227
++ LE
Sbjct: 177 LIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-20
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIV-------EEGESEFRNEMKIIGRIHHKNLVD 93
+G G G VY+G G AV+ + + E+ ES+F E I+ + +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLF----RAEQ--RLSWSERRRIALEIMEGLHYLH 147
L+G E R ++ E M G L + L R E+ L+ + A ++ +G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 148 DECETRIIHCDIKPHNILMD---ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG----- 199
E IH DI N L+ AKI+DFG+++ D R +G R
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPIK 186
Query: 200 YTAPELHSRNNRITVKADVYSFGVMLLEI 228
+ PE + T K DV+SFGV+L EI
Sbjct: 187 WMPPEAF-LDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-19
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 41 IGRGGSGRVYKGC--INGGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLV 95
+G+GG G V C GK A KKL K +GE NE KI+ ++ + +V L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECET 152
+ E + L LV M G L ++ + + E R I A +I+ GL +LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
RI++ D+KP N+L+D+ +ISD GL+ LK + GT GY APE+ +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEV-LQGEVY 171
Query: 213 TVKADVYSFGVMLLEIVCCR 232
D ++ G L E++ R
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 39 EEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRN----EMKIIGRIHHKNLV 92
+G G G V K C N G+ +A+KK K E+ E + + E+K++ ++ H+N+V
Sbjct: 7 GVVGEGAYGVVLK-CRNKATGEIVAIKKF-KESEDDE-DVKKTALREVKVLRQLRHENIV 63
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+L LV+E++ +L LL + L R ++++ + Y H
Sbjct: 64 NLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
IIH DIKP NIL+ ES K+ DFG ++ L+ T TR Y APEL +
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 213 TVKADVYSFGVMLLEI 228
DV++ G ++ E+
Sbjct: 180 GKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 39 EEIGRGGSGRVYKGC--INGGKEIAVKKLIKIVEE-----GESEFRNEMKIIGRIHHKNL 91
+E+G G G V KG + GKE+ V +K +++ G+ EF E ++ ++ H +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVA--VKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
V L+G C +G +LV E G L L + + + S+ + +A ++ G+ YL
Sbjct: 59 VRLIGVC-KGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLE---S 113
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSR 208
+H D+ N+L+ +AKISDFG+S+ L Y R + APE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPE--CI 170
Query: 209 NNRI-TVKADVYSFGVMLLEIV 229
N + K+DV+S+GV L E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-19
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 23/202 (11%)
Query: 41 IGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESE-----FRNEMKIIGRIHHKNLVD 93
IG G G V G + G +EI V IK ++ G +E F +E I+G+ H N++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVA--IKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L G ++ ++V E+M NGSL L + + + + + + I G+ YL D
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MG 126
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG------YTAPELHS 207
+H D+ NIL++ + K+SDFGLS++L+ D YT TRG +TAPE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAPEAIA 182
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
+ T +DV+S+G+++ E++
Sbjct: 183 Y-RKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-19
Identities = 60/193 (31%), Positives = 105/193 (54%), Gaps = 13/193 (6%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS 99
++G+G G V+ G NG +A+K L E+ F E +++ ++ H+ LV L S
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 100 EGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158
E +V E+M GSL + L + L + +A +I G+ Y+ +H D
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 159 IKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRITVK 215
++ NIL+ E+ K++DFGL++L++ ++ YT +G + +TAPE + R T+K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEA-ALYGRFTIK 183
Query: 216 ADVYSFGVMLLEI 228
+DV+SFG++L E+
Sbjct: 184 SDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 61/200 (30%), Positives = 109/200 (54%), Gaps = 17/200 (8%)
Query: 35 ENFKEEIGRGGSGRVYKGCI----NGGKEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHK 89
+NF + IG G +G V CI + G+++AVKK+ ++ + E F NE+ I+ H
Sbjct: 22 DNFVK-IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHP 76
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
N+V++ G +V EF+ G+L +++ R++ + + L +++ L +LH +
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
+IH DIK +IL+ + K+SDFG + + R + L GT + APE+ SR
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPEVISRL 190
Query: 210 NRITVKADVYSFGVMLLEIV 229
T + D++S G+M++E+V
Sbjct: 191 PYGT-EVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 41 IGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRN----EMKIIGRIHHKNLVDL 94
+G G G V K C + G+ +A+KK ++ E + + E++++ ++ H+NLV+L
Sbjct: 9 VGEGSYGMVMK-CKHKETGQIVAIKKFLE--SEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ LV+EF+ + L + L + L S R+ +I+ G+ + H I
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NI 121
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
IH DIKP NIL+ +S K+ DFG ++ L YT TR Y APEL + +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 215 KADVYSFGVMLLEIV 229
D+++ G ++ E++
Sbjct: 181 AVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 19/201 (9%)
Query: 41 IGRGGSGRVYKGCI--NGGKEI--AVKKLIKIVEEGE-SEFRNEMKIIGRIHHKNLVDLV 95
IG+G G VY G + + G++I AVK L +I + E +F E I+ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 96 GFC--SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
G C SEGS L+V +M++G L N + + + L++ +G+ YL +
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---ASKK 118
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP----ELHS-R 208
+H D+ N ++DES+ K++DFGL++ + + Y + G P L S +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDI---YDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 209 NNRITVKADVYSFGVMLLEIV 229
+ T K+DV+SFGV+L E++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN---EMKIIGRIHHKNLVDLV 95
E IG+G G VYKG N KE+ K+I + EE E E + E+ ++ + +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G +G+ ++ E++ GS +LL L + I EI++GL YLH E R I
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKI 123
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H DIK N+L+ E K++DFG++ L Q + T + GT + APE+ + + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV-IKQSAYDFK 181
Query: 216 ADVYSFGVMLLEI 228
AD++S G+ +E+
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-19
Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEF----RNEMKIIGRIHHKNLVDLVG 96
+G+G G VY V+ IK + E +S + E+ + + H+N+V +G
Sbjct: 16 LGKGTYGIVYAA---RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECETRI 154
SE + E + GSL LL L +E+ I +I+EGL YLHD +I
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QI 129
Query: 155 IHCDIKPHNILMDE-SWKAKISDFGLSKLLK--TDQTRTYTVLRGTRGYTAPELHSRNNR 211
+H DIK N+L++ S KISDFG SK L T T+T GT Y APE+ + R
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDKGPR 186
Query: 212 -ITVKADVYSFGVMLLEI 228
AD++S G ++E+
Sbjct: 187 GYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-19
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 32 LASENFKE---EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIH 87
L E F E E+G G G+VYK +A K+I E E E + E+ I+
Sbjct: 1 LNPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD 60
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
H N+V L+ +N ++ EF G++ ++ E+ L+ + R + + +E L+YLH
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAPEL- 205
E +IIH D+K NIL K++DFG+S K +T Q R + GT + APE+
Sbjct: 121 ---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVV 175
Query: 206 ---HSRNNRITVKADVYSFGVMLLEI 228
S++ KADV+S G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-19
Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFC 98
+++G G G V+ G N ++AVK L K F E ++ + H LV L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 99 SEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
++ ++ E+M GSL + L E ++ + + +I EG+ Y+ IH
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRITV 214
D++ N+L+ ES KI+DFGL+++++ ++ YT G + +TAPE + + T+
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS-FTI 183
Query: 215 KADVYSFGVMLLEIV 229
K+DV+SFG++L EIV
Sbjct: 184 KSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 17/196 (8%)
Query: 39 EEIGRGGSGRVYKGCING-GKEIAVKKLIKIV--EEGESE---FRNEMKIIGRIHHKNLV 92
E IG+G G VYK + +A IK++ EE E E + E++ + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVA----IKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
G +GS ++ E+ GS +LL +L + I E++ GL YLH+E
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE--- 117
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
IH DIK NIL+ E K++DFG+S L + ++ T + GT + APE+ ++
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176
Query: 213 TVKADVYSFGVMLLEI 228
KAD++S G+ +E+
Sbjct: 177 E-KADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIHHKNLVDL- 94
+IG G G+VYK E+ K +++ E E + R E+KI+ +++H+N+V+L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNLK 72
Query: 95 ---------VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY 145
+ F + LV+E+M + +G LL S + +++EGL+Y
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIKSFMKQLLEGLNY 131
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
H +H DIK NIL++ + K++DFGL++L ++++R YT T Y PEL
Sbjct: 132 CHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPEL 188
Query: 206 HSRNNRITVKADVYSFGVMLLEI 228
R DV+S G +L E+
Sbjct: 189 LLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 58/185 (31%), Positives = 104/185 (56%), Gaps = 19/185 (10%)
Query: 55 NGGKEIAVKKLIKIVEEGESEFRN---EMKIIGRIHHKNLVDLVGFCSEGSNR--LLVYE 109
N G+++AVK L E G + + E++I+ ++H+N+V G C+E L+ E
Sbjct: 31 NTGEQVAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88
Query: 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169
F+ +GSL L R + +++ ++ + A++I +G+ YL + +H D+ N+L++
Sbjct: 89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE 145
Query: 170 WKAKISDFGLSKLLKTDQTRTYTV---LRGTRGYTAPE--LHSRNNRITVKADVYSFGVM 224
+ KI DFGL+K ++TD+ YTV L + APE + S + + +DV+SFGV
Sbjct: 146 HQVKIGDFGLTKAIETDK-EYYTVKDDLDSPVFWYAPECLIQS---KFYIASDVWSFGVT 201
Query: 225 LLEIV 229
L E++
Sbjct: 202 LYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 26/206 (12%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLI--KIVEEGESEFRN-------EMKIIGRIHHKN 90
IG G G VY G + G+ +AVK++ + + R+ E+ ++ + H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 91 LVDLVGFCSEGSNRLLVY-EFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLH 147
+V +G S ++ L ++ E++ GS+ LL ++ E R +I++GL+YLH
Sbjct: 68 IVQYLG-SSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT-----VLRGTRGYTA 202
+ IIH DIK NIL+D KISDFG+SK L+ + T T L+G+ + A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 203 PELHSRNNRITVKADVYSFGVMLLEI 228
PE+ + T KAD++S G +++E+
Sbjct: 181 PEV-VKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-18
Identities = 58/194 (29%), Positives = 106/194 (54%), Gaps = 14/194 (7%)
Query: 40 EIGRGGSGRVYKGCI----NGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
+IG G +G V CI + GK++AVKK+ ++ NE+ I+ HH+N+VD+
Sbjct: 29 KIGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G +V EF+ G+L +++ R++ + + L ++ L YLH++ +I
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQ---GVI 140
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H DIK +IL+ + K+SDFG + + + +++ GT + APE+ SR T +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGT-E 198
Query: 216 ADVYSFGVMLLEIV 229
D++S G+M++E++
Sbjct: 199 VDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 9/195 (4%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE--SEFRNEMKIIGRIHHKNLVDL 94
+ IG G G VYK E+ K+IK+ E G+ + E+ ++ H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKL-EPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
G +V E+ GSL ++ LS + + E ++GL YLH ET
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGK 122
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL--HSRNNRI 212
IH DIK NIL+ E K++DFG+S L + + + GT + APE+ R
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 213 TVKADVYSFGVMLLE 227
K D+++ G+ +E
Sbjct: 182 DGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 35/203 (17%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRN----EMKIIGRIHHKNLVDLV 95
IG G G VYK G+ A+K I E R E++I+ ++H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKV---IYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
++ EFM GSL EQ L+ +A +I+ G+ YLH I+
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLH---RRHIV 190
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLL-KTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
H DIKP N+L++ + KI+DFG+S++L +T +V GT Y +PE RI
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPE------RINT 242
Query: 215 K----------ADVYSFGVMLLE 227
D++S GV +LE
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE-SEFRNEMKIIGRIHH---KNLVD 93
E IGRG G VY+G + G+ +A+K + + + S+ + E+ ++ ++ N+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIAL---EIMEGLHYLHDEC 150
G +G ++ E+ GS+ L+ + + I++ E++ L Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVLVALKYIH--- 118
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
+ +IH DIK NIL+ + K+ DFG++ LL + ++ T GT + APE+ +
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGK 177
Query: 211 RITVKADVYSFGVMLLEIV 229
KAD++S G+ + E+
Sbjct: 178 YYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-18
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 41 IGRGGSGRVY---KGCINGGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDL 94
I +G GRV+ K + G A+K + K I + + E I+ + +V L
Sbjct: 1 ISKGAYGRVFLAKK--KSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 95 V-GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
F + N LV E++ G L +LL L R EI+ L YLH
Sbjct: 59 YYSFQGK-KNLYLVMEYLPGGDLASLL-ENVGSLDEDVARIYIAEIVLALEYLH---SNG 113
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKL--------LKTDQTRTYTVLRGTRGYTAPEL 205
IIH D+KP NIL+D + K++DFGLSK+ L D+ ++ GT Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEV 172
Query: 206 HSRNNRITVKADVYSFGVMLLEIVC 230
+ D +S G +L E +
Sbjct: 173 -ILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-18
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 41 IGRGGSGRVYKGCI-------NGGKEIAVKKLIK-IVEEGESEFRNEMKIIGRIHHKNLV 92
+G G G VY+G +G +AVK L K ++ + EF E ++ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR------LSWSERRRIALEIMEGLHYL 146
L+G C + ++ E M G L + L A L+ E I L++ +G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 147 HDECETRIIHCDIKPHNILMDESWKA-----KISDFGLSK-LLKTDQTRTYTVLRGTR-- 198
IH D+ N L+ E KI DFGL++ + K+D Y G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD----YYRKEGEGLL 175
Query: 199 --GYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
+ APE + + T ++DV+SFGV++ EI+
Sbjct: 176 PVRWMAPE-SLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 60/196 (30%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNLVDLVG-F 97
E+G G G+VYK +A K+I+ E E E + E++I+ +H +V L+G F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
+G +++ EF G++ ++ ++ L+ + + I +++E L YLH +IIH
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHR 134
Query: 158 DIKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAPEL----HSRNNRI 212
D+K N+L+ K++DFG+S K +KT Q R + GT + APE+ ++
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPY 192
Query: 213 TVKADVYSFGVMLLEI 228
KAD++S G+ L+E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 7e-18
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIKIVE--EGESEFRN-------------EMKIIG 84
+G G G+V K GK +A+KK+ KI+E ++ R E+KI+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 85 RIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLH 144
I H+N++ LV EG LV + M L + + RL+ S+ + I L+I+ GL+
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKV-VDRKIRLTESQVKCILLQILNGLN 133
Query: 145 YLHDECETRIIHCDIKPHNILMDESWKAKISDFGL-------------SKLLKTDQTRTY 191
LH + +H D+ P NI ++ KI+DFGL SK +
Sbjct: 134 VLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
T T Y APEL + D++S G + E+
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227
|
Length = 335 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 68/221 (30%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 32 LASENFKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVE-EGE--SEFRNEMKIIGRIH 87
L ++G G G VYK I G+ +A+KK++ E +G + R E+KI+ ++
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLK 65
Query: 88 HKN---LVDLVGFCSEGSNRL-----LVYEFMR---NGSLGNLLFRAEQRLSWSERRRIA 136
H N L+D+ + S R +V +M +G L N + + S+ +
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE----SQIKCYM 121
Query: 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ--------- 187
L+++EG++YLH E I+H DIK NIL+D KI+DFGL++
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 188 -TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLE 227
TR YT L TR Y PEL R T D++ G + E
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAE 219
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 64/190 (33%), Positives = 97/190 (51%), Gaps = 13/190 (6%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE 100
IG+G G V G G K +AVK IK ++ F E ++ ++ H NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYRGNK-VAVK-CIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 101 GSNRL-LVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158
L +V E+M GSL + L R L + +L++ E + YL +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127
Query: 159 IKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADV 218
+ N+L+ E AK+SDFGL+K + Q ++ +TAPE R + + K+DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEA-LREKKFSTKSDV 182
Query: 219 YSFGVMLLEI 228
+SFG++L EI
Sbjct: 183 WSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKL--IKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
E IG+G G V K + GK + K++ + E+ + + +E+ I+ + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 96 GFCSEGSNRLL--VYEFMRNGSLGNLLFRA-EQRLSWSERR--RIALEIMEGLHYLH--D 148
+ SN+ L V E+ G L L+ + ++R E RI +++ L+ H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
+ ++H D+KP NI +D + K+ DFGL+K+L D + T + GT Y +PE +
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 209 NNRITVKADVYSFGVMLLEI 228
K+D++S G ++ E+
Sbjct: 185 -MSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 20/223 (8%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN----EMKIIGRIHHKNLVDLV 95
++G G G V K + KK++ I +S R E++I+ +V
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHI--GAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 96 G-FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
G F +E N + EFM GSL + +++ + +IA+ ++EGL YL++ RI
Sbjct: 70 GAFLNEN-NICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRI 125
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
+H DIKP NIL++ + K+ DFG+S L T+ GT Y +PE + + TV
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPE-RIQGGKYTV 181
Query: 215 KADVYSFGVMLLEIVCCR-----KNVDESLRDDEIVLIDWAHQ 252
K+DV+S G+ ++E+ + N+D+ +DD + ++D Q
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-17
Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 27/230 (11%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKE-----IAVKKLIKIVEEGESEFRNEMKIIGRIHHKN 90
K E+G G G+V+ C N E +AVK L + +F E +++ + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLL--------FRAE----QRLSWSERRRIALE 138
+V G C EG ++V+E+M++G L L AE L+ S+ IA +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 139 IMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQTRT--YTVLR 195
I G+ YL + +H D+ N L+ E+ KI DFG+S+ + TD R +T+L
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245
R + R + T ++DV+S GV+L EI K L ++E++
Sbjct: 186 -IRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 21/197 (10%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN----EMKIIGRIHHKNLVDLV 95
E+G G G V K I +KLI + E + RN E+K++ H N +V
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVL---HECNSPYIV 62
Query: 96 G----FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
G F S+G + + E M GSL +L +A R+ + +I++ ++ GL YL ++
Sbjct: 63 GFYGAFYSDGEISICM-EHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK-- 118
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
+I+H D+KP NIL++ + K+ DFG+S L ++ GTR Y +PE +
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPE-RLQGTH 174
Query: 212 ITVKADVYSFGVMLLEI 228
TV++D++S G+ L+E+
Sbjct: 175 YTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 32/209 (15%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLI---KIVEEGESEFRN---EMKIIGRIHHKNLV 92
E +G+G G VY G N G+ IAVK++ V E E+ E+ ++ + H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+G C + + + EF+ GS+ ++L R L + +I++G+ YLH+ C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGP-LPEPVFCKYTKQILDGVAYLHNNC-- 122
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLL--------KTDQTRTYTVLRGTRGYTAPE 204
++H DIK +N+++ + K+ DFG ++ L ++ ++ + GT + APE
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS---MHGTPYWMAPE 178
Query: 205 L-----HSRNNRITVKADVYSFGVMLLEI 228
+ + R K+D++S G + E+
Sbjct: 179 VINESGYGR------KSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 54/190 (28%), Positives = 99/190 (52%), Gaps = 5/190 (2%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIK-IVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E +G+G G V+KG + +AVK + + +E + +F +E +I+ + H N+V L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
C++ +V E + G + L + + L + + AL+ G+ YL + IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHR 117
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
D+ N L+ E+ KISDFG+S+ + + + +TAPE + R + ++D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESD 176
Query: 218 VYSFGVMLLE 227
V+S+G++L E
Sbjct: 177 VWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEM---KIIGRIHHKNLVDLVG 96
+G+GG G V + GK A KKL K + + M +I+ ++H + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRI--ALEIMEGLHYLHDECETR 153
++ LV M G L ++ E+ + E R +I+ GL +LH + R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT--YTVLRGTRGYTAPELHSRNNR 211
II+ D+KP N+L+D +ISD GL+ LK Q++T Y GT G+ APEL +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---GTPGFMAPEL-LQGEE 173
Query: 212 ITVKADVYSFGVMLLEIVCCR 232
D ++ GV L E++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 15/196 (7%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+G+GG G V + GK A KKL K +GES NE +I+ +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECETR 153
+ E + L LV M G L ++ + + E R + A EI GL LH E R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE---R 122
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
I++ D+KP NIL+D+ +ISD GL+ + QT V GT GY APE+ +N R T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEV-VKNERYT 179
Query: 214 VKADVYSFGVMLLEIV 229
D ++ G +L E++
Sbjct: 180 FSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 57/179 (31%), Positives = 90/179 (50%), Gaps = 20/179 (11%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKL-IKIVEEG--ESEFRNE---MKIIGRIHHKNL 91
EIG G G VYK +N G+ +A+KK+ + + EEG S R E +K + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 92 VDLVGFC--SEGSNRL---LVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHY 145
V L+ C L LV+E + + L L + + L + + +++ G+ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE 204
LH RI+H D+KP NIL+ + KI+DFGL+++ + T V+ T Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-17
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG---ESEFRNEMKIIGRIHHKNLVDL 94
+IG+G G V+K K + K I + + E +E +++ ++ ++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
+ +V E+ NG L LL + + L + R ++I+ GL +LH + +
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---K 121
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
I+H DIK N+ +D KI D G++KLL + T++ GT Y +PEL +
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPEL-CEDKPYN 179
Query: 214 VKADVYSFGVMLLEIVCC 231
K+DV++ GV+L E CC
Sbjct: 180 EKSDVWALGVVLYE--CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-17
Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 18/196 (9%)
Query: 37 FKEEIGRGGSGRVYKGC-INGGKEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHKNLVDL 94
++E +G G G VYK + + +AVK + + I E + + +E++I+ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 95 VG-FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
G F E NR+ + EFM GSL E L RIA+ +++GL YL
Sbjct: 65 YGAFFVE--NRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYLWS---L 114
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
+I+H D+KP N+L++ + K+ DFG+S L +TY GT Y APE S +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERIS-GEQY 170
Query: 213 TVKADVYSFGVMLLEI 228
+ +DV+S G+ +E+
Sbjct: 171 GIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKE-----IAVKKLIKIVEEGESEFRNEMKIIGRIHHKN 90
K E+G G G+V+ C N E +AVK L + E +F+ E +++ + H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLL--------------FRAEQRLSWSERRRIA 136
+V G C+EG L+V+E+MR+G L L A +L+ + IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQ----TRTY 191
+I G+ YL +H D+ N L+ + KI DFG+S+ + TD RT
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
+R + PE + T ++D++SFGV+L EI
Sbjct: 186 LPIR----WMPPE-SILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 17/196 (8%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN---EMKIIGRIHHKNLVDLV 95
E IG+G G V+KG N +++ K+I + EE E E + E+ ++ + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIAL---EIMEGLHYLHDECET 152
G +G+ ++ E++ GS +LL R + +IA EI++GL YLH E
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSE--- 120
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
+ IH DIK N+L+ E K++DFG++ L Q + T + GT + APE+ + +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV-IQQSAY 178
Query: 213 TVKADVYSFGVMLLEI 228
KAD++S G+ +E+
Sbjct: 179 DSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 57/183 (31%), Positives = 93/183 (50%), Gaps = 26/183 (14%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE------FRNEMKIIGRIHHKNLVD 93
IG+G G V+K + +A+KK ++ E E E R E+KI+ + H+N+V+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKK---VLMENEKEGFPITALR-EIKILQLLKHENVVN 75
Query: 94 LVGFC---SEGSNR-----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY 145
L+ C + NR LV+EF + L LL + + SE +++ ++ GL+Y
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK---LLKTDQTRTYTVLRGTRGYTA 202
+H +I+H D+K NIL+ + K++DFGL++ L K + YT T Y
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191
Query: 203 PEL 205
PEL
Sbjct: 192 PEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-17
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 39 EEIGRGGSGRVYK--GCINGGKEIAVKKLI-------KIVEEGESEFR---NEMKIIG-R 85
E +G G G VYK NG +A+K++ K E + +E+ II +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 86 IHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR-AEQRLSWSERR--RIALEIMEG 142
+ H N+V E +V + + LG E++ ++E R I ++++
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
L YLH E RI+H D+ P+NI++ E K I+DFGL+K + + T V GT Y+
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTILYSC 181
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PE+ +N KADV++FG +L ++
Sbjct: 182 PEI-VKNEPYGEKADVWAFGCILYQMC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-17
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 41 IGRGGSGRVYKGCINGGKE------IAVKKLIKIVEEG-ESEFRNEMKIIGRIHHKNLVD 93
+GRG G V+ G +E + VK L K +E +SEFR E+ + ++ HKN+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLL--------FRAEQRLSWSERRRIALEIMEGLHY 145
L+G C E ++ E+ G L L LS ++ + +I G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTA 202
L + R +H D+ N L+ + K+S LS K Y LR + A
Sbjct: 133 LSN---ARFVHRDLAARNCLVSSQREVKVSLLSLS---KDVYNSEYYKLRNALIPLRWLA 186
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245
PE + + + K+DV+SFGV++ E+ + L D+E++
Sbjct: 187 PEA-VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 78/297 (26%), Positives = 139/297 (46%), Gaps = 48/297 (16%)
Query: 36 NFKEEIGRGGSGRVYKG----CINGGKEIAVKKLIKIVEEGES-----EFRNEMKIIGRI 86
E+G+G G VY+G I G E V +K V E S EF NE ++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVA--VKTVNESASLRERIEFLNEASVMKGF 66
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQR-------LSWSERRRIAL 137
++V L+G S+G L+V E M +G L + L R E + E ++A
Sbjct: 67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQTRTYTVLRG 196
EI +G+ YL+ + + +H D+ N ++ + KI DFG+++ + +TD R +G
Sbjct: 127 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KG 178
Query: 197 TRG-----YTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH 251
+G + APE ++ T +D++SFGV+L EI + + L +++++
Sbjct: 179 GKGLLPVRWMAPE-SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF---- 233
Query: 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308
+ G L DQ D E +L+++ C + +RPT +++ +++ + P
Sbjct: 234 -VMDGGYL-----DQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-17
Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E+IG+G SG VY + G+E+A+K++ + + NE+ ++ H N+V+ +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
G +V E++ GSL +++ E + + + E ++ L +LH ++IH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
DIK NIL+ K++DFG + +Q++ T++ GT + APE+ +R K D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR-KAYGPKVD 197
Query: 218 VYSFGVMLLEIV 229
++S G+M +E+V
Sbjct: 198 IWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-17
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 39 EEIGRGGSGRVYKGCIN-----GGKEIAVKKLIK-IVEEGESEFRNEMKIIGRIHHKNLV 92
+G G G+V C + G+ +AVK L + ++ S ++ E+ I+ ++H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 93 DLVGFCSEGSNR--LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
G CSE + L+ E++ GSL + L + +L+ ++ A +I EG+ YLH +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPELHS 207
IH D+ N+L+D KI DFGL+K + Y V + A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYAVEC-L 182
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
+ N+ + +DV+SFGV L E++
Sbjct: 183 KENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 20/198 (10%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIHHKNLVDL- 94
IG G G VY+ G+ +A+KK +++ E + S R E+ ++ + H N+V+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKK-VRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 95 ---VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
VG + LV E+ L +LL S S+ + + L+++ GL YLH+
Sbjct: 73 EVVVG--KHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF- 128
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT-DQTRTYTVLRGTRGYTAPELHSRNN 210
IIH D+K N+L+ + KI+DFGL++ + T V+ T Y APEL
Sbjct: 129 --IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCT 184
Query: 211 RITVKADVYSFGVMLLEI 228
T D+++ G +L E+
Sbjct: 185 TYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 52/192 (27%), Positives = 104/192 (54%), Gaps = 8/192 (4%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E+IG+G SG V+ + G+E+A+K++ + + NE+ ++ + + N+V+ +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
G +V E++ GSL +++ E + ++ + E ++ L +LH ++IH
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLH---ANQVIHR 139
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
DIK N+L+ K++DFG + +Q++ T++ GT + APE+ +R K D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR-KAYGPKVD 197
Query: 218 VYSFGVMLLEIV 229
++S G+M +E+V
Sbjct: 198 IWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 13/195 (6%)
Query: 39 EEIGRGGSGRVYKGCINGGKE-IAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVG 96
E IGRG G V+ G + +AVK + + + +++F E +I+ + H N+V L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
C++ +V E ++ G L RL E ++ G+ YL + IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR----GYTAPELHSRNNRI 212
D+ N L+ E KISDFG+S + ++ Y G + +TAPE + R
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMKQIPVKWTAPEALNY-GRY 173
Query: 213 TVKADVYSFGVMLLE 227
+ ++DV+SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 39 EEIGRGGSGRVYKGCINGGKEI-AVKKLIKIVEEGESEFR-NEMKIIGRI-HHKNLVDLV 95
+++G G G VY E+ A+KK+ K E E+K + ++ H N+V L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETR 153
E ++ L V+E+M G+L L+ + + S S R I +I++GL ++H
Sbjct: 65 EVFRE-NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HG 119
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSRNNR 211
H D+KP N+L+ KI+DFGL++ + YT TR Y APE L S +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRSTSYS 177
Query: 212 ITVKADVYSFGVMLLEIVCCR 232
V D+++ G ++ E+ R
Sbjct: 178 SPV--DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 14/194 (7%)
Query: 40 EIGRGGSGRVYKGCI----NGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
+IG G +G V CI + GK +AVKK+ ++ NE+ I+ H+N+V++
Sbjct: 27 KIGEGSTGIV---CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G +V EF+ G+L +++ R++ + + L +++ L LH + +I
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H DIK +IL+ + K+SDFG + + R +++ GT + APEL SR +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLP-YGPE 196
Query: 216 ADVYSFGVMLLEIV 229
D++S G+M++E+V
Sbjct: 197 VDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 37 FKEEIGRGGSGRVYKGCI--NGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRI-HHKNL 91
F++ IG G G+V + I +G K A K++K E +F E++++ ++ HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQR-----------------LSWSERR 133
++L+G C NR +Y + GNLL F + R L+ +
Sbjct: 66 INLLGACE---NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 134 RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193
+ A ++ G+ YL ++ + IH D+ N+L+ E+ +KI+DFGLS+ + +T
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-- 177
Query: 194 LRGTRGYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
G + S N + T K+DV+SFGV+L EIV
Sbjct: 178 --GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN---EMKIIGRIHHKNLVD 93
+E+G+G G VYK K I++ E ES+F E+ I+ + +VD
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 94 LVG-FCSEGSNRLLVY---EFMRNGSLGNLL--FRAEQRLSWSERRRIALEIMEGLHYLH 147
G F EG+ VY E+M GSL L A + + RRI +++GL +L
Sbjct: 64 FYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-- 205
+E IIH D+KP N+L++ + + K+ DFG+S L +T G + Y APE
Sbjct: 120 EE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIK 174
Query: 206 ---HSRNNRITVKADVYSFGVMLLEI 228
++N TV++DV+S G+ +LE+
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 3e-16
Identities = 55/192 (28%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E+IG+G SG VY I G+E+A+K++ + + NE+ ++ + N+V+ +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
G +V E++ GSL +++ E + + + E ++ L +LH ++IH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLH---SNQVIHR 139
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
DIK NIL+ K++DFG + +Q++ T++ GT + APE+ +R K D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR-KAYGPKVD 197
Query: 218 VYSFGVMLLEIV 229
++S G+M +E+V
Sbjct: 198 IWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 37 FKEEIGRGGSGRVYKGCING-GKE-----IAVKKLIKIVEEGESE-FRNEMKIIGRI-HH 88
F + +G G G+V + G K +AVK L E E +E+KI+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR-AEQRLSWSERRRIALEIMEGLHYLH 147
+N+V+L+G C+ G L++ E+ G L N L R E L+ + + ++ +G+ +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 148 DE-CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAP 203
+ C IH D+ N+L+ KI DFGL++ + D Y V R + AP
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS--NYVVKGNARLPVKWMAP 212
Query: 204 ELHSRNNRITVKADVYSFGVMLLEI 228
E N T ++DV+S+G++L EI
Sbjct: 213 E-SIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 56/205 (27%), Positives = 109/205 (53%), Gaps = 23/205 (11%)
Query: 36 NFK--EEIGRGGSGRVYK-GCINGGKEIAVKK--LIKIVEEGESEFRNEMKIIGRIHHKN 90
+FK +++G+G G VYK ++ + A+K+ L + ++ + NE++I+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR-------LSWSERRRIALEIMEGL 143
++ +G+ +V E+ G L + + +++ W RI ++++ GL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
LH++ +I+H D+K NIL+ + KI D G+SK+LK + +T GT Y AP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAP 170
Query: 204 ELHSRNNRITVKADVYSFGVMLLEI 228
E+ + + K+D++S G +L E+
Sbjct: 171 EVW-KGRPYSYKSDIWSLGCLLYEM 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 31/228 (13%)
Query: 40 EIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGES-----EFRNEMKIIGRIHHKNLV 92
E+G+G G VY+G G E + IK V E S EF NE ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQR-------LSWSERRRIALEIMEGL 143
L+G S+G L++ E M G L + L R E S + ++A EI +G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQTRTYTVLRGTRG--- 199
YL+ + +H D+ N ++ E + KI DFG+++ + +TD R +G +G
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184
Query: 200 --YTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245
+ +PE ++ T +DV+SFGV+L EI + + + +++++
Sbjct: 185 VRWMSPE-SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 51/227 (22%)
Query: 40 EIGRGGSGRVYK----GCINGGKEIAVKKLIKIVEEGES-----EFRNEMKIIGRIHHKN 90
+IG+G GRV++ G + V +K+++E S +F+ E ++ H N
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVA--VKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR---------------------LSW 129
+V L+G C+ G L++E+M G L L R LS
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 130 SERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL------ 183
+E+ IA ++ G+ YL E + +H D+ N L+ E+ KI+DFGLS+ +
Sbjct: 130 TEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 184 KTDQTRTYTVLRGTRGYTAPE--LHSRNNRITVKADVYSFGVMLLEI 228
K + + + PE + NR T ++DV+++GV+L EI
Sbjct: 187 KASENDAIPIR-----WMPPESIFY---NRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 39/232 (16%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKG------CINGGKEIAVKKLIKIVEEGE-SEFR 77
+++ L + +G G G+V K N +AVK L E + S+
Sbjct: 9 LPRDRLTLG-----KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV 63
Query: 78 NE---MKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRA----------- 123
+E MK+IG+ HKN+++L+G C++ +V E+ +G+L + L RA
Sbjct: 64 SEMEMMKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPD 120
Query: 124 -----EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFG 178
E+ L+ + A ++ G+ +L + + IH D+ N+L+ E KI+DFG
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFG 177
Query: 179 LSK-LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
L++ + D R T R + APE + T ++DV+SFGV+L EI
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-16
Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN---EMKIIGRIHHKNLVDLV 95
E+IG+G G V+KG N +++ K+I + EE E E + E+ ++ + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G + + ++ E++ GS +LL L ++ I EI++GL YLH E + I
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKI 123
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H DIK N+L+ E + K++DFG++ L TD GT + APE+ + + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEV-IKQSAYDSK 181
Query: 216 ADVYSFGVMLLEI 228
AD++S G+ +E+
Sbjct: 182 ADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 35 ENFKEE--IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN----EMKIIGRIH 87
NFK E IG+G VYK C+ G+ +A+KK ++I E +++ R E+ ++ ++
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK-VQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQRLSWSERR--RIALEIMEGL 143
H N++ + E + +V E G L ++ F+ ++RL ER + +++ L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLCSAL 119
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
++H RI+H DIKP N+ + + K+ D GL + + T ++ L GT Y +P
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSP 175
Query: 204 ELHSRNNRITVKADVYSFGVMLLEIVCCR 232
E N K+D++S G +L E+ +
Sbjct: 176 ER-IHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 21/190 (11%)
Query: 54 INGGKEIAVKKLIKIVEEGESE-------FRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106
+ G +AVK+ + V SE R E++++ R++H +++ ++G E S+ L
Sbjct: 22 VKTGTLMAVKQ-VTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80
Query: 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIA--LEIMEGLHYLHDECETRIIHCDIKPHNI 164
E+M GS+ +LL + ++ E I +++ GL YLH+ +IIH D+K N+
Sbjct: 81 FVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANL 134
Query: 165 LMDESWK-AKISDFGLSKLLKTDQTRTYTV---LRGTRGYTAPELHSRNNRITVKADVYS 220
L+D + + +I+DFG + L T L GT + APE+ R + DV+S
Sbjct: 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-LRGEQYGRSCDVWS 193
Query: 221 FGVMLLEIVC 230
G +++E+
Sbjct: 194 VGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHH 88
+I S ++++G G G V+ N ++AVK + K F E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 60
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLH 147
LV L ++ ++ EFM GSL + L E + + + +I EG+ ++
Sbjct: 61 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE 204
+ IH D++ NIL+ S KI+DFGL+++++ ++ YT G + +TAPE
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPE 173
Query: 205 LHSRNNRITVKADVYSFGVMLLEIV 229
+ + T+K+DV+SFG++L+EIV
Sbjct: 174 AINFGS-FTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 38 KEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGES-EFRNEMKIIGRIHHKNLVDLV 95
EIGRG G V K G +AVK++ V+E E ++ ++ R + +V
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR--SSDCPYIV 66
Query: 96 GF----CSEGSNRLLVYEFMRNGSLGNLLFRA----EQRLSWSERRRIALEIMEGLHYLH 147
F EG + + E M + SL + + +IA+ ++ L+YL
Sbjct: 67 KFYGALFREG-DCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--L 205
+ E +IIH D+KP NIL+D + K+ DFG+S L +T G R Y APE
Sbjct: 125 E--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERID 180
Query: 206 HSRNNRITVKADVYSFGVMLLEI 228
S + V++DV+S G+ L E+
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 58/199 (29%), Positives = 108/199 (54%), Gaps = 15/199 (7%)
Query: 35 ENFKEEIGRGGSGRVYKGCI----NGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN 90
EN+ + IG G +G V CI + G+++AVK + ++ NE+ I+ H+N
Sbjct: 24 ENYIK-IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V++ G ++ EF++ G+L +++ ++ RL+ + + +++ L YLH +
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ- 136
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
+IH DIK +IL+ + K+SDFG + D + + L GT + APE+ SR
Sbjct: 137 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRTP 193
Query: 211 RITVKADVYSFGVMLLEIV 229
T + D++S G+M++E+V
Sbjct: 194 YGT-EVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKE-----IAVKKLIKIVEEGESEFRNEMKIIGRIHHKN 90
K E+G G G+V+ C N +AVK L +F+ E +++ + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLL---------------FRAEQRLSWSERRRI 135
+V G C +G ++V+E+M++G L L +A+ L S+ I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQTRT--YT 192
A +I G+ YL + +H D+ N L+ + KI DFG+S+ + TD R +T
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
+L R + R + T ++DV+SFGV+L EI
Sbjct: 186 MLP-IRWMPPESIMYR--KFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 23/203 (11%)
Query: 41 IGRGGSGRVYKGC--INGGKEIAVKKLIKIVEEGE-----SEFRNEMKIIGRIHHKNLVD 93
+G+G GRVY C ++ G+E+A K++ E E S E++++ + H+ +V
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 94 LVGFCSEGSNRLLV--YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
G + + + L E+M GS+ + L +A L+ S R+ +I+EG+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS--- 124
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT-----DQTRTYTVLRGTRGYTAPELH 206
I+H DIK NIL D + K+ DFG SK L+T R+ T GT + +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT---GTPYWMSPEVI 181
Query: 207 SRNNRITVKADVYSFGVMLLEIV 229
S KADV+S G ++E++
Sbjct: 182 S-GEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 19/201 (9%)
Query: 41 IGRGGSGRVYKGC--INGGKEIAVKKLIKIVEEGE-----SEFRNEMKIIGRIHHKNLVD 93
+G+G GRVY C + G+E+AVK++ E E + E++++ + H+ +V
Sbjct: 10 LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 94 LVGFCSEGSNRLL--VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
G + R L E M GS+ + L ++ L+ + R+ +I+EG+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLH---S 124
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT---DQTRTYTVLRGTRGYTAPELHSR 208
I+H DIK NIL D K+ DFG SK L+T T +V GT + +PE+ S
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEVIS- 182
Query: 209 NNRITVKADVYSFGVMLLEIV 229
KAD++S G ++E++
Sbjct: 183 GEGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 12/156 (7%)
Query: 77 RNEMKIIGRIHHKNLVDL-VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--R 133
+ E I+ ++H +V L F +EG L+ +F+R G +L R + + ++E +
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEG-KLYLILDFLRGG---DLFTRLSKEVMFTEEDVK 101
Query: 134 RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193
E+ L +LH II+ D+KP NIL+DE K++DFGLSK + + Y+
Sbjct: 102 FYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158
Query: 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
GT Y APE+ +R T AD +SFGV++ E++
Sbjct: 159 C-GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 40/242 (16%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKE---------------IAVKKL-IKIVEEGESEFRNEM 80
KE++G G G V+ G E +AVK L + + ++F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 81 KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR-----------LSW 129
KI+ R+ + N++ L+G C ++ E+M NG L L + E +S
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 130 SERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD--- 186
+ +A++I G+ YL +H D+ N L+ + KI+DFG+S+ L +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 187 --QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI 244
Q R +R + A E + T +DV++FGV L E+ K SL DE
Sbjct: 186 RIQGRAVLPIR----WMAWE-SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
Query: 245 VL 246
V+
Sbjct: 241 VI 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 33 ASENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESE-----FRNEMKIIGR 85
S + +G G G + +GC+ +E+ V I + G S+ F E +G+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVA--IHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 86 IHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY 145
H N+V L G + G+ ++V E+M NG+L + L + E +L + + + G+ Y
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRG--YTA 202
L E +H + H +L++ KIS F L+ D++ YT + G + A
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAA 176
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PE + + + +DV+SFG+++ E++
Sbjct: 177 PEA-IQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 15/177 (8%)
Query: 57 GKEIAVKKLIKIVEE---GESEFRNEMKIIGRIHHKNLVDLVG-FCSEGSNRLLVYEFMR 112
G+ +A+KK++K + +R E+K++ + H+N++ L F S + V E +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172
L LL + L + +I+ GL Y+H ++H D+KP NIL++E+
Sbjct: 94 T-DLHRLL--TSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDL 147
Query: 173 KISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
KI DFGL+++ Q T TR Y APE+ + V+ D++S G + E++
Sbjct: 148 KICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 39 EEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRN--EMKIIGRIHHKNLVDLV 95
E IG G G V GK++A+KK+ + R E+KI+ H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 96 GFC----SEGSNRLLVYEFMRNGSLGNL--LFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
++ + +V + M + +L + ++Q L+ R +++ GL Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLL---KTDQTRTYTVLRGTRGYTAPELH 206
+IH D+KP N+L++E + +I DFG+++ L T+ T TR Y APEL
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 207 SRNNRITVKADVYSFGVMLLEIV 229
T D++S G + E++
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 5e-15
Identities = 59/186 (31%), Positives = 90/186 (48%), Gaps = 26/186 (13%)
Query: 40 EIGRGGSGRVYKGCI---NGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIHHKNLV 92
IGRG GRVYK GKE A+KK E+ S R E+ ++ + H+N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVV 65
Query: 93 DLVGFCSEGSNRL--LVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLHYLH 147
LV E +++ L++++ + + F R +R+S + + +I+ G+HYLH
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125
Query: 148 DECETRIIHCDIKPHNILM----DESWKAKISDFGLSKL----LKTDQTRTYTVLRGTRG 199
++H D+KP NIL+ E KI D GL++L LK V+ T
Sbjct: 126 ---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV--TIW 180
Query: 200 YTAPEL 205
Y APEL
Sbjct: 181 YRAPEL 186
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 50/266 (18%)
Query: 36 NFKEEIGRGGSGRVY---KGCINGGKE--------------IAVKKLIKIV-EEGESEFR 77
NF E++G G G V+ + E +AVK L + +F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 78 NEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR----------L 127
E+KI+ R+ N+ L+G C+ ++ E+M NG L L + L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 128 SWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187
S+S +A +I G+ YL +H D+ N L+ +++ KI+DFG+S+ L
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---Y 181
Query: 188 TRTYTVLRGTRGYTAPELHSR--------NNRITVKADVYSFGVMLLEIVC-CRKNVDES 238
+ Y ++G L R + T K+DV++FGV L EI+ CR+ E
Sbjct: 182 SSDYYRVQGR-----APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 239 LRDDEIVLIDWAHQCYEAGELQNLVS 264
L D ++ I+ A + Q +
Sbjct: 237 LTDQQV--IENAGHFFRDDGRQIYLP 260
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 5e-15
Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 49/227 (21%)
Query: 41 IGRGGSGRVYKGC------INGGKEIAVKKLIKIVEEGESEFR---NEMKIIGRIHHKNL 91
+G G G+V K G +AVK L + SE R +E ++ +++H ++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE--NASSSELRDLLSEFNLLKQVNHPHV 65
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRA-----------------------EQRLS 128
+ L G CS+ LL+ E+ + GSL + L + E+ L+
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 129 WSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188
+ A +I G+ YL E +++H D+ N+L+ E K KISDFGLS+ + +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED- 181
Query: 189 RTYTVLRGTRG-----YTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
+ ++ ++G + A E S + I T ++DV+SFGV+L EIV
Sbjct: 182 ---SYVKRSKGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 6e-15
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 41 IGRGGSGRVYKGCING--GKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLV 95
IG G G V ++ G+++A+KK+ + + + + R E+K++ + H+N++ L+
Sbjct: 8 IGSGAYGVVCS-AVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLL 65
Query: 96 G-FCSEGSNRL----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V E M L ++ ++ Q L+ + +I+ GL YLH
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET-DLHKVI-KSPQPLTDDHIQYFLYQILRGLKYLH--- 120
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT-----YTVLRGTRGYTAPEL 205
+IH D+KP NIL++ + KI DFGL++ + D+ Y V TR Y APEL
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV---TRWYRAPEL 177
Query: 206 HSRNNRITVKADVYSFGVMLLEIV 229
++R T D++S G + E++
Sbjct: 178 LLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-15
Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 19/196 (9%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVE----EGESEFRNEMKIIGRIHHKNLVDLVG 96
+G G GRV+ + K++ I E + E NE +++ + H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 97 FCSEGSNRLL--VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
F +E R L + E++ G L + L R R S S A EI+ L YLH + I
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSK---EI 122
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE-LHSRNNRIT 213
++ D+KP NIL+D+ K++DFG +K L+ RT+T L GT Y APE + S+ +
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWT-LCGTPEYLAPEVIQSKGHNKA 178
Query: 214 VKADVYSFGVMLLEIV 229
V D ++ G+++ E++
Sbjct: 179 V--DWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFR--NEMKIIGRIHHKNLVDLVG- 96
+G G G+V G+++A+KKL + + R E++++ + H+N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 97 FCSEGSNR-----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
F S LV M L N++ Q+LS + + +I+ GL Y+H
Sbjct: 83 FTPASSLEDFQDVYLVTHLM-GADLNNIV--KCQKLSDDHIQFLVYQILRGLKYIH---S 136
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
IIH D+KP NI ++E + KI DFGL++ + T Y TR Y APE+
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-GYVA---TRWYRAPEIMLNWMH 192
Query: 212 ITVKADVYSFGVMLLEIVCCR 232
D++S G ++ E++ +
Sbjct: 193 YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-15
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 20/199 (10%)
Query: 41 IGRGGSGRVYKGC--INGGKEIAVK----KLIKIVEEGESEFRNEMKIIGRIHHKN--LV 92
IGRGG G VY GC + GK A+K K IK+ ++GE+ NE ++ + + +
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 59
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDEC 150
+ + ++L + NG G+L + Q +SE+ R A EI+ GL ++H+
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
+++ D+KP NIL+DE +ISD GL+ + GT GY APE+ +
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 211 RITVKADVYSFGVMLLEIV 229
AD +S G ML +++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-15
Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKL-IKIVEEG-ESEFRNEMKIIGRIHHKNLVDLV 95
E+IG G G VYKG G+ +A+KK+ ++ EEG S E+ ++ + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
+ S L++EF+ + L L Q + + +I++G+ + H R
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
++H D+KP N+L+D K++DFGL++ R YT T Y APE+ + R +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGSPRYS 180
Query: 214 VKADVYSFGVMLLEIV 229
D++S G + E+
Sbjct: 181 TPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 7e-15
Identities = 68/229 (29%), Positives = 111/229 (48%), Gaps = 29/229 (12%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRI-HHKNLVDLV 95
+G+G G+V + G E+ AVK L K I+++ + E E +++ H L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECET 152
C + +RL V E++ NG G+L+F ++ + E R A EI+ GL +LH E
Sbjct: 63 S-CFQTKDRLFFVMEYV-NG--GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ER 115
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
II+ D+K N+L+D KI+DFG+ K +L T T+ GT Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC---GTPDYIAPEI-LSYQ 171
Query: 211 RITVKADVYSFGVMLLEIVCCRKNVD--------ESLRDDEIVLIDWAH 251
D ++ GV+L E++ + + +S+ +DE+ W
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLS 220
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 33/222 (14%)
Query: 41 IGRGGSGRVY--------KGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV 92
IG G G++Y + C+ KEI + K+ V+E E+ + E+ ++ ++ H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVI--KEIDLTKMP--VKEKEAS-KKEVILLAKMKHPNIV 62
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSL-------GNLLFRAEQRLSWSERRRIALEIMEGLHY 145
E +V E+ G L +LF +Q LSW ++I GL +
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKH 116
Query: 146 LHDECETRIIHCDIKPHNILMDESWK-AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE 204
+HD +I+H DIK NI + ++ AK+ DFG+++ L YT + GT Y +PE
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPE 172
Query: 205 LHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVL 246
+ +N K D++S G +L E+ C K+ E ++VL
Sbjct: 173 I-CQNRPYNNKTDIWSLGCVLYEL-CTLKHPFEGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-15
Identities = 52/192 (27%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E+IG+G SG VY + G+E+A++++ + + NE+ ++ + N+V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
G +V E++ GSL +++ E + + + E ++ L +LH ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
DIK NIL+ K++DFG + +Q++ T++ GT + APE+ +R K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR-KAYGPKVD 198
Query: 218 VYSFGVMLLEIV 229
++S G+M +E++
Sbjct: 199 IWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 26/226 (11%)
Query: 25 FSYEQIVLASENFK---------EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE 75
F Y +L E+ E IG+G G+VYK +A K++ + + + E
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE 64
Query: 76 FRNEMKIIGRI-HHKNLVDLVGFCSE-----GSNRLLVYEFMRNGSLGNL---LFRAEQR 126
E I+ + +H N+V G + G LV E GS+ L L QR
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
L + I + GL +LH+ RIIH D+K +NIL+ K+ DFG+S L +
Sbjct: 125 LDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 187 QTRTYTVLRGTRGYTAPEL----HSRNNRITVKADVYSFGVMLLEI 228
+ R T + GT + APE+ + + DV+S G+ +E+
Sbjct: 182 RLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 32 LASENFKE--EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN----EMKIIGR 85
L ++F+ E+G G G V K I +KLI + E + RN E++++
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHE 59
Query: 86 IHHKNLVDLVG-FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLH 144
+ +V G F S+G + + E M GSL +L A +R+ ++++ ++ GL
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLA 117
Query: 145 YLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE 204
YL ++ +I+H D+KP NIL++ + K+ DFG+S L ++ GTR Y +PE
Sbjct: 118 YLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPE 172
Query: 205 LHSRNNRITVKADVYSFGVMLLEIVCCR 232
+ +V++D++S G+ L+E+ R
Sbjct: 173 -RLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 52/195 (26%), Positives = 101/195 (51%), Gaps = 15/195 (7%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
+GRG G V+ +++ + K I + ++ +NE +++ + H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIA---LEIMEGLHYLHDECETRI 154
E ++V E+ G+L + ++ S + I ++I+ LH++H + I
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTK---LI 122
Query: 155 IHCDIKPHNILMDESWK-AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
+H D+K NIL+D+ KI DFG+SK+L + +++ YTV+ GT Y +PEL
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTVV-GTPCYISPEL-CEGKPYN 179
Query: 214 VKADVYSFGVMLLEI 228
K+D+++ G +L E+
Sbjct: 180 QKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVG- 96
E +G G G+VYKG ++A K++ + + E E + E+ ++ + HH+N+ G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 97 FCSEGSNRL-----LVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDEC 150
F + + LV EF GS+ +L+ + L I EI+ GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 128
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL----H 206
+ ++IH DIK N+L+ E+ + K+ DFG+S L R T + GT + APE+
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 187
Query: 207 SRNNRITVKADVYSFGVMLLEI 228
+ + K+D++S G+ +E+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGF 97
E +G G G+VYKG ++A K++ + E+ E E + E+ ++ + HH+N+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 98 CSEGS-----NRL-LVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDEC 150
+ S ++L LV EF GS+ +L+ + L I EI+ GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL----H 206
++IH DIK N+L+ E+ + K+ DFG+S L R T + GT + APE+
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 197
Query: 207 SRNNRITVKADVYSFGVMLLEI 228
+ + ++D++S G+ +E+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 63/199 (31%), Positives = 89/199 (44%), Gaps = 15/199 (7%)
Query: 39 EEIGRGGSGRVYKGCIN--GGKEI--AVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVD 93
+++G G G V +G + GGK I AVK L + +F E I+ + H+NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 94 LVGFCSEGSNRLLVYEFMRNGSL-GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
L G ++V E GSL L A S A++I G+ YL
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKT--DQTRTYTVLRGTRGYTAPE-LHSRN 209
R IH D+ NIL+ K KI DFGL + L D L+ + APE L +R
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR- 175
Query: 210 NRITVKADVYSFGVMLLEI 228
+ +DV+ FGV L E+
Sbjct: 176 -TFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 56/207 (27%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 32 LASENFKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN----EMKIIGRI 86
LA+ +++IGRG VY+ C+ K +A+KK ++I E +++ R E+ ++ ++
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKK-VQIFEMMDAKARQDCVKEIDLLKQL 59
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQRLSWSERR--RIALEIMEG 142
+H N++ + E + +V E G L ++ F+ ++RL ER + +++
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI-PERTVWKYFVQLCSA 118
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
+ ++H R++H DIKP N+ + + K+ D GL + + T ++ L GT Y +
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 174
Query: 203 PE-LHSRNNRITVKADVYSFGVMLLEI 228
PE +H N K+D++S G +L E+
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 35/227 (15%)
Query: 29 QIVLASENFKEEIGRGGSGRVYKG-----CINGGKEIAVKKLIKIVEEGE-SEFRNEMKI 82
++ L++ F EE+G G++YKG ++ + +A+K L I + EF+ E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 83 IGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF----------------RAEQR 126
+ +HH N+V L+G ++ +++E++ G L L +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
L + IA++I G+ YL +H D+ NIL+ E KISD GLS+ + +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 187 -----QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
Q ++ +R + PE + + +D++SFGV+L EI
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEA-IMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 48/182 (26%), Positives = 95/182 (52%), Gaps = 11/182 (6%)
Query: 62 VKKLIKIVEEGESEFR---NEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGN 118
V K + + E E R NE+ I+ + H N++ + + L+ E+ G+L +
Sbjct: 29 VWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYD 88
Query: 119 LLFRAEQRLSWSERRRIAL--EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISD 176
+ R + +L + E + +I+ + Y+H + I+H DIK NI + ++ K+ D
Sbjct: 89 KIVRQKGQL-FEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGD 144
Query: 177 FGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVD 236
FG+SK+L ++ + TV+ GT Y +PEL + + K+D+++ G +L E++ ++ D
Sbjct: 145 FGISKILGSEYSMAETVV-GTPYYMSPEL-CQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
Query: 237 ES 238
+
Sbjct: 203 AT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 36 NFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE---SEFRNEMKIIGRIHHK 89
NF+ E+IG G G VYK G+ +A+KK I++ E E S E+ ++ ++H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHP 59
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
N+V L+ + LV+EF+ + + + ++++GL + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
R++H D+KP N+L++ K++DFGL++ RTYT T Y APE+
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGC 175
Query: 210 NRITVKADVYSFGVMLLEIV 229
+ D++S G + E+V
Sbjct: 176 KYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 25/212 (11%)
Query: 32 LASENFKE--EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN----EMKIIGR 85
L ++F++ E+G G G V+K I +KLI + E + RN E++++
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHE 59
Query: 86 IHHKNLVDLVG-FCSEGSNRLLVYEFMRNGSLGNLLFRA----EQRLSWSERRRIALEIM 140
+ +V G F S+G + + E M GSL +L +A EQ L ++++ ++
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 113
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
+GL YL ++ +I+H D+KP NIL++ + K+ DFG+S L ++ GTR Y
Sbjct: 114 KGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSY 168
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
+PE + +V++D++S G+ L+E+ R
Sbjct: 169 MSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 63/221 (28%), Positives = 88/221 (39%), Gaps = 41/221 (18%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
IGRG G V+ ++ A+K L K I + R E I+ +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL-- 66
Query: 97 FCS-EGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ S + L LV E+M G L NLL R + R E++ L +H
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHK---LGF 122
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR------------------- 195
IH DIKP NIL+D K++DFGL K + + R Y +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 196 ---------GTRGYTAPELHSRNNRITVKADVYSFGVMLLE 227
GT Y APE+ R ++ D +S GV+L E
Sbjct: 183 RRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVK---KLIKIVEEGESE---FRNEMKIIGRIHHKNLVDL 94
+G G G V +G ++ +K K +K+ SE F +E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 95 VGFCSEGSNR------LLVYEFMRNGSLGNLLFR-----AEQRLSWSERRRIALEIMEGL 143
+G C E S+ +++ FM++G L + L ++L + ++I G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
YL + IH D+ N ++ E ++DFGLSK + + R R P
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-----DYYRQGRIAKMP 178
Query: 204 ----ELHSRNNRI-TVKADVYSFGVMLLEI 228
+ S +R+ T K+DV++FGV + EI
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 41 IGRGGSGRVYKGC--INGGKEIAVK----KLIKIVEEGESEFRNEMKIIGRIHHKN--LV 92
IGRGG G VY GC + GK A+K K IK+ ++GE+ NE ++ + + +
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKM-KQGETLALNERIMLSLVSTGDCPFI 59
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSERRRIALEIMEGLHYLHDEC 150
+ + ++L + NG G+L + Q S +E R A EI+ GL ++H+
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNG--GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
+++ D+KP NIL+DE +ISD GL+ + GT GY APE+ +
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 211 RITVKADVYSFGVMLLEIV 229
AD +S G ML +++
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 59/198 (29%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIKIVEE-----GESEFRNEMKIIGRIHHKNLVDL 94
+G G G VYKG + G+ + + IKI+ E EF +E I+ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+G C + +L V + M +G L + + + + ++I +G+ YL E R+
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRL 130
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR--GYTAPE-LHSRNNR 211
+H D+ N+L+ KI+DFGL++LL+ D+ + Y G + A E +H R +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGKMPIKWMALECIHYR--K 187
Query: 212 ITVKADVYSFGVMLLEIV 229
T ++DV+S+GV + E++
Sbjct: 188 FTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 15/196 (7%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+G+GG G V + GK A KKL K +GE+ NE +I+ +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECETR 153
+ E + L LV M G L ++ + E R + A EI GL LH E R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLHRE---R 122
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
I++ D+KP NIL+D+ +ISD GL+ + +T V GT GY APE+ +N R T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEV-VKNERYT 179
Query: 214 VKADVYSFGVMLLEIV 229
D + G ++ E++
Sbjct: 180 FSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGE-SEFRNEMKIIGRIHHKNLVDLVG 96
IG+G G+VY+ + I A+K L K IV + E + E I+ R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 97 --FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRR---IALEIMEGLHYLHDEC 150
F + + L LV ++M S G L + ++ +SE R IA E++ L +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYM---SGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH--- 113
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELHSR 208
+ I++ D+KP NIL+D + + DFGLSK L T T+ GT Y APE+
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLLD 170
Query: 209 NNRITVKADVYSFGVMLLEIVC 230
T D +S GV++ E+ C
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIH 87
+ ++ I G G VY+ G+ +A+KK +K+ +E E + R E+ I+ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKK-LKMEKEKEGFPITSLR-EINILLKLQ 62
Query: 88 HKNLVDL----VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGL 143
H N+V + VG S +V E++ + L +L+ +Q SE + + L+++ G+
Sbjct: 63 HPNIVTVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
+LHD I+H D+K N+L++ KI DFGL++ + YT L T Y AP
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAP 175
Query: 204 ELHSRNNRITVKADVYSFGVMLLEI 228
EL + D++S G + E+
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHH-KNLVDLV 95
EIG G G+VYK G +AVK++ + +E ++ ++ + H +V
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G+ S+ + E M L LL R + + ++ + I++ LHYL ++ +I
Sbjct: 81 GYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVI 137
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT-- 213
H D+KP NIL+D S K+ DFG+S L + +T + G Y APE RI
Sbjct: 138 HRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPE------RIDPP 189
Query: 214 -------VKADVYSFGVMLLEIV 229
++ADV+S G+ L+E+
Sbjct: 190 DPNPKYDIRADVWSLGISLVELA 212
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 19/104 (18%)
Query: 134 RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193
+IA+ I++ L YLH + +IH D+KP N+L++ + + K+ DFG+S L + T+
Sbjct: 107 KIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TI 162
Query: 194 LRGTRGYTAPELHSRNNRIT---------VKADVYSFGVMLLEI 228
G + Y APE RI VK+DV+S G+ ++E+
Sbjct: 163 DAGCKPYMAPE------RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-14
Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 27/202 (13%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+G+GG G V + GK A K+L K +GES NE +I+ +++ + +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 97 FCSEGSNRL-LVYEFMRNGSL-------GNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
+ E + L LV M G L GN F E+ L + A EI+ GL LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY------AAEILCGLEDLHR 120
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAPELHS 207
E ++ D+KP NIL+D+ +ISD GL+ K+ + + R GT GY APE+
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEV-L 173
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
N R T+ D + G ++ E++
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 37 FKEEIGRGGSGRVYKGCINGG---KEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNL 91
F++ IG G G+V K I + A+K++ + ++ +F E++++ ++ HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLL---------------FRAEQRLSWSERRRIA 136
++L+G C L E+ +G+L + L LS + A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG 196
++ G+ YL + + IH D+ NIL+ E++ AKI+DFGLS+ + +T G
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM----G 183
Query: 197 TRGYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
+ S N + T +DV+S+GV+L EIV
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-14
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 41 IGRGGSGRVYKGCI--NGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRI-HHKNLVDLV 95
IG G G+V K I +G + A K +K ++ +F E++++ ++ HH N+++L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQR-----------------LSWSERRRIAL 137
G C +R +Y + GNLL F + R LS + A
Sbjct: 63 GACE---HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGT 197
++ G+ YL + + IH D+ NIL+ E++ AKI+DFGLS+ + +T G
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM----GR 172
Query: 198 RGYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
+ S N + T +DV+S+GV+L EIV
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 54/207 (26%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 32 LASENFKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFR----NEMKIIGRI 86
LA+ +++IGRG VY+ C+ G +A+KK ++I + +++ R E+ ++ ++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKK-VQIFDLMDAKARADCIKEIDLLKQL 59
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQRLSWSERR--RIALEIMEG 142
+H N++ E + +V E G L ++ F+ ++RL E+ + +++
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI-PEKTVWKYFVQLCSA 118
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
L ++H R++H DIKP N+ + + K+ D GL + + T ++++ GT Y +
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 203 PE-LHSRNNRITVKADVYSFGVMLLEI 228
PE +H N K+D++S G +L E+
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 40 EIGRGGSGRVYKG--CINGGKEIAVKKL-IKIVEEGE--SEFRNEMKIIGRIH---HKNL 91
EIG G G+V+K NGG+ +A+K++ ++ EEG S R E+ ++ + H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNV 66
Query: 92 VDLVGFCS-----EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYL 146
V L C+ + LV+E + L E + + + +++ GL +L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 147 HDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELH 206
H R++H D+KP NIL+ S + K++DFGL+++ T V+ T Y APE+
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVL 181
Query: 207 SRNNRITVKADVYSFGVMLLEI 228
+++ T D++S G + E+
Sbjct: 182 LQSSYAT-PVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 8/176 (4%)
Query: 62 VKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF 121
+KK + + +E S F E I+ + + L + N LV E+ G L +LL
Sbjct: 34 MKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN 93
Query: 122 RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181
R E + + E++ +H +H + +H DIKP N+L+D + K++DFG +
Sbjct: 94 RYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150
Query: 182 LLKTDQTRTYTVLRGTRGYTAPEL-----HSRNNRITVKADVYSFGVMLLEIVCCR 232
L ++ + GT Y APE+ V+ D +S GV+ E++ R
Sbjct: 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 31 VLASENFKEE--IGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGES-----EFRNEMKI 82
+L FK+ +G G G VYKG I G+++ + IK + E S E +E +
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 83 IGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
+ + + ++ L+G C S L+ + M G L + + + + ++I +G
Sbjct: 63 MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
++YL E R++H D+ N+L+ KI+DFGL+KLL D+ + Y G
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE-KEYHAEGGKVPIKW 177
Query: 203 PELHSRNNRI-TVKADVYSFGVMLLEIV 229
L S +RI T ++DV+S+GV + E++
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGE---SEFRNEMKIIGRIHHKNLVDL 94
E+IG G G VYK G+ +A+KK I++ E E S E+ ++ ++H N+V L
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKK-IRLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETR 153
+ + LV+EF+ + L + + L + ++++G+ Y H R
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---R 119
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSRNNR 211
++H D+KP N+L+D K++DFGL++ RTYT T Y APE L SR
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGSRQYS 178
Query: 212 ITVKADVYSFGVMLLEIV 229
V D++S G + E+V
Sbjct: 179 TPV--DIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 58/215 (26%), Positives = 106/215 (49%), Gaps = 32/215 (14%)
Query: 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESE--------- 75
YE++ +IG G G V+K C N G+ +A+KK + ESE
Sbjct: 3 YEKL--------SKIGEGSYGVVFK-CRNRETGQIVAIKKFV------ESEDDPVIKKIA 47
Query: 76 FRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI 135
R E++++ ++ H NLV+L+ LV+E+ + ++ N L + + + ++I
Sbjct: 48 LR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKI 105
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195
+ ++ +++ H + IH D+KP NIL+ + + K+ DFG +++L T YT
Sbjct: 106 IWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYV 161
Query: 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230
TR Y APEL + + DV++ G + E++
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 27/222 (12%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+G+GG G V + GK A KKL K +GE+ NE +I+ +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECETR 153
+ E + L LV M G L ++ + E+R I A E+ GL L E R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQRE---R 122
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
I++ D+KP NIL+D+ +ISD GL+ + +T V GT GY APE+ N + T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEV-INNEKYT 179
Query: 214 VKADVYSFGVMLLEIV------------CCRKNVDESLRDDE 243
D + G ++ E++ R+ VD +++D+
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 69/266 (25%), Positives = 125/266 (46%), Gaps = 27/266 (10%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIKIVEE--GESEFR---NEMKIIGRIHHKNLVDL 94
+G G G V+KG I G I + IK +++ G F+ + M +G + H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+G C G++ LV + GSL + + + L ++I +G++YL E R+
Sbjct: 75 LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRM 130
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPE-LHSRNNRI 212
+H ++ NIL+ +I+DFG++ LL D + Y+ + + A E + R
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG--RY 188
Query: 213 TVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272
T ++DV+S+GV + E++ +R E+ E GE ++ + I+
Sbjct: 189 THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEKGE---RLAQPQICTID 239
Query: 273 EFENLVKIGLWCVECELNLRPTMKQV 298
+ +VK C + N+RPT K++
Sbjct: 240 VYMVMVK----CWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 38 KEEIGRGGSGRVYKGCING--GKEIAVK-KLIKIVEEGE--SEFRNEMKIIGRIHHKNLV 92
IG G G VY+G ++IAV K K +F E I+ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
L+G +E + +V E G L + L + L + + ++ L YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN-NR 211
R +H DI N+L+ K+ DFGLS+ L+ + + + + APE S N R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE--SINFRR 184
Query: 212 ITVKADVYSFGVMLLEI 228
T +DV+ FGV + EI
Sbjct: 185 FTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-13
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIA---VKKLIKIVEEGES-EFRNEMKIIGRIHHKNLVDL 94
+EIG G G+V G + G A VK+L E F E++ ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERR----RIALEIMEGLHYLHDEC 150
+G C E LLV EF G L N L ++ ++ R+A E+ GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAPEL-HSR 208
+ IH D+ N + KI D+GL+ + D T + APEL R
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 209 NNRI-----TVKADVYSFGVMLLEI 228
+ T K++++S GV + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 15/195 (7%)
Query: 40 EIGRGGSGRVYKG-CINGGKEIAVKKLI---KIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
EIG G G VY + + +A+KK+ K E + E++ + ++ H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G LV E+ GS ++L ++ L E I ++GL YLH I
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---I 137
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSRNNRIT 213
H DIK NIL+ E K++DFG + L+ + GT + APE L +
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMDEGQYD 192
Query: 214 VKADVYSFGVMLLEI 228
K DV+S G+ +E+
Sbjct: 193 GKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 40 EIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG-ESEFRNEMKIIGRIHHK----NLVD 93
E+G G G V KG K+I V IK+++ E R+EM I H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVA--IKVLKNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
++G C E +LV E G L L + ++ S + ++ G+ YL
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKN 115
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRN 209
+H D+ N+L+ AKISDFGLSK L D + Y + + APE ++ R
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-YYKARSAGKWPLKWYAPECINFR- 173
Query: 210 NRITVKADVYSFGVMLLE 227
+ + ++DV+S+G+ + E
Sbjct: 174 -KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 40 EIGRGGSGRVYKGCIN---GGKEIAVKKLIKIVEEGESEFRNEM----KIIGRIHHKNLV 92
E+G G G V KG K +AVK L + + ++E+ ++ ++ + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKN--DNNDPALKDELLREANVMQQLDNPYIV 59
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIAL--EIMEGLHYLHDEC 150
++G C E + +LV E G L L ++ +E+ L ++ G+ YL
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLE--- 112
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT--RTYTVLRGTRGYTAPELHSR 208
ET +H D+ N+L+ AKISDFGLSK L D+ + T + + APE +
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 209 NNRITVKADVYSFGVMLLE 227
+ + K+DV+SFGV++ E
Sbjct: 173 -YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 40/242 (16%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKL-------------IKIVEE-----GESEFRN 78
FKE++G G G V+ G ++ K +K++ E ++F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 79 EMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR----------LS 128
E+KI+ R+ N++ L+ C ++ E+M NG L L R E + +S
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 129 WSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188
+S +A +I G+ YL +H D+ N L+ +++ KI+DFG+S+ L +
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD- 184
Query: 189 RTYTVLRGTRGYTAPELHSRNN----RITVKADVYSFGVMLLEIVC-CRKNVDESLRDDE 243
Y ++G R S + + T +DV++FGV L EI+ C++ L D++
Sbjct: 185 --YYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
Query: 244 IV 245
++
Sbjct: 242 VI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 41 IGRGGSGRVYKGCI-NGGKEIAVKKLIK--IVEEGESEFR-NEMKIIGRIHHKNLVDLVG 96
+G+G G+V + G+ AVK L K I+++ + E E +I+ + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 97 FCSEGSNRLL-VYEFMRNGSLGNLLFRAEQRLSWSERRR--IALEIMEGLHYLHDECETR 153
C + +RL V EF+ NG G+L+F ++ + E R A EI L +LHD+
Sbjct: 63 CCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---G 116
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
II+ D+K N+L+D K++DFG+ K + T T GT Y APE+ +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEI-LQEMLYG 174
Query: 214 VKADVYSFGVMLLEIVCCR-----KNVD---ESLRDDEIVLIDWAHQ 252
D ++ GV+L E++C +N D E++ +DE+V W Q
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQ 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 18/183 (9%)
Query: 57 GKEIAVKKLIKIVEEGESEFR--NEMKIIGRIHHKNLVDLV--------GFCSEGSNRLL 106
GK +A+KK+ + + S R E+K++ H N++ + E +
Sbjct: 25 GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE---IYV 81
Query: 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166
V E M++ L ++ Q LS + +I+ GL YLH I+H DIKP N+L+
Sbjct: 82 VTELMQS-DLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLV 136
Query: 167 DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLL 226
+ + KI DFGL+++ + D+++ T T+ Y APE+ + T D++S G +
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196
Query: 227 EIV 229
E++
Sbjct: 197 ELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 40 EIGRGGSGRV----YKGCINGGKEIAVKKLIKIVEEGESEFR--NEMKIIGRIH---HKN 90
E+G+G G V + + +A+KK+ + + R E+K++ H HKN
Sbjct: 7 ELGQGAYGIVCSARNAE-TSEEETVAIKKITNVFSKKILAKRALRELKLL--RHFRGHKN 63
Query: 91 ---LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
L D+ N L +YE + L + + R+ Q L+ + + +I+ GL Y+H
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADL-HQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG---TRGYTAPE 204
++H D+KP N+L++ + KI DFGL++ + + TR Y APE
Sbjct: 123 ---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 205 LHSRNNRITVKADVYSFGVMLLEI 228
+ T DV+S G +L E+
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGK--EIAVKKL--IKIVEEGESE-FRNEMKIIGRIHHKN 90
NF +G G GRV +A+K+ KI+++ + + +E KI+ I+H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
V+L G + S LV EF+ G L R +R A +I+ YL
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVLIFEYLQ--- 148
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL----- 205
I++ D+KP N+L+D+ K++DFG +K++ TRTYT L GT Y APE+
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVG 204
Query: 206 HSRNNRITVKADVYSFGVMLLEIV 229
H + AD ++ G+ + EI+
Sbjct: 205 HGK------AADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGES-----EFRNEMKIIGRIHHKNLVDL 94
+G G G VYKG I G+ + + IK++ E S E +E ++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+G C S LV + M G L + + + R+ + ++I +G+ YL E R+
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRL 130
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS-RNNRIT 213
+H D+ N+L+ KI+DFGL++LL D+T Y G L S + R T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE-YHADGGKVPIKWMALESILHRRFT 189
Query: 214 VKADVYSFGVMLLEIV 229
++DV+S+GV + E++
Sbjct: 190 HQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE---SEFRNEMKIIGRIHHKNLVDLV 95
E+IG G G VYK E K I++ +E E S E+ ++ + H N+V L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIA----LEIMEGLHYLHDECE 151
LV+E++ +L + +++ R+ +I+ G+ Y H
Sbjct: 68 DVVHSEKRLYLVFEYLDL----DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 152 TRIIHCDIKPHNILMDESWKA-KISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
R++H D+KP N+L+D A K++DFGL++ RT+T T Y APE+ +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVVTLWYRAPEILLGSR 179
Query: 211 RITVKADVYSFGVMLLEIV 229
+ D++S G + E+V
Sbjct: 180 HYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/184 (30%), Positives = 95/184 (51%), Gaps = 31/184 (16%)
Query: 63 KKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR 122
K L +V E E MK+IG+ HKN+++L+G C++ ++ E+ G+L L R
Sbjct: 59 KDLSDLVSEMEM-----MKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYL-R 110
Query: 123 A----------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166
A E++L++ + A ++ G+ YL + + IH D+ N+L+
Sbjct: 111 ARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167
Query: 167 DESWKAKISDFGLSK-LLKTDQTRTYTVLRGTRGYTAPELHSRNNRI-TVKADVYSFGVM 224
E KI+DFGL++ + D + T R + APE + +R+ T ++DV+SFGV+
Sbjct: 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVL 225
Query: 225 LLEI 228
L EI
Sbjct: 226 LWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 41 IGRGGSGRVYKGC--INGGKEIAVKKLIKIVEEGESE-----FRNEMKIIGRIHHKNLVD 93
+GRG G VY C + G+E+AVK++ + E+ E++++ + H +V
Sbjct: 10 LGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 94 LVGFCSEGSNRLL--VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
G + + L E+M GS+ + L +A L+ + RR +I++G+ YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHS--- 124
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT---DQTRTYTVLRGTRGYTAPELHSR 208
I+H DIK NIL D + K+ DFG SK ++T T +V GT + +PE+ S
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV-TGTPYWMSPEVIS- 182
Query: 209 NNRITVKADVYSFGVMLLEIV 229
KADV+S ++E++
Sbjct: 183 GEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 41 IGRGGSGRVYKGC--ING--GKEIAVKKLIKIVEEGESEFRN--EMKIIGRIHHKNLVDL 94
IGRG G V C N +++A+KK+ + R E+K++ + H+N++ +
Sbjct: 13 IGRGAYGIV---CSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 95 VGFCSEGSNR-----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
+VYE M + L ++ R+ Q LS + +++ GL Y+H
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQII-RSSQTLSDDHCQYFLYQLLRGLKYIH-- 125
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELHS 207
++H D+KP N+L++ + KI DFGL++ K D Y V TR Y APEL
Sbjct: 126 -SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV---TRWYRAPELLL 181
Query: 208 RNNRITVKADVYSFGVMLLEI 228
+ T DV+S G + E+
Sbjct: 182 NCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 35 ENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE--SEFRNEMKIIGRIHHKN 90
E+F+ + IG G G VYK E+A K+IK+ E GE + + E+ ++ H N
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL-EPGEDFAVVQQEIIMMKDCKHSN 67
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V G + EF GSL ++ + LS S+ ++ E ++GL+YLH +
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDI-YHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS--R 208
+ +H DIK NIL+ ++ K++DFG+S + + + + GT + APE+ + R
Sbjct: 127 K---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER 182
Query: 209 NNRITVKADVYSFGVMLLEI 228
D+++ G+ +E+
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 52/182 (28%), Positives = 96/182 (52%), Gaps = 20/182 (10%)
Query: 57 GKEIAVKKLIKIVEE---GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR------LLV 107
G ++A+KKL + + + +R E++++ + H+N++ L+ + + LV
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98
Query: 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD 167
FM LG L+ ++LS + + ++++GL Y+H IIH D+KP N+ ++
Sbjct: 99 MPFM-GTDLGKLM--KHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVN 152
Query: 168 ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLE 227
E + KI DFGL++ +TD T V+ TR Y APE+ T D++S G ++ E
Sbjct: 153 EDCELKILDFGLAR--QTDSEMTGYVV--TRWYRAPEVILNWMHYTQTVDIWSVGCIMAE 208
Query: 228 IV 229
++
Sbjct: 209 ML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 41 IGRGGSGRVYKGCINGGKEI---AVKKL-IKIVEEGESE-FRNEMKIIGRIHHKNLVDLV 95
+G G G V +G +N I AVK + I I E E F +E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 96 GFCSEGSNR------LLVYEFMRNGSLGNLLFRAE-----QRLSWSERRRIALEIMEGLH 144
G C + +++ FM++G L + L + Q L + +I G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 145 YLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAP 203
YL + IH D+ N +++E+ ++DFGLS K+ D R + + + A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 204 ELHSRNNRI-TVKADVYSFGVMLLEI 228
E S +R+ T K+DV+SFGV + EI
Sbjct: 184 E--SLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 9/212 (4%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIV-EEGE--SEFRNEMKIIGRIHHKNLVDLV 95
E++G G V+KG + + K I++ EEG + R E+ ++ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+ LV+E++ + L + +S + +I+ GL Y H +++
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVL 126
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H D+KP N+L++E + K++DFGL++ K+ T+TY+ T Y P++ ++ + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 216 ADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI 247
D++ G + E+ R S +DE+ LI
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 54/184 (29%), Positives = 94/184 (51%), Gaps = 31/184 (16%)
Query: 63 KKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR 122
K L ++ E E MK+IG+ HKN+++L+G C++ ++ E+ G+L L R
Sbjct: 59 KDLADLISEMEL-----MKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-R 110
Query: 123 A----------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166
A E++LS+ + A ++ G+ YL R IH D+ N+L+
Sbjct: 111 ARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167
Query: 167 DESWKAKISDFGLSK-LLKTDQTRTYTVLRGTRGYTAPELHSRNNRI-TVKADVYSFGVM 224
E KI+DFGL++ + D + + R + APE + +R+ T ++DV+SFG++
Sbjct: 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGIL 225
Query: 225 LLEI 228
+ EI
Sbjct: 226 MWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 19/198 (9%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEFRN-EMKIIG-RIHHKNLVDLV 95
+G+G G+V + G E A+K L K ++E+ + E E +++ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 96 GFCSEGSNRLL--VYEFMRNGSLGNLLFRAEQRLSWSERRR--IALEIMEGLHYLHDECE 151
FC+ + L V E++ NG G+L+F + + E R A EI+ GL +LH +
Sbjct: 62 -FCTFQTKEHLFFVMEYL-NG--GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---K 114
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
II+ D+K N+L+D+ KI+DFG+ K + + T GT Y APE+ + +
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEI-LKGQK 172
Query: 212 ITVKADVYSFGVMLLEIV 229
D +SFGV+L E++
Sbjct: 173 YNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 60/192 (31%), Positives = 101/192 (52%), Gaps = 30/192 (15%)
Query: 59 EIAVKKLIKIVEEGE-SEFRNEM---KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114
++AVK L E + S+ +EM K+IG+ HKN+++L+G C++ ++ E+ G
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 115 SLGNLLFRA----------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158
+L L RA E++LS+ + A ++ G+ YL + + IH D
Sbjct: 110 NLREYL-RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRD 165
Query: 159 IKPHNILMDESWKAKISDFGLSK-LLKTDQTRTYTVLRGTRGYTAPELHSRNNRI-TVKA 216
+ N+L+ E KI+DFGL++ + D + T R + APE + +RI T ++
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE--ALFDRIYTHQS 223
Query: 217 DVYSFGVMLLEI 228
DV+SFGV+L EI
Sbjct: 224 DVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 39 EEIGRGGSGRVYK--GCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLV 95
E IG+G G+V+K NG K A K++ + + + E E I+ + H N+V
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSK--AAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 96 GF-----CSEGSNRLLVYEFMRNGSLGNL---LFRAEQRLSWSERRRIALEIMEGLHYLH 147
G G LV E GS+ +L + +R+ I E + GL +LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-- 205
+ IH D+K +NIL+ K+ DFG+S L + + R T + GT + APE+
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 206 --HSRNNRITVKADVYSFGVMLLEI 228
++ + DV+S G+ +E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 35/209 (16%)
Query: 44 GGSGRVYKGCIN---GGKEIAVKKLIKIVEEGESE------FRNEMKIIGRIHHKNLVDL 94
G GR++ G + GKE V +K V++ SE + + G + H+N++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEV--FVKTVKDHASEIQVTLLLQESCLLYG-LSHQNILPI 73
Query: 95 VGFCSEGSNRLLV-YEFMRNGSLGNLL-------FRAEQRLSWSERRRIALEIMEGLHYL 146
+ C E V Y +M G+L L Q LS + +A++I G+ YL
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 147 HDECETRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQTRTYTVL-----RGTRGY 200
H + +IH DI N ++DE + KI+D LS+ L D Y L R + +
Sbjct: 134 H---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD----YHCLGDNENRPVK-W 185
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIV 229
A E N + +DV+SFGV+L E++
Sbjct: 186 MALE-SLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 40/213 (18%)
Query: 58 KEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL- 116
KEI + K+ E E R E+ ++ + H N+V E N +V ++ G L
Sbjct: 31 KEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLY 87
Query: 117 ------GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170
+LF +Q L W ++I L ++HD +I+H DIK NI + +
Sbjct: 88 KKINAQRGVLFPEDQILDW------FVQICLALKHVHDR---KILHRDIKSQNIFLTKDG 138
Query: 171 KAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230
K+ DFG++++L + T + GT Y +PE+ N K+D+++ G +L E+ C
Sbjct: 139 TIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEI-CENRPYNNKSDIWALGCVLYEM-C 195
Query: 231 CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263
K+ +EAG ++NLV
Sbjct: 196 TLKHA------------------FEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-12
Identities = 52/184 (28%), Positives = 95/184 (51%), Gaps = 31/184 (16%)
Query: 63 KKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR 122
K L +V E E MK+IG+ HKN+++L+G C++ ++ E+ G+L L R
Sbjct: 62 KDLSDLVSEMEM-----MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYL-R 113
Query: 123 A----------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166
A ++++++ + ++ G+ YL + + IH D+ N+L+
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170
Query: 167 DESWKAKISDFGLSKLLKT-DQTRTYTVLRGTRGYTAPELHSRNNRI-TVKADVYSFGVM 224
E+ KI+DFGL++ + D + T R + APE + +R+ T ++DV+SFGV+
Sbjct: 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVL 228
Query: 225 LLEI 228
+ EI
Sbjct: 229 MWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-12
Identities = 50/206 (24%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 26 SYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFR--NEMKII 83
SYE++ E++G G VYKG ++ K+I++ EE + F E ++
Sbjct: 6 SYEKL--------EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL 57
Query: 84 GRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGL 143
+ H N+V L LV+E++ L + + L + +++ GL
Sbjct: 58 KGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGL 116
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
Y+H + I+H D+KP N+L+ ++ + K++DFGL++ K+ + TY+ T Y P
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPP 172
Query: 204 ELHSRNNRITVKADVYSFGVMLLEIV 229
++ + + D++ G + +E++
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 41 IGRGGSGRVY----KGCINGGKEIAVKKLIK--IVEEGES--EFRNEMKIIGRIHHKNLV 92
+G G G+V+ G + GK A+K L K IV++ ++ R E +++ + +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 93 DLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
+ + + +L L+ +++ G L L++ E + SE R EI+ L +LH +
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---Q 123
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNN 210
II+ DIK NIL+D ++DFGLSK ++ R Y+ GT Y APE+ +
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGGS 182
Query: 211 RITVKA-DVYSFGVMLLEIV 229
KA D +S GV+ E++
Sbjct: 183 GGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 43/159 (27%), Positives = 84/159 (52%), Gaps = 17/159 (10%)
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYL 146
+ N + L + +L+ +++++G L +LL + E +LS +E ++I +++E L+ L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVEALNDL 125
Query: 147 HDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE- 204
H + IIH DIK N+L D + + + D+GL K++ T + GT Y +PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEK 177
Query: 205 LHSRNNRITVKADVYSFGVMLLEIVCCR----KNVDESL 239
+ N ++ D ++ GV+ E++ + ++ DE L
Sbjct: 178 IKGHNYDVSF--DWWAVGVLTYELLTGKHPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS 99
+G G +G V+ + K +AVKK++ + E+KII R+ H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 100 EGSNRL--------------LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY 145
+ L +V E+M L N+L + LS R +++ GL Y
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLSEEHARLFMYQLLRGLKY 129
Query: 146 LHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRTYTVLRG--TRGYTA 202
+H ++H D+KP N+ ++ E KI DFGL++++ + + G T+ Y +
Sbjct: 130 IH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
P L N T D+++ G + E++
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 63/197 (31%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 39 EEIGRGGSGRVYKGCINGGKEI-AVKKLIKIVEEGESEFR---NEMKIIGRIHHKNLVDL 94
++G+GG G+V+ EI A+K++ K + +E R E I+ + LV L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ + L E++ G LL LS R E+ E + LH E
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALH---ELGY 122
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE-LHSRNNRIT 213
IH D+KP N L+D S K++DFGLSK + T +V+ G+ Y APE L + T
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVLRGKGYDFT 178
Query: 214 VKADVYSFGVMLLEIVC 230
V D +S G ML E +C
Sbjct: 179 V--DYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 13/219 (5%)
Query: 36 NFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKI-VEEGE-SEFRNEMKIIGRIHHKNL 91
NFK E++G G VYKG EI K I + EEG S E+ ++ + H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDEC 150
V L + +LV+E+M + + L + + ++++G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--- 117
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSR 208
E R++H D+KP N+L+++ + K++DFGL++ T++ T Y AP+ L SR
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI-PVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 209 NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI 247
++ D++S G ++ E++ R + +D+++ I
Sbjct: 177 TYSTSI--DIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 41 IGRGGSGRVYKG--CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIHHK 89
IG G G V G K +A+KK+ S F + E+KI+ R H+
Sbjct: 13 IGEGAYGMVCSATHKPTGVK-VAIKKI--------SPFEHQTFCQRTLREIKILRRFKHE 63
Query: 90 NLVDLVGFCSEGS-----NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLH 144
N++ ++ S + +V E M L L+ Q LS + +I+ GL
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILRGLK 120
Query: 145 YLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL--LKTDQTRTYTVLRGTRGYTA 202
Y+H ++H D+KP N+L++ + KI DFGL+++ + D T T TR Y A
Sbjct: 121 YIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIVCCR 232
PE+ + T D++S G +L E++ R
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 15/195 (7%)
Query: 40 EIGRGGSGRVYKGCINGGKEI-AVKKLI---KIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
EIG G G VY + E+ AVKK+ K E + E+K + ++ H N ++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G + LV E+ GS +LL ++ L E I ++GL YLH +I
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSRNNRIT 213
H DIK NIL+ E + K++DFG + + GT + APE L +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAPEVILAMDEGQYD 198
Query: 214 VKADVYSFGVMLLEI 228
K DV+S G+ +E+
Sbjct: 199 GKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNL 91
NF +G+G G+V G E+ A+K L K I+++ + E E +++
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 92 VDLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHD 148
+ + C + +RL V E++ NG G+L++ +Q + E + A EI GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELH 206
+ II+ D+K N+++D KI+DFG+ K + TRT+ GT Y APE+
Sbjct: 120 K---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAPEII 173
Query: 207 SRNNRITVKADVYSFGVMLLEIV 229
+ D ++FGV+L E++
Sbjct: 174 A-YQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKL---IKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+G G G V G +AVKKL + + + +R E++++ + H+N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 97 FCS-----EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
+ E N + + + L N++ Q+L+ + + +I+ GL Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIH---S 138
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
IIH D+KP N+ ++E + KI DFGL++ TD T V TR Y APE+
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV--ATRWYRAPEIMLNWMH 194
Query: 212 ITVKADVYSFGVMLLEIVCCR 232
D++S G ++ E++ R
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 41 IGRGGSGRV----YKGCINGGKEIAVKKLIK--IVEEGESE-FRNEMKI---IGRIHHKN 90
+GRG G+V YK G+ A+K L K I+ E E E +I H
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 91 LVDLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLH 147
LV+L C + + + V E+ G L +SE R + A ++ GL YLH
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDL----MMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPEL 205
E +I++ D+K N+L+D KI+DFGL K + D+T T+ GT + APE+
Sbjct: 119 ---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---GTPEFLAPEV 172
Query: 206 HSRNNRITVKADVYSFGVMLLEIVCC 231
+ T D + GV++ E++
Sbjct: 173 LT-ETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 41 IGRGGSGRVYKGCI-NGGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+G+GG G V + N GK A KKL K + GE E +I+ +++ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETRII 155
++ LV M G L ++ +R L + +I G+ +LH I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE-LHSRNNRITV 214
+ D+KP N+L+D+ ++SD GL+ LK +T T GT GY APE L V
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYSYPV 175
Query: 215 KADVYSFGVMLLEIVCCR---KNVDESLRDDEI 244
D ++ G + E+V R K+ E + +E+
Sbjct: 176 --DWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 39 EEIGRGGSGRVYKGCINGG---KEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHKNLVDL 94
+EIG G G+V G +N G ++ VK+L + + + +F E + + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQRLSWSER--RRIALEIMEGLHYLHDEC 150
+G C+E + LLV EF G L L R + ++ +R+A EI GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKL-LKTD----QTRTYTVLRGTRGYTAPEL 205
+ IH D+ N L+ KI D+GLS K D + + LR + APEL
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPEL 173
Query: 206 --HSRNNRITV----KADVYSFGVMLLEI 228
N + V +++V+S GV + E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 41 IGRGGSGRVYKGCI-NGGKEIAVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
IGRG G V + N K A+K L K +++ E+ FR E ++ ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ +N LV ++ G L LL + E RL R E++ + +H + +H
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVH 125
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE----LHSRNNRI 212
DIKP NILMD + +++DFG L D T +V GT Y +PE + +
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185
Query: 213 TVKADVYSFGVMLLEIV 229
+ D +S GV + E++
Sbjct: 186 GPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 64/251 (25%), Positives = 110/251 (43%), Gaps = 50/251 (19%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKE-----------------IAVKKL-IKIVEEGESEFRN 78
FKE++G G G V+ + ++ +AVK L + ++F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 79 EMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGN------LLFRAEQ------- 125
E+KI+ R+ N++ L+G C + ++ E+M NG L L + E
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 126 -----RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180
+S+S +AL+I G+ YL +H D+ N L+ E+ KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 181 KLLKTD-----QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV-CCRKN 234
+ L Q R +R + A E + T +DV++FGV L EI+ C++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWEC-ILMGKFTTASDVWAFGVTLWEILMLCKEQ 240
Query: 235 VDESLRDDEIV 245
L D++++
Sbjct: 241 PYGELTDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 9/212 (4%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIV-EEGE--SEFRNEMKIIGRIHHKNLVDLV 95
+++G G V+KG + + K I++ EEG + R E+ ++ + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
LV+E++ + L L +S + +++ GL Y H + +I+
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKIL 125
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H D+KP N+L++E + K++DFGL++ K+ T+TY+ T Y P++ + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184
Query: 216 ADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI 247
D++ G +L E+ R S +E+ LI
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 39 EEIGRGGSGRVYKGC--INGGKEIAVKKLIKIVEEGE--SEFRNEMKIIGRIHHKNLVDL 94
E++G G VYKG ING + +A+K + EEG + R E ++ + H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRING-QLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLL 68
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
V+E+M L + + L R +++ GL Y+H + I
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
+H D+KP N+L+ + K++DFGL++ K+ ++TY+ T Y P++ +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 215 KADVYSFGVMLLEIV 229
D++ G + +E++
Sbjct: 184 ALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 17/150 (11%)
Query: 94 LVGF--CSEGSNRL-LVYEFMRNGSLGNLLFRAEQ--RLSWSERRRIALEIMEGLHYLHD 148
LVG C + +RL V EF+ G +L+F ++ +L R + EI L++LH
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLH- 113
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELH 206
E II+ D+K N+L+D K++D+G+ K + D T T+ GT Y APE+
Sbjct: 114 --ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNYIAPEI- 167
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCRKNVD 236
R D ++ GV++ E++ R D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE----EGESEFRNEMKIIGRIH 87
L+ E +G G GRV G E K +K E + E I+ +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 88 HKNLVDLV-GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY 145
H +V+++ F E NR+ + EF+ G L L R R + E++ Y
Sbjct: 77 HPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAELVLAFEY 133
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE- 204
LH II+ D+KP N+L+D K++DFG +K + D RT+T L GT Y APE
Sbjct: 134 LH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PD--RTFT-LCGTPEYLAPEV 186
Query: 205 LHSRNNRITVKADVYSFGVMLLEIV 229
+ S+ + V D ++ GV+L E +
Sbjct: 187 IQSKGHGKAV--DWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-11
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 37/207 (17%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKL------IKIVEEGESEFRNEMKII---GRIHH- 88
+ I +G G VY +A K+ IK++++ + +N++ + I
Sbjct: 2 KPISKGAFGSVY---------LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI 52
Query: 89 ----KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLH 144
+ L LV E++ G +L+ + L ++ E++ G+
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVE 111
Query: 145 YLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTA 202
LH IIH DIKP N+L+D++ K++DFGLS+ L GT Y A
Sbjct: 112 DLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-------FVGTPDYLA 161
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PE + +D +S G ++ E +
Sbjct: 162 PETILGVGDDKM-SDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 15/195 (7%)
Query: 40 EIGRGGSGRVYKGC-INGGKEIAVKKLI---KIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
EIG G G VY + + +A+KK+ K E + E+K + RI H N ++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G LV E+ GS +LL ++ L E I ++GL YLH +I
Sbjct: 92 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMI 147
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSRNNRIT 213
H DIK NIL+ E + K++DFG + + + GT + APE L +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMDEGQYD 202
Query: 214 VKADVYSFGVMLLEI 228
K DV+S G+ +E+
Sbjct: 203 GKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFR--NEMKIIGRIHHKNLVDLV 95
E IG+G G V G+++A+KK+ + E R E+K++ + H ++V++
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 96 GFCSEGSNR-----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
S R +V+E M S + + +A L+ + +++ L Y+H
Sbjct: 66 HIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH--- 120
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPEL-HS 207
+ H D+KP NIL + K KI DFGL++ T +T TR Y APEL S
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
++ T D++S G + E++
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 56/225 (24%)
Query: 38 KEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------------EMK 81
+++G+G G V+K + +A+KK+ FRN E+
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIF-------DAFRNATDAQRTFREIMFLQELG 64
Query: 82 IIGRIHHKNLVDLVGFCSEGSNR--LLVYEFM--------RNGSLGNLLFRAEQRLSWSE 131
H N+V L+ +++ LV+E+M R L ++
Sbjct: 65 -----DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV-----------H 108
Query: 132 RRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL-KTDQTRT 190
+R I ++++ L Y+H +IH D+KP NIL++ + K++DFGL++ L + ++
Sbjct: 109 KRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 191 YTVLR---GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
VL TR Y APE+ + R T D++S G +L E++ +
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 39 EEIGRGGSGRVYKGC----INGGK----EIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN 90
E +G+G +++KG + G+ E+ +K L K F ++ ++ HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
LV G C G ++V E+++ GSL L + + ++ S + +A ++ LH+L D+
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK- 119
Query: 151 ETRIIHCDIKPHNILM--DESWKA------KISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
+ H ++ N+L+ +E K K+SD G+S T + + R +
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS---ITVLPKEILLERIP--WVP 172
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIVC 230
PE +++ AD +SFG L EI
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 8/172 (4%)
Query: 62 VKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL-LVYEFMRNGSLGNLL 120
+KK + I ++ + E +++ H L L + + +RL V E++ G L L
Sbjct: 28 LKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHL 86
Query: 121 FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180
R E+ S R EI+ L YLH +I++ D+K N+++D+ KI+DFGL
Sbjct: 87 SR-ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLC 142
Query: 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
K TD T GT Y APE+ +N D + GV++ E++C R
Sbjct: 143 KEGITDAA-TMKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 31 VLASENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHH 88
V+AS + + + G GRV+ G + V +KI ++G + E ++ ++H
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVV---LKIGQKGTTLI--EAMLLQNVNH 116
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
+++ + G+ +V + L L + + L + I +I+EGL YLH
Sbjct: 117 PSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA 175
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
+ RIIH D+K NI +++ + I D G ++ + L GT APE+ +R
Sbjct: 176 Q---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLAR 230
Query: 209 NNRITVKADVYSFGVMLLEIV 229
++ KAD++S G++L E++
Sbjct: 231 -DKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 39 EEIGRGGSGRVYKGCIN---------GGKEIAVKKLIKIVEEGESE----FRNEMKIIGR 85
E +GRG ++Y G +N E +K ++K+++ + F ++ +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 86 IHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY 145
+ HK++V L G C ++V EF+ G L + R L+ + ++A ++ L Y
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 146 LHDECETRIIHCDIKPHNILM-------DESWKAKISDFGLSKLLKTDQTRTYTVLRGTR 198
L D+ ++H ++ NIL+ + K+SD G+ + + Q +
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI----- 172
Query: 199 GYTAPELHSRNNRITVKADVYSFGVMLLEI 228
+ APE + +++ AD +SFG L EI
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 16/196 (8%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIK---IVEEGE-SEFRNEMKIIGRIHHKNLVDLVG 96
IG+G G+V + + I K I+ IV E + E ++ +++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
F + +L LV F+ G L + L R E R S R E++ L LH + +I
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLH---KFNVI 115
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKL--LKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
+ D+KP NIL+D + DFGL KL D+T T+ GT Y APEL + T
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLL-GHGYT 171
Query: 214 VKADVYSFGVMLLEIV 229
D ++ GV+L E++
Sbjct: 172 KAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 15/195 (7%)
Query: 40 EIGRGGSGRVYKGC-INGGKEIAVKKLI---KIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
EIG G G VY + + +A+KK+ K E + E++ + ++ H N +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G LV E+ GS +LL ++ L E + ++GL YLH +I
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMI 137
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSRNNRIT 213
H D+K NIL+ E K+ DFG + ++ GT + APE L +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQYD 192
Query: 214 VKADVYSFGVMLLEI 228
K DV+S G+ +E+
Sbjct: 193 GKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 36/110 (32%), Positives = 63/110 (57%), Gaps = 12/110 (10%)
Query: 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL----LKTDQTRTYT 192
++++ +H++H + +IH DIK NIL+ + K+ DFG SK+ + D RT+
Sbjct: 150 IQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVD-ESLRD 241
GT Y APE+ R + KAD++S GV+L E++ ++ D E++ +
Sbjct: 207 ---GTPYYVAPEIW-RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252
|
Length = 496 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE--SEFRNEMKIIGRIHHKNLVDLVG 96
+ +G G G VYK E+A K+IK+ E G+ S + E+ ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ E+ GSL ++ + LS + + E ++GL YLH + + +H
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDI-YHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 157 CDIKPHNILMDESWKAKISDFGL-SKLLKTDQTRTYTVLRGTRGYTAPELHS--RNNRIT 213
DIK NIL+ ++ K++DFG+ +K+ T R + GT + APE+ + +N
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGGYN 187
Query: 214 VKADVYSFGVMLLEI 228
D+++ G+ +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 64/249 (25%), Positives = 110/249 (44%), Gaps = 32/249 (12%)
Query: 39 EEIGRGGSGRVYKGCI-------NGGKEIAVKKLIKIVEEGES---EFRNEMKIIGRIHH 88
E +G+G +YKG + G V ++K++ F ++ ++ H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
K+LV L G C N ++V E+++ G L L R + +S + +A ++ LHYL D
Sbjct: 61 KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 149 ECETRIIHCDIKPHNILM-----DESWK--AKISDFGLSKLLKTDQTRTYTVLRGTRGYT 201
+ +++H ++ NIL+ +E + K+SD G+ T +R V R +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP---ITVLSREERVERIP--WI 171
Query: 202 APE-LHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY----EA 256
APE + + +T+ AD +SFG LLEI C S + Q +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI-CSNGEEPLSTLSSSEKERFYQDQHRLPMPDC 230
Query: 257 GELQNLVSD 265
EL NL++
Sbjct: 231 AELANLINQ 239
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 46/194 (23%), Positives = 89/194 (45%), Gaps = 10/194 (5%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIHHKNLVDL 94
E+IG G G V+K EI K +++ ++ E S R E+ ++ + HKN+V L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL 64
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
LV+E+ + L + + ++++GL + H +
Sbjct: 65 YDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
+H D+KP N+L++++ + K++DFGL++ R Y+ T Y P++ +
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYST 179
Query: 215 KADVYSFGVMLLEI 228
D++S G + E+
Sbjct: 180 SIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 40 EIGRGGSGRVYKGC-INGGKEIAVKKL-IKIVEEGE--SEFRNEMKIIGRIH---HKNLV 92
EIG G G VYK + G +A+K + ++ E+G S R E+ ++ R+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 93 DLVGFCS-----EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
L+ C+ + LV+E + L L + + + + GL +LH
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
C I+H D+KP NIL+ + K++DFGL+++ T V+ T Y APE+
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLL 180
Query: 208 RNNRITVKADVYSFGVMLLEI 228
++ T D++S G + E+
Sbjct: 181 QSTYAT-PVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 58/185 (31%), Positives = 87/185 (47%), Gaps = 31/185 (16%)
Query: 41 IGRGGSGRVYK----GCINGGKEIAVKKLIK--IV--EEGESEFRNEMKIIGRIHHKNLV 92
+G+GG G+V++ + GK A+K L K IV ++ + + E I+ + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALE---------IMEGL 143
DL+ G L+ E++ G L L ER I +E I L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEISLAL 113
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
+LH + II+ D+KP NIL+D K++DFGL K + T T+T GT Y AP
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAP 169
Query: 204 ELHSR 208
E+ R
Sbjct: 170 EILMR 174
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 29 QIVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVEEG-ESEFRNEMK 81
+I L++ F EE+G G+VYKG + G + +A+K L E EF++E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 82 IIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF---------------RAEQR 126
+ R+ H N+V L+G ++ +++ + + L L +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
L ++ I +I G+ +L ++H D+ N+L+ + KISD G L +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLG---LFREV 174
Query: 187 QTRTYTVLRGTR----GYTAPELHSRNNRITVKADVYSFGVMLLEI 228
Y L G + +PE + ++ +D++S+GV+L E+
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 49/197 (24%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIV-EEGE--SEFRNEMKIIGRIHHKNLVDLV 95
+++G G VYKG + K I++ EEG + R E+ ++ + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+ LV+E++ + L L ++ + +++ GL+Y H +++
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVL 126
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H D+KP N+L++E + K++DFGL++ K+ T+TY+ T Y P++ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 216 ADVYSFGVMLLEIVCCR 232
D++ G + E+ R
Sbjct: 186 IDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 12/194 (6%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFR-NEMKIIGRI-HHKNLVDLVGF 97
IG G V K GK A+K + K + E E++ + R+ H N++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 98 C-SEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+ RL LV+E M + +L L+ ++ L + ++++ L ++H I
Sbjct: 67 LFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIF 122
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H DIKP NIL+ + K++DFG + YT TR Y APE + K
Sbjct: 123 HRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179
Query: 216 ADVYSFGVMLLEIV 229
D+++ G + EI+
Sbjct: 180 MDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMK--------IIGRIHHKNLV 92
IG+G G+V + K +K++++ + E K ++ + H LV
Sbjct: 3 IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 93 DLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
L + + +++L V +++ G L L R E+ R A EI L YLH
Sbjct: 60 GL-HYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLH---S 114
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPE-LHSR 208
II+ D+KP NIL+D ++DFGL K + + T T+ GT Y APE L +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---GTPEYLAPEVLRKQ 171
Query: 209 NNRITVKADVYSFGVMLLEIV 229
TV D + G +L E++
Sbjct: 172 PYDRTV--DWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 17/150 (11%)
Query: 94 LVGF--CSEGSNRL-LVYEFMRNGSLGNLLF--RAEQRLSWSERRRIALEIMEGLHYLHD 148
LVG C + ++RL LV E++ NG G+L+F + +++L R A EI L++LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYV-NG--GDLMFHMQRQRKLPEEHARFYAAEICIALNFLH- 113
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELH 206
E II+ D+K N+L+D K++D+G+ K L D T T+ GT Y APE+
Sbjct: 114 --ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEI- 167
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCRKNVD 236
R D ++ GV++ E++ R D
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEM--KIIGRIHHKN--LVDLV 95
+G+G G+V + G G+ AVK L K V + + M K + + +N L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECETR 153
+ V EF+ NG G+L+F + + + R A EI+ GL +LH +
Sbjct: 63 CTFQTKEHLFFVMEFL-NG--GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---G 116
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
II+ D+K N+++D KI+DFG+ K R T GT Y APE+ + + T
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEI-LQGLKYT 174
Query: 214 VKADVYSFGVMLLEIV 229
D +SFGV+L E++
Sbjct: 175 FSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 41 IGRGGSGRVYKGCI----NGGKEIAVKKL-IKIVEEGE-SEFRNEMKIIGRIHHKNLVDL 94
+G+G G V + + +++AVK L I + EF E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 95 VGFC--SEGSNRL----LVYEFMRNGSLGNLLFRA---EQRLSWSERR--RIALEIMEGL 143
+G S RL ++ FM++G L L + E+ + + R ++I G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTA 202
YL + IH D+ N +++E+ ++DFGLS K+ D R + + A
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
E + +N T +DV++FGV + EI+
Sbjct: 184 LESLA-DNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 62 VKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL-LVYEFMRNGSLGNLL 120
++K + I ++ + E +++ H L L + + +RL V E+ G L L
Sbjct: 28 LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL 86
Query: 121 FRAEQRLSWSERRRI-ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
R +R+ ER R EI+ L YLH +++ DIK N+++D+ KI+DFGL
Sbjct: 87 SR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL 141
Query: 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
K +D T GT Y APE+ +N D + GV++ E++C R
Sbjct: 142 CKEGISDGA-TMKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 57/183 (31%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 56 GGKEIAVKKLIKIVEEGESEFRN---EMKIIGRIHHKNLVDLVGFCSEGSNRL-LVYEFM 111
GK A+K L K V + E + E +++ H L L + + +RL V E+
Sbjct: 19 TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYA 77
Query: 112 RNGSLGNLLFRAEQRLSWSERRR--IALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169
NG G L F + +SE R EI+ L YLH C+ +++ D+K N+++D+
Sbjct: 78 -NG--GELFFHLSRERVFSEDRARFYGAEIVSALGYLH-SCD--VVYRDLKLENLMLDKD 131
Query: 170 WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
KI+DFGL K +D T GT Y APE+ +N D + GV++ E++
Sbjct: 132 GHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMM 189
Query: 230 CCR 232
C R
Sbjct: 190 CGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 41 IGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRI-----HHKNLVDL 94
+G+G G+V+ + G + A+K L K V + + M + R+ H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTM-VEKRVLSLAWEHPFLTHL 61
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAE--QRLSWSERRRIALEIMEGLHYLHDECET 152
N V E++ NG G+L+F + + A EI+ GL +LH +
Sbjct: 62 YCTFQTKENLFFVMEYL-NG--GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK--- 115
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
I++ D+K NIL+D KI+DFG+ K +T T GT Y APE+ +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEI-LLGQKY 173
Query: 213 TVKADVYSFGVMLLEIV 229
D +SFGV+L E++
Sbjct: 174 NTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 21/199 (10%)
Query: 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMK----IIGRIHHKNLVDLV 95
IG+G G+V GK AVK L K + E ++ M ++ + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRR--IALEIMEGLHYLHDECET 152
+ + + +L V +F+ NG G L F ++ S+ E R A EI L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFV-NG--GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SI 115
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
I++ D+KP NIL+D ++DFGL K + ++D T T+ GT Y APE+ R
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---GTPEYLAPEV-IRKQ 171
Query: 211 RITVKADVYSFGVMLLEIV 229
D + G +L E++
Sbjct: 172 PYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 41 IGRGGSGRVYKGC--INGGKEIAVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLV 95
IGRG G V + + G A+KKL K ++E+ + R E I+ + +V L
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL- 66
Query: 96 GFCS--EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
+ S + + L+ E++ G + LL + + + E R E + + +H +
Sbjct: 67 -YYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIH---KLG 121
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191
IH DIKP N+L+D K+SDFGL LK +
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 47/180 (26%), Positives = 91/180 (50%), Gaps = 18/180 (10%)
Query: 58 KEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCS-----EGSNRLLVYE 109
+++AVKKL + + +R E++++ + H+N++ L+ + E N + +
Sbjct: 41 QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99
Query: 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169
+ L N++ Q+LS + + +++ GL Y+H IIH D+KP N+ ++E
Sbjct: 100 NLMGADLNNIV--KCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNED 154
Query: 170 WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
+ +I DFGL++ + D T V TR Y APE+ D++S G ++ E++
Sbjct: 155 CELRILDFGLAR--QADDEMTGYV--ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 41 IGRGGSGRVY----KGCINGGKEIAVKKLIK--IVEEGES--EFRNEMKIIGRIHHKNLV 92
+G G G+V+ + GK A+K L K IV++ ++ R E +++ I +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 93 DLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
+ + + +L L+ +++ G L L + E R E + + EI+ L +LH +
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---K 123
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNN 210
II+ DIK NIL+D + ++DFGLSK D+ R Y+ GT Y AP++ +
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEYMAPDIVRGGD 182
Query: 211 RITVKA-DVYSFGVMLLEIV 229
KA D +S GV++ E++
Sbjct: 183 GGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 39 EEIGRGGSGRVY----KGCINGGKEIAVKKLIKIVEEGESEFRN---EMKIIGRIHHKNL 91
+ +G+G GRV+ KG GK A+K L K ++ + E +I+ + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
L + LV ++ G L LL + + LS R A E++ L YLH
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL- 122
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLL-KTDQTRTYTVLRGTRG---------- 199
I++ D+KP NIL+ ES +SDF LSK + + +G+R
Sbjct: 123 --GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 200 -----------------YTAPELHSRNNRITVKADVYSFGVMLLEIV 229
Y APE+ S + D ++ G++L E++
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIK---IVEEGESEFRN-EMKIIGRIHHKNL 91
NF +G+G G+V G E+ K++K ++++ + E E +++
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDE 149
+ + C + +RL Y M + G+L++ +Q + E + + A EI GL +LH
Sbjct: 63 LTQLHSCFQTVDRL--YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH-- 118
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELHS 207
II+ D+K N+++D KI+DFG+ K ++ TRT+ GT Y APE+ +
Sbjct: 119 -RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPEIIA 174
Query: 208 RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD 242
D +++GV+L E++ + D D+
Sbjct: 175 YQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIK---IVEEGESEFRN-EMKIIGRIHHKNL 91
NF +G+G G+V G E+ K++K ++++ + E E +++
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 92 VDLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHD 148
+ + C + +RL V E++ NG G+L+++ +Q + E + A EI GL +LH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYV-NG--GDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
+ II+ D+K N+++D KI+DFG+ K D T T GT Y APE+
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEI-IA 174
Query: 209 NNRITVKADVYSFGVMLLEIV 229
D ++FGV+L E++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-09
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE------SEFRNEMKIIGRIHHKNL 91
++ +G+G G VY K++K + GE + E +++ ++ H +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLF---RAEQRLSWSERRRIALEIMEGLHYLHD 148
V E ++ E+ L L + LS ++ ++++ G+HY+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL--KTDQTRTYTVLRGTRGYTAPELH 206
+ RI+H D+K NI + + KI DFG+S+LL D T+T GT Y +PE
Sbjct: 124 --QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEAL 177
Query: 207 SRNNRITVKADVYSFGVMLLEIVC 230
+ K+D++S G +L E+ C
Sbjct: 178 KHQGYDS-KSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 50/192 (26%), Positives = 94/192 (48%), Gaps = 22/192 (11%)
Query: 48 RVYKGCINGGKEIAVK------KLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101
+YKG N KE+ ++ K K++ + NE+K + RI N++ + GF +
Sbjct: 35 SIYKGIFNN-KEVIIRTFKKFHKGHKVLID---ITENEIKNLRRIDSNNILKIYGFIIDI 90
Query: 102 SNRL----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
+ L L+ E+ G L +L E+ LS+ + +A++ +GL+ L+ +
Sbjct: 91 VDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE-LHSRNNRITVKA 216
++ + L+ E++K KI GL K+L + + + Y + + L+ + T+K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKD 203
Query: 217 DVYSFGVMLLEI 228
D+YS GV+L EI
Sbjct: 204 DIYSLGVVLWEI 215
|
Length = 283 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 9/169 (5%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIHHKNLVDLVG 96
+G G G V K KEI K K EE E + R E+K++ + +N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVELKE 67
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
LV+E++ L LL + + R ++++ +H+ H + I+H
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVH 123
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
DIKP N+L+ + K+ DFG ++ L YT TR Y +PEL
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 41 IGRGGSGRV-YKGCINGGKEIAVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
IGRG G V N G+ A+K L K +++ E+ FR E ++ + + +L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ +N LV ++ G L LL + E RL R E++ + +H + +H
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVH 125
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE----LHSRNNRI 212
DIKP N+L+D++ +++DFG L D T V GT Y +PE + R
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 213 TVKADVYSFGVMLLEI 228
+ D +S GV + E+
Sbjct: 186 GPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 41 IGRGGSGRVY----KGCINGGKEIAVKKLIK--IVEEGESE--FRNEMKIIGRIHHKNLV 92
+G G G+V+ + GK A+K L K +V++ ++ R E ++ + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 93 DLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
+ + + +L L+ +++ G + L++ S E R + EI+ L +LH +
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLH---K 123
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSK-LLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
I++ DIK NIL+D ++DFGLSK L ++ RTY+ GT Y APE+
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAPEIIRGKG 182
Query: 211 RITVKADVYSFGVMLLEIV 229
D +S G+++ E++
Sbjct: 183 GHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKK-LIKIVEEG-ESEFRNEMKIIGRIHHKN----L 91
E+IG G G+VYK N GK +A+KK +++ EEG E+ ++ + L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 92 VDLVGFCSEG--SNRLLVYEFMRNG--SLGNLLFRAEQR-LSWSERRRIALEIMEGLHYL 146
+D+ + + LV+E++ + + R R L + ++++G+ +
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 147 HDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
H ++H D+KP N+L+D+ KI+D GL + + ++YT T Y APE+
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIVTLWYRAPEV 182
Query: 206 HSRNNRITVKADVYSFGVMLLEIVCCRKN 234
+ + D++S G + E+ RK
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMS--RKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 78/264 (29%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLI--KIVEEG--ESEFR---NEMKIIGRI-HH 88
+ +GRG G+V + G ++ A + + K+++EG SE++ E+KI+ I HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 89 KNLVDLVGFCSEGSNRLLV-YEFMRNGSLGNLL---------FRAE-------------- 124
N+V+L+G C++ L+V E+ + G+L N L +R +
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 125 QRL------------SWSERRRI-------------------------ALEIMEGLHYLH 147
QRL + E + + + ++ G+ +L
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL--KTDQTRTYTVLRGTRGYTAPEL 205
+ IH D+ NIL+ E+ KI DFGL++ + D R R + APE
Sbjct: 191 SR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RLPLKWMAPE- 245
Query: 206 HSRNNRI-TVKADVYSFGVMLLEI 228
S +++ T ++DV+SFGV+L EI
Sbjct: 246 -SIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 9/173 (5%)
Query: 62 VKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF 121
+KK + + ++ + E +++ H L L + + +RL NG G L F
Sbjct: 28 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG--GELFF 84
Query: 122 RAEQRLSWSERRR--IALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
+ +SE R EI+ L YLH E +++ D+K N+++D+ KI+DFGL
Sbjct: 85 HLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGL 142
Query: 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
K D T GT Y APE+ +N D + GV++ E++C R
Sbjct: 143 CKEGIKDGA-TMKTFCGTPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 24/200 (12%)
Query: 41 IGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEE---GESEFRNEMKIIGRIHHKNLVDLV 95
+G G G V I+ G+++A+KKL + + + +R E+ ++ + H+N++ L+
Sbjct: 23 VGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 96 G-FCSEGSNR-----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
F S S LV +M+ +L LS + + + +++ GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIH-- 134
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
IIH D+KP N+ ++E + KI DFGL++ + T Y V TR Y APE+
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-GYVV---TRWYRAPEVILNW 189
Query: 210 NRITVKADVYSFGVMLLEIV 229
D++S G ++ E++
Sbjct: 190 MHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 50/150 (33%), Positives = 78/150 (52%), Gaps = 17/150 (11%)
Query: 94 LVGF--CSEGSNRLL-VYEFMRNGSLGNLLF--RAEQRLSWSERRRIALEIMEGLHYLHD 148
LVG C + +RL V E++ NG G+L+F + +++L R + EI L+YLH
Sbjct: 58 LVGLHSCFQTESRLFFVIEYV-NG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH- 113
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELH 206
E II+ D+K N+L+D K++D+G+ K L D T T+ GT Y APE+
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEI- 167
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCRKNVD 236
R D ++ GV++ E++ R D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 50/202 (24%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGES--EFRNEMKIIGRIHHKNLVDLV-GF 97
+G G GR + K I++ + + + R E ++ ++ H N+V F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 98 CSEGSNRLLVYEFMRNGSL-------GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
++G + +V E+ G L LF + L W +++ G+ ++H++
Sbjct: 68 EADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
R++H DIK NI + ++ K K+ DFG ++LL + T + GT Y PE+ N
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW-ENM 175
Query: 211 RITVKADVYSFGVMLLEIVCCR 232
K+D++S G +L E+ +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 41/223 (18%)
Query: 41 IGRGGSGRVY----KGCINGGKEIAVKKLIKIVEEGE---SEFRNEMKIIGRIHHKNLVD 93
IG+GG G VY C + +A+KK+ + + E F E KI + H +V
Sbjct: 10 IGKGGMGEVYLAYDPVC---SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERR----------RIALEIMEGL 143
+ CS+G ++ +L +LL Q+ S S+ I +I +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV---------- 193
Y+H + ++H D+KP NIL+ + I D+G + K ++ +
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 194 -------LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
+ GT Y APE + D+Y+ GV+L +++
Sbjct: 184 SMTIPGKIVGTPDYMAPE-RLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLI---KIVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
IGRG G V + + I K++ ++++ E+ FR E ++ + + L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ + LV ++ G L LL + E RL R E++ +H +H + +H
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVH 125
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE----LHSRNNRI 212
DIKP N+L+D + +++DFG + D T +V GT Y +PE + +
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185
Query: 213 TVKADVYSFGVMLLEIV 229
+ D +S GV + E++
Sbjct: 186 GPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 52/209 (24%), Positives = 104/209 (49%), Gaps = 37/209 (17%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN-EMKIIGRIHHKNLVDLVGF- 97
IG G G VY+ CI+ +++A+KK+++ + +++N E+ I+ ++H N++ L +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 98 ---CSEGSNRLL------------VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
C + + + + V+++M++ + R L + + ++
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA------RNNHALPLFLVKLYSYQLCRA 182
Query: 143 LHYLHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSK-LLKTDQTRTYTVLRGTRGY 200
L Y+H + I H D+KP N+L+D + K+ DFG +K LL ++ +Y +R Y
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFY 236
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIV 229
APEL T D++S G ++ E++
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 41/177 (23%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 62 VKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV--------YEFMRN 113
+ K +K + NE+ +GR++H+N++ + +N ++ Y FM +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAK 173
+ F + R + R I +++ + Y+HD+ ++IH DIK NI ++ K
Sbjct: 256 EA-----FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIV 307
Query: 174 ISDFG-LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
+ DFG K + Y + GT +PE+ + + + D++S G++LL+++
Sbjct: 308 LGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 35/193 (18%)
Query: 57 GKEIAVKKLIKIVEEGESEFR---NEMKIIGRIHHKNLVD--------------LVGFCS 99
GK+ +KKL + E + E +++ ++ H N+V ++GFC
Sbjct: 25 GKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 100 EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDI 159
G +Y ++ G LL Q + W ++I L YLH E I+H D+
Sbjct: 84 GGD----LYHKLKEQK-GKLLPE-NQVVEW------FVQIAMALQYLH---EKHILHRDL 128
Query: 160 KPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVY 219
K N+ + + K+ D G++++L+ +Q + L GT Y +PEL S N K+DV+
Sbjct: 129 KTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFS-NKPYNYKSDVW 186
Query: 220 SFGVMLLEIVCCR 232
+ G + E+ +
Sbjct: 187 ALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 27 YEQIV-------LASENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLI---KIVEEGES 74
YE+IV + +E++ + IGRG G V +++ KL+ ++++ +S
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 75 EF-RNEMKIIGRIHHKNLVDLVGFCSEGSNRLL--VYEFMRNGSLGNLLFRAEQRLSWSE 131
F E I+ + +V L FC+ ++ L V E+M G L NL+ + W+
Sbjct: 88 AFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA- 144
Query: 132 RRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT--- 188
+ E++ L +H +IH D+KP N+L+D+ K++DFG +K D+T
Sbjct: 145 -KFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETGMV 198
Query: 189 RTYTVLRGTRGYTAPEL---HSRNNRITVKADVYSFGVMLLEIV 229
R T + GT Y +PE+ + + D +S GV L E++
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 25/225 (11%)
Query: 39 EEIGRGGSGRVYKGCI---NGGKEIAVKKLIKIVEEGE-SEFRNEMKIIGRIHHKNLVDL 94
+EIG G G+V I G + VK+L E +EF + + H N++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER---RRIALEIMEGLHYLHDECE 151
+G C E LLV+E+ G L + L + + S+ +R+A EI G+ ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLS-KLLKTDQTRT----YTVLRGTRGYTAPEL- 205
+H D+ N + K+ D+G+ K D T LR + APEL
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPELV 173
Query: 206 HSRNNRI-----TVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245
+ + T ++V++ GV L E+ L D E++
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL 218
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 57/231 (24%), Positives = 106/231 (45%), Gaps = 22/231 (9%)
Query: 7 ISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLI 66
++R + + ++++++ YE + + IGRG G V +++ KL+
Sbjct: 25 LNRYKDTINKIRDLRMKAEDYEVVKV--------IGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 67 ---KIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL-LVYEFMRNGSLGNLLFR 122
++++ +S F E + I + V + + + L +V E+M G L NL+
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 136
Query: 123 AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS-K 181
+ W+ R E++ L +H IH D+KP N+L+D+S K++DFG K
Sbjct: 137 YDVPEKWA--RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
Query: 182 LLKTDQTRTYTVLRGTRGYTAPEL---HSRNNRITVKADVYSFGVMLLEIV 229
+ K R T + GT Y +PE+ + + D +S GV L E++
Sbjct: 192 MNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 18/181 (9%)
Query: 57 GKEIAVKKLIKIVEEGESEFR--NEMKIIGRIHHKNLVDLVGFCS------EGSNRLLVY 108
G +AVKKL + + R E+ ++ ++HKN++ L+ + E + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE 168
E M NL L + +++ G+ +LH IIH D+KP NI++
Sbjct: 106 ELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158
Query: 169 SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
KI DFGL++ T+ T V+ TR Y APE+ D++S G ++ E+
Sbjct: 159 DCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEV-ILGMGYKENVDIWSVGCIMGEL 215
Query: 229 V 229
V
Sbjct: 216 V 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 8e-08
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 35 ENFKEEIGRGGSGRV---YKGCINGGKEIAVKKLIKIVEEGESEFR--NEMKIIGRIHHK 89
+N K IG G G V Y ++ + +A+KKL + + R E+ ++ ++HK
Sbjct: 20 QNLKP-IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 90 NLVDLVGFCS------EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGL 143
N++ L+ + E + LV E M NL + L + +++ G+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
+LH IIH D+KP NI++ KI DFGL++ T T V+ TR Y AP
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAP 187
Query: 204 EL-----HSRNNRITVKADVYSFGVMLLEIV 229
E+ + N D++S G ++ E+V
Sbjct: 188 EVILGMGYKEN------VDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 8e-08
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGES-EFRNEMKIIGRIHHKNLVDLVGFC 98
++GRG G VYK GK+ L +I G S E+ ++ + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 99 SEGSNR--LLVYEFMRNGSLGNLLF-RAEQ------RLSWSERRRIALEIMEGLHYLHDE 149
S+R L++++ + + F RA + +L S + + +I++G+HYLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 150 CETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTV--LRGTRGYTAP 203
++H D+KP NIL+ E + KI+D G ++L + + + T Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 204 ELHSRNNRITVKADVYSFGVMLLEIV 229
EL T D+++ G + E++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 55/198 (27%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEFR-NEMKIIGRIHHKNLVDLVG 96
+G+G G+V + G E+ A+K L K I+++ + + E +I+ + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 97 FCSEGSNRLL-VYEFMRNGSLGNLLFRAEQRLSWSERRR--IALEIMEGLHYLHDECETR 153
C + +RL V E++ NG G+L+F+ ++ + E R A E+ L +LH
Sbjct: 63 CCFQTKDRLFFVMEYV-NG--GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHG 116
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
+I+ D+K NIL+D K++DFG+ K +L T T+ GT Y APE+ +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC---GTPDYIAPEI-LQELE 172
Query: 212 ITVKADVYSFGVMLLEIV 229
D ++ GV++ E++
Sbjct: 173 YGPSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 13/188 (6%)
Query: 44 GGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103
G G V+ C G E K ++K V G++ R E+ I+ I H+ +++L+ S
Sbjct: 103 GSEGEVFV-CTKHGDEQRKKVIVKAVTGGKTPGR-EIDILKTISHRAIINLIHAYRWKST 160
Query: 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALE--IMEGLHYLHDECETRIIHCDIKP 161
+V + +L ++ + I ++ ++E L YLH IIH D+K
Sbjct: 161 VCMVMPKYKC----DLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKT 213
Query: 162 HNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYS 220
NI +DE A + DFG + KL T GT +PEL + + K D++S
Sbjct: 214 ENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWS 272
Query: 221 FGVMLLEI 228
G++L E+
Sbjct: 273 AGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 23/184 (12%)
Query: 58 KEIAVKKLIKIVEEGESEF-RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116
KE V K + + +E ++ + R+E+ + H +V LL+ E+ GS
Sbjct: 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY---GSG 149
Query: 117 GNLLFRAEQRLSWSERRRIALEIME-GLHYLH-----DECETR-IIHCDIKPHNILMDES 169
G+L + +QRL + + + E GL + DE +R ++H D+K NI + +
Sbjct: 150 GDLNKQIKQRL----KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205
Query: 170 WKAKISDFGLSKL----LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVML 225
K+ DFG SK + D ++ GT Y APEL R R + KAD++S GV+L
Sbjct: 206 GIIKLGDFGFSKQYSDSVSLDVASSFC---GTPYYLAPELWER-KRYSKKADMWSLGVIL 261
Query: 226 LEIV 229
E++
Sbjct: 262 YELL 265
|
Length = 478 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 61/197 (30%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK---IVEEGESEFRNEMKIIGR-IHHKNLVDLV 95
IG+G G+V ++ AVK L K + ++ E +E ++ + + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI-ALEIMEGLHYLHDECETR 153
F + +++L V +++ G L L R +R R R A EI L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLH---SLN 116
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE-LHSRNNRI 212
I++ D+KP NIL+D ++DFGL K + T + GT Y APE LH +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 213 TVKADVYSFGVMLLEIV 229
TV D + G +L E++
Sbjct: 176 TV--DWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 39 EEIGRGGSGRVYKG--CINGGKEIAVKKLIKIVEEGESEFR--NEMKIIGRIHHKNLVDL 94
+++G G VYKG + G + +A+K+ I++ E + F E ++ + H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTG-QLVALKE-IRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
LV+E++ L + LS R +++ GL Y H R+
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RV 124
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT------------VLRGTRGYTA 202
+H D+KP N+L+ E + K++DFGL++ K+ ++TY+ VL G+ Y+
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 203 P 203
Sbjct: 184 S 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGES-EFRNEMKIIGRIHHKNLVDLVG-F 97
++GRG G VYK GK+ L +I G S E+ ++ + H N++ L F
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 98 CSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIAL----------EIMEGLHYL 146
S ++ L++++ + + F R S + ++ + L +I++G+HYL
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKF---HRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 147 HDECETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTV--LRGTRGY 200
H ++H D+KP NIL+ E + KI+D G ++L + + + T Y
Sbjct: 125 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIV 229
APEL T D+++ G + E++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 41/128 (32%), Positives = 64/128 (50%), Gaps = 10/128 (7%)
Query: 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNIL 165
+V E+M G L NL+ + W+ R E++ L +H IH D+KP N+L
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWA--RFYTAEVVLALDAIH---SMGFIHRDVKPDNML 174
Query: 166 MDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAPE-LHSR--NNRITVKADVYSF 221
+D+S K++DFG K+ R T + GT Y +PE L S+ + + D +S
Sbjct: 175 LDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 222 GVMLLEIV 229
GV L E++
Sbjct: 234 GVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 35 ENFKEEIGRGGSGRV---YKGCINGGKEIAVKKLIKIVEEGESEFR--NEMKIIGRIHHK 89
+N K IG G G V Y + + +A+KKL + + R E+ ++ ++HK
Sbjct: 27 QNLKP-IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 90 NLVDLVGFCS------EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGL 143
N++ L+ + E + +V E M NL + L + +++ G+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
+LH IIH D+KP NI++ KI DFGL++ T T V+ TR Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAP 194
Query: 204 EL-----HSRNNRITVKADVYSFGVMLLEIVC 230
E+ + N D++S G ++ E++
Sbjct: 195 EVILGMGYKEN------VDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 67/263 (25%), Positives = 111/263 (42%), Gaps = 83/263 (31%)
Query: 41 IGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGE--SEFR---NEMKIIGRI-HHKNLV 92
+G G G+V + G K +K+++EG SE + +E+KI+ I +H N+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 93 DLVGFCSEGSNRLLV-YEFMRNGSLGNLL--------------------FRAEQRLSWSE 131
+L+G C++ + L+V EF + G+L N L FRA S +
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134
Query: 132 RRR-----------------------------------------IALEIMEGLHYLHDEC 150
RR + ++ G+ +L
Sbjct: 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---A 191
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR----GYTAPELH 206
+ IH D+ NIL+ E+ KI DFGL++ + D V +G+ + APE
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---YVRKGSARLPLKWMAPE-- 246
Query: 207 SRNNRI-TVKADVYSFGVMLLEI 228
S +++ T ++DV+SFGV+L EI
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 37/208 (17%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKL---IKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
IG G G V G+ +A+KKL + V + +R E+ ++ ++HKN++ L+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82
Query: 97 F------CSEGSNRLLVYEFMRNGSLGNLLFRA--EQRLSWSERRRIALEIMEGLHYLHD 148
E + LV E M + +L ++ +R+S+ + +++ G+ +LH
Sbjct: 83 VFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHS 136
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPEL-- 205
IIH D+KP NI++ KI DFGL++ T T Y V TR Y APE+
Sbjct: 137 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVIL 190
Query: 206 ---HSRNNRITVKADVYSFGVMLLEIVC 230
+ N D++S G ++ E++
Sbjct: 191 GMGYKEN------VDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 12/116 (10%)
Query: 130 SERRRIAL--------EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181
+ +R IA+ ++ + YLH E RIIH DIK NI ++ + DFG +
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230
Query: 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDE 237
Y GT APEL +R+ D++S G++L E+ C ++ E
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 41 IGRGGSGRVY---KGCINGGKEIAVKKLIKIVEEGESEFRNEMK----IIGRIHHKNLVD 93
IG+G G+V + G AVK L K + E + M ++ + H LV
Sbjct: 3 IGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 94 LVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
L + + + +L V +++ G L L R E+ R A E+ + YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSL--- 115
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
II+ D+KP NIL+D ++DFGL K + + T T+ GT Y APE+ R
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---GTPEYLAPEV-LRKE 171
Query: 211 RITVKADVYSFGVMLLEIV 229
D + G +L E++
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 76 FRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI 135
F ++ ++ H +L + G C GS ++V EF+ +G L L + + R+ + + +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA-------KISDFGLSKLLKTDQT 188
A ++ L YL D+ ++H ++ NIL+ A K+SD G+S + +
Sbjct: 123 AQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
R + + APE N ++ AD +SFG LLEI
Sbjct: 180 RVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 18/151 (11%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
I RG G+VY G N K AVK + K I + + + E + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLL-----FRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
+N LV E++ G + +LL F E + I+ E+ L YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYIS-EVALALDYLH---R 122
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKL 182
IIH D+KP N+L+ K++DFGLSK+
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 15/96 (15%)
Query: 106 LVYEFMRNGSLGNLLFRAEQRLSWSE---RRRIALEIM--EGLHYLHDECETRIIHCDIK 160
L+ EF+ G L +L + + ++SE R +A ++ E +H L IH DIK
Sbjct: 78 LIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG------FIHRDIK 128
Query: 161 PHNILMDESWKAKISDFGLSK-LLKTDQTRTYTVLR 195
P NIL+D K+SDFGLS K + Y L
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 61/300 (20%), Positives = 106/300 (35%), Gaps = 55/300 (18%)
Query: 40 EIGRGGSGR----VYKGCINGGKEIAVKK--LIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
IG+ + K +AVKK L +E + E+ ++ H N++
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECET 152
V S +V M GS +LL + L I +++ L Y+H +
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK--- 120
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRG------YTAPEL 205
IH +K +IL+ K +S S ++K + R V + + +PE+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK-RQRVVHDFPKSSVKNLPWLSPEV 179
Query: 206 HSRNNR-ITVKADVYSFGVMLLEIVCCR--------KNVD------ESLRDDEIVLIDWA 250
+N + K+D+YS G I C K++ E +R L+D +
Sbjct: 180 LQQNLQGYNEKSDIYSVG-----ITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 251 HQCYEAGELQNLVSDQEDVNI-------------EEFENLVKIGLWCVECELNLRPTMKQ 297
+ S E N E F V++ C++ + RP+ Q
Sbjct: 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---CLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 134 RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193
R + ++ +G+ +L IH D+ N+L+ + AKI DFGL++ + D Y V
Sbjct: 216 RFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--NYVV 270
Query: 194 LRGTR---GYTAPELHSRNNRITVKADVYSFGVMLLEI 228
R + APE + TV++DV+S+G++L EI
Sbjct: 271 KGNARLPVKWMAPE-SIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 37 FKEEIGRGGSGRVYKGCING-GKE-----IAVKKLIKIVEEGESE-FRNEMKIIGRI-HH 88
F + +G G G+V + G GKE +AVK L E E +E+KI+ + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQ 125
KN+V+L+G C+ G L++ E+ G L N L + +
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAE 138
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 21/149 (14%)
Query: 97 FCSEGSNRLL--VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
FCS + R L V E++ G LL + L R E + L YLH+ I
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVLALEYLHN---YGI 122
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKL-LKTDQTRTY-------------TVLRGTRGY 200
+H D+KP N+L+ K++DFGLSK+ L + T Y + GT Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIV 229
APE+ R D ++ G++L E +
Sbjct: 183 IAPEVILRQG-YGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE----FRNEMKIIGRIHHKNLVDLVG 96
IGRG G V I K+++ + E E R E I+ +V +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ N L+ EF+ G + LL + + LS + E + + +H + IH
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIH---QLGFIH 124
Query: 157 CDIKPHNILMDESWKAKISDFGL-SKLLKTDQTRTY 191
DIKP N+L+D K+SDFGL + L K +T Y
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 6/77 (7%)
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNR 211
IH D+ NIL+ KI DFGL++ ++ D Y V R + APE N
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDS--NYVVKGNARLPVKWMAPE-SIFNCV 292
Query: 212 ITVKADVYSFGVMLLEI 228
T ++DV+S+G++L EI
Sbjct: 293 YTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 47/229 (20%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE----FRNEMKIIGRIHHKNLVDLVG 96
IGRG G V + K+++ + E E R E I+ +V +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ N L+ EF+ G + LL + + L+ E + E + + +H + IH
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIH---QLGFIH 124
Query: 157 CDIKPHNILMDESWKAKISDFGL-SKLLKTDQTRTYTVLR-------------------- 195
DIKP N+L+D K+SDFGL + L K +T Y L
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 196 -------------GTRGYTAPELHSRN--NRITVKADVYSFGVMLLEIV 229
GT Y APE+ + N++ D +S GV++ E++
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL---CDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 13/98 (13%)
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195
+ ++ +G+ +L + IH D+ NIL+ E+ KI DFGL++ + D V +
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---YVRK 238
Query: 196 GTR----GYTAPELHSRNNRI-TVKADVYSFGVMLLEI 228
G + APE + +R+ T+++DV+SFGV+L EI
Sbjct: 239 GDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 29/186 (15%)
Query: 70 EEGESEFRNEMKIIGRIHHKNLVDLVG-FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRL 127
E +S+ E+ ++ + HKN+V + F ++ + +L ++ EF G L + + +
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 128 SWSERRRI---ALEIMEGLHYLHDECE----TRIIHCDIKPHNILMDESWK--------- 171
E I +++ L Y H+ + R++H D+KP NI + +
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 172 --------AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR-ITVKADVYSFG 222
AKI DFGLSK + + V GT Y +PEL + K+D+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 223 VMLLEI 228
++ E+
Sbjct: 231 CIIYEL 236
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
LS+ + + ++ G+ +L + +H D+ N+L+ E KI DFGL++ + D
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 187 QT-----RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
T+ L+ + APE NN T +DV+SFG++L EI
Sbjct: 293 SNYISKGSTFLPLK----WMAPE-SIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 50/185 (27%), Positives = 71/185 (38%), Gaps = 39/185 (21%)
Query: 23 RSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLI--KIVEEGESE-FRNE 79
SF + VL +++G G G VYK + + K + K E G E + NE
Sbjct: 127 PSFKKDDFVLG-----KKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE 181
Query: 80 MKIIGRIHHKNLVDLV-GFCSEGSNR-----LLVYEFMRNGSLGNL-------------L 120
+ R + D V GF S++ LV+ + +L +L L
Sbjct: 182 R--VRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYL 239
Query: 121 FRAEQRLSWSERR------RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAK 173
Q L R I +I+ L LH T I+H D+KP NI+ E S K
Sbjct: 240 LGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSFK 296
Query: 174 ISDFG 178
I D G
Sbjct: 297 IIDLG 301
|
Length = 566 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 31/89 (34%), Positives = 53/89 (59%), Gaps = 9/89 (10%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLI--KIVEEG--ESEFR---NEMKIIGRI-HHKNLV 92
+GRG G+V + G + A + + K+++EG SE R +E+KI+ I HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 93 DLVGFCSE-GSNRLLVYEFMRNGSLGNLL 120
+L+G C++ G +++ EF + G+L N L
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 29/112 (25%), Positives = 54/112 (48%), Gaps = 10/112 (8%)
Query: 41 IGRGGSGRVYKGCING------GKEIAVKKLIKIVEEGESE-FRNEMKIIGRIH-HKNLV 92
+G G GRV + +G ++AVK L E + +E+KI+ + H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRL--SWSERRRIALEIMEG 142
+L+G C++G ++ E+ R G L + L R + + ++ R ++ G
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISG 156
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 59/238 (24%), Positives = 89/238 (37%), Gaps = 57/238 (23%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
IG G G V + A+K L K ++ + + E I+ ++ +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETR 153
+ N V +++ G + +LL R E+ L+ R IA E+ + +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIESVH---KMG 121
Query: 154 IIHCDIKPHNILMDESWKAKISDFGL---------------------------------- 179
IH DIKP NIL+D K++DFGL
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 180 SKLLKT-------DQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
LK R L GT Y APE+ R T D +S GV+L E++
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 8/143 (5%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGE-SEFRNEMKIIGRIHHKNLVDLVG 96
+G G G V C ++ A+K L K ++ + + + E I+ ++ +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ N V +++ G + +LL R E R IA E+ + +H + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH---KMGFIH 124
Query: 157 CDIKPHNILMDESWKAKISDFGL 179
DIKP NIL+D K++DFGL
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 27/95 (28%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGT 197
++ G+ +L + +H D+ N+L+ + KI DFGL++ + D V +G+
Sbjct: 245 QVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN---YVSKGS 298
Query: 198 R----GYTAPELHSRNNRITVKADVYSFGVMLLEI 228
+ APE +N T +DV+S+G++L EI
Sbjct: 299 TFLPVKWMAPE-SIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.14 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.05 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.41 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.94 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.82 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.73 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.72 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.54 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.47 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.39 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.37 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.09 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.04 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.03 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.02 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.0 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.86 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.77 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.76 | |
| PLN02236 | 344 | choline kinase | 96.62 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.51 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.43 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.01 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.81 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.77 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.7 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.53 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.27 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.83 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.67 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.7 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.67 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=352.95 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=218.8
Q ss_pred HHHhhhhhcCcCCceeEEEEEe-CCCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCI-NGGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~-~~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|+..+.||+|||+.||.+++ ..|..+|+|++.+. .......+.+|+++-+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999999 68999999999763 3344566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|.|..++|..+++ ..+.+++.+++.+++||+.|+.|||++ +|+|||||..|+|++++-+|||+|||+++....+.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999995 668899999999999999999999999 99999999999999999999999999999876543
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
......+||+.|.|||++ .....+..+||||+||++|-||.|+|||+...-.+.+. .+......
T Consensus 173 Erk~TlCGTPNYIAPEVl-~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~---------------~Ik~~~Y~ 236 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVL-NKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN---------------KIKLNEYS 236 (592)
T ss_pred cccceecCCCcccChhHh-ccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH---------------HHHhcCcc
Confidence 334557799999999999 57778999999999999999999999999764433322 22223333
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHH-hccCC
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMM-EGIVP 307 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L-~~~~~ 307 (325)
.+...+.++.+||.++|+.||.+|||+++|+ .++ .+..|
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 4445567899999999999999999999999 566 55554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=334.83 Aligned_cols=260 Identities=27% Similarity=0.382 Sum_probs=214.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeec-cchhcHHHHHHHHHHHhccCCCCcceeeEEeecCC-ceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIK-IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS-NRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~l 106 (325)
+..++.+..+.||+|+.|+|+++.++ .++-+|+|++.. ......+++.+|+++++..+||+||.+|+.|..++ ...|
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 45567778889999999999999998 677888998843 34566778999999999999999999999999888 4999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||++|+|.+++.. .+++++..+..++.++++||.|||+ . +|+||||||+||||+..|.|||+|||.+.....
T Consensus 156 ~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred ehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999843 4789999999999999999999996 6 999999999999999999999999999876644
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc-
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS- 264 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 264 (325)
. ......||..|||||.+ .+..|+.++||||||+.++|+++|+.|+.......... .+ -+..++.
T Consensus 232 S---~a~tfvGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~-~~---------Ll~~Iv~~ 297 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI-FE---------LLCAIVDE 297 (364)
T ss_pred h---hcccccccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH-HH---------HHHHHhcC
Confidence 4 33344599999999999 67789999999999999999999999998752211111 11 1223333
Q ss_pred CCCCCCHH-HHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 265 DQEDVNIE-EFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 265 ~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
+.+..+.. ++.++++|+..||++||.+|||++|++ -++++...
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 23334443 778899999999999999999999999 45555443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=339.97 Aligned_cols=286 Identities=45% Similarity=0.764 Sum_probs=247.2
Q ss_pred ccccccHHHHHHHHHhhh--hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEe
Q 047716 21 KLRSFSYEQIVLASENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFC 98 (325)
Q Consensus 21 ~~~~~~~~~~~~~~y~~~--~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (325)
..+.|++.++...+-.+. ..||+|+||.||+|...++..+|||++.........+|.+|+.++.+++|||+|+++|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 677799999998887777 699999999999999998899999988664433145599999999999999999999999
Q ss_pred ecCC-ceEEEEeecCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEee
Q 047716 99 SEGS-NRLLVYEFMRNGSLGNLLFRAEQ-RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISD 176 (325)
Q Consensus 99 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~D 176 (325)
.+.+ +..||+||++.|+|.+.+..... .++|..+..|+.+++.||+|||..|...|+|+|||++|||+|.+...|++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999966555 899999999999999999999998777799999999999999999999999
Q ss_pred ccccccccCCCccceeee-cCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH
Q 047716 177 FGLSKLLKTDQTRTYTVL-RGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 177 fg~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
||++...... ....... .||.+|++||+. ..+..++++||||||+++.||++|+.+.+.........+.+|+...+.
T Consensus 221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~-~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYA-STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc-ccceeeecCCCCccCChhhh-ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999544331 1111111 589999999999 558889999999999999999999999987765566668999999999
Q ss_pred hCcccccccCCC---CCCH-HHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 256 AGELQNLVSDQE---DVNI-EEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 256 ~~~~~~~~~~~~---~~~~-~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
.+.+.+++++.. .... .....+..++..|++.+|.+||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999984 3333 5788899999999999999999999999999776644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=322.81 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=214.1
Q ss_pred cccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeec--cchhcHHHHHHHHHHHhccCCCCcceeeE-Eee
Q 047716 24 SFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLVG-FCS 99 (325)
Q Consensus 24 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~ 99 (325)
.++.++...++|++.++||.|.||+||++... +++.+|.|.+.- ......+.+..|+.+|++|+|||||++++ .+.
T Consensus 10 ~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 10 DFSPPQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred CCCCCcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 34446777899999999999999999999876 799999998862 23344556888999999999999999998 444
Q ss_pred cCCc-eEEEEeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccC-CCCeeeccCCCCceEEcCCCcEEE
Q 047716 100 EGSN-RLLVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDEC-ETRIIHCDIKPHNILMDESWKAKI 174 (325)
Q Consensus 100 ~~~~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~-~~~i~h~di~p~nilv~~~~~vkl 174 (325)
+++. ++||||+|.+|+|.+.++.. ...+++..+|.++.|++.|+..+|++. ++-+.||||||.|||++.+|.|||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 4444 89999999999999988533 456999999999999999999999941 224999999999999999999999
Q ss_pred eeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH
Q 047716 175 SDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 175 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
+|||+++.+........ ...|||-||+||.+ ....|+.++|||||||++|||+.-++||.+..-. . ..+.+
T Consensus 170 GDfGL~r~l~s~~tfA~-S~VGTPyYMSPE~i-~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~----L~~KI 240 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTFAH-SLVGTPYYMSPERI-HESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---S----LCKKI 240 (375)
T ss_pred ccchhHhHhcchhHHHH-hhcCCCcccCHHHH-hcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---H----HHHHH
Confidence 99999998776554333 34499999999999 7888999999999999999999999999987221 1 22344
Q ss_pred HhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 255 EAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
.++.+.++. ...++..+..+|..|+.+||+.||+...+++-+.
T Consensus 241 ~qgd~~~~p------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 241 EQGDYPPLP------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HcCCCCCCc------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 444333222 2456788999999999999999999665554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=334.48 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=209.8
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-------hcHHHHHHHHHHHhccCCCCcceeeEEe
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-------EGESEFRNEMKIIGRIHHKNLVDLVGFC 98 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (325)
.+......|-+.+.||+|+||.|-+|..+ .++.||+|++.+... .....+.+|+++|++|+|||||+++++|
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 44457788999999999999999999987 799999999975321 1233467999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC---CcEEEe
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES---WKAKIS 175 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~---~~vkl~ 175 (325)
+.....|+||||+.||.|.+++. ..+.+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999999884 445678888899999999999999999 99999999999999776 679999
Q ss_pred eccccccccCCCccceeeecCCCCcCCccccccCC--CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHH
Q 047716 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN--RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253 (325)
Q Consensus 176 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 253 (325)
|||++...+. .......+||+.|.|||++.+.+ .+..+.|+|||||++|-+|+|.+||......... .+.
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl------~eQ 393 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL------KEQ 393 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH------HHH
Confidence 9999987763 34455677999999999985432 2345899999999999999999999766544311 122
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
+..+.+.. .+....+..++..++|.+||..||++|||+.|++
T Consensus 394 I~~G~y~f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 394 ILKGRYAF----GPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred HhcCcccc----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 22333221 1223445668899999999999999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=341.04 Aligned_cols=265 Identities=25% Similarity=0.330 Sum_probs=219.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhc-HHHHHHHHHHHhccC-CCCcceeeEEeecCC-ceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG-ESEFRNEMKIIGRIH-HKNLVDLVGFCSEGS-NRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~ 105 (325)
+...+|+++++||.|.||.||+|+.. .+..||+|++++..... +..-.+|+..|++++ ||||+++.+++.+.. .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 56789999999999999999999977 78889999987644333 333457999999999 999999999998776 999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||| ..+|.++++.....+++..++.|+.||++||+|+|.+ |++|||+||+|||+..+..|||+|||+++...+
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 999999 5699999988888899999999999999999999999 999999999999999888999999999998876
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc----
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN---- 261 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 261 (325)
.++...+. .|.||+|||++.....|+.+.||||+|||++|+.+-++.|.+....++...+.-+-.......+.+
T Consensus 163 kpPYTeYV--STRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 KPPYTEYV--STRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CCCcchhh--hcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 66544443 799999999998999999999999999999999999999999988777665532111111111100
Q ss_pred ------cccC-----CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 ------LVSD-----QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ------~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+.. ....-+....++.++|..|++.||++|||++|.++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 0000 02223335678999999999999999999999994
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=318.14 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=213.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
..|+...++|+|+||.|++++++ .|+-||||++..... .-.+-..+|+++|++++|+|+|.++++|.....+++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888999999999999999998 688999999976333 223347789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
||+..-|.++ .....+++...+..+++|++.|+.|+|++ +++||||||+|||++.+|.+||+|||+++.... +..
T Consensus 82 ~~dhTvL~eL-e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDHTVLHEL-ERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecchHHHHHH-HhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 9987666554 46778899999999999999999999999 999999999999999999999999999987763 222
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHHHhCcccc
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCYEAGELQN 261 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 261 (325)
.......|.||+|||.+.+...|....||||+||++.||++|.+.|.+.++.+....+... ...+....+-.
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 2233347999999999988899999999999999999999999999999998887776421 12222222211
Q ss_pred cccCC-C-------CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 262 LVSDQ-E-------DVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 262 ~~~~~-~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
-+.-+ + .--+....-+.+++..||+.||++|++.+|++
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11111 1 01122234689999999999999999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=332.79 Aligned_cols=264 Identities=31% Similarity=0.462 Sum_probs=217.5
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhc--HHHHHHHHHHHhccCCCCcceeeEEeecCC-
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG--ESEFRNEMKIIGRIHHKNLVDLVGFCSEGS- 102 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 102 (325)
....+......+.+.+|.|+||+||+|.+++...+|+|++....... .+.+.+|+.+|.+++|||||++++++.+..
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 44556677777888899999999999999866669999987643322 558999999999999999999999998876
Q ss_pred ceEEEEeecCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHhhccCCCC-eeeccCCCCceEEcCCC-cEEEeeccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFR-AEQRLSWSERRRIALEIMEGLHYLHDECETR-IIHCDIKPHNILMDESW-KAKISDFGL 179 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~-i~h~di~p~nilv~~~~-~vkl~Dfg~ 179 (325)
.+.+||||+++|+|.+++.. ....++...+..++.+|+.|+.|||++ + |+|+||||+|||++.++ ++||+|||+
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 79999999999999999976 367899999999999999999999999 8 99999999999999997 999999999
Q ss_pred cccccCCCccceeeecCCCCcCCcccccc-CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSR-NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
+....... .......||+.|||||.+.. ...++.++||||||+++|||+||+.||......... ......
T Consensus 191 sr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~------~~v~~~-- 261 (362)
T KOG0192|consen 191 SREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA------SAVVVG-- 261 (362)
T ss_pred ceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhc--
Confidence 97655422 11122348999999999943 568999999999999999999999999877652211 111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..++..+..+...+..+|.+||+.||..||++.+++..|+.+.
T Consensus 262 -----~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 262 -----GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred -----CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1122233335677999999999999999999999999999877
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=323.94 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=201.7
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
.+|.+.++||.|+||+||+|+++ .+..||||.+... ..+..+.+..|+.+|+.++|||||.+++++..++.+++|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57889999999999999999987 6899999999775 55566678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC------CcEEEeeccccccc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES------WKAKISDFGLSKLL 183 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~------~~vkl~Dfg~~~~~ 183 (325)
||+||+|.+++. ..+++++..++.++.||+.|+++||++ +|+||||||.|||++.. ..+||+|||+++..
T Consensus 90 yC~gGDLs~yi~-~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 90 YCNGGDLSDYIR-RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred eCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999994 456899999999999999999999999 99999999999999765 56899999999987
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
... ......+|++-|||||++ ....|+.|+|+||+|+++|+|++|++||+.....+....+.. .....
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~-~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k------~~~~~--- 233 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVI-MSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK------GNEIV--- 233 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHH-HhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc------ccccc---
Confidence 643 334456799999999999 688999999999999999999999999997655443322110 00111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
+..+......+.+++...++.+|.+|-+..+-.
T Consensus 234 ---~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 234 ---PVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ---CchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 111112223355666677777777776665544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=335.47 Aligned_cols=264 Identities=28% Similarity=0.397 Sum_probs=222.7
Q ss_pred ccHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 25 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
....++....+++.+.||+|.||.||.|.+++...+++|.+... ......+.+|+.+|++|+|++||++++++..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 55667888999999999999999999999998889999998764 34445677999999999999999999999998899
Q ss_pred EEEEeecCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFR-AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
+|||||++.|+|.+++.. .+..+....++.++.||++|++||+++ ++|||||.+.||||+++..+||+|||+++..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999999975 466799999999999999999999999 9999999999999999999999999999965
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
.++.........-+..|.|||.+ ....++.++||||||++||||+| |+.|+......+....+ .+..
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~-~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l---e~Gy-------- 421 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEAL-NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL---ERGY-------- 421 (468)
T ss_pred CCCceeecCCCCCCceecCHHHH-hhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH---hccC--------
Confidence 55554333333345679999999 67889999999999999999987 67777776554332211 1111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
+.+.+..++.++.++|..||+.+|++|||++.+...|+.+..
T Consensus 422 ---Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 ---RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ---cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 233344566789999999999999999999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=304.39 Aligned_cols=267 Identities=23% Similarity=0.295 Sum_probs=219.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
.+|...+++|+|.||.||+|++. .|+.||+|++.... ..-.....+|++.|+.++|+||+.+++.|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 47889999999999999999987 79999999997532 2334567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+ ..+|..+++...-.++...+..++.+++.|++|||++ .|.|||+||.|+|++++|.+|++|||+++.+...+..
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 99 5699999977777899999999999999999999999 9999999999999999999999999999988765543
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc------
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV------ 263 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 263 (325)
.... ..|.+|+|||.+.+...|....||||.|||+.||+-|.+-|.+..+.++...+-.+-.....+.+.++.
T Consensus 158 ~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 3332 369999999999899999999999999999999999999999988877665542221111111111111
Q ss_pred ------cCCCC-CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhc
Q 047716 264 ------SDQED-VNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEG 304 (325)
Q Consensus 264 ------~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~ 304 (325)
.+... .-+.....+.+++..|+..||.+|+|++|++ ..+..
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 11111 2223346789999999999999999999999 44554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=324.25 Aligned_cols=265 Identities=24% Similarity=0.293 Sum_probs=217.0
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--CceE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNRL 105 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 105 (325)
....|+.+++||+|.||.||+|++. .|+.||+|++.... ........+|+.+|++|+||||+++.+...+. +.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3678999999999999999999987 78999999987544 44556677899999999999999999988665 6899
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+|+|||++ +|..++....-++++..+.-+++||+.|+.|||++ |+.|||||.+||||+.+|.+||+|||+++++..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999965 88888866666899999999999999999999999 999999999999999999999999999998876
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc-----
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ----- 260 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 260 (325)
...........|.||+|||.+.+...|+.+.|+||.|||+.||+.|++.|++....++...|-.........-+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 665555555579999999999899999999999999999999999999999987766655442211111111111
Q ss_pred --ccccCCCCCC-------HHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 --NLVSDQEDVN-------IEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 --~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..+.+..... ....+...+|+..+|..||++|.|+.+++
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 1111111111 11135688999999999999999999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=312.31 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=203.8
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCC--ceEEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS--NRLLVY 108 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 108 (325)
..++...+.||+|+||+||++.... +...|||.+........+.+.+|+.+|.+++|||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4567788999999999999999874 8899999887653333667899999999999999999999744433 689999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-CCcEEEeeccccccccC--
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAKISDFGLSKLLKT-- 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~~~~~~~-- 185 (325)
||+++|+|.+++.+.++++++..++.+.+|+++|+.|||++ |++||||||+|||++. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999977666899999999999999999999999 9999999999999999 79999999999886653
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
..........||+.|+|||++..+.....++|||||||++.||+||.+||....... .+........ .
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~-----~~~~~ig~~~-------~ 240 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA-----EALLLIGRED-------S 240 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH-----HHHHHHhccC-------C
Confidence 222222334589999999999543334469999999999999999999998641111 1111111111 1
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+.++...+..+.+++..|+..+|.+|||++++++
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 12344445678999999999999999999999994
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=319.97 Aligned_cols=249 Identities=25% Similarity=0.319 Sum_probs=211.1
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 105 (325)
..++|.+++.||.|+|++|++|+.. .++.+|+|++.+. .+...+.+..|-.+|..| +||.|++++..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3578999999999999999999987 7999999998753 344556677888999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+|+||.++|.|.+++.+ -+.+++.-.+.++.||+.||.|||++ |||||||||+|||++.+++++|+|||.+..+..
T Consensus 151 FvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999954 47899999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcc------------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHH
Q 047716 186 DQTR------------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253 (325)
Q Consensus 186 ~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 253 (325)
.... ......||..|.+||.+ .....+..+|+|+|||++|+|+.|.+||.+...- .
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---l-------- 294 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELL-NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---L-------- 294 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHh-cCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---H--------
Confidence 2211 11224599999999999 6788899999999999999999999999876421 1
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.++++++-..++++..++.+.+|+.+.|-.||.+|+|++||.
T Consensus 295 ----iFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 295 ----IFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred ----HHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 112333334445555557899999999999999999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=321.11 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=213.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
...|+-.++||+|+.|.||.|... .+..||+|++....+....-+.+|+.+|+..+|+|||.+++.|...+.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 466888899999999999999876 7888999999887788888899999999999999999999998888999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++|+|.|++. ...+++..+..+++.+++||+|||.+ ||+|+|||.+|||++.+|.+||+|||++.........
T Consensus 352 m~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 352 MEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred cCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence 99999999984 34599999999999999999999999 9999999999999999999999999999877655542
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....||+-|||||+. ....|.++.||||||++++||+.|.+||..........++. .-..+....+
T Consensus 426 R~TmVGTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------------~ng~P~lk~~ 492 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------TNGTPKLKNP 492 (550)
T ss_pred cccccCCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------------hcCCCCcCCc
Confidence 3334499999999999 78889999999999999999999999998654433333221 1111223334
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...+..+++|+.+||+.|+.+|+++.|||
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL 521 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELL 521 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHh
Confidence 44556799999999999999999999999
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=320.36 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=209.2
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc----ch-hcHHHHHHHHHHHhccC-CCCcceeeEEeecC
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI----VE-EGESEFRNEMKIIGRIH-HKNLVDLVGFCSEG 101 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 101 (325)
......|.+.+.||+|+||.|+.|... .+..+|+|.+... .. .....+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 455678999999999999999999876 6799999966542 11 34556778999999999 99999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-CcEEEeecccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-WKAKISDFGLS 180 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vkl~Dfg~~ 180 (325)
...++||||+.+|.|.+++.. .+++.+.+++.+++|++.|++|||++ ||+||||||+|++++.+ +++||+|||++
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999999966 78999999999999999999999999 99999999999999999 99999999999
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCC-CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNN-RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
.... .........+|++.|+|||.+.+.. +...++||||+|++||-|++|+.||+........ ..+
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-------~ki----- 235 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-------RKI----- 235 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-------HHH-----
Confidence 8764 2223344566999999999997656 5568999999999999999999999974322211 111
Q ss_pred cccccCCCCCCHHH-HHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 260 QNLVSDQEDVNIEE-FENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 260 ~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.......+... +.++.+++.+||..||.+|+|+.+++
T Consensus 236 ---~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 236 ---RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 22222222222 57799999999999999999999999
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=307.23 Aligned_cols=245 Identities=26% Similarity=0.280 Sum_probs=204.4
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
.....+|++.+.||+|+||.|+.++.+ .++.+|+|++.+.. ..+......|..+|..++||.||+++..|.+...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 455788999999999999999999887 68888999887633 34556788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++|++|+.||.|...+ +..+.+++..++.++..|+.||.|||++ ||+|||+||+|||++.+|+++|+|||++....
T Consensus 101 ylVld~~~GGeLf~hL-~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHL-QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEeccCCccHHHHH-HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999998 4567899999999999999999999999 99999999999999999999999999998544
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.... .....+||+.|+|||++ ....++..+|-||||+++|+|++|.+||.......... .+..+.
T Consensus 177 ~~~~-~t~tfcGT~eYmAPEil-~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~-------~I~~~k------ 241 (357)
T KOG0598|consen 177 KDGD-ATRTFCGTPEYMAPEIL-LGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD-------KILKGK------ 241 (357)
T ss_pred cCCC-ccccccCCccccChHHH-hcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH-------HHhcCc------
Confidence 3322 22335699999999999 56688999999999999999999999998875433221 111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRP 293 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 293 (325)
....+.-...+.++++.++|+.+|++|.
T Consensus 242 -~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0112222346799999999999999995
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=299.55 Aligned_cols=276 Identities=22% Similarity=0.319 Sum_probs=216.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeec--cchhcHHHHHHHHHHHhccCCCCcceeeEEeec-----CCc
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-----GSN 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 103 (325)
...|..++.||.|+||.|+.|.+. ++..||+|++.. ......+...+|+.+|+.++|+||+.+++++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 445666889999999999999987 789999999973 445566778899999999999999999998854 367
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++|+|+| ..+|.+.+ +.++.++...+..+++|++.|+.|+|+. +++|||+||+|++++.+..+|++|||+++..
T Consensus 101 vYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeec
Confidence 89999999 77899888 4555699999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH--------HHHHH
Q 047716 184 KTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW--------AHQCY 254 (325)
Q Consensus 184 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~ 254 (325)
..... ........|.+|+|||.+.....|+.+.||||+|||++||++|++.|.+....++..++.. ....+
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 53211 1112234699999999998899999999999999999999999999998887666555521 11111
Q ss_pred HhCcccccccCCCC--------CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCCCCCC
Q 047716 255 EAGELQNLVSDQED--------VNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPPHQNM 312 (325)
Q Consensus 255 ~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~~~~~ 312 (325)
..+.....+...+. .-+.......+++.+||..||.+|+|++|.+ -.|...-++.-.|
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 11111111111111 1112235688999999999999999999999 4566666444444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=299.66 Aligned_cols=268 Identities=23% Similarity=0.304 Sum_probs=213.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+..+.|++.+.||.|..++||+|+.. .+..||||++.-. ...+...+.+|+..+..++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 34689999999999999999999876 6788999998753 344457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|++|.+|++.+++... ..++++..+..+++++++||.|||.+ |.+|||+|+.||||+.+|.|+|+|||....+-..
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999998543 56799999999999999999999999 9999999999999999999999999976543222
Q ss_pred Ccc---ceeeecCCCCcCCccc-cccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc-c
Q 047716 187 QTR---TYTVLRGTRGYTAPEL-HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ-N 261 (325)
Q Consensus 187 ~~~---~~~~~~~~~~y~aPE~-~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 261 (325)
..+ ......++++|+|||+ .+.-..|+.|+||||||+...||.+|..||....+-.... ..++...-. .
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl------~tLqn~pp~~~ 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL------LTLQNDPPTLL 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH------HHhcCCCCCcc
Confidence 111 1133458999999999 6667789999999999999999999999998664433221 112111110 0
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
......+........+++++..||..||++|||+++++ .+++..+
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 11111222333445799999999999999999999999 4555554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=310.01 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=203.0
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
.+...+|++.++||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 345688999999999999999999752 34678999886533 23345688999999999 89999999998765
Q ss_pred C-CceEEEEeecCCCCHHHHHhhcc-------------------------------------------------------
Q 047716 101 G-SNRLLVYEFMRNGSLGNLLFRAE------------------------------------------------------- 124 (325)
Q Consensus 101 ~-~~~~lv~e~~~~~~L~~~~~~~~------------------------------------------------------- 124 (325)
. ...+++|||+++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 46899999999999999885421
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc-ceeeecCC
Q 047716 125 ------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGT 197 (325)
Q Consensus 125 ------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~ 197 (325)
..+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++......... ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 2367788899999999999999999 9999999999999999999999999998754322211 11112245
Q ss_pred CCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHH
Q 047716 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFEN 276 (325)
Q Consensus 198 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
..|+|||.+ ....++.++||||||+++|+|++ |..||......+.. ......+... ..+......
T Consensus 240 ~~y~aPE~~-~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~~~-------~~~~~~~~~ 305 (338)
T cd05102 240 LKWMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLKDGTRM-------RAPENATPE 305 (338)
T ss_pred ccccCcHHh-hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH------HHHHhcCCCC-------CCCCCCCHH
Confidence 789999998 45678899999999999999997 99999765432211 1111111111 111223456
Q ss_pred HHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 277 LVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 277 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
+.+++.+||+.+|.+|||+.|++++|+.+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=301.81 Aligned_cols=262 Identities=23% Similarity=0.373 Sum_probs=220.7
Q ss_pred cccccccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcH---HHHHHHHHHHhccCCCCc
Q 047716 16 VFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGE---SEFRNEMKIIGRIHHKNL 91 (325)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~---~~~~~e~~~l~~l~h~~i 91 (325)
+.+-.+.+.+.--.-...+|++.+.||+|.||.|-+|+.. .|+.||+|.|.+....+. -.+++|++++..|+||||
T Consensus 36 P~k~~gvkrhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhI 115 (668)
T KOG0611|consen 36 PLKMSGVKRHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHI 115 (668)
T ss_pred CcccccccccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCce
Confidence 3344445555556667899999999999999999999985 899999999977554443 458899999999999999
Q ss_pred ceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc
Q 047716 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK 171 (325)
Q Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~ 171 (325)
+.++++|++.+.+.|||||..+|.|.+++. ..+.+++.+.+.+++||+.|+.|||.+ +++|+|+|.+|||++.+++
T Consensus 116 I~IyEVFENkdKIvivMEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~N 191 (668)
T KOG0611|consen 116 IQIYEVFENKDKIVIVMEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNN 191 (668)
T ss_pred eehhhhhcCCceEEEEEEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCC
Confidence 999999999999999999999999999994 456899999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH
Q 047716 172 AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 172 vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 251 (325)
+||.|||++..+.... .....+|++-|.+||++.+..+-.+..|.||||++||-|..|.-||++..... .-
T Consensus 192 iKIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lv 262 (668)
T KOG0611|consen 192 IKIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LV 262 (668)
T ss_pred eeeeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HH
Confidence 9999999998775443 33445699999999999777888899999999999999999999999875321 12
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
+.+..+.+.+- +.+....-||.|||-.||+.|.|+++|.
T Consensus 263 rQIs~GaYrEP---------~~PSdA~gLIRwmLmVNP~RRATieDiA 301 (668)
T KOG0611|consen 263 RQISRGAYREP---------ETPSDASGLIRWMLMVNPERRATIEDIA 301 (668)
T ss_pred HHhhcccccCC---------CCCchHHHHHHHHHhcCcccchhHHHHh
Confidence 33333443322 2224477899999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=312.36 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=210.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++|.+.+.||+|+||.||+|+.+ ..+.||+|.+.+. ..++.+.+.+|+++++.++||||+.++++|+...++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47899999999999999999987 5777888888653 34455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+.| +|..++ ...+.+++..+..++.+++.|+.|||++ +|.|+|+||.||++..+|.+|++|||+++-+.....
T Consensus 82 ~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 82 YAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence 9966 999999 4567899999999999999999999999 999999999999999999999999999987765433
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
....+.||+-|||||.. .+..|+..+|+|||||++|||++|++||........ ...+..+...+
T Consensus 156 vltsikGtPlYmAPElv-~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L---------------v~~I~~d~v~~ 219 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELV-EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL---------------VKSILKDPVKP 219 (808)
T ss_pred eeeeccCcccccCHHHH-cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH---------------HHHHhcCCCCC
Confidence 33445699999999999 688899999999999999999999999986533211 12334444455
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
+......+..++...|.+||.+|.|..+++
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 556777899999999999999999999999
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=289.74 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=208.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh--cHHHHHHHHHHHhccCCCCcceeeEEeecC--CceEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE--GESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 106 (325)
.+.|+....|++|.||.||+|+++ .+.-||+|++.-.... -.-...+|+.+|.+.+|||||.+-++.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467899999999999999999998 6888899988643221 122356899999999999999999988553 57899
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|||||++ +|..++....+++...++.-++.|++.|+.|||.+ .|+|||+|++|+|++..|.+|++|||+++.+++.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999965 89999988888999999999999999999999999 9999999999999999999999999999988765
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc---cc---
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE---LQ--- 260 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~--- 260 (325)
.. .......|.+|+|||.+.+...|++..||||+|||+.||+++++.|.+....++...+- +.+..+. +.
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If---~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIF---KLLGTPSEAIWPGYS 306 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHH---HHhCCCccccCCCcc
Confidence 32 22333469999999999899999999999999999999999999999987766554431 1111111 00
Q ss_pred ccc--------cCC-----CCCCHH-HHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 NLV--------SDQ-----EDVNIE-EFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 ~~~--------~~~-----~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.+. ... ..+... ..+.-++|+..+|..||.+|.|++|.|
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 000 000 000000 236678999999999999999999999
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=285.74 Aligned_cols=237 Identities=27% Similarity=0.328 Sum_probs=205.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh---cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE---GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
..+|++.+.||.|+||.|.+++.+ ++..+|+|++.+..-- -.....+|-.+|+.+.||.++++++.+.+.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 456889999999999999999988 6888999998764322 233466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||++||.|..++ +..++++++.++.++.|++.|+.|||++ +|++||+||+|||++.+|.+|++|||.+.+....
T Consensus 123 meyv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999999 4557899999999999999999999999 9999999999999999999999999999876432
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
....|||+.|+|||.+ ..+.+..++|=||||+++|||+.|.+||........ +.+++....
T Consensus 198 ---T~TlCGTPeYLAPEii-~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i---------------Y~KI~~~~v 258 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEII-QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI---------------YEKILEGKV 258 (355)
T ss_pred ---EEEecCCccccChHHh-hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH---------------HHHHHhCcc
Confidence 5667899999999999 577788899999999999999999999987765322 234445555
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCC
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLR 292 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~R 292 (325)
..+......+.+|+.+.|+.|-.+|
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 5666666789999999999999999
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=304.26 Aligned_cols=260 Identities=20% Similarity=0.304 Sum_probs=200.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
.+|++.++||.|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46899999999999999999887 67889999886432 22344677899999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++ +|.+++......++...+..++.|++.|++|||++ |++|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~- 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT- 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence 964 88888865556689999999999999999999999 9999999999999999999999999998654322211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh------------Cc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA------------GE 258 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~ 258 (325)
.....+++.|+|||.+.+...++.++||||||+++++|++|++||......+....+ ...... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI---FRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChHHhhccccchh
Confidence 122236889999998865667889999999999999999999999765443322111 111000 00
Q ss_pred ccccccCCC------CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQNLVSDQE------DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+.....+.. ...+....++.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 011111000 001122356889999999999999999999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=308.09 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=212.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc-eEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN-RLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 107 (325)
.++|..++++|+|+||.+++++.+ +++.+++|++.-. .........+|+.++++++|||||.+++.|.+++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367999999999999999999887 6888999988642 33444568899999999999999999999988888 8999
Q ss_pred EeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|+|++||++.+.+.... .-+++..++.|+.|++.|+.|||++ .|.|+|||+.|||++.++.|+|+|||++...+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999986554 5689999999999999999999998 9999999999999999999999999999988766
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. ....+.||+.|++||.+ .+..|..++|||||||++|||++-+++|.+.........+. ... .
T Consensus 160 ~~-~a~tvvGTp~YmcPEil-~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-------~~~-------~ 223 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEIL-SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-------RGL-------Y 223 (426)
T ss_pred hh-hhheecCCCcccCHHHh-CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-------hcc-------C
Confidence 53 23344599999999999 78889999999999999999999999999875543322111 111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
...+..++.++..++..||+.+|..||++.+|+..
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 23444566789999999999999999999999943
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=297.01 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=204.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
+...+|++.+.||+|+||.||+|.+. .+..+++|.+.... ......+.+|+..++.++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 45678999999999999999999764 35678889886543 23345678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++......+++..++.++.|++.|++|||++ +++|+||+|+||+++.++.++++|||......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999999866556789999999999999999999999 99999999999999999999999999765432
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...........++..|+|||.+ ....++.++||||||++++++++ |..||......+.. .....+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~~~---- 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------KAVEDGFR---- 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHH-hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCCC----
Confidence 2211111111245689999998 45678899999999999999775 99999765432211 11111110
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
...+...+..+.+++.+||+.+|.+||++++|++.|+.+
T Consensus 227 ---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111223446799999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=303.33 Aligned_cols=266 Identities=19% Similarity=0.294 Sum_probs=201.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
.+|++.++||.|+||.||+|.+. .++.+|+|++..... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 57999999999999999999987 688899998864332 2334567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+. ++|.+++....+.+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++........ .
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 159 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-T 159 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-c
Confidence 95 678777766667799999999999999999999999 999999999999999999999999998864332211 1
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc---------c
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ---------N 261 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 261 (325)
.....+++.|+|||.+.+...++.++|||||||++++|++|..||......... +............. .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchhhccc
Confidence 122336889999999855667888999999999999999999999865432111 11111111110000 0
Q ss_pred cccCC----CCCC-------HHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhcc
Q 047716 262 LVSDQ----EDVN-------IEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGI 305 (325)
Q Consensus 262 ~~~~~----~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~ 305 (325)
..... .... ......+.+++.+||+.||++|||++|++ ..++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000 0000 01124688999999999999999999999 345444
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.84 Aligned_cols=262 Identities=21% Similarity=0.254 Sum_probs=200.3
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|+||.||+|++. ++..+++|++.... ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 6889999999999999999987 67789999886532 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++++++..+. .....+++..++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++..........
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9887666554 4456799999999999999999999999 99999999999999999999999999987654333222
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH---------HHHHhCcccc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH---------QCYEAGELQN 261 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 261 (325)
.....++..|+|||.+ .+..++.++|+||||+++++|++|++||......+....+.... ..........
T Consensus 158 ~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 158 YTEYVATRWYRSPELL-LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred ccccccccccCCcHHH-cCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 2233478899999998 45567899999999999999999999998654433222111100 0000000000
Q ss_pred cccCCC--------CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 LVSDQE--------DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...+.. ......+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 001113456999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=304.77 Aligned_cols=242 Identities=22% Similarity=0.238 Sum_probs=198.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6889999999999999999987 68889999986432 1234557889999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++.. .+.+++..+..++.|++.|++|||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 82 YVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 9999999999844 45789999999999999999999999 99999999999999999999999999987653321
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
....+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... ...... ....
T Consensus 156 --~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~--------~~~~ 217 (291)
T cd05612 156 --WTLCGTPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-------EKILAG--------KLEF 217 (291)
T ss_pred --ccccCChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhC--------CcCC
Confidence 123478999999998 5566789999999999999999999999765432211 111111 1112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCC-----HhHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPT-----MKQVI 299 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell 299 (325)
+......+.+++.+||+.||.+||+ +++++
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 2223456899999999999999995 88988
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=313.42 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=212.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.-|++++-||.|+.|.|-+|++. .|+..|||++.+. +......+.+|+.+|+-+.|||++.+|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34678889999999999999987 7999999998764 2333456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++|.|.+++ -..+++++.+.+.+++||+.|+.|||.. +|+|+|+||+|+|++..+++||+|||++..-..+.
T Consensus 92 Eyv~gGELFdyl-v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 92 EYVPGGELFDYL-VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred EecCCchhHHHH-HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 999999999998 4567899999999999999999999999 99999999999999999999999999998654433
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....||++.|.+||++.+..+...++||||+|+|||.||+|+.||+.... ..++.. + -...-+
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlK----V--------~~G~f~ 230 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLK----V--------QRGVFE 230 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHH----H--------HcCccc
Confidence 334456999999999997778888999999999999999999999994332 222221 1 122233
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
++...+.++++|+.+|+..||..|.|++||++ +|.+..
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 44455578999999999999999999999994 455554
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.93 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=212.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCC-cEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeE-Eeec------CC
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGG-KEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVG-FCSE------GS 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~-~~~~------~~ 102 (325)
..+++|.+.|.+|||+.||+|.+..+ ..+|+|++........+.+++|+.+|+.|+ |+|||.+++ .... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 46788899999999999999999865 999999998888888889999999999997 999999999 3321 13
Q ss_pred ceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
+..|+||||.++.|.|+++++ ..++++.+++.|++++++|+++||.. ...|+|||||.+|||++.+|..||||||.++
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 578999999999999999654 45699999999999999999999996 4459999999999999999999999999987
Q ss_pred cccCCCccce--------eeecCCCCcCCccccc--cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH
Q 047716 182 LLKTDQTRTY--------TVLRGTRGYTAPELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 182 ~~~~~~~~~~--------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 251 (325)
..-....... -...-|+.|+|||.+. .+...++|+|||+|||+||-|+....||+.....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 5432221100 1123689999999864 4567789999999999999999999999875321
Q ss_pred HHHHhCcccccccCCCC--CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 252 QCYEAGELQNLVSDQED--VNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.++..... ..+.++..+.+||..||+.||.+||++-|++..+-.+..
T Consensus 265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 23333322 235788899999999999999999999999988887774
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=307.30 Aligned_cols=245 Identities=22% Similarity=0.257 Sum_probs=200.2
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
...+|++.+.||+|+||.||+|++. .++.+|+|++.... ......+.+|+.+++.++||||+++++.+.+++..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3578999999999999999999987 67889999986532 2234457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
+|||+.+++|.+++. ..+.+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++......
T Consensus 96 v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999999884 346789999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
. ....+++.|+|||.+ .+..++.++|||||||++|+|++|+.||......... .....+.
T Consensus 172 ~----~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i~~~~-------- 231 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-------EKILAGR-------- 231 (329)
T ss_pred c----ceecCChhhcCHHHH-cCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-------HHHhcCC--------
Confidence 2 123488999999998 4566789999999999999999999999764321111 1111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPT-----MKQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell 299 (325)
...+......+.+++.+||+.||.+||+ +++++
T Consensus 232 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 232 LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1111123356899999999999999997 68887
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.35 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=209.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..+|++.++||.|++|.||+|.+.++..+++|.+..........+..|+.+++.++||||+++++++......+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 56899999999999999999999888999999987766656677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++++|.+++... ...+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++++|||.+..........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 999999998553 34689999999999999999999999 99999999999999999999999999987654322211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
. ...++..|+|||.+ ....++.++|+||||+++++|++ |+.||......+.. .... .+ . ....
T Consensus 162 ~-~~~~~~~~~~PE~~-~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~~~~----~~-~------~~~~ 225 (261)
T cd05148 162 S-DKKIPYKWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---DQIT----AG-Y------RMPC 225 (261)
T ss_pred c-CCCCceEecCHHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHH----hC-C------cCCC
Confidence 1 12245679999998 45677889999999999999998 88999765422111 1111 10 0 1111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=298.51 Aligned_cols=250 Identities=26% Similarity=0.302 Sum_probs=198.9
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||+|.+. ++..+|+|.+..... .....+.+|+.+++.++|++|+++++.+.+++..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4778899999999999999886 788999998865322 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++++|.+.+... ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999998877443 34689999999999999999999999 999999999999999999999999999876532221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....++..|+|||.+ .+..++.++||||||+++++|++|+.||........... ....... ....
T Consensus 158 --~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~--------~~~~ 223 (285)
T cd05631 158 --VRGRVGTVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKE--------DQEE 223 (285)
T ss_pred --ecCCCCCCCccCHhhh-cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhc--------cccc
Confidence 1223478999999999 566788999999999999999999999987544321111 1111111 1111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPT-----MKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 300 (325)
........+.+++.+||+.||.+||+ ++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 22233467999999999999999997 788883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=287.73 Aligned_cols=267 Identities=23% Similarity=0.297 Sum_probs=211.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCC-cceeeEEeecCC-----
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKN-LVDLVGFCSEGS----- 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----- 102 (325)
...|...++||+|+||+||+|+.. .|+.||+|++.-... .......+|+.+|+.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 677889999999999999999987 788999999875433 23445678999999999999 999999997766
Q ss_pred -ceEEEEeecCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecc
Q 047716 103 -NRLLVYEFMRNGSLGNLLFRAE---QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFG 178 (325)
Q Consensus 103 -~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg 178 (325)
.+++||||+ ..+|.+++.... ..++...++.+++||+.|++|||++ +|+||||||.||+|++.|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 789999999 568999986554 4688889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC-
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG- 257 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 257 (325)
++.-...... ......+|.+|+|||.+.+...|++..||||+|||++||+++++.|.+....++...+- +.+..+
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If---~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF---RLLGTPN 241 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH---HHcCCCC
Confidence 9985543222 22333478999999999888899999999999999999999999999888755554432 222222
Q ss_pred --cccccc---cCC---CCC---------CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH--HhccC
Q 047716 258 --ELQNLV---SDQ---EDV---------NIEEFENLVKIGLWCVECELNLRPTMKQVIWM--MEGIV 306 (325)
Q Consensus 258 --~~~~~~---~~~---~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--L~~~~ 306 (325)
.+..+. +.. ... .+.......+++.+||+.+|.+|.|++.++.. +..+.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 111111 000 000 01111468899999999999999999999954 55553
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=293.30 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=202.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.++|++.+.||+|+||.||++.+.++..+++|.+... ......+.+|+.+++.++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4678999999999999999999988788999987543 333556888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++....+.+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||.+...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999865556789999999999999999999999 999999999999999999999999998875433222111
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
....++..|+|||.+ ....++.++|+||||+++++|++ |+.||......+.. . ....+... ..+
T Consensus 159 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~---~----~i~~~~~~-------~~~ 223 (256)
T cd05114 159 SGAKFPVKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV---E----MISRGFRL-------YRP 223 (256)
T ss_pred CCCCCchhhCChhhc-ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----HHHCCCCC-------CCC
Confidence 111245579999998 45678889999999999999999 89998755332111 1 11111100 001
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
......+.+++.+||+.+|++|||+.++++.|.
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112356899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=279.84 Aligned_cols=260 Identities=24% Similarity=0.281 Sum_probs=208.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----Cc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-----SN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 103 (325)
|.+++|+|.+.||.|||+-|++++.- .++.+|+|++.....++.+..++|+..-++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45789999999999999999999854 6889999999998888889999999999999999999999876333 35
Q ss_pred eEEEEeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeeccCCCCceEEcCCCcEEEeecc
Q 047716 104 RLLVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETR--IIHCDIKPHNILMDESWKAKISDFG 178 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nilv~~~~~vkl~Dfg 178 (325)
.+++++|...|+|.+.+... +..+++..+..++.++++|+.+||+. . ++|+||||.||++++.+.+++.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~---~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK---EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc---CCcccccCCCcceeEecCCCceEEEecc
Confidence 89999999999999988543 34699999999999999999999998 7 9999999999999999999999999
Q ss_pred ccccccCCCcc--------ceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHH
Q 047716 179 LSKLLKTDQTR--------TYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLID 248 (325)
Q Consensus 179 ~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 248 (325)
.++.....-.. .......|..|+|||.+.- +...++++|||||||++|.|+.|..||+......
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------ 248 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------ 248 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC------
Confidence 98754321110 0111125788999998743 4556899999999999999999999997543211
Q ss_pred HHHHHHHhCcccccccC-C--CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 249 WAHQCYEAGELQNLVSD-Q--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 249 ~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
+.+.--+.. . ..-...+++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus 249 --------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 --------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111100100 1 1112226788999999999999999999999999888764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.82 Aligned_cols=252 Identities=22% Similarity=0.250 Sum_probs=202.8
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
...+|+++..||+|+||.||+|+.+ .|..+|+|++.+.. ......++.|-.+|....+|.||+++..|.+...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4678999999999999999999987 68888899887632 3334557789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC-
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT- 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~- 185 (325)
||||++||++..++. ..+.+++..++.++.+++.||..+|+. |++|+||||+|+||+..|++||+|||++.-...
T Consensus 219 iMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999994 557899999999999999999999999 999999999999999999999999999852211
Q ss_pred -------------------CCc-cc-------------------------eeeecCCCCcCCccccccCCCCCccccchh
Q 047716 186 -------------------DQT-RT-------------------------YTVLRGTRGYTAPELHSRNNRITVKADVYS 220 (325)
Q Consensus 186 -------------------~~~-~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 220 (325)
... .. .....|||.|+|||++ .+..|+..+|.||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl-l~kgY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL-LGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH-hcCCCCccccHHH
Confidence 000 00 0112289999999999 4566899999999
Q ss_pred HHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HhH
Q 047716 221 FGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT---MKQ 297 (325)
Q Consensus 221 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~e 297 (325)
||||+||||.|-+||.+....+..-.+..-...+. .+.+. ....++.+||.+|+. ||..|.- ++|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------fP~~~--~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------FPEEV--DLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------CCCcC--cccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 99999999999999998776554433321112221 11111 122679999999999 9999964 777
Q ss_pred HH
Q 047716 298 VI 299 (325)
Q Consensus 298 ll 299 (325)
|.
T Consensus 442 IK 443 (550)
T KOG0605|consen 442 IK 443 (550)
T ss_pred Hh
Confidence 76
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=293.88 Aligned_cols=265 Identities=25% Similarity=0.318 Sum_probs=207.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC--C---ceEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--S---NRLLV 107 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~---~~~lv 107 (325)
.|.-.+.+|+|+||.||.|... .++.+|+|++...... -..|+.+|+.+.|||||+++.+|... + ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4556789999999999999987 5789999998664432 24689999999999999999887442 2 35789
Q ss_pred EeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-CcEEEeeccccccc
Q 047716 108 YEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLL 183 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vkl~Dfg~~~~~ 183 (325)
|||++ .+|.+++.. .+.+++...++-+.+||+.|++|||+. ||+||||||.|+||+.+ |.+||+|||++...
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99995 588888853 256789999999999999999999999 99999999999999877 89999999999988
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh-------
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA------- 256 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 256 (325)
..+.++..+. .+..|+|||.+.+...|+.+.||||.||++.||+-|++.|.+.+..++...+-.+......
T Consensus 177 ~~~epniSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPNISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7666654443 5889999999999999999999999999999999999999998877766555321111111
Q ss_pred CcccccccCCC------C-CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCC
Q 047716 257 GELQNLVSDQE------D-VNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPP 308 (325)
Q Consensus 257 ~~~~~~~~~~~------~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~ 308 (325)
+...+...+.. . .......++.+|+.++|+.+|.+|.++.|++ .++.++.++
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11111111110 0 1222346799999999999999999999999 556666543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=303.02 Aligned_cols=240 Identities=24% Similarity=0.271 Sum_probs=194.1
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+.||+|+||.||+|.+. +++.+|+|++.... ......+..|+.+++.++||||+++++.+...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999886 68889999987532 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeee
Q 047716 115 SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL 194 (325)
Q Consensus 115 ~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 194 (325)
+|.+++. ..+.+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLS-RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 9998884 346789999999999999999999999 99999999999999999999999999986432221 112233
Q ss_pred cCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHH
Q 047716 195 RGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF 274 (325)
Q Consensus 195 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
.|++.|+|||.+ .+..++.++|||||||++++|++|+.||......... ...... ....+....
T Consensus 156 ~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~~~~~--------~~~~p~~~~ 219 (323)
T cd05571 156 CGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILME--------EIRFPRTLS 219 (323)
T ss_pred ecCccccChhhh-cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-------HHHHcC--------CCCCCCCCC
Confidence 489999999998 5667889999999999999999999999764322111 111111 111222334
Q ss_pred HHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 275 ENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 275 ~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
..+.+++.+||+.||++|| ++.+++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 249 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIM 249 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHH
Confidence 6789999999999999999 799988
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=291.53 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=206.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+...+|++.+.||.|++|.||+|.+.+++.+++|.+.... ...+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4567899999999999999999998878889999876432 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+.+++|.+++.... ..+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999985433 4689999999999999999999999 999999999999999999999999999876643221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
........+..|+|||.+ ....++.++|+||||+++++|++ |+.||......... ..... ... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~-~~~------~ 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQVDQ-GYR------M 223 (261)
T ss_pred cccCCCcCceeccCcccc-ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHc-CCC------C
Confidence 111111123579999988 56678899999999999999999 99998754322111 11111 000 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.........+.+++.+|++.+|.+||+++++++.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11122346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=305.99 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=201.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+..|+.++..++||||+++++.+...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5889999999999999999987 57899999987532 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++. ..+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~g~~L~~~l~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999984 345789999999999999999999999 999999999999999999999999999875433
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC--C
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ--E 267 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 267 (325)
......+++.|+|||.+ .+..++.++|||||||++++|++|..||......+....+. . ....+... .
T Consensus 154 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~--~~~~~~~~~~~ 223 (333)
T cd05600 154 YANSVVGSPDYMAPEVL-RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK-------Y--WKETLQRPVYD 223 (333)
T ss_pred ccCCcccCccccChhHh-cCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH-------h--ccccccCCCCC
Confidence 11223478999999998 45578899999999999999999999998654332211110 0 00011111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........++.+++.+||+.+|.+||+++++++
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 111233467899999999999999999999994
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=306.32 Aligned_cols=269 Identities=20% Similarity=0.243 Sum_probs=200.8
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
...+|++.+.||+|+||.||+|.+. .++.+|+|+.. ...+.+|+.+++.++||||+++++++..+...++++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999987 67888888643 2346789999999999999999999998899999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
++. ++|..++.. ...+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++.........
T Consensus 164 ~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 164 RYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred cCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 994 678877743 45689999999999999999999999 9999999999999999999999999998654332222
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccch----hhHHHHHHHHHHh---------
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDE----IVLIDWAHQCYEA--------- 256 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~~~--------- 256 (325)
......+++.|+|||.+ ....++.++||||||+++|+|++|+.||......+. ...+.........
T Consensus 239 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 22334589999999998 456788999999999999999999988754321110 0000000000000
Q ss_pred ------------CcccccccCCC--CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCCCCC
Q 047716 257 ------------GELQNLVSDQE--DVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPPHQN 311 (325)
Q Consensus 257 ------------~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~~~~ 311 (325)
........... ........++.+++.+||+.||.+|||++|++ ..++.+.++.+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~ 388 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPN 388 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCC
Confidence 00000000000 00112345789999999999999999999999 566665544443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=308.81 Aligned_cols=268 Identities=26% Similarity=0.425 Sum_probs=218.4
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeec--cchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
..++|..+...+.+.||+|.||+||+|.|.+ .||||++.- ......+.|++|+.++++-+|-||+-+.|++-.+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5677888999999999999999999999985 688888864 344566779999999999999999999999988766
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.||+.||.|.+|..++.....++.....++|+.|+++|+.|||.+ +|+|+|||..|||+.+++.|||+|||+++.-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999977778899999999999999999999999 9999999999999999999999999999754
Q ss_pred cCCCc-cceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 184 KTDQT-RTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 184 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
..... .......+...|+|||++.. ...|++++||||||+++|||++|..||.....+...+. ...+
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm-------VGrG--- 608 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM-------VGRG--- 608 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE-------eccc---
Confidence 33221 12222236778999998743 35678999999999999999999999984333222110 0011
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
....+.......+..++++|+..||.+++++||.+.+|+..|+.+.+..
T Consensus 609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 0111223345556678999999999999999999999999999998643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=303.14 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=208.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..|+..+.||+|+||.||+|.+. .++.||+|++.-.. ......+.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777799999999999999987 68888999987543 44456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
|.||++.+.+ +.+..+.+..+..++++++.|+.|||.. +.+|+|||+.||++..+|.+|++|||.+..........
T Consensus 93 ~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999999 3445558899999999999999999999 99999999999999999999999999998777665554
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC-CCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD-QEDV 269 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 269 (325)
....||+.|||||++ ....|+.++||||||++.+||++|.+|+....+....++ +... ++..
T Consensus 169 -~tfvGTPfwMAPEVI-~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl---------------Ipk~~PP~L 231 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVI-KQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL---------------IPKSAPPRL 231 (467)
T ss_pred -ccccccccccchhhh-ccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe---------------ccCCCCCcc
Confidence 444599999999999 477899999999999999999999999976554322221 1111 1223
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...+...+++|+..||..||+.|||+.+++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 335567799999999999999999999999
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.69 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=206.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+..++|++.++||+|++|.||+|...++..+++|.+.... .....+..|+.+++.++|+||+++++.+...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 5568899999999999999999998888889999875432 335678899999999999999999999988889999999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++++|.+++... ...++...+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999988543 45688899999999999999999999 999999999999999999999999999876543222
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......++..|+|||.+ ....++.++|+||||+++++|++ |..||......+.. . ..... .. .
T Consensus 159 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~----~~~~~-~~------~ 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---S----ALQRG-YR------M 223 (261)
T ss_pred eccCCCccceecCCHHHh-ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---H----HHHcC-CC------C
Confidence 111112245679999998 45667889999999999999998 89999754322211 1 11111 00 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
......+..+.+++.+||+.+|++||+++++.++|+.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11112335689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=295.01 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=200.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC-----------------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING-----------------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNL 91 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-----------------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~i 91 (325)
+...+|++.++||+|+||.||+|.+.+ +..+|+|.+.... ......+.+|+.+++.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 346789999999999999999998642 2368999876533 2334568899999999999999
Q ss_pred ceeeEEeecCCceEEEEeecCCCCHHHHHhhcc------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 047716 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE------------------QRLSWSERRRIALEIMEGLHYLHDECETR 153 (325)
Q Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~ 153 (325)
+++++++.+.+..+++|||+.+++|.+++.... ..+++..++.++.|++.|+.|||+. |
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 999999998889999999999999999884321 2367788999999999999999999 9
Q ss_pred eeeccCCCCceEEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh--
Q 047716 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-- 230 (325)
Q Consensus 154 i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-- 230 (325)
++|+||||+||+++.++.++|+|||++......... ......++..|+|||.+ ....++.++||||||+++++|++
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI-LMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH-hcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999998754332211 11112246789999998 45668899999999999999987
Q ss_pred CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 231 CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
+..||......+ .+................. .++.++..+.+++.+||+.+|.+|||+++|.+.|++
T Consensus 238 ~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTDEQ---VIENAGEFFRDQGRQVYLF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCHHH---HHHHHHHHhhhcccccccc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 456676543221 1222222222111111111 112234579999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=301.94 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=200.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+...+|++.+.||+|+||.||++.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 34578999999999999999999987 57778888776532 23345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++.. ...+++..+..++.|++.|+.|||++ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 82 MEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred eecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999999843 45689999999999999999999985 259999999999999999999999999987553322
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc---------
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE--------- 258 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 258 (325)
. ....++..|+|||.+ .+..++.++||||||+++++|++|+.||......+.... .........
T Consensus 159 ~---~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 159 A---NSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSISP 231 (331)
T ss_pred c---ccCCCCcCcCCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCccccCc
Confidence 1 123478999999998 456788999999999999999999999975433211100 000000000
Q ss_pred -------------------------ccccccC--CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 259 -------------------------LQNLVSD--QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 259 -------------------------~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...+... ..........++.+++.+||+.||++|||++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000 0001112446799999999999999999999999
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.35 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=202.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..+|++.+.||+|++|.||.|.+.++..+++|.+.... .....+.+|+..++.++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 46789999999999999999988877779999876432 33466889999999999999999999998888899999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
.+++|.+++......+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||.+...........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99999999865555789999999999999999999999 999999999999999999999999998875533222111
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
....++..|+|||.+ ....++.++||||||+++++|++ |..||......+.. .....+... ...
T Consensus 159 ~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~~-------~~~ 223 (256)
T cd05113 159 VGSKFPVRWSPPEVL-LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV-------EKVSQGLRL-------YRP 223 (256)
T ss_pred CCCccChhhCCHHHH-hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHhcCCCC-------CCC
Confidence 112245679999998 45568889999999999999998 99998754432111 111111110 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112467999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=294.39 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=197.0
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhc---HHHHHHHHHHHhccCCCCcceeeEEeec----CCceEEEEeec
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG---ESEFRNEMKIIGRIHHKNLVDLVGFCSE----GSNRLLVYEFM 111 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 111 (325)
..+|+|++|.||+|.+ +++.+|+|.+....... ...+.+|+.++++++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5699999999999988 57899999987643332 3567799999999999999999998866 34679999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++.. .+.+++.....++.|++.|+.+||+. .+++|+||+|+||+++.++.+|++|||++........
T Consensus 105 ~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~--- 178 (283)
T PHA02988 105 TRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF--- 178 (283)
T ss_pred CCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc---
Confidence 99999999954 45788999999999999999999973 2888999999999999999999999999875543221
Q ss_pred eeecCCCCcCCcccccc-CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSR-NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
...++..|+|||.+.+ ...++.++||||||+++|+|++|+.||......+.. ........ ....+
T Consensus 179 -~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~-------~~i~~~~~------~~~~~ 244 (283)
T PHA02988 179 -KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY-------DLIINKNN------SLKLP 244 (283)
T ss_pred -cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcCC------CCCCC
Confidence 1236789999999843 257899999999999999999999999865432111 11111110 11122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 234567999999999999999999999999998765
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.66 Aligned_cols=251 Identities=20% Similarity=0.219 Sum_probs=198.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccc----hhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCce
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV----EEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 104 (325)
+|++.+.||+|+||.||+++.. .+..+++|++.... ......+..|+.+++.++ ||+|+++++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999998763 57889999886532 223345778999999995 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++.. ...+++..+..++.|++.|+.|||++ |++|+||||+|||++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 999999999999998843 45789999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
...........|+..|+|||.+.+...++.++||||||+++++|++|+.||...........+ . .....
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~-~~~~~-------- 225 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--S-RRILK-------- 225 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--H-HHHhc--------
Confidence 333222233458999999999855556788999999999999999999999754332221111 1 11111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
.....+......+.+++.+||+.||++|| ++++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 265 (332)
T cd05614 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265 (332)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHH
Confidence 11112222345689999999999999999 777887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.35 Aligned_cols=238 Identities=23% Similarity=0.261 Sum_probs=191.4
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
||+|+||.||+|.+. .+..+|+|++.... ......+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999987 57889999886532 23345577899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecC
Q 047716 117 GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG 196 (325)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 196 (325)
.+++.. .+.+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++........ ......+
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 155 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG 155 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence 998844 45789999999999999999999999 999999999999999999999999999875332221 1222348
Q ss_pred CCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHH
Q 047716 197 TRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFEN 276 (325)
Q Consensus 197 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
++.|+|||.+ .+..++.++||||||+++++|++|+.||........ . .... ......+......
T Consensus 156 t~~y~aPE~~-~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~-~~~~--------~~~~~~~~~~~~~ 219 (312)
T cd05585 156 TPEYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------Y-RKIL--------QEPLRFPDGFDRD 219 (312)
T ss_pred CcccCCHHHH-cCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------H-HHHH--------cCCCCCCCcCCHH
Confidence 8999999998 566788999999999999999999999976432211 1 1111 1112222334467
Q ss_pred HHHHHhhcccCCCCCCCC---HhHHH
Q 047716 277 LVKIGLWCVECELNLRPT---MKQVI 299 (325)
Q Consensus 277 l~~li~~~l~~~p~~Rps---~~ell 299 (325)
+.+++.+||+.||.+||+ +.|++
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 899999999999999986 55555
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=305.11 Aligned_cols=249 Identities=25% Similarity=0.255 Sum_probs=201.6
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeCC--CcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCING--GKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS 102 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (325)
..+...+|++.+.||+|+||.||+|.+.. +..+++|++.... ......+..|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 44566789999999999999999998653 3679999886532 233456778999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+.+++|.+++. ..+.+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++..
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 9999999999999999984 445789999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
..... ....+++.|+|||.+ .+..++.++|+|||||++++|++|..||........ ........
T Consensus 181 ~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~---- 244 (340)
T PTZ00426 181 VDTRT----YTLCGTPEYIAPEIL-LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGI---- 244 (340)
T ss_pred cCCCc----ceecCChhhcCHHHH-hCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCC----
Confidence 54321 223489999999998 456678999999999999999999999986533211 11111111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
...+......+.+++.+||+.+|.+|+ +++++++
T Consensus 245 ----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 ----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 111222335688999999999999995 8999883
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=289.32 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=205.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
+...+|.+.++||.|++|.||+|.+. .+..+++|.+... ......+.+|+.+++.++||||+++++++..+...+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 44567889999999999999999987 5778888887643 334556888999999999999999999999889999999
Q ss_pred eecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+++++|.+++... ...+++..++.++.|++.++.+||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999988543 34589999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.........+..|+|||.+ .+..++.++||||||+++++|++ |..||......+.. ...... ..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~-~~------ 223 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKG-YR------ 223 (263)
T ss_pred eeccCCCCCccccCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCC-CC------
Confidence 2211112235679999988 56677889999999999999998 88998764322111 111111 10
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
...+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111222346799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=287.59 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=201.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..+|++.+.||+|++|.||+|.+..+..+++|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 46789999999999999999998877789999875432 23446778999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++......+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||.+...........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999999866566789999999999999999999999 999999999999999999999999998875533221111
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....+..|+|||.+ ....++.++|+||||+++++|++ |..||......+.. . ..... . ....+
T Consensus 159 ~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----~~~~~-~------~~~~~ 223 (256)
T cd05059 159 QGTKFPVKWAPPEVF-DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E----SVSAG-Y------RLYRP 223 (256)
T ss_pred CCCCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H----HHHcC-C------cCCCC
Confidence 111134579999998 45668889999999999999998 78888754332211 1 11110 0 01111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
...+.++.+++.+||+.+|++|||++|+++.|.
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 223467999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=295.50 Aligned_cols=250 Identities=28% Similarity=0.369 Sum_probs=201.0
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--------------hcHHHHHHHHHHHhccCCCCccee
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--------------EGESEFRNEMKIIGRIHHKNLVDL 94 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~ 94 (325)
...++|++++.||+|.||.|-+|++. +++.+|+|++.+... .......+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45789999999999999999999987 789999999965221 122468899999999999999999
Q ss_pred eEEeecC--CceEEEEeecCCCCHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc
Q 047716 95 VGFCSEG--SNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK 171 (325)
Q Consensus 95 ~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~ 171 (325)
+++..+. ..+|||+|||..|.+...- ..+. +++.+++.+++.++.||.|||.+ ||+||||||+|+|++++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 9998664 6889999999888775443 2334 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCCCc----cceeeecCCCCcCCccccccC---CCCCccccchhHHHHHHHHHhCCCCCCCccccchh
Q 047716 172 AKISDFGLSKLLKTDQT----RTYTVLRGTRGYTAPELHSRN---NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI 244 (325)
Q Consensus 172 vkl~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 244 (325)
|||+|||.+..+..... .......||+.|+|||....+ ...+.+.||||+|++||.|+.|+.||.+...-+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l- 327 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL- 327 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH-
Confidence 99999999876632211 112224599999999987552 3346789999999999999999999986543221
Q ss_pred hHHHHHHHHHHhCcccccccCCCCC--CHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 245 VLIDWAHQCYEAGELQNLVSDQEDV--NIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
+.+++..+..+ .++..+.++++|.+||++||..|.++.+|.
T Consensus 328 --------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 328 --------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred --------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 12223333222 234567899999999999999999999998
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=301.93 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=201.4
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
.+..++|++.+.||+|+||.||+|++. .+..+|+|++.... ......+.+|+.+++.+ +||||+++++.+..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 345678999999999999999999742 35678999886432 23345678899999999 79999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc--------------------------------------------------------
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE-------------------------------------------------------- 124 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------------- 124 (325)
.+..++||||+++|+|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999998885321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 125 ------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 125 ------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
..+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 1367888999999999999999999 9999999999999999999999999998765432
Q ss_pred Cccce-eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 187 QTRTY-TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 187 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..... ....++..|+|||.+ ....++.++||||||+++++|++ |..||........ ... ....+. ...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~----~~~~~~-~~~-- 337 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYK----MIKEGY-RML-- 337 (375)
T ss_pred ccccccCCCCCCcceeChhHh-cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHH----HHHhCc-cCC--
Confidence 22111 111235679999998 56678899999999999999998 8888865432221 111 111111 000
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.+.....++.+++.+||+.||++|||+.||++.|++.
T Consensus 338 ----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 ----SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111235699999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=286.71 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=203.5
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++...+|++.++||+|++|.||+|.+.++..+++|.+..... ....+.+|+.+++.++||+++++++++.. ...+++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT 79 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence 356789999999999999999999988888899998865332 34568899999999999999999998754 5689999
Q ss_pred eecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+++++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999998543 34589999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
........++..|+|||.+ ....++.++|+||||+++++|++ |..||......+.. . . ..... .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~---~-~~~~~-------~ 221 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---E---Q-VERGY-------R 221 (260)
T ss_pred cccccCCCCCccccChHHH-hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH---H---H-HHcCC-------C
Confidence 2211112245679999988 55678889999999999999999 88888654322111 1 1 11110 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
.+.+...+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122334579999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=291.29 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=203.8
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
...+|++.+.||.|++|.||+|.+.. ...+++|.+.... ......+.+|+..++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 34689999999999999999998753 2568888876433 2334568889999999999999999999988889
Q ss_pred eEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE 168 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~ 168 (325)
.+++|||+++++|.+++.... ..++...++.++.|++.|+.+||++ +++|+||+|+||++++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 999999999999999885431 4578899999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhH
Q 047716 169 SWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVL 246 (325)
Q Consensus 169 ~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 246 (325)
++.++|+|||++........ .......++..|+|||.+ ....++.++||||||+++++|++ |..||.+....+..
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~-- 236 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI-- 236 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHh-ccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--
Confidence 99999999999875432221 111222356789999988 45668899999999999999998 99999765432211
Q ss_pred HHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 247 IDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
..+..+... ..+..++.++.+++.+||+.+|.+||+++||++.|+++
T Consensus 237 -----~~i~~~~~~-------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 237 -----EMIRSRQLL-------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -----HHHHcCCcC-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111111111 12233456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=300.28 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=195.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
..+|++.++||+|+||.||+|++. +++.+++|++.... ......+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 567889999999999999999987 68899999986532 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+.+++|.+.. ...+..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++........
T Consensus 153 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 153 FMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred cCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99999886532 356778889999999999999999 999999999999999999999999999876543221
Q ss_pred ceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 190 TYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
......++..|+|||.+.. +...+.++|||||||++|+|++|+.||......+...... . .. ...
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~-~~-------~~~ 292 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A-IC-------MSQ 292 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H-Hh-------ccC
Confidence 1122347899999998732 2334568999999999999999999998433322111111 0 00 011
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..........++.++|.+||+.+|++|||+.|+++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222234467999999999999999999999994
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.50 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=202.3
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+..++|++.++||.|+||.||+|.+. .+..+++|.+.... ......+.+|+++++.++||||+++++++..++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 45689999999999999999999988 56777777765432 23345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+.+++|.+++.. .+.+++..+..++.|++.|+.|||+. .+++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999999844 45689999999999999999999974 279999999999999999999999999986543221
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH------H-----------
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW------A----------- 250 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~------~----------- 250 (325)
. ....++..|+|||.+ .+..++.++|+|||||++++|++|+.||.............. .
T Consensus 159 ~---~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 A---NSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred c---ccCCCCccccCHHHh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1 122378899999998 556788899999999999999999999975433211100000 0
Q ss_pred ---HHHHHhC---------cccccccCC-CCC-CHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhcc
Q 047716 251 ---HQCYEAG---------ELQNLVSDQ-EDV-NIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGI 305 (325)
Q Consensus 251 ---~~~~~~~---------~~~~~~~~~-~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~ 305 (325)
....... ....+.... ... ......++.+++.+||+.||++|||+.|++ .+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000 000000000 000 001235689999999999999999999998 455443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.79 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=204.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
.++|++.+.||+|+||.||+|.+.. ...+++|.+.... ......+..|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 5789999999999999999998852 3568888876533 2334567889999999999999999999999899999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
+|||+++++|.+++....+.+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999866666789999999999999999999999 9999999999999999999999999999876422
Q ss_pred Ccc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 187 QTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 187 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
... ......++..|+|||.+ ....++.++|+||||+++++|++ |..||........ . .......
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~----~~~~~~~------ 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---I----KAVEDGY------ 225 (266)
T ss_pred ccceeccCCCCCccccChhhh-ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---H----HHHHcCC------
Confidence 111 11112245679999998 55678899999999999999998 9999865432211 1 1111110
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
........+..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 226 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011122345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=297.14 Aligned_cols=269 Identities=20% Similarity=0.297 Sum_probs=203.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
.+|.+.++||+|+||.||+|++. .+..+++|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56899999999999999999987 67789999886433 22334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++ +|.+++......++...+..++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 964 78887755556689999999999999999999999 9999999999999999999999999998654322211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH--------HHHHh-Ccccc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH--------QCYEA-GELQN 261 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~-~~~~~ 261 (325)
.....++..|+|||.+.+...++.++||||||+++++|++|++||......+....+.... ..... .....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 1122368899999988666678899999999999999999999997665433222111100 00000 00000
Q ss_pred --cccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 262 --LVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 262 --~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
..... ....+.....+.+++.+||+.||.+|||+.|+++ .++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000 0011123456889999999999999999999993 555554
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=298.71 Aligned_cols=241 Identities=24% Similarity=0.272 Sum_probs=193.3
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+.||+|+||.||++.+. ++..+|+|++.... ......+..|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999986 68899999987532 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeee
Q 047716 115 SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL 194 (325)
Q Consensus 115 ~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 194 (325)
+|.+++. ....+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........ .....
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 155 (323)
T cd05595 81 ELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccc
Confidence 9988884 345789999999999999999999999 999999999999999999999999998764322211 11223
Q ss_pred cCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHH
Q 047716 195 RGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF 274 (325)
Q Consensus 195 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
.+++.|+|||.+ ....++.++||||||+++++|++|+.||......... ...... ....+....
T Consensus 156 ~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-------~~~~~~--------~~~~p~~~~ 219 (323)
T cd05595 156 CGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILME--------EIRFPRTLS 219 (323)
T ss_pred cCCcCcCCcccc-cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcC--------CCCCCCCCC
Confidence 478999999998 5667789999999999999999999999765332111 111111 111122334
Q ss_pred HHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 275 ENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 275 ~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
..+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 6789999999999999998 8888873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=304.22 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=199.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC-----ceE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS-----NRL 105 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 105 (325)
+|++.++||+|+||.||+|.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3678899999999999999986 78899999886432 233456888999999999999999999987765 789
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+|+||+. ++|.+.+. ....++...+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999995 57777763 446799999999999999999999999 999999999999999999999999999875543
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH----------------
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW---------------- 249 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---------------- 249 (325)
..........++..|+|||.+.+...++.++|||||||++++|++|+.||......+....+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 3222222223678899999986656688999999999999999999999986654322211110
Q ss_pred HHHHHHhCcc-cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhc
Q 047716 250 AHQCYEAGEL-QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEG 304 (325)
Q Consensus 250 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~ 304 (325)
.......... ...............+++.+++.+||+.||.+|||+.|+++ .+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 0000000000 00000000111122467899999999999999999999993 3444
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=300.93 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=203.1
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
.+...+|++.+.||+|+||.||+|.+. ++..+|+|++.... ......+.+|+.+++.+ +||||+++++.+..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 466789999999999999999998853 23579999886533 23345678899999999 89999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc--------------------------------------------------------
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE-------------------------------------------------------- 124 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------------- 124 (325)
....++||||+++++|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999874321
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 125 -------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 125 -------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
.++++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++...........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 2367788999999999999999999 999999999999999999999999999875433221111
Q ss_pred -eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 192 -TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 192 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
....++..|+|||.+ ....++.++||||||+++++|++ |+.||.......... .... ..... ..
T Consensus 271 ~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~------~~~~-~~~~~------~~ 336 (374)
T cd05106 271 KGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY------KMVK-RGYQM------SR 336 (374)
T ss_pred ccCCCCccceeCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH------HHHH-cccCc------cC
Confidence 111234679999998 45678999999999999999997 999997654322111 1111 11000 00
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
+...+.++.+++.+||+.+|.+|||+.+|+++|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1112356999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.26 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=203.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+...+|++.++||+|++|.||+|.+.++..+++|++.... .....+..|+.+++.++||||+++++.+.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 4567899999999999999999998877789999886422 234568889999999999999999998754 56799999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++++|.+++... ...+++..+..++.|++.|+++||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999998543 34578999999999999999999999 999999999999999999999999999876543322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......++..|+|||.. ....++.++|+||||+++++|++ |..||......+.. ....... ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~~-------~~ 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY-------RM 222 (262)
T ss_pred ccccCCcccceecCHhHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcCC-------CC
Confidence 222222245679999988 45667899999999999999999 88888755332111 1111100 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
......+..+.+++.+|++.+|++||++.+++++|+...
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 122334567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=297.87 Aligned_cols=241 Identities=25% Similarity=0.293 Sum_probs=193.9
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+.||+|+||.||++.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999987 68899999987532 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeee
Q 047716 115 SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL 194 (325)
Q Consensus 115 ~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~ 194 (325)
+|.+.+. ....+++..++.++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++........ .....
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 155 (328)
T cd05593 81 ELFFHLS-RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF 155 (328)
T ss_pred CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccccc
Confidence 9988884 345789999999999999999999999 999999999999999999999999999865322211 12223
Q ss_pred cCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHH
Q 047716 195 RGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF 274 (325)
Q Consensus 195 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
.+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... .... ......+....
T Consensus 156 ~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-------~~~~--------~~~~~~p~~~~ 219 (328)
T cd05593 156 CGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELIL--------MEDIKFPRTLS 219 (328)
T ss_pred cCCcCccChhhh-cCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-------HHhc--------cCCccCCCCCC
Confidence 488999999998 5667789999999999999999999999764322111 0111 11111222334
Q ss_pred HHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 275 ENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 275 ~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
..+.+++.+||+.||.+|| ++.|+++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 5689999999999999997 8999884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=295.36 Aligned_cols=258 Identities=19% Similarity=0.311 Sum_probs=223.9
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+..=|.+.+-||+|.|+.|-+|++- .|..||||++.+.. .-....+.+|++.++.++|||||++|++......+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 3456888999999999999999877 79999999997643 33445688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE-cCCCcEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM-DESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv-~~~~~vkl~Dfg~~~~~~~~ 186 (325)
.|.-++|+|.+++-+...++.+.....+++||+.|+.|+|.. .++|+|+||+||.+ ..-|-|||+|||+...+...
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999999988888999999999999999999999999 99999999999766 56789999999999877554
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. ....+|+..|-|||++.+..+..++.||||||+|||.|.+|++||+...+.+... .+++=.
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCK 235 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCK 235 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhccc
Confidence 33 3445699999999999888888899999999999999999999999887765443 344555
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCC
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPP 308 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~ 308 (325)
...+.....++++||.+||..||++|.|.+||. ..|+.+-+.
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 666777788999999999999999999999998 566666543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=303.52 Aligned_cols=251 Identities=23% Similarity=0.277 Sum_probs=201.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||+|.+. .++.+|+|++..... .....+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 6889999999999999999987 688899999875332 234557889999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++......+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999966657899999999999999999999999 9999999999999999999999999998766443332
Q ss_pred ceeeecCCCCcCCcccccc-----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 190 TYTVLRGTRGYTAPELHSR-----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
......+++.|+|||.+.. ...++.++||||||+++++|++|+.||......... ...........+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~-- 230 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRFLKF-- 230 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCccCC--
Confidence 2223347899999998842 455778999999999999999999999765432211 111111111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...+.....+.+++..||+ +|.+|||+++++
T Consensus 231 ---~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 231 ---PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred ---CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 1111234568899999998 999999999999
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=288.92 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=203.4
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
...+|.+.+.||+|++|.||+|.+.+ +..+++|.+...... ....+.+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 35789999999999999999998743 467899988664433 45678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcc-------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE-------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~ 170 (325)
.+++|||+++++|.+++...+ ..+++..+..++.|++.++.+||++ |++|+||+|+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 999999999999999985432 3478889999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHH
Q 047716 171 KAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLID 248 (325)
Q Consensus 171 ~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 248 (325)
.++|+|||++........ .......++..|+|||.+ ....++.++||||||+++++|++ |..||......+. ..
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~ 235 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE 235 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhh-ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH
Confidence 999999998865422211 111112246789999998 56678899999999999999998 9999875543221 11
Q ss_pred HHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 249 WAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
....+.... .+......+.+++.+||+.+|++||+++|+++.|++
T Consensus 236 ----~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 ----CITQGRLLQ-------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HHHcCCcCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111111 111234569999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=298.73 Aligned_cols=269 Identities=22% Similarity=0.346 Sum_probs=197.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----CceE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-----SNRL 105 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 105 (325)
+|++.++||+|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999987 68899999886422 23345678899999999999999999987533 3479
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+. ++|.+++. ....+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999994 68888884 345799999999999999999999999 999999999999999999999999999875432
Q ss_pred CCcc--ceeeecCCCCcCCcccccc-CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH--------HHHHH
Q 047716 186 DQTR--TYTVLRGTRGYTAPELHSR-NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW--------AHQCY 254 (325)
Q Consensus 186 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~ 254 (325)
.... ......+++.|+|||.+.+ ...++.++|||||||++++|++|++||...........+.. .....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 2211 1122347899999998743 25678899999999999999999999976543221110000 00000
Q ss_pred HhCccccc---ccCCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 255 EAGELQNL---VSDQEDV-----NIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 255 ~~~~~~~~---~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
........ +...... .+.....+.+++.+||+.+|++|||++|++ ..++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000000 0000000 011235688999999999999999999999 44555553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=316.08 Aligned_cols=264 Identities=29% Similarity=0.449 Sum_probs=217.8
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
++...+-.+.+.||+|+||.||+|+.. ....||||.++..... ...+|++|++++..++|||||+++|.+.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 455666778899999999999999854 3557899999876655 677899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcc---------C----CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAE---------Q----RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE 168 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~---------~----~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~ 168 (325)
+.+++|+|||..|+|.+|+.... . .++..+.+.++.||+.|+.||-++ .++|+||..+|.||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999999985332 1 278889999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccc-cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhH
Q 047716 169 SWKAKISDFGLSKLL-KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVL 246 (325)
Q Consensus 169 ~~~vkl~Dfg~~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 246 (325)
+-.|||+|||+++.. ..+..........+.+|||||.+ ....+++++||||+|++|||+++ |..|+.+....+..
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI-ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-- 715 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI-LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-- 715 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh-hcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH--
Confidence 999999999998743 33333333233346799999999 68889999999999999999986 77888877655432
Q ss_pred HHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCC
Q 047716 247 IDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQ 310 (325)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 310 (325)
..++.+++- ..+..++.++.+||..||+.+|++||+++||-..|+......+
T Consensus 716 -----e~i~~g~lL-------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 716 -----ECIRAGQLL-------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -----HHHHcCCcc-------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 334444442 2233455679999999999999999999999999998775443
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=288.15 Aligned_cols=257 Identities=20% Similarity=0.266 Sum_probs=202.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
....+|++.++||+|+||.||+|++. ++..+++|++..........+.+|+.+++.++||||+++++.+......++||
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 34678999999999999999999986 67888999886554455566888999999999999999999999889999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+++. ..+.+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.++++|||++........
T Consensus 86 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 86 EYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred eCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999999884 345789999999999999999999999 999999999999999999999999999876543221
Q ss_pred cceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 189 RTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
. .....++..|+|||.+.. ...++.++|+||||+++++|++|+.||........... .....+ ....
T Consensus 162 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~---~~~~ 230 (267)
T cd06646 162 K-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSNF---QPPK 230 (267)
T ss_pred c-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCCC---CCCC
Confidence 1 112236788999998742 34467899999999999999999999864432211100 000000 0011
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
.......+..+.+++.+||+.+|++|||++++++.
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 11112234679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=285.59 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=205.1
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++...+|+++++||+|+||.||+|...++..+++|.+.... .....+.+|+.+++.++||||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 46788999999999999999999998888999999886533 33457888999999999999999999874 45789999
Q ss_pred eecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+.+++|.+++... ...++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999987543 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
........++..|+|||.+ ....++.++|+||||+++++|++ |+.||......+.. ....... .
T Consensus 157 ~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~-~------ 221 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-------QNLERGY-R------ 221 (260)
T ss_pred cccccCCcccccccCHHHh-ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-------HHHHcCC-C------
Confidence 2211122245689999988 55667889999999999999998 99999765432211 1111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.......+.++.+++.+||+.+|++|||+++++..|+.+
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 011112335799999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=290.20 Aligned_cols=260 Identities=25% Similarity=0.416 Sum_probs=206.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
|.+.+|.+.+.||.|+||.||++... .+..+++|.+..........+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 45688999999999999999999752 345578888876555556678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK 171 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~ 171 (325)
.+++|||+++++|.+++.... ..+++..+..++.|++.|+.+||++ |++|+||+|+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999999985332 2489999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHH
Q 047716 172 AKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDW 249 (325)
Q Consensus 172 vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 249 (325)
++|+|||++........ .......++..|+|||.+ ....++.++|+||||+++++|++ |.+||......+..
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~----- 232 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----- 232 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----
Confidence 99999999875432211 111111245689999998 56778899999999999999998 88998765432211
Q ss_pred HHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 250 AHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.....+..... ....+..+.+++.+||+.+|.+|||++++++.|+.+..
T Consensus 233 --~~i~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 233 --ECITQGRVLQR-------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred --HHHHcCCcCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11111111111 11123569999999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=304.42 Aligned_cols=250 Identities=24% Similarity=0.273 Sum_probs=201.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||+|++. .++.+|+|++.... ......+..|+.++..++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 6889999999999999999987 68899999987532 1334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC--
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ-- 187 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~-- 187 (325)
|+++++|.+++... +.+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999998544 6799999999999999999999999 99999999999999999999999999987654332
Q ss_pred --------------------------ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc
Q 047716 188 --------------------------TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241 (325)
Q Consensus 188 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 241 (325)
........+++.|+|||.+ .+..++.++|||||||++++|++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHH-cCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 1112223478999999998 5567899999999999999999999999876532
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HhHHHH
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT-MKQVIW 300 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~ 300 (325)
.... . +.. +...... .........+.++|.+|++ +|.+||+ ++++++
T Consensus 237 ~~~~------~-i~~--~~~~~~~--p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 237 ETYN------K-IIN--WKESLRF--PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHH------H-Hhc--cCCcccC--CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 2111 1 110 0000000 0011134678999999998 9999999 999994
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=290.18 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=208.3
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
...+|.+.+.||+|++|.||+|.+. ....+++|.+..........+.+|+..++.++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 4567889999999999999999753 3456788887665555566788999999999999999999999998999
Q ss_pred EEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC
Q 047716 105 LLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~ 169 (325)
++||||+++++|.+++.... +.+++..++.++.|++.|+.+||++ +++|+||+|+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 99999999999999985432 3478899999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHH
Q 047716 170 WKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLI 247 (325)
Q Consensus 170 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 247 (325)
+.++|+|||++........ .......++..|+|||.+ ....++.++||||||+++++|++ |..||......+. .
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~ 235 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---I 235 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H
Confidence 9999999999865433221 111112246789999988 55678889999999999999998 9999876543221 1
Q ss_pred HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCC
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQ 310 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 310 (325)
.....+..... ....+..+.+++.+||+.+|.+|||+++++++|+.+....+
T Consensus 236 ----~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 236 ----ECITQGRVLER-------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred ----HHHhCCCCCCC-------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 11122211111 11234569999999999999999999999999999976544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.79 Aligned_cols=254 Identities=21% Similarity=0.227 Sum_probs=201.3
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
+...+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+..|+.+++.++||||+++++.+.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45678999999999999999999987 68889999986532 223345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998843 4588899999999999999999999 999999999999999999999999999876543
Q ss_pred CCccceeeecCCCCcCCccccccC---CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRN---NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
..........|++.|+|||.+... ..++.++|||||||++++|++|+.||......... ...........
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~~~~- 267 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKNSLT- 267 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCCcCC-
Confidence 322222234489999999987532 34788999999999999999999999865432111 11111000000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHhHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNL--RPTMKQVI 299 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~ell 299 (325)
.......+..+.+++.+||+.+|.+ |+|++|++
T Consensus 268 ----~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell 302 (370)
T cd05596 268 ----FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIK 302 (370)
T ss_pred ----CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHh
Confidence 1111123467899999999999987 99999998
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.16 Aligned_cols=257 Identities=32% Similarity=0.470 Sum_probs=206.3
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+...+|++.++||.|++|.||+|.+.++..+++|.+.... .....+..|+.+++.++||||+++++++......+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 5678999999999999999999998888889999876533 345678899999999999999999999988889999999
Q ss_pred ecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
++++++|.+++.... ..++...+..++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||.+........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999985543 4689999999999999999999999 999999999999999999999999999876543222
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
........+..|+|||.+ .+...+.++|+||||+++++|++ |+.||........ .. . .... .. .
T Consensus 159 ~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~---~-~~~~-~~------~ 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LE---Q-VERG-YR------M 223 (261)
T ss_pred hhhhccCCCccccCHHHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---H-HHcC-CC------C
Confidence 111112245679999988 45668889999999999999998 9999965432211 11 1 1100 00 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
..+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 11112245799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=310.38 Aligned_cols=248 Identities=21% Similarity=0.273 Sum_probs=200.1
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-C-CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-G-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.|.+.+.||.|++|.||.|... + +..+++|++..........+..|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4999999999999999999876 3 5678888765555555566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 112 RNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 112 ~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999877432 34688999999999999999999999 999999999999999999999999999876543222
Q ss_pred -cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 -RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......|++.|+|||.+ ....++.++|||||||++++|++|+.||......+.. .....+....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~-------~~~~~~~~~~------ 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM-------QQVLYGKYDP------ 290 (478)
T ss_pred cccccccCCCccccCHhHh-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCC------
Confidence 112234489999999998 5667889999999999999999999999764332111 1111111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.+......+.++|.+||+.+|++||++.+++
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 1122335699999999999999999999987
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=295.72 Aligned_cols=242 Identities=24% Similarity=0.279 Sum_probs=192.8
Q ss_pred hhhcCcCCceeEEEEEeC----CCcEEEEEEeeccc----hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 38 KEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV----EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++.||+|+||.||+++.. .+..+|+|.+.... ......+..|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999863 57889999986532 2233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++. ..+.+.+..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 81 YLSGGELFMHLE-REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCCchHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 999999999884 345688899999999999999999999 999999999999999999999999999864322221
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
......+++.|+|||.+ ....++.++||||||+++++|++|+.||........ . .....+ ....
T Consensus 156 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~-~~~~~~--------~~~~ 219 (323)
T cd05584 156 VTHTFCGTIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------I-DKILKG--------KLNL 219 (323)
T ss_pred cccccCCCccccChhhc-cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------H-HHHHcC--------CCCC
Confidence 11223478999999998 456678899999999999999999999976543211 1 111111 1112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
+......+.+++.+||+.+|++|| +++++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 222345689999999999999999 8888874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=286.78 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=203.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.||.|++|.||+|.+. ++..+++|.+..........+..|+.+++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999986 6788999988765555666788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++......+++..++.++.|++.++.|||++ +++|+||+|+||+++.++.++++|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK- 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc-
Confidence 999999999866666799999999999999999999999 9999999999999999999999999987654332221
Q ss_pred eeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 191 YTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|+.||......... . . ..... ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~----~-~~~~~-----~~~ 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--L----K-ILKSE-----PPT 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--H----H-HhcCC-----CCC
Confidence 122337888999998742 334677899999999999999999999765322111 0 1 11110 011
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...+......+.+++.+||+.+|.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 111223345689999999999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=287.18 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=202.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
...|++.++||.|++|.||+|.+. .+..+++|.+..........+..|+..++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999987 5788899988766656667788899999999999999999999888999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|..++.+....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~- 166 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR- 166 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccc-
Confidence 999999888766566789999999999999999999999 9999999999999999999999999987654322111
Q ss_pred eeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 191 YTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|++||........ .... .... .+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~~-----~~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKI-AKSE-----PPT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHH-hcCC-----Ccc
Confidence 122336788999998742 33467789999999999999999999975432111 0011 1100 011
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...+......+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1112233456899999999999999999999983
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=296.29 Aligned_cols=244 Identities=22% Similarity=0.236 Sum_probs=192.3
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHH---hccCCCCcceeeEEeecCCceEEE
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKII---GRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
|++.+.||+|++|.||+|.+. .++.+|+|++.... ......+..|..++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999987 68899999987532 22234566666554 566799999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+.+++|...+. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 99999999988873 35799999999999999999999999 99999999999999999999999999876432221
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
. ......+++.|+|||.+ .+..++.++|+||||+++++|++|+.||......+.. ....... .
T Consensus 156 ~-~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~-------~~i~~~~--------~ 218 (324)
T cd05589 156 D-RTSTFCGTPEFLAPEVL-TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF-------DSIVNDE--------V 218 (324)
T ss_pred C-cccccccCccccCHhHh-cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC--------C
Confidence 1 12233478999999998 5667889999999999999999999999765432211 1111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
..+......+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11122345688999999999999999 5777764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=282.30 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=195.8
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
+.||+|+||.||+|++. +++.+++|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999986 68889999875432 33456688999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce-eeec
Q 047716 117 GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY-TVLR 195 (325)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~-~~~~ 195 (325)
.+++......+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999865555689999999999999999999999 999999999999999999999999999875432211110 0111
Q ss_pred CCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHH
Q 047716 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF 274 (325)
Q Consensus 196 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
.+..|+|||.+ ....++.++|+||||+++++|++ |..||......... ...... . ....+...+
T Consensus 158 ~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-------~~~~~~-~------~~~~~~~~~ 222 (252)
T cd05084 158 IPVKWTAPEAL-NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQG-V------RLPCPELCP 222 (252)
T ss_pred CceeecCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-------HHHHcC-C------CCCCcccCC
Confidence 24569999998 45567889999999999999997 88888654322111 111110 0 111122334
Q ss_pred HHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 275 ENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 275 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
..+.+++.+||+.+|++|||+++++++|+.
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.03 Aligned_cols=259 Identities=22% Similarity=0.337 Sum_probs=203.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC-Cc----EEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING-GK----EIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~----~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+...+|++.+.||+|+||.||+|.+.. +. .+++|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 446789999999999999999998752 33 37888876432 34456788899999999999999999998764 5
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++++|+++++|.+++......++...+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 7899999999999999976666789999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCccce-eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 184 KTDQTRTY-TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
........ .....+..|+|||.+ ....++.++||||||+++|+|++ |+.||......+. ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~--- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGE--- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCC---
Confidence 43322111 111235679999998 56678899999999999999997 9999976432211 11111111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
....++.+...+.+++.+||+.+|.+||++.+++..|..+..
T Consensus 229 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 011112233568999999999999999999999999888774
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=284.32 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=204.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|++.+.||.|+||.||+|++. ++..+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47899999999999999999986 78899999875422 233345788999999999999999999998889999999
Q ss_pred eecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||+++++|.+++.. ....++...+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988743 234578899999999999999999999 999999999999999999999999998876543
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
..... ....++..|+|||.+ .+...+.++|+||||+++++|++|+.||......... +. .........
T Consensus 159 ~~~~~-~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~----~~-~~~~~~~~~----- 226 (267)
T cd08228 159 KTTAA-HSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS----LC-QKIEQCDYP----- 226 (267)
T ss_pred hhHHH-hcCCCCccccChhhh-ccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH----HH-HHHhcCCCC-----
Confidence 32211 122367889999998 4556788999999999999999999998654322111 11 111111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..........+.+++.+||+.+|++||++.++++.|+++.
T Consensus 227 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 -PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1112234467999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=283.78 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=202.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+...+|++.++||.|++|.||+|.+.++..+++|.+.... .....+.+|+.+++.++|||++++++++.. +..+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 4567899999999999999999998877778999875432 334567889999999999999999998754 56789999
Q ss_pred ecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+.+++|.+++.... ..+++..+..++.|++.|+.|||+. |++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999985433 3478999999999999999999999 999999999999999999999999999876543322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......++..|+|||.. .....+.++|+||||+++++|++ |..||......+.. .. .... . ..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~----~~~~-~------~~ 222 (260)
T cd05069 158 TARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQ----VERG-Y------RM 222 (260)
T ss_pred cccCCCccchhhCCHHHh-ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcC-C------CC
Confidence 221122245679999988 45668899999999999999999 88898764332111 11 1111 0 01
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
......+..+.+++.+||+.+|.+||++++++++|+..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11223446799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.34 Aligned_cols=269 Identities=18% Similarity=0.274 Sum_probs=203.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
.+|++.++||.|++|.||+|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57899999999999999999887 67889999886432 22334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++ ++|.+++......+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 96 588888866666789999999999999999999999 9999999999999999999999999998654322211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc------
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS------ 264 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 264 (325)
.....++..|+|||.+.+...++.++||||||+++++|++|++||......+....+...........+..+..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 11223578899999886666678899999999999999999999976543222111100000000000000000
Q ss_pred ---CC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 265 ---DQ------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 265 ---~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
+. ..........+.++|.+||+.||.+|||++|+++ .++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 0011123456899999999999999999999994 555444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=282.57 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=201.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.||+|++|.||+|.+. +++.+++|.+..........+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 568999999999999999999886 6888899988665444555678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++. ..+.+++..++.++.|++.++.|||+. |++|+||+|+||+++.++.++|+|||++........ .
T Consensus 88 ~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06645 88 CGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-K 162 (267)
T ss_pred cCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-c
Confidence 99999999884 445799999999999999999999999 999999999999999999999999999875543221 1
Q ss_pred eeeecCCCCcCCccccc--cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 191 YTVLRGTRGYTAPELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....++..|+|||.+. ....++.++|+||||+++++|++|+.||.......... . ....... .....
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~-~~~~~~~---~~~~~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MTKSNFQ---PPKLK 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------h-hhccCCC---CCccc
Confidence 12234788999999873 23457889999999999999999999986543221111 0 0001110 00001
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11123356889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=279.47 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=197.3
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCHH
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLG 117 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (325)
+.||+|++|.||+|...++..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4689999999999998888889999876543 233446788999999999999999999999989999999999999999
Q ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCC
Q 047716 118 NLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGT 197 (325)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~ 197 (325)
+++......+++..+..++.|++.++.+||++ |++|+||+|+||+++.++.++++|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 99866556789999999999999999999999 999999999999999999999999998865433222111112245
Q ss_pred CCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHH
Q 047716 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFEN 276 (325)
Q Consensus 198 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
..|+|||.+ ....++.++|+||||++++++++ |..||......... ....... . .......+..
T Consensus 158 ~~y~aPE~~-~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~~-~------~~~~~~~~~~ 222 (250)
T cd05085 158 IKWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKGY-R------MSCPQKCPDD 222 (250)
T ss_pred ccccCHHHh-ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCC-C------CCCCCCCCHH
Confidence 679999998 55678889999999999999998 89999755332111 1111110 0 1111223467
Q ss_pred HHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 277 LVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 277 l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.66 Aligned_cols=245 Identities=22% Similarity=0.241 Sum_probs=194.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCC-CcceeeEEeecCCceEEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHK-NLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 108 (325)
+|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+..|..++..++|+ +|+.+++.+...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999987 56789999987532 23345577889999999765 5888899998889999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+++. ....+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQ-QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999999999884 345789999999999999999999999 99999999999999999999999999886432211
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.......+++.|+|||.+ .+..++.++||||||+++++|++|+.||......+... .... ....
T Consensus 156 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~-------~i~~--------~~~~ 219 (324)
T cd05587 156 KTTRTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-------SIME--------HNVS 219 (324)
T ss_pred CceeeecCCccccChhhh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-------HHHc--------CCCC
Confidence 122234589999999998 45667899999999999999999999997654322111 1111 1111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCH-----hHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTM-----KQVI 299 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell 299 (325)
.+......+.+++.+||+.+|.+|++. ++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~ 255 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIR 255 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 122234568999999999999999986 5665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=302.17 Aligned_cols=250 Identities=23% Similarity=0.258 Sum_probs=197.1
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+..|+.+++.++||||+++++.+.++...++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 6889999999999999999987 68889999987532 2233457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+.+++|.+++.. .+.+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999843 45799999999999999999999999 9999999999999999999999999998654221100
Q ss_pred -------------------------------------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCC
Q 047716 190 -------------------------------------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232 (325)
Q Consensus 190 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 232 (325)
......||+.|+|||.+ ....++.++|||||||++++|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF-LQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH-cCCCCCCeeeeecchhHHHHhhcCC
Confidence 00113478999999998 5667889999999999999999999
Q ss_pred CCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HhHHHH
Q 047716 233 KNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT---MKQVIW 300 (325)
Q Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 300 (325)
.||......+... ... . ....+.. .........+.+++.+|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~~~~~~~~~------~i~-~--~~~~~~~--~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQETYR------KII-N--WKETLQF--PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHHHHH------HHH-c--CCCccCC--CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997654322111 111 0 0000000 0011223568899999997 9999998 999884
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=296.30 Aligned_cols=241 Identities=23% Similarity=0.265 Sum_probs=192.6
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+.||+|+||.||++.+. .+..+|+|++.... ......+..|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999986 68899999987532 223345677999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 115 SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 115 ~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
+|.+++. ....+++..++.++.|++.|+.|||+ . |++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 81 ELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 9998884 34578999999999999999999997 7 999999999999999999999999999864322211 1122
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ .+..++.++||||||+++++|++|+.||.......... ..... ....+...
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~-------~i~~~--------~~~~p~~~ 219 (325)
T cd05594 156 FCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILME--------EIRFPRTL 219 (325)
T ss_pred ccCCcccCCHHHH-ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH-------HHhcC--------CCCCCCCC
Confidence 3488999999998 56678899999999999999999999997654321111 11111 11111223
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 274 FENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
...+.+++.+||+.||++|+ ++.++++
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 45689999999999999996 8999983
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=287.33 Aligned_cols=248 Identities=31% Similarity=0.519 Sum_probs=190.7
Q ss_pred hhhhcCcCCceeEEEEEeC-----CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 37 FKEEIGRGGSGRVYKGCIN-----GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~-----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+.+.||.|.||.||+|.+. .+..|+||.+.... ......+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 5678999999999999987 36678899885532 33467889999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-
Q 047716 111 MRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT- 188 (325)
Q Consensus 111 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~- 188 (325)
+++++|.+++... ...+++..+..++.|++.|+.|||++ +++|++|+++||+++.++.+||+|||+.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999665 56799999999999999999999999 999999999999999999999999999876632211
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
...........|+|||.+ ....++.++||||||++++||++ |+.||......+. . .....+....
T Consensus 160 ~~~~~~~~~~~~~aPE~~-~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~------~-~~~~~~~~~~------ 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVL-KDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI------I-EKLKQGQRLP------ 225 (259)
T ss_dssp EESTTSESGGGGS-HHHH-HHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH------H-HHHHTTEETT------
T ss_pred cccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc------c-ccccccccce------
Confidence 111112256789999998 45558999999999999999999 6788866532211 1 1112222111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMM 302 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 302 (325)
.+......+.+++..||+.+|++|||++++++.|
T Consensus 226 -~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112235689999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=285.49 Aligned_cols=253 Identities=32% Similarity=0.476 Sum_probs=199.6
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHH--HHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGES--EFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
|++++.||+|+||+||++... .+..+|+|.+......... ....|+.+++.++||||+++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678999999999999999998 4568999998765433332 2345999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
.+++|.+++. ....++...++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred cccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999995 456789999999999999999999999 999999999999999999999999999875421 12222
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
....++..|.|||.+......+.++|+||||+++++|++|..||......+.................. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 227 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ--------QSR 227 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--------SHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--------ccc
Confidence 233478899999998447888999999999999999999999998763222222111111100000000 000
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00167999999999999999999999984
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=289.77 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=191.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeC--CCcEEEEEEeeccch--hcHHHHHHHHHHHhcc---CCCCcceeeEEee-----cC
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRI---HHKNLVDLVGFCS-----EG 101 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~--~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~~ 101 (325)
+|++.+.||+|+||.||+|.+. ++..+|+|.+..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6899999999999999999874 467789998764322 2233455677666655 6999999999874 34
Q ss_pred CceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
...+++|||++ ++|.+++... ...+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999995 5888887543 34589999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC---
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG--- 257 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 257 (325)
....... ......++..|+|||.+ ....++.++||||||+++++|++|++||......+....+. ......
T Consensus 158 ~~~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~---~~~~~~~~~ 231 (290)
T cd07862 158 RIYSFQM--ALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL---DVIGLPGEE 231 (290)
T ss_pred EeccCCc--ccccccccccccChHHH-hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH---HHhCCCChh
Confidence 7654321 12223478999999998 45677889999999999999999999998765433221111 110000
Q ss_pred ccc-------ccccCCC-----CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 258 ELQ-------NLVSDQE-----DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 258 ~~~-------~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+. ....... ...+.....+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000 011223456889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.76 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=199.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+-|++.+.||+|++|.||+|.+. .+..+++|.+..........+.+|+.+++.++|||++++++.+..++..++++||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34789999999999999999987 46677888876555555667888999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|..++......+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||++........ ..
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 160 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence 99999988765566799999999999999999999999 999999999999999999999999999865432221 11
Q ss_pred eeecCCCCcCCccccc----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 192 TVLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
....++..|+|||.+. ....++.++|+||||+++++|++|++||.......... .... .... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-~~~~-----~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL------KIAK-SEPP-----TL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH------HHhh-cCCC-----CC
Confidence 2223788999999874 23456789999999999999999999997643221111 1100 0000 00
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..+......+.+++.+||+.+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11112345799999999999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=280.37 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=204.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
++|++.+.||+|++|.||+|.+.. +..+++|.+..... ...+.+|+..++.++||||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 579999999999999999999874 78899998865433 667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++......+++..+..++.|++.|+.+||+. +++|+|++|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 99999999866667799999999999999999999999 999999999999999999999999999876544332 11
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
....++..|+|||.+ .+..++.++||||||+++++|++|+.||.......... . ...........+.
T Consensus 157 ~~~~~~~~y~~PE~~-~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---------~---~~~~~~~~~~~~~ 223 (256)
T cd06612 157 NTVIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---------M---IPNKPPPTLSDPE 223 (256)
T ss_pred ccccCCccccCHHHH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------h---hccCCCCCCCchh
Confidence 223367889999998 45677889999999999999999999997653322110 0 0001111122233
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+.+++.+||+.+|++|||++|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 34567999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=287.71 Aligned_cols=249 Identities=27% Similarity=0.325 Sum_probs=198.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||++.+. .+..+|+|++..... .....+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999986 688899998865322 223446779999999999999999999998889999999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+.+++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999887543 34689999999999999999999999 999999999999999999999999999876533222
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
. ....++..|+|||.+ ....++.++|+||+|+++++|++|+.||.......... ....... .....
T Consensus 158 ~--~~~~~~~~y~aPE~~-~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~--------~~~~~ 223 (285)
T cd05605 158 I--RGRVGTVGYMAPEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVK--------EDQEE 223 (285)
T ss_pred c--ccccCCCCccCcHHh-cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhh--------hcccc
Confidence 1 122478899999998 45678889999999999999999999998654321110 0111111 11112
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
........+.+++.+||+.||.+|| ++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK 259 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh
Confidence 2233456789999999999999999 888987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=293.81 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=215.6
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh---cHHHHHHHHHHHhccC-CCCcceeeEEeecC
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE---GESEFRNEMKIIGRIH-HKNLVDLVGFCSEG 101 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 101 (325)
..+-....|++.+.||.|.||.||.+..+ .|+.+|+|.+.+.... +...+.+|+.+|+.+. ||||+.+++.+++.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 44555678999999999999999999998 4999999999765443 3457899999999999 99999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC----CcEEEeec
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES----WKAKISDF 177 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~----~~vkl~Df 177 (325)
...++|||++.||.|.+.+... .+++..+..++.|++.++.|||+. |++|+|+||+|+|+... +.++++||
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999988555 399999999999999999999999 99999999999999533 47999999
Q ss_pred cccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 178 GLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
|++..... .......+|++.|+|||.+ ....++...||||+|+++|.|++|.+||.+........ .+..+
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl-~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~ 253 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVL-GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRG 253 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhh-cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcC
Confidence 99988766 4455667799999999999 66888999999999999999999999998876543322 22222
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+ .-..+.....++.+.+++..|+..||..|+|+.++++
T Consensus 254 ~~----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 DF----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CC----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 22 2223334445678999999999999999999999996
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=281.22 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=205.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.+|++.+.||.|++|.||+|.+. .+..+++|.+..........+.+|+.+++.++||||+++++.+......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999986 57788999887655556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++......+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++++|||.+......... .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-R 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhc-c
Confidence 99999998865557899999999999999999999999 9999999999999999999999999998765432211 1
Q ss_pred eeecCCCCcCCccccccC--CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRN--NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
....++..|+|||.+... ..++.++|+||||+++++|++|++||........... .....+. ......
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~~~---~~~~~~ 228 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSNFP---PPKLKD 228 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhccCC---Cccccc
Confidence 222367789999998432 2678899999999999999999999976543222110 1111111 111122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
......++.+++.+||+.+|.+|||+++++.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3344567999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.74 Aligned_cols=251 Identities=22% Similarity=0.238 Sum_probs=194.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
.|++++.||+|+||.||+|.+. .+..+|+|++.... ......+..|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788999999999999999887 67889999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT- 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~- 188 (325)
|+++++|.+++.. .+.+++..++.++.|++.|+.|||+. ||+|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999999999844 45689999999999999999999999 999999999999999999999999998753211000
Q ss_pred ---------------------------------------------cceeeecCCCCcCCccccccCCCCCccccchhHHH
Q 047716 189 ---------------------------------------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGV 223 (325)
Q Consensus 189 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 223 (325)
.......|+..|+|||.+ ....++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL-LRKGYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHH-cCCCCCCccceeehhh
Confidence 000123488999999998 4566789999999999
Q ss_pred HHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhh--cccCCCCCCCCHhHHHH
Q 047716 224 MLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLW--CVECELNLRPTMKQVIW 300 (325)
Q Consensus 224 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--~l~~~p~~Rps~~ell~ 300 (325)
++++|++|+.||......+... .......... .........++.+++.+ |+..+|..||++.+++.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i~~~~~~~~-----~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL------KVINWENTLH-----IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH------HHHccccccC-----CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999998654322111 0110000000 01111233568888887 45666667999999993
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.37 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=206.6
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
.+++|.-....-.+-||+|+.|.||+|+.+ +..||||++.... ..+++-|++|+||||+.+.++|...-.++
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 344444444444567999999999999886 7889999985422 24788999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||||||..|.|..++ +.+..++...+.+|..+|+.++.|||.+ .|+|+|||.-||||+.+..|||+|||.+.....
T Consensus 189 IiMEfCa~GqL~~VL-ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVL-KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred EeeeccccccHHHHH-hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 999999999999999 5667899999999999999999999999 999999999999999999999999998876554
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
. .......||..|||||++ .....++|+||||||++|||||||..||.......... .+-..
T Consensus 265 ~--STkMSFaGTVaWMAPEvI-rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw---------------GVGsN 326 (904)
T KOG4721|consen 265 K--STKMSFAGTVAWMAPEVI-RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW---------------GVGSN 326 (904)
T ss_pred h--hhhhhhhhhHhhhCHHHh-hcCCcccccceehhHHHHHHHHhcCCCccccchheeEE---------------eccCC
Confidence 3 223334589999999999 67788999999999999999999999997654322110 01111
Q ss_pred --CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 266 --QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 266 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+..+..+++-++-|+++||+..|..||++.+++..|+-..
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 13445566778999999999999999999999998776443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=286.76 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=202.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+.+.++.++++||+|+||.||++... .+..+++|.+..........+.+|+++++.++|+||+++++++.....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 34678899999999999999999642 355788888776666666788999999999999999999999998889
Q ss_pred eEEEEeecCCCCHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE--------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~ 169 (325)
.+++|||+++++|.+++.... ..+++..+..++.|++.|++|||+. |++|+||+|+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 999999999999999985432 2478899999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHH
Q 047716 170 WKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLI 247 (325)
Q Consensus 170 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 247 (325)
+.++|+|||++........ .......++..|+|||.+ ....++.++||||||+++++|++ |.+||......+..
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 234 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI--- 234 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---
Confidence 9999999999865432221 111111245789999988 45668899999999999999998 89998654332211
Q ss_pred HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
....... ....+...+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus 235 ----~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ----ECITQGR-------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----HHHHcCc-------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111110 011111233568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=293.11 Aligned_cols=240 Identities=23% Similarity=0.266 Sum_probs=191.2
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|++. .+..+|+|++.... ......+..|..++..+ +||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 57789999987532 22334466788888766 799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|...+. ....+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQ-RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 99998884 345789999999999999999999999 999999999999999999999999998865322221 1222
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ ....++.++||||||+++++|++|+.||......+... . ..... ...+...
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~------~-i~~~~--------~~~p~~~ 219 (321)
T cd05591 156 FCGTPDYIAPEIL-QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE------S-ILHDD--------VLYPVWL 219 (321)
T ss_pred cccCccccCHHHH-cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH------H-HHcCC--------CCCCCCC
Confidence 3478999999998 56678899999999999999999999998654322111 1 11111 1111123
Q ss_pred HHHHHHHHhhcccCCCCCCC-------CHhHHH
Q 047716 274 FENLVKIGLWCVECELNLRP-------TMKQVI 299 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rp-------s~~ell 299 (325)
..++.+++.+||+.+|++|| ++++++
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 35789999999999999999 888887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=293.00 Aligned_cols=240 Identities=25% Similarity=0.330 Sum_probs=190.5
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. +++.+|+|++.... ......+..|..++..+ +||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 57889999886532 22334566788888776 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++.. ...+++..++.++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST 155 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence 999988843 45799999999999999999999999 999999999999999999999999999865322211 1222
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ .+..++.++||||||+++++|++|+.||......+.. ...... ....+...
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~i~~~--------~~~~~~~~ 219 (320)
T cd05590 156 FCGTPDYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILND--------EVVYPTWL 219 (320)
T ss_pred cccCccccCHHHH-cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHhcC--------CCCCCCCC
Confidence 3489999999998 5667788999999999999999999999865432211 111111 11111223
Q ss_pred HHHHHHHHhhcccCCCCCCCCH------hHHH
Q 047716 274 FENLVKIGLWCVECELNLRPTM------KQVI 299 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~------~ell 299 (325)
...+.+++.+||+.||.+||++ ++++
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~ 251 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAIL 251 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHH
Confidence 4568999999999999999998 6666
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=291.48 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=188.3
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhc-cCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGR-IHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. .+..+|+|++.... .........|..++.. .+||||+++++.+..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 57789999887532 2223344556666654 4799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++.. ...+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 999988843 45799999999999999999999999 99999999999999999999999999987543222 12223
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ .+..++.++|||||||++++|++|+.||......+.. .... ......+...
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~--------~~~~~~~~~~ 219 (316)
T cd05592 156 FCGTPDYIAPEIL-KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-------DSIL--------NDRPHFPRWI 219 (316)
T ss_pred ccCCccccCHHHH-cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHH--------cCCCCCCCCC
Confidence 3489999999998 4566889999999999999999999999865432111 1111 1111122223
Q ss_pred HHHHHHHHhhcccCCCCCCCCHh-HHH
Q 047716 274 FENLVKIGLWCVECELNLRPTMK-QVI 299 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~-ell 299 (325)
...+.+++.+||+.+|.+||++. +++
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 45688999999999999999975 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.31 Aligned_cols=255 Identities=20% Similarity=0.224 Sum_probs=199.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
+...+|++.+.||+|+||.||+|.+. .++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999987 57788999886422 223445778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+++++|.+++.. ..+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999843 3688999999999999999999999 999999999999999999999999999876543
Q ss_pred CCccceeeecCCCCcCCccccccC---CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRN---NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
..........+++.|+|||.+... ..++.++|+||||+++++|++|+.||......... ...........
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~~~~- 267 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKNSLN- 267 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCcccC-
Confidence 322222234589999999998432 24788999999999999999999999765432111 11111100000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHhHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNL--RPTMKQVIW 300 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~ell~ 300 (325)
..........+.+++..|++.++.. |+++.|+++
T Consensus 268 ----~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 268 ----FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred ----CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 1111223456889999999865543 899999994
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=281.10 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=204.7
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++|++.+.||+|++|.||+|.+. ++..+++|.+.... ......+.+|+.+++.++||||+++++.+..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47899999999999999999976 78899999876432 223346778999999999999999999999889999999
Q ss_pred eecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||+++++|.+++.. ....+++..++.++.|++.++.+||++ |++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998743 234689999999999999999999999 999999999999999999999999998876543
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
.... .....++..|+|||.+ .....+.++|+||||+++++|++|..||........ .. ........ .
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~~------~ 225 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL----CKKIEQCD------Y 225 (267)
T ss_pred CCcc-cccccCCcCccCHHHh-cCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HH----hhhhhcCC------C
Confidence 3221 1123377889999998 456678899999999999999999999965432111 10 01111111 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111234567999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=293.86 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=193.0
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. .+..+|+|++.... ......+..|..+++.+ +||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999987 68889999987532 22334577899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++. ..+.+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 99998874 346799999999999999999999999 99999999999999999999999999886422111 11223
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc--hhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD--EIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
..|+..|+|||.+ .+..++.++|+||||+++++|++|+.||+.....+ .....++......... ...+.
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~p~ 226 (329)
T cd05588 156 FCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IRIPR 226 (329)
T ss_pred ccCCccccCHHHH-cCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CCCCC
Confidence 3488999999998 56678889999999999999999999997432211 1111122222222211 11122
Q ss_pred HHHHHHHHHHhhcccCCCCCCCC------HhHHH
Q 047716 272 EEFENLVKIGLWCVECELNLRPT------MKQVI 299 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps------~~ell 299 (325)
.....+.+++.+||+.||.+||+ +++++
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 23456899999999999999997 67776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=283.90 Aligned_cols=260 Identities=25% Similarity=0.323 Sum_probs=204.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
+...+|.+.+.||.|++|.||+|.+.+ ...+++|...... ......+.+|+.+++.++||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 345778999999999999999998753 2457888776544 3445578899999999999999999998865 567
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++|||+++++|.+++......+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 899999999999999966555689999999999999999999999 99999999999999999999999999987554
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...........++..|+|||.+ ....++.++||||||+++++|++ |..||......+... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-------~~~~~~----- 225 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-------RIENGE----- 225 (270)
T ss_pred cccceecCCCCccccccChhhh-ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHHcCC-----
Confidence 3322111112234679999988 56678899999999999999986 999997654322111 111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
........+..+.+++.+|+..+|++|||+.++++.|+++...
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111223345799999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=281.86 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=204.0
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++...+|++.++||+|+||.||+|.+..+..+++|.+... ......+.+|+.+++.++|+||+++++.+.. ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 4567889999999999999999999877778999887643 2334567889999999999999999999877 7789999
Q ss_pred eecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+++++|.+++... ...++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999998543 34578889999999999999999999 99999999999999999999999999987654322
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
........++..|+|||.+ ....++.++|+||||++++++++ |..||......+.. .....+. .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~-------~ 221 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERGY-------R 221 (260)
T ss_pred cccccCCcccccccCHhHh-ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCC-------C
Confidence 2211112245679999998 45678889999999999999998 89998764332211 1111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
..........+.+++.+||+.+|++||++.++.++|+.+
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111123345699999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=284.39 Aligned_cols=243 Identities=25% Similarity=0.327 Sum_probs=191.8
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeeccchh---cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE---GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
||+|+||.||++.+. .++.+++|++...... ....+..|+.+++.++||||+++.+.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999987 6788999998653322 224567899999999999999999999998999999999999999
Q ss_pred HHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 117 GNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 117 ~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
.+.+.. ....+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 887633 234689999999999999999999999 9999999999999999999999999998755433221 112
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ .+..++.++|+||||+++++|++|+.||.......... .... .........+...
T Consensus 157 ~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-------~~~~----~~~~~~~~~~~~~ 224 (280)
T cd05608 157 YAGTPGFMAPELL-QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-------ELKQ----RILNDSVTYPDKF 224 (280)
T ss_pred cCCCcCccCHHHh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-------HHHH----hhcccCCCCcccC
Confidence 3478899999998 45677889999999999999999999997643321110 0000 1111112222334
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 274 FENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
+..+.+++.+||+.+|++|| ++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l 255 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLR 255 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHh
Confidence 56799999999999999999 778888
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=268.87 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=209.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
...++|++.+.||.|.||.||.|+.+ +.--+|+|++.+. ......++.+|+++-..|+||||+++|++|.+....+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 44567899999999999999999987 6677889988653 2344567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 106 LVYEFMRNGSLGNLLFR-AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++||...|.+...+.. ...++++...+.++.|++.|+.|+|.+ +++||||||+|+|++..+.+|++|||-+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999988853 345699999999999999999999999 99999999999999999999999999776533
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.......+||..|.+||.. .+...+...|+|++|++.+|++.|.+||+....++....+. .
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv-~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---------------k 236 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMV-EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---------------K 236 (281)
T ss_pred ---CCCceeeecccccCCHhhc-CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH---------------H
Confidence 3444566799999999999 67888999999999999999999999999876544433222 1
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
-....+......+.++|.+|+..+|.+|.+..|++.
T Consensus 237 ~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 237 VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 122222334467999999999999999999999983
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=286.54 Aligned_cols=258 Identities=23% Similarity=0.376 Sum_probs=200.2
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
++..++|++.+.||+|++|.||.|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 346788999999999999999998764 24578899875432 23344578899999999999999999999988
Q ss_pred CceEEEEeecCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAE---------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
...++||||+++++|.+++.... ..++...+..++.|++.|+.|||+. +++|+||+|+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 99999999999999999985422 2356778899999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHH
Q 047716 173 KISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWA 250 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 250 (325)
+++|||++.......... .....++..|+|||.+ ....++.++||||||+++++|++ |..||.........
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~------ 231 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL------ 231 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHh-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------
Confidence 999999886543222111 1111246689999998 45668899999999999999999 68888755332111
Q ss_pred HHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 251 HQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
........... .......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 232 -~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 -RFVMEGGLLDK-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HHHHcCCcCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111111 11233568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=283.51 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=202.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCC-C---cEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCING-G---KEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~-~---~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
.+.|++.+.||+|+||.||+|.+.. + ..+++|.+... .......+..|+.+++.++||||+++++++.++...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 4678999999999999999998763 2 35899988654 23345678899999999999999999999998889999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
+|||+++++|.+++....+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++++|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999866666789999999999999999999999 9999999999999999999999999988655432
Q ss_pred Cccceee--ec--CCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 187 QTRTYTV--LR--GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 187 ~~~~~~~--~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
....... .. .+..|+|||.+ ....++.++||||||+++++|++ |..||......+. ..+. ... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i----~~~-~-- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAI----EQD-Y-- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHh-ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHH----HcC-C--
Confidence 2211111 10 13469999998 56677889999999999999886 9999976543211 1111 110 0
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
........+..+.+++.+||+.+|.+||++++++..|+.+
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111223345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=282.50 Aligned_cols=258 Identities=25% Similarity=0.444 Sum_probs=204.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCc---EEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGK---EIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~---~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
|..++|+..+.||+|++|.||+|... .+. .+++|++.... ......+..|+++++.++|||++++.+++...+..
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 44678899999999999999999875 232 67888876432 33455688899999999999999999999998999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++|||+++++|.+++....+.+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999999866667789999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccceeee--cCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 185 TDQTRTYTVL--RGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 185 ~~~~~~~~~~--~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
.......... ..+..|+|||.+ ....++.++|+||||+++++|++ |+.||......+.. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~-------~~i~~~~--- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-------KAINDGF--- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHh-hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH-------HHHhcCC---
Confidence 3322211111 123469999988 45667899999999999999997 99999654332111 1111110
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
...........+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111112345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=295.55 Aligned_cols=238 Identities=24% Similarity=0.268 Sum_probs=190.5
Q ss_pred hhcCcCCceeEEEEEeC----CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 39 EEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
+.||+|+||.||++... .+..+++|++..... .....+..|+.+++.++||||+++++.+..++..++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998762 578899999875432 233456779999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+++|.+++.+ ...+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 9999998843 45689999999999999999999999 999999999999999999999999999875433221 222
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
...+++.|+|||.+ ....++.++||||||+++++|++|+.||......... .. ... .....+..
T Consensus 157 ~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~-i~~--------~~~~~p~~ 220 (318)
T cd05582 157 SFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TM-ILK--------AKLGMPQF 220 (318)
T ss_pred cccCChhhcCHHHH-cCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HH-HHc--------CCCCCCCC
Confidence 34478999999998 4566788999999999999999999999765332111 11 111 11112222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHhH
Q 047716 273 EFENLVKIGLWCVECELNLRPTMKQ 297 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rps~~e 297 (325)
....+.+++.+||+.||.+||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3456899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=284.84 Aligned_cols=256 Identities=21% Similarity=0.336 Sum_probs=201.3
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
...+|++.++||.|+||.||+|.+.+ +..+++|++...... ....+..|+.++..++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 45679999999999999999998743 467899988754322 23557889999999999999999999998889
Q ss_pred eEEEEeecCCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC
Q 047716 104 RLLVYEFMRNGSLGNLLFRA---------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE 168 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~ 168 (325)
.+++++|+.+++|.+++... ...+++..+..++.|++.|+.|||+. |++|+||||+||++++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence 99999999999999987421 13478888999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhH
Q 047716 169 SWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVL 246 (325)
Q Consensus 169 ~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 246 (325)
++.++|+|||++........ .......+++.|+|||.+ ....++.++||||||+++++|++ |..||......+.
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--- 235 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--- 235 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---
Confidence 99999999998875533221 111222246789999998 45668889999999999999998 7788865432211
Q ss_pred HHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 247 IDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
.......... ..+..+...+.+++.+||+.+|.+||++++|+..|+.
T Consensus 236 ----~~~i~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ----IEMIRNRQVL-------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHHHHcCCcC-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1112222211 1122344669999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.04 Aligned_cols=249 Identities=22% Similarity=0.233 Sum_probs=194.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
.|+++++||+|+||.||+|.+. .++.+|+|++.... ......+..|+.+++.++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999987 68889999886532 2234557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT- 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~- 188 (325)
|+++++|.+++.. .+.+++..++.++.|++.|+.|||++ ||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999844 45688999999999999999999999 999999999999999999999999998753210000
Q ss_pred -----------------------------------------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHH
Q 047716 189 -----------------------------------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLE 227 (325)
Q Consensus 189 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 227 (325)
.......|++.|+|||.+ ....++.++|||||||++++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-cCCCCCcceeeeeccceeee
Confidence 000123488999999998 56677899999999999999
Q ss_pred HHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCC---CHhHHH
Q 047716 228 IVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRP---TMKQVI 299 (325)
Q Consensus 228 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell 299 (325)
|++|+.||......+.... .. . ...... ..........+.+++.+|+ .+|.+|+ ++.|++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~------i~-~--~~~~~~--~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 237 MLVGQPPFLADTPAETQLK------VI-N--WETTLH--IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhhCCCCCCCCCHHHHHHH------Hh-c--cCcccc--CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 9999999987643222111 00 0 000000 0011122345778888876 5999999 899998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=297.46 Aligned_cols=251 Identities=23% Similarity=0.240 Sum_probs=193.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+..|+.++..++||+|+++++.+.+....++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 6889999999999999999887 68899999986532 2233457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++.+ .+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999854 46799999999999999999999999 9999999999999999999999999998754321100
Q ss_pred ----------------------------------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCC
Q 047716 190 ----------------------------------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV 235 (325)
Q Consensus 190 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 235 (325)
......||+.|+|||.+ .+..++.++|||||||++++|++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH-cCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 01123589999999998 4667889999999999999999999999
Q ss_pred CCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhccc--CCCCCCCCHhHHHH
Q 047716 236 DESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVE--CELNLRPTMKQVIW 300 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~~p~~Rps~~ell~ 300 (325)
......+... ..........+.+ .......+.+++.+|+. .++..||+++||++
T Consensus 237 ~~~~~~~~~~-------~i~~~~~~~~~p~----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 237 CSETPQETYK-------KVMNWKETLIFPP----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCHHHHHH-------HHHcCcCcccCCC----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 7654322111 1111000000111 11123457778877554 23445689999994
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=300.51 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=213.2
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeCC--C--cE-EEEEEeec---cchhcHHHHHHHHHHHhccCCCCcceeeEEee
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCING--G--KE-IAVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS 99 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~--~--~~-~~vk~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (325)
+++..++-.+.++||+|+||.||+|.... + .. ||+|.... ........+.+|++++++++|||||+++|+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 55667788888999999999999998762 2 23 78888764 33555677999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
....+++|||+|.+|+|.+++.+..+.++..+...++.+.+.|++|||++ +++||||.++|+|++.++.+|++|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence 99999999999999999999977777799999999999999999999999 999999999999999998999999999
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
+............ ...+..|+|||.+ ....+++++||||+|+++||+++ |..||.+....+.. ..+....
T Consensus 309 s~~~~~~~~~~~~-~klPirWLAPEtl-~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~-------~kI~~~~ 379 (474)
T KOG0194|consen 309 SRAGSQYVMKKFL-KKLPIRWLAPETL-NTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK-------AKIVKNG 379 (474)
T ss_pred ccCCcceeecccc-ccCcceecChhhh-ccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH-------HHHHhcC
Confidence 8654311111111 1246789999999 45599999999999999999998 78899887654221 1111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCC
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQ 310 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 310 (325)
+. ...+...+..+..++.+||..+|++||||.++.+.|+.+.....
T Consensus 380 ~r------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 YR------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cc------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11 11112334568888889999999999999999999999885433
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=288.28 Aligned_cols=263 Identities=26% Similarity=0.380 Sum_probs=200.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-----CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec--CCce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-----GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--GSNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 104 (325)
..+|++.+.||+|+||.||.|... .+..+++|++..........+.+|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357899999999999999999742 577899999876665566778899999999999999999997643 3468
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++|+||+++++|.+++......+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 999999999999999865556789999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccce--eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccch---------hhHHHHHHHH
Q 047716 185 TDQTRTY--TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDE---------IVLIDWAHQC 253 (325)
Q Consensus 185 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---------~~~~~~~~~~ 253 (325)
....... ....++..|+|||.+ .+..++.++|+||||+++++|++|..++......-. ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHh-ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 3222111 111133459999998 456688899999999999999998876543221100 0000000001
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
..... ...........+.+++.+||+.+|++|||++||++.|+.+
T Consensus 239 ~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNG-------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCC-------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11000 0111222345699999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=292.48 Aligned_cols=254 Identities=22% Similarity=0.241 Sum_probs=197.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||++... .++.+|+|++.... ......+.+|..+++.++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 6889999999999999999987 68899999986522 2234457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+.+++|.+++.+....+++..+..++.|++.|++|||++ +++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999966567799999999999999999999999 9999999999999999999999999998765433322
Q ss_pred ceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 190 TYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
......+++.|+|||.+.. ...++.++|||||||++++|++|+.||......+.. ...........+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~~~- 231 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHFQFPP- 231 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCcccCCC-
Confidence 2222348999999999852 345678999999999999999999999765332211 11111111111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCC--CCCCCHhHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECEL--NLRPTMKQVIW 300 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p--~~Rps~~ell~ 300 (325)
.....+..+.+++.+|+...+ ..||+++++++
T Consensus 232 ---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 232 ---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred ---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 111234568888888776533 34789999983
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.46 Aligned_cols=250 Identities=22% Similarity=0.245 Sum_probs=194.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.++||+|+||.||+|.+. .++.+|+|++.... ......+..|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 6889999999999999999887 68889999886532 2233557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT- 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~- 188 (325)
|+++++|.+++.. .+.+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999843 46789999999999999999999999 999999999999999999999999999863211000
Q ss_pred ------------c---------------------------------ceeeecCCCCcCCccccccCCCCCccccchhHHH
Q 047716 189 ------------R---------------------------------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGV 223 (325)
Q Consensus 189 ------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 223 (325)
. ......|++.|+|||.+ ....++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF-LQQGYGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH-ccCCCCCceeeEecch
Confidence 0 00012478899999998 5667889999999999
Q ss_pred HHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCC---CCHhHHHH
Q 047716 224 MLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLR---PTMKQVIW 300 (325)
Q Consensus 224 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~ell~ 300 (325)
++++|++|.+||......+... ..........+ . ........+.+++.+||+ +|.+| +++.|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i~~~~~~~~~-p----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYR------KIINWRETLYF-P----DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHH------HHHccCCccCC-C----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 9999999999997654322111 11100000000 0 011123568899999997 67765 59999884
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.53 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=202.3
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++...+|++.+.||.|+||.||+|.+. .++.+++|++.... ......+..|+.+++.+ +||||+++++++..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 345679999999999999999999643 24689999886432 23345677899999999 79999999998754
Q ss_pred -CCceEEEEeecCCCCHHHHHhhcc-------------------------------------------------------
Q 047716 101 -GSNRLLVYEFMRNGSLGNLLFRAE------------------------------------------------------- 124 (325)
Q Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------------------------- 124 (325)
+...++++||+++++|.+++....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 467889999999999998874321
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc-ceeeecCCC
Q 047716 125 -----QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTR 198 (325)
Q Consensus 125 -----~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~ 198 (325)
..+++..+..++.|++.|+.|||++ +|+|+||||+||+++.++.++|+|||++......... ......++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 2578899999999999999999999 9999999999999999999999999998765332211 111122456
Q ss_pred CcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHH
Q 047716 199 GYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENL 277 (325)
Q Consensus 199 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (325)
.|+|||.+ .+..++.++|||||||++++|++ |..||......+.. ........ .. ..+.....++
T Consensus 240 ~y~aPE~~-~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~-~~------~~~~~~~~~~ 305 (337)
T cd05054 240 KWMAPESI-FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF------CRRLKEGT-RM------RAPEYATPEI 305 (337)
T ss_pred cccCcHHh-cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH------HHHHhccC-CC------CCCccCCHHH
Confidence 79999988 46678899999999999999998 99999764332211 11111111 10 1111233568
Q ss_pred HHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 278 VKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 278 ~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.61 Aligned_cols=252 Identities=30% Similarity=0.420 Sum_probs=204.3
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+...+|++.+.||.|++|.||+|... +..+++|.+..... ....+..|+.+++.++|+||+++++++......+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 34678999999999999999999876 78899999876544 45678889999999999999999999988889999999
Q ss_pred ecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++++|.+++.... ..+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999999985443 3689999999999999999999999 999999999999999999999999999876532221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
....+..|+|||.+ ....++.++|+||||+++++|++ |..||......+.. .....+. ..
T Consensus 158 ----~~~~~~~~~ape~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~-------~~ 218 (256)
T cd05039 158 ----SGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PHVEKGY-------RM 218 (256)
T ss_pred ----cCCCcccccCchhh-cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhcCC-------CC
Confidence 11245679999988 45667889999999999999997 99998654322111 1111110 01
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
..+...+..+.+++.+||+.+|++|||+++++++|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11122346799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=290.98 Aligned_cols=240 Identities=24% Similarity=0.279 Sum_probs=191.8
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. .+..+|+|++.... ......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 57889999987532 22334566788888877 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++. ..+.+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQ-RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 99998884 345799999999999999999999999 999999999999999999999999998864322221 1122
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..++..|+|||.+ .+..++.++|+||||+++++|++|+.||......... ....... ...+...
T Consensus 156 ~~g~~~y~aPE~~-~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-------~~i~~~~--------~~~~~~~ 219 (318)
T cd05570 156 FCGTPDYIAPEIL-SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-------QSILEDE--------VRYPRWL 219 (318)
T ss_pred eecCccccCHHHh-cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCC--------CCCCCcC
Confidence 3478999999998 5667889999999999999999999999765422111 1111111 1112223
Q ss_pred HHHHHHHHhhcccCCCCCCCCH-----hHHH
Q 047716 274 FENLVKIGLWCVECELNLRPTM-----KQVI 299 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~-----~ell 299 (325)
...+.+++.+||+.||.+|||+ .+++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll 250 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIK 250 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHh
Confidence 4578999999999999999999 8887
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=295.17 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=194.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG----- 101 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 101 (325)
....+|++.+.||+|+||.||+|.+. .+..+|+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45789999999999999999999986 6889999998643 233445677899999999999999999988543
Q ss_pred -CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 102 -SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 102 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
...++||||+++ +|.+.+. ..++...+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 347999999965 5655552 3578899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHH------------H
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI------------D 248 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~------------~ 248 (325)
........ .....++..|+|||.+ .+..++.++||||||+++++|++|+.||......+..... .
T Consensus 171 ~~~~~~~~--~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTNFM--MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccCcc--CCCCcccCCCCCchhc-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 65432221 1122378899999998 5667889999999999999999999999865432211000 0
Q ss_pred H----HHHHHH-hCccc-----cc----ccC-CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 249 W----AHQCYE-AGELQ-----NL----VSD-QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 249 ~----~~~~~~-~~~~~-----~~----~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. ...... ..... +. ..+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000 00000 00 000 00011112356899999999999999999999994
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=292.80 Aligned_cols=243 Identities=23% Similarity=0.283 Sum_probs=188.9
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. .+..+|+|++.... ......+..|+.++..+ +||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999987 57889999987532 22334567788888776 799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|...+. ....+++..++.++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 99988874 346799999999999999999999999 999999999999999999999999999864322111 1122
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc--hhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD--EIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
..++..|+|||.+ .+..++.++|+||||+++++|++|+.||....... ......+......... ...+.
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~~~p~ 226 (329)
T cd05618 156 FCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------IRIPR 226 (329)
T ss_pred ccCCccccCHHHH-cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------CCCCC
Confidence 3478999999998 56677889999999999999999999996422211 1111112222222111 12222
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCH
Q 047716 272 EEFENLVKIGLWCVECELNLRPTM 295 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~ 295 (325)
.....+.+++.+||+.||++||++
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 334568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.82 Aligned_cols=258 Identities=21% Similarity=0.347 Sum_probs=205.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++|++.+.||+|++|.||+|... ++..+++|.+.... ......+.+|+.+++.++|++++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46889999999999999999987 78899999875422 222456889999999999999999999999989999999
Q ss_pred eecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||+++++|.+++.. ....++...+..++.|++.++.+||+. |++|+||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998843 234589999999999999999999999 999999999999999999999999999875543
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
.... .....++..|+|||.+ .+..++.++|+||||+++++|++|+.||........ ... .....+.....
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~-~~~~~~~~~~~--- 228 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLC-KKIEKCDYPPL--- 228 (267)
T ss_pred CCcc-cceecCCccccCHHHh-ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH----HHH-hhhhcCCCCCC---
Confidence 2221 1222367889999998 466678899999999999999999999965432111 101 11111111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
........+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 229 ---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 ---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11234467999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=298.42 Aligned_cols=249 Identities=21% Similarity=0.206 Sum_probs=193.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|+++++||+|+||.||+|.+. .+..+|+|++.... ......+..|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999986 67889999886532 2234467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT- 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~- 188 (325)
|+++++|.+++.+ .+.+++..++.++.|++.|+.|||++ +|+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999998844 35689999999999999999999999 999999999999999999999999998743210000
Q ss_pred ---------------------------------------------cceeeecCCCCcCCccccccCCCCCccccchhHHH
Q 047716 189 ---------------------------------------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGV 223 (325)
Q Consensus 189 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 223 (325)
.......|++.|+|||.+ .+..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHh-cCCCCCCeeeEEechH
Confidence 000113478999999998 5667889999999999
Q ss_pred HHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HhHHH
Q 047716 224 MLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT---MKQVI 299 (325)
Q Consensus 224 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~ell 299 (325)
++++|++|++||......+... .... ..... ..........++.+++.+|+ .+|.+|++ +++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~------~i~~---~~~~~--~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQM------KVIN---WQTSL--HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHH------HHHc---cCCCc--CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 9999999999998654322111 1110 00000 01111223456788888876 59999997 88877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=281.24 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=203.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-C---CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-G---GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~---~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
..+|++.+.||+|+||.||+|.+. . +..+++|.+.... ......+..|+.+++.++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 578999999999999999999874 2 3368888876432 3334578889999999999999999999998899999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
+|||+++++|.+++....+.++...+..++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999966666789999999999999999999999 9999999999999999999999999998765443
Q ss_pred Cccceee--ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 187 QTRTYTV--LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 187 ~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
....... ...+..|+|||.+ ....++.++|+||||++++++++ |..||......+.. . ..... .
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~----~~~~~-~---- 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---K----AIEEG-Y---- 226 (267)
T ss_pred cceeeecCCCccceeecCHhHh-ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---H----HHhCC-C----
Confidence 2211111 1124579999998 45668899999999999999886 99999765432211 1 11111 0
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
..+.....+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111122345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.63 Aligned_cols=264 Identities=24% Similarity=0.355 Sum_probs=199.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC---------------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING---------------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVD 93 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~---------------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~ 93 (325)
+...+|++.+.||+|+||.||+|.+.. ...+++|.+.... ......+.+|+++++.++|||+++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 346789999999999999999987642 2247888876532 233456888999999999999999
Q ss_pred eeEEeecCCceEEEEeecCCCCHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE-----------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
+++++...+..++||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ +++|+||+|+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 9999999899999999999999999884322 1367888999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh--CCCCCCCcc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC--CRKNVDESL 239 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~ 239 (325)
||+++.++.++|+|||++........ .......++..|+|||.+ ....++.++|+||||+++++|++ +..||....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh-ccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999999875432221 111112245689999988 45668999999999999999988 556776543
Q ss_pred ccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 240 RDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
..+. +................. .++..+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 238 ~~~~---~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQV---IENTGEFFRNQGRQIYLS----QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHHH---HHHHHHhhhhccccccCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 3221 111111111111111111 111223579999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.18 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=200.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|.+.+.||+|++|.||+|.+. ++..+++|.+... .......+.+|+.+++.++|||++++++.+.+.+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3778899999999999999987 6888999987642 234456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 111 MRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
+++++|.+++... ...++...++.++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999998654 45789999999999999999999999 9999999999999999999999999988765433221
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....++..|+|||.+ ....++.++|+||||+++++|++|+.||........ . .....+.. ...
T Consensus 158 -~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~~~~-------~~~ 221 (256)
T cd08529 158 -ANTIVGTPYYLSPELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---I----LKIIRGVF-------PPV 221 (256)
T ss_pred -hhccccCccccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHHcCCC-------CCC
Confidence 1223467889999998 455678899999999999999999999976542111 1 11111111 111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1134467999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=280.78 Aligned_cols=253 Identities=25% Similarity=0.437 Sum_probs=201.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..+|++.+.||.|++|.||+|.+..+..+++|.+.... .....+..|+++++.++||+++++++++......++++||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 35788999999999999999998878889999876433 23456888999999999999999999998888999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
.+++|.+++....+.+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999865556789999999999999999999999 999999999999999999999999998875433222111
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....+..|+|||.+ .+..++.++|+||||+++++|++ |..||......... .....+ ... .. +
T Consensus 159 ~~~~~~~~~~aPe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~-~~~-~~-----~ 223 (256)
T cd05112 159 TGTKFPVKWSSPEVF-SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV-------ETINAG-FRL-YK-----P 223 (256)
T ss_pred CCCccchhhcCHhHh-ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH-------HHHhCC-CCC-CC-----C
Confidence 111235689999988 45678889999999999999998 89998754332111 111111 000 00 1
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
......+.+++.+||+.+|++|||+.++++.|.
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112357999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.75 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=199.0
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-----hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-----EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
++|++.+.||+|++|.||.|... .+..+++|.+.... ......+.+|+.+++.++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 36889999999999999999876 68889999876432 1123467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
++||+++++|.+++.. .+.+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999998843 45688999999999999999999999 9999999999999999999999999998754332
Q ss_pred Cccce--eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 187 QTRTY--TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 187 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..... ....++..|+|||.+ .+..++.++||||||+++++|++|+.||......... .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~------- 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQP------- 223 (263)
T ss_pred ccccccccCCCcCccccCccee-ccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccC-------
Confidence 21111 122367789999998 4556889999999999999999999999754221111 0111110
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
.....+......+.+++.+||+.+|.+|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111222344678999999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=290.13 Aligned_cols=240 Identities=24% Similarity=0.294 Sum_probs=189.2
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. .+..+|+|++.... .........|..++... +||+|+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999987 67889999987532 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++.. ...+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 999988843 45789999999999999999999999 99999999999999999999999999876432211 12223
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..++..|+|||.+ .+..++.++||||||+++++|++|+.||......... ...... ....+...
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-------~~~~~~--------~~~~~~~~ 219 (316)
T cd05620 156 FCGTPDYIAPEIL-QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-------ESIRVD--------TPHYPRWI 219 (316)
T ss_pred cCCCcCccCHHHH-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhC--------CCCCCCCC
Confidence 4489999999998 5667889999999999999999999999765332111 111111 11111123
Q ss_pred HHHHHHHHhhcccCCCCCCCCHh-HHH
Q 047716 274 FENLVKIGLWCVECELNLRPTMK-QVI 299 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~-ell 299 (325)
...+.+++.+||+.||++||++. +++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 45689999999999999999985 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.66 Aligned_cols=259 Identities=23% Similarity=0.312 Sum_probs=199.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCc----EEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGK----EIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
..+|++.+.||.|+||.||+|.+. .+. .+++|.+..... .....+..|+..++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 467889999999999999999985 333 366676643322 233457778889999999999999998754 4578
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+++||+++++|.+++....+.+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++.....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 89999999999999976667799999999999999999999999 999999999999999999999999999875533
Q ss_pred CCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 186 DQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 186 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.... ......++..|+|||.+ ....++.++||||||+++|+|++ |..||........ . .....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~----~~~~~~~~~~-- 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESI-LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---P----DLLEKGERLA-- 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHh-ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHHCCCcCC--
Confidence 2211 11122356689999998 45668899999999999999998 9999976532211 1 1111111110
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
.+..+...+.+++.+||..+|.+|||+.|+++.|+.+....
T Consensus 232 -----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 232 -----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 01112346888999999999999999999999999877433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=289.44 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=200.8
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCc--EEEEEEeecc-chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCc
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGK--EIAVKKLIKI-VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~--~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 103 (325)
.+..++|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|+.++..+ +||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 456788999999999999999999876 343 3466665432 233445678899999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE 168 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~ 168 (325)
.+++|||+++++|.+++.... ..++...++.++.|++.|+++||++ |++|+||+|+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence 999999999999999985432 2578999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHH
Q 047716 169 SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLI 247 (325)
Q Consensus 169 ~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 247 (325)
++.++|+|||++........ ......+..|+|||.+ ....++.++||||||+++++|++ |..||......+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--- 233 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--- 233 (303)
T ss_pred CCcEEeCccccCcccchhhh--cccCCCcccccCHHHH-hccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---
Confidence 99999999998853221111 1111135679999988 55667889999999999999998 99999754332111
Q ss_pred HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
...... . ...........+.+++.+||+.+|++||+++++++.|+.+...
T Consensus 234 ----~~~~~~-~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 234 ----EKLPQG-Y------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ----HHHhcC-C------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 0 0011112335689999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.28 Aligned_cols=241 Identities=22% Similarity=0.386 Sum_probs=189.3
Q ss_pred hhcCcCCceeEEEEEeCC-------------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 39 EEIGRGGSGRVYKGCING-------------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~-------------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
+.||+|++|.||+|+... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2247778766544455556788999999999999999999998888999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc-------EEEeecc
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK-------AKISDFG 178 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~-------vkl~Dfg 178 (325)
++|||+++++|..++......+++..++.++.|++.|++|||++ +++|+||+|+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999988865566799999999999999999999999 9999999999999976654 8999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHH-hCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV-CCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
++........ ..++..|+|||.+.....++.++||||||+++|+|+ .|..|+......+.. . ....
T Consensus 158 ~~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~-~~~~ 224 (262)
T cd05077 158 IPITVLSRQE-----CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------R-FYEG 224 (262)
T ss_pred CCccccCccc-----ccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------H-HHhc
Confidence 8865432221 225778999998855677889999999999999997 577777654321110 1 1111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
... ........+.++|.+||+.+|.+||++.+|++.++
T Consensus 225 ~~~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 QCM--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Ccc--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111 11112356899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.90 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=201.3
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.+|++.+.||.|++|.||+|.+. .+..+++|.+..........+.+|+.+++.++|||++++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 58899999999999999999876 68899999887655555667889999999999999999999998889999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++.. ..+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......... .
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~ 173 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence 99999998843 4578999999999999999999999 9999999999999999999999999988754332211 1
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
....+++.|+|||.+ ....++.++|+||||+++++|++|+.||.......... ...... ......+.
T Consensus 174 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~------~~~~~~------~~~~~~~~ 240 (296)
T cd06654 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNG------TPELQNPE 240 (296)
T ss_pred CcccCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH------HHhcCC------CCCCCCcc
Confidence 122367899999998 45667899999999999999999999997654321110 000000 01111122
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+.+++.+||..+|++|||+.++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 34456899999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=306.18 Aligned_cols=265 Identities=20% Similarity=0.247 Sum_probs=195.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC--------C
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--------S 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~ 102 (325)
..+|++.+.||+|+||.||+|.+. .+..+|+|++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999986 67899999885432 2345799999999999999998876321 2
Q ss_pred ceEEEEeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeecc
Q 047716 103 NRLLVYEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFG 178 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg 178 (325)
.+++||||+++ ++.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999964 67666532 345789999999999999999999999 999999999999998664 69999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHH-----H
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQ-----C 253 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~ 253 (325)
++.......... ...+++.|+|||.+.+...++.++|||||||++++|++|.+||.+....+....+..... .
T Consensus 217 la~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 217 SAKNLLAGQRSV--SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cchhccCCCCcc--cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 997654322211 223788999999886666789999999999999999999999987654332222111000 0
Q ss_pred H--HhCcccccccCC-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 254 Y--EAGELQNLVSDQ-------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 254 ~--~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
. ..+.+..+.-+. ...+...+.++.+|+.+||+.+|.+|||+.|++ ..++.+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0 000011000000 001111235789999999999999999999999 5555554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.79 Aligned_cols=263 Identities=27% Similarity=0.449 Sum_probs=216.3
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeCC--Cc----EEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEee
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCING--GK----EIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCS 99 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~--~~----~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (325)
+.++...+-++.+.||+|+||.||.|...+ +. .|++|.+.+. +..+...|.+|..+|+.++|||||+++|++.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 556677888888999999999999998752 33 3788888764 3556677999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEE
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRA------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAK 173 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vk 173 (325)
+....+|++|||.+|+|..|+++. ...++..+++.++.++++|+.||+++ ++|||||.++|.|++....||
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 999999999999999999999777 56699999999999999999999999 999999999999999999999
Q ss_pred Eeeccccccc-cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHH
Q 047716 174 ISDFGLSKLL-KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 174 l~Dfg~~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 251 (325)
++|||+++.. +.+..+....-..+..|||||.+ ....++.|+||||||+++||+++ |..||......+... .
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl-~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~--- 916 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESL-KDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--D--- 916 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHH-hhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--H---
Confidence 9999999833 22222222111234689999999 56889999999999999999998 677887765433221 1
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.... .+.+.+..++..+.++|..||+.+|++||++..|++.+..+.+
T Consensus 917 -~~~g--------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 917 -VLEG--------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred -HHhC--------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 1111 1345556677789999999999999999999999998888873
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=280.36 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=194.9
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+|++.+.||+|++|.||+|.+. .+..+++|.+... .......+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5788899999999999999876 6788999987653 2333456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|..+ ..+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~--- 150 (279)
T cd06619 82 DGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--- 150 (279)
T ss_pred CCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc---
Confidence 99998654 2468888999999999999999999 999999999999999999999999999875533221
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
....++..|+|||.+ .+..++.++|+||||+++++|++|+.||.............-............. ...
T Consensus 151 ~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 223 (279)
T cd06619 151 KTYVGTNAYMAPERI-SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL------PVG 223 (279)
T ss_pred cCCCCChhhcCceee-cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC------CCC
Confidence 123478899999998 4566889999999999999999999999754332211100000111111110000 111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....++.+++.+||+.+|++||+++|+++
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 12356899999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.41 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=203.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccch-hcHHHHHHHHHHHhccC-CCCcceeeEEeecC
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVE-EGESEFRNEMKIIGRIH-HKNLVDLVGFCSEG 101 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 101 (325)
....+|.+.+.||+|+||.||+|++.. +..+|+|++..... .....+..|+.+++.+. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 336788999999999999999998642 34689998865332 33456889999999996 99999999999998
Q ss_pred CceEEEEeecCCCCHHHHHhhcc---------------------------------------------------------
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAE--------------------------------------------------------- 124 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~--------------------------------------------------------- 124 (325)
...++||||+++++|.+++....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999998874321
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE
Q 047716 125 --------------------------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166 (325)
Q Consensus 125 --------------------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv 166 (325)
..+++..+..++.|++.|+.|||+. +++|+||+|+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 2367788899999999999999999 99999999999999
Q ss_pred cCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchh
Q 047716 167 DESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEI 244 (325)
Q Consensus 167 ~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 244 (325)
+.++.++|+|||++......... ......++..|+|||.+ .+..++.++||||||+++++|++ |+.||.........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI-FDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 99999999999998755332211 11112256789999998 45667899999999999999997 88998765332211
Q ss_pred hHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 245 VLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
. .....+. ...........+.+++.+||+.+|++|||+.+|.++|+.+.+
T Consensus 350 ~------~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 Y------NKIKSGY-------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H------HHHhcCC-------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1 1111110 011122334679999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=292.15 Aligned_cols=240 Identities=24% Similarity=0.253 Sum_probs=187.4
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHH-HHHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNE-MKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. ++..+++|++..... .....+..| ..+++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 567899998865321 222233334 3457788999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++.. ...+.+..+..++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 999998843 45688899999999999999999999 999999999999999999999999999864322221 1223
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ .+..++.++||||||+++++|++|.+||......+.. .. ... ......+..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~-i~~--------~~~~~~~~~ 219 (325)
T cd05602 156 FCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DN-ILN--------KPLQLKPNI 219 (325)
T ss_pred ccCCccccCHHHH-cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH------HH-HHh--------CCcCCCCCC
Confidence 3489999999998 5667888999999999999999999999764432211 11 111 111122233
Q ss_pred HHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 274 FENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...+.+++.+||+.+|.+||++.+.+
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 45689999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=288.67 Aligned_cols=240 Identities=23% Similarity=0.295 Sum_probs=189.3
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhc-cCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGR-IHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. .+..+|+|.+.... .........|..++.. ++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999987 57889999987542 2233445567777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++.. ...+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 999998843 45789999999999999999999999 999999999999999999999999999864322211 1223
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..++..|+|||.+ .+..++.++|||||||++++|++|+.||......+.. ....... ...+...
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-------~~i~~~~--------~~~~~~~ 219 (316)
T cd05619 156 FCGTPDYIAPEIL-LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF-------QSIRMDN--------PCYPRWL 219 (316)
T ss_pred ecCCccccCHHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC--------CCCCccC
Confidence 3488999999998 4567889999999999999999999999765432111 1111111 1111123
Q ss_pred HHHHHHHHhhcccCCCCCCCCHh-HHH
Q 047716 274 FENLVKIGLWCVECELNLRPTMK-QVI 299 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~-ell 299 (325)
...+.+++.+||+.+|++||++. +++
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 35689999999999999999997 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=297.08 Aligned_cols=257 Identities=20% Similarity=0.211 Sum_probs=199.5
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
..+...+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|..+++.++||||+++++.+.++..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3455689999999999999999999987 67788899876422 2233457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++.. ..+++..+..++.|++.|+.|||++ ||+|+||||+||+++.++.++|+|||++...
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999999999999843 4588999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCccceeeecCCCCcCCccccccC---CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRN---NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
............|++.|+|||.+... ..++.++|||||||++|+|++|+.||......... ..........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~~~~ 266 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMNHKNSL 266 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHHHcCCCcc
Confidence 43322222234589999999998532 24788999999999999999999999865432111 1111111100
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHhHHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNL--RPTMKQVIW 300 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~ell~ 300 (325)
.+ .........+.++|.+||+.++.. |++++|+++
T Consensus 267 ~~-----~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 267 TF-----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred cC-----CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 11 111234467899999999844433 789999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=290.93 Aligned_cols=237 Identities=24% Similarity=0.262 Sum_probs=186.5
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHH-HHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEM-KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. ++..+++|++..... .....+..|. .+++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999987 688899999865321 2223344444 456789999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++. ..+.+++..+..++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 99998884 345789999999999999999999999 99999999999999999999999999886432211 11222
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ .+..++.++||||||+++++|++|+.||......+.. ..... ......+..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~--------~~~~~~~~~ 219 (323)
T cd05575 156 FCGTPEYLAPEVL-RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY-------DNILN--------KPLRLKPNI 219 (323)
T ss_pred ccCChhhcChhhh-cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH-------HHHHc--------CCCCCCCCC
Confidence 3478999999998 5667889999999999999999999999765322111 11111 111122223
Q ss_pred HHHHHHHHhhcccCCCCCCCCHh
Q 047716 274 FENLVKIGLWCVECELNLRPTMK 296 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~ 296 (325)
...+.+++.+||+.+|.+||++.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCC
Confidence 46789999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.62 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=200.2
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-----CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-----GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
..++|++.+.||+|+||.||+|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 3578899999999999999999852 45678898886433 23335688899999999999999999999998999
Q ss_pred EEEEeecCCCCHHHHHhhc----------------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC
Q 047716 105 LLVYEFMRNGSLGNLLFRA----------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE 168 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~ 168 (325)
+++|||+++++|.+++... ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 9999999999999988422 12477888999999999999999999 9999999999999999
Q ss_pred CCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhH
Q 047716 169 SWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVL 246 (325)
Q Consensus 169 ~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 246 (325)
++.++++|||++........ .......++..|+|||.+ ....++.++|+||||+++++|++ |..||........
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~--- 235 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV--- 235 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHh-ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---
Confidence 99999999999876533221 111112245679999998 45668899999999999999998 8889876432111
Q ss_pred HHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 247 IDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
.......... ..+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 236 ----~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 ----IEMVRKRQLL-------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHHHHcCCcC-------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111 1112233568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=285.76 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=203.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||.|++|.||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999986 68899999886543 33345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+ +++|.+++......+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 9999999866667799999999999999999999999 99999999999999999999999999987665433222
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC------------c
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG------------E 258 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------~ 258 (325)
.....++..|+|||.+.....++.++||||||+++++|++|.++|.......... ......... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA---IVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH---HHHHHcCCCChHHHhhccCcch
Confidence 2233478899999998555667899999999999999999988886544322111 111111000 0
Q ss_pred ccccccCC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQNLVSDQ------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+..+.... ....+.....+.+++.+||+.+|.+|||+++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 0011123467999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=291.31 Aligned_cols=241 Identities=23% Similarity=0.237 Sum_probs=191.1
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
+|++.+.||+|+||.||+|.+. .+..+|+|++..... ........|..++..+ +|++|+.+++.+...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999987 577899998875332 2233456677777777 4889999999999989999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+.+.. .+.+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999999988843 45789999999999999999999999 999999999999999999999999999864332211
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
......|++.|+|||.+ ....++.++|||||||++++|++|+.||.......... ..... ...
T Consensus 157 -~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~-------~i~~~--------~~~ 219 (323)
T cd05616 157 -TTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ-------SIMEH--------NVA 219 (323)
T ss_pred -ccccCCCChhhcCHHHh-cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH-------HHHhC--------CCC
Confidence 12223478999999998 56678899999999999999999999998654322111 11111 111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTM 295 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~ 295 (325)
.+.....++.+++.+||+.+|.+|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 222334678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=277.24 Aligned_cols=247 Identities=30% Similarity=0.478 Sum_probs=200.2
Q ss_pred hhcCcCCceeEEEEEeCC----CcEEEEEEeeccchhc-HHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCING----GKEIAVKKLIKIVEEG-ESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+.. +..+++|.+....... ...+..|+..++.++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999874 7888999887644333 56788999999999999999999999998999999999999
Q ss_pred CCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 114 GSLGNLLFRA--------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 114 ~~L~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
++|.+++... ...+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999655 46799999999999999999999999 999999999999999999999999999986654
Q ss_pred CCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 186 DQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 186 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
... .......++..|+|||.+ ....++.++||||||+++++|++ |..||......+.. .....+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~----- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESL-KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-------EYLRKGY----- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHh-ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC-----
Confidence 321 111222367789999988 44578899999999999999999 58999776322111 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
....+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112223567999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.16 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=204.0
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++..++|++.+.||+|++|.||++.+.. ...+++|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3556789999999999999999998742 3578888876532 23345678899999999 79999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceE
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRA---------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNIL 165 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil 165 (325)
++..+++|||+.+++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 89999999999999999998532 34688999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccch
Q 047716 166 MDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDE 243 (325)
Q Consensus 166 v~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~ 243 (325)
++.++.++|+|||++.......... .....++..|+|||.+ ....++.++||||||+++++|++ |..||......+.
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh-ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 9999999999999987654322111 1111235679999988 56678899999999999999997 8888875433221
Q ss_pred hhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 244 IVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
. .....+. ....+......+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 244 ~-------~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 F-------KLLKEGY-------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-------HHHHcCC-------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 1111111 11122233457999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=284.43 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=201.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEe-----CCCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--Cc
Q 047716 32 LASENFKEEIGRGGSGRVYKGCI-----NGGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SN 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 103 (325)
...|++.+.||+|+||.||+|+. ..+..+++|.+.... ......+.+|+.+++.++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45689999999999999999974 257789999886543 33345688999999999999999999988765 56
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++|||+++++|.+++......+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 8999999999999999865555689999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc--------hhhHHHHHHHH
Q 047716 184 KTDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD--------EIVLIDWAHQC 253 (325)
Q Consensus 184 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--------~~~~~~~~~~~ 253 (325)
...... ......++..|+|||.+ .+..++.++||||||+++++|++++.|........ ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECL-IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHh-ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 432211 11122356679999988 45668889999999999999999887653321100 00000111111
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
...+.. .+.....+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 239 ~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR-------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc-------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 111222446799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=279.10 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=199.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+|++.+.||.|++|.||++.+. .+..+++|.+... .......+..|+.+++.++||||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999987 6888999987542 2334556788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++++|.+++... ...+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++++|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999887543 34588999999999999999999999 999999999999999999999999999875543221 1
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....++..|+|||.+ ....++.++|+||||+++++|++|..||......... .....+.... .+
T Consensus 157 ~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~-------~~ 221 (255)
T cd08219 157 ACTYVGTPYYVPPEIW-ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-------LKVCQGSYKP-------LP 221 (255)
T ss_pred cccccCCccccCHHHH-ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH-------HHHhcCCCCC-------CC
Confidence 1123378889999998 5566888999999999999999999999764321111 1111122111 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
......+.+++.+||+.+|++|||+.+++..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2234568999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=283.24 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=196.3
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|++|.||+|++. .+..+++|++.... ......+.+|+.+++.++||||+++++.+.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999986 68889999876432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 111 MRNGSLGNLLFRAE--QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 111 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
+. ++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 96 58888774432 5689999999999999999999999 999999999999999999999999999875433221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH-----HHH----HhCcc
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH-----QCY----EAGEL 259 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~----~~~~~ 259 (325)
......++..|+|||.+.+...++.++|+||||+++++|++|++||......+......... ... ....+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 11112357889999988555667889999999999999999999998654322111100000 000 00000
Q ss_pred cccc----cCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 260 QNLV----SDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 260 ~~~~----~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.... ... .........++.+++.+||+.||.+|||+++|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000 0001113456889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=278.88 Aligned_cols=243 Identities=25% Similarity=0.316 Sum_probs=189.6
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
||+|+||.||++... .++.+++|++..... .....+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999886 688999998864221 2233456799999999999999999999999999999999999999
Q ss_pred HHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeec
Q 047716 117 GNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195 (325)
Q Consensus 117 ~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 195 (325)
.+++... ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence 9887443 34588999999999999999999999 999999999999999999999999999876543221 12234
Q ss_pred CCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHH
Q 047716 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFE 275 (325)
Q Consensus 196 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
++..|+|||.+. ...++.++|+||||+++++|++|+.||......... ........ .... .. .......
T Consensus 156 ~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~-~~~~----~~---~~~~~~~ 224 (277)
T cd05607 156 GTNGYMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL-EDEV----KF---EHQNFTE 224 (277)
T ss_pred CCCCccCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh-cccc----cc---ccccCCH
Confidence 788999999984 555889999999999999999999999754322111 11111111 1111 00 0112345
Q ss_pred HHHHHHhhcccCCCCCCCCHhHHH
Q 047716 276 NLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 276 ~l~~li~~~l~~~p~~Rps~~ell 299 (325)
++.+++.+||+.||.+||+++|++
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccch
Confidence 689999999999999999997765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=281.71 Aligned_cols=257 Identities=26% Similarity=0.356 Sum_probs=199.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS 102 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (325)
+...+|.+.+.||+|++|.||+|.+.. +..+++|.+.... ......+..|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 446789999999999999999998863 4567788765433 233456788999999999999999999998888
Q ss_pred ceEEEEeecCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---cEE
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAE------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---KAK 173 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---~vk 173 (325)
..+++|||+++++|.+++.... ..+++..+..++.|++.++.|||++ +++|+||+|+||+++.++ .++
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 8999999999999999985443 2488999999999999999999999 999999999999998654 599
Q ss_pred EeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHH
Q 047716 174 ISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 251 (325)
|+|||++.......... ......+..|+|||.+ .+..++.++||||||+++++|++ |..||.........
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~------- 231 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF-LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM------- 231 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHH-hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------
Confidence 99999987653221111 1111134579999998 45668999999999999999997 99998765432211
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
...... .....+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 232 ~~~~~~-------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 232 EFVTGG-------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHHcC-------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111111 0111122334678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.86 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=198.8
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCC-Cc--EEEEEEeecc-chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCING-GK--EIAVKKLIKI-VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~-~~--~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 107 (325)
++|++.+.||+|+||.||+|.+.. +. .+++|.+... .......+..|+.++.++ +||||+++++.+...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998763 32 3577776542 233445688899999999 699999999999988899999
Q ss_pred EeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 108 YEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
+||+++++|.+++.... ..+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999985422 2478899999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHH
Q 047716 173 KISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 251 (325)
+|+|||++........ ......+..|+|||.+ ....++.++||||||+++++|++ |..||......+..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~------- 228 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------- 228 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------
Confidence 9999998753221111 1111124569999988 45667889999999999999997 99999765432211
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
.....+ . ....+......+.+++.+||+.+|.+|||++++++.|+.+....
T Consensus 229 ~~~~~~-~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 EKLPQG-Y------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHhcC-C------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111 0 01111223356899999999999999999999999998887533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.88 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=207.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.||+|++|.||+|.+. .+..+++|.+..........+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 488999999999999999999975 7889999998765555566788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++.+ ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 171 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence 999999999843 4578899999999999999999999 9999999999999999999999999988754332221
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....+++.|+|||.+ ....++.++|+||||+++++|++|..||.......... .......+....+
T Consensus 172 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------------~~~~~~~~~~~~~ 238 (297)
T cd06656 172 RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------------LIATNGTPELQNP 238 (297)
T ss_pred cCcccCCccccCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------------eeccCCCCCCCCc
Confidence 1122367889999998 45677899999999999999999999997643321110 0000001111122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCCCC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVPPH 309 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~~ 309 (325)
......+.+++.+||+.+|++||++.++++ .++...+..
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 233456889999999999999999999994 555555433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=271.53 Aligned_cols=253 Identities=28% Similarity=0.379 Sum_probs=206.8
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--------hcHHHHHHHHHHHhccC-CCCcceeeEEee
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--------EGESEFRNEMKIIGRIH-HKNLVDLVGFCS 99 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 99 (325)
-..+.|.-++.||.|..++|-++..+ .++.+++|++..... .-...-.+|+.+|+++. ||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34577888999999999999998876 788999998864221 11223456999999995 999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
.+..+++|+|.++.|.|.|++ ...-.+++...+.+++|+++++.|||.+ +|+|+|+||+|||++++-+++|+|||+
T Consensus 94 s~sF~FlVFdl~prGELFDyL-ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYL-TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred CcchhhhhhhhcccchHHHHh-hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999999 4556799999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeeecCCCCcCCccccc-----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHS-----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
++...... .....+||++|+|||.+. +...|+...|+|++|+|+|-||.|.+||-+... .. +-+.+
T Consensus 170 a~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--ml-----MLR~I 240 (411)
T KOG0599|consen 170 ACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--ML-----MLRMI 240 (411)
T ss_pred eeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--HH-----HHHHH
Confidence 98765433 344567999999999874 245677889999999999999999999976532 11 22333
Q ss_pred HhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 255 EAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..++++ -..+...+.+...+++|.+||+.||.+|.|++|.+
T Consensus 241 meGkyq----F~speWadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 241 MEGKYQ----FRSPEWADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred Hhcccc----cCCcchhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 333332 11222344556799999999999999999999999
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=281.09 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=202.7
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
++..++|++.+.||+|+||.||+|.+.. +..+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3567899999999999999999998752 3678899876443 23345678899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAE---------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
...+++|||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 99999999999999999985321 2367888999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHH
Q 047716 173 KISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWA 250 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 250 (325)
+|+|||++........ .......++..|+|||.+ ....++.++||||||+++++|++ |..||........ ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~-- 232 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LK-- 232 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHH-hcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HH--
Confidence 9999999875433221 111122246789999988 45668899999999999999998 8899875433221 11
Q ss_pred HHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 251 HQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
....+.... .+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 233 --~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 --FVIDGGHLD-------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --HHhcCCCCC-------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111111 111224679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=281.44 Aligned_cols=241 Identities=24% Similarity=0.409 Sum_probs=188.9
Q ss_pred hhcCcCCceeEEEEEeCC--------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 39 EEIGRGGSGRVYKGCING--------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~--------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+.||.|+||.||+|.+.. ...+++|.+..........+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998752 223677776554444456688899999999999999999999988899999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc--------EEEeecccccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK--------AKISDFGLSKL 182 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~--------vkl~Dfg~~~~ 182 (325)
+++++|.+++......+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999966556789999999999999999999999 9999999999999977654 69999998765
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCC-CCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR-KNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
..... ...++..|+|||.+.....++.++||||||+++++|++|. .|+......... ... ..
T Consensus 158 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~-~~---- 220 (258)
T cd05078 158 VLPKE-----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFY-ED---- 220 (258)
T ss_pred cCCch-----hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHH-Hc----
Confidence 43221 1236788999999865566789999999999999999995 555433221110 000 00
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
....+......+.+++.+||+.+|++|||++++++.|+
T Consensus 221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111122356899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=291.07 Aligned_cols=238 Identities=26% Similarity=0.258 Sum_probs=186.9
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHH-HHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEM-KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. ++..+++|++.... ......+..|. .+++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999987 68899999986532 12223444444 457788999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|...+. ....+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (325)
T cd05604 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT 155 (325)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence 99988874 456799999999999999999999999 999999999999999999999999999864322111 1222
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..++..|+|||.+ .+..++.++||||||+++++|++|..||......+.. ...... .....+..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-------~~~~~~--------~~~~~~~~ 219 (325)
T cd05604 156 FCGTPEYLAPEVI-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-------DNILHK--------PLVLRPGA 219 (325)
T ss_pred ccCChhhCCHHHH-cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-------HHHHcC--------CccCCCCC
Confidence 3478999999998 5667788999999999999999999999765322111 111111 11112223
Q ss_pred HHHHHHHHhhcccCCCCCCCCHhH
Q 047716 274 FENLVKIGLWCVECELNLRPTMKQ 297 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~e 297 (325)
...+.+++.+|++.+|.+||++.+
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCC
Confidence 456889999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=286.79 Aligned_cols=243 Identities=23% Similarity=0.265 Sum_probs=190.8
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+. ++..+|+|++..... .....+..|..++..+ +||+|+.+++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999987 678899999875322 2334577889988888 599999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++. ..+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~L~~~~~-~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 81 GDLMFHMQ-RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 99998874 345799999999999999999999999 99999999999999999999999999886432211 11223
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ .+..++.++||||||+++++|++|+.||.............+......... ...+...
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~p~~~ 226 (327)
T cd05617 156 FCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IRIPRFL 226 (327)
T ss_pred ccCCcccCCHHHH-CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CCCCCCC
Confidence 4489999999998 566788999999999999999999999975433322221222222222111 1122223
Q ss_pred HHHHHHHHhhcccCCCCCCCCH
Q 047716 274 FENLVKIGLWCVECELNLRPTM 295 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~ 295 (325)
...+.+++.+||+.||++|+++
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCC
Confidence 3568899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.20 Aligned_cols=269 Identities=21% Similarity=0.300 Sum_probs=205.5
Q ss_pred cccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeec
Q 047716 24 SFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE 100 (325)
Q Consensus 24 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (325)
.|..++....+|+++++||.|+||.||+|.+. .+..+++|.+... .......+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 45566777889999999999999999999987 5667778877542 23344568889999999999999999998744
Q ss_pred --CCceEEEEeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccC----CCCeeeccCCCCceEEcC---
Q 047716 101 --GSNRLLVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDEC----ETRIIHCDIKPHNILMDE--- 168 (325)
Q Consensus 101 --~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~----~~~i~h~di~p~nilv~~--- 168 (325)
...++|||||+++++|.+++... .+.+++..++.++.||+.||.|||+.. ..+|+|+||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 45689999999999999988542 356999999999999999999999851 025999999999999964
Q ss_pred --------------CCcEEEeeccccccccCCCccceeeecCCCCcCCcccccc-CCCCCccccchhHHHHHHHHHhCCC
Q 047716 169 --------------SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR-NNRITVKADVYSFGVMLLEIVCCRK 233 (325)
Q Consensus 169 --------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~ 233 (325)
.+.++|+|||++......... ....+++.|+|||.+.. ...++.++|||||||++|+|++|..
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~--~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccc--cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 234899999998765432221 22347999999998743 3457889999999999999999999
Q ss_pred CCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCC
Q 047716 234 NVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPP 308 (325)
Q Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~ 308 (325)
||......... + ..+.... ..........+.+||..||+.+|.+||++.|++ ..+..+.++
T Consensus 242 PF~~~~~~~ql--i----~~lk~~p--------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 242 PFHKANNFSQL--I----SELKRGP--------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCCcCCcHHHH--H----HHHhcCC--------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 99754322111 1 1111111 000111235699999999999999999999999 667666543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=274.13 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=197.6
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCHH
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLG 117 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (325)
++||.|++|.||+|.+..++.+++|.+...... ....+.+|+.+++.++||||+++++++......+++|||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877899999988764433 4557889999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce-eeecC
Q 047716 118 NLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY-TVLRG 196 (325)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~-~~~~~ 196 (325)
+++......++...+..++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+........... .....
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99866556789999999999999999999999 999999999999999999999999999875432211111 11113
Q ss_pred CCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHH
Q 047716 197 TRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFE 275 (325)
Q Consensus 197 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
+..|+|||.+ ....++.++|+||||+++++|++ |..||.......... ...... ....+...+.
T Consensus 158 ~~~y~~PE~~-~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~-------~~~~~~-------~~~~~~~~~~ 222 (251)
T cd05041 158 PIKWTAPEAL-NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-------RIESGY-------RMPAPQLCPE 222 (251)
T ss_pred eeccCChHhh-ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH-------HHhcCC-------CCCCCccCCH
Confidence 4569999988 45668899999999999999999 788886554322111 111100 0111122345
Q ss_pred HHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 276 NLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 276 ~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
.+.+++.+||+.+|++|||++|+++.|+.
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 79999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=275.73 Aligned_cols=246 Identities=26% Similarity=0.384 Sum_probs=193.2
Q ss_pred hcCcCCceeEEEEEeC---CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 40 EIGRGGSGRVYKGCIN---GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+||+|+||.||+|.+. .+..+++|++.... ......+..|+.+++.++||||+++++++.. ...+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 57788999875432 2234568889999999999999999998754 5678999999999
Q ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce--e
Q 047716 115 SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY--T 192 (325)
Q Consensus 115 ~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~--~ 192 (325)
+|.+++. ....+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++++|||++........... .
T Consensus 81 ~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999984 345789999999999999999999999 999999999999999999999999999876543322111 1
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
...++..|+|||.+ ....++.++|+||||+++++|++ |..||......+.. ........ .+.+.
T Consensus 157 ~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~i~~~~~-------~~~~~ 221 (257)
T cd05116 157 HGKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-------QMIESGER-------MECPQ 221 (257)
T ss_pred CCCCCccccCHhHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHCCCC-------CCCCC
Confidence 11134689999988 45667889999999999999998 99999765332211 11111111 11222
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
..+..+.++|.+||+.+|++||++.+|.+.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=276.56 Aligned_cols=251 Identities=28% Similarity=0.394 Sum_probs=198.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEe-ecCCceEEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFC-SEGSNRLLVY 108 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 108 (325)
+...+|++.+.||+|++|.||++... +..+++|.+.... ....+..|+.+++.++|+|++++++++ ..++..++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999775 6778888875432 345688899999999999999999875 4556789999
Q ss_pred eecCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRAEQ-RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+++++|.+++..... .+++..+..++.|++.++.+||++ |++|+||+|+||+++.++.++++|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999999855433 488999999999999999999999 99999999999999999999999999886543222
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
. ....+..|+|||.+ ....++.++||||||+++++|++ |+.||......+. . .....+. .
T Consensus 157 ~----~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~----~~~~~~~-------~ 217 (256)
T cd05082 157 D----TGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKGY-------K 217 (256)
T ss_pred C----CCccceeecCHHHH-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHhcCC-------C
Confidence 1 11245679999998 56678889999999999999997 8999865432111 1 1111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.70 Aligned_cols=237 Identities=23% Similarity=0.246 Sum_probs=186.0
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHH-HHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEM-KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|++. ++..+++|++..... .....+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 678899998865321 2223344444 467889999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|...+. ....+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05603 81 GELFFHLQ-RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST 155 (321)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence 99988874 346788999999999999999999999 999999999999999999999999998864322211 1222
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ ....++.++|||||||++++|++|..||........ . .... ......++..
T Consensus 156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~-~~i~--------~~~~~~~~~~ 219 (321)
T cd05603 156 FCGTPEYLAPEVL-RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------Y-DNIL--------HKPLQLPGGK 219 (321)
T ss_pred ccCCcccCCHHHh-cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------H-HHHh--------cCCCCCCCCC
Confidence 3478999999998 566788899999999999999999999976532111 0 1111 1112222233
Q ss_pred HHHHHHHHhhcccCCCCCCCCHh
Q 047716 274 FENLVKIGLWCVECELNLRPTMK 296 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~ 296 (325)
...+.+++.+||+.+|.+||++.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCC
Confidence 45789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=276.13 Aligned_cols=248 Identities=29% Similarity=0.413 Sum_probs=194.7
Q ss_pred hhcCcCCceeEEEEEeC-CC---cEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GG---KEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~---~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
++||+|+||.||+|.+. .+ ..+++|.+..... .....+..|+.+++.+.||||+++++++. ....+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999865 22 6788998865443 34556888999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.............
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999543 4789999999999999999999999 99999999999999999999999999987654332211111
Q ss_pred --ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 194 --LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 194 --~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
..++..|+|||.+ ....++.++||||||+++++|++ |.+||......+. ... ..... ....+
T Consensus 156 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~----~~~~~-------~~~~~ 220 (257)
T cd05060 156 TAGRWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAM----LESGE-------RLPRP 220 (257)
T ss_pred cCccccccccCHHHh-cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHH----HHcCC-------cCCCC
Confidence 1123579999988 56678899999999999999998 9999976533211 111 11111 01112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 223457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=282.79 Aligned_cols=267 Identities=26% Similarity=0.380 Sum_probs=198.3
Q ss_pred HHH-hhhhhcCcCCceeEEEEEe-----CCCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--Cc
Q 047716 33 ASE-NFKEEIGRGGSGRVYKGCI-----NGGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SN 103 (325)
Q Consensus 33 ~~y-~~~~~lg~g~~g~v~~~~~-----~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 103 (325)
++| ++.+.||+|+||.||++.. ..+..+++|.+.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 8999999999999988653 257788999886543 23345678899999999999999999987553 45
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++|||+.+++|.+++.. ..+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 7899999999999999843 4699999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCccc--eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 184 KTDQTRT--YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
....... .....++..|+|||.+ ....++.++||||||+++++|++|..|+......-.. .............+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECL-KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHh-cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhhh
Confidence 4322111 1111245569999988 4566789999999999999999999998653321100 0000000000000000
Q ss_pred cccC--CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 262 LVSD--QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 262 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.... ....+...+..+.+++.+||+.+|++|||+++++++|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000 01112233467999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=297.46 Aligned_cols=244 Identities=28% Similarity=0.367 Sum_probs=208.9
Q ss_pred hcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCHHH
Q 047716 40 EIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGN 118 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 118 (325)
+||+|.||+||-|++. ....+|+|.+........+.+.+|+.+=++|+|.|||+++|.+.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5999999999999998 466788999987777777889999999999999999999999999999999999999999999
Q ss_pred HHhhccCCC--CHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc-CCCcEEEeeccccccccCCCccceeeec
Q 047716 119 LLFRAEQRL--SWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRTYTVLR 195 (325)
Q Consensus 119 ~~~~~~~~~--~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 195 (325)
++...-+++ .+..+-.+.+||++|+.|||++ .|+|||||-+||+|+ -.|.+||+|||.+.+...-++- .....
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-TETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc-ccccc
Confidence 998777777 8889999999999999999999 999999999999995 5678999999998876543332 12233
Q ss_pred CCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHH
Q 047716 196 GTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF 274 (325)
Q Consensus 196 ~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (325)
||..|||||++..+ ..|..++|||||||.+.||.||++||-........+ +. ....+-.++++.+..
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------Fk----VGmyKvHP~iPeels 805 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FK----VGMYKVHPPIPEELS 805 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hh----hcceecCCCCcHHHH
Confidence 89999999998654 568899999999999999999999997655433222 11 122344577888889
Q ss_pred HHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 275 ENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 275 ~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
++.+.+|.+|+.++|.+||++++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhc
Confidence 9999999999999999999999999
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.65 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=205.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.+|++.+.||.|++|.||+|.+. +++.+++|.+..........+.+|+..++.++|||++++++.+......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 56889999999999999999875 78899999887655555667889999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++.. ..+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence 99999998843 4689999999999999999999999 9999999999999999999999999988754433221 1
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
....++..|+|||.+ ....++.++|+||||+++++|++|+.||........... ..... . .......
T Consensus 173 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~-------~~~~~-~----~~~~~~~ 239 (296)
T cd06655 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNG-T----PELQNPE 239 (296)
T ss_pred CCcCCCccccCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcC-C----cccCCcc
Confidence 122367899999998 456678899999999999999999999977544222110 11000 0 0111122
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
.....+.++|.+||..+|.+|||+.+++ ..++...
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 2335688999999999999999999999 5555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=278.36 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=197.2
Q ss_pred HhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc-----
Q 047716 35 ENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN----- 103 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 103 (325)
|++.+.||+|+||.||.|.... +..+++|.+.... ......+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5688999999999999998752 3678999876432 2334568889999999999999999998755443
Q ss_pred -eEEEEeecCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeec
Q 047716 104 -RLLVYEFMRNGSLGNLLFRA-----EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDF 177 (325)
Q Consensus 104 -~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Df 177 (325)
.++++||+++++|.+++... ...+++..++.++.|++.|+.|||++ +++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 79999999999999887432 23589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHH
Q 047716 178 GLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 178 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
|++......... .......+..|+|||.+ ....++.++||||||+++++|++ |..||......+. .+ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~----~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YD----YLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHH
Confidence 998765432221 11112245679999998 56778899999999999999999 8888865432211 11 111
Q ss_pred hCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 256 AGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.+.. ...+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 230 ~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR-------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC-------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 111223446799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=275.35 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=194.0
Q ss_pred hcCcCCceeEEEEEeC---CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCC
Q 047716 40 EIGRGGSGRVYKGCIN---GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGS 115 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 115 (325)
.||+|+||.||+|.+. .+..+++|.+..... .....+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 345688888765432 234568899999999999999999998754 57899999999999
Q ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce--ee
Q 047716 116 LGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY--TV 193 (325)
Q Consensus 116 L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~--~~ 193 (325)
|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++++|||++........... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999865566799999999999999999999999 999999999999999999999999999875543322111 11
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
..++..|+|||.+ ....++.++||||||+++++|++ |..||......+.. .....+. ....+..
T Consensus 158 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~-------~~~~~~~ 222 (257)
T cd05115 158 GKWPLKWYAPECI-NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGK-------RLDCPAE 222 (257)
T ss_pred CCCCcccCCHHHH-ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCC-------CCCCCCC
Confidence 1134679999988 45567889999999999999996 99999765432211 1111111 1112223
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 273 EFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
...++.+++..||+.+|++||++.+|++.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=284.45 Aligned_cols=259 Identities=23% Similarity=0.333 Sum_probs=195.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+|++.+.||+|+||.||++.+. .+..+++|.+.... ......+.+|+++++.++||||+++++.+..++..+++|||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5889999999999999999987 56677777765432 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++++|.+++.+ .+.+++..+..++.|++.|+.|||+ . +++|+||+|+||+++.++.++++|||++........
T Consensus 82 ~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (308)
T cd06615 82 DGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 155 (308)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccccc--
Confidence 99999999854 3678999999999999999999997 5 899999999999999999999999998765432211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC-------------
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG------------- 257 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 257 (325)
....++..|+|||.+ .+..++.++|+||||+++++|++|+.||......................
T Consensus 156 -~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 156 -NSFVGTRSYMSPERL-QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred -ccCCCCcCccChhHh-cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 122368899999998 45668889999999999999999999996543221111000000000000
Q ss_pred --------cccccccCC-CCC-CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 258 --------ELQNLVSDQ-EDV-NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 258 --------~~~~~~~~~-~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
......... +.. .......+.+++.+||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 000 0113456999999999999999999999993
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=279.90 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=202.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCc----EEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGK----EIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~----~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+...+|++.++||+|+||.||+|++. ++. .+++|.+... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 45678999999999999999999875 333 4788887643 23345568889999999999999999998865 45
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++++|+++++|.+++....+.+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 7899999999999999866566799999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 184 KTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
....... .....++..|+|||.. ....++.++||||||+++++|++ |..||......... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~--- 228 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESI-LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-------DLLEKGE--- 228 (279)
T ss_pred ccccceeecCCCccchhhCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCC---
Confidence 4322211 1111245679999998 45668889999999999999998 88998654322111 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...........+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01112233457899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=280.69 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=199.1
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-----------------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-----------------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLV 92 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-----------------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv 92 (325)
..++|++.++||+|+||.||++.+. +...+++|.+.... ......+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4578999999999999999998543 23457888876532 33346788999999999999999
Q ss_pred eeeEEeecCCceEEEEeecCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE----------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
++++++..+...+++|||+++++|.+++.... ..+++..+..++.|++.|+++||+. |++|+||+|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 99999999899999999999999999885432 2367788999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh--CCCCCCCcc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC--CRKNVDESL 239 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~ 239 (325)
||+++.++.++++|||++.......... ......+..|++||.. ....++.++|+||||+++++|++ |..||....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI-LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH-hcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999987553322111 1111235679999987 44568899999999999999998 667876543
Q ss_pred ccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 240 RDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
..+. +................ ..+..+...+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 239 ~~~~---~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 239 DEQV---IENTGEFFRDQGRQVYL----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hHHH---HHHHHHHHhhccccccC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2221 11111111111111111 1112233679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.95 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=199.3
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCC-----
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS----- 102 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 102 (325)
...+|++.+.||+|+||.||+|.+. ++..+|+|.+... .......+..|+..+..++|+|++++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3469999999999999999999876 6889999998653 2334456778999999999999999987664322
Q ss_pred ---ceEEEEeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEee
Q 047716 103 ---NRLLVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISD 176 (325)
Q Consensus 103 ---~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~D 176 (325)
.+++||||+++++|.+++... ...+++..++.++.|++.|+.|||++ +++|+||||+||+++.++.++|+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999988532 34689999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH
Q 047716 177 FGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 177 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
||++........ .......|++.|+|||.+ ....++.++||||||+++|+|++|+.||......+. ... ..
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~-~~ 258 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIW-RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHK-TL 258 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHH-Hh
Confidence 999876543221 112234588999999998 566788999999999999999999999976532211 111 11
Q ss_pred hCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 256 AGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+... ..+......+.+++.+||+.+|.+||++.+++.
T Consensus 259 ~~~~~-------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 259 AGRYD-------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred cCCCC-------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 11111 122233467999999999999999999999984
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.39 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=205.2
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC--------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEe
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN--------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFC 98 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 98 (325)
++...+|++.+.||+|+||.||.|++. .+..+++|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 466789999999999999999999742 23468888876432 33456688999999999 799999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
......+++|||+++++|.+++.... ..++...+..++.|++.|+.|||++ |++|+||+|+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 99899999999999999999985431 2477888999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
|+++.++.++|+|||++.......... .....++..|+|||.+ .+..++.++||||||+++++|++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999999999987654332211 1112245679999988 45668889999999999999998 77888654322
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
+.. .....+.. ..........+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 247 ~~~-------~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 ELF-------KLLKEGHR-------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHH-------HHHHcCCc-------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111 11111110 011123346799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=277.69 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=193.9
Q ss_pred hhhhhcCcCCceeEEEEEeCCCc---EEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecC------Cce
Q 047716 36 NFKEEIGRGGSGRVYKGCINGGK---EIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------SNR 104 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~~~~---~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~ 104 (325)
.+.+.||+|+||.||+|.+..+. .+++|.+... .......+..|+.+++.++||||+++++.+... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 46789999999999999987433 5788877543 234456688899999999999999999976322 246
Q ss_pred EEEEeecCCCCHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 105 LLVYEFMRNGSLGNLLFR-----AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
+++|||+.+++|.+++.. ....+++..+..++.|++.|++|||++ +++|+||||+||+++.++.++++|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999987632 223478999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 180 SKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 180 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
+......... .......++.|++||.+ ....++.++||||||+++++|++ |+.||........ . .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~----~~~~~~ 230 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---Y----DYLRQG 230 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHc-cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHHcC
Confidence 8765432211 11122356689999998 56678899999999999999999 7888875432211 1 111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
... .........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 231 ~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL-------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 11122345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=280.46 Aligned_cols=240 Identities=23% Similarity=0.360 Sum_probs=187.6
Q ss_pred hcCcCCceeEEEEEeCC-------------------------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCccee
Q 047716 40 EIGRGGSGRVYKGCING-------------------------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDL 94 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~-------------------------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 94 (325)
+||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23477777755444444567889999999999999999
Q ss_pred eEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC----
Q 047716 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---- 170 (325)
Q Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---- 170 (325)
++++......++||||+++++|..++....+.+++..+..++.|++.|+.|||++ +++|+||+|+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999998999999999999999999866567789999999999999999999999 999999999999997543
Q ss_pred ---cEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHH-HhCCCCCCCccccchhhH
Q 047716 171 ---KAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI-VCCRKNVDESLRDDEIVL 246 (325)
Q Consensus 171 ---~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l-l~g~~p~~~~~~~~~~~~ 246 (325)
.++++|||.+........ ..++..|+|||.+.....++.++||||||+++++| ++|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~- 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSREE-----RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER- 232 (274)
T ss_pred ccceeeecCCccccccccccc-----cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-
Confidence 389999998754322211 12577899999885556788999999999999998 47899987654322111
Q ss_pred HHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 247 IDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
..... ...+......+.++|.+||+.+|++|||+.++++.|.
T Consensus 233 ------~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 ------FYEKK---------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ------HHHhc---------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11100 0001111246899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=287.52 Aligned_cols=255 Identities=22% Similarity=0.239 Sum_probs=196.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.++||+|+||.||++.+. .+..+++|.+.+.. ......+..|+.++..++|++|+++++.+.+....++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 6889999999999999999987 57778899886422 2223347789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++.+....+++..++.++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999966567799999999999999999999999 9999999999999999999999999998654333222
Q ss_pred ceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 190 TYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
......|++.|+|||.+.. ...++.++||||||+++++|++|+.||......+... ..........+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~~~--- 229 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKERFQF--- 229 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCCccccC---
Confidence 2223348999999998842 3457889999999999999999999997653322111 11111000000
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCC--CCCCHhHHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELN--LRPTMKQVIWM 301 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~--~Rps~~ell~~ 301 (325)
+.........+.+++.+|+..++. .|++++|+++.
T Consensus 230 -p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111122345688999998865444 46899999843
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=281.41 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=199.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
+|++.+.||+|+||.||+|.+. ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3778899999999999999864 23457777775433 2334568889999999999999999999998899999
Q ss_pred EEeecCCCCHHHHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 107 VYEFMRNGSLGNLLFRAE-----------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
++||+.+++|.+++.... ..+++..++.++.|++.|+.+||+. +++|+||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999874321 2478889999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
|++++++.++|+|||++......... ......++..|+|||.+ .+..++.++||||||+++++|++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999998754322211 11112245689999988 56678899999999999999998 99998754322
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.. .. ..... .. ...+......+.+++.+||+.+|.+||++.|+++.|+++..
T Consensus 237 ~~---~~----~~~~~-~~------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RL---FN----LLKTG-YR------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH---HH----HHhCC-CC------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 11 11111 00 11112233579999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=278.11 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=199.7
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++|++.+.||.|++|.||+|.+. ++..+++|.+.... ......+.+|+.+++.++|||++++.+.+.++...++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36899999999999999999987 67889999876533 33445678899999999999999999999988999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++.. ..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 81 CGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred eCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 999999999843 3789999999999999999999999 9999999999999999999999999998766543221
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....++..|+|||.+ .+..++.++||||||+++++|++|+.||......... ........ ....
T Consensus 155 ~~~~~~~~~y~~PE~~-~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-------~~~~~~~~-------~~~~ 219 (274)
T cd06609 155 RNTFVGTPFWMAPEVI-KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-------FLIPKNNP-------PSLE 219 (274)
T ss_pred cccccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-------HHhhhcCC-------CCCc
Confidence 1122367789999998 4555899999999999999999999999765422111 01111100 1111
Q ss_pred HH-HHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 271 IE-EFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 271 ~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.. ....+.+++.+||+.+|++|||++++++
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 4456999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=293.10 Aligned_cols=274 Identities=26% Similarity=0.365 Sum_probs=229.7
Q ss_pred CccccccccccccHHH-----HHHHHHhhhhhcCcCCceeEEEEEeCC---Cc--EEEEEEeecc-chhcHHHHHHHHHH
Q 047716 14 PDVFEEIKLRSFSYEQ-----IVLASENFKEEIGRGGSGRVYKGCING---GK--EIAVKKLIKI-VEEGESEFRNEMKI 82 (325)
Q Consensus 14 ~~~~~~~~~~~~~~~~-----~~~~~y~~~~~lg~g~~g~v~~~~~~~---~~--~~~vk~~~~~-~~~~~~~~~~e~~~ 82 (325)
.++|.++.-++|+-+. +......+.++||.|-||.||.|...+ |+ .||||..+.+ ...+.+.|..|..+
T Consensus 365 tDdYAEI~dety~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~i 444 (974)
T KOG4257|consen 365 TDDYAEIGDETYSTPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASI 444 (974)
T ss_pred cchhhhcccccccCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHH
Confidence 3566666666665543 456666778899999999999998652 33 4677776653 34456779999999
Q ss_pred HhccCCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 83 IGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
++++.||||++++|++.+ ...+||||.++.|.|..+++.....++...+..++.|++.|++|||+. .++||||...
T Consensus 445 MrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaR 520 (974)
T KOG4257|consen 445 MRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAAR 520 (974)
T ss_pred HHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhh
Confidence 999999999999999976 588999999999999999988888899999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHH-hCCCCCCCcccc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV-CCRKNVDESLRD 241 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~ 241 (325)
||||.+...|||+|||+++...............+.-|+|||.+ +-..++.++|||.||+++||++ .|..||++....
T Consensus 521 NiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 521 NILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred heeecCcceeeecccchhhhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence 99999999999999999998887777666655567789999999 7888999999999999999986 588999987765
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
+....+ -..++++.++.++..|..++.+||..+|.+||.+.|+...|..+.
T Consensus 600 DVI~~i--------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 600 DVIGHI--------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ceEEEe--------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 543211 123456678888899999999999999999999999997777665
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=278.44 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=201.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCC-----------------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCING-----------------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLV 92 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----------------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv 92 (325)
...+|++.+.||+|+||.||+|.+.. +..+++|.+.... ......+..|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 35789999999999999999988652 2457888876543 23455688899999999999999
Q ss_pred eeeEEeecCCceEEEEeecCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE----------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
++++++..+...+++||++.+++|.+++.... ..+++..++.++.|++.|+.+||+. +++|+||+|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 99999998899999999999999999985443 2689999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh--CCCCCCCcc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC--CRKNVDESL 239 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~p~~~~~ 239 (325)
||+++.++.++++|||++........ .......++..|+|||.+ ....++.++||||||+++++|++ +..||....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV-LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh-hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999999999999865432221 111122246789999998 45568899999999999999998 667776543
Q ss_pred ccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 240 RDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
..+ ........+......... ......+.++.+++.+||+.+|.+|||+.||++.|+.
T Consensus 239 ~~~---~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQ---VIENAGHFFRDDGRQIYL----PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHH---HHHHHHhccccccccccC----CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 221 111111111111111111 1122234679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=286.43 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=196.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC------C
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------S 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 102 (325)
..+|++.+.||.|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 578999999999999999999886 67889999886532 22334577899999999999999999877432 4
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..+++++++ +++|.+++. ...+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++..
T Consensus 94 ~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcccee
Confidence 568999988 778988773 35699999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHH
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCY 254 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~ 254 (325)
..... ....++..|+|||.+.+...++.++||||||+++++|++|+.||......+....+... ....
T Consensus 168 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 168 ADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred cCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 54322 12237889999999865567889999999999999999999999764332211110000 0000
Q ss_pred HhCcccccccCCCCCCH--------HHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 255 EAGELQNLVSDQEDVNI--------EEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 255 ~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
...............+. .....+.+++.+||+.||.+|||+.|++ ..+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 00000000000000000 1123578999999999999999999999 3444443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.63 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=203.7
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCC--------CcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEe
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCING--------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFC 98 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~--------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 98 (325)
++...+|.+.+.||+|+||.||+|.+.. ...+++|.+.... ......+..|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4556889999999999999999997632 2468888886532 33445677899999999 799999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
...+..++||||+++++|.+++.... ..+++..++.++.|++.|++|||+. |++|+||+|+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 99999999999999999999985432 2478889999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
|+++.++.++|+|||.+.......... .....++..|+|||.+ .+..++.++|+||||+++++|++ |..||......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh-ccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999999999999999987553221111 1111134679999988 45667899999999999999998 88888654321
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
+. ......... .+.+......+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 250 ~~-------~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 EL-------FKLLKEGHR-------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HH-------HHHHHcCCC-------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11 111111111 111222345789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=281.21 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=201.0
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
++...+|++.++||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 355789999999999999999998754 24578898875432 22334577899999999999999999999888
Q ss_pred CceEEEEeecCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAE---------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
...+++|||+++++|.+++.... ...+...+..++.|++.|+.|||++ +++|+||+|+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 89999999999999999985422 2346678899999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHH
Q 047716 173 KISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWA 250 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 250 (325)
+++|||++.......... .....++..|+|||.+ ....++.++|+||||+++++|++ |..||......+..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~-~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~------ 231 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL------ 231 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHh-ccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------
Confidence 999999887543222111 1111245679999998 45667889999999999999998 78888754332211
Q ss_pred HHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 251 HQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.....+.... .+......+.+++.+||+.+|++|||+.++++.|++..
T Consensus 232 -~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 -KFVMDGGYLD-------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -HHHHcCCCCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111111111 11122357999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.89 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=204.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-----CCcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeec--CCc
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-----GGKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSE--GSN 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 103 (325)
...|++.+.||+|+||.||+|.+. .+..+++|.+...... ....+.+|+..++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 457889999999999999999864 3678999988764443 45678899999999999999999999877 557
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++|||+++++|.+++......+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++.++++|||.+...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 8999999999999999966555799999999999999999999999 9999999999999999999999999998766
Q ss_pred cCCCccce--eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh--------hHHHHHHHH
Q 047716 184 KTDQTRTY--TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI--------VLIDWAHQC 253 (325)
Q Consensus 184 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~ 253 (325)
........ ....++..|++||.+ ....++.++|+||||+++++|++|..|+......... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECL-RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHH-ccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 42221111 111235569999988 4567788999999999999999999998654322110 001111111
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
...+. .......+..++.+++.+||+.+|++|||+.||+++|+.+
T Consensus 239 ~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE-------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC-------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 0111122336799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=274.52 Aligned_cols=249 Identities=31% Similarity=0.483 Sum_probs=199.2
Q ss_pred hhhhhcCcCCceeEEEEEeCC-----CcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 36 NFKEEIGRGGSGRVYKGCING-----GKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~~-----~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++.+.||.|+||.||++.+.. +..+++|++...... ....+..|+..++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 577899999999999999873 377899988654433 45678899999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
++++++|.+++...... +++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999998554433 89999999999999999999999 999999999999999999999999999876554322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......++..|+|||.+ ....++.++|+||||+++++|++ |.+||......... ........ .
T Consensus 159 ~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~-------~ 223 (258)
T smart00219 159 YKKKGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL-------EYLKKGYR-------L 223 (258)
T ss_pred cccccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCCC-------C
Confidence 111112256789999988 56778899999999999999998 78888763222111 11111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMM 302 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 302 (325)
......+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11122456799999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=287.62 Aligned_cols=241 Identities=23% Similarity=0.251 Sum_probs=190.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 108 (325)
+|++.+.||+|+||.||+|.+. ++..+|+|++.... ......+..|..+++.+. |++|+++++.+...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4678899999999999999987 68889999887532 223345667888888886 567888999998888999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+++. ..+.+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........
T Consensus 81 Ey~~~g~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQ-QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 9999999999884 345799999999999999999999999 999999999999999999999999998864322211
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
......+++.|+|||.+ ....++.++|+||||+++++|++|+.||......... ....... ..
T Consensus 157 -~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-------~~i~~~~--------~~ 219 (323)
T cd05615 157 -TTRTFCGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF-------QSIMEHN--------VS 219 (323)
T ss_pred -cccCccCCccccCHHHH-cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC--------CC
Confidence 11223478999999998 4566889999999999999999999999865432111 1111111 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTM 295 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~ 295 (325)
.+......+.+++.+||+.+|.+|++.
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 122234568999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=277.13 Aligned_cols=257 Identities=24% Similarity=0.288 Sum_probs=214.7
Q ss_pred ccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 23 RSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 23 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
..-++......-|.+.++||+|+||.||+|.++ +|..+|+|++.. ..+.+++.+|+.++++...|++|++|+.+...
T Consensus 23 d~~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~ 100 (502)
T KOG0574|consen 23 DSSALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH 100 (502)
T ss_pred ChhhhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccC
Confidence 334455566778999999999999999999887 788889998754 56778899999999999999999999999899
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
..++||||||..|++.+.+....+++++.++..+++..+.+|+|||.. .-+|||||+.|||++.+|..||.|||.+.
T Consensus 101 sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 101 SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccc
Confidence 999999999999999999988889999999999999999999999998 88999999999999999999999999987
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
...... .....+.||+.|+|||++ ..-.|+.++||||||+...||..|++|+....+-...+ .-
T Consensus 178 QLTDTM-AKRNTVIGTPFWMAPEVI-~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------------MI 241 (502)
T KOG0574|consen 178 QLTDTM-AKRNTVIGTPFWMAPEVI-EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------------MI 241 (502)
T ss_pred hhhhhH-HhhCccccCcccccHHHH-HHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------------ec
Confidence 654433 233345599999999999 56677889999999999999999999997654422111 00
Q ss_pred cccCCCCC--CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 LVSDQEDV--NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
-..+++.. +..-+.++.+++++||-.+|++|.|+.++++
T Consensus 242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 01111111 2334567999999999999999999999883
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=279.38 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=203.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC-----CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeec-CC
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING-----GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-GS 102 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 102 (325)
+...+|++.+.||+|+||.||+|.+.. +..+++|++.... ......+.+|+.+++.++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456889999999999999999999875 6778888876432 3334567889999999999999999998755 56
Q ss_pred ceEEEEeecCCCCHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEe
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAE-------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~ 175 (325)
..+++++|+++++|.+++.... ..+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 7899999999999999885432 4588999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHH
Q 047716 176 DFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQC 253 (325)
Q Consensus 176 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 253 (325)
|||++..+....... .....++..|+|||.+ ....++.++||||||++++++++ |+.||......+ ...+
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~---- 231 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESL-VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY---- 231 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHH-hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH----
Confidence 999987553322111 1112245679999988 45668899999999999999998 999997643221 1111
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+ . ........+.++.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 232 ~~~~-~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 232 LKDG-Y------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHcC-C------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111 0 01111223456899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=270.49 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=204.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEee--ccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLI--KIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
+...+|.+.+.||+|.|+.|+++... .|..+++|++. +.+..+.+.+.+|+++-+.|+||||+++.+.+.+.+..++
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 45678999999999999999998766 68888888774 3455678889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCcEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWKAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~vkl~Dfg~~~~~ 183 (325)
|+|.+.|+.|-.-+-+. --+++..+.-+++||++++.|+|.+ +|+|+|+||.|+++.+ ..-+||+|||++...
T Consensus 88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999886443222 3478888899999999999999999 9999999999999943 345999999999887
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
+ .........|+|.|+|||++ +...++..+|||+.|+++|-||.|.+||-+....... +.+..+.+.
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvv-rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly-------e~I~~g~yd--- 230 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-------EQIKAGAYD--- 230 (355)
T ss_pred C--CccccccccCCCcccCHHHh-hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-------HHHhccccC---
Confidence 7 33334445599999999999 6778889999999999999999999999875433222 222222222
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
-.....+...++.++|+.+||..||.+|.|+.|.+
T Consensus 231 -~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 231 -YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 11112223446799999999999999999999988
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.13 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=203.2
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
.+...+|.+.+.||+|+||.||+|.+. .+..+++|.+.... ......+.+|+.+++++ +||||+++++.+..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 466789999999999999999999752 34578888876543 23345688899999999 79999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
.+..+++|||+.+++|.+++.... ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 899999999999999999985433 3389999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 180 SKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 180 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
+......... ......++..|+|||.+ ....++.++||||||+++++|++ |..||......+.. . .....+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~----~~~~~~ 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--Y----KLIKEG 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhh-ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--H----HHHHcC
Confidence 8755432211 11112245789999988 45667889999999999999998 99998754332211 0 111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.. ..........+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 261 -~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -YR------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -Cc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 10 001112235699999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=282.37 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=190.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhcc---CCCCcceeeEEeec-----CC
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRI---HHKNLVDLVGFCSE-----GS 102 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~ 102 (325)
+|++.+.||+|++|.||+|.+. .++.+++|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999987 678899998764321 2223455667666655 69999999998754 24
Q ss_pred ceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
..+++||++. ++|.+++... ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999996 4788877543 34589999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC---c
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG---E 258 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 258 (325)
....... .....++..|+|||.+ .+..++.++||||||+++++|++|++||......+....+ ....... .
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~ 230 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVL-LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI---FDLIGLPPEDD 230 (288)
T ss_pred cccCccc--CCCccccccccCchHh-hCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH---HHHhCCCChhh
Confidence 6543221 1122368899999998 4566889999999999999999999999765433221111 0100000 0
Q ss_pred ccc-------cccCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQN-------LVSDQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~-------~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+.. ..... ....+.....+.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000 0111233466899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=283.08 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=203.0
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC--------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEe
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN--------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFC 98 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 98 (325)
++...+|.+.++||+|++|.||+|+.. ....+++|.+.... ......+..|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 345678999999999999999999752 24567888876432 23345678899999999 599999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
...+..+++|||+++++|.+++.... ..+++..+..++.|++.|+.|||++ |++|+||+|+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 88889999999999999999985432 3478889999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
|+++.++.++|+|||.+.......... .....++..|+|||.+ ....++.++||||||+++++|++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHH-ccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999987654322111 1111134579999998 45678899999999999999999 88888654322
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
+.. ........ ..........+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 244 ~~~-------~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 ELF-------KLLREGHR-------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHH-------HHHHcCCC-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111 11111111 11122334568899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=288.28 Aligned_cols=254 Identities=21% Similarity=0.228 Sum_probs=197.3
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||++.+. .++.+|+|.+.... ......+.+|..++..++|++|+.+++.+.+.+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6889999999999999999987 67788999886522 2233447789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++......+++..+..++.|++.|+.+||++ +++|+||||+||+++.++.++|+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999966567789999999999999999999999 9999999999999999999999999998765443332
Q ss_pred ceeeecCCCCcCCccccccC----CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 190 TYTVLRGTRGYTAPELHSRN----NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
......+++.|+|||.+... ..++.++|+||||+++|+|++|+.||......+... .......-..+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~~~--- 229 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEERFQF--- 229 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCCcccC---
Confidence 22334589999999988432 456789999999999999999999997643321111 11110000000
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCC--CCCHhHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNL--RPTMKQVIW 300 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~ell~ 300 (325)
+......++++.+++.+|++..++. |++++++++
T Consensus 230 -p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 230 -PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1111123467899999999866544 468888873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=274.36 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=201.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||.|++|.|+.++.. ++..+++|.+... .......+.+|+.+++.++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4888999999999999999876 6888899987643 234455688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 111 MRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
+++++|.+++... ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999998654 45689999999999999999999999 999999999999999999999999999876543331
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
......++..|.|||.+ .+..++.++|+||||+++++|++|+.||......+.. .. ...+.+.. .
T Consensus 157 ~~~~~~~~~~y~ape~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~-~~~~~~~~-------~ 221 (256)
T cd08221 157 MAETVVGTPYYMSPELC-QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VK-IVQGNYTP-------V 221 (256)
T ss_pred cccccCCCccccCHhhc-CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HH-HHcCCCCC-------C
Confidence 11223478899999998 4556788999999999999999999999764332111 11 11122111 1
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
.......+.+++.+||+.+|.+||+++++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12334679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=277.73 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=198.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+|++.+.||+|++|.||+|.+. .+..+++|.+... .......+.+|+.+++.++||||+++++.+..++..+++|||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 6899999999999999999987 7889999987643 2333456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 112 RNGSLGNLLFRA--EQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 112 ~~~~L~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
++++|.+++... ...+++..+..++.|++.|+.|||+ . +++|+||+|+||+++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 999999888543 2378999999999999999999996 5 899999999999999999999999998865532221
Q ss_pred cceeeecCCCCcCCccccccCC-----CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 189 RTYTVLRGTRGYTAPELHSRNN-----RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
....++..|+|||.+.+.. .++.++|+||||+++++|++|+.||.......... .. ......
T Consensus 159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~-~~~~~~------ 225 (286)
T cd06622 159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA---QL-SAIVDG------ 225 (286)
T ss_pred ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---HH-HHHhhc------
Confidence 1123677899999874322 35789999999999999999999997543221110 00 011111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+......+.+++.+||+.+|++||++++++.
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 -DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112233345677999999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=281.29 Aligned_cols=262 Identities=21% Similarity=0.329 Sum_probs=199.9
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|++|.||+|.+. +++.+++|++..... ...+.+.+|+.+++.++|||++++++.+......+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 6889999999999999999987 588899998864322 2334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|..+. .....+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 82 CDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred cCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9988887776 3445789999999999999999999999 999999999999999999999999999876543321 1
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH--------HHHHhCccc-c
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH--------QCYEAGELQ-N 261 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~-~ 261 (325)
.....++..|+|||.+.+...++.++|+||||+++++|++|++||......+....+.... .......+. .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 1122367889999998555667889999999999999999999998655433221111000 000000000 0
Q ss_pred cccCCC--CC-----CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 LVSDQE--DV-----NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ~~~~~~--~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...+.. .. .......+.+++.+||+.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 00 0122467899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=295.11 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=207.2
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCc
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSN 103 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 103 (325)
.+...+|++.++||+|+||.|++|..+ .++.+|||.+++. ..++....+.|-+++...+ ||.++.++..|.+..+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455688999999999999999999988 6788999998763 3455667788888887776 9999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
++.||||+.||++..+. ..+.+++..++.++..++.||.|||++ ||+|||||.+|||++..|.+||+|||++...
T Consensus 444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999944333 457899999999999999999999999 9999999999999999999999999999754
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
... .......+||+.|+|||++ .+..|+.+.|=||||++||+||.|..||.+...++.. ..++
T Consensus 519 m~~-g~~TsTfCGTpey~aPEil-~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F---------------dsI~ 581 (694)
T KOG0694|consen 519 MGQ-GDRTSTFCGTPEFLAPEVL-TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF---------------DSIV 581 (694)
T ss_pred CCC-CCccccccCChhhcChhhh-ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHh
Confidence 322 2345567799999999999 7889999999999999999999999999986543321 2333
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTM 295 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 295 (325)
.+....+...+.+..+++.++|..+|.+|.-+
T Consensus 582 ~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 582 NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 34444555566789999999999999999776
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.76 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=199.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
...|+..+.||+|++|.||+|.+. .+..+++|.+.... ......+.+|+..++.++||||+++++.+..+...++|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 467889999999999999999876 57788888876432 3344568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++. .+.+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++.........
T Consensus 83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 83 YLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred ccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 999999999884 35689999999999999999999999 9999999999999999999999999998765432211
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....++..|+|||.+ .+..++.++|+||||+++++|++|+.|+.......... ...... ....
T Consensus 158 -~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~-------~~~~ 221 (277)
T cd06642 158 -RNTFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKNS-------PPTL 221 (277)
T ss_pred -hhcccCcccccCHHHh-CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcCC-------CCCC
Confidence 1112367889999998 45677889999999999999999999987543221110 011000 1112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2234467999999999999999999999995
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=286.07 Aligned_cols=249 Identities=21% Similarity=0.363 Sum_probs=200.5
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeec--cchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 106 (325)
+....|++.++||+||.+.||++...+..-+++|++.. ........+.+|+..|.+|+ |.+|+.++++...++.+++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45688999999999999999999888778888887754 33455667999999999997 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|||+- ..+|..++.+.....+...++.+..|++.|+.++|.. ||||.||||.|+++-.+ .+||+|||.+.-...+
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhcccCcc
Confidence 99976 5699999977766666679999999999999999999 99999999999999876 8999999999877655
Q ss_pred Cccc-eeeecCCCCcCCccccccC----------CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH
Q 047716 187 QTRT-YTVLRGTRGYTAPELHSRN----------NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 187 ~~~~-~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
...- ...+.||+.||+||.+-.. -..+.++||||||||||+|+.|++||...... +.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----~a------- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----IA------- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----HH-------
Confidence 5432 3346699999999986311 12567899999999999999999999754321 10
Q ss_pred hCcccccccCCC-----CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 256 AGELQNLVSDQE-----DVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 256 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.+..+.++.- +.+. ..++.++|+.||..||++|||+.+||
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred --HHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHh
Confidence 1122222211 1111 12399999999999999999999999
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=274.16 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=201.8
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
...|+..+.||.|++|.||.|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++.+.++...++|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 357889999999999999999987 57888999876432 3445678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++. .+.++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 83 ~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 83 YLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred cCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 999999999884 35688999999999999999999999 9999999999999999999999999998655432211
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....++..|+|||.+ .+...+.++|+||||+++++|++|..||.......... .... ...+..
T Consensus 158 -~~~~~~~~~y~apE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~-------~~~~~~ 221 (277)
T cd06640 158 -RNTFVGTPFWMAPEVI-QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPK-------NNPPTL 221 (277)
T ss_pred -cccccCcccccCHhHh-ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhc-------CCCCCC
Confidence 1122367789999998 45667899999999999999999999997654321111 0000 011233
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 4455677999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=282.58 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=199.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh-----cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE-----GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+|++.+.||.|++|.||+|.+. ++..+++|++...... ....+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999986 6889999998654322 234567899999999999999999999998999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+ +++|.+++......+++..+..++.|+++|+.+||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 8899999855444799999999999999999999999 99999999999999999999999999987654432
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC---------c
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG---------E 258 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~ 258 (325)
... ....++..|+|||.+.+...++.++|+||||+++++|++|.++|......+.... ........ .
T Consensus 157 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 157 RKM-THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK---IFEALGTPTEENWPGVTS 232 (298)
T ss_pred ccc-cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH---HHHHcCCCchhhhhhccc
Confidence 211 1122567899999885556778999999999999999999888875543221111 11110000 0
Q ss_pred ccccccCC--C-----CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQNLVSDQ--E-----DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~~~~~~--~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+....... . .........+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000 0 011223467899999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=276.00 Aligned_cols=258 Identities=26% Similarity=0.342 Sum_probs=203.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+...+|++.+.||+|++|.||++.+. .+..+++|++.... ......+.+|+++++.++||||+++++.+......++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 45689999999999999999999987 57788888775432 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|||+++++|.+++.. .+.+++..+..++.|++.++.|||+ . +++|+||+|+||+++.++.++++|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999998843 4578999999999999999999996 5 8999999999999999999999999987654222
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc-----hhhHHHHHHHHHHhCcccc
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD-----EIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 261 (325)
.. ....++..|+|||.+ ....++.++|+||||+++++|++|+.||......+ ......+...... ..
T Consensus 158 ~~---~~~~~~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--- 229 (284)
T cd06620 158 IA---DTFVGTSTYMSPERI-QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EP--- 229 (284)
T ss_pred cc---CccccCcccCCHHHH-ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-cc---
Confidence 11 122378899999998 45678889999999999999999999998654321 1111111111111 10
Q ss_pred cccCCCCC-CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 262 LVSDQEDV-NIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 262 ~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
.... .......+.+++.+||+.+|++|||+.|++++.-
T Consensus 230 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 ----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0111 1124467999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=273.32 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=195.9
Q ss_pred hhcCcCCceeEEEEEeCC--C--cEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCING--G--KEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~--~--~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|++|.||+|.+.. + ..+++|.+..... ...+.+..|+..+++++||||+++++.+.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 2588998876554 456678899999999999999999999887 889999999999
Q ss_pred CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc--c
Q 047716 114 GSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR--T 190 (325)
Q Consensus 114 ~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~--~ 190 (325)
++|.+++.... ..+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999986544 4689999999999999999999999 9999999999999999999999999998765432211 1
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....++..|+|||.+ ....++.++||||||+++++|++ |..||......+... ...... .....
T Consensus 157 ~~~~~~~~~y~~pE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------~~~~~~-------~~~~~ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESL-RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK------KIDKEG-------ERLER 222 (257)
T ss_pred ccCCCCCceecCHHHh-cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhcC-------CcCCC
Confidence 1112356789999988 56678889999999999999998 999997553322111 111000 01111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
....+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1223457999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=291.98 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=199.0
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC---CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN---GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
...+...+|++.++||.|+||.||+|... .+..+++|.+... ....+|+.+++.++||||+++++.+.....
T Consensus 86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 34455678999999999999999999764 3567888876542 234579999999999999999999998899
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++|+++. ++|.+++ .....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++...
T Consensus 161 ~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999999995 6788887 4456799999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc----
Q 047716 184 KTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE---- 258 (325)
Q Consensus 184 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 258 (325)
...... ......++..|+|||.+ ....++.++|||||||++++|++|+.||.+.........+...........
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 433221 12233489999999998 566788999999999999999999999976544321111111111111100
Q ss_pred -------------ccccccCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 -------------LQNLVSDQEDVN-----IEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 -------------~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+..........+ ......+.++|.+||+.+|++|||+.|++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 112356889999999999999999999993
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.49 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=191.9
Q ss_pred hhcCcCCceeEEEEEeCC-Cc--EEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCING-GK--EIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~-~~--~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||+|+||.||+|.+.. +. .+++|.+.... ......+..|+.+++.+ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999864 33 45777766432 33445688899999999 799999999999998899999999999
Q ss_pred CCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecc
Q 047716 114 GSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFG 178 (325)
Q Consensus 114 ~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg 178 (325)
++|.+++.... ..+++..++.++.|++.|++|||+. |++|+||+|+||+++.++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 2478899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
++........ ......+..|+|||.+ ....++.++|+||||+++++|++ |+.||......+.. .....+
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------EKLPQG 227 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH-------HHHhCC
Confidence 8753221111 1111135579999988 56678899999999999999997 99999754322111 111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
. ..+........+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus 228 ~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 Y-------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C-------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 01111223356899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=288.24 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=194.8
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC------
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------ 101 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 101 (325)
..++|++.+.||+|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678999999999999999999987 68889999886532 33345677899999999999999999877432
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...++||||+++ +|.+.+. ..++...+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999964 6766663 3478899999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH------------
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW------------ 249 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~------------ 249 (325)
........ ....++..|+|||.+ .+..++.++|||||||++++|++|+.||......+....+..
T Consensus 175 ~~~~~~~~--~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTSFMM--TPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCCCcc--cCCcccCCcCCHHHH-hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 65432211 122378899999998 566788999999999999999999999976543222111100
Q ss_pred H----HHH-HHhCcccc-----cccC-----CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 250 A----HQC-YEAGELQN-----LVSD-----QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 250 ~----~~~-~~~~~~~~-----~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. ... ...+.+.. .... ...........+.+++.+||+.||.+|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000 00000000 0000 00111112356899999999999999999999994
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=282.91 Aligned_cols=260 Identities=18% Similarity=0.249 Sum_probs=196.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|++|.||+|.+. .+..+++|.+.... ......+..|+.+++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999987 68889999886432 22234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+. ++|.+++....+.+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 96 578777755567799999999999999999999999 9999999999999999999999999998755432211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh------------Cc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA------------GE 258 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------~~ 258 (325)
.....++..|+|||.+.+...++.++||||||+++++|++|+.|+......... .......... ..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhhccc
Confidence 112235788999998855566789999999999999999999887543322111 1111110000 00
Q ss_pred ccccccCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQNLVSDQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........ ....+....++.+++.+||+.||.+|||+++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000 0111223467899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.71 Aligned_cols=248 Identities=21% Similarity=0.312 Sum_probs=197.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeec-CCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-GSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 109 (325)
+|++.+.||.|++|.||++.+. +++.+++|++.... ......+.+|+.+++.++|||++++++.+.. +...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999987 57889999886432 2344567889999999999999999988764 446799999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++++|.+++... ...+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999988553 34589999999999999999999999 999999999999999999999999999876533221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
......+++.|+|||.+ ....++.++|+||||+++++|++|+.||........ .. ....+.+ ..
T Consensus 158 -~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~-~~~~~~~-------~~ 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELF-SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VY-RIIEGKL-------PP 221 (257)
T ss_pred -ccccccCCcCccChhHh-cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HH-HHHhcCC-------CC
Confidence 12223468899999998 556778899999999999999999999975432111 11 1111111 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+.+++.+||+.+|.+|||+.++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 22334467999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=275.98 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=196.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhc---------HHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG---------ESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+|.+.+.||.|++|.||+|.+. .+..+++|.+....... ...+..|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999876 67889999876533221 2457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++++||+++++|.+++.. .+.++...+..++.|++.|+.+||++ |++|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999999999843 46788999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCc-----cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 184 KTDQT-----RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 184 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
..... .......++..|+|||.+ ....++.++|+||||+++++|++|+.||......... .. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FK-IGEN- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHh-ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HH-Hhcc-
Confidence 42211 011112367889999998 4566788999999999999999999999764321110 00 0000
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+..+......+.+++.+||+.+|.+||++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111122234467999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=279.71 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=200.3
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
..++|++.+.||.|+||.||+|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4578999999999999999999864 46788899876533 2334568889999999999999999999998889
Q ss_pred eEEEEeecCCCCHHHHHhhcc---------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE---------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~---------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
.+++|||+++++|.+++.... ..+++..++.++.|++.|+.+||++ +++|+||+|+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999985321 2367888999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLR 240 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 240 (325)
||+++.++.++++|||++........ ........+..|+|||.+ ....++.++||||||+++++|++ |..||.....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH-hcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999998865432211 111111235679999988 45678899999999999999997 7788865433
Q ss_pred cchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 241 DDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
.+.. .....+.... .+...+.++.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 239 ~~~~-------~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVI-------YYVRDGNVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH-------HHHhcCCCCC-------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2111 1122222111 111234579999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=278.45 Aligned_cols=249 Identities=25% Similarity=0.298 Sum_probs=195.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|+..+.||+|+||.||.|.+. .++.+|+|.+..... .....+.+|+.+++.++|++++.+++.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3667788999999999999987 688899998865322 223456789999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+.+++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999887543 34699999999999999999999999 999999999999999999999999998865432211
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....++..|+|||.+ .+..++.++|+||||+++++|++|..||.......... . ........ ...
T Consensus 158 --~~~~~g~~~~~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~-~~~~~~~~--------~~~ 223 (285)
T cd05632 158 --IRGRVGTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--E-VDRRVLET--------EEV 223 (285)
T ss_pred --ccCCCCCcCccChHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHhhhcc--------ccc
Confidence 1223478999999998 45678899999999999999999999998653321111 1 11111111 011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPT-----MKQVI 299 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell 299 (325)
........+.+++..||+.+|++||+ +.+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~ 259 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK 259 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHH
Confidence 12223456889999999999999999 66777
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=275.88 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=197.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc------hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV------EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+|++.+.||.|+||.||+|....+..+++|.+.... ......+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998888899999876422 12234578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
+||+++++|.+++.+ .+.+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 999999999999843 35688999999999999999999999 99999999999999999999999999887542211
Q ss_pred -----ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 188 -----TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 188 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
........++..|+|||.+ ....++.++|+||||+++++|++|..||.......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~---- 226 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAHRGL---- 226 (265)
T ss_pred ccccccccccccCCCccccChhhh-cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----HhhhccCC----
Confidence 1111223377889999998 45667889999999999999999999997543221110 00000001
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+..+......+.+++.+||+.+|.+||++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ---MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11122234467899999999999999999999984
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.49 Aligned_cols=250 Identities=27% Similarity=0.327 Sum_probs=196.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||++.+. .++.+++|.+..... .....+..|+.+++.++|++++.+++.+...+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999987 678899998865322 223446789999999999999999999998899999999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+.+++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999888443 34589999999999999999999999 999999999999999999999999998865432221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....++..|+|||.+ ....++.++|+||||+++++|++|+.||............ ...... ... .
T Consensus 158 --~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~--~~~------~ 223 (285)
T cd05630 158 --IKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE--VQE------E 223 (285)
T ss_pred --ccCCCCCccccChHHH-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh--hhh------h
Confidence 1122478899999998 4566889999999999999999999999865332111100 000000 000 0
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPT-----MKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 300 (325)
........+.+++.+||+.+|.+||| ++|+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11123356899999999999999999 889883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=289.79 Aligned_cols=262 Identities=24% Similarity=0.400 Sum_probs=203.9
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccchh-cHHHHHHHHHHHhccC-CCCcceeeEEee
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVEE-GESEFRNEMKIIGRIH-HKNLVDLVGFCS 99 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 99 (325)
.++..++|.+.+.||+|+||.||+|++. .+..+|+|++...... ....+..|+.++..+. ||||+++++.+.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4567789999999999999999999864 3467999998754322 2346888999999997 999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcc-------------------------------------------------------
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRAE------------------------------------------------------- 124 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------------------------- 124 (325)
..+..++|+||+.+++|.+++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 8889999999999999999885421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 125 ------------------------------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 125 ------------------------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
..+++..++.++.|++.|+.|||+. +++|+||+|+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 1256677888999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLR 240 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 240 (325)
||+++.++.++++|||++........ .......++..|+|||.+ ....++.++|+||||+++++|++ |+.||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI-FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh-cCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999875432221 111112356789999998 45667889999999999999998 8889865433
Q ss_pred cchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 241 DDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+... .....+ . ....+......+.+++.+||+.+|.+||++++|++.|+.+.
T Consensus 348 ~~~~~------~~~~~~-~------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFY------NAIKRG-Y------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHH------HHHHcC-C------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 22110 111111 0 01111223467999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=282.89 Aligned_cols=196 Identities=23% Similarity=0.391 Sum_probs=158.3
Q ss_pred hhhcCcCCceeEEEEEeC---CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec--CCceEEEEeecC
Q 047716 38 KEEIGRGGSGRVYKGCIN---GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--GSNRLLVYEFMR 112 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 112 (325)
.++||+|+||.||+|.+. .+..+++|.+.... ....+.+|+.+++.++||||+++++.+.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 458999999999999865 46788999875432 23456789999999999999999998854 456789999985
Q ss_pred CCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE----cCCCcEEEeecccc
Q 047716 113 NGSLGNLLFRA--------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM----DESWKAKISDFGLS 180 (325)
Q Consensus 113 ~~~L~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv----~~~~~vkl~Dfg~~ 180 (325)
++|.+++... ...+++..++.++.|++.|+.|||++ |++|+||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5777776322 12488999999999999999999999 99999999999999 45578999999999
Q ss_pred ccccCCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcc
Q 047716 181 KLLKTDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESL 239 (325)
Q Consensus 181 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 239 (325)
........ .......+++.|+|||.+.+...++.++|||||||++++|++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543321 111223478899999998665678899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=289.88 Aligned_cols=261 Identities=22% Similarity=0.263 Sum_probs=194.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG----- 101 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 101 (325)
....+|++.+.||+|+||.||+|.+. .++.+++|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35679999999999999999999876 68889999886532 23345677899999999999999999987543
Q ss_pred -CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 102 -SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 102 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
...+++|||+++ ++.+.+. ..++...+..++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999965 6666652 3578899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHH------------
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLID------------ 248 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~------------ 248 (325)
......... ....++..|+|||.+ .+..++.++||||||+++++|++|+.||.+....+......
T Consensus 167 ~~~~~~~~~--~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 167 RTAGTSFMM--TPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccCCCcccc--CCccccCCccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 765432221 122378899999998 56678899999999999999999999997654322111000
Q ss_pred ----HHHHHHH-hCcccccc----------cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 249 ----WAHQCYE-AGELQNLV----------SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 249 ----~~~~~~~-~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....... .+...... .............+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000 00000000 0000111122456899999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.33 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=205.9
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-C-----CCcceeeEEe
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-H-----KNLVDLVGFC 98 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~ 98 (325)
...+....+|.+.+.||+|+||.|.+|.+. .++.||||++++.. .-..+...|+.+|..|+ | -|+|+++++|
T Consensus 179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 344445559999999999999999999988 58889999886643 34556678999999997 3 3899999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC--CcEEEe
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES--WKAKIS 175 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~--~~vkl~ 175 (325)
...++++||+|.+ ..+|.++++.+ ..+++...++.++.||+.+|.+||+. +||||||||+|||+..- ..||++
T Consensus 258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEE
Confidence 9999999999999 67999999654 35699999999999999999999999 99999999999999644 369999
Q ss_pred eccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH------
Q 047716 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW------ 249 (325)
Q Consensus 176 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~------ 249 (325)
|||++........ ....+..|+|||++ -+..|+.+.||||||||++||++|.+.|.+....+...++.-
T Consensus 334 DFGSSc~~~q~vy----tYiQSRfYRAPEVI-LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 334 DFGSSCFESQRVY----TYIQSRFYRAPEVI-LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred ecccccccCCcce----eeeeccccccchhh-ccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 9999987654433 33368899999999 578889999999999999999999999988877665544410
Q ss_pred --H-------HHHHHh-C-ccc-----c-----------------cccCC-C--------CCCHHHHHHHHHHHhhcccC
Q 047716 250 --A-------HQCYEA-G-ELQ-----N-----------------LVSDQ-E--------DVNIEEFENLVKIGLWCVEC 287 (325)
Q Consensus 250 --~-------~~~~~~-~-~~~-----~-----------------~~~~~-~--------~~~~~~~~~l~~li~~~l~~ 287 (325)
+ ...+.. . .+. . ..... + .........+.+++++||..
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 0 000000 0 000 0 00000 0 00112245689999999999
Q ss_pred CCCCCCCHhHHH
Q 047716 288 ELNLRPTMKQVI 299 (325)
Q Consensus 288 ~p~~Rps~~ell 299 (325)
||.+|+|..|.+
T Consensus 489 dP~~R~tp~qal 500 (586)
T KOG0667|consen 489 DPAERITPAQAL 500 (586)
T ss_pred CchhcCCHHHHh
Confidence 999999999999
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.03 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=204.0
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCC-Cc----EEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCING-GK----EIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~-~~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
...+|++.+.||+|+||.||+|.+.. +. .+++|.+..... .....+.+|+..++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45788999999999999999998753 22 477887765432 334568889999999999999999999877 788
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++++||+++++|.+++......+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999999976666799999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccee-eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 185 TDQTRTYT-VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 185 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
........ ....+..|+|||.+ ....++.++|+||||++++++++ |+.||......+.. .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~---- 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-------DLLEKGE---- 228 (279)
T ss_pred CcccceecCCCcccccccCHHHh-hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhCCC----
Confidence 32221111 11134579999988 45677889999999999999998 99999765332211 1111111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
....+......+.+++.+||..+|.+||++.++++.|+.+..-
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0111112234688999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=288.61 Aligned_cols=241 Identities=25% Similarity=0.261 Sum_probs=186.5
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeeccchh---cHHHHHHHHHHHhcc---CCCCcceeeEEeecCCceEEEEeecCC
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE---GESEFRNEMKIIGRI---HHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
||+|+||.||+|++. .+..+|+|++...... .......|..++... +||+|+.+++.+.+....++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999987 6889999998653221 222344456666555 699999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++. ..+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 99998884 456799999999999999999999999 999999999999999999999999999865322221 1223
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..|+..|+|||.+.+...++.++||||||+++++|++|+.||......+.. .....+... +. ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~~-~~------~~~~ 221 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-------RNIAFGKVR-FP------KNVL 221 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-------HHHHcCCCC-CC------CccC
Confidence 348899999999855566789999999999999999999999765332111 111111110 00 1112
Q ss_pred HHHHHHHHhhcccCCCCCCC----CHhHHHH
Q 047716 274 FENLVKIGLWCVECELNLRP----TMKQVIW 300 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rp----s~~ell~ 300 (325)
...+.+++.+||+.+|.+|| ++.++++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 35688999999999999998 5667663
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.73 Aligned_cols=249 Identities=23% Similarity=0.257 Sum_probs=194.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|+||.||+|... .+..+|+|++.... ......+..|+.++..++||+|+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5788999999999999999887 68889999886532 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT- 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~- 188 (325)
|+++++|.+++.+ .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999843 45789999999999999999999999 999999999999999999999999999864422110
Q ss_pred ---------------------------------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCC
Q 047716 189 ---------------------------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV 235 (325)
Q Consensus 189 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 235 (325)
.......|++.|+|||.+ .+..++.++|+|||||++++|++|++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF-MQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH-cCCCCCCcceeccccceeeecccCCCCC
Confidence 001123488999999998 5667889999999999999999999999
Q ss_pred CCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HhHHH
Q 047716 236 DESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT---MKQVI 299 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~ell 299 (325)
.......... ..........+.+ ......++.+++.+|+ .+|.+|++ ++|++
T Consensus 237 ~~~~~~~~~~-------~i~~~~~~~~~p~----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 237 CSETPQETYR-------KVMNWKETLVFPP----EVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCHHHHHH-------HHHcCCCceecCC----CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 8654322111 1111000000000 1113356888888876 49999985 66776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.70 Aligned_cols=248 Identities=20% Similarity=0.298 Sum_probs=199.3
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|++|.+|.+... +++.+++|.+... .......+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999886 6888999988643 233445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 111 MRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
+.+++|.+++... ...+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++++|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999988543 33578999999999999999999999 9999999999999999999999999998765432221
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
. ....++..|+|||.+ .+...+.++|+||||+++++|++|+.||......+. .... ..+.. ...
T Consensus 158 ~-~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~-~~~~~-------~~~ 221 (256)
T cd08218 158 A-RTCIGTPYYLSPEIC-ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKI-IRGSY-------PPV 221 (256)
T ss_pred h-hhccCCccccCHHHh-CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHH-hcCCC-------CCC
Confidence 1 122367889999998 456678899999999999999999999975432211 1111 11111 111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......+.+++.+||+.+|.+||++.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2233457999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=273.85 Aligned_cols=252 Identities=24% Similarity=0.397 Sum_probs=199.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch------hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE------EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
+|+..+.||+|++|.||+|.+. ++..+++|++..... .....+..|+..++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999875 688999998864321 124568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~~~~ 185 (325)
|+||+.+++|.+++.+ .+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999999853 45789999999999999999999999 999999999999998775 599999999876543
Q ss_pred CCcc---ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 186 DQTR---TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 186 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
.... ......++..|+|||.+ .+..++.++|+||||+++++|++|..||...........+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~------- 225 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVL-RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIAS------- 225 (268)
T ss_pred ccccCCccccccccccceeCHhHh-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HHhc-------
Confidence 3211 11122367899999998 45677899999999999999999999996543322211110 1000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......+......+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01112233345567999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.11 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=200.4
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
....|.....||+|++|.||++.+. .+..+++|.+..........+.+|+..++.++||||+++++.+..++..+++||
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3456666788999999999999876 688899998866555556678899999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++. .+.+++..++.++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||++.........
T Consensus 100 ~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 100 FLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred CCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 999999999873 34689999999999999999999999 9999999999999999999999999988654332221
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....++..|+|||.+ ....++.++|+||||+++++|++|+.||.......... ... ..+. .....
T Consensus 175 -~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------~~~-~~~~----~~~~~ 240 (292)
T cd06658 175 -RKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------RIR-DNLP----PRVKD 240 (292)
T ss_pred -CceeecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHH-hcCC----Ccccc
Confidence 1223378899999998 55667889999999999999999999997543321111 010 0111 11111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......+.+++.+||..+|.+|||++|+++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1223456889999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.28 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=204.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeec---cchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.-|.-.+.||.|+||.||.|++. +...||+|++.- .+...-+.+.+|+..|++++|||++.+.++|..+.+.|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 45666789999999999999987 677788998864 23334456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||| -|+-.|++.-..+++-+.++..+..+.+.||+|||+. +.+|+|||+.|||+++.|.|||+|||.+......+.
T Consensus 106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 999 6688888877778899999999999999999999999 999999999999999999999999999987655443
Q ss_pred cceeeecCCCCcCCccccc--cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 189 RTYTVLRGTRGYTAPELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
..|||.|||||++. ..+.|+-++||||||++..+|...+||......-.....+.. + +.+
T Consensus 182 -----FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-------N------esP 243 (948)
T KOG0577|consen 182 -----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------N------ESP 243 (948)
T ss_pred -----ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-------c------CCC
Confidence 33999999999875 357889999999999999999999999987765444333221 0 111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.-..++-+..+.+|+..||++-|.+|||.++++
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 111344456789999999999999999999987
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=273.25 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=201.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+|++.+.||.|++|.||+|.+. .++.+++|.+.... ......+.+|+..++.++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5889999999999999999987 68889999886643 344556888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++++|.+++......+++..+..++.|++.++.+||+ . +++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 9999999996555788999999999999999999999 8 99999999999999999999999999886543222111
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
..++..|+|||.+ .+..++.++|+||||+++++|++|+.||......... ........... . .+...
T Consensus 159 ---~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~-~-------~~~~~ 225 (265)
T cd06605 159 ---FVGTSSYMAPERI-QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVNE-P-------PPRLP 225 (265)
T ss_pred ---ccCChhccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhcC-C-------CCCCC
Confidence 3378899999998 4567889999999999999999999999765321111 11111111111 1 11111
Q ss_pred HH-HHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 271 IE-EFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 271 ~~-~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.. ....+.++|.+||..+|++|||+.+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 11 456799999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.59 Aligned_cols=195 Identities=23% Similarity=0.353 Sum_probs=163.4
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.+...+|++.+.||+|+||.||+|.+. .+..+++|+.... ....|+.+++.++||||+++++++......++|
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 344567999999999999999999987 5667888864332 234689999999999999999999998999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
++++. ++|.+++......+++..+..++.|++.|+.|||++ ||+|+||||+||+++.++.++|+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 99994 588888766667899999999999999999999999 99999999999999999999999999986433221
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVD 236 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 236 (325)
. .....++..|+|||.+ .+..++.++|||||||++|+|+++..++.
T Consensus 212 ~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 A--FLGLAGTVETNAPEVL-ARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred c--cccccccccccCCeec-CCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1 1223478999999998 45678899999999999999998665553
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=279.18 Aligned_cols=261 Identities=20% Similarity=0.318 Sum_probs=196.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++|++.+.||.|++|.||+|.+. ++..+++|.+..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999987 678899998865332 2234466899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+. ++|.+++......+++..++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 97 489888866556789999999999999999999999 999999999999999999999999998864332111 1
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC---cc--------
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG---EL-------- 259 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-------- 259 (325)
.....++..|+|||.+.+...++.++||||||+++++|++|+.||............ ........ .+
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK--IFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH--HHHhcCCCChhhhhhhhhccc
Confidence 111225778999998855566788999999999999999999999755421111100 00000000 00
Q ss_pred -cc----cccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 260 -QN----LVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 260 -~~----~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.. ..... ..........+.+++.+||+.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000 0000111256889999999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=272.86 Aligned_cols=247 Identities=26% Similarity=0.325 Sum_probs=195.2
Q ss_pred hhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 38 KEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
...||+|+||.||+|.+. ++..+++|.+..........+.+|+.+++.++|+||+++++++..++..++++||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 357999999999999976 5778999988766555667788999999999999999999999998999999999999999
Q ss_pred HHHHhhccCCC--CHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-CCcEEEeeccccccccCCCccceee
Q 047716 117 GNLLFRAEQRL--SWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 117 ~~~~~~~~~~~--~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
.+++......+ +...+..++.|++.|+.|||++ +++|+||+|+||+++. ++.++|+|||.+......... ...
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-ccc
Confidence 99986544455 8888999999999999999999 9999999999999976 678999999988755332221 112
Q ss_pred ecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 194 LRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
..++..|+|||.+... ..++.++|+||||+++++|++|++||.......... +... ........+..
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~---------~~~~~~~~~~~ 236 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVG---------MFKIHPEIPES 236 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhh---------hhccCCCCCcc
Confidence 2367899999988443 347889999999999999999999997543221110 0000 00111222233
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 273 EFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...++.+++.+||+.+|.+|||+.|++.
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 4467999999999999999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=276.04 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=199.3
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
...+|++.+.||.|+||.||+|+.. ..+.+++|.+...... ....+..|+.+++.++||||+++++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 3578999999999999999999864 2456888877654333 34568899999999999999999999988889
Q ss_pred eEEEEeecCCCCHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEe
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE--------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~ 175 (325)
.+++|||+++++|.+++.... ..+++..+..++.|++.++.|||++ +++|+||+|+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 999999999999999985433 1589999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHH
Q 047716 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 176 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
|||++...............++..|+|||.+ .....+.++||||||+++++|++ |..||........ . ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~----~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAV-QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---L----NRL 231 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---H----HHH
Confidence 9998764322221111222246679999988 44567889999999999999998 7788865432211 1 111
Q ss_pred HhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 255 EAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
....+.. ......+..+.+++.+||+.+|.+|||+.|++..|..
T Consensus 232 ~~~~~~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 232 QAGKLEL------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HcCCcCC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1111110 0111233579999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=274.58 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=197.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCC------c
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGS------N 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~ 103 (325)
.++|++.+.||+|++|.||+|.+. .+..+++|.+..... ....+..|+.+++.+ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 478999999999999999999986 577888888765433 345688999999999 6999999999986544 4
Q ss_pred eEEEEeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
.+++|||+++++|.+++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccc
Confidence 89999999999999987543 35789999999999999999999999 9999999999999999999999999988
Q ss_pred ccccCCCccceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
........ ......++..|+|||.+.. ...++.++||||||+++++|++|..||.......... .. ..
T Consensus 161 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~ 232 (275)
T cd06608 161 AQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF------KI-PR 232 (275)
T ss_pred eecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH------Hh-hc
Confidence 65433222 1122337888999998743 2346788999999999999999999997543221111 11 11
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. ..............+.+++.+||..||.+|||+.++++
T Consensus 233 ~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 N-----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-----CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11111112234567999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=282.30 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=198.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh--cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE--GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.++||+|++|.||+|.+. .++.+++|++...... ....+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 6888999999999999999987 5888999987643322 345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.++.. ....+++..+..++.|++.++.|||+. +++|+|++|+||+++.++.++++|||++........ .
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07846 82 VDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 156 (286)
T ss_pred CCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-c
Confidence 99988887763 345689999999999999999999999 999999999999999999999999999876533221 1
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH--------HHHHhCcc-cc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH--------QCYEAGEL-QN 261 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~-~~ 261 (325)
.....++..|+|||.+.+...++.++||||||+++++|++|++||......+....+.... ........ ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 1222367889999998555667889999999999999999999997544322111111000 00000000 00
Q ss_pred cccCC-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 LVSDQ-------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..... ....+.....+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 0001223467999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.13 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=199.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++|++.++||+|+||.||+|.+. .++.+|+|++..... .....+.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46899999999999999999987 588999999865322 23456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecc
Q 047716 109 EFMRNGSLGNLLFRA----------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFG 178 (325)
Q Consensus 109 e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg 178 (325)
||+++++|.+++... ....+...+..++.|++.|++|||++ |++||||||+||+++.++.++++|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988532 12355677889999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCc-----------------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc
Q 047716 179 LSKLLKTDQT-----------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241 (325)
Q Consensus 179 ~~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 241 (325)
++........ .......|++.|+|||.+ .+..++.++|||||||++++|++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l-~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh-cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9875521100 011113488999999998 5667789999999999999999999999764322
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCC--CCHHHHHHHHHHHhhcccCCCCCCC-CHhHHHHHHhccCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQED--VNIEEFENLVKIGLWCVECELNLRP-TMKQVIWMMEGIVP 307 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~L~~~~~ 307 (325)
.... . . ....... .....+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 238 ki~~----~-~---------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KISY----R-D---------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh----h-h---------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 0 0 0000000 0112335688999999999999995 67777788877753
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=281.90 Aligned_cols=261 Identities=26% Similarity=0.381 Sum_probs=199.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec-
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE- 100 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~- 100 (325)
....+|++.+.||+|+||.||+|.+. .++.+|+|.+.... ......+.+|+.++..+ +||||+++++++..
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 45679999999999999999999742 46789999986533 23345688899999999 68999999997754
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc--------------------------------------------------------
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE-------------------------------------------------------- 124 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------------- 124 (325)
+...+++|||+++++|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456789999999999999885321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc-ceee
Q 047716 125 ----------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTV 193 (325)
Q Consensus 125 ----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~ 193 (325)
..+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++++|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1357778889999999999999999 9999999999999999999999999998764322211 1111
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
..++..|+|||.+ ....++.++||||||+++++|++ |..||......... ......+.... .+..
T Consensus 241 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~~~~-------~~~~ 306 (343)
T cd05103 241 ARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMR-------APDY 306 (343)
T ss_pred CCCCcceECcHHh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH------HHHHhccCCCC-------CCCC
Confidence 2245679999988 45678899999999999999997 88898754332111 01111111110 0111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 273 EFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
....+.+++..||+.+|.+|||+.||++.|+.+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 23468999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=279.36 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=200.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|++|.||+|.+. ++..+++|++.... ......+.+|+.+++.++|+||+++++++..++..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6889999999999999999987 57789999876432 23345688999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++++.+..+. .....++...+..++.|++.++.+||+. +++|+|++|+||+++.++.++|+|||.+..........
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9886666555 4456689999999999999999999999 99999999999999999999999999987665443222
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH---------hCcccc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE---------AGELQN 261 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 261 (325)
.....++..|+|||.+.....++.++|+||||+++++|++|++||......+....+........ ...+..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 22234678899999985544788999999999999999999999976543222111110000000 000000
Q ss_pred --cccCC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 --LVSDQ------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 --~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..... ...+......+.++|.+||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0011112567999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.43 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=198.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.-|.....||.|+||.||+|.+. ++..+++|.+..........+.+|+..++.++|||++++++.+..+...++++||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 44555678999999999999886 68899999986544455567888999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++. ...+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++......... .
T Consensus 101 ~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~ 174 (297)
T cd06659 101 QGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-R 174 (297)
T ss_pred CCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-c
Confidence 9999998773 35689999999999999999999999 9999999999999999999999999988654332221 1
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
....++..|+|||.+ ....++.++|+||||+++++|++|+.||......+... ...... ........
T Consensus 175 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~~~~~ 241 (297)
T cd06659 175 KSLVGTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-------RLRDSP-----PPKLKNAH 241 (297)
T ss_pred cceecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhccC-----CCCccccC
Confidence 223378899999998 45667889999999999999999999997543322111 111110 00111111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+.+++.+||+.+|.+||+++++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 23356899999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=276.68 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=198.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecC--CceEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNRLLV 107 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 107 (325)
.+|++.+.||.|++|.||+|.+. ++..+++|.+..... .....+.+|+.+++.++||||+++++++... ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 58999999999999999999987 578899998864332 2223466899999999999999999988776 889999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
+||+. ++|.+++......+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 589888865555689999999999999999999999 99999999999999999999999999887665432
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHHHh---
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCYEA--- 256 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~--- 256 (325)
. ......++..|+|||.+.+....+.++|+||||+++++|++|.+||......+....+... ......
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 1122236788999998855556788999999999999999999999865432221111000 000000
Q ss_pred ---CcccccccCC--CCCCHH-HHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 257 ---GELQNLVSDQ--EDVNIE-EFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 257 ---~~~~~~~~~~--~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......... ...... ....+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000 000000 2456899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=270.90 Aligned_cols=247 Identities=22% Similarity=0.341 Sum_probs=197.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|++|.||+|.+. .+..+++|.+.... ......+.+|+.+++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788999999999999999886 68889999886532 23455688899999999999999999999888999999999
Q ss_pred cCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-CcEEEeeccccccccCCCc
Q 047716 111 MRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 111 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vkl~Dfg~~~~~~~~~~ 188 (325)
+++++|.+++.... ..+++..+..++.|++.++.+||++ +++|+||+|+||+++.+ +.++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999986543 4589999999999999999999999 99999999999999855 4579999999876543322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
. ....++..|+|||.+ .....+.++|+||||+++++|++|+.||......... . . ........
T Consensus 158 ~--~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~---~-~~~~~~~~------- 220 (256)
T cd08220 158 A--YTVVGTPCYISPELC-EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---L---K-IMSGTFAP------- 220 (256)
T ss_pred c--cccccCCcccCchhc-cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---H---H-HHhcCCCC-------
Confidence 1 123368899999998 4566788999999999999999999999765432111 0 1 11111111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+.+++.+||+.+|++|||++|+++
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11123456999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=277.04 Aligned_cols=261 Identities=18% Similarity=0.242 Sum_probs=195.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
.+|++.+.||+|++|.||+|.+. .+..+++|.+..... .....+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 56889999999999999999886 688999998865332 2233567899999999999999999999998899999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+. +++.+++......+.+..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 95 677766655556688889999999999999999999 9999999999999999999999999988654322211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH------------hCc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE------------AGE 258 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------------~~~ 258 (325)
.....++..|+|||.+.+...++.++|+||||+++++|++|+.||+........... ...... ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK--IWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH--HHHHcCCCChhhhhhhhhccc
Confidence 111235788999999855556788999999999999999999999765432111100 000000 000
Q ss_pred cccc-ccCCCCC-------CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQNL-VSDQEDV-------NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~~-~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.... ....... .......+.+++.+|+..||.+|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 0000000 0011356889999999999999999999873
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=271.22 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=187.3
Q ss_pred hhcCcCCceeEEEEEeCCCc-----------EEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 39 EEIGRGGSGRVYKGCINGGK-----------EIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~-----------~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+.||+|+||.||+|.+.... .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999987433 4566665443322 5678899999999999999999999877 778999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-------cEEEeecccc
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-------KAKISDFGLS 180 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-------~vkl~Dfg~~ 180 (325)
|||+++++|.+++......++...+..++.|++.|+.|||++ +++|+||+|+||+++.++ .++++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999966555789999999999999999999999 999999999999999887 7999999998
Q ss_pred ccccCCCccceeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
....... ...++..|+|||.+... ..++.++|+||||+++++|++ |..||.......... ......
T Consensus 156 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~~~~ 223 (259)
T cd05037 156 ITVLSRE-----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQDQH 223 (259)
T ss_pred ccccccc-----ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHhcCC
Confidence 7654311 12256789999998544 377899999999999999999 567776543221110 111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
.. . ......+.+++.+||..+|.+|||+.++++.|+
T Consensus 224 ~~------~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 RL------P---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC------C---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 001157899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=271.37 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=189.7
Q ss_pred hhcCcCCceeEEEEEeC----CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEee-cCCceEEEEeecC
Q 047716 39 EEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCS-EGSNRLLVYEFMR 112 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 112 (325)
+.||+|+||.||+|.+. ....+++|.+.... ......+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 23568888875432 334456788999999999999999999765 4556789999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc---c
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT---R 189 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~---~ 189 (325)
+++|.+++.......+...+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 9999999966556678888899999999999999999 999999999999999999999999999865432111 1
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhC-CCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCC-RKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
......++..|+|||.+ ....++.++||||||+++++|++| .+||......+ .. .. ...+. ...
T Consensus 158 ~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~---~~-~~~~~-------~~~ 222 (262)
T cd05058 158 NHTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT---VY-LLQGR-------RLL 222 (262)
T ss_pred ccccCcCCccccChhHh-ccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HH-HhcCC-------CCC
Confidence 11112246689999988 456788899999999999999995 45555432111 11 11 11110 011
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11122356899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=277.42 Aligned_cols=242 Identities=26% Similarity=0.309 Sum_probs=197.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|++|.||++.+. .++.+++|++.... ......+.+|+++++.++||||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 6889999999999999999987 68889999886532 2234557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++.. .+.++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 9999999999844 46799999999999999999999999 9999999999999999999999999998765433
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....+++.|+|||.+ .....+.++|+||||+++++|++|..||......... .....+ ....
T Consensus 155 -~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~--------~~~~ 217 (290)
T cd05580 155 -TYTLCGTPEYLAPEII-LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY-------EKILEG--------KVRF 217 (290)
T ss_pred -CCCCCCCccccChhhh-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcC--------CccC
Confidence 1223478899999988 4556788999999999999999999999765421110 111111 1111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
+......+.+++.+||+.+|.+|+ +++|++
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 222246789999999999999999 788887
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=278.76 Aligned_cols=261 Identities=18% Similarity=0.231 Sum_probs=195.3
Q ss_pred hhhhhcCcC--CceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 36 NFKEEIGRG--GSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 36 ~~~~~lg~g--~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++.++||+| ++++||++... +++.+|+|++.... ......+..|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 367889999 67899999886 78889999886532 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 111 MRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
+++++|.+++... ...+++..++.++.|++.|+.|||++ +++|+||||+||+++.++.+++.||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999998543 34589999999999999999999999 9999999999999999999999999864332111000
Q ss_pred ------ceeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 190 ------TYTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 190 ------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
......++..|+|||.+... ..++.++|||||||++++|++|+.||......... .... .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-----~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL-----NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHh-----cCCcccc
Confidence 00111256679999998543 45789999999999999999999999754322111 0000 0000000
Q ss_pred cc--------------------------------------CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HH
Q 047716 263 VS--------------------------------------DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MM 302 (325)
Q Consensus 263 ~~--------------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L 302 (325)
.+ ............+.+++.+||+.||++|||++|+++ .+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 00 000011223457899999999999999999999994 45
Q ss_pred hccC
Q 047716 303 EGIV 306 (325)
Q Consensus 303 ~~~~ 306 (325)
+.+.
T Consensus 311 ~~~~ 314 (327)
T cd08227 311 KQIK 314 (327)
T ss_pred hhcc
Confidence 4443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=272.58 Aligned_cols=247 Identities=22% Similarity=0.349 Sum_probs=198.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-chhcHHHHHHHHHHHhccC---CCCcceeeEEeecCCceEEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIH---HKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.|++.+.||.|++|.||+|.+. ++..+++|.+... .......+.+|+.+++.++ |||++++++.+..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999986 6888999987653 2334456788999999986 999999999998888999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+++.. +.+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999998843 4789999999999999999999999 999999999999999999999999999876654332
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.. ....++..|+|||.+..+..++.++|+||||+++++|++|..||.......... ..... ....
T Consensus 157 ~~-~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-------~~~~ 221 (277)
T cd06917 157 KR-STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-------KPPR 221 (277)
T ss_pred cc-ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-------CCCC
Confidence 21 222377889999998656667899999999999999999999997543221110 00000 0011
Q ss_pred CCH-HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNI-EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~-~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
... .....+.+++.+||+.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 13457999999999999999999999983
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=268.56 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=198.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-----hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-----EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+|+..+.||+|++|.||+|.+. ++..+++|.+.... ......+..|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999987 78899999876533 23445688899999999999999999999998999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
+||+++++|.+++.. .+.+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999999999844 35689999999999999999999999 99999999999999999999999999887654332
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
......++..|++||.+.....++.++|+||||+++++|++|+.||......... ......... .
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~-------~ 221 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKEL-------P 221 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcccC-------C
Confidence 1122337888999999844334889999999999999999999999765421111 111110111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+......+.+++.+||+.+|.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 122223467899999999999999999999984
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=270.96 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=201.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|+..++.++|+|++++++.+......++++|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 6889999999999999999876 67788899875432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 112 RNGSLGNLLFRA--EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 112 ~~~~L~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
++++|.+++... ...+++..+..++.|++.|+.+||+. |++|+|++|+||++++++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999998543 24689999999999999999999999 9999999999999999999999999988765433222
Q ss_pred ---ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 190 ---TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 190 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
......++..|+|||.+.....++.++|+||||+++++|++|+.||.......... ..... .... .. .
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~~~~-~~~~-~~-~ 229 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM------LTLQN-DPPS-LE-T 229 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH------HHhcC-CCCC-cC-C
Confidence 11222367889999998555578899999999999999999999997553322111 11110 0000 00 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..........+.+++.+||+.+|++|||++++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011234567899999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.96 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=202.5
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCC--------CcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEe
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCING--------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFC 98 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~--------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 98 (325)
++...+|++.+.||+|+||.||+|.+.. ...+++|.+.... ......+.+|+.+++++ +||||+++++.+
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 4556789999999999999999997531 2357888776432 33345788899999999 799999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
...+..++++||+++++|.+++.... ..++...+..++.|++.|+.|||++ |++|+||+|+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 98889999999999999999985422 2477888899999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
|+++.++.++|+|||++.......... .....++..|+|||.+ ....++.++||||||+++++|++ |..||......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh-ccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999987554322111 1111134579999998 56677889999999999999998 88888654322
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
+.. ........ .+........+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 244 ~~~-------~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 244 ELF-------KLLKEGHR-------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHH-------HHHHcCCC-------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 211 11111111 1112233457999999999999999999999999999888
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=269.49 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=196.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..+|++.+.||+|+||.||.+.. .+..+++|.+.... ....+.+|+.+++.++|||++++++.+..+ ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 46799999999999999999875 57778999876532 335678899999999999999999998654 579999999
Q ss_pred CCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
.+++|.+++.... ..+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 9999999985443 3588999999999999999999999 999999999999999999999999998865432211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
....+..|+|||.+ ....++.++|+||||+++++|++ |+.||......+.. .....+. ....
T Consensus 156 --~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~-------~~~~ 218 (254)
T cd05083 156 --NSKLPVKWTAPEAL-KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKGY-------RMEP 218 (254)
T ss_pred --CCCCCceecCHHHh-ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCCC-------CCCC
Confidence 11235679999988 45678889999999999999997 99998765432111 1111110 0111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
....+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 12234678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=269.92 Aligned_cols=250 Identities=27% Similarity=0.369 Sum_probs=203.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+|++.+.||.|++|.||+|.+. .++.+++|++..... .....+..|+..+..++|+|++++++++......+++|||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5788999999999999999988 588999998866443 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++++|.+++... ..+++..++.++.|++.++.+||+ . +++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 999999998543 679999999999999999999999 9 99999999999999999999999999887654333221
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
....++..|+|||.+ ....++.++|+||||+++++|++|+.||.............. ...... ....
T Consensus 158 -~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~~~-------~~~~ 224 (264)
T cd06623 158 -NTFVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDGPP-------PSLP 224 (264)
T ss_pred -cceeecccccCHhhh-CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----HhcCCC-------CCCC
Confidence 122367889999998 556788899999999999999999999976643221111111 111111 1112
Q ss_pred HH-HHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 271 IE-EFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 271 ~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.. .+..+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 22 4467999999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=271.82 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=195.8
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecC------Cc
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEG------SN 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~ 103 (325)
.+.|++.+.||+|+||.||+|.+. .+..+++|.+... ......+..|+.+++.+ +||||+++++.+... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 467999999999999999999887 5777888887543 34455788899999998 699999999988542 45
Q ss_pred eEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
.+++|||+.+++|.+++... ...+++..+..++.|++.|++|||++ +++|+|++|+||+++.++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 78999999999999988653 34689999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCccceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
...... ......++..|+|||.+.. ...++.++|+||||+++++|++|+.||.......... ......
T Consensus 161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-------~~~~~~ 232 (272)
T cd06637 161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-------LIPRNP 232 (272)
T ss_pred cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHhcCC
Confidence 433221 1222347889999998742 2357789999999999999999999996543221111 111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.... ........+.+++.+||+.+|.+|||+.++++
T Consensus 233 ~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRL------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 11123356899999999999999999999984
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=270.61 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=196.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch----------hcHHHHHHHHHHHhccCCCCcceeeEEeecCC
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE----------EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS 102 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (325)
+|.+.+.||.|++|.||+|... ++..+++|.+..... ...+.+..|+..++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999876 688899998753211 11235778999999999999999999999989
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+++++|.+++... +.++...+..++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998544 6789999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCcc-ceeeecCCCCcCCccccccCC-CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 183 LKTDQTR-TYTVLRGTRGYTAPELHSRNN-RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 183 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
....... ......++..|+|||.+.... .++.++|+||||+++++|++|..||.......... .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~-~~~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF------KLGN-KRSA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH------Hhhc-cccC
Confidence 4322111 111233678899999885433 47889999999999999999999996432211100 0000 0101
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+ ...........+.+++.+||+.+|++|||++++++
T Consensus 231 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPI--PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcC--CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 011 11122234567999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=273.68 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=204.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.||+|+||.||++.+. .+..+++|.+..........+.+|+.+++.++|||++++++.+......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 479999999999999999999875 6788999988654445556788899999999999999999999988999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++.+ ..++...+..++.|++.|+.+||++ |++|+|++|+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred CCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 999999999843 3578999999999999999999999 9999999999999999999999999987655433221
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....+++.|++||.+ ....++.++|+||||+++++|++|+.||............ .. .. .......
T Consensus 172 ~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~-~~-----~~~~~~~ 238 (293)
T cd06647 172 RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT-NG-----TPELQNP 238 (293)
T ss_pred cccccCChhhcCchhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hc-CC-----CCCCCCc
Confidence 1122367789999998 4566788999999999999999999999765432211100 00 00 0011111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
......+.+++.+||..+|.+||++.+++ ..++...+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 22345689999999999999999999999 45655553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=269.26 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=199.3
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|++|.||+|.+. ++..+++|.+..... .....+..|+.+++.++|+||+++++.+......++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4888999999999999999876 688899998865443 2566788999999999999999999999888999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++.. ...+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 999999999844 35688999999999999999999999 99999999999999999999999999987664433221
Q ss_pred ee---eecCCCCcCCccccccCC--CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 191 YT---VLRGTRGYTAPELHSRNN--RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 191 ~~---~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
.. ...++..|+|||.+.... ..+.++||||||+++++|++|+.||......... .+. ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~---~~~---~~~~~-----~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFH---VGAGH-----KP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH---HHH---HhcCC-----CC
Confidence 11 233678999999984332 3788999999999999999999999754321111 000 00000 00
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...........+.+++.+||+.+|.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111122456889999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=268.03 Aligned_cols=255 Identities=24% Similarity=0.275 Sum_probs=208.4
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
+-..+-..++++++.||+|.-|+||++...+ +..+|+|++.+.. .+....++.|-++|+.+.||.++.+|..++.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 3345667899999999999999999999984 5889999998744 34445577899999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
...+++||||+||+|..+.++. .+.+++..++.++..++.||.|||.. |||+|||||+||||.++|+|-|+||.++
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccc
Confidence 9999999999999999887544 45699999999999999999999999 9999999999999999999999999886
Q ss_pred ccccCCC-------------------------------c-c-----------------------ceeeecCCCCcCCccc
Q 047716 181 KLLKTDQ-------------------------------T-R-----------------------TYTVLRGTRGYTAPEL 205 (325)
Q Consensus 181 ~~~~~~~-------------------------------~-~-----------------------~~~~~~~~~~y~aPE~ 205 (325)
....... . . ......||.+|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 5331100 0 0 0000227889999999
Q ss_pred cccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC--CHHHHHHHHHHHhh
Q 047716 206 HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV--NIEEFENLVKIGLW 283 (325)
Q Consensus 206 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 283 (325)
+ .+...+.++|=|+||+++|||+.|..||.+....+... .++...... .+..+..+++||.+
T Consensus 307 I-~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~ 370 (459)
T KOG0610|consen 307 I-RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRK 370 (459)
T ss_pred e-ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHH
Confidence 9 67777889999999999999999999999887654332 122222111 12445679999999
Q ss_pred cccCCCCCCCC----HhHHH
Q 047716 284 CVECELNLRPT----MKQVI 299 (325)
Q Consensus 284 ~l~~~p~~Rps----~~ell 299 (325)
.|.+||.+|.- +.||.
T Consensus 371 LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 371 LLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred HhccChhhhhccccchHHhh
Confidence 99999999998 88887
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=272.74 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=198.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..|+-.+.||.|++|.||++.+. .+..+++|++..........+.+|+.+++.++|||++++++++...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 34555678999999999999876 67889999886555555566889999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
.+++|.+++.. .+++...+..++.|++.++.+||++ |++|+||+|+||+++.++.++++|||.+......... .
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~ 172 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-R 172 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-c
Confidence 99999999854 5789999999999999999999999 9999999999999999999999999987654332221 1
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
....++..|+|||.+ ....++.++|+||||+++++|++|+.||......... . ...... . .......
T Consensus 173 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~-~~~~~~-~----~~~~~~~ 239 (285)
T cd06648 173 KSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------K-RIRDNL-P----PKLKNLH 239 (285)
T ss_pred ccccCCccccCHHHh-cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------H-HHHhcC-C----CCCcccc
Confidence 223378899999998 4556788999999999999999999999754321111 1 111110 0 1111111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 23457999999999999999999999993
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=273.88 Aligned_cols=259 Identities=24% Similarity=0.309 Sum_probs=198.6
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--CceEEEEe
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNRLLVYE 109 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 109 (325)
|++.++||.|++|.||+|.+. .+..+++|++.... ......+..|+.+++.++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999987 57889999987653 33345677899999999999999999999887 78999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|++ ++|.+++......+++..++.++.|++.|+.+||+. +++|+||+|+||++++++.++++|||++.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 996 488888855546799999999999999999999999 9999999999999999999999999998766544321
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC---ccc---cc-
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG---ELQ---NL- 262 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~- 262 (325)
......++..|+|||.+.+...++.++||||||+++++|++|+.||........... ........ .+. ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchhhccccccch
Confidence 222223577899999875556678999999999999999999999976543221111 11100000 000 00
Q ss_pred ----ccCCCC-------CCHH-HHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 263 ----VSDQED-------VNIE-EFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 263 ----~~~~~~-------~~~~-~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...... .... ....+.+++.+||+.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 0000 1467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=269.56 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=197.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeec--CCceEEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--GSNRLLVY 108 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 108 (325)
+|++.+.||.|++|.||+|.+. .+..+++|.+... .......+..|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999876 6778888887542 23344567889999999999999999997753 45679999
Q ss_pred eecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhh-----ccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 109 EFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLH-----DECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 109 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh-----~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
||+++++|.+++... ...+++..++.++.|++.|+.+|| +. +++|+||+|+||+++.++.++++|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988543 457899999999999999999999 77 9999999999999999999999999998
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
......... .....++..|+|||.+ ....++.++|+||||+++++|++|+.||....... . .+........
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~----~~~~~~~~~~ 228 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQL-NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---L----ASKIKEGKFR 228 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhh-cCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---H----HHHHhcCCCC
Confidence 866443321 1122378899999998 45668889999999999999999999998654211 1 1112222111
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+......+.+++.+||+.+|++||++++|++
T Consensus 229 -------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 -------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 122234467999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=266.88 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=202.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
.|++.+.||+|++|.||++.+. ++..+++|++..........+.+|+..++.++||+++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999987 688899999876555556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+++|.+++......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 9999999865546799999999999999999999998 999999999999999999999999999876654332 22
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
...++..|+|||.+ .....+.++|+||||+++++|++|+.||.......... . ........ ......
T Consensus 156 ~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~~-----~~~~~~ 222 (253)
T cd05122 156 TMVGTPYWMAPEVI-NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------K-IATNGPPG-----LRNPEK 222 (253)
T ss_pred ceecCCcccCHHHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------H-HHhcCCCC-----cCcccc
Confidence 23478899999998 45557889999999999999999999997553221111 0 00011111 111111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 273 EFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+.+++.+||+.+|++|||+.|+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2467999999999999999999999984
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.96 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=187.8
Q ss_pred hhcCcCCceeEEEEEeCC---CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCING---GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~---~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+.||+|+||.||+|.+.+ +..+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998653 4568888876533 233446888999999999999999999998888899999999999
Q ss_pred CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc-
Q 047716 115 SLGNLLFRAE----QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR- 189 (325)
Q Consensus 115 ~L~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~- 189 (325)
+|.+++.... ...++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999985422 2456778889999999999999999 9999999999999999999999999988643322211
Q ss_pred ceeeecCCCCcCCccccccC------CCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 190 TYTVLRGTRGYTAPELHSRN------NRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
......++..|+|||.+... ..++.++|+||||+++++|++ |+.||......+... .. . .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~---~-~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YT---V-REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH---h-hcccCCC
Confidence 11122356789999988432 135789999999999999996 999997654322111 00 0 1111111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
..+ .........+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~--~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKP--RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCC--ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111 111122345888999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=273.13 Aligned_cols=246 Identities=23% Similarity=0.292 Sum_probs=196.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
..|++.+.||+|++|.||+|++. +++.+++|++.... ......+.+|+.+++.++||||+++.+++......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999986 68889999886432 223346788999999999999999999999989999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+. +++.+++....+.+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence 9996 577777755566799999999999999999999999 99999999999999999999999999886543222
Q ss_pred cceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 189 RTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
...++..|+|||.+.. ...++.++||||||+++|+|++|.+||........... ..... ..
T Consensus 170 ----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-------~~~~~------~~ 232 (307)
T cd06607 170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------IAQND------SP 232 (307)
T ss_pred ----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-------HhcCC------CC
Confidence 1236788999998742 35578899999999999999999999976532211110 00000 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..........+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1111224467999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=276.77 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=199.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCc----EEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGK----EIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~----~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+...+|+..+.||+|++|.||+|.+. .+. .+++|.+..... .....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 34567888999999999999999875 333 467777654332 2234678899999999999999999998654 4
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
..++++|+++++|.+++......+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 6799999999999999866556789999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 184 KTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
...... ......++..|+|||.+ .+..++.++||||||+++++|++ |+.||........ .. ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~~-- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECI-HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PD----LLEKGER-- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHh-ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHCCCC--
Confidence 432221 11112245689999988 56678899999999999999997 8899876432211 11 1111110
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..........+.+++..||..+|++||++.++++.|+.+.
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 -----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111122346889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=274.68 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=196.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++++.||.|++|.||+|++. .+..+++|++.... ......+.+|+++++.++||||+++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999986 68889999876432 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 111 MRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
+. ++|.+++... ...+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 95 5788877443 35689999999999999999999999 9999999999999999999999999988754332211
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh-------------
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA------------- 256 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 256 (325)
.....++..|+|||.+.+...++.++|+||||+++++|++|+.||......+... .........
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCCChhhhhhhhHHHH
Confidence 1112257789999988555667889999999999999999999997654322111 100000000
Q ss_pred --CcccccccCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 257 --GELQNLVSDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 257 --~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+....... ....+.....+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0011122356889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=278.34 Aligned_cols=260 Identities=24% Similarity=0.285 Sum_probs=197.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh--cHHHHHHHHHHHhccCCCCcceeeEEeecC--CceEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE--GESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 106 (325)
..+|++.+.||.|++|.||+|.+. .+..+++|++...... ....+.+|+.+++.++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999987 6888999988643222 223456799999999999999999998654 56899
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+. ++|.+++......+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999996 478888865557799999999999999999999999 9999999999999999999999999998765433
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC---------
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG--------- 257 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 257 (325)
.... ....++..|+|||.+.+...++.++|+||||+++++|++|++||......+....+ .......
T Consensus 162 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKPM-TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI---IQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCC-CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChhhchhhh
Confidence 2111 11124678999999866667889999999999999999999999865443222111 1111000
Q ss_pred --cc-cccccC--CCC----CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 258 --EL-QNLVSD--QED----VNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 258 --~~-~~~~~~--~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.. ...... ... ........+.++|.+||+.||++|||++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 00 000000 000 0011245688999999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=273.31 Aligned_cols=259 Identities=22% Similarity=0.253 Sum_probs=194.2
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccC-CCCcceeeEEeecC--CceEEEEe
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEG--SNRLLVYE 109 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 109 (325)
|++.++||+|++|.||+|.+. ++..+++|++.... .........|+..+.++. |||++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999986 68889999876532 222233456888888885 99999999999877 88999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+. +++.+.+......+++..++.++.|++.|+.+||+. +++|+||+|+||+++. +.++|+|||++.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 996 577777755556789999999999999999999999 9999999999999999 99999999998765433221
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH--------HHHHHHhCcccc
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW--------AHQCYEAGELQN 261 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 261 (325)
. ...++..|+|||.+.....++.++|+||||+++++|++|.+||......+....+.- ............
T Consensus 156 ~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 156 T--EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred C--CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 1 123678899999875666778899999999999999999999976543221110000 000000000000
Q ss_pred cccCC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 LVSDQ------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...+. .......+..+.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000 0011234578999999999999999999999984
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=282.09 Aligned_cols=272 Identities=26% Similarity=0.392 Sum_probs=221.1
Q ss_pred ccccHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcH-HHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 23 RSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE-SEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 23 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
...++.++..+.-.++++||+|-||.|.++...++..||+|++......+. +.|.+|+++|.+++||||+.++++|..+
T Consensus 528 k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 528 KGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred cCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 346788899999999999999999999999999889999999988776665 7899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
+.+++|+||++.|+|.+|+..+.-+ ........++.||+.|++||.+. +++|||+.+.|+|+++++++|++|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 9999999999999999999665322 34455567999999999999999 9999999999999999999999999998
Q ss_pred ccc-cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHH--hCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 181 KLL-KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV--CCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 181 ~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
+.. ..+..........+.+|+|||.+ -.+++++++|+|++|+++||++ +...||....+++ .++.....+..+
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsi-llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~ 760 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESI-LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQ 760 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHH-HhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCC
Confidence 743 22233333333356799999998 5778899999999999999974 6778887654432 223333334333
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
....++.. ++-++..+.++|..||..+-.+|||++++...|++.
T Consensus 761 ~~~~~l~~----P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSR----PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccC----CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 33333332 334555688999999999999999999999888764
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=273.16 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=195.0
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEee-----cCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCS-----EGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~ 103 (325)
...+|++.+.||+|++|.||+|.+. .+..+++|++... ......+..|+.+++.+ +||||+++++.+. .+..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 3578999999999999999999886 5778888876542 22345677899999999 6999999999873 3456
Q ss_pred eEEEEeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 104 RLLVYEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
.+++|||+++++|.+++.. ....+++..++.++.|++.|+.+||+. +++|+|++|+||+++.++.++++|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCce
Confidence 8999999999999988742 235688999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
......... .....++..|+|||.+.. ...++.++|+||||+++++|++|+.||.......... . ...
T Consensus 172 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~------~-~~~ 243 (286)
T cd06638 172 AQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF------K-IPR 243 (286)
T ss_pred eecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh------h-ccc
Confidence 765432211 122237889999998742 2446889999999999999999999997553321110 0 000
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
........+......+.+++.+||+.+|++|||+.|+++.
T Consensus 244 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 -----NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -----cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000000111123569999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=266.73 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=197.1
Q ss_pred HHhhhhhcCcCCceeEEEEEeCC--CcEEEEEEeecc----------chhcHHHHHHHHHHHhc-cCCCCcceeeEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCING--GKEIAVKKLIKI----------VEEGESEFRNEMKIIGR-IHHKNLVDLVGFCSE 100 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~~--~~~~~vk~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 100 (325)
+|++.+.||+|++|.||+|.+.. ++.+++|.+... .......+..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999874 678888987532 12223446678887764 789999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEee
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISD 176 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~D 176 (325)
++..+++|||+++++|.+++.. ....+++..++.++.|++.++.+||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988733 34568999999999999999999996 5 899999999999999999999999
Q ss_pred ccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 177 FGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 177 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
||.+....... ......++..|++||.+ ....++.++|+||||+++|+|++|++||......... .....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~-~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~-------~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA-------TKIVE 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhh-cCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-------HHHhh
Confidence 99987654332 22223478889999998 4566789999999999999999999999654321111 11111
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
....... .......+.+++.+||+.||++||++.|+..+++.
T Consensus 228 ~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYEPLP------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCCcCC------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1111111 11223569999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=294.21 Aligned_cols=265 Identities=18% Similarity=0.237 Sum_probs=190.9
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC------CCCcceeeEEeecC-C
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH------HKNLVDLVGFCSEG-S 102 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~-~ 102 (325)
...+|++.++||+|+||.||+|.+. .+..||+|++.... ........|+.+++.++ |.+++.+++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 3578999999999999999999886 57789999885432 22334455676666665 44588888888654 5
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCC-----------
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESW----------- 170 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~----------- 170 (325)
+.++||+++ +++|.+++.+ .+.+++..+..++.|++.||.|||+ . ||+|+||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred eEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccccccc
Confidence 789999988 7788888743 4579999999999999999999997 6 999999999999998665
Q ss_pred -----cEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhh
Q 047716 171 -----KAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245 (325)
Q Consensus 171 -----~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 245 (325)
.+||+|||.+...... .....+++.|+|||.+ .+..++.++|||||||++|+|++|++||......+...
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~-~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVV-LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCCceEEECCCCccccCccc----cccccCCccccCcHHh-hcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 4999999987543221 1223489999999998 56678899999999999999999999998765433222
Q ss_pred HHHH---------HHH--------HHH-hCcccccccC---------CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHH
Q 047716 246 LIDW---------AHQ--------CYE-AGELQNLVSD---------QEDVNIEEFENLVKIGLWCVECELNLRPTMKQV 298 (325)
Q Consensus 246 ~~~~---------~~~--------~~~-~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 298 (325)
.+.. ... .+. ...+.....+ ...........+.+||.+||+.||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 2111 000 000 0000000000 000001113457899999999999999999999
Q ss_pred HH--HHhccC
Q 047716 299 IW--MMEGIV 306 (325)
Q Consensus 299 l~--~L~~~~ 306 (325)
++ ++....
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 94 555544
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=275.48 Aligned_cols=265 Identities=24% Similarity=0.317 Sum_probs=199.3
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC---
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS--- 102 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 102 (325)
+....+|++.+.||.|++|.||+|.+. .+..+++|.+.... ......+..|+.+++.++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 355788999999999999999999987 57888999886533 223345678999999999999999999876543
Q ss_pred -------ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEe
Q 047716 103 -------NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175 (325)
Q Consensus 103 -------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~ 175 (325)
..++++||+++ ++.+.+......+++..++.++.|++.|++|||+. +++|+||+|+||++++++.++|+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 67777755556799999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH
Q 047716 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 176 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
|||.+...............++..|+|||.+.+....+.++||||||+++++|++|++||......+....+ .....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~---~~~~~ 235 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI---SRLCG 235 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhC
Confidence 999987654433222222225678999998855556788999999999999999999999764432221111 11110
Q ss_pred hC---cccccccC--------------C-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 256 AG---ELQNLVSD--------------Q-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 256 ~~---~~~~~~~~--------------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.. .+..+... . .......+..+.+++.+||+.+|.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00000000 0 0000012456899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=270.07 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=192.2
Q ss_pred hhcCcCCceeEEEEEeCC-------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 39 EEIGRGGSGRVYKGCING-------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~-------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+.||+|++|.||+|++.+ +..+++|.+.... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998752 2467888775432 23455688899999999999999999999888899999999
Q ss_pred cCCCCHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-----cEEEeeccc
Q 047716 111 MRNGSLGNLLFRA------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-----KAKISDFGL 179 (325)
Q Consensus 111 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-----~vkl~Dfg~ 179 (325)
+++++|.+++... ...+++..+..++.|++.++.|||+. +++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999988542 23478899999999999999999999 999999999999999887 899999999
Q ss_pred cccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 180 SKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 180 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
+........ ........+..|+|||.+ ....++.++||||||+++++|++ |..||......+. ... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~----~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH----VTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHH-ccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH----HhcC
Confidence 865432211 111112245789999998 45667899999999999999998 9999875432211 111 1111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
.........+..+.+++.+||+.+|.+||+++++++.|++
T Consensus 230 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 -------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111222334678999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=277.37 Aligned_cols=195 Identities=25% Similarity=0.398 Sum_probs=156.9
Q ss_pred hhcCcCCceeEEEEEeC---CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec--CCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN---GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--GSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 113 (325)
.+||+|+||.||+|+.. .+..+++|.+.... ....+.+|+.+++.++||||+++++++.. +...++++||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 57999999999999865 35678899875432 23457789999999999999999998743 467799999985
Q ss_pred CCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE----cCCCcEEEeeccccc
Q 047716 114 GSLGNLLFRA--------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM----DESWKAKISDFGLSK 181 (325)
Q Consensus 114 ~~L~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv----~~~~~vkl~Dfg~~~ 181 (325)
++|.+++... ...+++..++.++.|++.|+.|||+. +++|+||||+||++ +.++.++|+|||++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 4776665321 12478899999999999999999999 99999999999999 456789999999997
Q ss_pred cccCCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcc
Q 047716 182 LLKTDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESL 239 (325)
Q Consensus 182 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 239 (325)
........ ......++..|+|||.+.+...++.++||||||+++++|++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 65433221 11223368899999998655678899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=274.53 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=200.3
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh--cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE--GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
|++.+.||.|++|.||+|... ++..+++|.+...... ....+..|+.+++.++|+||+++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567889999999999999986 6888999987653322 3456778999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++ ++.+++......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 65 88888766556899999999999999999999999 99999999999999999999999999987665433 111
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh---Cccccccc----
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA---GELQNLVS---- 264 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---- 264 (325)
....++..|+|||.+.+...++.++|+||||+++++|++|+.||......+....+. ..+.. ..+.....
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF---RTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCchHhcccchhhhhh
Confidence 222367789999998555578899999999999999999999997655432211110 00000 00000000
Q ss_pred -----------CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 265 -----------DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 265 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
......+.....+.++|.+||+.+|.+||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 001122334578999999999999999999999984
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=286.21 Aligned_cols=258 Identities=18% Similarity=0.235 Sum_probs=192.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
...|.+.+.||+|+||.||+|.+. .+..+++|.... ..+.+|+.+|+.++||||+++++++...+..+++|++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 447999999999999999999987 577888885322 2356799999999999999999999888999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc-
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR- 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~- 189 (325)
+ .++|.+++......+++..++.++.|++.||.|||++ ||+|+||||+|||++.++.++|+|||++.........
T Consensus 242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9 4688888755556799999999999999999999999 9999999999999999999999999998755332211
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc-----hhhHHHHHHHHHH-hCcccccc
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD-----EIVLIDWAHQCYE-AGELQNLV 263 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~ 263 (325)
......|+..|+|||.+ .+..++.++|||||||++|+|++|..++....... ...+......... ...+....
T Consensus 318 ~~~~~~GT~~Y~APE~~-~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHH-cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 11223489999999998 55678899999999999999999887654322111 0111111111000 00000000
Q ss_pred ----------------c---CCCCCC--HHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 264 ----------------S---DQEDVN--IEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 264 ----------------~---~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. ....+. ......+.+|+.+||+.||.+|||+.|+++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 000000 011236889999999999999999999994
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=274.23 Aligned_cols=262 Identities=20% Similarity=0.315 Sum_probs=198.3
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+|++.++||.|++|.||+|++. ++..+++|++..... .....+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999987 688899998865432 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 112 RNGSLGNLLFRAE--QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
.+ +|.+++.... ..+++..+..++.|++.|+.+||+. |++|+||+|+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 74 8888775443 4689999999999999999999999 999999999999999999999999999865433211
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHHH-hCccc
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCYE-AGELQ 260 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~-~~~~~ 260 (325)
......++..|++||.+.+...++.++|+||||+++++|++|.+||......+....+... ...+. ...+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1111225788999998866666788999999999999999999999866543221111000 00000 00000
Q ss_pred ccccCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 261 NLVSDQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 261 ~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.-.... ....+.....+.+++.+|++.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0011223466889999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.73 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=192.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-----hhcHHHHHHHHHHHhccCCCCcceeeEEeec--CCceE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-----EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--GSNRL 105 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 105 (325)
+|++.+.||+|++|.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6888999999999999999886 58889999875432 1223457889999999999999999998865 35678
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+++||+++++|.+++.. .+.+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 99999999999998843 45689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 186 DQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 186 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
... .......++..|+|||.+ ....++.++|+||||+++++|++|+.||......... .......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~------ 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVI-SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQP------ 225 (266)
T ss_pred ccccCCccccCCccccccCHHHh-CCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCC------
Confidence 111 111122367889999998 4567888999999999999999999999754321111 0100000
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+......+.+++ +||..+|++||+++|+++
T Consensus 226 -~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01222233445677777 788899999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.64 Aligned_cols=250 Identities=25% Similarity=0.258 Sum_probs=198.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh---cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE---GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|++|.||+|... .++.+++|.+...... ....+..|+.+++.++||||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5888999999999999999987 5889999988754322 34567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+.+++|.+++... ...+++..++.++.|++.++.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998543 35689999999999999999999999 999999999999999999999999998765432111
Q ss_pred c----------------------------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccc
Q 047716 189 R----------------------------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLR 240 (325)
Q Consensus 189 ~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 240 (325)
. ......++..|+|||.+ .+..++.++||||||+++++|++|..||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH-cCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 00012367789999998 456678899999999999999999999976543
Q ss_pred cchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC----HhHHHH
Q 047716 241 DDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT----MKQVIW 300 (325)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~ell~ 300 (325)
..... ... ..... ..........+.+++.+||+.+|++||| ++|++.
T Consensus 238 ~~~~~------~~~-~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFS------NIL-KKEVT------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHH------HHh-cCCcc------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 22111 000 11100 0011114467999999999999999999 777774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=275.83 Aligned_cols=254 Identities=20% Similarity=0.186 Sum_probs=197.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||+|++|.||++.+. .++.+++|.+.... ......+.+|+.+++.++||||+++++.+..++..+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999987 57889999886543 2233467789999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT- 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~- 188 (325)
|+++++|.+++.. .+.+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 9999999999844 45789999999999999999999999 999999999999999999999999998753111000
Q ss_pred -------------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH
Q 047716 189 -------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 189 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
.......++..|+|||.+ ....++.++|+||||+++++|++|..||.+....+. ... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~------~~~-~~ 229 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVI-LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQ-VI 229 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HH
Confidence 000112357789999998 456678999999999999999999999975432211 111 11
Q ss_pred hCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 256 AGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
..... . +......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~~~~-~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDDIE-W----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcccC-C----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11100 0 00111234568999999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=270.10 Aligned_cols=257 Identities=25% Similarity=0.318 Sum_probs=196.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeec--CCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSE--GSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 109 (325)
+|+..+.||.|++|.||+|.+. .+..+++|.+..... .....+.+|+++++.++||||+++++++.. .+..+++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5778899999999999999986 578888888764322 344568889999999999999999998754 346899999
Q ss_pred ecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 110 FMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 110 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|+++++|.+++.. ....++...+..++.|++.++.|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999887643 245688999999999999999999999 9999999999999999999999999998654322
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
... ...++..|+|||.+ .+..++.++|+||||+++++|++|..||....... ....+.... ...... ..+...
T Consensus 159 ~~~---~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~~~~~-~~~~~~ 231 (287)
T cd06621 159 LAG---TFTGTSFYMAPERI-QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSY-IVNMPN-PELKDE 231 (287)
T ss_pred ccc---cccCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHH-HhcCCc-hhhccC
Confidence 211 22367889999998 56678889999999999999999999998663311 111111111 111011 111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+.+.+++.+||+.+|.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111223467999999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=271.21 Aligned_cols=247 Identities=26% Similarity=0.264 Sum_probs=199.9
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+|++.+.||.|++|.||+|.+. .+..+++|.+..... .....+.+|+++++.++||||+++++.+.+....++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999987 688899998875332 345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+.+++|.+++... ..+++..+..++.|+++++.+||++ +++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 155 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL- 155 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence 99999999998543 6789999999999999999999999 999999999999999999999999998876543321
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....++..|+|||.+ ....++.++|+||||+++++|++|+.||.......... ....... .....
T Consensus 156 -~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~--------~~~~~ 221 (258)
T cd05578 156 -TTSTSGTPGYMAPEVL-CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQET--------ADVLY 221 (258)
T ss_pred -ccccCCChhhcCHHHH-cccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhcc--------ccccC
Confidence 1223367889999998 45558899999999999999999999998665421111 1111110 11122
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCH--hHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTM--KQVI 299 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~--~ell 299 (325)
+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22334679999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=272.24 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=196.0
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
|++.+.||.|++|.||+|.+. ++..+++|++.... ......+.+|+..++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999986 78899999886433 222345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+ ++|.+++.... ..+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68888874433 3689999999999999999999999 9999999999999999999999999998654322211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH-----------HhCcc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY-----------EAGEL 259 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~ 259 (325)
.....++..|+|||.+.....++.++|+||||+++++|++|++||...........+ ..... .....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI--FRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCChHHhhhhhhchhh
Confidence 111225778999998755556788999999999999999999999765432221111 00000 00000
Q ss_pred c-cccc----CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 260 Q-NLVS----DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 260 ~-~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. .+.. ......+.....+.+++.+||+.+|.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000 001111223356899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=272.67 Aligned_cols=258 Identities=25% Similarity=0.286 Sum_probs=201.3
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS 102 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (325)
+.+-....|+..+.||+|+||.||+|.+. ++..+++|++.... ......+..|+.+++.++|||++++++++..+.
T Consensus 19 ~~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 19 FKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred cCCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 33344566899999999999999999976 67889999876432 233446788999999999999999999999989
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+. +++.+.+......+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++++|||++..
T Consensus 99 ~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 99 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred eEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 9999999996 477777755566789999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCccceeeecCCCCcCCccccc--cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
..... ...++..|+|||.+. ....++.++|+||||+++++|++|+.||.......... .... ...
T Consensus 175 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-~~~- 241 (317)
T cd06635 175 ASPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NES- 241 (317)
T ss_pred cCCcc-----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHHh-ccC-
Confidence 43322 123678899999873 23557889999999999999999999987643221111 1111 100
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...........+.+++.+||+.+|.+||++.++++.+-.+.
T Consensus 242 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 -----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00111123456899999999999999999999996544333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=269.40 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=202.1
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
....|++.+.||+|++|.||+|.+. .+..+++|++..... ....+..|+..++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567889999999999999999987 688899998875443 45668889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++......++...+..++.|++.++.+||+. |++|+|++|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 9999999999965544799999999999999999999999 999999999999999999999999998765433221
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
......++..|+|||.+ .+..++.++|+||||+++++|++|..||.......... . ........ ...
T Consensus 172 ~~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~-~~~~~~~~-----~~~ 238 (286)
T cd06614 172 KRNSVVGTPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------L-ITTKGIPP-----LKN 238 (286)
T ss_pred hhccccCCcccCCHhHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhcCCCC-----Ccc
Confidence 11222367889999988 45667899999999999999999999997543321111 0 11111110 111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.......+.+++.+||+.+|.+|||+.+++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 112345799999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=267.31 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=185.4
Q ss_pred hhcCcCCceeEEEEEeCC---CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCING---GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~---~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+.||+|+||.||+|.... ...+++|.+.... ......+.+|+..++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3457777665432 233445778999999999999999999999889999999999999
Q ss_pred CHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-c
Q 047716 115 SLGNLLFRAEQ----RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT-R 189 (325)
Q Consensus 115 ~L~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~-~ 189 (325)
+|.+++..... ..++..+..++.|++.|++|||++ +++|+||||+||+++.++.++++|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999854332 246777889999999999999999 999999999999999999999999998864322211 1
Q ss_pred ceeeecCCCCcCCcccccc------CCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 190 TYTVLRGTRGYTAPELHSR------NNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
......++..|+|||.+.. ...++.++||||||+++++|++ |..||......+. ....... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~-~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVRE-QDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhhc-cCccC
Confidence 1111224567999998642 2356789999999999999999 7778765432211 0111111 11111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
.. +.........+.+++..|+ .+|++|||+++|++.|.
T Consensus 231 ~~--~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PK--PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC--CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 1122234456778888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=267.54 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=198.0
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
.-|++.+.||.|+||.||+|.+. ++..+++|.+.... ......+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45788899999999999999876 67889999875432 33345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++. ...++...+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 84 ~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 84 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence 99999999884 34689999999999999999999999 9999999999999999999999999988655432211
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....++..|+|||.+ .....+.++|+||||+++++|++|..||......... ....... .....
T Consensus 158 ~~~~~~~~~y~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~-------~~~~~ 222 (277)
T cd06641 158 RNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL-------FLIPKNN-------PPTLE 222 (277)
T ss_pred hccccCCccccChhhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH-------HHHhcCC-------CCCCC
Confidence 1122367789999998 4566788999999999999999999999754321111 0111111 11122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
......+.+++.+||+.+|.+||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 233467899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=277.09 Aligned_cols=273 Identities=22% Similarity=0.276 Sum_probs=201.2
Q ss_pred cccccHHH---HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceee
Q 047716 22 LRSFSYEQ---IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLV 95 (325)
Q Consensus 22 ~~~~~~~~---~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~ 95 (325)
++++.+++ ....+|++.+.||+|++|.||+|.+. .+..+++|.+... .......+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (353)
T cd07850 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81 (353)
T ss_pred ceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCccee
Confidence 34455555 45789999999999999999999987 6889999988642 223345677899999999999999999
Q ss_pred EEeecC------CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC
Q 047716 96 GFCSEG------SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 96 ~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~ 169 (325)
+++... ...++||||+. ++|.+.+.. .++...+..++.|++.|+.+||++ |++|+||+|+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~ 154 (353)
T cd07850 82 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD 154 (353)
T ss_pred eeeccCCCccccCcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC
Confidence 987543 35799999995 578777632 288999999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHH-
Q 047716 170 WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLID- 248 (325)
Q Consensus 170 ~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~- 248 (325)
+.++|+|||++........ .....++..|+|||.+ .+..++.++||||||+++++|++|+.||...........+.
T Consensus 155 ~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 155 CTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CCEEEccCccceeCCCCCC--CCCCcccccccCHHHH-hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999999876543322 1122367889999998 56678899999999999999999999997553221110000
Q ss_pred --------H-------HHHHHHh-C-----cccccccCC------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--
Q 047716 249 --------W-------AHQCYEA-G-----ELQNLVSDQ------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI-- 299 (325)
Q Consensus 249 --------~-------~~~~~~~-~-----~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell-- 299 (325)
+ ....... . .+....... ..........+.+++.+||+.||++|||+.|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000000 0 000000000 000112345689999999999999999999999
Q ss_pred HHHhc
Q 047716 300 WMMEG 304 (325)
Q Consensus 300 ~~L~~ 304 (325)
..|+.
T Consensus 312 ~~~~~ 316 (353)
T cd07850 312 PYINV 316 (353)
T ss_pred hhHhh
Confidence 44543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.14 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=194.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCC-------
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------- 102 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 102 (325)
++|++.++||+|++|.||+|.+. ++..+++|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46999999999999999999987 688899998764322 22334567999999999999999999876543
Q ss_pred -ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 103 -NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 103 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
..++||||+. ++|.+.+......+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999995 578887755555799999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCcc---ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 182 LLKTDQTR---TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 182 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
........ ......++..|+|||.+.+...++.++|+||||+++++|++|++||...........+.........+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 55332211 111223577899999885555578899999999999999999999976543322221111110000000
Q ss_pred ccc-----------cccCCCCC------CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQN-----------LVSDQEDV------NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~-----------~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+.. ........ .......+.++|.+||+.||.+|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 00000000 0001245789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=280.39 Aligned_cols=272 Identities=21% Similarity=0.287 Sum_probs=201.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----Cc
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-----SN 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 103 (325)
..+|.+.+.||.|++|.||+|.+. .+..+++|.+... .......+..|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357899999999999999999986 6889999988653 222344567899999999999999999977543 35
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++++||+. ++|.+++. ..+.+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999995 68888874 346799999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH--------HHHH
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH--------QCYE 255 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~ 255 (325)
..... ......++..|+|||.+.....++.++|+||||+++++|++|++||...........+.... ....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 43211 11122367889999987555568899999999999999999999997653221111110000 0000
Q ss_pred hCcccccc---cCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH--HhccCCCC
Q 047716 256 AGELQNLV---SDQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM--MEGIVPPH 309 (325)
Q Consensus 256 ~~~~~~~~---~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--L~~~~~~~ 309 (325)
........ ... ....+.....+.+++.+||+.+|.+|||++++++. ++.+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 00000000 000 00112344678999999999999999999999944 77665433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=270.35 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=194.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecC-----Cce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEG-----SNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~ 104 (325)
.++|.+.+.||+|++|.||+|... +++.+++|.+.... .....+..|+.+++.+ +|||++++++++... +..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 567999999999999999999986 67788888875432 2345567889999998 799999999988643 357
Q ss_pred EEEEeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 105 LLVYEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
++|+||+++++|.+++.. ....+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 999999999999998743 345689999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCccceeeecCCCCcCCccccccCC----CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNN----RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
......... ....++..|+|||.+.... .++.++|+||||+++++|++|+.||.......... . ....
T Consensus 177 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~------~-~~~~ 248 (291)
T cd06639 177 QLTSTRLRR-NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF------K-IPRN 248 (291)
T ss_pred hcccccccc-cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH------H-HhcC
Confidence 554322111 1123678899999874332 35789999999999999999999997543221111 1 1111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.... ..........+.+++.+||+.+|++||++.|+++
T Consensus 249 ~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 249 PPPT-----LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCC-----CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1110 1111223356999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=273.03 Aligned_cols=271 Identities=23% Similarity=0.335 Sum_probs=201.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecC--Cc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEG--SN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~ 103 (325)
....+|++.+.||+|++|.||+|.+. ++..+++|++... .......+..|+.+++.+ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45688999999999999999999987 6788999988542 222334567899999999 999999999987543 46
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||++ ++|.+++... .+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 799999996 5888887432 788899999999999999999999 9999999999999999999999999988755
Q ss_pred cCCCc----cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH---------
Q 047716 184 KTDQT----RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------- 250 (325)
Q Consensus 184 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------- 250 (325)
..... .......++..|+|||.+.+...++.++|+||||+++++|++|+.||......+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 33221 11122336888999998866667788999999999999999999999765433221111000
Q ss_pred ---HHHHHhCcccccccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 251 ---HQCYEAGELQNLVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 251 ---~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
........+....... ....+.....+.+++.+||+.+|++|||+.++++ .++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0000000000000000 1111113467999999999999999999999994 455554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=265.20 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=194.0
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-----hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--Cce
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-----EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNR 104 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 104 (325)
.+|++.+.||+|++|.||.|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++.+.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 36888999999999999999986 58889999875321 12234678899999999999999999988653 467
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++|||+++++|.+++.. ...+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 899999999999998843 35688999999999999999999999 99999999999999999999999999887543
Q ss_pred CCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 185 TDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 185 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
.... .......++..|+|||.+ .+...+.++|+||||+++++|++|+.||........ ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~-~---- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVI-SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQ-P---- 225 (265)
T ss_pred cccccccccccCCCCccccChhhh-cCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhcC-C----
Confidence 2111 111223477889999998 456678899999999999999999999975422111 0011100 0
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+......+.+++.+|+. +|.+||+++|+++
T Consensus 226 --~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 --TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1122334445678899999995 9999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=241.47 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=210.1
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
.|+-.++||+|.||+||+|+.. ..+-||+|.+.-. .+.......+|+-+|+.++|+|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4667889999999999999987 5677888887543 334456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
| ...|..+.....+.++.+.++.++.|++.++.++|+. ++.|+|+||.|.+++.+|.+|+.|||+++-++.... -
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-c 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-C 157 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-e
Confidence 9 5688888877788899999999999999999999999 999999999999999999999999999987765432 2
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccC---C
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD---Q 266 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 266 (325)
......|.+|++|+++.+.+-|++..|+||.||++.|+.. |++.|.+....++..++-+.-.....+++..+..- .
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2222368999999999899999999999999999999975 66777777766666666554444434433322211 1
Q ss_pred -----------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 267 -----------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 267 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...-+.....=+++++..+..+|.+|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0111222344578899999999999999999874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=267.61 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=194.8
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeec------CC
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE------GS 102 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~ 102 (325)
....|++.+.||.|+||.||+|.+. .+..+++|.+.... .....+..|+.+++.+ +||||+++++++.. ..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 4578999999999999999999986 57788888875533 3345677889999998 69999999998742 45
Q ss_pred ceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
..+++|||+++++|.+++... ...+++..+..++.|++.|+.|||+. +++|+|++|+||+++.++.++|+|||++.
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 789999999999999988543 34588888999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCccceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
....... ......++..|+|||.+.. ...++.++|+||||+++++|++|..||.......... . ....
T Consensus 170 ~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------~-~~~~ 241 (282)
T cd06636 170 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPRN 241 (282)
T ss_pred hhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------h-HhhC
Confidence 5432221 1122337888999998742 3456789999999999999999999996543221111 0 0000
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.. ........+..+.++|.+||+.+|.+|||+.||++
T Consensus 242 ~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PP------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 00011123457999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=267.12 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=193.2
Q ss_pred HhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC------
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------ 102 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 102 (325)
|++.+.||+|++|.||+|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 577889999999999999864 35789999886532 333456788999999999999999999875432
Q ss_pred ceEEEEeecCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeec
Q 047716 103 NRLLVYEFMRNGSLGNLLFRA-----EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDF 177 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Df 177 (325)
..+++++|+.+++|.+++... ...++...+..++.|++.|++|||++ +++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 237889999999998876322 12478889999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHH
Q 047716 178 GLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 178 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
|.+......... ......++..|++||.+ ....++.++||||||+++++|++ |++||......+. ..+ ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~----~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNY----LI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHH-hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHH----HH
Confidence 998765332211 11112245679999988 45667889999999999999999 8888865432111 111 11
Q ss_pred hCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 256 AGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
... ...........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~~~-------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGN-------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCC-------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 0111122345799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=267.76 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=193.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 108 (325)
..+|+..+.||+|+||.||++.+. .+..+++|++.... ......+..|+.++.++. ||||+++++++..+...+++|
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 457788899999999999999987 67899999886533 234556788999999996 999999999998888999999
Q ss_pred eecCCCCHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 109 EFMRNGSLGNLLF----RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 109 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
|++. .++.++.. .....+++..+..++.|++.|++|||+. .+++|+||+|+||+++.++.++|+|||++....
T Consensus 83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9985 45554431 1235789999999999999999999963 289999999999999999999999999987544
Q ss_pred CCCccceeeecCCCCcCCccccccC--CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRN--NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
..... ....++..|+|||.+... ..++.++||||||+++++|++|+.||...... ......... ......
T Consensus 160 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~~ 231 (288)
T cd06616 160 DSIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQVVK-GDPPIL 231 (288)
T ss_pred cCCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHhhhcC-CCCCcC
Confidence 32211 112367889999998544 36889999999999999999999999754310 010111110 000000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+..+.+++.+||+.+|++|||+++|+.
T Consensus 232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 232 ---SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred ---CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111234567999999999999999999999993
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=264.28 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=201.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||.|++|.||++.+. ++..+++|++..... .....+..|+++++.++|||++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999987 688899998875432 4556788999999999999999999999888999999999
Q ss_pred cCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 111 MRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 111 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
+++++|.+++... ...++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998654 36799999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......+++.|+|||.. ....++.++|+||+|+++++|++|..||........ . ..........+
T Consensus 158 -~~~~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~~~----- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELC-QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------A-LKILKGQYPPI----- 223 (258)
T ss_pred -ceecceeeeecccChhHh-ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------H-HHHhcCCCCCC-----
Confidence 122223477889999987 455678899999999999999999999976542111 1 11111111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+......+.+++.+||..+|++|||+.++++
T Consensus 224 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 --PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1133457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=272.55 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=193.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++|++.+.||.|++|.||+|.+. +++.+++|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999987 688899998754322 233567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-CCcEEEeeccccccccCCC
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~~~~~~~~~ 187 (325)
|++ ++|.+.+... ...+++..++.++.|++.|+.+||++ +++|+||+|+||+++. ++.++++|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 5777766433 23367888899999999999999999 9999999999999985 5579999999987543321
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC---ccc----
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG---ELQ---- 260 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---- 260 (325)
. ......++..|+|||.+.+...++.++|+||||+++++|++|++||......+..... ......+ .+.
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEETWPGVTS 233 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChhhcccccc
Confidence 1 1112235788999998855566788999999999999999999999765332221110 0000000 000
Q ss_pred --c---cc----cCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 261 --N---LV----SDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 261 --~---~~----~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. .. ... ....+.....+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 000 0011223456899999999999999999999994
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=268.65 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=198.9
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
|+-..+||+|++|.||++... ++..+++|++..........+.+|+.+++.++|+|++++++.+..++..+++|||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334578999999999999886 6888999987654445566788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++. ...+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++++|||++........ ....
T Consensus 102 ~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 102 GALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 99998873 34689999999999999999999999 999999999999999999999999998765543221 1122
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..++..|+|||.+ ....++.++|+||+|+++++|++|..||.......... ... ..+.. ........
T Consensus 176 ~~~~~~y~~pE~~-~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-------~~~-~~~~~----~~~~~~~~ 242 (292)
T cd06657 176 LVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIR-DNLPP----KLKNLHKV 242 (292)
T ss_pred cccCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHH-hhCCc----ccCCcccC
Confidence 3367889999988 45667889999999999999999999997643321111 010 01111 11111122
Q ss_pred HHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 274 FENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
...+.+++.+||+.+|.+||++.+++. .+....
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 345889999999999999999999994 444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=279.71 Aligned_cols=267 Identities=22% Similarity=0.308 Sum_probs=198.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----Cce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-----SNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 104 (325)
..+|++.+.||+|++|.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 368999999999999999999886 68899999886432 22344577899999999999999999876543 357
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++++||+. ++|.+.+. ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 99999995 57777763 35689999999999999999999999 99999999999999999999999999987553
Q ss_pred CCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc---c
Q 047716 185 TDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE---L 259 (325)
Q Consensus 185 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 259 (325)
..... ......++..|+|||.+.+...++.++||||||+++++|++|++||......... ......+..+. +
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHHH
Confidence 32211 1112346888999998755567889999999999999999999999754321110 00000000000 0
Q ss_pred c--------cc---ccCCCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH--HhccCC
Q 047716 260 Q--------NL---VSDQED-----VNIEEFENLVKIGLWCVECELNLRPTMKQVIWM--MEGIVP 307 (325)
Q Consensus 260 ~--------~~---~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~--L~~~~~ 307 (325)
. .. ...... ..+....++.+++.+||+.+|.+|||+.|+++. ++....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 00 000000 011234678999999999999999999999954 666654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.05 Aligned_cols=259 Identities=19% Similarity=0.245 Sum_probs=192.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccC-CCCcceeeEEeecCCc-----e
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSN-----R 104 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~-----~ 104 (325)
+|++.+.||+|++|.||+|.+. ++..+++|++..... .....+.+|+.+++.++ ||||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5888999999999999999987 688899998754322 23356778999999995 6999999998876555 7
Q ss_pred EEEEeecCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-CCcEEEeeccc
Q 047716 105 LLVYEFMRNGSLGNLLFRA----EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAKISDFGL 179 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~ 179 (325)
+++|||+++ +|.+++... ...+++..++.++.|++.|+.|||++ +++|+||+|+||+++. ++.++++|||.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999975 788877433 23579999999999999999999999 9999999999999998 88999999998
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
+......... .....+++.|+|||.+.+...++.++|+||||+++++|++|.+||...........+ ......+..
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~ 233 (295)
T cd07837 158 GRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI---FKLLGTPTE 233 (295)
T ss_pred ceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHHhCCCCh
Confidence 8754322111 111225778999998855566789999999999999999999999765332211110 010000000
Q ss_pred c---c---------cccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 260 Q---N---------LVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 260 ~---~---------~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. . ..... ....+.....+.++|.+||+.+|.+||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0 00000 0011223467999999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=275.65 Aligned_cols=271 Identities=22% Similarity=0.317 Sum_probs=201.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeec----CCce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE----GSNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 104 (325)
..+|++.+.||.|++|.||+|... .+..+++|++.... ......+..|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999987 68899999886532 2334567789999999999999999987743 3568
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+. ++|.+++. ..+.+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 68888884 345699999999999999999999999 99999999999999999999999999987554
Q ss_pred CCCccc---eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHH
Q 047716 185 TDQTRT---YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQC 253 (325)
Q Consensus 185 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~ 253 (325)
...... .....++..|+|||.+.....++.++||||||+++++|++|+.||...........+... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 322211 112246788999999855566889999999999999999999999765432211111000 000
Q ss_pred HHhCcccc---cccCCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 254 YEAGELQN---LVSDQEDV-----NIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 254 ~~~~~~~~---~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
...+.... ........ .+.....+.+++.+||+.+|++|||+.+++ ..+++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 00000000 00111111 122356799999999999999999999999 45555553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.70 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=183.9
Q ss_pred hhcCcCCceeEEEEEeCCC---cEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCINGG---KEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~---~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
++||+|+||.||+|....+ ..+++|.+.... ......+.+|+..++.++||||+++++.+......+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976533 344556554332 334567888999999999999999999999888999999999999
Q ss_pred CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC-ccc
Q 047716 115 SLGNLLFRAE---QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ-TRT 190 (325)
Q Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~-~~~ 190 (325)
+|.+++.+.. ...+...+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999985432 3456677889999999999999999 99999999999999999999999999875322111 111
Q ss_pred eeeecCCCCcCCcccccc------CCCCCccccchhHHHHHHHHHhC-CCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 191 YTVLRGTRGYTAPELHSR------NNRITVKADVYSFGVMLLEIVCC-RKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.....++..|+|||.+.. ...++.++||||||+++++|+++ ..||......+. ....... ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhh-cccccC
Confidence 122336788999998742 12356789999999999999974 667754332111 1111111 111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
.+. ........+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~--~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQ--LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCc--cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 11223456888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.48 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=199.0
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCC
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS 102 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (325)
+.+.....|...+.||.|++|.||+|++. ++..+++|.+... .......+.+|+.+++.++|+|++++++++....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred hcCCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 33456677999999999999999999986 6778889987542 2233446778999999999999999999999989
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+. +++.+.+......+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++..
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccccee
Confidence 9999999996 578777755556789999999999999999999999 999999999999999999999999998865
Q ss_pred ccCCCccceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
..... ...++..|+|||.+.. ....+.++||||||+++++|++|..||......+... . .......
T Consensus 165 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~-~~~~~~~ 232 (308)
T cd06634 165 MAPAN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-IAQNESP 232 (308)
T ss_pred ecCcc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------H-HhhcCCC
Confidence 44322 1236788999998742 3457889999999999999999999986543221111 0 1100000
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
..........+.++|.+||+.+|.+||++++++..
T Consensus 233 ------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 233 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 00112344668999999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=265.86 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=197.1
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|.+.+.||.|++|.||+|.+. ++..+++|.+.... ......+.+|+.+++.++|+||+++++.+..+...++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999987 57888999876532 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeeccccccccCCCc
Q 047716 111 MRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 111 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~~~~~~~ 188 (325)
+++++|.+++.... ..+++..+..++.|++.|+.+||+. +++|+|++|+||++++++ .++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999885433 3578999999999999999999999 999999999999998885 469999998876543221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
......++..|+|||.+ ....++.++|+||||+++++|++|..||........ ..... .... ..
T Consensus 158 -~~~~~~~~~~~~ape~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~-------~~ 221 (257)
T cd08225 158 -LAYTCVGTPYYLSPEIC-QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKIC-QGYF-------AP 221 (257)
T ss_pred -cccccCCCccccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh-cccC-------CC
Confidence 11222377889999988 455678899999999999999999999975432111 11111 1111 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+.....+.+++.+||+.+|++|||++++++
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12233457999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=272.39 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=194.3
Q ss_pred HHhhhhhcCcCCceeEEEEEeCC---CcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--CceE
Q 047716 34 SENFKEEIGRGGSGRVYKGCING---GKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNRL 105 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 105 (325)
.|++.++||+|++|.||+|.+.. +..+++|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 37888999999999999999864 7889999887633 33345677899999999999999999999887 7899
Q ss_pred EEEeecCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC----CCcEEEeec
Q 047716 106 LVYEFMRNGSLGNLLFRA----EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE----SWKAKISDF 177 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~----~~~vkl~Df 177 (325)
+||||+++ ++.+++... ...+++..++.++.|++.|+.|||+. +++|+||+|+||+++. ++.++++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 666655322 23688999999999999999999999 9999999999999999 899999999
Q ss_pred cccccccCCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh----h--HHHH
Q 047716 178 GLSKLLKTDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI----V--LIDW 249 (325)
Q Consensus 178 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~----~--~~~~ 249 (325)
|++........ .......++..|+|||.+.+...++.++||||||+++++|++|++||......... . ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876543222 11122236788999998755567789999999999999999999999765443200 0 0000
Q ss_pred HHHHHH------------hCcccc---cccCC--C-CCCH-------HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 250 AHQCYE------------AGELQN---LVSDQ--E-DVNI-------EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 250 ~~~~~~------------~~~~~~---~~~~~--~-~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+. ...+.. ..... . .... .....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000000 00000 0 0000 22356899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=276.62 Aligned_cols=270 Identities=23% Similarity=0.338 Sum_probs=203.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC-----ceE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS-----NRL 105 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 105 (325)
+|++.+.||.|++|.||+|++. .+..+++|++.... ....+.+..|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4888999999999999999987 58899999887643 344567888999999999999999999887664 789
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
++|+|+. ++|.+++. ....+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999996 57888884 344899999999999999999999999 999999999999999999999999999886544
Q ss_pred CCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHH-----H---HH
Q 047716 186 DQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQ-----C---YE 255 (325)
Q Consensus 186 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~---~~ 255 (325)
... .......++..|+|||.+.+...++.++|+||||+++++|++|.+||......+....+..... . ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 321 1112223678899999985554788999999999999999999999976653221111100000 0 00
Q ss_pred hCccccccc---CC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCCC
Q 047716 256 AGELQNLVS---DQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVPP 308 (325)
Q Consensus 256 ~~~~~~~~~---~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~ 308 (325)
.......+. .. ....+.....+.+++.+||+.+|.+|||+++++. .++++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 000000000 00 0011123467899999999999999999999995 57776643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=273.93 Aligned_cols=265 Identities=26% Similarity=0.327 Sum_probs=194.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh--cHHHHHHHHHHHhccCCCCcceeeEEeecC-------
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE--GESEFRNEMKIIGRIHHKNLVDLVGFCSEG------- 101 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------- 101 (325)
..+|++.++||.|++|.||+|.+. ++..+++|++...... ....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999987 6788999988653322 233567899999999999999999876433
Q ss_pred -CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 102 -SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 102 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
..++++++|+.+ ++.+.+......+++..+..++.|+++|+.+||++ |++|+|++|+||+++.++.++++|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999954 67766655556799999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccc----------eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH
Q 047716 181 KLLKTDQTRT----------YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA 250 (325)
Q Consensus 181 ~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 250 (325)
.......... .....+++.|+|||.+.+...++.++||||||+++++|++|++||...........+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 7543322111 111235678999998755566889999999999999999999999765443222111100
Q ss_pred HHHHHhCc------ccc----cccCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 251 HQCYEAGE------LQN----LVSDQEDVN-----IEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 251 ~~~~~~~~------~~~----~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........ +.. ......... ......+.+++.+||+.+|.+|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 000 000000000 112256889999999999999999999983
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=265.15 Aligned_cols=260 Identities=26% Similarity=0.362 Sum_probs=196.6
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEeec
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
|++.+.||.|++|.||+|... .++.+++|++..... .......+|+..++.++ |||++++++.+..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999987 577889998765432 22334456899999999 999999999998899999999999
Q ss_pred CCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++|.+.+.... ..+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 778888875443 4789999999999999999999999 9999999999999999999999999998765432221
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHH----------HHHHHHHHhCccc
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI----------DWAHQCYEAGELQ 260 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~~ 260 (325)
....++..|+|||.+.....++.++|+||||+++++|++|++||......+..... .|...........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 11236778999998866667889999999999999999999999765433221110 0111111111111
Q ss_pred ccccCCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 261 NLVSDQEDV-----NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 261 ~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
......... .+.....+.+++.+||+.+|++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 111111000 0111356999999999999999999999984
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=260.17 Aligned_cols=250 Identities=27% Similarity=0.363 Sum_probs=201.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecC--CceEEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNRLLVY 108 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 108 (325)
+|++.+.||+|++|.||+|.+. ++..+++|++..... .....+.+|+..+++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677889999999999999987 688899998865442 4456788999999999999999999999887 8899999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|++++++|.+++... ..+++..++.++.|++.++.+||+. +++|+|++|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999998544 3899999999999999999999999 999999999999999999999999999876654432
Q ss_pred c-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 R-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
. ......++..|.|||.+ .....+.++|+||||+++++|++|..||........ . ....... ....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~~~~-------~~~~ 223 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVI-RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-A----LYKIGSS-------GEPP 223 (260)
T ss_pred cccccCCCCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-H----HHhcccc-------CCCc
Confidence 1 11223378899999998 455588999999999999999999999987651111 0 0011000 1111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+......+.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 222233567999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=291.88 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=218.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
|..+..+|.+.||.|.||.|++|+.+ ....||+|.++.-. ++....|..|+.+|-++.||||+++.++.......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 44566677789999999999999986 25578999987644 34455699999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
.||+|||+.|+|+.|+.++.+.++...+..+++.|+.++.||.+. +++||||.+.||||+.+...|++|||+++...
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999999998899999999999999999999999998 99999999999999999999999999998776
Q ss_pred CCCccceeeec--CCCCcCCccccccCCCCCccccchhHHHHHHHHH-hCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 185 TDQTRTYTVLR--GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV-CCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 185 ~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
++........- -+.+|.|||.+ ...+++.++||||+|++|||.+ .|..|+=.....+... -+++
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAI-a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk---aIe~--------- 849 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK---AIEQ--------- 849 (996)
T ss_pred cCCCccccccCCccceeecChhHh-hhcccCchhhccccceEEEEecccCCCcccccchHHHHH---HHHh---------
Confidence 55533322221 24589999999 6888999999999999999965 5888886654433221 1111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.-+++.+++++..|.+||+.||++|-..||.+.||+.+|.+++
T Consensus 850 --gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 850 --GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred --ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 1235667778889999999999999999999999999999998
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=262.11 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=200.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|++|.||++.+. .++.+++|.+..... .....+.+|+++++.++|||++++++++...+..+++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999887 678899998876543 3455788999999999999999999999988999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++... ..+++..++.++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998543 6799999999999999999999999 9999999999999999999999999998866543332
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....++..|+|||... ....+.++|+||||+++++|++|+.||......... + ... ... ....+
T Consensus 156 ~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~--~~~-~~~-------~~~~~ 220 (254)
T cd06627 156 DASVVGTPYWMAPEVIE-MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----F--RIV-QDD-------HPPLP 220 (254)
T ss_pred ccccccchhhcCHhhhc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----H--HHh-ccC-------CCCCC
Confidence 12233688899999984 445788999999999999999999999754321111 0 100 111 11112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
......+.+++.+||+.+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 223467899999999999999999999983
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=264.59 Aligned_cols=242 Identities=25% Similarity=0.322 Sum_probs=189.3
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
||+|+||.||+|.+. .++.+++|.+.... ......+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999876 68889999886532 22234456799999999999999999999988999999999999999
Q ss_pred HHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeec
Q 047716 117 GNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195 (325)
Q Consensus 117 ~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~ 195 (325)
.+++.... ..+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence 99885443 3689999999999999999999999 999999999999999999999999998865433211 11223
Q ss_pred CCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHH
Q 047716 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFE 275 (325)
Q Consensus 196 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
++..|+|||.+. +..++.++|+||||+++++|++|+.||........... ..... .......+.....
T Consensus 156 ~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~~~~ 223 (277)
T cd05577 156 GTPGYMAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-------LKRRT----LEMAVEYPDKFSP 223 (277)
T ss_pred CCCCcCCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-------HHhcc----ccccccCCccCCH
Confidence 677899999984 45588899999999999999999999976543211110 00000 1111112222346
Q ss_pred HHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 276 NLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 276 ~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
.+.+++.+||+.+|.+|| ++.+++
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 789999999999999999 666676
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.36 Aligned_cols=269 Identities=27% Similarity=0.526 Sum_probs=208.0
Q ss_pred ccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 25 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+...++. ..++..+.||+|+||.||+|.+. ++..+|+|++....... ..|++.+++++||||+++++++.+...
T Consensus 683 ~~~~~~~-~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 683 ITINDIL-SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhHHHHH-hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 4444443 35677788999999999999985 78899999886433222 246888999999999999999999899
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++. .+++..+..++.|++.|++|||..+..+++|+|+||+||+++.++..++. ++.....
T Consensus 758 ~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999999999983 47899999999999999999995444599999999999999988877765 5544322
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
..... ..++..|+|||.+ ....++.++||||||+++|||++|+.||+..... ......|............++
T Consensus 833 ~~~~~-----~~~t~~y~aPE~~-~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 833 CTDTK-----CFISSAYVAPETR-ETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred ccCCC-----ccccccccCcccc-cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhhee
Confidence 11111 1367899999998 5677899999999999999999999999654332 223445554444333333333
Q ss_pred cC----CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCC
Q 047716 264 SD----QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQ 310 (325)
Q Consensus 264 ~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 310 (325)
++ ..........++.+++.+||+.+|++|||++|++++|+++....+
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 32 234455667789999999999999999999999999999876443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.91 Aligned_cols=242 Identities=23% Similarity=0.286 Sum_probs=193.5
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
||.|++|.||+|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 58889999886532 23345688999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecC
Q 047716 117 GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG 196 (325)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 196 (325)
.+++.+ ...++...+..++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 999844 35689999999999999999999999 99999999999999999999999999987654432 1122246
Q ss_pred CCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHH
Q 047716 197 TRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFEN 276 (325)
Q Consensus 197 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
+..|++||.+ ....++.++|+||||+++++|++|..||.......... ..... .. ......+......
T Consensus 155 ~~~~~~PE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~-~~------~~~~~~~~~~~~~ 222 (262)
T cd05572 155 TPEYVAPEII-LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI----YNDIL-KG------NGKLEFPNYIDKA 222 (262)
T ss_pred CcCccChhHh-cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH----HHHHh-cc------CCCCCCCcccCHH
Confidence 8899999998 45667889999999999999999999997664321111 11111 00 0111122222567
Q ss_pred HHHHHhhcccCCCCCCCC-----HhHHHH
Q 047716 277 LVKIGLWCVECELNLRPT-----MKQVIW 300 (325)
Q Consensus 277 l~~li~~~l~~~p~~Rps-----~~ell~ 300 (325)
+.+++.+||+.+|++||+ ++|+++
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999999 788774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.81 Aligned_cols=242 Identities=26% Similarity=0.290 Sum_probs=186.3
Q ss_pred hcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHH---hccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 40 EIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKII---GRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
.||+|+||.||++.+. .+..+++|.+..... ........+..++ ...+||+|+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999986 578899998865321 1122233444333 33479999999999988889999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+++|.+++. ..+.+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||++........ .
T Consensus 81 ~~~L~~~i~-~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 153 (279)
T cd05633 81 GGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (279)
T ss_pred CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence 999998884 345699999999999999999999999 999999999999999999999999998865432221 1
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
...++..|+|||.+..+..++.++|+||+|+++++|++|..||.......... + ..... ......+..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~---~~~~~--------~~~~~~~~~ 221 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I---DRMTL--------TVNVELPDS 221 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-H---HHHhh--------cCCcCCccc
Confidence 22378899999988555667899999999999999999999997554322211 0 01100 011122233
Q ss_pred HHHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 273 EFENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
....+.+++.+||+.||.+|| |++|+++
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 456799999999999999999 6999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=278.59 Aligned_cols=269 Identities=22% Similarity=0.282 Sum_probs=197.3
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC----------
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG---------- 101 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------- 101 (325)
.+|++.+.||.|++|.||+|.+. .+..+++|++..........+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 68999999999999999999987 6889999988665555556788899999999999999998766443
Q ss_pred ----CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc-CCCcEEEee
Q 047716 102 ----SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKISD 176 (325)
Q Consensus 102 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~-~~~~vkl~D 176 (325)
...++++||+. ++|.+++. .+.+++..++.++.|++.|+.|||+. |++|+||+|+||+++ .++.++++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999996 58888773 34689999999999999999999999 999999999999997 455789999
Q ss_pred ccccccccCCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH----
Q 047716 177 FGLSKLLKTDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA---- 250 (325)
Q Consensus 177 fg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---- 250 (325)
||.+......... ......++..|+|||.+.....++.++||||||+++++|++|+.||...............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998754322111 1111236778999998755567888999999999999999999999755432211110000
Q ss_pred ----HHHHHh---CcccccccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 251 ----HQCYEA---GELQNLVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 251 ----~~~~~~---~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
...... .......... ....+....++.+++.+||+.+|.+|||++|++ ..++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~ 308 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence 000000 0000000000 000112335688999999999999999999999 55665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.08 Aligned_cols=261 Identities=19% Similarity=0.233 Sum_probs=185.3
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeCCC----cEEEEEEeeccchhc-----------HHHHHHHHHHHhccCCCCc
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCINGG----KEIAVKKLIKIVEEG-----------ESEFRNEMKIIGRIHHKNL 91 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~----~~~~vk~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i 91 (325)
+.++...+|++.+.||+|+||.||+|.+.++ ..+++|+........ ......+...+..+.|+++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 3456678899999999999999999998743 444555432211110 0111233455667789999
Q ss_pred ceeeEEeecCC----ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc
Q 047716 92 VDLVGFCSEGS----NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD 167 (325)
Q Consensus 92 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~ 167 (325)
+.+++...... ..+++++++ ..++.+.+.. ....++..+..++.|++.|+.|||++ +++||||||+||+++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99998764432 336777776 4466666633 33467888999999999999999999 999999999999999
Q ss_pred CCCcEEEeeccccccccCCCc------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc
Q 047716 168 ESWKAKISDFGLSKLLKTDQT------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241 (325)
Q Consensus 168 ~~~~vkl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 241 (325)
.++.++|+|||++........ .......+++.|+|||.+ .+..++.++||||||+++++|++|+.||......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 999999999999876532211 111123488999999998 5677899999999999999999999999876433
Q ss_pred chhhHH---HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 242 DEIVLI---DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
...... ++..+ +..+... .......+.+++..|++.+|++||+++++++.|+
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAAKCDFIKR-LHEGKIK---------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHhHHHHHHH-hhhhhhc---------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 221111 11111 1111110 1112366999999999999999999999998763
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=261.65 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=199.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.++||.|++|.||++.+. ++..+++|.+.... ......+..|+.+++.++||||+++.+.+.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788999999999999999877 67889999886532 23345677899999999999999999999888999999999
Q ss_pred cCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 111 MRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 111 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
+++++|.+++... ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988542 34689999999999999999999999 99999999999999999999999999987654431
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
. ....++..|+|||.+ ....++.++|+||||+++++|++|+.||......... ........ .
T Consensus 158 ~---~~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-------~ 219 (256)
T cd08530 158 A---KTQIGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRGKY-------P 219 (256)
T ss_pred c---ccccCCccccCHHHH-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCC-------C
Confidence 1 122367899999998 5666788999999999999999999999765432111 11111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........++.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 222345577999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=264.39 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=189.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHH-HhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKI-IGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+|++.+.||+|+||.||+|.+. +++.+|+|++.... ......+..|+.. ++.++||||+++++++..++..+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 6888999999999999999987 68899999886532 2233445555554 6667899999999999998999999999
Q ss_pred cCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 111 MRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 111 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
++ ++|.+++.. ....+++..++.++.|++.|+.|||++ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 95 678777643 234689999999999999999999984 289999999999999999999999999987553322
Q ss_pred ccceeeecCCCCcCCccccccC---CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 188 TRTYTVLRGTRGYTAPELHSRN---NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.. ....++..|+|||.+.+. ..++.++|+||||+++++|++|+.||......... ...... .....+.
T Consensus 159 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~-~~~~~~~- 229 (283)
T cd06617 159 AK--TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-----LKQVVE-EPSPQLP- 229 (283)
T ss_pred cc--ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-----HHHHHh-cCCCCCC-
Confidence 11 112367889999987432 34678999999999999999999999643221110 011111 1101110
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+..+.+++.+||+.+|++||+++++++
T Consensus 230 -----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 230 -----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123467999999999999999999999994
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=260.60 Aligned_cols=244 Identities=22% Similarity=0.226 Sum_probs=185.7
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHH-HhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKI-IGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.||.|++|.||+|.+. .++.+++|.+..... .....+..|..+ ....+|||++++++.+..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999986 678899998865322 112223344443 4455899999999999998999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++.. .+.+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~ 152 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KK 152 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc-----cc
Confidence 999999843 45789999999999999999999999 9999999999999999999999999987654321 11
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..++..|+|||.+. +..++.++|+||||+++++|++|..||......... ......... .........
T Consensus 153 ~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~----~~~~~~~~~ 220 (260)
T cd05611 153 FVGTPDYLAPETIL-GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-------DNILSRRIN----WPEEVKEFC 220 (260)
T ss_pred CCCCcCccChhhhc-CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcccC----CCCcccccC
Confidence 23678899999984 445789999999999999999999999765332111 111111110 111111123
Q ss_pred HHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 274 FENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
...+.+++.+||+.+|++||++.++.+.|.
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 467999999999999999998765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=281.17 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=203.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcE-EEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKE-IAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..-++|+..||.|+||.||+|..+..+. .|.|+|.-.+......+.-|+.+|....||+||++++.|..++.++|+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 4557889999999999999998885444 456777666777778899999999999999999999998888999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
|.||-...++-.-+..+++..+..+++|++.||.|||++ +|+|+|+|+.|||++-+|.|+|.|||.+....... ..
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-hh
Confidence 999999988877788899999999999999999999999 99999999999999999999999999876433222 22
Q ss_pred eeeecCCCCcCCccccc----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 191 YTVLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.....||+.|||||+.- +...|+.++||||||+.|.+|..+.+|...... ..+++.... ...+ -
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVllKiaK--SePP----T---- 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAK--SEPP----T---- 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHHHHHhh--cCCC----c----
Confidence 23344999999999753 345688899999999999999999999875533 222222111 0000 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
+--+..-...+.+++..||..||+.||++.+|+
T Consensus 255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 111222345688999999999999999999998
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.35 Aligned_cols=251 Identities=22% Similarity=0.250 Sum_probs=195.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccch----hcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCce
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIVE----EGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 104 (325)
+|++.+.||.|+||.||.|.+. ++..+++|.+..... .....+..|+.+++.+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 3788899999999999999873 578899998865322 2335577899999999 599999999999988899
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++|+||+++++|.+++.. ...+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999999998843 45688999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccceeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...........++..|+|||.+... ...+.++||||||+++++|++|..||......... ..........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~------- 227 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS------- 227 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhcc-------
Confidence 4333322334478899999988432 34678999999999999999999999643221111 1111111110
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
....+......+.+++.+||+.+|++|| ++++++
T Consensus 228 --~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 228 --EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred --CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 1111222345689999999999999997 777776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=267.90 Aligned_cols=247 Identities=24% Similarity=0.304 Sum_probs=198.8
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 108 (325)
+|.+.+.||+|++|.||+|.+. ++..+++|++... .......+..|+.+++.++ ||||+++++++...+..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 6888999999999999999987 6889999988652 2233456788999999998 999999999999889999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|++.+++|.+++.+ ...+++..++.++.|++.++.+||+. |++|+|++|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999854 45799999999999999999999999 999999999999999999999999999876543321
Q ss_pred -------------------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH
Q 047716 189 -------------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW 249 (325)
Q Consensus 189 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 249 (325)
.......++..|+|||.. .....+.++|+||||++++++++|+.||........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~-- 231 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---F-- 231 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---H--
Confidence 111222367889999988 456688899999999999999999999986542111 0
Q ss_pred HHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCH----hHHHH
Q 047716 250 AHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTM----KQVIW 300 (325)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~ell~ 300 (325)
.... ......+......+.+++.+||+.+|.+|||+ +++++
T Consensus 232 --~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --QKIL--------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHH--------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0111 11111222224679999999999999999999 77763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=262.31 Aligned_cols=245 Identities=25% Similarity=0.317 Sum_probs=191.9
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
||.|++|.||++.+. .+..+++|.+..... .....+.+|+.+++.++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 488999998865433 3445688899999999999999999999888999999999999999
Q ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-------c
Q 047716 117 GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT-------R 189 (325)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~-------~ 189 (325)
.+++... +.+++..+..++.|++.++++||++ +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9998543 4789999999999999999999999 999999999999999999999999998865432211 0
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
......++..|++||.. .....+.++|+||||+++++|++|..||......+.. ......... .. .
T Consensus 157 ~~~~~~~~~~~~~Pe~~-~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~----~~--~ 222 (265)
T cd05579 157 EDKRIVGTPDYIAPEVI-LGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF-------QNILNGKIE----WP--E 222 (265)
T ss_pred cccCcccCccccCHHHh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCcC----CC--c
Confidence 11223367789999998 4455788999999999999999999999765432111 111111110 00 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
.......+.+++.+||+.+|++|||+.++.+.|+
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1012467899999999999999999955555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=263.36 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=193.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.-|...++||+|++|.||+|++. .+..+++|++..... .....+..|+.+++.++|||++++++++.+....+++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 33777788999999999999986 678899998864322 23345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+. +++.+++......+++..+..++.|++.++.|||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~- 175 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN- 175 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCCC-
Confidence 9995 577777755566789999999999999999999999 99999999999999999999999999876432221
Q ss_pred cceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 189 RTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
...++..|+|||.+.. ...++.++|+||||+++++|++|.+||.......... .... .....
T Consensus 176 ----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-~~~~~----- 239 (313)
T cd06633 176 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NDSPT----- 239 (313)
T ss_pred ----CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHh-cCCCC-----
Confidence 2236788999998742 3557889999999999999999999987654322111 1111 11110
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.........+.+++.+||+.+|.+||++.+++
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11112234689999999999999999999999
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=284.74 Aligned_cols=269 Identities=17% Similarity=0.260 Sum_probs=186.1
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeCC--CcEEEEE--------------Eee---ccchhcHHHHHHHHHHHhcc
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCING--GKEIAVK--------------KLI---KIVEEGESEFRNEMKIIGRI 86 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~vk--------------~~~---~~~~~~~~~~~~e~~~l~~l 86 (325)
..++....+|+++++||+|+||.||+|..+. +...+.| .+. .........+.+|+.+|+.+
T Consensus 141 ~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 141 KHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred ccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 3345567899999999999999999987542 1111111 111 11122344578899999999
Q ss_pred CCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRA----EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 87 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
+||||+++++++...+..+++++++. ++|.+++... ........++.++.|++.||.|||++ ||+|+||||+
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~ 296 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE 296 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 99999999999999999999999984 4666665322 12244567788999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccc-c
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLR-D 241 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~ 241 (325)
|||++.++.++|+|||++...............|+..|+|||.+ .+..++.++|||||||++++|++|+.++..... .
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL-AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 99999999999999999976654332222233489999999998 456788999999999999999999865433222 1
Q ss_pred chhhHHHHHHHHHH--hCcc-------cccc-----cCCCCCCH------HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 242 DEIVLIDWAHQCYE--AGEL-------QNLV-----SDQEDVNI------EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 242 ~~~~~~~~~~~~~~--~~~~-------~~~~-----~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+..... .+. ...+ ...+ .......+ .....+.+++.+||+.||.+|||+.|++.
T Consensus 376 ~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 376 PGKQLLKIID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111111110 000 0000 0000 00000000 01234678899999999999999999983
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=270.88 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=195.0
Q ss_pred HHHhh-hhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhc--------------HHHHHHHHHHHhccCCCCcceeeE
Q 047716 33 ASENF-KEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG--------------ESEFRNEMKIIGRIHHKNLVDLVG 96 (325)
Q Consensus 33 ~~y~~-~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~~ 96 (325)
.+|.. .+.||.|++|.||+|.+. .+..+++|++....... ...+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 567999999999999977 68899999886533222 124678999999999999999999
Q ss_pred EeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEee
Q 047716 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISD 176 (325)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~D 176 (325)
++......+++|||+. ++|.+++. ....++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence 9999899999999996 68888884 445789999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC-------------ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccch
Q 047716 177 FGLSKLLKTDQ-------------TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDE 243 (325)
Q Consensus 177 fg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 243 (325)
||.+....... ........++..|+|||.+.+...++.++|+||||+++++|++|.+||......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99887654110 01111122567899999986555678999999999999999999999976643322
Q ss_pred hhHHHHHHHHHHhCc---cc---------ccccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 244 IVLIDWAHQCYEAGE---LQ---------NLVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 244 ~~~~~~~~~~~~~~~---~~---------~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
... .......+. +. ...... ..........+.+++.+||+.+|++|||++|++
T Consensus 243 ~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 243 LGR---IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHH---HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 111 111111000 00 000000 001112245688999999999999999999999
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=277.67 Aligned_cols=248 Identities=23% Similarity=0.396 Sum_probs=196.4
Q ss_pred hhhhcCcCCceeEEEEEeC-CCcEEE--EEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCC--ceEEEEe
Q 047716 37 FKEEIGRGGSGRVYKGCIN-GGKEIA--VKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS--NRLLVYE 109 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~-~~~~~~--vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 109 (325)
+..+||+|+|-+||+|.+. .|-+|| -+++... .......+..|+.+|+.|+||||+++++.+.+.. ...+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4567999999999999986 455555 2222222 2333477889999999999999999999887654 4789999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-CcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vkl~Dfg~~~~~~~~~~ 188 (325)
.+..|+|..+.. ..++++...+..|++||++||.|||++ ...|+|||||-+||||+++ |.|||+|+|+++.......
T Consensus 124 L~TSGtLr~Y~k-k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 124 LFTSGTLREYRK-KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cccCCcHHHHHH-HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 999999999994 456899999999999999999999997 4569999999999999765 8999999999987754443
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
. .+.|||.|||||.+ ...|++..||||||+++.||+|+..||..=... ......+.....+..+..+.+
T Consensus 202 k---svIGTPEFMAPEmY--EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiKP~sl~kV~d---- 270 (632)
T KOG0584|consen 202 K---SVIGTPEFMAPEMY--EENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIKPAALSKVKD---- 270 (632)
T ss_pred c---eeccCccccChHHH--hhhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCCHHHhhccCC----
Confidence 2 24599999999998 478999999999999999999999999643222 222222333333334444433
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhc
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEG 304 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~ 304 (325)
.++++||.+||.. .++|||+.|+| .+|..
T Consensus 271 ------Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 271 ------PEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ------HHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 4799999999999 99999999999 44444
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.08 Aligned_cols=257 Identities=21% Similarity=0.231 Sum_probs=198.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccc----hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCce
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV----EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 104 (325)
+|++.+.||+|++|.||++++. .+..+++|.+.... ......+..|+.++..+ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3778899999999999999853 46789999886432 12234577899999999 599999999999888899
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++.. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 999999999999998843 35689999999999999999999999 99999999999999999999999999887654
Q ss_pred CCCccceeeecCCCCcCCccccccCC-CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNN-RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...........++..|++||.+.+.. ..+.++|+||||+++++|++|..||......... .........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~-------- 226 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILK-------- 226 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHc--------
Confidence 33222222234788999999874332 3678999999999999999999999643221111 111111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.....+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 -SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11112222335689999999999999999999888777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=259.95 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=186.4
Q ss_pred HHHHhhhhhc--CcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEI--GRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~l--g~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 107 (325)
.+.|++.+.+ |+|+||.||++... .+..+++|.+....... .|+.....+ +|||++++++.+..++..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 4677888876 99999999999886 57778888775422111 122222222 699999999999988999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~~~~~ 186 (325)
|||+++++|.+++... ..+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++ .++++|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999998543 4899999999999999999999999 999999999999999988 9999999988755432
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. ..++..|+|||.+ .+..++.++|+||||+++++|++|+.||....... .....+.... ...
T Consensus 164 ~~-----~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~----------~~~ 226 (267)
T PHA03390 164 SC-----YDGTLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ----------QKK 226 (267)
T ss_pred cc-----CCCCCcccChhhh-cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh----------ccc
Confidence 21 2378899999998 45667889999999999999999999998443322 1111111111 111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCC-HhHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPT-MKQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell 299 (325)
..........+.+++.+||+.+|.+||+ ++|++
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred CCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 1112234467999999999999999996 69988
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=274.81 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=210.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
.....|.+...||+|.|+.|.+|++. .+..||+|.+.+..- .....+.+|+.+++.++|||||+++.+.+....+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 44567899999999999999999987 789999998876432 233457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+.+|.+.+++. ..++..+.+....+.|++.|++|||++ .|+|+|||++|++++.+-++||+|||++..+...
T Consensus 133 V~eya~~ge~~~yl~-~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLV-KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHH-hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence 999999999999994 456777799999999999999999999 9999999999999999989999999999988754
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. ....+|++.|.|||.+.+..+..+.+|+||||+++|-|++|..||++....... .+.+..+
T Consensus 209 ~~--lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~gk 271 (596)
T KOG0586|consen 209 LM--LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLRGK 271 (596)
T ss_pred cc--ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chheeee
Confidence 43 334459999999999988788889999999999999999999999976442211 1222233
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..++...+.++.++|+++|-.+|.+|++++++-
T Consensus 272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred ecccceeechhHHHHHHhhccCccccCCHHHhh
Confidence 333444445689999999999999999999997
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=291.07 Aligned_cols=254 Identities=30% Similarity=0.431 Sum_probs=192.6
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEee---------
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCS--------- 99 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--------- 99 (325)
..++|+..+.||+||||.||+++++ +|..+|||+|... +......+.+|+..|.+|+|||||+++..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 5678888999999999999999998 9999999999754 3444556889999999999999999963110
Q ss_pred ---------------------------------------------------------------------cC---------
Q 047716 100 ---------------------------------------------------------------------EG--------- 101 (325)
Q Consensus 100 ---------------------------------------------------------------------~~--------- 101 (325)
++
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 00
Q ss_pred --------------------------------CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhcc
Q 047716 102 --------------------------------SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149 (325)
Q Consensus 102 --------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~ 149 (325)
..+||=||||+..++.+++..+...-.....|.++++|++|+.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 125788999988888888854432225788999999999999999999
Q ss_pred CCCCeeeccCCCCceEEcCCCcEEEeecccccccc----C-------------CCccceeeecCCCCcCCccccccCC--
Q 047716 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK----T-------------DQTRTYTVLRGTRGYTAPELHSRNN-- 210 (325)
Q Consensus 150 ~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~----~-------------~~~~~~~~~~~~~~y~aPE~~~~~~-- 210 (325)
|++||||||.|||+++++.|||+|||+++... . ..........||.-|+|||.+.+..
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998721 0 0001112234888999999996655
Q ss_pred CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCC
Q 047716 211 RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELN 290 (325)
Q Consensus 211 ~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 290 (325)
.|+.|+||||||++++||+. ||........ +-..++.+.+..- .+...+....-.++|.||++.||.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~------iL~~LR~g~iP~~----~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERAS------ILTNLRKGSIPEP----ADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHH------HHHhcccCCCCCC----cccccccchHHHHHHHHHhcCCCc
Confidence 69999999999999999996 5654432211 1122222222211 222334445677999999999999
Q ss_pred CCCCHhHHHH
Q 047716 291 LRPTMKQVIW 300 (325)
Q Consensus 291 ~Rps~~ell~ 300 (325)
+|||+.|||+
T Consensus 861 kRPtA~eLL~ 870 (1351)
T KOG1035|consen 861 KRPTATELLN 870 (1351)
T ss_pred cCCCHHHHhh
Confidence 9999999993
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=264.79 Aligned_cols=267 Identities=21% Similarity=0.278 Sum_probs=193.8
Q ss_pred hhhcCcC--CceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 38 KEEIGRG--GSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 38 ~~~lg~g--~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
...||.| ++|+||+|.+. .++.+++|.+.... ....+.+.+|+.+++.++||||+++++++..+...++++||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 4567777 89999999986 78999999876422 2334678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc-
Q 047716 113 NGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT- 190 (325)
Q Consensus 113 ~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~- 190 (325)
++++.+++.+. ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999988554 34589999999999999999999999 99999999999999999999999997543221111000
Q ss_pred -----eeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH--------------H
Q 047716 191 -----YTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW--------------A 250 (325)
Q Consensus 191 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------------~ 250 (325)
.....++..|+|||.+.+. ..++.++||||||+++++|++|..||.............. .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0011134569999998543 4478899999999999999999999976543221100000 0
Q ss_pred HHH-------HHhC----cc-----cccccCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 251 HQC-------YEAG----EL-----QNLVSDQ--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 251 ~~~-------~~~~----~~-----~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
... ...+ .. ....... ..........+.+++.+||+.||.+|||+.|++ ..++.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000 0000 00 0000000 111233556799999999999999999999998 45555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=259.91 Aligned_cols=242 Identities=26% Similarity=0.289 Sum_probs=186.7
Q ss_pred hcCcCCceeEEEEEeC-CCcEEEEEEeeccchh---cHHHHHHHH---HHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 40 EIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE---GESEFRNEM---KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
.||+|+||.||+|.+. .++.+++|.+...... .......|. ..++...||+|+.+++.+......++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999876 5789999988653211 111233333 34445579999999999999899999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+++|.+++. ..+.+++..++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 999998884 445799999999999999999999999 999999999999999999999999999865432221 1
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
...++..|+|||.+.++..++.++|+||+|+++++|++|+.||........... ..... ......+..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~--------~~~~~~~~~ 221 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL--------TMAVELPDS 221 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhh--------ccCCCCCCc
Confidence 224788999999986555688999999999999999999999976533222110 00000 011112222
Q ss_pred HHHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 273 EFENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
.+..+.+++.+||..+|.+|| ++.++++
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 346799999999999999999 9999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=262.90 Aligned_cols=266 Identities=17% Similarity=0.162 Sum_probs=195.0
Q ss_pred HhhhhhcCcCCceeEEEEEeCCCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 35 ENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
+.+.+.+|.|+++.++.+.. .++.+|+|++... .......+.+|+.+++.++||||+++++.+.+....+++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 45666676666666666544 6889999998654 34455678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc---
Q 047716 113 NGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT--- 188 (325)
Q Consensus 113 ~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~--- 188 (325)
+++|.+++... ...+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++||+.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999998543 34688999999999999999999999 999999999999999999999999998764422111
Q ss_pred ---cceeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH----------
Q 047716 189 ---RTYTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY---------- 254 (325)
Q Consensus 189 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------- 254 (325)
.......++..|+|||.+... ..++.++|+||||+++++|++|..||........ ..+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence 011112356789999998543 3578899999999999999999999976432211 111000000
Q ss_pred -HhCcccc----------cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 255 -EAGELQN----------LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 255 -~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
....... ..............++.+++.+||+.||++|||+++++ .+++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000000 00000111223346789999999999999999999999 4444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=257.37 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=194.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-----chhcHHHHHHHHHHHhccCCCCcceeeEEeecC--Cce
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-----VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNR 104 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 104 (325)
.+|++.+.||+|++|.||+|++. .+..+++|.+... .......+.+|+.+++.++||||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999986 5888999987432 123345688899999999999999999988653 467
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++++||+++++|.+++.. .+.+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 899999999999998843 34688999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 185 TDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 185 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
.... .......++..|+|||.+ .+...+.++|+||||+++++|++|+.||........ ..+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~----- 225 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVI-SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIATQP----- 225 (264)
T ss_pred cccccCccccccCCcccccCHhhh-cCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHHcCC-----
Confidence 2111 111123367889999998 456678899999999999999999999975422111 01111110
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.....+......+.+++.+||+ +|..||++.+++.
T Consensus 226 --~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1122233445679999999999 5799999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.69 Aligned_cols=261 Identities=23% Similarity=0.290 Sum_probs=198.7
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
|++.+.||+|++|.||+|+.. .+..+++|.+.... ......+..|+.+++.++|+|++++++++......++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999987 58899999887643 333456778999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
. ++|.+++......+++..+..++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 589999865546799999999999999999999999 999999999999999999999999999876543322 11
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH--------HHHHHH-----hCc
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW--------AHQCYE-----AGE 258 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~-----~~~ 258 (325)
.....+..|+|||.+.....++.++|+||||+++++|++|++||......+....+.. ...... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 1222567899999985555788999999999999999999999976543222111100 000000 000
Q ss_pred ccccccCCC-CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 LQNLVSDQE-DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+........ ...+.....+.+++.+||+.+|++||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 111122467999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=269.83 Aligned_cols=273 Identities=23% Similarity=0.319 Sum_probs=199.4
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC------
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------ 101 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 101 (325)
...+|.+.+.||+|+||.||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3578999999999999999999875 68889999886532 22345577899999999999999999987532
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...+++++++ +++|.+++. ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++.
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred ccEEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3467888877 788988773 34689999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH--------HHHH
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW--------AHQC 253 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~ 253 (325)
...... ....++..|+|||.+.+...++.++|+||||+++++|++|+.||...........+.. ....
T Consensus 169 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 169 HTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccccc----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 543221 1223678899999885556678899999999999999999999965433221111000 0000
Q ss_pred HHhCccccc---ccCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCCCCCCC
Q 047716 254 YEAGELQNL---VSDQEDVN-----IEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPPHQNML 313 (325)
Q Consensus 254 ~~~~~~~~~---~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~~~~~~ 313 (325)
+........ +...+... ......+.+++.+||+.+|.+||++.+++ ..+.+...+.+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~ 314 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 314 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcccc
Confidence 000000000 00000000 01235688999999999999999999999 55655555444443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=262.70 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=192.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeeccch-hcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVE-EGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 106 (325)
+...+|++.+.||+|++|.||+|.+.. +..+++|.+..... .....+..|+..+.... ||||+++++++......++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 345778999999999999999999884 88899999865332 23344556676666664 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+|||+ .+++.++.......+++..+..++.|++.+++|||+ . +++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred Eeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99998 457777775555678999999999999999999997 5 899999999999999999999999999875543
Q ss_pred CCccceeeecCCCCcCCccccccC---CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRN---NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
..... ...++..|+|||.+... ..++.++|+||||+++++|++|+.||........ ........ ....
T Consensus 168 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~-~~~~- 238 (296)
T cd06618 168 SKAKT--RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-----VLTKILQE-EPPS- 238 (296)
T ss_pred CCccc--CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-----HHHHHhcC-CCCC-
Confidence 22211 12357789999998533 3467899999999999999999999975322111 01111111 1000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.........++.+++.+||+.+|.+||++++++
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 271 (296)
T cd06618 239 ----LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271 (296)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 011112345799999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=268.96 Aligned_cols=266 Identities=21% Similarity=0.314 Sum_probs=196.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC------Cc
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------SN 103 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 103 (325)
.+|.+.+.||+|++|.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57888999999999999999976 68899999886432 22234577899999999999999999988643 34
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++++|+. .+|.++. ...+++..+..++.|++.|+++||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 689999985 4666654 34689999999999999999999999 9999999999999999999999999998754
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHHH
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCYE 255 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~ 255 (325)
..... ...++..|+|||.+.+...++.++|+||||+++++|++|+.||...........+... .....
T Consensus 168 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAEMT----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCC----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 32211 1225778999999855556788999999999999999999999865322211110000 00000
Q ss_pred hCcccccc-------cCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCCC
Q 047716 256 AGELQNLV-------SDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPPH 309 (325)
Q Consensus 256 ~~~~~~~~-------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~~ 309 (325)
........ ... ....+.....+.+++.+||+.||.+||++++++ ..++.+.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 00000000 000 000112335688999999999999999999999 5577777543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=260.37 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=190.8
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh--cHHHHHHHHHHHhcc---CCCCcceeeEEeecCCc-----
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE--GESEFRNEMKIIGRI---HHKNLVDLVGFCSEGSN----- 103 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 103 (325)
|++.+.||+|++|.||+|.+. ++..+++|.+...... ....+.+|+.+++.+ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678889999999999999987 5889999988643222 123455677666655 59999999999877665
Q ss_pred eEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
.+++|||++ ++|.+++.... ..+++..++.++.|++.|+.+||+. +++|+|++|+||+++.++.++|+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 47888875543 3689999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC-----
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG----- 257 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 257 (325)
....... ....++..|+|||.+ ....++.++|+||||+++++|++|.+||......+....+ ........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~-~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVL-LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI--FDVIGLPSEEEWP 231 (287)
T ss_pred ccCCccc--ccccccccccChHHh-ccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH--HHHcCCCChHhcC
Confidence 5433221 112257789999998 4566788999999999999999999999765433221111 11000000
Q ss_pred --------cccccccCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 258 --------ELQNLVSDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 258 --------~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+....... ....+.....+.+++.+||+.+|++||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 1112234567899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=273.51 Aligned_cols=270 Identities=23% Similarity=0.316 Sum_probs=199.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC------
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------ 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 102 (325)
.++|++.+.||+|++|.||+|.+. ++..+++|++.... ......+..|+.+++.++|||++++.+.+....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 567999999999999999999987 67889999876432 223355678999999999999999988775544
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++|++|+ +++|.+++.. ..+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 389999998 6799988843 5799999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHH
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCY 254 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~ 254 (325)
..... ....++..|+|||.+.....++.++||||||+++++|++|+.||...........+... ....
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccccc----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 54321 11236788999998855557788999999999999999999999755432211110000 0000
Q ss_pred HhCcccccccC---CC-----CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCCCCCC
Q 047716 255 EAGELQNLVSD---QE-----DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVPPHQN 311 (325)
Q Consensus 255 ~~~~~~~~~~~---~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~~~~ 311 (325)
.......++.. .. .........+.+++.+||+.+|.+|||+.+|++ .++........
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~ 310 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE 310 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc
Confidence 00000000000 00 000112467999999999999999999999983 55555544333
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=274.70 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=206.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC--CCc--EEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN--GGK--EIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~--~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
|...+.++.++||+|+||.|++|.|. +|+ .||||.+...... .-..|.+|+.+|.+|+|||++++|++..+ ...
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 44567788899999999999999997 344 4688888765444 45679999999999999999999999987 788
Q ss_pred EEEEeecCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFR-AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+|||.++.|+|.+.+.+ ....+-...+..++.||+.|+.||.++ ++||||+...|+++.....|||+|||+.+-.
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence 999999999999999966 345688889999999999999999999 9999999999999988889999999999866
Q ss_pred cCCCc-cc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 184 KTDQT-RT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 184 ~~~~~-~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
+.+.. .. .......+.|.|||.+ +...++.++|+|++|+.+|||++ |..||.+....+....++
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsL-rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------------ 329 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESL-RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------------ 329 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHh-ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc------------
Confidence 54332 11 1112356789999999 78899999999999999999997 567888765443322211
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
-.+++.-+..+++.+++++..||..+|.+|||+..|.
T Consensus 330 --~~erLpRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 330 --AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred --ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 1233444566788999999999999999999999997
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=264.89 Aligned_cols=268 Identities=21% Similarity=0.308 Sum_probs=198.7
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeec-CCceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-GSNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 106 (325)
..++|++.+.||.|+||.||+|.+. .+..+++|++.... ......+..|+.+++.++||||+++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 4567999999999999999999877 78889999875422 2234567789999999999999999998865 567899
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
++||+ +++|.+++. ...++...+..++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||.+......
T Consensus 88 v~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred Eeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 99998 568888873 34678889999999999999999999 9999999999999999999999999988754322
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHH---------HHHHHHHhC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLID---------WAHQCYEAG 257 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~ 257 (325)
.. ...++..|+|||.+.....++.++|+||||+++++|++|++||...........+. +........
T Consensus 162 ~~----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 162 MT----GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred cC----CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 11 12357789999987555678899999999999999999999997654321111000 000000000
Q ss_pred ccc--ccccCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCC
Q 047716 258 ELQ--NLVSDQEDVN-----IEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPP 308 (325)
Q Consensus 258 ~~~--~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~ 308 (325)
... .........+ +.....+.++|.+||+.+|++|||+++++ ..++....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 000 0000000111 11246799999999999999999999998 335554433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=287.46 Aligned_cols=275 Identities=24% Similarity=0.245 Sum_probs=222.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeec---cchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
+...+|+|++.||+|+||.|.+++.+ .++-+|+|++.+ ....+..-|+.|-.+|..-+.+=|+.++-.|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 45789999999999999999999987 577778888876 22444556888888998888999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||++||+|-.++.+.. ++++..++.++..++.||.-||+. |+|||||||+|||++..|++||+|||.+..+..
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999999999996665 899999999999999999999999 999999999999999999999999999988876
Q ss_pred CCccceeeecCCCCcCCcccccc---C-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSR---N-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~---~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
+..-......|||.|.+||+++. + +.|.+..|-||+|+++|||+.|..||......+.+-.|......+..+
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP---- 303 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP---- 303 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC----
Confidence 66555555669999999999862 3 678999999999999999999999998766555554444332222221
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC---HhHHH----------HHHhccCCCCCCCCCCCCCCC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPT---MKQVI----------WMMEGIVPPHQNMLTHPTSTN 320 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~ell----------~~L~~~~~~~~~~~~~~~~~~ 320 (325)
.....++++.+||++.+. +|+.|.. ++++. ..|++..|+..+.++++..|.
T Consensus 304 -------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTs 367 (1317)
T KOG0612|consen 304 -------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTS 367 (1317)
T ss_pred -------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccc
Confidence 112245678999988775 6778888 88887 344444555555555555543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=266.39 Aligned_cols=265 Identities=23% Similarity=0.316 Sum_probs=197.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC------
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------ 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 102 (325)
..+|++.+.||+|++|.||+|.+. .+..+++|++.... ......+..|+.+++.++||||+++++.+..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 567999999999999999999876 68889999875422 223345778999999999999999999886543
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||+++ +++|.+++. ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++++|||++..
T Consensus 94 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 358999998 778988874 35689999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHH
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCY 254 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~ 254 (325)
...... ...+++.|+|||.+.+...++.++|+||||+++++|++|+.||...........+... ...+
T Consensus 168 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSEMT----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccCcc----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 533221 1236788999998855456788999999999999999999999754332111100000 0000
Q ss_pred HhCcccccccCC--------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 255 EAGELQNLVSDQ--------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 255 ~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
............ ..........+.+++.+|++.||.+|||+.+++ ..++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 000000000000 001112234688999999999999999999999 5565554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=272.31 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=217.2
Q ss_pred ccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 25 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+.-+++...+..+.++||.|-||.||.|.|+ -.-.||||.++.+ .....+|..|+.+++.++|||+|+++++|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4667788888888899999999999999998 4667889988664 3556778999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
.|||+|||..|+|.+++.... ..++...++.++.||..|+.||..+ +++|+||.+.|.||.++..||+.|||++++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999996653 3477778899999999999999999 999999999999999999999999999998
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
+..+....-..-.-..-|.|||.+ ....++.++|||+||++|||+.| |-.||.+....+.+-++ ..+--+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsL-AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-------EkgyRM- 485 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-------EKGYRM- 485 (1157)
T ss_pred hcCCceecccCccCcccccCcccc-cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-------hccccc-
Confidence 876554322222235679999998 67788999999999999999987 55788776544332222 111111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
+-+..|++.+.+||+.||+.+|.+||++.|+-+.+|.+...
T Consensus 486 ------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 486 ------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 11223446799999999999999999999999999998743
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=267.16 Aligned_cols=268 Identities=21% Similarity=0.260 Sum_probs=194.1
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-C--CcEEEEEEeeccc--hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec----CCc
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-G--GKEIAVKKLIKIV--EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE----GSN 103 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~--~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 103 (325)
+|++.+.||+|+||.||++.+. . +..+++|++.... ......+.+|+.+++.+ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999987 3 6789999876432 22345677899999999 49999999986432 245
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++++++. ++|.+++. ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788999885 68888873 456789999999999999999999999 9999999999999999999999999998755
Q ss_pred cCCCcc---ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HH
Q 047716 184 KTDQTR---TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQ 252 (325)
Q Consensus 184 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~ 252 (325)
...... ......++..|+|||.+.+...++.++|+||||+++++|++|.+||...........+... ..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 1112247888999998755566789999999999999999999999765422111000000 00
Q ss_pred HHHhCc-------ccccccC-CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 253 CYEAGE-------LQNLVSD-QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 253 ~~~~~~-------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
...... ....... .....+.....+.+++.+||+.+|.+|||+.+++ ..|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 000000 0000000 0001111245799999999999999999999999 5555554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=257.77 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=190.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeecc-----chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKI-----VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+|.+.++||+|++|.||++.+.. +..+++|.+... .......+..|+.+++.++||||+++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48889999999999999998863 344555554321 122334566789999999999999999999888899999
Q ss_pred EeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 108 YEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+||+++++|.+++.. ....+++..++.++.|++.|+.+||+. |++|+|++|+||+++.+ .++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~~-~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKNN-LLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeecC-CEeecccCceeecC
Confidence 999999999988743 245689999999999999999999999 99999999999999864 79999999886553
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..... .....++..|+|||.+ ....++.++|+||||+++++|++|..||....... ..... ..+.
T Consensus 157 ~~~~~-~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~-~~~~------ 221 (260)
T cd08222 157 GSCDL-ATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRI-VEGP------ 221 (260)
T ss_pred CCccc-ccCCCCCcCccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH-HcCC------
Confidence 32211 1122367889999988 45667889999999999999999999996432211 11111 1111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+..+.....++.+++.+||+.+|++||++.|+++
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 -TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11122344567999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=252.69 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=196.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC---C--CcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeec-CCc
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN---G--GKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSE-GSN 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~---~--~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 103 (325)
...|+++..||+|.||.||+|.-. + ++.+|+|++..... .-....-+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457899999999999999999543 2 44789998865322 223456689999999999999999998866 789
Q ss_pred eEEEEeecCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC----CcEEEe
Q 047716 104 RLLVYEFMRNGSLGNLLFRA----EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES----WKAKIS 175 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~----~~vkl~ 175 (325)
+++++||.+. +|..++... ...++...+..++.||+.++.|||++ =+.|||+||.||+|..+ |+|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999966 777777322 24589999999999999999999998 89999999999999887 899999
Q ss_pred eccccccccCCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc---chhhHHHHH
Q 047716 176 DFGLSKLLKTDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD---DEIVLIDWA 250 (325)
Q Consensus 176 Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~~~~~~~ 250 (325)
|+|+++.+...-.. ....+..|.+|+|||.+.+...|+.+.|||+.|||+.||++..+.|.+.... ...+..+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999987643321 2233446899999999989999999999999999999999999998654321 101111111
Q ss_pred H---HHHHhCcccccccCC--CCC-------------C---HH-------HHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 251 H---QCYEAGELQNLVSDQ--EDV-------------N---IE-------EFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 251 ~---~~~~~~~~~~~~~~~--~~~-------------~---~~-------~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. ..+..+.-..+.+-. ++. + .. ......+|+.+||+.||.+|.|+++.++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 1 111111101000000 000 0 00 0123789999999999999999999984
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=251.47 Aligned_cols=236 Identities=27% Similarity=0.278 Sum_probs=188.8
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeeccchh---cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCH
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE---GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
||.|++|.||++.+. .+..+++|.+...... ....+..|+.+++.++||||+++++.+..+...+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999987 5888999988654322 344688899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecC
Q 047716 117 GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG 196 (325)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~ 196 (325)
.+++... ..+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++++|||.+........ ......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCG 155 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcC
Confidence 9998543 4689999999999999999999998 999999999999999999999999999876543321 1122336
Q ss_pred CCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHH
Q 047716 197 TRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFEN 276 (325)
Q Consensus 197 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
+..|+|||.. .....+.++|+||||+++++|++|..||........ . ..... .....+......
T Consensus 156 ~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~----~~~~~--------~~~~~~~~~~~~ 219 (250)
T cd05123 156 TPEYLAPEVL-LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---Y----EKILK--------DPLRFPEFLSPE 219 (250)
T ss_pred CccccChHHh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHhc--------CCCCCCCCCCHH
Confidence 7889999998 455578899999999999999999999975532111 1 11111 111122222467
Q ss_pred HHHHHhhcccCCCCCCCCHhH
Q 047716 277 LVKIGLWCVECELNLRPTMKQ 297 (325)
Q Consensus 277 l~~li~~~l~~~p~~Rps~~e 297 (325)
+.+++.+||..+|++||++.+
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHhcCCHhhCCCccc
Confidence 899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=242.81 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=195.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh-cHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE-GESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++.+++..||.|..|.|++++.. .|...|||.+...... ..+.+...+.++..-+ +|.||+++++|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 44566788999999999999988 5888999998765433 3344666666655554 8999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
.| ..-+..++....+.+++..+-.+...++.||.||.++ .+|+|||+||+|||++..|++|++|||.+-++-.....
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 88 5566777767778899998889999999999999987 59999999999999999999999999998766443332
Q ss_pred ceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 190 TYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.. ..|-+.|||||.+.- ...|+..+||||||+.++||.||+.||.+-..+ ..++. ..+. .....+.
T Consensus 249 tr--sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~lt----kvln--~ePP~L~--- 316 (391)
T KOG0983|consen 249 TR--SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLT----KVLN--EEPPLLP--- 316 (391)
T ss_pred cc--ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHH----HHHh--cCCCCCC---
Confidence 22 237789999998853 356788999999999999999999999875432 11111 1111 1111222
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.....+..+.+++..||+.|+.+||...+++
T Consensus 317 -~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 317 -GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred -cccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 2222556689999999999999999999998
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=247.30 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=203.8
Q ss_pred HHHHhhh-hhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEE
Q 047716 32 LASENFK-EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 32 ~~~y~~~-~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 108 (325)
..-|++- +.||+|+++.|-.+..- .+.++|||++.+...-....+.+|++++.+.+ |+||+.+++||+++...|+||
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 3445554 67999999999988754 79999999999887777788999999999986 999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---cEEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---KAKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---~vkl~Dfg~~~~~~~ 185 (325)
|-+.||+|...+. ...-+++.++..+.+.|+.||.|||.+ ||.|+|+||+|||..... -|||+||.+..-...
T Consensus 156 EKm~GGplLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQ-KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred ecccCchHHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 9999999999884 445699999999999999999999999 999999999999996554 389999988754321
Q ss_pred C------CccceeeecCCCCcCCccccc----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccc------hhhHH--
Q 047716 186 D------QTRTYTVLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD------EIVLI-- 247 (325)
Q Consensus 186 ~------~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~------~~~~~-- 247 (325)
. ........+|+..|||||+.. ....|+.+.|.||||+|+|-||+|.+||.+....+ ..+..
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 112222345788999999753 34678889999999999999999999998665433 11111
Q ss_pred HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
......++.+.+. +. ..-....+.+..+++...+-.++.+|.++.++++
T Consensus 312 ~~LFesIQEGkYe-FP---dkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 NKLFESIQEGKYE-FP---DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHhccCCc-CC---hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1112222222211 11 1123445678999999999999999999999984
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=257.75 Aligned_cols=279 Identities=21% Similarity=0.341 Sum_probs=213.1
Q ss_pred CCCccccccccccccHHHHHH-HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC--
Q 047716 12 SSPDVFEEIKLRSFSYEQIVL-ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-- 87 (325)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~-~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-- 87 (325)
+..++|.-++|++...++... .+|-++++||-|.|++||+|.+. ..+.||+|+.+. .+--......|+++|++++
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhc
Confidence 567789999999999999998 99999999999999999999988 455666776644 3333445678999999984
Q ss_pred ------CCCcceeeEEee----cCCceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeee
Q 047716 88 ------HKNLVDLVGFCS----EGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156 (325)
Q Consensus 88 ------h~~iv~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h 156 (325)
..+||+++++|. ++.++++|+|++ |.+|..++... -.+++..-+..|++|++.||.|||..| ||+|
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIH 211 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIH 211 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--Cccc
Confidence 247999999984 456899999999 77888888655 356999999999999999999999998 9999
Q ss_pred ccCCCCceEEcCC-------------------------------------------------------------------
Q 047716 157 CDIKPHNILMDES------------------------------------------------------------------- 169 (325)
Q Consensus 157 ~di~p~nilv~~~------------------------------------------------------------------- 169 (325)
.||||+|||+..+
T Consensus 212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~ 291 (590)
T KOG1290|consen 212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL 291 (590)
T ss_pred cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence 9999999998200
Q ss_pred --------------------------------------------------------------------------------
Q 047716 170 -------------------------------------------------------------------------------- 169 (325)
Q Consensus 170 -------------------------------------------------------------------------------- 169 (325)
T Consensus 292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~ 371 (590)
T KOG1290|consen 292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP 371 (590)
T ss_pred ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence
Q ss_pred -------------------CcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh
Q 047716 170 -------------------WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230 (325)
Q Consensus 170 -------------------~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 230 (325)
-++||.|||.+..+....... ..|..|+|||++ -+..|++.+||||++|++|||+|
T Consensus 372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~D----IQTRQYRapEVl-lGsgY~~~ADiWS~AC~~FELaT 446 (590)
T KOG1290|consen 372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTED----IQTRQYRAPEVL-LGSGYSTSADIWSTACMAFELAT 446 (590)
T ss_pred cccccccccCCCCCCCccceeEEEeeccchhhhhhhhchh----hhhhhccCccee-ecCCCCCchhHHHHHHHHHHhhc
Confidence 013444444443322111111 157889999999 57788999999999999999999
Q ss_pred CCCCCCCccccc---hhhHHHHHH------------------HHHH-hC-----------cccccccCCCCCCHHHHHHH
Q 047716 231 CRKNVDESLRDD---EIVLIDWAH------------------QCYE-AG-----------ELQNLVSDQEDVNIEEFENL 277 (325)
Q Consensus 231 g~~p~~~~~~~~---~~~~~~~~~------------------~~~~-~~-----------~~~~~~~~~~~~~~~~~~~l 277 (325)
|...|+...... +...+..+- ..+. .+ .+.+++.+..+++.+...++
T Consensus 447 GDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~f 526 (590)
T KOG1290|consen 447 GDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQF 526 (590)
T ss_pred CceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHH
Confidence 999997554322 222221111 1111 11 34455556678888889999
Q ss_pred HHHHhhcccCCCCCCCCHhHHH
Q 047716 278 VKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 278 ~~li~~~l~~~p~~Rps~~ell 299 (325)
.+|+.-||+.+|++|||+.+.+
T Consensus 527 sdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 527 SDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHHHHhcCccccccHHHHh
Confidence 9999999999999999999999
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=245.25 Aligned_cols=250 Identities=21% Similarity=0.258 Sum_probs=193.2
Q ss_pred HHHHhhh-hhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeec----CCce
Q 047716 32 LASENFK-EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE----GSNR 104 (325)
Q Consensus 32 ~~~y~~~-~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~ 104 (325)
..+|.+. ++||-|-.|.|-.+..+ .+..+|+|++.. ....++|++.=-.. .|||||.+++++++ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4577776 57999999999999877 688889988733 33456677665544 49999999998854 3567
Q ss_pred EEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC---CcEEEeecccc
Q 047716 105 LLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES---WKAKISDFGLS 180 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~---~~vkl~Dfg~~ 180 (325)
.+|||.++||.|...+... .+.+++.++..+++||+.|+.|||+. +|.|||+||+|+|.+.+ ..+||+|||++
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 8999999999999888554 45699999999999999999999999 99999999999999644 46999999999
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
....... .....+-|+.|.|||++ +...|+...|+||||+++|-||+|-+||-....... ..-+...+..+.+.
T Consensus 212 K~t~~~~--~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 212 KETQEPG--DLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQYE 285 (400)
T ss_pred cccCCCc--cccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccCcc
Confidence 8654322 22333468999999999 777899999999999999999999999965543111 00112222222211
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
-+.+.....++..+++|+.+|..+|.+|.|++++.
T Consensus 286 ----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m 320 (400)
T KOG0604|consen 286 ----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVM 320 (400)
T ss_pred ----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhh
Confidence 11222334567899999999999999999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=267.77 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=201.8
Q ss_pred hhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCC------ceEEEE
Q 047716 37 FKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------NRLLVY 108 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~ 108 (325)
..+.||+|+||.||+|+++ .|..||||.+..... ......-.|+++|++++|||||+++++-++.. ...++|
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3567999999999999976 899999999977543 33455678999999999999999999865543 458999
Q ss_pred eecCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC----CcEEEeecccccc
Q 047716 109 EFMRNGSLGNLLFRA--EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES----WKAKISDFGLSKL 182 (325)
Q Consensus 109 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~----~~vkl~Dfg~~~~ 182 (325)
|||.+|+|...+.+- ..++++.+++.++..++.|+.|||++ ||+||||||.||++..+ ...||+|||.++.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999542 46799999999999999999999999 99999999999998433 3479999999987
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
...+. ......||..|++||.+...+.++...|.||||+++|+++||..||...........+.|....-.+......
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 76554 4455569999999999955688999999999999999999999999766554333333333333222221111
Q ss_pred ccC--------------CCCCCHHHHHHHHHHHhhcccCCCCCCC--CHhHHHHHHhccC
Q 047716 263 VSD--------------QEDVNIEEFENLVKIGLWCVECELNLRP--TMKQVIWMMEGIV 306 (325)
Q Consensus 263 ~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp--s~~ell~~L~~~~ 306 (325)
..+ .-.........+-.++..+|..+|++|- ...+.-..+..+.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 111 1112233345677788889999999998 5555544444443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=266.01 Aligned_cols=238 Identities=24% Similarity=0.296 Sum_probs=192.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
...|++...+|.|+|+.|-.+... .+...++|++.+... ...+|+.++... +||||++..+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 468899999999999999998876 688899999876522 223456444444 69999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE-cCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM-DESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv-~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
.+.++-+.+.+... +.....+..|+++|+.|+.|||++ |++|||+||+|||+ ++.++++|+|||.+......
T Consensus 397 ~l~g~ell~ri~~~--~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK--PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhc--chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 99999888877332 223377788999999999999999 99999999999999 68889999999999876544
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
....+-|..|.|||.+ ....+++++|+||||++||+||+|+.||.....+.. ....+..+...
T Consensus 470 --~~tp~~t~~y~APEvl-~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i~~~i~~~~~s-------- 532 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVL-AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------IHTRIQMPKFS-------- 532 (612)
T ss_pred --hcccchhhcccChhhh-ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH------HHHhhcCCccc--------
Confidence 2222357899999999 588899999999999999999999999987655411 12333333333
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...+..+++|+.+||++||.+||++.++.
T Consensus 533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 533 --ECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred --cccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 33446799999999999999999999998
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=253.68 Aligned_cols=266 Identities=19% Similarity=0.299 Sum_probs=203.6
Q ss_pred cccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC--CC----CcceeeE
Q 047716 24 SFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH--HK----NLVDLVG 96 (325)
Q Consensus 24 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~--h~----~iv~~~~ 96 (325)
.|..+++..++|.+...+|+|.||.|..+.+. .+..+|+|++.. ...-....+-|+++|++++ .| -++.+.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 38889999999999999999999999999887 467788887754 3333445667999999994 33 3677788
Q ss_pred EeecCCceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-------
Q 047716 97 FCSEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE------- 168 (325)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~------- 168 (325)
+|+..++.+||+|.+ |-++.+++..+ -.+++...++.+++|+++++++||+. +++|-|+||+||++.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence 899999999999998 77999999553 35689999999999999999999999 9999999999999831
Q ss_pred -------------CCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCC
Q 047716 169 -------------SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV 235 (325)
Q Consensus 169 -------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 235 (325)
+..|+++|||.++...... ..+..|..|+|||++ -+-.++..+||||+||||+||.+|...|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEVi-LgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVI-LGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchhe-eccCcCCccCceeeeeEEEEeeccceec
Confidence 3359999999998765544 233468999999999 5788899999999999999999999999
Q ss_pred CCccccchhhHHH--------------HHHHHHHhCccc-----------ccccCC------CCCCHHHHHHHHHHHhhc
Q 047716 236 DESLRDDEIVLID--------------WAHQCYEAGELQ-----------NLVSDQ------EDVNIEEFENLVKIGLWC 284 (325)
Q Consensus 236 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~-----------~~~~~~------~~~~~~~~~~l~~li~~~ 284 (325)
+...+.+....-+ ...+.+..+.++ .+.+.. -........+|.+|+..|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 8776544221110 011111111111 000000 001112235699999999
Q ss_pred ccCCCCCCCCHhHHH
Q 047716 285 VECELNLRPTMKQVI 299 (325)
Q Consensus 285 l~~~p~~Rps~~ell 299 (325)
|.+||.+|+|+.|++
T Consensus 390 L~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 390 LEFDPARRITLREAL 404 (415)
T ss_pred HccCccccccHHHHh
Confidence 999999999999998
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=247.81 Aligned_cols=244 Identities=25% Similarity=0.281 Sum_probs=202.2
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
.+..++|++.+.||+|.||.|.+++.+ .++.+|+|++.+.. ......-..|-++|+..+||.+..+.-.|.....+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 456778999999999999999999987 78999999887643 22333455789999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+.||||.+||.|.-.+. ....+++...+.+-..|+.|+.|||++ +|+++|+|.+|.+++.+|++|+.|||++..-
T Consensus 244 CFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred EEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-
Confidence 99999999999987773 456789999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..........+||+.|+|||++ ....|..+.|-|.+|+++|||++|+.||-.........++. .
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl---------------~ 382 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL---------------M 382 (516)
T ss_pred ccccceeccccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---------------h
Confidence 2233445567799999999999 68889999999999999999999999998765544332221 1
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRP 293 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 293 (325)
.....+-....+.+.|+...|..||.+|.
T Consensus 383 ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 EDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 12222333345789999999999999995
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=258.03 Aligned_cols=249 Identities=25% Similarity=0.307 Sum_probs=202.6
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
..+.|+.-+.||+||||.|+-+... .|+.+|.|++.+... ....-...|-.+|+.++.+.||.+--.|+..+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456777789999999999999877 789999998865332 233446789999999999999999888999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
|+..|+||+|.-.+.+. ...++++.++.++.+|+.++.+||+. +|++||+||+|||+|+.|+++|+|+|++..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999998777544 34799999999999999999999999 999999999999999999999999999998766
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
...-... .||.+|||||++++ ..|+...|-|||||++|+|+.|+.||.......... .+. +.++..
T Consensus 340 g~~~~~r--vGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-------Evd----rr~~~~ 405 (591)
T KOG0986|consen 340 GKPIRGR--VGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-------EVD----RRTLED 405 (591)
T ss_pred CCccccc--cCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-------HHH----HHHhcc
Confidence 5543322 49999999999954 459999999999999999999999997654321110 111 122333
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHh
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMK 296 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 296 (325)
..+.+...+++++++....|+.||.+|.-..
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 3445556678899999999999999996544
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=288.94 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=196.4
Q ss_pred hhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 38 KEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
...||.|.||.||.|.+. .|...|+|.+.-.. ......+.+|+.++..++|||+|+++++-.+....+|.||||.+|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 457999999999999887 57777888664322 333445788999999999999999999999999999999999999
Q ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc---cce
Q 047716 115 SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT---RTY 191 (325)
Q Consensus 115 ~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~---~~~ 191 (325)
+|.+.+ +.++..++.....+..|++.|++|||+. ||||+||||.||+++.+|.+|++|||.+........ ...
T Consensus 1320 sLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1320 SLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred cHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 999998 3444566667788999999999999999 999999999999999999999999999987755431 122
Q ss_pred eeecCCCCcCCccccccCC--CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNN--RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
....||+.|||||.+.+.. ...-+.|||||||++.||+||+.||...... ..+.+.-. ....+.+
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~----------~gh~Pq~ 1462 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVA----------AGHKPQI 1462 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHh----------ccCCCCC
Confidence 2234999999999985432 3456899999999999999999999765432 22222111 1223444
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+...+.+-.+++.+||+.||++|-++.||++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 5556678899999999999999999888874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=244.48 Aligned_cols=219 Identities=20% Similarity=0.165 Sum_probs=173.9
Q ss_pred CCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhh
Q 047716 44 GGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR 122 (325)
Q Consensus 44 g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 122 (325)
|.+|.||++.+. +++.+++|++.... ....|...+....||||+++++++......+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999987 68889999986533 223445555566799999999999998999999999999999998844
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCC
Q 047716 123 AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202 (325)
Q Consensus 123 ~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 202 (325)
...+++..+..++.|++.|+.+||++ +++|+||+|+||+++.++.++++|||.+........ ...++..|+|
T Consensus 79 -~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~y~a 150 (237)
T cd05576 79 -FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD----GEAVENMYCA 150 (237)
T ss_pred -hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccc----cCCcCccccC
Confidence 34689999999999999999999999 999999999999999999999999998765443221 1224667999
Q ss_pred ccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHh
Q 047716 203 PELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGL 282 (325)
Q Consensus 203 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (325)
||.. ....++.++|+||+|+++++|++|..|+........ . ......+......+.+++.
T Consensus 151 PE~~-~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~--~~~~~~~~~~~~~~~~li~ 210 (237)
T cd05576 151 PEVG-GISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------T--HTTLNIPEWVSEEARSLLQ 210 (237)
T ss_pred Cccc-CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------c--ccccCCcccCCHHHHHHHH
Confidence 9988 556678899999999999999999988754321100 0 0001112223467899999
Q ss_pred hcccCCCCCCCCH
Q 047716 283 WCVECELNLRPTM 295 (325)
Q Consensus 283 ~~l~~~p~~Rps~ 295 (325)
+||+.||++||++
T Consensus 211 ~~l~~dp~~R~~~ 223 (237)
T cd05576 211 QLLQFNPTERLGA 223 (237)
T ss_pred HHccCCHHHhcCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=260.10 Aligned_cols=242 Identities=25% Similarity=0.403 Sum_probs=201.4
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeec--cchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCC
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGS 115 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 115 (325)
+.||+|-||+||-|+.+ .|+.||||+|.+ ...+....++.|+.+|+++.||.||.+...|+.....++|||-+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 68999999999999987 899999999976 345556789999999999999999999999999999999999996665
Q ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC---CcEEEeeccccccccCCCcccee
Q 047716 116 LGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES---WKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 116 L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~---~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
|.-++....+++++..-..++.||+.|+.|||-+ +|+|+|+||+|||+.+. ..+||+|||.++..+...-+.
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr-- 724 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR-- 724 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh--
Confidence 6666666678899999999999999999999999 99999999999999655 469999999999877654433
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
.+.||+.|+|||++ ..+.|+...||||.|+|+|--|+|..||....+..+ .++... +..++....+
T Consensus 725 sVVGTPAYLaPEVL-rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---------QIQNAa----FMyPp~PW~e 790 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVL-RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---------QIQNAA----FMYPPNPWSE 790 (888)
T ss_pred hhcCCccccCHHHH-hhccccccccceeeeEEEEEEecccccCCCccchhH---------Hhhccc----cccCCCchhh
Confidence 34499999999999 677788899999999999999999999976543221 111111 1223334445
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 273 EFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
......++|...|+..-.+|-|.+.-+
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 566799999999999999999998876
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=241.18 Aligned_cols=264 Identities=24% Similarity=0.365 Sum_probs=202.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeec--cchhcHHHHHHHHHHHhccCCCCcceeeEEeec--------
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-------- 100 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 100 (325)
.+.|+-..++|+|.||.||+|+.+ .++.|++|++.- ....-.....+|+.+|+.++|+|++.+++.+..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 467777889999999999999877 577778776532 122223346689999999999999999886622
Q ss_pred CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
...+++||++|.+ +|..++.....+++..++..++.++..++.|+|+. .|+|||+||.|++++.+|.++|.|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2457999999954 78888866667899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc---cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 181 KLLKTDQT---RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 181 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
+-+..... ........|.+|++||.+.+...++++.|||..||++.+|.++.+-+++........++......+..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 65432221 112223358999999999899999999999999999999999999998877666666554333222222
Q ss_pred cccc--------------cccCCCCCCHHHH------HHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 258 ELQN--------------LVSDQEDVNIEEF------ENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 258 ~~~~--------------~~~~~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
-+.. +.......-.+.. .+..+++.+++..||.+|+++++++
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 1111 1111111111112 3688999999999999999999998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=246.12 Aligned_cols=260 Identities=25% Similarity=0.300 Sum_probs=197.7
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-------hhcHHHHHHHHHHHhccCCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-------EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (325)
-..+.+|-+.+.||.|||+.||+|.+- ..+.+|+|+-.-.. ..-.+...+|..+-+.|.||.||++|+++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 367899999999999999999999887 56667777543211 1112335579999999999999999999854
Q ss_pred -CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCcEEEee
Q 047716 101 -GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWKAKISD 176 (325)
Q Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~vkl~D 176 (325)
....+-|.|||+|.+|.=++. ...-+++.+++.++.||+.||.||... +..|+|-|+||.|||+.+ .|.+||+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 467789999999999887774 446799999999999999999999985 678999999999999943 47899999
Q ss_pred ccccccccCCCcc------ceeeecCCCCcCCcccccc---CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHH
Q 047716 177 FGLSKLLKTDQTR------TYTVLRGTRGYTAPELHSR---NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI 247 (325)
Q Consensus 177 fg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 247 (325)
||++..+..+... ...-..||.||++||.+.- .+..+.+.||||+|+|+|.++.|+.||..........-.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999887654432 1222348999999998753 356788999999999999999999999876543322110
Q ss_pred HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
. ..+.. -.-. -+..|....+...+|.+||+.--++|....++.
T Consensus 697 N---TIlkA--tEVq----FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 N---TILKA--TEVQ----FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h---chhcc--eecc----CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 0 00000 0001 111223345689999999999999999999988
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=269.94 Aligned_cols=145 Identities=29% Similarity=0.362 Sum_probs=129.7
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|++.++||.|+||.||+|.+. .+..+|+|++.... ......+..|+.+++.++||||+++++.+......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999987 68899999986532 222356788999999999999999999999889999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
||+.+++|.+++.. .+.+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.++|+|||++.
T Consensus 84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 45688999999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=265.40 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=208.9
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC--------CCcEEEEEEeeccch-hcHHHHHHHHHHHhccC-CCCcceeeE
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN--------GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIH-HKNLVDLVG 96 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~ 96 (325)
..++..++..+.+.||+|+||.|++|... ....||||.+..... .....+..|+++++.+. |+||+.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 55667777788889999999999999743 145688998876433 45567889999999996 999999999
Q ss_pred EeecCCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCC
Q 047716 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKP 161 (325)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p 161 (325)
.+...+..++|+||+..|+|.+++.... ..++..+++.++.||+.|+.||++. .++|||+.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9998899999999999999999996655 3489999999999999999999999 999999999
Q ss_pred CceEEcCCCcEEEeeccccccccCCCccceeeec--CCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCc
Q 047716 162 HNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR--GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDES 238 (325)
Q Consensus 162 ~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~ 238 (325)
+|||++.+..+|++|||+++.............. .+..|+|||.+ ....++.++||||+|+++||+++ |..|+.+.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl-~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL-FDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh-ccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999865443332211111 24569999999 45899999999999999999988 66777663
Q ss_pred cccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 239 LRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...... . +.+..+.-. +.+..+..++.++|+.||+.+|++||++.++.+.++.+.
T Consensus 526 ~~~~~l--~----~~l~~G~r~-------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 526 PPTEEL--L----EFLKEGNRM-------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CcHHHH--H----HHHhcCCCC-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 212111 1 123222211 222233567899999999999999999999999988853
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=243.98 Aligned_cols=269 Identities=23% Similarity=0.331 Sum_probs=207.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhc--cCCCCcceeeEEeecC----Cc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGR--IHHKNLVDLVGFCSEG----SN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~ 103 (325)
.+..+-.+.+.||+|.||.||+|.|+ |..||||++.. .++....+|.++.+. |+|+||+.+++.-..+ ..
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 44667788899999999999999998 77899999865 445566666666665 4899999999865433 35
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhcc-----CCCCeeeccCCCCceEEcCCCcEEEeecc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE-----CETRIIHCDIKPHNILMDESWKAKISDFG 178 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-----~~~~i~h~di~p~nilv~~~~~vkl~Dfg 178 (325)
++||++|.+.|+|.|++.. ..++......++..++.||++||.. .+..|.|||||..||+|..++...|+|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 7999999999999999944 6799999999999999999999965 35679999999999999999999999999
Q ss_pred ccccccCCCc---cceeeecCCCCcCCccccccCCCCC-----ccccchhHHHHHHHHHh----------CCCCCCCccc
Q 047716 179 LSKLLKTDQT---RTYTVLRGTRGYTAPELHSRNNRIT-----VKADVYSFGVMLLEIVC----------CRKNVDESLR 240 (325)
Q Consensus 179 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~----------g~~p~~~~~~ 240 (325)
++........ -......||.+|||||++...-+.. ..+||||||+++||++. -++||....+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9987655422 2223345999999999985432221 25899999999999984 2478876666
Q ss_pred cchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 241 DDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.++..... .+.+=-.++++.+..+.. ..+....+.++|+.||..||.-|.|+-.+.+.|.++.+
T Consensus 442 ~DPs~eeM--rkVVCv~~~RP~ipnrW~-s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEM--RKVVCVQKLRPNIPNRWK-SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHH--hcceeecccCCCCCcccc-cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 55443221 122222334444444333 33456779999999999999999999999999998874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=227.54 Aligned_cols=257 Identities=20% Similarity=0.343 Sum_probs=198.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecC--CceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEG--SNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~l 106 (325)
...+|++.+++|.|.++.||.|..- ++..+++|.+++ -..+.+.+|+.+|+.|. +|||++++++..+. ....+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 5689999999999999999999865 677788888765 33457889999999997 99999999998664 56789
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-CcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vkl~Dfg~~~~~~~ 185 (325)
++||++..+...+. .+++..+++.++.+++.|+.|||+. ||.|+|+||.|++++.. -.++|+|+|++.++..
T Consensus 113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999988877765 5688999999999999999999999 99999999999999865 4599999999987754
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccc-cchhhHHHHHHHH-----------
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLR-DDEIVLIDWAHQC----------- 253 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~----------- 253 (325)
... ......+.-|-.||.+..-..++.+.|+|||||+++.|+..+.||....+ .++.+.+..+-..
T Consensus 186 ~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 GKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred Cce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 432 23333567788999987788899999999999999999999999865443 3444444211100
Q ss_pred -HHhCcccccccCCC----------CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 254 -YEAGELQNLVSDQE----------DVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 254 -~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..++.+..++.... +...-...++.+++.+.|..|-.+|||++|..
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 01111111111110 00111136789999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=236.19 Aligned_cols=238 Identities=28% Similarity=0.358 Sum_probs=189.7
Q ss_pred CceeEEEEEeC-CCcEEEEEEeeccchhc-HHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhh
Q 047716 45 GSGRVYKGCIN-GGKEIAVKKLIKIVEEG-ESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR 122 (325)
Q Consensus 45 ~~g~v~~~~~~-~~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 122 (325)
++|.||+|.+. ++..+++|++....... ...+.+|+..++.++|+|++++++++......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48899999987654444 67889999999999999999999999988999999999999999999854
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCC
Q 047716 123 AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202 (325)
Q Consensus 123 ~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 202 (325)
. ..++...++.++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+....... ......++..|++
T Consensus 81 ~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 R-GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred c-cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 3 3389999999999999999999999 99999999999999999999999999987665432 1222336788999
Q ss_pred ccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHh
Q 047716 203 PELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGL 282 (325)
Q Consensus 203 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (325)
||.+ .....+.++|+||||+++++|++|..||........ .. .......... ..........+.+++.
T Consensus 155 pE~~-~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~----~~~~~~~~~~-----~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 155 PEVL-LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LF----KKIGKPKPPF-----PPPEWKISPEAKDLIR 222 (244)
T ss_pred HHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HH----HHHhccCCCC-----ccccccCCHHHHHHHH
Confidence 9998 456678899999999999999999999976322111 11 1111111110 0000003357999999
Q ss_pred hcccCCCCCCCCHhHHHH
Q 047716 283 WCVECELNLRPTMKQVIW 300 (325)
Q Consensus 283 ~~l~~~p~~Rps~~ell~ 300 (325)
+|+..+|++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=252.75 Aligned_cols=252 Identities=21% Similarity=0.248 Sum_probs=207.1
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeCCCc-EEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCINGGK-EIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
.++..++.+.+.-||-|+||.|-++..++.. .+|+|.+.+. ...-...+..|-.+|...+.|.||++|-.|.+...
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 4456677888889999999999999887544 4777766542 23344557789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.|++||-|-||.++..+ +..+.++....+.++..+++|+.|||++ ||++||+||+|.+++.+|-+||.|||++...
T Consensus 495 vYmLmEaClGGElWTiL-rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTIL-RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhHHhhcCchhhhhh-hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 99999999999999999 4567899999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
+... .....+||+.|.|||++ -.+..+.++|.||||++++||++|.+||.+..+-..+..+. +.+.
T Consensus 571 ~~g~--KTwTFcGTpEYVAPEII-LnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL---kGid-------- 636 (732)
T KOG0614|consen 571 GSGR--KTWTFCGTPEYVAPEII-LNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL---KGID-------- 636 (732)
T ss_pred ccCC--ceeeecCCcccccchhh-hccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH---hhhh--------
Confidence 6544 34556799999999998 45667889999999999999999999999876655444332 1111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPT-----MKQVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell 299 (325)
..+++-.......++|++....+|.+|.- +.+|.
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIk 675 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIK 675 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHH
Confidence 12223334467889999999999999976 56665
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=242.89 Aligned_cols=266 Identities=27% Similarity=0.392 Sum_probs=200.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHH--hccCCCCcceeeEEeecCC----ceE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKII--GRIHHKNLVDLVGFCSEGS----NRL 105 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l--~~l~h~~iv~~~~~~~~~~----~~~ 105 (325)
...-++.+.+|+|.||.||+|... ++.||||++.. .....+..|-.+. -.++|+||+.+++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 556678889999999999999886 58999999865 3344455555444 4557999999999875544 789
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhcc------CCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE------CETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~------~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
||++|.+.|+|.+++. ...+++.+...++..++.||+|||+. .+..|+|||||..||||.++++..|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999994 45799999999999999999999976 256799999999999999999999999999
Q ss_pred cccccCCCc-cceeeecCCCCcCCccccccCCCCC-----ccccchhHHHHHHHHHhCCCCC------------CCcccc
Q 047716 180 SKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRIT-----VKADVYSFGVMLLEIVCCRKNV------------DESLRD 241 (325)
Q Consensus 180 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g~~p~------------~~~~~~ 241 (325)
+..+..... ...-...||.+|||||++.+.-+.. .+.||||+|+++|||++.-.-+ +.....
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 987764332 2222356999999999996655444 3689999999999999754333 211111
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+. ++-++......+.+..+....... ....-+.+.+..||..||+-|.|+.=+-+++.++.
T Consensus 443 hPt--~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 443 HPT--LEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCC--HHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 110 112333333333333333332222 45567999999999999999999999998888877
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=237.54 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=192.4
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-hcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeec
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.+-...||.|+||+|++-..+ .|+..|||++..... .+.+++..|.....+- +.||||++++....++..||.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 334668999999999998776 899999999986544 5666777777665544 6999999999998889999999999
Q ss_pred CCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 112 RNGSLGNLLFR----AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 112 ~~~~L~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
..+|..+... ....+++..+-.+.-..+.||.||... ..|+|||+||+|||++..|.|||+|||.+-......
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 5677655421 235688888888888889999999876 589999999999999999999999999986553322
Q ss_pred ccceeeecCCCCcCCccccccCCC-CCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNR-ITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.... -.|-..|+|||.+..... |+.++|+||||++|+|++||+.|+...... .+...+.. .+....+..+
T Consensus 223 AkT~--daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv-~gdpp~l~~~- 293 (361)
T KOG1006|consen 223 AKTV--DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVV-IGDPPILLFD- 293 (361)
T ss_pred Hhhh--ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHH-cCCCCeecCc-
Confidence 2211 126678999999865554 899999999999999999999999877541 11112221 1111111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+....+..+|.-|+.+|-..||...++++
T Consensus 294 -~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 -KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 112334567999999999999999999999983
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=259.49 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=208.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-C----CcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-G----GKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~----~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
...+-.++||+|+||+||+|.|- . .-+|++|++... ..+...++.+|+..|..+.|||++++++++.... +.|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 33444578999999999999874 2 446788887653 4556678999999999999999999999997654 889
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|++|++.|.|.++++....++..+.++.|..||++|+.|||.+ .++||||.++||||..-..+|+.|||++.....+
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999999988889999999999999999999999999 9999999999999999999999999999877654
Q ss_pred Cccce-eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 187 QTRTY-TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 187 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..... ....-..-|+|-|.+ ....++.++||||+|+.+||++| |..|+++....+...++ ..+
T Consensus 852 ~~ey~~~~gK~pikwmale~i-~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~g------- 916 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESI-RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKG------- 916 (1177)
T ss_pred cccccccccccCcHHHHHHHh-hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hcc-------
Confidence 33221 111234568888888 67889999999999999999987 88999987765433222 111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
+++.-++.+.-.+..++.+||..|+..||+++++...+..+.
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 124445556677999999999999999999999998887776
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=255.56 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=200.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEee-----cCCceE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCS-----EGSNRL 105 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-----~~~~~~ 105 (325)
..++|.+.+|.|.+|.||+++.. .+...|+|+... ......++..|+++|+.+. |||++.+++++. .++.+|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 56788999999999999999987 566666666544 4455667888999999885 999999999873 346899
Q ss_pred EEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 106 LVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+|||||.+|+..|+++.. +.++.+..+..+++.++.|+.+||.+ .++|+|+|-.||+++.++.|||+|||.+....
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999998543 56799999999999999999999999 99999999999999999999999999987665
Q ss_pred CCCccceeeecCCCCcCCccccccC----CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRN----NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
..-.+.. ...||+.|||||++... ..|+..+|+||||++..||.-|.+|+....+....+.+ .
T Consensus 175 sT~grRn-T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I------------p 241 (953)
T KOG0587|consen 175 STVGRRN-TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------------P 241 (953)
T ss_pred ccccccc-CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC------------C
Confidence 4433222 23389999999998543 34567899999999999999999999877654332211 1
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.-..+.+.-+..-..++.++|..||..|...||++.+++
T Consensus 242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 111122223444567899999999999999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=249.88 Aligned_cols=271 Identities=20% Similarity=0.221 Sum_probs=216.1
Q ss_pred ccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC------CCCcce
Q 047716 21 KLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH------HKNLVD 93 (325)
Q Consensus 21 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~ 93 (325)
+|-.+.++++...+|.+....|+|-|++|.+|.+. .+..||||+|.+.. ...+.=..|+++|++|+ .-|++.
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 45668999999999999999999999999999987 57799999986643 33444567999999996 348999
Q ss_pred eeEEeecCCceEEEEeecCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-C
Q 047716 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQ--RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-W 170 (325)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~ 170 (325)
++-.|...+++|||||.+ ..+|.+++.+.+. ++....++.++.|++.||..|... ||+|+||||+||||+.. .
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 999999999999999998 6799999976643 478889999999999999999998 99999999999999866 4
Q ss_pred cEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH-
Q 047716 171 KAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW- 249 (325)
Q Consensus 171 ~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~- 249 (325)
.+||||||.+...+.+...++. .+..|+|||++ -+..|+...|+||.||+||||.||+..|.+....+.+-+.+-
T Consensus 575 iLKLCDfGSA~~~~eneitPYL---VSRFYRaPEIi-LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITPYL---VSRFYRAPEII-LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeeccCccccccccccccHHH---HHHhccCccee-ecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 5899999999887766554433 47789999999 577889999999999999999999999988776655433311
Q ss_pred ----HHHHHHhCc---------------------------ccccccC-------------CCCCCHHHHHHHHHHHhhcc
Q 047716 250 ----AHQCYEAGE---------------------------LQNLVSD-------------QEDVNIEEFENLVKIGLWCV 285 (325)
Q Consensus 250 ----~~~~~~~~~---------------------------~~~~~~~-------------~~~~~~~~~~~l~~li~~~l 285 (325)
..+.+..++ +...+.+ .++-.+.....+.+|+..||
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 111111111 1111111 12334455678999999999
Q ss_pred cCCCCCCCCHhHHHH
Q 047716 286 ECELNLRPTMKQVIW 300 (325)
Q Consensus 286 ~~~p~~Rps~~ell~ 300 (325)
..||.+|.|..|.|+
T Consensus 731 ~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 731 ILDPEKRITVNQALK 745 (752)
T ss_pred ccChhhcCCHHHHhc
Confidence 999999999999983
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=258.49 Aligned_cols=258 Identities=21% Similarity=0.210 Sum_probs=165.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-C----CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEE------eec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-G----GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF------CSE 100 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~----~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~ 100 (325)
.++|.+.++||+|+||.||+|.+. + +..+|+|++...... ..... +.++...+.++..+... ...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~--e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMN--ERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHH--HHHHhhchhhHHHHHHhhhccccccc
Confidence 468999999999999999999987 4 688999987542211 11111 11222222222222211 234
Q ss_pred CCceEEEEeecCCCCHHHHHhhccCC-------------------CCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCC
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAEQR-------------------LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKP 161 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p 161 (325)
+...++|+||+.+++|.+++...... .....+..++.|++.||.|||++ +|+|+||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence 56789999999999999988533211 12334668999999999999999 999999999
Q ss_pred CceEEcC-CCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCC---------------------CCCccccch
Q 047716 162 HNILMDE-SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN---------------------RITVKADVY 219 (325)
Q Consensus 162 ~nilv~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Diw 219 (325)
+|||++. ++.+||+|||++...............+++.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999985 578999999999765433222223344789999999653221 234567999
Q ss_pred hHHHHHHHHHhCCCCCCCccccchhhHHHHHHHH-HHhCcccccccCCCC--------CCHHHHHHHHHHHhhcccCCCC
Q 047716 220 SFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC-YEAGELQNLVSDQED--------VNIEEFENLVKIGLWCVECELN 290 (325)
Q Consensus 220 slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~ 290 (325)
||||++++|+++..+++.... .+....... .....+......... ..........+|+.+||+.||.
T Consensus 364 SlGviL~el~~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSNLI----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHhCcCCCchHHH----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999997765442210 000000000 000000001111000 0000112456899999999999
Q ss_pred CCCCHhHHHH
Q 047716 291 LRPTMKQVIW 300 (325)
Q Consensus 291 ~Rps~~ell~ 300 (325)
+|||++|+++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999994
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=239.01 Aligned_cols=244 Identities=23% Similarity=0.247 Sum_probs=196.3
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCc
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSN 103 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 103 (325)
-|...+|+++.+||+|+||.|.+|..+ ....+|+|++.+.. ..+..--..|-++|.... -|.++.++..|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 366789999999999999999999877 56778999887633 122222334666776664 5678888888888899
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
++.||||+.||+|--.+++ -+++.++.+..++..|+-+|-+||++ ||++||||.+||+++.+|++||.|||++..-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999888844 46899999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
- .........+||+.|+|||++ ....|..++|-||+|++||||+.|++||++....+... .+.
T Consensus 501 i-~~~~TTkTFCGTPdYiAPEIi-~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------------aI~ 563 (683)
T KOG0696|consen 501 I-FDGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------AIM 563 (683)
T ss_pred c-cCCcceeeecCCCcccccceE-EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHH
Confidence 2 223344556799999999999 67788899999999999999999999999876543321 122
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRP 293 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 293 (325)
+.....+...+.+..+++...|..+|.+|.
T Consensus 564 ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 222333445557899999999999999994
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=227.72 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=197.8
Q ss_pred hhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecC-----CceEEE
Q 047716 36 NFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-----SNRLLV 107 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv 107 (325)
+--+.||-|+||.||.+++. +++.+++|++.+.-. ...+.+.+|+..|.-++|.|++..+++.... .+++++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34578999999999999987 899999999875322 3345677899999999999999988876432 356778
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
+|.+ ..+|-.++ -+.+.++...+.-+++||+.++.|||+. +|.|+||||.|.+|+++..+||+|||+++....+.
T Consensus 136 TELm-QSDLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELM-QSDLHKII-VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHH-Hhhhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8877 44666655 4567799999999999999999999998 99999999999999999999999999998765554
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHH------------HHHHHHH
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLID------------WAHQCYE 255 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~------------~~~~~~~ 255 (325)
.....-...|-.|+|||.+-+...|+.+.||||.|||+.||+..+..|+.....+...++. .+...-.
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 4333323356789999999888999999999999999999999999998777666554441 1111111
Q ss_pred hCcccccccCC-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 256 AGELQNLVSDQ-------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 256 ~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
...++.-...+ .........+...+.+.++.++|+.|.+..+.+..
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11111111111 11111223567888999999999999999998843
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=241.90 Aligned_cols=260 Identities=18% Similarity=0.210 Sum_probs=176.0
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEe-----------------CCCcEEEEEEeeccchhcHHH--------------HHHH
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCI-----------------NGGKEIAVKKLIKIVEEGESE--------------FRNE 79 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~-----------------~~~~~~~vk~~~~~~~~~~~~--------------~~~e 79 (325)
..++|++.++||+|+||.||+|.+ ..+..|+||++.......... ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 466899999999999999999964 234679999986543322222 2235
Q ss_pred HHHHhccCCCCc-----ceeeEEeec--------CCceEEEEeecCCCCHHHHHhhcc----------------------
Q 047716 80 MKIIGRIHHKNL-----VDLVGFCSE--------GSNRLLVYEFMRNGSLGNLLFRAE---------------------- 124 (325)
Q Consensus 80 ~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~---------------------- 124 (325)
+..+.+++|.++ +++++++.. .+..++||||+.+++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666666665544 566666532 356799999999999999885321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCc
Q 047716 125 -QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203 (325)
Q Consensus 125 -~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 203 (325)
..+++..++.++.|++.++.|||+. +++|+||||+||+++.++.++|+|||++................++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1235667889999999999999999 999999999999999999999999999865443222111122247899999
Q ss_pred cccccCCC---------------------CCccccchhHHHHHHHHHhCCC-CCCCccccchhhHH-HH---HHHHHHhC
Q 047716 204 ELHSRNNR---------------------ITVKADVYSFGVMLLEIVCCRK-NVDESLRDDEIVLI-DW---AHQCYEAG 257 (325)
Q Consensus 204 E~~~~~~~---------------------~~~~~DiwslG~il~~ll~g~~-p~~~~~~~~~~~~~-~~---~~~~~~~~ 257 (325)
|.+..... ...+.|+||+||++++|++|.. ||............ .. .++.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98742211 1235799999999999999885 66432211110000 00 01111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCC---CCCCCHhHHH
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECEL---NLRPTMKQVI 299 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~ell 299 (325)
.+. ...........++++.+||..+| .+|+|++|++
T Consensus 460 ~~~------~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 460 KYD------FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred CCC------cccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 110 11112234678999999999766 6899999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=211.79 Aligned_cols=211 Identities=37% Similarity=0.584 Sum_probs=180.2
Q ss_pred cCcCCceeEEEEEeCC-CcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCHHH
Q 047716 41 IGRGGSGRVYKGCING-GKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGN 118 (325)
Q Consensus 41 lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 118 (325)
||+|++|.||++.... +..+++|++...... ....+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999874 888999988664332 34678899999999999999999999998889999999999899999
Q ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-CCcEEEeeccccccccCCCccceeeecCC
Q 047716 119 LLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAKISDFGLSKLLKTDQTRTYTVLRGT 197 (325)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~ 197 (325)
++......++...++.++.+++.++.+||+. +++|+|++|.||+++. ++.++++|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 9855435689999999999999999999999 9999999999999999 88999999999876544321 11122367
Q ss_pred CCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHH
Q 047716 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENL 277 (325)
Q Consensus 198 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 277 (325)
..|.+||........+.+.|+|+||+++++| ..+
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~~~ 190 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------PEL 190 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------HHH
Confidence 8899999984433778899999999999998 348
Q ss_pred HHHHhhcccCCCCCCCCHhHHHHH
Q 047716 278 VKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 278 ~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
.+++..|++.+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=240.45 Aligned_cols=197 Identities=24% Similarity=0.402 Sum_probs=169.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--------hcHHHHHHHHHHHhccC---CCCcceeeEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--------EGESEFRNEMKIIGRIH---HKNLVDLVGFCSE 100 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 100 (325)
++|...+++|.|+||.|++|.++ +...|++|.|.+..- .+.-.+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 56899999999999999999988 577788887765221 12223557999999998 9999999999999
Q ss_pred CCceEEEEeecC-CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 101 GSNRLLVYEFMR-NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 101 ~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
++..+|+||... +.+|.+++ .....+++.+...+++|++.++++||++ ||+|||||-+|+.++.+|.+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 999999999874 55888998 4567899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCC
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVD 236 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 236 (325)
+....+.+ .....||..|.|||.+.+.++....-|||+||+++|.+.....||-
T Consensus 717 aa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98776554 3444589999999999777777888999999999999988888874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=247.41 Aligned_cols=239 Identities=27% Similarity=0.388 Sum_probs=184.0
Q ss_pred hhhcCcCCce-eEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEeecCCCC
Q 047716 38 KEEIGRGGSG-RVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYEFMRNGS 115 (325)
Q Consensus 38 ~~~lg~g~~g-~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 115 (325)
.+.+|.|+.| .||+|... +++||||.+.. .....+.+|+..|+.-. ||||+++++...+.+..||..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 4578999997 67888775 78999998855 33446778999999885 999999999999999999999999 669
Q ss_pred HHHHHhhccCC---CCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---C--CcEEEeeccccccccCCC
Q 047716 116 LGNLLFRAEQR---LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---S--WKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 116 L~~~~~~~~~~---~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~--~~vkl~Dfg~~~~~~~~~ 187 (325)
|.+++...... ......+..+.|++.|+++||+. +|+|||+||.||||+. + .+++|+|||++.....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999653111 22245688999999999999998 9999999999999965 2 468999999999876544
Q ss_pred cc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhC-CCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 188 TR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCC-RKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 188 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.. ......||.+|+|||.+. ....+.++|||||||++|+.++| .+||......+... ..+...-..
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~-~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI---------l~~~~~L~~- 734 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLR-EDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI---------LTGNYTLVH- 734 (903)
T ss_pred chhhcccCCCCcccccCHHHHh-ccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh---------hcCccceee-
Confidence 32 233355899999999994 44446699999999999999887 78998665443221 111111000
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.....++ +..+||.+|++++|..||++.+|+
T Consensus 735 --L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 --LEPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred --eccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111112 789999999999999999999999
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=225.40 Aligned_cols=252 Identities=22% Similarity=0.267 Sum_probs=198.8
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeec---cchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCc
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIK---IVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~---~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 103 (325)
.+-.++|++.++||.|+|+.|..++.. ..+-+|+|++++ +...+....+.|-.+..+- +||.+|-++..|..++.
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 345678999999999999999999887 566778888765 2344555677777777665 59999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
++.|.||++||+|-=.+ +.+.+++++.++.+...|+.|+.|||++ ||+++|+|.+|++++..|++||+|+|++..-
T Consensus 326 lffvieyv~ggdlmfhm-qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEEecCcceeeeh-hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999986555 3456899999999999999999999999 9999999999999999999999999998743
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc-chhhHHHHHHHHHHhCccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD-DEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 262 (325)
- .+.......+||+.|.|||++ .+..|....|-|+||++++||+.|+.||+..... ......++..+.+...+
T Consensus 402 l-~~gd~tstfcgtpnyiapeil-rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq---- 475 (593)
T KOG0695|consen 402 L-GPGDTTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ---- 475 (593)
T ss_pred C-CCCcccccccCCCcccchhhh-cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc----
Confidence 2 223344556799999999999 7889999999999999999999999999744322 22223334333333222
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPT 294 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 294 (325)
..++-..+-....+++.-|++||.+|.-
T Consensus 476 ----iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 476 ----IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 2223333345667888899999999853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=206.40 Aligned_cols=204 Identities=27% Similarity=0.379 Sum_probs=164.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.....-+..||+|++|.|-+.++. +|.-.|+|.+.... ....+++..|+.+.... .+|.+|.+++........+|.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 445555678999999999887776 78889999886533 23344566677665554 5999999999988889999999
Q ss_pred eecCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLF---RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
|.+ ..+|..+-. ..++.+++..+-.++..++.|+.|||++ ..++|||+||+|||++..|+||++|||.+-...+
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999 668876643 3467899999999999999999999998 6899999999999999999999999999876543
Q ss_pred CCccceeeecCCCCcCCcccccc---CCCCCccccchhHHHHHHHHHhCCCCCCCccc
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSR---NNRITVKADVYSFGVMLLEIVCCRKNVDESLR 240 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 240 (325)
.-.... ..|--.|+|||.+.. ...|+.++||||||+.+.||.+++.|++....
T Consensus 202 SiAkt~--daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 202 SIAKTM--DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred hhHHHH--hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 332221 125678999998753 34688999999999999999999999987654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=224.91 Aligned_cols=260 Identities=19% Similarity=0.251 Sum_probs=201.6
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeec
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE 100 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (325)
-++...++++.-.+-+|.||.||.|.|.+ .+.+.+|.+.... +-....+.+|...+....|||++.+.++..+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34556777888899999999999997653 4445667665432 3334457788999999999999999998754
Q ss_pred -CCceEEEEeecCCCCHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 101 -GSNRLLVYEFMRNGSLGNLLFRA-------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
....++++.+..-|+|..|+... .+.++...+..++.|++.|+++||+. |++|.||.++|.++++.-+|
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeE
Confidence 46789999999999999998622 23478888899999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHH
Q 047716 173 KISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWA 250 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 250 (325)
||+|=.+++..-..+.. ......++..||+||.+ ....++.++|+||||+++|||+| |+.|+...++.+....+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal-~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl--- 511 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL-QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL--- 511 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHH-hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH---
Confidence 99998887644332222 11222356789999999 57889999999999999999987 77888766554433211
Q ss_pred HHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 251 HQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.... +..-+.+++.+|+.+|.-||...|++||+++|+..-|.++
T Consensus 512 kdGy-----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 KDGY-----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred hccc-----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111 1223445667899999999999999999999999877764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=234.53 Aligned_cols=216 Identities=24% Similarity=0.269 Sum_probs=174.5
Q ss_pred ccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeec
Q 047716 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSE 100 (325)
Q Consensus 25 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (325)
-.-..+-.+.|..++.||-|+||.|.+++.. ....+|+|.+.+..- .-....+.|-.+|..-.++=||++|-.|.+
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 3334444555666778999999999998765 466778887765332 222336678889999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
.+.+|+||+|++||++-.++.+. +-+.+..++.++..+..|+.+.|.. |++||||||+||||+.+|+|||+|||++
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccc
Confidence 99999999999999999988654 5688889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCccc-----------------------------------------eeeecCCCCcCCccccccCCCCCccccch
Q 047716 181 KLLKTDQTRT-----------------------------------------YTVLRGTRGYTAPELHSRNNRITVKADVY 219 (325)
Q Consensus 181 ~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 219 (325)
+-+....... .-...||+.|+|||++ ....++...|-|
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl-~r~g~~q~cdww 855 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVL-ARTGYTQLCDWW 855 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHh-cccCccccchhh
Confidence 7543211000 0012289999999999 566778899999
Q ss_pred hHHHHHHHHHhCCCCCCCccccchhh
Q 047716 220 SFGVMLLEIVCCRKNVDESLRDDEIV 245 (325)
Q Consensus 220 slG~il~~ll~g~~p~~~~~~~~~~~ 245 (325)
|.|+|||+|+.|++||......+...
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCccee
Confidence 99999999999999998776655443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=239.86 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=208.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.+|+|.+|.||+|++. .++..++|.++-....+...+++|+-+++..+||||+.+++.+.....+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 468999999999999999999987 7889999999888888888899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
|.+|+|++.- ...+.+++..+..+.+..++++.|||+. |-+|||||-.||++++.|.+|+.|||.+......-...
T Consensus 94 cgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 94 CGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred cCCCccccee-eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 9999999876 4678899999999999999999999999 99999999999999999999999999887665443332
Q ss_pred eeeecCCCCcCCccccc--cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 191 YTVLRGTRGYTAPELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
....||+-|+|||+-. ....|...+|+|++|+...|+-..++|......-....+- ....+... ...
T Consensus 170 -ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~qpp--------~lk 238 (829)
T KOG0576|consen 170 -KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQPP--------TLK 238 (829)
T ss_pred -hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCCCC--------ccc
Confidence 2334999999999742 4567889999999999999999988887655443222111 00111111 111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
-...-.+.+.+|++.|+..+|++|||++.++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 2222345688999999999999999999876
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=216.38 Aligned_cols=257 Identities=23% Similarity=0.275 Sum_probs=192.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecC------C
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------S 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 102 (325)
..+|--.+.+|.|+. .|..|.+. .+..+++|+.... .....+...+|..++..++|+||+.++.++... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456666778999998 66666665 6889999988653 234456677899999999999999999988433 4
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++|||++ ..+|.+++. -.++-..+..++.|++.|+++||+. ||+||||||+||++..+..+|+.|||++..
T Consensus 95 e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 579999999 568888874 4577889999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHH--------------
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLID-------------- 248 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-------------- 248 (325)
...+.. ......+.-|+|||.+.+.. +.+.+||||+||++.||++|...|.+....+....+.
T Consensus 168 e~~~~~--mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 168 EDTDFM--MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cCcccc--cCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 554422 22233688999999985444 9999999999999999999999998665444322220
Q ss_pred --HHHHHHH-hC-----cccccccCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 249 --WAHQCYE-AG-----ELQNLVSDQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 249 --~~~~~~~-~~-----~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.+..... .+ ...+.+.+. .+.++.....+.+++.+||-.+|++|.|++++|
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 0000000 00 111111111 111222345689999999999999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=208.45 Aligned_cols=200 Identities=32% Similarity=0.508 Sum_probs=170.6
Q ss_pred HhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeeccchh-cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 35 ENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEE-GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
|++.+.||.|++|.||++.... +..+++|.+...... ....+.+|+..++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678899999999999999874 888999998765444 56778899999999999999999999988889999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+++|.+++......+++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++++|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999854432389999999999999999999999 9999999999999999999999999988766543211112
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDE 237 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 237 (325)
...++..|++||.+.....++.++|+|+||+++++|++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 233677899999874445667799999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=213.33 Aligned_cols=261 Identities=24% Similarity=0.330 Sum_probs=197.0
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 104 (325)
...+.|+++++||.|.|++||+|++. ....|++|.+...+ .-..+..|++.|..+. +.||+++.+.+..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34678999999999999999999864 46788999886633 3455889999999996 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-CCcEEEeeccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAKISDFGLSKLL 183 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~~~~~ 183 (325)
.+|+||+++....++.. .++..++..+++.++.|+.++|.+ ||+|+|+||+|++.+. .+.-.|+|||++...
T Consensus 111 ~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999998883 467899999999999999999999 9999999999999964 467899999998721
Q ss_pred cCC---------------C----------------c------------cceeeecCCCCcCCccccccCCCCCccccchh
Q 047716 184 KTD---------------Q----------------T------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYS 220 (325)
Q Consensus 184 ~~~---------------~----------------~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws 220 (325)
... . + .......||++|+|||++.+....++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 000 0 0 00011238999999999988888899999999
Q ss_pred HHHHHHHHHhCCCCCCCccccc-hhhHHHH------H-HHHHHhCc------------------cccc----ccC-----
Q 047716 221 FGVMLLEIVCCRKNVDESLRDD-EIVLIDW------A-HQCYEAGE------------------LQNL----VSD----- 265 (325)
Q Consensus 221 lG~il~~ll~g~~p~~~~~~~~-~~~~~~~------~-~~~~~~~~------------------~~~~----~~~----- 265 (325)
.|+|+..+++++.||....++- ....+.. + .-....+. +..+ +.+
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 9999999999999996544332 2121110 0 00000011 0001 000
Q ss_pred --CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 266 --QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 266 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
......-.+..+.+++.+|++.||.+|.|+++.|
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 0111111234689999999999999999999999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=199.31 Aligned_cols=253 Identities=16% Similarity=0.273 Sum_probs=185.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEE-eecCCceEEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGF-CSEGSNRLLVY 108 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~~~~~~lv~ 108 (325)
...|+|.+.||+|.||.+-++.++ +...+++|.+.. .......|.+|...--.|. |.||+..|+. |...+....++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 568999999999999999999998 566777777654 3455667777776655554 9999998875 45566788999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc--CCCcEEEeeccccccccCC
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD--ESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~--~~~~vkl~Dfg~~~~~~~~ 186 (325)
||++.|+|...+. ..++.+..-..++.|++.|+.|+|++ +++|||||.+||||- +.-+|||+|||.....+..
T Consensus 102 E~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999998873 35688888899999999999999999 999999999999993 2348999999998765433
Q ss_pred CccceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 187 QTRTYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
... ..-...|.+||.... .-...+.+|+|+||++++.+++|.+||+-....+.. ... ...+........
T Consensus 177 V~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~-Y~~--~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 177 VKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP-YWE--WEQWLKRKNPAL 249 (378)
T ss_pred ehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch-HHH--HHHHhcccCccC
Confidence 221 123556889987532 223467899999999999999999999843332222 222 223333322222
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
.+.-. ...+.+..+.++-|..++.+|=.+.++.++
T Consensus 250 P~~F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 250 PKKFN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred chhhc----ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 22211 223567788888999999999666666643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=186.76 Aligned_cols=168 Identities=20% Similarity=0.196 Sum_probs=125.2
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
|+|.+++...+..+++..++.++.|++.|+.|||++ + ||+||+++.++.+++ ||++........
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~----- 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQS----- 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccccC-----
Confidence 688899866566799999999999999999999998 6 999999999999999 998876543221
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
.+++.|+|||.+ .+..++.++||||||+++|+|++|+.||.......... . ... ........ .........
T Consensus 65 -~g~~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~--~---~~~-~~~~~~~~-~~~~~~~~~ 135 (176)
T smart00750 65 -RVDPYFMAPEVI-QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL--E---ILL-NGMPADDP-RDRSNLESV 135 (176)
T ss_pred -CCcccccChHHh-cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH--H---HHH-HHhccCCc-cccccHHHH
Confidence 378999999999 56678899999999999999999999996543322111 1 111 00000000 000111122
Q ss_pred HH--HHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 274 FE--NLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 274 ~~--~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.. ++.+++.+||+.+|.+||++.|+++.+..+.
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 22 6999999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=232.02 Aligned_cols=194 Identities=19% Similarity=0.275 Sum_probs=133.8
Q ss_pred cCC-CCcceeeEEe-------ecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeec
Q 047716 86 IHH-KNLVDLVGFC-------SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157 (325)
Q Consensus 86 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~ 157 (325)
++| +||+.+++.+ .+...+..++|++ +++|.+++......+++..+..++.||+.||.|||++ ||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 345 5777777765 2224567778887 6699999965556699999999999999999999999 99999
Q ss_pred cCCCCceEEcCCCcEEE-------------------eeccccccccCCCc---------------cceeeecCCCCcCCc
Q 047716 158 DIKPHNILMDESWKAKI-------------------SDFGLSKLLKTDQT---------------RTYTVLRGTRGYTAP 203 (325)
Q Consensus 158 di~p~nilv~~~~~vkl-------------------~Dfg~~~~~~~~~~---------------~~~~~~~~~~~y~aP 203 (325)
||||+||||+..+.+++ +|||++........ .......+++.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999976555554 45554432110000 000012367789999
Q ss_pred cccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhh
Q 047716 204 ELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLW 283 (325)
Q Consensus 204 E~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (325)
|.+ .+..++.++|||||||++|||++|.+|+..... .... ..... ..+ ..........+++.+
T Consensus 185 E~~-~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~-----~~~~~----~~~---~~~~~~~~~~~~~~~ 247 (793)
T PLN00181 185 EED-NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS-----LRHRV----LPP---QILLNWPKEASFCLW 247 (793)
T ss_pred hhh-ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH-----HHHhh----cCh---hhhhcCHHHHHHHHH
Confidence 998 456679999999999999999999888653211 0000 00000 000 001112346688899
Q ss_pred cccCCCCCCCCHhHHHH
Q 047716 284 CVECELNLRPTMKQVIW 300 (325)
Q Consensus 284 ~l~~~p~~Rps~~ell~ 300 (325)
||+.+|.+||++.|+++
T Consensus 248 ~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hCCCChhhCcChHHHhh
Confidence 99999999999999984
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=187.39 Aligned_cols=263 Identities=18% Similarity=0.258 Sum_probs=205.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 107 (325)
++.-.|++.++||+|+||.++.|+.- ++.+||+|.= ......-+++.|.+..+.|. .++|...+-|..++.+-.+|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE--PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE--PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEec--cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 67889999999999999999999876 7899999964 33455667888999999886 89999999999888888999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-----CCcEEEeecccccc
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-----SWKAKISDFGLSKL 182 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-----~~~vkl~Dfg~~~~ 182 (325)
+|.+ |.+|.|++.-.+.+++...+..++.|++.-+.++|++ .+|+|||||+|+||.. ...|-++|||++..
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9998 8899999988888999999999999999999999999 9999999999999943 23589999999987
Q ss_pred ccCCC------ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 183 LKTDQ------TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 183 ~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
+.+.. .++.....||.+||+-... -+...+..-|+=|||-++++.|-|..||++..........+.+....+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTH-lGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCccccccccccceeeeEeecc-ccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 75433 3444556699999998877 4677788999999999999999999999998877665544444444443
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..+..+... .++++..-+.-.-..+-.+-|..+-+...+..+.
T Consensus 258 T~i~~Lc~g-------~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 258 TPIEVLCEG-------FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred CCHHHHHhc-------CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 344433333 1233334343344445556677666554444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=192.21 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=195.4
Q ss_pred HHhhhhhcCcCCceeEEEEEeCCC--cEEEEEEeeccchhcHHHHHHHHHHHhccC----CCCcceeeEEe-ecCCceEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCINGG--KEIAVKKLIKIVEEGESEFRNEMKIIGRIH----HKNLVDLVGFC-SEGSNRLL 106 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~~~--~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~l 106 (325)
+|++.++||+|+||.||.+.+... ..+|+|............+..|..++..+. .+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999998754 467777765543333336778888888887 36899999988 47778899
Q ss_pred EEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-----CcEEEeecccc
Q 047716 107 VYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-----WKAKISDFGLS 180 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-----~~vkl~Dfg~~ 180 (325)
||+.+ |.+|.++..... +.++...+..++.|++.+|.++|+. |++||||||+|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 889999885554 7899999999999999999999999 99999999999999755 35999999999
Q ss_pred c--cccCCCc------cc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH
Q 047716 181 K--LLKTDQT------RT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 181 ~--~~~~~~~------~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 251 (325)
. .+..... +. .....||..|.++... .+...+.+.|+||++.++.+|+.|..||................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H-~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH-LGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHh-CCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8 3322211 11 1223389999999988 67888999999999999999999999997665433322111111
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
.... ........+ ..+.++...+-+.+...+|....+...|+......
T Consensus 254 ~~~~-------~~~~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 254 RKLL-------TDRFGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhc-------cccccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111 110111112 34556666666689999999999998887776443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=187.32 Aligned_cols=165 Identities=18% Similarity=0.142 Sum_probs=125.9
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC--CCcEEEEEEeecc-----chhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKI-----VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
-....+|++.+.||+|+||.||+|.+. ++..+|+|++... .......+.+|+++|+.++|+|+++.+...
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345678999999999999999999875 4666789886532 122345688999999999999998633322
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccC-CCCceEEcCCCcEEEeecccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDI-KPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di-~p~nilv~~~~~vkl~Dfg~~ 180 (325)
+..++||||+++++|.... . .. ...++.|+++++.+||+. ||+|||| ||+||+++.++.++|+|||++
T Consensus 91 ~~~~LVmE~~~G~~L~~~~--~---~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR--P---HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CCcEEEEEccCCCCHHHhC--c---cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 4579999999999996321 1 11 146789999999999999 9999999 999999998899999999999
Q ss_pred ccccCCCccce-------eeecCCCCcCCccccc
Q 047716 181 KLLKTDQTRTY-------TVLRGTRGYTAPELHS 207 (325)
Q Consensus 181 ~~~~~~~~~~~-------~~~~~~~~y~aPE~~~ 207 (325)
........... ....+++.|.+||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 86643321111 1233677899999874
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=171.02 Aligned_cols=215 Identities=24% Similarity=0.300 Sum_probs=173.7
Q ss_pred cHHH-HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCC
Q 047716 26 SYEQ-IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGS 102 (325)
Q Consensus 26 ~~~~-~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 102 (325)
++++ +....|+++++||+|+||.+|.|..- +|.+||+|.=... .....+..|..+.+.|+ ...|..+..+..+..
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 3344 56789999999999999999999865 8999999985443 33445677888888887 467777777777777
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCcEEEeeccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWKAKISDFGL 179 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~vkl~Dfg~ 179 (325)
.-.+||+.+ |.+|.+++.-....++..+++-++-|++.-+.|+|.+ +++|+||||+|++..- ...+.++|||+
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence 889999998 8899999877778899999999999999999999999 9999999999999853 34699999999
Q ss_pred cccccCCC------ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHH
Q 047716 180 SKLLKTDQ------TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI 247 (325)
Q Consensus 180 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 247 (325)
+..+.+.. .+......||.+|.+-... -+...+...|+-|+|.++.++.-|..||++..........
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh-~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAH-LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhh-hhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 98764332 2233334488888876655 3556678899999999999999999999988765544433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=211.37 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=185.2
Q ss_pred HHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc-hhcHHHHHHHHHH--HhccCCCCcceeeEEeecCCceEEEEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV-EEGESEFRNEMKI--IGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~-~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++...+.||++.|=.|.+|+++.|. +++|++.+.. .-+...+.+.++. ...+++||.+++.-+...+...++|.+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 7888999999999999999998776 8999887644 3333344443332 4555899999999988888888999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc--cccCCCc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK--LLKTDQT 188 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~--~~~~~~~ 188 (325)
. ..+|.|.+. .+.-+...+...++.|++.|+..+|.. ||+|||||.+||||+.-+-+.|+||.... +...+++
T Consensus 103 v-khnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 V-KHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred H-hhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8 458888883 233467788899999999999999999 99999999999999999999999998764 3344444
Q ss_pred cceeeec----CCCCcCCccccccC----------CCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHH-
Q 047716 189 RTYTVLR----GTRGYTAPELHSRN----------NRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQ- 252 (325)
Q Consensus 189 ~~~~~~~----~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~- 252 (325)
..+.... +.-+|.|||.+... ...+++-||||+||+++||++ |++||+... +..+...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr~~~ 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYRSGN 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHhccC
Confidence 4443332 34579999976431 124678899999999999976 578886332 1111100
Q ss_pred HHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 253 CYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
......+.+.+.+ ..++.++..|++.||++|.++++.|+--+++.
T Consensus 252 ~~~~e~~Le~Ied---------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 252 ADDPEQLLEKIED---------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred ccCHHHHHHhCcC---------ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 0000011111111 35899999999999999999999997766654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-25 Score=206.80 Aligned_cols=259 Identities=19% Similarity=0.237 Sum_probs=189.0
Q ss_pred hhhhhcCcCCceeEEEEEeC-CCcEEEEEEee----c-cchhcHH-HHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 36 NFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLI----K-IVEEGES-EFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~----~-~~~~~~~-~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
...+.+|.|++|.++.+... ..+....|... . ....... .+..|+.+=..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34568999999988777654 33333444332 1 1111111 1556777777889999988877665554444459
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++ +|..++ ...+.+...++.-++.|++.|+.|+|+. |+.|+|+|++|++++.+|.+|++|||.+..+.....
T Consensus 401 E~~~~-Dlf~~~-~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLV-MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHH-hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99988 998888 3345799999999999999999999999 999999999999999999999999999876643332
Q ss_pred ---cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 189 ---RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 189 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
.......|+..|+|||.+....+.....||||.|++++.|.+|+.||......+... .......-..+...
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNIFEG 549 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccccccC
Confidence 334445688999999999656666678999999999999999999998766654432 11111112222223
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhcc
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGI 305 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~ 305 (325)
..........+.+.+|.+||+.+|.+|.|+++|+ ..++.+
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 3333444557789999999999999999999999 444444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-22 Score=174.52 Aligned_cols=258 Identities=27% Similarity=0.321 Sum_probs=196.2
Q ss_pred HhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchh---cHHHHHHHHHHHhccCCC-CcceeeEEeecCCceEEEEee
Q 047716 35 ENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEE---GESEFRNEMKIIGRIHHK-NLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 110 (325)
|++.+.||.|+||.||.+.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 678889999999999999887 77888888764433 356788899999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeeccccccccCCC
Q 047716 111 MRNGSLGNLLFRAE--QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 111 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~~~~~~ 187 (325)
+.++++.+++.... ..+.......++.|++.++.++|+. +++|+|++|+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997774433 2799999999999999999999999 999999999999999998 69999999987554333
Q ss_pred cc-----ceeeecCCCCcCCccccccC--CCCCccccchhHHHHHHHHHhCCCCCCCcccc-chhhHHHHHHHHHHhCcc
Q 047716 188 TR-----TYTVLRGTRGYTAPELHSRN--NRITVKADVYSFGVMLLEIVCCRKNVDESLRD-DEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 188 ~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 259 (325)
.. ......++..|++||.+... ...+...|+|++|++++++++|..||...... .... ..........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~----~~~~~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH----HHHHHHhcCC
Confidence 21 23445589999999998543 57888999999999999999999997665431 0011 1111111111
Q ss_pred c-ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 260 Q-NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 260 ~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
. ................+.+++..|+..+|..|.+..+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 00000000002233568899999999999999999987753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-24 Score=174.54 Aligned_cols=175 Identities=13% Similarity=0.172 Sum_probs=134.9
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHH---------HHHHHHHHhccCCCCcceeeEE
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE---------FRNEMKIIGRIHHKNLVDLVGF 97 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~---------~~~e~~~l~~l~h~~iv~~~~~ 97 (325)
+.++...+|++++.+|.|+||.||++.. ++..+++|.+.+........ +.+|+..+.+++||+|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4567899999999999999999999765 56789999987544333332 6789999999999999999887
Q ss_pred eecC--------CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC
Q 047716 98 CSEG--------SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 98 ~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~ 169 (325)
+... +..+++|||++|.+|.++. .++. ....+++.++..+|+. |++|+|++|+||+++++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 5432 3578999999999998874 1222 2456999999999999 99999999999999998
Q ss_pred CcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHH
Q 047716 170 WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229 (325)
Q Consensus 170 ~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 229 (325)
| ++++|||............ .+.....+..++|+|+||+.+..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 8 9999999876442222111 1112334457899999999976543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-24 Score=172.35 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=190.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeec--cchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
|..++.++.-+|.....|..|+|+|.++ .+++|++.. -.....+.|.+|.-.|+.+.||||+++++.+...-++.++
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 3445667788999999999999999754 455665532 3344456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEe--ecccccccc
Q 047716 108 YEFMRNGSLGNLLFRAEQ-RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS--DFGLSKLLK 184 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~--Dfg~~~~~~ 184 (325)
..|++.++|..++..... .++......++..++.+++|||+. ..-|.--.++...++++++-+.+++ |--++..
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--
Confidence 999999999999854432 367778889999999999999997 1123333678889999988766654 3211110
Q ss_pred CCCccceeeecCCCCcCCccccccCCC--CCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNR--ITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
... ..-.+.|++||.++.... .-.++|+|||++++|||.|...||.....-+.-+.+. .+
T Consensus 343 --e~g----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------le----- 404 (448)
T KOG0195|consen 343 --EVG----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------LE----- 404 (448)
T ss_pred --ccc----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------hc-----
Confidence 000 113678999999976543 3467999999999999999999998776544322211 00
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.-+..+++..+..+..+|.-|++.||.+||.+..++-.||.+.
T Consensus 405 -glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 -GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1124456666678999999999999999999999999998764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=160.23 Aligned_cols=139 Identities=22% Similarity=0.280 Sum_probs=109.3
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchh--c------------------------HHHHHHHHHHHhccCCCCc
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEE--G------------------------ESEFRNEMKIIGRIHHKNL 91 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i 91 (325)
...||+|++|.||+|...+|+.+|+|++...... . ......|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998653211 1 1123459999999988877
Q ss_pred ceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHh-hccCCCCeeeccCCCCceEEcCCC
Q 047716 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYL-HDECETRIIHCDIKPHNILMDESW 170 (325)
Q Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l-h~~~~~~i~h~di~p~nilv~~~~ 170 (325)
.....+... ..++||||++++++..... ....++...+..++.|++.++.++ |+. |++|+||||+||++++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~-~ 154 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD-G 154 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-C
Confidence 544433222 2389999998877665432 245789999999999999999999 798 9999999999999984 6
Q ss_pred cEEEeeccccccc
Q 047716 171 KAKISDFGLSKLL 183 (325)
Q Consensus 171 ~vkl~Dfg~~~~~ 183 (325)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=153.33 Aligned_cols=141 Identities=20% Similarity=0.203 Sum_probs=111.2
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhc--------------------------HHHHHHHHHHHhccCCCCc
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG--------------------------ESEFRNEMKIIGRIHHKNL 91 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~i 91 (325)
.+.||+|++|.||+|.+.+|..+|+|++....... ......|...+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999998789999999987532110 1123578899999999987
Q ss_pred ceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCC
Q 047716 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESW 170 (325)
Q Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~ 170 (325)
.....+... ..++||||++++++..... ....++......++.|++.++.++|. . |++|+||||+||+++ ++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence 655444333 2489999998875543321 23467888999999999999999999 8 999999999999999 78
Q ss_pred cEEEeeccccccccC
Q 047716 171 KAKISDFGLSKLLKT 185 (325)
Q Consensus 171 ~vkl~Dfg~~~~~~~ 185 (325)
.++++|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.6e-21 Score=160.98 Aligned_cols=229 Identities=22% Similarity=0.269 Sum_probs=145.5
Q ss_pred hhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccC----------CCCcceeeEEe----
Q 047716 37 FKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIH----------HKNLVDLVGFC---- 98 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~---- 98 (325)
..+.||.|+++.||.+++. .+..+++|++.-.. ....+.+++|.-....+. |-.++..++..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4567999999999999998 58999999886433 334455666665554432 22333333322
Q ss_pred -----ecC---C-----ceEEEEeecCCCCHHHHHhh---ccCC---CCHHHHHHHHHHHHHHHHHhhccCCCCeeeccC
Q 047716 99 -----SEG---S-----NRLLVYEFMRNGSLGNLLFR---AEQR---LSWSERRRIALEIMEGLHYLHDECETRIIHCDI 159 (325)
Q Consensus 99 -----~~~---~-----~~~lv~e~~~~~~L~~~~~~---~~~~---~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di 159 (325)
... . ..+++|+-+ .++|.+++.. .... ........+..|++..+++||.. |++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 111 1 236677777 6688877532 1111 23334456678999999999999 9999999
Q ss_pred CCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccC-------CCCCccccchhHHHHHHHHHhCC
Q 047716 160 KPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN-------NRITVKADVYSFGVMLLEIVCCR 232 (325)
Q Consensus 160 ~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~ 232 (325)
+|+|++++.+|.+.|+||+.....+..... ...+..|.|||..... ..++.+.|.|+||+++|.|.|++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999987765443221 1245778999975322 24678899999999999999999
Q ss_pred CCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCC
Q 047716 233 KNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLR 292 (325)
Q Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 292 (325)
.||+.......... .+ .... +.++.++++|..+|+.+|.+|
T Consensus 248 lPf~~~~~~~~~~~---------------~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---------------DF---SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG---------------GG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc---------------cc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99986644322110 11 1222 455779999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-21 Score=182.51 Aligned_cols=255 Identities=16% Similarity=0.167 Sum_probs=183.4
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC---CCCcceeeEEeecCC
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH---HKNLVDLVGFCSEGS 102 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~ 102 (325)
..-++....|.|.+.+|.|+||.||.|...+++.+|+|+-........ .+ -.+++.+|+ -+.|..+...+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-YI--~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-YI--CLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-ee--hHHHHHhhchhhhcchHHHHHHHccCC
Confidence 334455678889999999999999999998899999998665443321 11 233444444 344555555555567
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc-------CCCcEEEe
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-------ESWKAKIS 175 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~-------~~~~vkl~ 175 (325)
..++|++|.+.|+|.++++ ..+.+++..+..++.|++..+..||.. +||||||||+|+++. +...++|+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 7889999999999999995 556799999999999999999999999 999999999999994 23459999
Q ss_pred eccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH
Q 047716 176 DFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 176 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
|||.+..+..-.. ......+.+-.+-.+|.. .++.++.+.|.|.|+.+++-||.|+.-- ...+.... .
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~-~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~~~~--------~ 912 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR-EGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGSSWM--------V 912 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHh-cCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCccee--------c
Confidence 9999876654333 345556688889999998 7889999999999999999999988533 10000000 0
Q ss_pred HhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 255 EAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
..++.+... ..-+.++...+|+.+-..=|...+|...|+++...
T Consensus 913 -~~~~~Ry~~---------~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 913 -KTNFPRYWK---------RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred -cccchhhhh---------HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 000111111 12245555567775555558888888888876543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=165.20 Aligned_cols=217 Identities=26% Similarity=0.399 Sum_probs=163.9
Q ss_pred HhccCCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCe-eeccCCC
Q 047716 83 IGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI-IHCDIKP 161 (325)
Q Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i-~h~di~p 161 (325)
|+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.....++++.....+++.++.++.|+|+. .+ .|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 4567899999999999999999999999999999999977777899999999999999999999997 44 9999999
Q ss_pred CceEEcCCCcEEEeeccccccccCCC-ccceeeecCCCCcCCccccccCC------CCCccccchhHHHHHHHHHhCCCC
Q 047716 162 HNILMDESWKAKISDFGLSKLLKTDQ-TRTYTVLRGTRGYTAPELHSRNN------RITVKADVYSFGVMLLEIVCCRKN 234 (325)
Q Consensus 162 ~nilv~~~~~vkl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~g~~p 234 (325)
.|.+++....+|++|||+........ ...........-|.|||.+.... ..+.+.|+||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987654211 11111111244699999885421 146679999999999999999999
Q ss_pred CCCccccchh-hHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 235 VDESLRDDEI-VLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
|......... .++..+.. .....++..+.... +...++..++..||..+|.+||+++++-..++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh-cCCCCcCcchhhhh----hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9875443332 11121111 11111222222111 333469999999999999999999999988887764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=143.99 Aligned_cols=186 Identities=16% Similarity=0.070 Sum_probs=135.7
Q ss_pred hhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcH----HHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEeec
Q 047716 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~----~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+...|++|+||+|+.+.. .+..++.+.+........ ..+.+|+++|++++ +++++.++++ +..+++|+|+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456799999999998755 567777666654333111 24778999999996 5789999886 3568999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccC-CCCceEEcCCCcEEEeeccccccccCCCcc-
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDI-KPHNILMDESWKAKISDFGLSKLLKTDQTR- 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di-~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~- 189 (325)
.|.+|.+.... ....++.|++.++.++|++ |++|+|| +|+||+++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99888654311 1135778999999999999 9999999 799999999999999999999855432210
Q ss_pred ---c--------eeeecCCCCcCCccccccCCCCC-ccccchhHHHHHHHHHhCCCCCCCc
Q 047716 190 ---T--------YTVLRGTRGYTAPELHSRNNRIT-VKADVYSFGVMLLEIVCCRKNVDES 238 (325)
Q Consensus 190 ---~--------~~~~~~~~~y~aPE~~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~ 238 (325)
. ......++.|++|+...--...+ ...+-++.|+-++.+.|++.++-..
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 01112466777777542222233 4567789999999999999887543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.8e-19 Score=145.77 Aligned_cols=134 Identities=19% Similarity=0.275 Sum_probs=104.3
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhcc-----CCCCcceeeEEeecCC---ce-EEEE
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-----HHKNLVDLVGFCSEGS---NR-LLVY 108 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~-~lv~ 108 (325)
.+.||+|++|.||. +......++|++..........+.+|+.+++.+ .||||++++++++++. .. .+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46799999999996 443344478887654444566789999999999 5799999999998863 32 3789
Q ss_pred ee--cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHH-HHhhccCCCCeeeccCCCCceEEcC----CCcEEEeecccc
Q 047716 109 EF--MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGL-HYLHDECETRIIHCDIKPHNILMDE----SWKAKISDFGLS 180 (325)
Q Consensus 109 e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l-~~lh~~~~~~i~h~di~p~nilv~~----~~~vkl~Dfg~~ 180 (325)
|| +.+++|.+++.+ +.+++. ..++.|++.++ .|||++ +|+|+||||+||+++. ++.++|+|++.+
T Consensus 85 e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99 557899999944 345555 35677887777 999999 9999999999999974 347999995543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-20 Score=170.12 Aligned_cols=225 Identities=24% Similarity=0.259 Sum_probs=179.8
Q ss_pred hcCcCCceeEEEEEe----CCCcEEEEEEeeccch--hcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEeecC
Q 047716 40 EIGRGGSGRVYKGCI----NGGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~----~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
.+|+|++|.|+++.. +.+..+++|+..+... ........|..++...+ ||.++++...+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999998753 2466677776654221 11113445778888887 9999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
++.+...+. ....+.......+...++-++.++|+. +++|+|+|++||+++.+|++++.|||+....-.....
T Consensus 81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 988887773 334677888888999999999999999 9999999999999999999999999998754333222
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
+|+..|||||++. ....++|-||+|+++++|++|..||.. + .+..++......+..
T Consensus 154 --cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~---------------~~~~Il~~~~~~p~~ 209 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----D---------------TMKRILKAELEMPRE 209 (612)
T ss_pred --ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----H---------------HHHHHhhhccCCchh
Confidence 6899999999984 456789999999999999999999987 1 112334445566777
Q ss_pred HHHHHHHHHhhcccCCCCCCCCH
Q 047716 273 EFENLVKIGLWCVECELNLRPTM 295 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rps~ 295 (325)
....+.+++..++..+|..|.-.
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhcc
Confidence 77889999999999999999766
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=145.96 Aligned_cols=141 Identities=23% Similarity=0.237 Sum_probs=109.6
Q ss_pred HHhhhhhcCcCCceeEEEEE--eCCCcEEEEEEeeccchh------------------------cHHHHHHHHHHHhccC
Q 047716 34 SENFKEEIGRGGSGRVYKGC--INGGKEIAVKKLIKIVEE------------------------GESEFRNEMKIIGRIH 87 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~--~~~~~~~~vk~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 87 (325)
-|.+.+.||+|++|.||+|. ...+..+|+|++...... ....+..|+..++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38899999999999999998 347899999988643210 1123567999999997
Q ss_pred CCC--cceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC-eeeccCCCCce
Q 047716 88 HKN--LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR-IIHCDIKPHNI 164 (325)
Q Consensus 88 h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~-i~h~di~p~ni 164 (325)
+.+ +.++++. ...++||||+++.++..... .........+..++.|++.++.+||+. | ++|+|++|+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 533 3344432 23589999999888766542 233466667789999999999999999 9 99999999999
Q ss_pred EEcCCCcEEEeeccccccc
Q 047716 165 LMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 165 lv~~~~~vkl~Dfg~~~~~ 183 (325)
+++ ++.++++|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 779999999987643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-18 Score=140.04 Aligned_cols=134 Identities=24% Similarity=0.343 Sum_probs=110.8
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchh--------cHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEE--------GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
+.||+|++|.||+|.+ .+..+++|+....... ....+..|+..+..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5667888876542211 123467899999999999988877777677788999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
++|++|.+++.... . ....++.+++.++.++|+. +++|+|++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999884321 2 7888999999999999999 999999999999999 67899999998753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.8e-18 Score=145.10 Aligned_cols=197 Identities=20% Similarity=0.213 Sum_probs=137.2
Q ss_pred CCCCcceeeEEe---------------------------ecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHH
Q 047716 87 HHKNLVDLVGFC---------------------------SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEI 139 (325)
Q Consensus 87 ~h~~iv~~~~~~---------------------------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql 139 (325)
+|||||.++++| .++..+++||... ..+|.+++- ....+....+-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~--~~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW--TRHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh--cCCCchHHHHHHHHHH
Confidence 499999998754 1335678999988 458888873 3446777788899999
Q ss_pred HHHHHHhhccCCCCeeeccCCCCceEE--cCC--CcEEEeeccccccccC-----CCccceeeecCCCCcCCccccccCC
Q 047716 140 MEGLHYLHDECETRIIHCDIKPHNILM--DES--WKAKISDFGLSKLLKT-----DQTRTYTVLRGTRGYTAPELHSRNN 210 (325)
Q Consensus 140 ~~~l~~lh~~~~~~i~h~di~p~nilv--~~~--~~vkl~Dfg~~~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~ 210 (325)
++|+.+||.+ |+.|+|+|.+||++ +++ ..+.+.|||.+--... .........-|...-+|||+...-.
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 99999999999999 333 3478899998642221 1111112233667899999873211
Q ss_pred -----CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcc
Q 047716 211 -----RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCV 285 (325)
Q Consensus 211 -----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 285 (325)
-.-.++|.|+.|.+.||++....||-.....-.. .+.++..++..+.+ .....+.+++...|
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------~r~Yqe~qLPalp~-------~vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------TRTYQESQLPALPS-------RVPPVARQLVFDLL 494 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------hhhhhhhhCCCCcc-------cCChHHHHHHHHHh
Confidence 1235899999999999999999999752211100 12233333332222 23356899999999
Q ss_pred cCCCCCCCCHhHHHHHH
Q 047716 286 ECELNLRPTMKQVIWMM 302 (325)
Q Consensus 286 ~~~p~~Rps~~ell~~L 302 (325)
+.||.+|++..=....|
T Consensus 495 ~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVL 511 (598)
T ss_pred cCCccccCCccHHHhHH
Confidence 99999999987665444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=136.99 Aligned_cols=146 Identities=19% Similarity=0.231 Sum_probs=112.4
Q ss_pred cHHHHHHHH--HhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccch----------------------hcHHHHHHHHH
Q 047716 26 SYEQIVLAS--ENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE----------------------EGESEFRNEMK 81 (325)
Q Consensus 26 ~~~~~~~~~--y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~----------------------~~~~~~~~e~~ 81 (325)
.++.+.... |.+.+.||+|++|.||++...++..+++|++..... ........|+.
T Consensus 6 ~~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 6 ALHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred HHHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 344555554 888999999999999999888899999998653210 01123567888
Q ss_pred HHhccCCCC--cceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccC
Q 047716 82 IIGRIHHKN--LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDI 159 (325)
Q Consensus 82 ~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di 159 (325)
.+..+.+++ +...++. ...+++|||+++++|.+... ......++.+++.++.++|+. |++|+||
T Consensus 86 ~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 86 ALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 888887774 4444432 34589999999998876542 134567889999999999999 9999999
Q ss_pred CCCceEEcCCCcEEEeeccccccccC
Q 047716 160 KPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 160 ~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+|+||+++.++.++++|||.+.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.4e-17 Score=135.05 Aligned_cols=130 Identities=23% Similarity=0.356 Sum_probs=104.5
Q ss_pred hcCcCCceeEEEEEeCCCcEEEEEEeeccch--------hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVE--------EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.||+|++|.||+|.+. +..+++|+...... .....+..|+.++..+.++++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999864 67888888654221 11245678999999999887666555555666778999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
++++|.+++..... .++.+++.++.+||+. |++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988733211 7899999999999999 999999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=7e-17 Score=152.37 Aligned_cols=136 Identities=20% Similarity=0.286 Sum_probs=108.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEe-eccch-------hcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKL-IKIVE-------EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~-~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
..|...+.||+|+||.||++.+.+.. +++|+. ..... .....+.+|+++++.++|++++....+.......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34456789999999999999886544 344432 22111 1224577899999999999998887777666778
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
++||||+++++|.+++. ....++.|++.++.+||+. +++|+|+||+||++ .++.++++|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 89999999999999873 3567899999999999999 99999999999999 567899999998854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-18 Score=153.25 Aligned_cols=170 Identities=23% Similarity=0.330 Sum_probs=126.7
Q ss_pred ceEEEEeecCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRA--EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
.++|.|++|...+|.+++... ....+......++.|++.++.| + +.+|+|++|.||+...+..++|+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999433 3457788889999999999999 6 9999999999999999989999999998
Q ss_pred ccccCCC-----ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHH
Q 047716 181 KLLKTDQ-----TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 181 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
+...... ........++.+|++||.+ .+..|+.++||||||++++||+. =...++... ....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi-~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQI-RGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHH-hhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence 8665444 1111223489999999999 78899999999999999999997 222222110 11223
Q ss_pred HhCcccc-cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhH
Q 047716 255 EAGELQN-LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQ 297 (325)
Q Consensus 255 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~e 297 (325)
+++.+.+ ++.+ ...-..|+.+++...|.+||++.+
T Consensus 473 r~g~ip~~~~~d--------~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RDGIIPPEFLQD--------YPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCCCChHHhhc--------CcHHHHHHHHhcCCCcccCchHHH
Confidence 3333331 1111 123457888999999999994443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-18 Score=163.69 Aligned_cols=256 Identities=23% Similarity=0.260 Sum_probs=194.0
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCC--CcEEEEEEeeccc--hhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCING--GKEIAVKKLIKIV--EEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 105 (325)
....|++.+.||+|+++.+-.+.... ...+++|.+.... ......+..|..+-+.+. |+|++.+++...+....+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 45678888999999999998876643 3344555544332 233334555777777777 999999999999999999
Q ss_pred EEEeecCCCCHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHhh-ccCCCCeeeccCCCCceEEcCCC-cEEEeecccccc
Q 047716 106 LVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLH-DECETRIIHCDIKPHNILMDESW-KAKISDFGLSKL 182 (325)
Q Consensus 106 lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~~ql~~~l~~lh-~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~ 182 (325)
++.++..++++.+.+ .......+....-.++.|+..++.|+| .. ++.|+|++|+|.+++..+ .+++.|||+++.
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988877 333336778888899999999999999 87 999999999999999999 999999999987
Q ss_pred ccC--CCccceeeecC-CCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 183 LKT--DQTRTYTVLRG-TRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 183 ~~~--~~~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
+.. .........+| ++.|.|||...+..+..+..|+||+|+++..+++|..|++......... ..|...... .
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~~~---~ 250 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNKGR---F 250 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccccc---c
Confidence 665 33344444567 9999999998665677889999999999999999999998765544221 111111100 0
Q ss_pred cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 260 QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.............+++.+++..+|..|.+.+++.
T Consensus 251 ------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 ------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ------ccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0111122234578888999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-17 Score=156.06 Aligned_cols=214 Identities=21% Similarity=0.185 Sum_probs=140.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|+.++.+..|++|.||.++++. ...+++ ++.++. -+.+- ++....+|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee------------------
Confidence 3578889999999999999998873 555666 443311 01000 22222333333
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC----
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD---- 186 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~---- 186 (325)
|+-...++ .-+.++... +.++.|||+. ||+|+|+||+|.+|+.-|++|++|||+...-.-.
T Consensus 136 ---gDc~tllk-~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLK-NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcc-cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33333342 222333222 7889999999 9999999999999999999999999987632110
Q ss_pred ----C------ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 187 ----Q------TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 187 ----~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
. .....-+++|+.|.|||++ -...|...+|=|++|+|+|+.+.|..||++....+..- +.+..
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi-lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd 273 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVI-LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISD 273 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhh-hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhh
Confidence 0 0111224699999999998 45667888999999999999999999999875433211 11110
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
. ..+... ......++++++.++|+.+|..|--....+
T Consensus 274 ~--i~wpE~----dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 274 D--IEWPEE----DEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred h--cccccc----CcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 0 011111 222335689999999999999995444333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.9e-16 Score=125.23 Aligned_cols=136 Identities=21% Similarity=0.253 Sum_probs=96.7
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcH--HH----------------------HHHHHHHHhccCCCC--c
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE--SE----------------------FRNEMKIIGRIHHKN--L 91 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~~--i 91 (325)
.+.||+|++|.||+|.+.++..+++|++........ .. ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 567999999999999988899999998765321111 00 124555555554432 3
Q ss_pred ceeeEEeecCCceEEEEeecCCCCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCC
Q 047716 92 VDLVGFCSEGSNRLLVYEFMRNGSLGN-LLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~ 169 (325)
.++++. ...+++|||++++.+.. .+.... .......++.+++.++.++|. . +++|+|++|+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LLEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hcccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 444443 24589999998844321 111111 115678899999999999999 8 999999999999999 8
Q ss_pred CcEEEeecccccccc
Q 047716 170 WKAKISDFGLSKLLK 184 (325)
Q Consensus 170 ~~vkl~Dfg~~~~~~ 184 (325)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.8e-15 Score=137.26 Aligned_cols=164 Identities=19% Similarity=0.269 Sum_probs=128.7
Q ss_pred CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHH
Q 047716 56 GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI 135 (325)
Q Consensus 56 ~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 135 (325)
++.++.|+..............+.+..|+.++||+|+++++.++..+..|||+|.+. .|..++++ +....+...
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~~G 109 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVCLG 109 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHHHH
Confidence 678888888766555445667888999999999999999999999999999999984 56666632 347788899
Q ss_pred HHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCcc
Q 047716 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215 (325)
Q Consensus 136 ~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 215 (325)
++||+.||.|||+.| +++|+++..+.|+|+..|.+||++|.++........ .......--.|..|+.+.... ..
T Consensus 110 l~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~---~s 183 (690)
T KOG1243|consen 110 LFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE---WS 183 (690)
T ss_pred HHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc---cc
Confidence 999999999998663 999999999999999999999999998765432221 111111234577777663221 45
Q ss_pred ccchhHHHHHHHHHhC
Q 047716 216 ADVYSFGVMLLEIVCC 231 (325)
Q Consensus 216 ~DiwslG~il~~ll~g 231 (325)
.|.|.|||++++++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 7999999999999999
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=3e-15 Score=117.35 Aligned_cols=134 Identities=20% Similarity=0.218 Sum_probs=110.5
Q ss_pred hhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCC--CCcceeeEEeecCCceEEEEeecCCC
Q 047716 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHH--KNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+..++.+++ .++++++.+....+..++++||+.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999998865 7788888755332 4567889999999976 58889988887778899999999887
Q ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 115 SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 115 ~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
.+..+ +......++.+++.++..+|.....+++|+|++|+||++++.+.++++||+.+.
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 66543 455667788999999999998533379999999999999998899999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.1e-14 Score=123.04 Aligned_cols=150 Identities=18% Similarity=0.184 Sum_probs=106.9
Q ss_pred ccccccccHHHHHHHHHhhhhhcC-cCCceeEEEEEeCCCcEEEEEEeecc------c-------hhcHHHHHHHHHHHh
Q 047716 19 EIKLRSFSYEQIVLASENFKEEIG-RGGSGRVYKGCINGGKEIAVKKLIKI------V-------EEGESEFRNEMKIIG 84 (325)
Q Consensus 19 ~~~~~~~~~~~~~~~~y~~~~~lg-~g~~g~v~~~~~~~~~~~~vk~~~~~------~-------~~~~~~~~~e~~~l~ 84 (325)
..+-..|+.+...... ..|| .||.|+||.+... +..+++|.+... . ......+.+|+.++.
T Consensus 21 ~~~~~~~~~~~~~~~~----~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~ 95 (239)
T PRK01723 21 DPDPALFDPDFWQQQA----RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLA 95 (239)
T ss_pred CCchhhcCHHHHhhcC----ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHH
Confidence 3334455554444333 3465 6777888877664 677888877431 0 122345778999999
Q ss_pred ccCCCCc--ceeeEEeecC-C---ceEEEEeecCC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeec
Q 047716 85 RIHHKNL--VDLVGFCSEG-S---NRLLVYEFMRN-GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157 (325)
Q Consensus 85 ~l~h~~i--v~~~~~~~~~-~---~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~ 157 (325)
.++|+++ +..+++.... . ..++|||++++ .+|.+++.. ..++.. .+.|++.++.+||+. ||+|+
T Consensus 96 ~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~---GI~Hr 166 (239)
T PRK01723 96 QLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDA---GVYHA 166 (239)
T ss_pred HHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHC---CCCCC
Confidence 9998875 5666654332 2 23599999987 689888743 344443 357899999999999 99999
Q ss_pred cCCCCceEEcCCCcEEEeecccccc
Q 047716 158 DIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 158 di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
||+|.|||++.++.++++|||.+..
T Consensus 167 Dlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 167 DLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCchhEEEcCCCCEEEEECCCccc
Confidence 9999999999988999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.8e-14 Score=127.76 Aligned_cols=140 Identities=23% Similarity=0.297 Sum_probs=96.5
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcH----------------------------------------HHHHH
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE----------------------------------------SEFRN 78 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~----------------------------------------~~~~~ 78 (325)
+.||+|++|.||+|+..+|+.||||+..+...... -.+..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 46999999999999999999999999854321100 01333
Q ss_pred HHHHHhccC----CCCcceeeEEe-ecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHH-HHHHhhccCCC
Q 047716 79 EMKIIGRIH----HKNLVDLVGFC-SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIME-GLHYLHDECET 152 (325)
Q Consensus 79 e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~-~l~~lh~~~~~ 152 (325)
|+..+..++ +.+-+.+-..+ ...+..++||||++|.+|.++......... ...++.+++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~--- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD--- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC---
Confidence 444444442 22223322222 334567999999999999887643222232 2334555555 46778888
Q ss_pred CeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 153 ~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
|++|+|++|.||+++.++.++++|||++....
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.5e-14 Score=128.11 Aligned_cols=253 Identities=19% Similarity=0.187 Sum_probs=183.7
Q ss_pred HHHHHHHHHhhhhhcCc--CCceeEEEEEe--C-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccC-CCCcceeeEEe
Q 047716 27 YEQIVLASENFKEEIGR--GGSGRVYKGCI--N-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIH-HKNLVDLVGFC 98 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~--g~~g~v~~~~~--~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 98 (325)
+.+.....+.+.+.+|. |.+|.+|.+.. . ++..+++|+-..... .....=.+|+..-.+++ |++.++.+..+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 34466678888999999 99999999876 3 677788887433222 22222234555555664 89999988889
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHH----HHHHhhccCCCCeeeccCCCCceEEcCC-CcEE
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIME----GLHYLHDECETRIIHCDIKPHNILMDES-WKAK 173 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~----~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vk 173 (325)
+..+..++-+|.+ +.+|.++......-++...++..+.+... |+..+|+. +++|.|++|.||+...+ ...+
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence 9999999999999 57888887555455888888988999888 99999999 99999999999999998 7899
Q ss_pred EeeccccccccCCCc-ccee---eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH
Q 047716 174 ISDFGLSKLLKTDQT-RTYT---VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW 249 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~-~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 249 (325)
++|||+....+.... .... ...+...|++||.. ...++...|+|+||.++.+-.++..++.......-
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W------ 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW------ 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccCCCCCCc------
Confidence 999999987765542 2221 11467789999987 45678899999999999998887765543311110
Q ss_pred HHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 250 AHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..+ +... -+.+.......++...+..|++.+|..|++.+.+.
T Consensus 336 --~~~-----r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 --SQL-----RQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred --ccc-----cccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 000 0000 01111111224566789999999999999998887
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-13 Score=115.91 Aligned_cols=196 Identities=22% Similarity=0.336 Sum_probs=134.6
Q ss_pred hccCCCCcceeeEEeecC-----CceEEEEeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCee
Q 047716 84 GRIHHKNLVDLVGFCSEG-----SNRLLVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRII 155 (325)
Q Consensus 84 ~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~ 155 (325)
-.+-|.|||+++.++.+. ....+++||+..+++.+++++. +..+......+|+-||+.||.|||+ |..-++
T Consensus 122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppii 200 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccc
Confidence 344599999999887443 3568899999999999999554 4558888889999999999999999 677899
Q ss_pred eccCCCCceEEcCCCcEEEeecccccc---ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCC
Q 047716 156 HCDIKPHNILMDESWKAKISDFGLSKL---LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232 (325)
Q Consensus 156 h~di~p~nilv~~~~~vkl~Dfg~~~~---~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 232 (325)
|++++.+.|++..+|.+|++--.-... .............+-++|.+||.- ...+.+.++|||++|....+|..+.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999998888764221111 011111122222256789999975 4455667899999999999998877
Q ss_pred CCC-CCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 233 KNV-DESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 233 ~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..- ...+......-+..+...+.+ ..-+.++.+|++..|..||++.+++
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~len------------------~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGLEN------------------GLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred eccCCCcceeehhhhhhhheeeccC------------------ccccCcCcccccCCCCCCcchhhhh
Confidence 542 222221111111100011110 0124567789999999999999987
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=8e-13 Score=122.70 Aligned_cols=142 Identities=15% Similarity=0.202 Sum_probs=95.8
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeeccchhc----------------------------------HH---
Q 047716 33 ASENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEG----------------------------------ES--- 74 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~~~----------------------------------~~--- 74 (325)
..|+. +.||+|++|.||+|+.++ |+.||||++.+..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34555 689999999999999987 9999999986532110 01
Q ss_pred ---HHHHHHHHHhccC----CCCcceeeEEeec-CCceEEEEeecCCCCHHHHHhhccCC-----CCHHHHHHHHHHHHH
Q 047716 75 ---EFRNEMKIIGRIH----HKNLVDLVGFCSE-GSNRLLVYEFMRNGSLGNLLFRAEQR-----LSWSERRRIALEIME 141 (325)
Q Consensus 75 ---~~~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~ql~~ 141 (325)
.+..|+..+.++. +.+.+.+-.++.+ .+..++||||++|+.+.++..-...+ +....+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 1233443343332 3444444444432 45678999999999998753211122 34444445555554
Q ss_pred HHHHhhccCCCCeeeccCCCCceEEcCCC----cEEEeeccccccccC
Q 047716 142 GLHYLHDECETRIIHCDIKPHNILMDESW----KAKISDFGLSKLLKT 185 (325)
Q Consensus 142 ~l~~lh~~~~~~i~h~di~p~nilv~~~~----~vkl~Dfg~~~~~~~ 185 (325)
.. |++|+|++|.||+++.++ .++++|||++.....
T Consensus 278 ------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 35 999999999999999887 999999999876644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=104.65 Aligned_cols=127 Identities=19% Similarity=0.140 Sum_probs=94.1
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEeecCCCCH
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
++.++.|.++.||+++.. ++.+++|....... ....+..|+.+++.+.+.+++ +++.+.. ...++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999998875 77899998654322 223467889999988765554 3444432 345899999998877
Q ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC-----eeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 117 GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR-----IIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~-----i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
.+.. ......+.+++.+++.||.. + ++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~---------~~~~~~~~~l~~~l~~LH~~---~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED---------FSDPENLEKIAKLLKKLHSS---PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc---------ccCHHHHHHHHHHHHHHhCC---CCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5431 11134567899999999998 6 59999999999999 5689999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.1e-11 Score=95.71 Aligned_cols=131 Identities=23% Similarity=0.330 Sum_probs=101.0
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhc--------HHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG--------ESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+++|+-+.++.+.+. |..+++|.-.+..... ...-.+|+.++..+..-.|....=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999998775 3346666543322111 12345689999998877777666666677788999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
++|..|.+.+... ...++..+-..+..||.. ||+|||++++||.+.++ .+.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 9999999888443 256777888888999999 99999999999999988 499999999753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.7e-11 Score=95.84 Aligned_cols=142 Identities=22% Similarity=0.301 Sum_probs=104.9
Q ss_pred hhhhcCcCCceeEEEEEeCCCcEEEEEEe-ecc-------chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKL-IKI-------VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~~~~~~~vk~~-~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
....+-+|+-+.|+++.+. |+..++|.- .+. ..-......+|++.|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3567889999999999886 455455533 221 1122345678999999988667766666666777788999
Q ss_pred eecCC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---cEEEeecccccc
Q 047716 109 EFMRN-GSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---KAKISDFGLSKL 182 (325)
Q Consensus 109 e~~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---~vkl~Dfg~~~~ 182 (325)
||+++ .++.+++... ...........++.++-+.+..||.+ +++|||++.+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 3677777433 33445555588999999999999999 999999999999996554 358999998753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.5e-11 Score=96.88 Aligned_cols=136 Identities=18% Similarity=0.212 Sum_probs=97.4
Q ss_pred hhcCcCCceeEEEEEeCC-------CcEEEEEEeeccc----------------------hhcHHH----HHHHHHHHhc
Q 047716 39 EEIGRGGSGRVYKGCING-------GKEIAVKKLIKIV----------------------EEGESE----FRNEMKIIGR 85 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~-------~~~~~vk~~~~~~----------------------~~~~~~----~~~e~~~l~~ 85 (325)
..||.|.-+.||.|...+ +..+|+|+..-.. ...... ..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 4789999764200 001112 3379999999
Q ss_pred cCCC--CcceeeEEeecCCceEEEEeecCCCCHHH-HHhhccCCCCHHHHHHHHHHHHHHHHHh-hccCCCCeeeccCCC
Q 047716 86 IHHK--NLVDLVGFCSEGSNRLLVYEFMRNGSLGN-LLFRAEQRLSWSERRRIALEIMEGLHYL-HDECETRIIHCDIKP 161 (325)
Q Consensus 86 l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~ql~~~l~~l-h~~~~~~i~h~di~p 161 (325)
+... ++..++++ ...++||||+.++.+.. .+. ...++......+..+++.++..| |.. |++|||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 8643 45555654 45689999997643321 221 12345556677889999999988 888 999999999
Q ss_pred CceEEcCCCcEEEeecccccccc
Q 047716 162 HNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 162 ~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
.||++.+ +.+.++|||.+....
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCC
Confidence 9999975 589999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-11 Score=112.33 Aligned_cols=247 Identities=20% Similarity=0.191 Sum_probs=175.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC--CCcEEEEEEeeccchhcHHHH--HHHHHHHhccC-CCCcceeeEEeecCCceEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEF--RNEMKIIGRIH-HKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~~~vk~~~~~~~~~~~~~--~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 106 (325)
..++.++..||.|.|+.++....+ ++..+++|-..+.......++ ..|+-+...+. |.+++.+...+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 456778889999999999987644 677788887766544433332 24555555554 8889988887777777788
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-CcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vkl~Dfg~~~~~~~ 185 (325)
=-||+.++++.... .....+.+...+....|++.++.++|+. .++|.|++|+||++..+ +.-+++||+..+.+..
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce
Confidence 99999888877665 3334578888999999999999999999 99999999999999876 6778999998865322
Q ss_pred CCccceeeecCCCCcC-CccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 186 DQTRTYTVLRGTRGYT-APELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..... ...-++. ..|.+.....+..+.|++|||.-+.+.+++...-.... .+..+..
T Consensus 420 ~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------------~~~~i~~ 477 (524)
T KOG0601|consen 420 SSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------------QSLTIRS 477 (524)
T ss_pred ecccc----cccccccccchhhccccccccccccccccccccccccCcccCcccc------------------cceeeec
Confidence 11111 1233444 25655566777889999999999999988876443221 1112222
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhc
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 304 (325)
......+.....+..+...+...++..||++.++....+.
T Consensus 478 ~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 478 GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 2222222223567788888999999999999988755443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.6e-10 Score=98.96 Aligned_cols=214 Identities=15% Similarity=0.216 Sum_probs=149.9
Q ss_pred CceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEee----cCCceEEEEeecCC-CCHHH
Q 047716 45 GSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS----EGSNRLLVYEFMRN-GSLGN 118 (325)
Q Consensus 45 ~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~~L~~ 118 (325)
-..+.|++..+ +|..+++|+++............-++..+++.|+|+|++-+++. .+..+.+|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34688888876 89999999995544444444455688899999999999988775 34577999999975 47776
Q ss_pred HHhhc--------------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 119 LLFRA--------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 119 ~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
..... +.+.++..+|.++.|+..||.++|+. |+..+-+.|.+|+++++.++++..+|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54321 12478899999999999999999999 99999999999999999999999998765543
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.+.. + .+.. ..+-|.=.||.+++.|.||...--..... ....+
T Consensus 445 ~d~~-------------~--~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~-~~s~~----------------- 487 (655)
T KOG3741|consen 445 EDPT-------------E--PLES----QQQNDLRDLGLLLLALATGTENSNRTDST-QSSHL----------------- 487 (655)
T ss_pred CCCC-------------c--chhH----HhhhhHHHHHHHHHHHhhcccccccccch-HHHHH-----------------
Confidence 3320 1 1101 12568999999999999997532111110 00000
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
..+....+.++++++.-....++++ -++++++.+
T Consensus 488 --~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 488 --TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 0112223345667777777777776 677777743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.7e-10 Score=94.44 Aligned_cols=141 Identities=19% Similarity=0.330 Sum_probs=104.2
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCC--cceeeEEeecC---CceEEEEeecC
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKN--LVDLVGFCSEG---SNRLLVYEFMR 112 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~---~~~~lv~e~~~ 112 (325)
+.|+.|..+.+|++...+|..+++|....... .....+..|..+++.+.+.+ +.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887667899998654322 13456788999999997644 56677776553 25689999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC------------------------------------------
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC------------------------------------------ 150 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~------------------------------------------ 150 (325)
+.++.+.+.. ..++......++.+++.++..||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 8887765421 34566666677777777777777420
Q ss_pred -----------CCCeeeccCCCCceEEcC--CCcEEEeeccccc
Q 047716 151 -----------ETRIIHCDIKPHNILMDE--SWKAKISDFGLSK 181 (325)
Q Consensus 151 -----------~~~i~h~di~p~nilv~~--~~~vkl~Dfg~~~ 181 (325)
...++|+|++++||+++. ++.+.++||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 135799999999999998 5668999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-09 Score=94.76 Aligned_cols=260 Identities=12% Similarity=0.111 Sum_probs=156.4
Q ss_pred hhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcce----eeEE--eecCC-ceEEEE
Q 047716 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVD----LVGF--CSEGS-NRLLVY 108 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~----~~~~--~~~~~-~~~lv~ 108 (325)
..+.||+|+-+.+|..-. -...+.|+..........+. +..|... .||-+-. .... ..+.+ ...++|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 457899999999986422 22345677665444433322 2223333 3553322 1111 12222 256778
Q ss_pred eecCCC-CHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 109 EFMRNG-SLGNLLFR-----AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 109 e~~~~~-~L~~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
+.+.+. .+..+... +.....+..+..+++.++.+.+-||.. |.+-||++++|+||++++.|.|.|-.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 777653 22233311 123478999999999999999999999 999999999999999999999998665544
Q ss_pred ccCCCccceeeecCCCCcCCccccc----cCCCCCccccchhHHHHHHHHHhC-CCCCCCccccc-----hhhHHHHHHH
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVCC-RKNVDESLRDD-----EIVLIDWAHQ 252 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~-----~~~~~~~~~~ 252 (325)
. .+.....+..+...|.+||... .+-.-+...|.|.||+++++||.| ++||.+..... ....+....-
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 3 2223333444888999999752 233456789999999999999877 89997544211 1111110000
Q ss_pred HHHhCcccccccCCCCCCHH-HHHHHHHHHhhcccC--CCCCCCCHhHHHHHHhccC
Q 047716 253 CYEAGELQNLVSDQEDVNIE-EFENLVKIGLWCVEC--ELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~--~p~~Rps~~ell~~L~~~~ 306 (325)
.+-.+.=.........++-+ ....+..+..+|+.. ++.-|||++-.+..|..+.
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 00000001111111111111 124566677788874 4679999998886665544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.8e-10 Score=101.63 Aligned_cols=142 Identities=18% Similarity=0.258 Sum_probs=96.9
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcH----------------------------------------HHHHH
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE----------------------------------------SEFRN 78 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~----------------------------------------~~~~~ 78 (325)
+.++.++-|.||+|+.++|+.||||+..+...... -.+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46889999999999999999999999865322110 11334
Q ss_pred HHHHHhccC-----CCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 047716 79 EMKIIGRIH-----HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153 (325)
Q Consensus 79 e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~ 153 (325)
|..-+.+++ .|.+.-..=+.+-.+...++|||++|..+.+.......+.+...+.....++.----+- . |
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~--d---g 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR--D---G 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh--c---C
Confidence 444444442 33332222233445677999999999999888544445566555554444433222222 3 9
Q ss_pred eeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 154 i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
++|+|.+|.||+++.+|++.+.|||.......
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876644
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.6e-09 Score=86.30 Aligned_cols=125 Identities=26% Similarity=0.299 Sum_probs=82.1
Q ss_pred EEEEEeCCCcEEEEEEeeccc--------------------------hhcHHHHHHHHHHHhccCCCC--cceeeEEeec
Q 047716 49 VYKGCINGGKEIAVKKLIKIV--------------------------EEGESEFRNEMKIIGRIHHKN--LVDLVGFCSE 100 (325)
Q Consensus 49 v~~~~~~~~~~~~vk~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~ 100 (325)
||.|...++..+|+|...... ........+|.+.|..+..-+ +.+++++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 888988888899999764210 001233668999999998664 55666553
Q ss_pred CCceEEEEeecC--CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHH-hhccCCCCeeeccCCCCceEEcCCCcEEEeec
Q 047716 101 GSNRLLVYEFMR--NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY-LHDECETRIIHCDIKPHNILMDESWKAKISDF 177 (325)
Q Consensus 101 ~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~-lh~~~~~~i~h~di~p~nilv~~~~~vkl~Df 177 (325)
...|||||++ |..+..+.... ++......++.+++..+.. +|.. |++|||+++.||+++++ .+.++||
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--G
T ss_pred --CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEec
Confidence 3479999998 65565544211 1134456677777775444 5787 99999999999999988 9999999
Q ss_pred ccccccc
Q 047716 178 GLSKLLK 184 (325)
Q Consensus 178 g~~~~~~ 184 (325)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.3e-09 Score=89.31 Aligned_cols=136 Identities=21% Similarity=0.259 Sum_probs=99.0
Q ss_pred HhhhhhcCcCCceeEEEEEeCCCcEEEEEEeec--cc--------------------hhcHHHHHHHHHHHhccCCC--C
Q 047716 35 ENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IV--------------------EEGESEFRNEMKIIGRIHHK--N 90 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~--~~--------------------~~~~~~~~~e~~~l~~l~h~--~ 90 (325)
+.++.+||-|.-+.||.|.+..|.++++|.=.. .+ .-.....++|.++|++|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 566789999999999999999999999985321 00 11223467899999999755 6
Q ss_pred cceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC
Q 047716 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170 (325)
Q Consensus 91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~ 170 (325)
+.+.+++ +...+|||+++|..|...- ++......++..|+.-+..+-.. |++|||+++-||+++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 7777766 4557999999887665432 12333334444555555555565 999999999999999999
Q ss_pred cEEEeeccccccc
Q 047716 171 KAKISDFGLSKLL 183 (325)
Q Consensus 171 ~vkl~Dfg~~~~~ 183 (325)
.+.++||..+...
T Consensus 240 ~~~vIDwPQ~v~~ 252 (304)
T COG0478 240 DIVVIDWPQAVPI 252 (304)
T ss_pred CEEEEeCcccccC
Confidence 9999999877543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.5e-09 Score=88.97 Aligned_cols=137 Identities=15% Similarity=0.073 Sum_probs=96.7
Q ss_pred cCcCCceeEEEEEeCCCcEEEEEEeeccch-----------hcHHHHHHHHHHHhccCCCCcce--eeEEeec-----CC
Q 047716 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVE-----------EGESEFRNEMKIIGRIHHKNLVD--LVGFCSE-----GS 102 (325)
Q Consensus 41 lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~--~~~~~~~-----~~ 102 (325)
+-......|.+... +|+.+++|....... .....+.+|...+..+...+|.. +..+.+. ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33344445666655 577899997643221 11123678888888886444433 3444432 23
Q ss_pred ceEEEEeecCCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-------CCcEE
Q 047716 103 NRLLVYEFMRNG-SLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-------SWKAK 173 (325)
Q Consensus 103 ~~~lv~e~~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-------~~~vk 173 (325)
..++|||++++. +|.+++... ....+......++.+++..+..||.. |++|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEE
Confidence 468999999876 898887432 23456677789999999999999999 9999999999999975 46799
Q ss_pred Eeeccccc
Q 047716 174 ISDFGLSK 181 (325)
Q Consensus 174 l~Dfg~~~ 181 (325)
++||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999774
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.7e-10 Score=105.40 Aligned_cols=149 Identities=17% Similarity=0.229 Sum_probs=101.5
Q ss_pred HHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce--------eeecCCCCcCCcccccc
Q 047716 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY--------TVLRGTRGYTAPELHSR 208 (325)
Q Consensus 137 ~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~ 208 (325)
.+++.|+.|+|.. .+++|++|.|++|.++.++.+|++.|+.+........... ........|.|||++ .
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~-~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL-L 182 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh-c
Confidence 3445899999987 7999999999999999999999999998865433211111 111145579999998 5
Q ss_pred CCCCCccccchhHHHHHHHHHhCC-CCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccC
Q 047716 209 NNRITVKADVYSFGVMLLEIVCCR-KNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVEC 287 (325)
Q Consensus 209 ~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 287 (325)
....+.++|+||||++++.+..|+ .-+.......... ........... ....+.+.++++-+.+++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~------~~~~~~~~~~~-----~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS------FSRNLLNAGAF-----GYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh------hhhcccccccc-----cccccCcHHHHHHHHHHhcC
Confidence 577889999999999999998544 4443332111110 01111111111 11133345788899999999
Q ss_pred CCCCCCCHhHHH
Q 047716 288 ELNLRPTMKQVI 299 (325)
Q Consensus 288 ~p~~Rps~~ell 299 (325)
++..||++.++.
T Consensus 252 ~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 252 DSAVRPTLDLLL 263 (700)
T ss_pred CcccCcchhhhh
Confidence 999999888776
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-08 Score=91.90 Aligned_cols=142 Identities=19% Similarity=0.222 Sum_probs=96.1
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhc----H---------------------------HH------HHHHH-
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG----E---------------------------SE------FRNEM- 80 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~----~---------------------------~~------~~~e~- 80 (325)
+.||..+.|.||+|+.++|..||||+-++..... . +. |.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4699999999999999999999999986532211 0 00 12222
Q ss_pred ---HHHhccCCCCc---ceeeEEe-ecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 047716 81 ---KIIGRIHHKNL---VDLVGFC-SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153 (325)
Q Consensus 81 ---~~l~~l~h~~i---v~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~ 153 (325)
+..+.+.|-+. |.+-.++ .......|+|||++|..+.|.-.-...+++...+...+.+...-.-+.| |
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~-----G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT-----G 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc-----C
Confidence 22222334441 1122222 2335779999999999887765444556788877766666555444444 8
Q ss_pred eeeccCCCCceEEcC----CCcEEEeeccccccccC
Q 047716 154 IIHCDIKPHNILMDE----SWKAKISDFGLSKLLKT 185 (325)
Q Consensus 154 i~h~di~p~nilv~~----~~~vkl~Dfg~~~~~~~ 185 (325)
++|+|.+|.||++++ ++.+.+.|||+......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=9.4e-10 Score=105.97 Aligned_cols=247 Identities=19% Similarity=0.157 Sum_probs=161.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
..+.+.+.+.+|+++.++.+.-. .+.....+..... .......+..+-.++-...+|.++...--+.-.....+++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34556678888999998887654 3333333332211 1111111222222222223455554443444456789999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC--
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD-- 186 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~-- 186 (325)
+|..+++|...+... +..+..-.+..+..+..+..+||.. .+.|+|++|.|.+...++..++.||+.....+..
T Consensus 884 ~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred HHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999998888444 3566666677788889999999997 7999999999999999999999999743221100
Q ss_pred ----------------------------CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 047716 187 ----------------------------QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDES 238 (325)
Q Consensus 187 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 238 (325)
.........+++.|.+||.. .+......+|.|+.|+++++.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~-lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL-LGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCccc-ccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 00111223478899999998 4666677899999999999999999999876
Q ss_pred cccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHh
Q 047716 239 LRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMK 296 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 296 (325)
..... + .+.+. ....-+........+..+++...+..+|.+|..+.
T Consensus 1039 tpq~~----------f-~ni~~-~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQI----------F-ENILN-RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhh----------h-hcccc-CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 54321 1 11111 11111333444556788999999999999998877
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.9e-08 Score=81.31 Aligned_cols=123 Identities=24% Similarity=0.327 Sum_probs=88.5
Q ss_pred CCcEEEEEEeeccch-------hcHHHHHHHHHHHhccCCCCc--ceeeEEeecC----CceEEEEeecCCC-CHHHHHh
Q 047716 56 GGKEIAVKKLIKIVE-------EGESEFRNEMKIIGRIHHKNL--VDLVGFCSEG----SNRLLVYEFMRNG-SLGNLLF 121 (325)
Q Consensus 56 ~~~~~~vk~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~ 121 (325)
.++.+.+|....... .......+|...+..+...+| .+++++.+.. ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 455666665432111 233457778888877764433 3444544332 2458999999874 7888885
Q ss_pred hccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---cEEEeecccccc
Q 047716 122 RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---KAKISDFGLSKL 182 (325)
Q Consensus 122 ~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---~vkl~Dfg~~~~ 182 (325)
... ..+......++.+++..+..||.. |++|+|+++.|||++.++ .+.++||+.+..
T Consensus 111 ~~~-~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWE-QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhc-ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 422 266777889999999999999999 999999999999999887 799999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.6e-07 Score=76.50 Aligned_cols=135 Identities=21% Similarity=0.187 Sum_probs=99.4
Q ss_pred CcCCceeEEEEEeCCCcEEEEEEeeccc------hhcHHHHHHHHHHHhccCCCC--cceeeEEee---c--CCceEEEE
Q 047716 42 GRGGSGRVYKGCINGGKEIAVKKLIKIV------EEGESEFRNEMKIIGRIHHKN--LVDLVGFCS---E--GSNRLLVY 108 (325)
Q Consensus 42 g~g~~g~v~~~~~~~~~~~~vk~~~~~~------~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~---~--~~~~~lv~ 108 (325)
|.||.+.|+..... |+.+.+|.-.... +.....+.+|...|+.+...+ +.++. ++. . ....+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 55999999986554 4478888775211 235667889999999996333 33333 221 1 12358999
Q ss_pred eecCC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc--EEEeeccccc
Q 047716 109 EFMRN-GSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK--AKISDFGLSK 181 (325)
Q Consensus 109 e~~~~-~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~--vkl~Dfg~~~ 181 (325)
|-+++ .+|.+++.+. ..+.+......++.+++..++.||+. |+.|+|+.+.||+++.++. +.++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 5888887432 23567777789999999999999999 9999999999999986667 9999998654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.8e-08 Score=78.60 Aligned_cols=140 Identities=19% Similarity=0.173 Sum_probs=92.3
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHH---------HHHHHHHhccC---CCCccee
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEF---------RNEMKIIGRIH---HKNLVDL 94 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~---------~~e~~~l~~l~---h~~iv~~ 94 (325)
+.++...+|++.+.+-...-..|.+-.. +++.+++|..........+.+ .+.+..+..+. -.....+
T Consensus 25 ~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 25 GEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 4567888899988888888777776544 467888887655332222222 23333333332 2222232
Q ss_pred eEE-----eecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC
Q 047716 95 VGF-----CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 95 ~~~-----~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~ 169 (325)
+.. +.-....+++|||++|..|.+... +++ .+...+.+++..+|+. |++|||++|+|++++++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 222 222345578999999988876541 222 2445677889999999 99999999999999976
Q ss_pred CcEEEeecccc
Q 047716 170 WKAKISDFGLS 180 (325)
Q Consensus 170 ~~vkl~Dfg~~ 180 (325)
.++++|++.-
T Consensus 172 -~i~iID~~~k 181 (229)
T PF06176_consen 172 -GIRIIDTQGK 181 (229)
T ss_pred -cEEEEECccc
Confidence 5999999754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=8e-07 Score=74.48 Aligned_cols=137 Identities=13% Similarity=0.211 Sum_probs=82.9
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceeeEEeecCCceEEEEeecCCCC-
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLVGFCSEGSNRLLVYEFMRNGS- 115 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~- 115 (325)
.++|+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+++++....+...++|++++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24467778765422 3445788999999987443 4567777777777889999998863
Q ss_pred HHHHH--------------hh----cc----CCCCHHHHHH-HHHH----------HHH-HHHHhhcc-CCCCeeeccCC
Q 047716 116 LGNLL--------------FR----AE----QRLSWSERRR-IALE----------IME-GLHYLHDE-CETRIIHCDIK 160 (325)
Q Consensus 116 L~~~~--------------~~----~~----~~~~~~~~~~-~~~q----------l~~-~l~~lh~~-~~~~i~h~di~ 160 (325)
+.... .. -. .......... +..+ +.. ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 00 00 0111111100 0000 000 01111111 12357999999
Q ss_pred CCceEEcCCCcEEEeeccccc
Q 047716 161 PHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 161 p~nilv~~~~~vkl~Dfg~~~ 181 (325)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-06 Score=72.83 Aligned_cols=136 Identities=24% Similarity=0.311 Sum_probs=92.8
Q ss_pred hcCcCCceeEEEEEeCCCcEEEEEEeeccchhc-------------------H-----HHHHHHHHHHhccCCC--Ccce
Q 047716 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG-------------------E-----SEFRNEMKIIGRIHHK--NLVD 93 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~-------------------~-----~~~~~e~~~l~~l~h~--~iv~ 93 (325)
.|++|.-+.||.|...++..+|+|+........ . ....+|..-|+++... .+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 467788889999988889999999885422110 0 1244677777777533 4445
Q ss_pred eeEEeecCCceEEEEeecCCCCH-HHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 94 LVGFCSEGSNRLLVYEFMRNGSL-GNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
.+++. .-.||||++..... .-.+ ..-.+...+...+..++++.+.-|-.. .+++|+||+.-|||+. ++.+
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeE
Confidence 56654 33699999954310 0011 112234446677788888888888762 3999999999999999 6689
Q ss_pred EEeecccccccc
Q 047716 173 KISDFGLSKLLK 184 (325)
Q Consensus 173 kl~Dfg~~~~~~ 184 (325)
.++|++.+....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999887554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.9e-06 Score=65.33 Aligned_cols=129 Identities=21% Similarity=0.322 Sum_probs=90.4
Q ss_pred hhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCC
Q 047716 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGS 115 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 115 (325)
+..+.|++|.+|.||++.+. +..+++|+-.. +.....+..|+++|..++--++.+=.-++.. -++.|||+.|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcc
Confidence 45678999999999999997 44788887554 3455678899999999987776654333322 235599999988
Q ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCC-CCceEEcCCCcEEEeeccccc
Q 047716 116 LGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIK-PHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 116 L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~-p~nilv~~~~~vkl~Dfg~~~ 181 (325)
|.+..... +...+. .++++.-.|-.. ||-|+.++ |....+.+++.+.|+||..++
T Consensus 99 L~~~~~~~----~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 99 LGKLEIGG----DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhcc----cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 88776211 333333 344554555565 99999987 444444444499999999886
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.40 E-value=1e-05 Score=65.95 Aligned_cols=128 Identities=23% Similarity=0.334 Sum_probs=90.9
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccc----------------hhcHHHHHHHHHHHhccC------CCCcceee
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV----------------EEGESEFRNEMKIIGRIH------HKNLVDLV 95 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~~ 95 (325)
...||+|+...||. +..+...+||+..... ....++..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35699999999997 5566677888876544 123445556665555554 78999999
Q ss_pred EEeecCCceEEEEeecCC------CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC
Q 047716 96 GFCSEGSNRLLVYEFMRN------GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 96 ~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~ 169 (325)
|+.+++....+|+|.+.. -+|.+++. .+.++. .+...+. +-..+|-+. +|+.+|++|.||++..+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEEec
Confidence 999999999999998742 36888883 334555 4444444 445566776 89999999999999533
Q ss_pred C----cEEEee
Q 047716 170 W----KAKISD 176 (325)
Q Consensus 170 ~----~vkl~D 176 (325)
. .+.++|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.1e-06 Score=70.59 Aligned_cols=75 Identities=13% Similarity=0.134 Sum_probs=51.1
Q ss_pred cCcCCc-eeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEeecCCCCHHH
Q 047716 41 IGRGGS-GRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGN 118 (325)
Q Consensus 41 lg~g~~-g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 118 (325)
|..|.+ +.||+.... +..+++|...... ...+..|+.+++.+. +--+.+++++....+..++||++++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 788988654 4677777764432 335667888888885 3345567777766667899999999887764
Q ss_pred H
Q 047716 119 L 119 (325)
Q Consensus 119 ~ 119 (325)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.8e-06 Score=69.98 Aligned_cols=78 Identities=15% Similarity=0.263 Sum_probs=55.7
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceeeEEe---ecCCceEEEEeecC
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLVGFC---SEGSNRLLVYEFMR 112 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~---~~~~~~~lv~e~~~ 112 (325)
++.++.|..+.+|.....+ ..+++|..... .....+..|..+++.+.... +..++... ......+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3568899999999998876 68888886553 45567778888888886333 44556533 22345689999999
Q ss_pred CCCHHH
Q 047716 113 NGSLGN 118 (325)
Q Consensus 113 ~~~L~~ 118 (325)
+..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.9e-07 Score=84.24 Aligned_cols=186 Identities=18% Similarity=0.127 Sum_probs=129.5
Q ss_pred HhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC-cceeeEEeecCCceEEEEeecCC
Q 047716 35 ENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN-LVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
|...+.+++++++.+++.+....+....+.+... ....-++++|.+++||| .+..++-+..+...++.++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3445568889999999987766666666655443 44556899999999999 66667777777788999999876
Q ss_pred C-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 114 G-SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 114 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+ +-........-.+.........+.-...++++|+. .=+|+| ||+..+ +..+.+||+......... ...
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 6 22221111122344445555666667888999986 446776 766665 489999999876554433 122
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCC
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVD 236 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 236 (325)
...+++.++|||.. ....+..+.|.|++|.-..++.-|-+|-.
T Consensus 389 t~~~~~~~~~pev~-~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVI-QENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhh-cccccccCCCccCCCcchhhcCCCCCCCC
Confidence 23378899999988 56677889999999987777887776653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.9e-05 Score=75.25 Aligned_cols=78 Identities=13% Similarity=0.309 Sum_probs=55.2
Q ss_pred hhhcCcCCceeEEEEEeCCC---cEEEEEEeeccc-hhcHHHHHHHHHHHhccC-CCCc--ceeeEEeecC---CceEEE
Q 047716 38 KEEIGRGGSGRVYKGCINGG---KEIAVKKLIKIV-EEGESEFRNEMKIIGRIH-HKNL--VDLVGFCSEG---SNRLLV 107 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~---~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv 107 (325)
.+.++.|.++.+|+.....+ ..+++|+..... ......+.+|+.+++.+. |+++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688899999999876643 356777653321 223456889999999996 6654 6677776553 467899
Q ss_pred EeecCCCC
Q 047716 108 YEFMRNGS 115 (325)
Q Consensus 108 ~e~~~~~~ 115 (325)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.8e-05 Score=63.74 Aligned_cols=74 Identities=16% Similarity=0.306 Sum_probs=45.1
Q ss_pred hhhcCcCCce-eEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCC---CcceeeEEeecC---CceEEEEee
Q 047716 38 KEEIGRGGSG-RVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHK---NLVDLVGFCSEG---SNRLLVYEF 110 (325)
Q Consensus 38 ~~~lg~g~~g-~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~ 110 (325)
++.++.|+.. .||.. +..+++|.... ......+..|...++.+... .+..+++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567777776 58875 33567775433 22344688899999888632 233444443222 234789999
Q ss_pred cCCCCHH
Q 047716 111 MRNGSLG 117 (325)
Q Consensus 111 ~~~~~L~ 117 (325)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9886653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.7e-05 Score=61.80 Aligned_cols=101 Identities=24% Similarity=0.388 Sum_probs=79.7
Q ss_pred HHHHHHhccCC-CCcceeeEEeecCCceEEEEeecCCCCHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 047716 78 NEMKIIGRIHH-KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF--RAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154 (325)
Q Consensus 78 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i 154 (325)
.|.-+++.+++ +++.+++|.+-. +++.||...+++..... ..-...++..+..++.++++.+..|+....+.+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 57888888875 699999999833 67889998665532100 011246899999999999999999998654468
Q ss_pred eeccCCCCceEEcCCCcEEEeecccccc
Q 047716 155 IHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 155 ~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..+|++++|+-+++++++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 9999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.94 E-value=7.8e-05 Score=63.83 Aligned_cols=136 Identities=13% Similarity=0.159 Sum_probs=75.4
Q ss_pred hcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEeecCCCCHHH
Q 047716 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYEFMRNGSLGN 118 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L~~ 118 (325)
.+..|-.+.+|+.. .++..+++|...............|..+++.+...++. +++.... -++|++|++|..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45678888999886 34667778765432222112346788888888654443 3333322 368999998865432
Q ss_pred H--------------Hhh---c---cCCCCHHH-HHHHHHHH---------HHHHHHhhcc-----CCCCeeeccCCCCc
Q 047716 119 L--------------LFR---A---EQRLSWSE-RRRIALEI---------MEGLHYLHDE-----CETRIIHCDIKPHN 163 (325)
Q Consensus 119 ~--------------~~~---~---~~~~~~~~-~~~~~~ql---------~~~l~~lh~~-----~~~~i~h~di~p~n 163 (325)
. +.+ . ..+++... +..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 100 0 01111111 11111111 1111111111 12358999999999
Q ss_pred eEEcCCCcEEEeeccccc
Q 047716 164 ILMDESWKAKISDFGLSK 181 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~ 181 (325)
|++++++ +.++||..+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999876 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00044 Score=60.52 Aligned_cols=76 Identities=12% Similarity=0.037 Sum_probs=54.2
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCC---CCcceeeEEeec---CCceEEEEeec
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHH---KNLVDLVGFCSE---GSNRLLVYEFM 111 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~~ 111 (325)
.+.||.|..+.||.....++ .+++|.... ......+..|...|+.+.. -.+.++++.+.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 35799999999999866555 466666422 1233577889999988863 357778877644 35689999999
Q ss_pred CCCCH
Q 047716 112 RNGSL 116 (325)
Q Consensus 112 ~~~~L 116 (325)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 88654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00018 Score=60.73 Aligned_cols=73 Identities=18% Similarity=0.207 Sum_probs=46.8
Q ss_pred hhcCcCCceeEEEEEeCC--CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEeecCCCC
Q 047716 39 EEIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYEFMRNGS 115 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~--~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~ 115 (325)
+.|..|-...+|+....+ ++.+++|...... ........|+.+++.+...+++ +++.... -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467788889999987654 5678888654322 2112334688888888644444 3444332 248999998866
Q ss_pred H
Q 047716 116 L 116 (325)
Q Consensus 116 L 116 (325)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.82 E-value=9.5e-05 Score=73.33 Aligned_cols=195 Identities=20% Similarity=0.226 Sum_probs=131.4
Q ss_pred HHHHHHHHhccCCCCcceeeEEeecCCce----EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCC
Q 047716 76 FRNEMKIIGRIHHKNLVDLVGFCSEGSNR----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151 (325)
Q Consensus 76 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~ 151 (325)
...|...+....|+|++.++.+-.+.... .+..+++...++...+ ..-+.++...++.+..++.+++.++|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 44577888888999999999887554332 3455677777777777 3446788999999999999999999998
Q ss_pred CCeeeccCCCC---ceEEcCCCcEEEe--eccccccccCCCccceeeecCCCCcCCccccccCCC--CCccccchhHHHH
Q 047716 152 TRIIHCDIKPH---NILMDESWKAKIS--DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR--ITVKADVYSFGVM 224 (325)
Q Consensus 152 ~~i~h~di~p~---nilv~~~~~vkl~--Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~i 224 (325)
...|.-+..+ +.-++..+.+..+ ||+............... ....+.+||... ... .....|+|++|..
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~--~~~~~~~~e~~~-~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDL--LAEIRNADEDLK-ENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhc--Cccccccccccc-cccchhhhhhHHHHHHHH
Confidence 6555555554 4445666667776 888776554433222211 345567777662 333 2345799999999
Q ss_pred HHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHH
Q 047716 225 LLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWM 301 (325)
Q Consensus 225 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 301 (325)
...+..|..+-........ + ..... ...+.+...+|+..++++|+++.+++..
T Consensus 382 ~~~~~~~~~i~~~~~~~~~----------~-----l~~~~---------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVPVS----------L-----LDVLS---------TSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCcccccccchhh----------h-----hcccc---------chhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999988765432211100 0 00000 0136777889999999999999999943
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00067 Score=61.43 Aligned_cols=74 Identities=19% Similarity=0.176 Sum_probs=52.2
Q ss_pred hhcCcCCceeEEEEEeCCC-cEEEEEEeeccc-------hhcHHHHHHHHHHHhccC---CCCcceeeEEeecCCceEEE
Q 047716 39 EEIGRGGSGRVYKGCINGG-KEIAVKKLIKIV-------EEGESEFRNEMKIIGRIH---HKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~-~~~~vk~~~~~~-------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 107 (325)
+.||.|..+.||++...++ +.++||.-.... .-.......|.+.|+.+. -.++.+++.+. ....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 5799999999999998766 489999754221 123445667888888874 23566667663 3557899
Q ss_pred EeecCCC
Q 047716 108 YEFMRNG 114 (325)
Q Consensus 108 ~e~~~~~ 114 (325)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00033 Score=61.60 Aligned_cols=139 Identities=22% Similarity=0.282 Sum_probs=96.9
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccc--------------------------hhcHHHHHHHHHHHhccCCCCcc
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--------------------------EEGESEFRNEMKIIGRIHHKNLV 92 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~~iv 92 (325)
.+|..|.-+.||.|+..+|..+|||+..-.. .--.-....|++-|++++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 3688889999999999999999999874200 00112355788888888766654
Q ss_pred eeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
-.--+... ...|||+++.... +..-.-..-.++...+..+-.|++.-+..|-..| ++||.||+--|+|+.++ .+
T Consensus 230 ~PePIlLk--~hVLVM~FlGrdg-w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~LyhdG-~l 303 (520)
T KOG2270|consen 230 CPEPILLK--NHVLVMEFLGRDG-WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHDG-KL 303 (520)
T ss_pred CCCceeee--cceEeeeeccCCC-CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEECC-EE
Confidence 33222222 3468999984221 1111112234677788888889999888888876 99999999999998876 89
Q ss_pred EEeeccccccc
Q 047716 173 KISDFGLSKLL 183 (325)
Q Consensus 173 kl~Dfg~~~~~ 183 (325)
.++|-+.+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99998876544
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0015 Score=57.76 Aligned_cols=145 Identities=14% Similarity=0.204 Sum_probs=77.3
Q ss_pred HHHhh-----hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceeeE------Eee
Q 047716 33 ASENF-----KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLVG------FCS 99 (325)
Q Consensus 33 ~~y~~-----~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~------~~~ 99 (325)
..|.+ .+.++.|....+|.....++ .+++|+... .....+..++..++.|...+ +.+++. +..
T Consensus 17 ~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~ 92 (319)
T PRK05231 17 APYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGE 92 (319)
T ss_pred HhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeee
Confidence 56765 24577788889999876544 688887642 12333444555555553222 223332 122
Q ss_pred cCCceEEEEeecCCCCHH-----------HHHhhc---cCCC-----------CHHHHH------------HHHHH-HHH
Q 047716 100 EGSNRLLVYEFMRNGSLG-----------NLLFRA---EQRL-----------SWSERR------------RIALE-IME 141 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~-----------~~~~~~---~~~~-----------~~~~~~------------~~~~q-l~~ 141 (325)
..+..+++++|++|..+. +.+.+. ...+ .+.... ..+.+ +..
T Consensus 93 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 172 (319)
T PRK05231 93 LAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAA 172 (319)
T ss_pred eCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHH
Confidence 345678999999886431 111110 0000 001100 01111 111
Q ss_pred HHHHhhcc----CCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 142 GLHYLHDE----CETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 142 ~l~~lh~~----~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
.+..+... -..+++|+|+.|+||+++++...-++||+.+.
T Consensus 173 ~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 173 QLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12222210 12389999999999999977556899998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00075 Score=59.04 Aligned_cols=140 Identities=16% Similarity=0.219 Sum_probs=80.4
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceeeE------EeecCCceEEEEe
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLVG------FCSEGSNRLLVYE 109 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~------~~~~~~~~~lv~e 109 (325)
.+.+..|....+|+.... +..+++|.... .....+..|+.+++.+.+.+ +.+++. +...++..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456788888899997654 44688887654 23445667888887775332 334433 1223456689999
Q ss_pred ecCCCCHHH-----------HHhh---ccCCC----------CHHHH----------HHHHHHHHHHHHHhhc----cCC
Q 047716 110 FMRNGSLGN-----------LLFR---AEQRL----------SWSER----------RRIALEIMEGLHYLHD----ECE 151 (325)
Q Consensus 110 ~~~~~~L~~-----------~~~~---~~~~~----------~~~~~----------~~~~~ql~~~l~~lh~----~~~ 151 (325)
+++|..+.. .+.+ ....+ .+... ......+..++..+.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865422 0100 00000 00000 0001112222333332 112
Q ss_pred CCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 152 TRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 152 ~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
.+++|+|+.|.|+++++++.+.++||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999998667899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00066 Score=55.17 Aligned_cols=137 Identities=27% Similarity=0.375 Sum_probs=93.1
Q ss_pred cccccccccHHHHHHHHHhhhhhcCcCCc-eeEEEEEeCCCcEEEEEEeeccc-----------h----------hcHHH
Q 047716 18 EEIKLRSFSYEQIVLASENFKEEIGRGGS-GRVYKGCINGGKEIAVKKLIKIV-----------E----------EGESE 75 (325)
Q Consensus 18 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~-g~v~~~~~~~~~~~~vk~~~~~~-----------~----------~~~~~ 75 (325)
++-+.++|+. ...++++++.||.|.. |.||++... |..+|+|.+.... . .-...
T Consensus 25 ~gPKL~~F~~---h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 25 PGPKLEPFTH---HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCCCcCCcCC---CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 5556677777 2388999999999999 999999886 6699999943200 0 01123
Q ss_pred HHHHHHHHhccC---CCCc--ceeeEEeecC------------------CceEEEEeecCCCCHHHHHhhccCCCCHHHH
Q 047716 76 FRNEMKIIGRIH---HKNL--VDLVGFCSEG------------------SNRLLVYEFMRNGSLGNLLFRAEQRLSWSER 132 (325)
Q Consensus 76 ~~~e~~~l~~l~---h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 132 (325)
+..|.++..+|+ +.++ ++++++..-. ....||.||.+... .+....
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~- 169 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD- 169 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH-
Confidence 566777766664 5566 8999987221 12356777764432 223333
Q ss_pred HHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 133 RRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 133 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
+.++.+-+..+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 170 ---~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 ---IPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---HHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 45566677789998 9999999999964 3489999853
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00014 Score=62.90 Aligned_cols=136 Identities=15% Similarity=0.171 Sum_probs=92.9
Q ss_pred HhhhhhcCcCCceeEEEEEeCCCcEEEEEEeec--cc----h----------------hcHHHHHHHHHHHhccCCC--C
Q 047716 35 ENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IV----E----------------EGESEFRNEMKIIGRIHHK--N 90 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~--~~----~----------------~~~~~~~~e~~~l~~l~h~--~ 90 (325)
+-++.+||-|.-+-||.+-+..|.+.++|.=.- .+ . -+.-...+|...|+.|... -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 556789999999999999988888888874210 00 0 0112245677888777532 3
Q ss_pred cceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC
Q 047716 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170 (325)
Q Consensus 91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~ 170 (325)
+.+.+++ +..++||+.+.+..|.+.- .-.+...+ ...+...+--|-.. |++|||++-=||+|++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~----~v~d~~~l---y~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVR----HVEDPPTL---YDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeee----ecCChHHH---HHHHHHHHHHHHHc---CceecccchheeEEecCC
Confidence 4444444 4557899999887776543 12233333 33444455566676 999999999999999999
Q ss_pred cEEEeecccccccc
Q 047716 171 KAKISDFGLSKLLK 184 (325)
Q Consensus 171 ~vkl~Dfg~~~~~~ 184 (325)
.++++||.......
T Consensus 240 ~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 240 KIVVIDFPQMVSTS 253 (465)
T ss_pred CEEEeechHhhccC
Confidence 99999998665443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0053 Score=54.06 Aligned_cols=145 Identities=17% Similarity=0.212 Sum_probs=80.0
Q ss_pred HHhh-----hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceeeEE------eec
Q 047716 34 SENF-----KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLVGF------CSE 100 (325)
Q Consensus 34 ~y~~-----~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~ 100 (325)
.|.+ ++.++.|....+|+.... +..+++|..... .....+..|.+++..|...+ +.+++.. ...
T Consensus 18 ~y~~~~~~~i~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 18 GYDLGELLSLKGIAEGVENSNYLLTTD-VGRYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred hcCCCCceeccccCCccccceEEEEeC-CCcEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 5655 346777777899998654 445778865442 12334556677777764222 3333321 122
Q ss_pred CCceEEEEeecCCCCHH-----------HHHhhc---cCCCC-------HHHHH----------------HHHHHHHHHH
Q 047716 101 GSNRLLVYEFMRNGSLG-----------NLLFRA---EQRLS-------WSERR----------------RIALEIMEGL 143 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~-----------~~~~~~---~~~~~-------~~~~~----------------~~~~ql~~~l 143 (325)
.+..+++++|++|..+. ..+.+. ...++ ....+ .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999875431 111100 00000 00000 0011122234
Q ss_pred HHhhc----cCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 144 HYLHD----ECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 144 ~~lh~----~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
.++.. ....+++|+|+++.|+++++++.+.++||+.+.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 44432 112489999999999999988767899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0017 Score=57.01 Aligned_cols=74 Identities=22% Similarity=0.305 Sum_probs=47.0
Q ss_pred hhcCcCCceeEEEEEeCC-------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEee
Q 047716 39 EEIGRGGSGRVYKGCING-------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~-------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~ 110 (325)
+.+..|-...+|+....+ ++.+++|...... ........|..+++.+...++. +++.++. + .+|++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 456678888999987654 4677888754432 2334566788888888644443 4444443 2 358898
Q ss_pred cCCCCHH
Q 047716 111 MRNGSLG 117 (325)
Q Consensus 111 ~~~~~L~ 117 (325)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 8876553
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0065 Score=52.75 Aligned_cols=72 Identities=18% Similarity=0.304 Sum_probs=45.8
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC---CCCcceeeEEeecCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH---HKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
+.++.|....+|+.. .+++.+++|.-.. .....+..|..-|+.|. .-.+.+++.+....+..++++||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468889999999876 6678899998652 22345677888888884 335678888887777779999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0042 Score=55.96 Aligned_cols=74 Identities=19% Similarity=0.193 Sum_probs=49.6
Q ss_pred hhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc------hhcHHHHHHHHHHHhccC--CCCcc-eeeEEeecCCceEEE
Q 047716 38 KEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV------EEGESEFRNEMKIIGRIH--HKNLV-DLVGFCSEGSNRLLV 107 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~------~~~~~~~~~e~~~l~~l~--h~~iv-~~~~~~~~~~~~~lv 107 (325)
.+.||.|....||++.+. +++.++||.-.... .-...+..-|.+.|+.+. .|..+ +++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 457899999999999875 36778888654321 234455667888888775 45444 45554 33455688
Q ss_pred EeecCC
Q 047716 108 YEFMRN 113 (325)
Q Consensus 108 ~e~~~~ 113 (325)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0094 Score=52.26 Aligned_cols=138 Identities=22% Similarity=0.335 Sum_probs=80.6
Q ss_pred hhhhcCcCCceeEEEEEeCCCcEEEEEEeec--cchhcHHHHHHHHHHHhccCCC--CcceeeEEeecCC--ceEEEEee
Q 047716 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHK--NLVDLVGFCSEGS--NRLLVYEF 110 (325)
Q Consensus 37 ~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~--~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~--~~~lv~e~ 110 (325)
+.+....|....+|..... ++.+++. ... ..........+|+.+++.+..- -+...++.+.++. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3344444545556655444 6677777 331 2334455567788888888642 2334455555544 66999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHH-HHHHHHHHHhh------------------------------------------
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIA-LEIMEGLHYLH------------------------------------------ 147 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~-~ql~~~l~~lh------------------------------------------ 147 (325)
+.|..+.+-.... ... ..++ ..++..|.-||
T Consensus 107 veGe~~~~~~~~~--~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 107 VEGEVVWSALPPE--SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred ecceeccCcCCcc--cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 9874322211000 000 1111 13333333333
Q ss_pred --------cc-----CCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 148 --------DE-----CETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 148 --------~~-----~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
.+ ....++|||+++.|+++++++-+-++||+++..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 21 124589999999999999998899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.012 Score=52.37 Aligned_cols=72 Identities=22% Similarity=0.239 Sum_probs=47.2
Q ss_pred hcCcCCceeEEEEEeCCC-cEEEEEEeeccc-------hhcHHHHHHHHHHHhccC--CCCcc-eeeEEeecCCceEEEE
Q 047716 40 EIGRGGSGRVYKGCINGG-KEIAVKKLIKIV-------EEGESEFRNEMKIIGRIH--HKNLV-DLVGFCSEGSNRLLVY 108 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~~-~~~~vk~~~~~~-------~~~~~~~~~e~~~l~~l~--h~~iv-~~~~~~~~~~~~~lv~ 108 (325)
.+|.|....||++...++ +.++||.-.... .-......-|...|+... .|..+ +++.+ +.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999987644 588898654321 223344556778887765 45444 44444 334556899
Q ss_pred eecCC
Q 047716 109 EFMRN 113 (325)
Q Consensus 109 e~~~~ 113 (325)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.018 Score=52.32 Aligned_cols=73 Identities=12% Similarity=0.182 Sum_probs=49.0
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccch-------hcHHHHHHHHHHHhccC--C-CCcceeeEEeecCCceEEE
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE-------EGESEFRNEMKIIGRIH--H-KNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~-------~~~~~~~~e~~~l~~l~--h-~~iv~~~~~~~~~~~~~lv 107 (325)
.+.+|.|....||+.... ++.++||.-..... -.......|...|+.+. . .++.+++.++. ....++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 457899999999998764 56788887652111 12333445677776664 2 36777888876 346788
Q ss_pred EeecCC
Q 047716 108 YEFMRN 113 (325)
Q Consensus 108 ~e~~~~ 113 (325)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0018 Score=59.44 Aligned_cols=166 Identities=17% Similarity=0.219 Sum_probs=93.0
Q ss_pred cHHHHHHHHHHHhccCCCCcceeeEEeecC-CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC
Q 047716 72 GESEFRNEMKIIGRIHHKNLVDLVGFCSEG-SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150 (325)
Q Consensus 72 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 150 (325)
....+.-....++.+.|+|...++++.... ....+|+|++ +.+|.+...... +...... | |
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~--------~----~--- 86 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESLL--------A----H--- 86 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhhc--------c----c---
Confidence 344566678899999999999999987553 3478899998 679988873322 2111111 1 1
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh
Q 047716 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230 (325)
Q Consensus 151 ~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 230 (325)
++.|-+ .+..+| .+++.. |-.. + +|+|||++|.++.++.-
T Consensus 87 --~~~~~~------------~~~~td-~~~t~~-------------------~~~~-~-----pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 87 --GVLHLN------------IIYITD-HFLTKY-------------------PSPI-G-----PKSDVWSLGFIILELYL 126 (725)
T ss_pred --ccceeh------------hhhccc-cccccC-------------------CCCC-C-----cchhhhhHHHHHHHHHH
Confidence 222211 233333 111100 1111 1 49999999999999999
Q ss_pred CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHH
Q 047716 231 CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQV 298 (325)
Q Consensus 231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 298 (325)
|...+......+....+. .....+.-...+...-....++.....++..+|+...|..||...++
T Consensus 127 ~~~l~~~~~~s~~l~~i~---k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 127 GISLEAELTESEYLEILL---KYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred hhHHHHHHHHHHHHHHHH---HhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 987765443332221111 11111110000000012223344668889999999999988865444
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0084 Score=49.32 Aligned_cols=117 Identities=19% Similarity=0.213 Sum_probs=69.1
Q ss_pred CCceeEEEEEeCCCcEEEEEEeec-cchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhh
Q 047716 44 GGSGRVYKGCINGGKEIAVKKLIK-IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR 122 (325)
Q Consensus 44 g~~g~v~~~~~~~~~~~~vk~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 122 (325)
++.++.-.++-+-| +..+|++.. +..-...-+..+.+++.++. .|+++..- ++....++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 34444444433332 344555543 23323445567788887764 34555422 34456788888843211
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 123 AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 123 ~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
...-.+.. =+.++.-.|+. .++..|||.+|+||+-++.|-+||.|-+..
T Consensus 142 -------~~~N~i~a-gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -------NFSNFITA-GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -------chhHHHHH-hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 01111111 13567778853 468999999999999999999999997754
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.02 Score=49.56 Aligned_cols=29 Identities=31% Similarity=0.587 Sum_probs=24.5
Q ss_pred CeeeccCCCCceEEcCCCc-EEEeeccccc
Q 047716 153 RIIHCDIKPHNILMDESWK-AKISDFGLSK 181 (325)
Q Consensus 153 ~i~h~di~p~nilv~~~~~-vkl~Dfg~~~ 181 (325)
.++|+|++|.||++++++. .-++||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 5899999999999997555 4699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.021 Score=51.09 Aligned_cols=137 Identities=19% Similarity=0.257 Sum_probs=76.7
Q ss_pred hcCcCCceeEEEEEeCC-----CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEeecCC
Q 047716 40 EIGRGGSGRVYKGCING-----GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~-----~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~ 113 (325)
.+..|-...+|++...+ ++.++++....... ..-...+|..+++.+...++. ++++++.. + .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 45568888999987542 35677776644332 222236788888888755554 34555533 2 57888877
Q ss_pred CCHHHH--------------Hh---hcc--C-C-C-CHHHHHHHHHHH-----------------HHHHHHh----hc-c
Q 047716 114 GSLGNL--------------LF---RAE--Q-R-L-SWSERRRIALEI-----------------MEGLHYL----HD-E 149 (325)
Q Consensus 114 ~~L~~~--------------~~---~~~--~-~-~-~~~~~~~~~~ql-----------------~~~l~~l----h~-~ 149 (325)
.++... +. ... . . . ....+..++.++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 655311 00 000 0 0 1 112222332221 1111111 11 1
Q ss_pred CCCCeeeccCCCCceEEcC-CCcEEEeeccccc
Q 047716 150 CETRIIHCDIKPHNILMDE-SWKAKISDFGLSK 181 (325)
Q Consensus 150 ~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~~~ 181 (325)
....++|+|+++.||++++ ++.+.++||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1236899999999999976 4679999998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.018 Score=51.27 Aligned_cols=73 Identities=15% Similarity=0.227 Sum_probs=43.9
Q ss_pred hhcCcCCceeEEEEEeCC----CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCING----GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~ 113 (325)
+.|..|=...+|+....+ +..++++....... ..-...+|..+++.+..-++. ++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345557778899886543 23677776644322 222345688888888755554 4455542 22 58888876
Q ss_pred CCH
Q 047716 114 GSL 116 (325)
Q Consensus 114 ~~L 116 (325)
..+
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.06 Score=47.43 Aligned_cols=30 Identities=20% Similarity=0.329 Sum_probs=27.3
Q ss_pred CCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 152 TRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 152 ~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
.+++|+|+.++|+++++++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 479999999999999999899999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.086 Score=47.84 Aligned_cols=74 Identities=15% Similarity=0.294 Sum_probs=42.6
Q ss_pred hcCcCCceeEEEEEeCCC--cEEEEE----EeeccchhcHHHHHHHHHHHhccCCCCcce-eeEEeecCCceEEEEeecC
Q 047716 40 EIGRGGSGRVYKGCINGG--KEIAVK----KLIKIVEEGESEFRNEMKIIGRIHHKNLVD-LVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~~--~~~~vk----~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~ 112 (325)
.+..|-.+.+|++...++ ..+.+| ++........-.-.+|+.+++.+...++-+ +++.+.. +++.||++
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIe 132 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVE 132 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEec
Confidence 455688889999875432 222222 221111111122356889999998666654 4555432 58999998
Q ss_pred CCCHH
Q 047716 113 NGSLG 117 (325)
Q Consensus 113 ~~~L~ 117 (325)
|.+|.
T Consensus 133 Gr~l~ 137 (383)
T PTZ00384 133 GNTMG 137 (383)
T ss_pred cccCC
Confidence 77653
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.27 Score=43.63 Aligned_cols=71 Identities=13% Similarity=0.135 Sum_probs=43.2
Q ss_pred CCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceee---E--EeecCCceEEEEeecCCCC
Q 047716 44 GGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLV---G--FCSEGSNRLLVYEFMRNGS 115 (325)
Q Consensus 44 g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~---~--~~~~~~~~~lv~e~~~~~~ 115 (325)
+.-..||.....++..+++|... ........+..|...+..|.... ++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r-~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYR-PERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcC-cccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34567888877777788888764 22234566777888887774221 22211 1 1223456788999987653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.12 Score=45.78 Aligned_cols=138 Identities=20% Similarity=0.297 Sum_probs=78.8
Q ss_pred hcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCc---ce---eeE----EeecCCceEEEEe
Q 047716 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL---VD---LVG----FCSEGSNRLLVYE 109 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i---v~---~~~----~~~~~~~~~lv~e 109 (325)
.|.+ .-..+|+....+++. ++|+.... .....+..|+..++.|...++ ++ .-| ........+.+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 567888887776666 77766543 556677788888888852221 12 111 1111136788999
Q ss_pred ecCCCCHHH-H-----------Hh---hccCC-----------CCHH-------------HHHHHHHHHHHHHHHhhcc-
Q 047716 110 FMRNGSLGN-L-----------LF---RAEQR-----------LSWS-------------ERRRIALEIMEGLHYLHDE- 149 (325)
Q Consensus 110 ~~~~~~L~~-~-----------~~---~~~~~-----------~~~~-------------~~~~~~~ql~~~l~~lh~~- 149 (325)
|++|..+.. . +. ..... ..+. .-.....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 998877662 1 00 00000 1111 0011222333333333332
Q ss_pred ----CCCC--eeeccCCCCceEEcCCCc-EEEeeccccc
Q 047716 150 ----CETR--IIHCDIKPHNILMDESWK-AKISDFGLSK 181 (325)
Q Consensus 150 ----~~~~--i~h~di~p~nilv~~~~~-vkl~Dfg~~~ 181 (325)
...+ ++|+|+.|+||+++.+.. +-++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1123 999999999999999875 8899998653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.22 Score=51.14 Aligned_cols=152 Identities=16% Similarity=0.232 Sum_probs=84.0
Q ss_pred cHHHHHHHHHhhh---hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC-------CCCcceee
Q 047716 26 SYEQIVLASENFK---EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-------HKNLVDLV 95 (325)
Q Consensus 26 ~~~~~~~~~y~~~---~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-------h~~iv~~~ 95 (325)
...++....|.+. +.|+ |..-.+|+....++..+++|+..... ....+..+...|..|. -|.+++..
T Consensus 15 ~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~ 91 (1013)
T PRK06148 15 DAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSL 91 (1013)
T ss_pred HHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecC
Confidence 3445667777774 3564 45688899887777789999876532 2334444555665442 33333322
Q ss_pred -----EEeec-CC--ceEEEEeecCCCCHHHHH-------h-------h-------ccC-----CCCH------------
Q 047716 96 -----GFCSE-GS--NRLLVYEFMRNGSLGNLL-------F-------R-------AEQ-----RLSW------------ 129 (325)
Q Consensus 96 -----~~~~~-~~--~~~lv~e~~~~~~L~~~~-------~-------~-------~~~-----~~~~------------ 129 (325)
..... ++ ..+.+++|++|..+.+.. . + ... .+.|
T Consensus 92 ~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l 171 (1013)
T PRK06148 92 SGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRL 171 (1013)
T ss_pred CCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhh
Confidence 11111 22 457789999987665410 0 0 000 0001
Q ss_pred -----HHHHHHHHHHHHHHH-----HhhccCCCCeeeccCCCCceEEcCCC--cEE-Eeeccccc
Q 047716 130 -----SERRRIALEIMEGLH-----YLHDECETRIIHCDIKPHNILMDESW--KAK-ISDFGLSK 181 (325)
Q Consensus 130 -----~~~~~~~~ql~~~l~-----~lh~~~~~~i~h~di~p~nilv~~~~--~vk-l~Dfg~~~ 181 (325)
...+..+.+++.... .+.. ...+++|+|+++.||+++.++ .+. |+|||-+.
T Consensus 172 ~~i~d~~~r~~l~~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 172 HFIDDPEDRALVERFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred hhcCCHHHHHHHHHHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 111222223322221 1211 123799999999999998875 555 99999764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.059 Score=47.84 Aligned_cols=111 Identities=17% Similarity=0.182 Sum_probs=72.3
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...+++|++. |+++... ......++..++++.+..+.-+..+ -..-|+|+.-.||+++ +|+|.|+||-+++
T Consensus 299 ~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence 3457777776 5555322 3356778888999988888888776 5789999999999999 8899999999987
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCC
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 232 (325)
.. ....-.. ....-.|-.+++ .-+.+-+||-+ |-.|+.|+
T Consensus 370 l~-~~q~~is-----y~rldhp~lF~G--~dd~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 370 LS-YSQGIIS-----YNRLDHPDLFNG--VDDYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred cc-cCCceee-----ccccCchhhhcC--ccceeeeHHHH---HHHHhcCc
Confidence 32 2211111 112223444532 22556777773 44455555
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.0017 Score=66.80 Aligned_cols=156 Identities=8% Similarity=0.013 Sum_probs=104.1
Q ss_pred HHHHHhccCCCCcceeeEEeec--CCceEEEEeecCCCCHHHHHhhccCCCCHH--HHHHHHHHH-HHHHHHhhccC--C
Q 047716 79 EMKIIGRIHHKNLVDLVGFCSE--GSNRLLVYEFMRNGSLGNLLFRAEQRLSWS--ERRRIALEI-MEGLHYLHDEC--E 151 (325)
Q Consensus 79 e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~--~~~~~~~ql-~~~l~~lh~~~--~ 151 (325)
|...++...|+++.....-... ....+..++++.+|.+...+.+...+.+.. ......+++ +.+..-+|++. +
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 3334555678888777665533 345688899999999998885543332222 122223333 55555655542 2
Q ss_pred CCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhC
Q 047716 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCC 231 (325)
Q Consensus 152 ~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 231 (325)
.-.+|.++++-|.++..+-.++++++|+.+.... .....+...+++-|+.|+.. +.-.++.++|+|.+|+.++.+..|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~-N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIK-NEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHH-HHHhhhhHHHHHHHHHHHHHHhcc
Confidence 2368999999999999999999999999873222 11222222356667788876 556677779999999999999888
Q ss_pred CCCCC
Q 047716 232 RKNVD 236 (325)
Q Consensus 232 ~~p~~ 236 (325)
..+|-
T Consensus 1437 n~~fi 1441 (2724)
T KOG1826|consen 1437 NAYFI 1441 (2724)
T ss_pred cHHHH
Confidence 87763
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.068 Score=48.17 Aligned_cols=60 Identities=18% Similarity=0.196 Sum_probs=39.7
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD 167 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~ 167 (325)
..++=+|..|.++..++... ..++.....++.-.+.|+..+--- -+++|.|++|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 35666677788888888433 334445555555555655443322 1899999999999994
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.77 Score=38.37 Aligned_cols=76 Identities=20% Similarity=0.270 Sum_probs=51.9
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC---CCCcceeeEEeecCCceEEEEeecCCC
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH---HKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
.+++..|.--..|...+ +..++.+|.=.. .....+..|+.-|+.|. .-.+.+++.+.....+.++|++|++.+
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34577777777777544 466788886322 22345666776666664 456778888888889999999999876
Q ss_pred CHH
Q 047716 115 SLG 117 (325)
Q Consensus 115 ~L~ 117 (325)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 543
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.70 E-value=0.059 Score=43.46 Aligned_cols=28 Identities=18% Similarity=0.332 Sum_probs=25.0
Q ss_pred CeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 153 RIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 153 ~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
-.+|+|+.|.|+++++++ ++++||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 579999999999998886 9999999874
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.67 E-value=0.16 Score=43.75 Aligned_cols=48 Identities=19% Similarity=0.298 Sum_probs=34.4
Q ss_pred HHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 133 RRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 133 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...+..+-.++.-.+.. ..-++|+|+.|+|++.++.+.++|+||..+.
T Consensus 135 ~~~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 135 RKKLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 33444444444444431 0148999999999999998899999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 325 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 343 bits (882), Expect = e-118
Identities = 116/294 (39%), Positives = 180/294 (61%), Gaps = 13/294 (4%)
Query: 22 LRSFSYEQIVLASENFKEE--IGRGGSGRVYKGCINGGKEIAVKKL-IKIVEEGESEFRN 78
L+ FS ++ +AS+NF + +GRGG G+VYKG + G +AVK+L + + GE +F+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 79 EMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF---RAEQRLSWSERRRI 135
E+++I H+NL+ L GFC + RLLVY +M NGS+ + L ++ L W +R+RI
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195
AL GL YLHD C+ +IIH D+K NIL+DE ++A + DFGL+KL+ T T +R
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 196 GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDES--LRDDEIVLIDWAHQC 253
GT G+ APE + + + K DV+ +GVMLLE++ ++ D + DD+++L+DW
Sbjct: 197 GTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 254 YEAGELQNLVSD---QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304
+ +L+ LV D Q + EE E L+++ L C + RP M +V+ M+EG
Sbjct: 256 LKEKKLEALV-DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-117
Identities = 103/315 (32%), Positives = 168/315 (53%), Gaps = 14/315 (4%)
Query: 8 SRQVSSPDVFEEIKLRSFSYEQIVLASENFKEE--IGRGGSGRVYKGCINGGKEIAVKKL 65
S + + A+ NF + IG G G+VYKG + G ++A+K+
Sbjct: 12 INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR 71
Query: 66 IKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE- 124
+G EF E++ + H +LV L+GFC E + +L+Y++M NG+L L+ ++
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 125 --QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182
+SW +R I + GLHYLH IIH D+K NIL+DE++ KI+DFG+SK
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 183 -LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241
+ DQT TV++GT GY PE + R+T K+DVYSFGV+L E++C R + +SL
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
Query: 242 DEIVLIDWAHQCYEAGELQNLVSD---QEDVNIEEFENLVKIGLWCVECELNLRPTMKQV 298
+ + L +WA + + G+L+ +V D + + E + C+ RP+M V
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIV-DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 299 IWMMEGIVPPHQNML 313
+W +E + ++++
Sbjct: 307 LWKLEYALRLQESVI 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-109
Identities = 106/306 (34%), Positives = 167/306 (54%), Gaps = 27/306 (8%)
Query: 19 EIKLRSFSYEQIVLASENFKEE--------IGRGGSGRVYKGCINGGKEIAVKKLIKIVE 70
+ + SFS+ ++ + NF E +G GG G VYKG +N +AVKKL +V+
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVD 67
Query: 71 ----EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR 126
E + +F E+K++ + H+NLV+L+GF S+G + LVY +M NGSL + L +
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127
Query: 127 --LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184
LSW R +IA G+++LH+ IH DIK NIL+DE++ AKISDFGL++ +
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 185 T-DQTRTYTVLRGTRGYTAPE-LHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD 242
QT + + GT Y APE L IT K+D+YSFGV+LLEI+ VDE +
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEH--RE 239
Query: 243 EIVLIDWAHQCY-EAGELQNLV-SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300
+L+D + E +++ + D + E + + C+ + N RP +K+V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 301 MMEGIV 306
+++ +
Sbjct: 300 LLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 8e-75
Identities = 67/307 (21%), Positives = 124/307 (40%), Gaps = 30/307 (9%)
Query: 25 FSYEQIVLASENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKI 82
E + S + E RG G V+K + + +AVK I ++ + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIF-PIQDKQSWQNEYEVYS 71
Query: 83 IGRIHHKNLVDLVGFCSEGSN----RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALE 138
+ + H+N++ +G G++ L+ F GSL + L +SW+E IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 139 IMEGLHYLHDECET-------RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191
+ GL YLH++ I H DIK N+L+ + A I+DFGL+ + ++
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 192 TVLR-GTRGYTAPEL----HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVL 246
T + GTR Y APE+ + ++ D+Y+ G++L E+ D + + +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 247 IDWAHQCYEAGELQNLVSDQ--------EDVNIEEFENLVKIGLWCVECELNLRPTMKQV 298
+ Q ++Q +V + L + C + + R + V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 299 IWMMEGI 305
+ +
Sbjct: 310 GERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-62
Identities = 68/200 (34%), Positives = 112/200 (56%), Gaps = 8/200 (4%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDL 94
KE+IG G G V++ +G ++AVK L++ E +EF E+ I+ R+ H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSERRRIALEIMEGLHYLHDECET 152
+G ++ N +V E++ GSL LL ++ R L R +A ++ +G++YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
I+H ++K N+L+D+ + K+ DFGLS+ LK + GT + APE+ R+
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEV-LRDEPS 216
Query: 213 TVKADVYSFGVMLLEIVCCR 232
K+DVYSFGV+L E+ +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-61
Identities = 66/231 (28%), Positives = 113/231 (48%), Gaps = 26/231 (11%)
Query: 17 FEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGES- 74
F + +L + + +I ++++IG+GG G V+KG + +A+K LI EGE+
Sbjct: 8 FPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 75 ------EFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLS 128
EF+ E+ I+ ++H N+V L G +V EF+ G L + L +
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIK 120
Query: 129 WSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK-----AKISDFGLSKLL 183
WS + R+ L+I G+ Y+ + I+H D++ NI + + AK++DFGLS+
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 184 KTDQTRTYTVLRGTRGYTAPE-LHSRNNRITVKADVYSFGVMLLEIVCCRK 233
+ + L G + APE + + T KAD YSF ++L I+
Sbjct: 178 --QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-61
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+E +GRG G V K K++A+K++ E F E++ + R++H N+V L G
Sbjct: 12 VEEVVGRGAFGVVCKAKWRA-KDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSERRRIALEIMEGLHYLHDECETRI 154
C LV E+ GSL N+L AE + + L+ +G+ YLH +
Sbjct: 69 ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 155 IHCDIKPHNILMDESWK-AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
IH D+KP N+L+ KI DFG + ++T T +G+ + APE+ + +
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----KGSAAWMAPEVF-EGSNYS 181
Query: 214 VKADVYSFGVMLLEIVCCRK 233
K DV+S+G++L E++ RK
Sbjct: 182 EKCDVFSWGIILWEVITRRK 201
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-59
Identities = 67/277 (24%), Positives = 129/277 (46%), Gaps = 26/277 (9%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDL 94
+ IG G G VYKG +G ++AVK L + F+NE+ ++ + H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+G+ + +V ++ SL + L +E + + IA + G+ YLH + I
Sbjct: 86 MGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLL-KTDQTRTYTVLRGTRGYTAPEL--HSRNNR 211
IH D+K +NI + E KI DFGL+ + + + L G+ + APE+ +N
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 212 ITVKADVYSFGVMLLEIVCCR---KNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268
+ ++DVY+FG++L E++ + N++ Q E +L D
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINN------------RDQIIEMVGRGSLSPDLSK 249
Query: 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
V + + ++ C++ + + RP+ +++ +E +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 9e-59
Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGES----EFRNEMKIIGRIHHKNLV 92
+E IG GG G+VY+ G E+AVK +E S R E K+ + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
L G C + N LV EF R G L +L + +R+ A++I G++YLHDE
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 153 RIIHCDIKPHNILMDES--------WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE 204
IIH D+K NIL+ + KI+DFGL++ + G + APE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAWMAPE 184
Query: 205 LHSRNNRITVKADVYSFGVMLLEIVCCR 232
+ R + + +DV+S+GV+L E++
Sbjct: 185 V-IRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-58
Identities = 77/336 (22%), Positives = 123/336 (36%), Gaps = 45/336 (13%)
Query: 25 FSYEQIVLASENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKI 82
+ + L +N K E IGRG G VYKG ++ + +AVK F NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVF---SFANRQNFINEKNI 58
Query: 83 --IGRIHHKNLVDLVGFCSEGS-----NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI 135
+ + H N+ + + LLV E+ NGSL L W R+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRL 116
Query: 136 ALEIMEGLHYLHDE------CETRIIHCDIKPHNILMDESWKAKISDFGLSKLL------ 183
A + GL YLH E + I H D+ N+L+ ISDFGLS L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 184 -KTDQTRTYTVLRGTRGYTAPEL------HSRNNRITVKADVYSFGVMLLEIV--CCRKN 234
++ GT Y APE+ + D+Y+ G++ EI C
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 235 VDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE---------DVNIEEFENLVKIGLWCV 285
ES+ + ++ ++Q LVS ++ N +L + C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 286 ECELNLRPTMKQVIWMMEGIVPPHQNMLTHPTSTNQ 321
+ + R T + M ++ + + + +
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-58
Identities = 66/293 (22%), Positives = 125/293 (42%), Gaps = 50/293 (17%)
Query: 37 FKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
E +G+G G+ K G+ + +K+LI+ EE + F E+K++ + H N++ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G + + E+++ G+L ++ + + WS+R A +I G+ YLH II
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR-------------GTRGYTA 202
H D+ HN L+ E+ ++DFGL++L+ ++T+ + G + A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262
PE+ K DV+SFG++L EI+ R N D +
Sbjct: 191 PEM-INGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFG--------------- 233
Query: 263 VSDQEDVNIEEF----------ENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
+N+ F + I + C + + RP+ ++ +E +
Sbjct: 234 ------LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-57
Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 15/204 (7%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVD 93
NF ++ SG ++KG G +I VK L +F E + H N++
Sbjct: 13 NFLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 94 LVGFCSE--GSNRLLVYEFMRNGSLGNLLFRAEQR-LSWSERRRIALEIMEGLHYLHDEC 150
++G C + L+ +M GSL N+L + S+ + AL++ G+ +LH
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL--HSR 208
E I + ++++DE A+IS + ++ + APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR------MYAPAWVAPEALQKKP 184
Query: 209 NNRITVKADVYSFGVMLLEIVCCR 232
+ AD++SF V+L E+V
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-57
Identities = 69/302 (22%), Positives = 126/302 (41%), Gaps = 48/302 (15%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDL 94
E IG+G G+VY G +G E+A++ + E+ F+ E+ + H+N+V
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+G C + ++ + +L +++ A+ L ++ R+IA EI++G+ YLH + I
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GI 151
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLK----TDQTRTYTVLRGTRGYTAPEL----- 205
+H D+K N+ D K I+DFGL + + + G + APE+
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 206 ---HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA------ 256
+ +DV++ G + E+ + Q EA
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE--------------WPFKTQPAEAIIWQMG 256
Query: 257 -GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQNMLTH 315
G NL +E +++ +C E RPT +++ M+E + P L+H
Sbjct: 257 TGMKPNLSQIGMG---KEISDILL---FCWAFEQEERPTFTKLMDMLEKL-PKRNRRLSH 309
Query: 316 PT 317
P
Sbjct: 310 PG 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-50
Identities = 67/306 (21%), Positives = 127/306 (41%), Gaps = 35/306 (11%)
Query: 28 EQIVLASE-NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKI--IG 84
Q +A + ++IG+G G V+ G G +++AVK E+ + E +I
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRG-EKVAVKVFF---TTEEASWFRETEIYQTV 86
Query: 85 RIHHKNLVDLVGFCSEGSNR----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIM 140
+ H+N++ + +G+ L+ ++ NGSL + L L ++A +
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSV 144
Query: 141 EGLHYLHDECETR-----IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL- 194
GL +LH E + I H D+K NIL+ ++ I+D GL+ +D
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 195 --RGTRGYTAPEL-----HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI 247
GT+ Y PE+ + + + + AD+YSFG++L E+ R + + ++
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV-ARRCVSGGIVEEYQLPYH 263
Query: 248 DWAHQCYEAGELQNLVSDQED-----VNIEEFENLVKIGLWCVEC---ELNLRPTMKQVI 299
D +++ +V ++ E L ++G EC R T +V
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 300 WMMEGI 305
+ +
Sbjct: 324 KTLAKM 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-49
Identities = 67/299 (22%), Positives = 123/299 (41%), Gaps = 40/299 (13%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKI--IGRIHHKNLVDL 94
+E IG+G G V++G G +E+AVK E + E +I + H+N++
Sbjct: 46 LQESIGKGRFGEVWRGKWRG-EEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGF 101
Query: 95 VGFCSEGSNR----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+ ++ + LV ++ +GSL + L R ++ ++AL GL +LH E
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 151 ETR-----IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL---RGTRGYTA 202
I H D+K NIL+ ++ I+D GL+ + GT+ Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 203 PEL-----HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257
PE+ + ++ +AD+Y+ G++ EI R ++ D ++ D
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEI-ARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 258 ELQNLVSDQ--------EDVNIEEFENLVKIGLWCVEC---ELNLRPTMKQVIWMMEGI 305
E++ +V +Q + E + KI EC R T ++ + +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKI---MRECWYANGAARLTALRIKKTLSQL 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-49
Identities = 63/302 (20%), Positives = 112/302 (37%), Gaps = 46/302 (15%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKI--IGRIHHKNLVDL 94
E +G+G G V++G G + +AVK E + E ++ + H+N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQG-ENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 95 VGFCSEGSNR----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+ + L+ + GSL + L L RI L I GL +LH E
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 151 ETR-----IIHCDIKPHNILMDESWKAKISDFGLSKLL---KTDQTRTYTVLRGTRGYTA 202
I H D+K NIL+ ++ + I+D GL+ + GT+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 203 PEL-----HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257
PE+ + D+++FG++L E+ R + + D + D
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV-ARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 258 ELQNLVSDQ-----------EDVNIEEFENLVKIGLWCVEC---ELNLRPTMKQVIWMME 303
+++ +V D + L+K EC + R T ++ +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK------ECWYQNPSARLTALRIKKTLT 298
Query: 304 GI 305
I
Sbjct: 299 KI 300
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 37 FKEEIGRGGSGRVYKGC-INGGKEIAVK--KLIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
F EIGRG VYKG E+A + K+ + F+ E +++ + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 94 LVGFC---SEGSNRLLVY-EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
+G +++ E M +G+L L + + + R +I++GL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 150 CETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
IIH D+K NI + + KI D GL+ L + + + GT + APE++
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204
Query: 209 NNRITVKADVYSFGVMLLEIV 229
DVY+FG+ +LE+
Sbjct: 205 K--YDESVDVYAFGMCMLEMA 223
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 37 FKEEIGRGGSGRVYKGCINGGK-EIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDL 94
E+IGRG G V+ G + +AVK + + + +++F E +I+ + H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+G C++ +V E ++ G L RL ++ + G+ YL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCC 234
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY----TAPELHSRNN 210
IH D+ N L+ E KISDFG+S+ Y G R TAPE
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWTAPEA-LNYG 290
Query: 211 RITVKADVYSFGVMLLEIV 229
R + ++DV+SFG++L E
Sbjct: 291 RYSSESDVWSFGILLWETF 309
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
F +E+G G G V G G ++A+K + K E EF E K++ + H+ LV L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
C++ ++ E+M NG L N L R + + ++ E + YL + + +H
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRNNRI 212
D+ N L+++ K+SDFGLS+ + D+ YT G++ ++ PE L ++
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLM--YSKF 198
Query: 213 TVKADVYSFGVMLLEIV 229
+ K+D+++FGV++ EI
Sbjct: 199 SSKSDIWAFGVLMWEIY 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 58/275 (21%), Positives = 102/275 (37%), Gaps = 32/275 (11%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDL 94
K+ +G G G + + +++AVK+++ E S E++++ H N++
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRY 83
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ + + E +L + + + E + + GL +LH I
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNI 139
Query: 155 IHCDIKPHNILMDES-----WKAKISDFGLSKLLKTDQTRTYTV--LRGTRGYTAPEL-- 205
+H D+KPHNIL+ KA ISDFGL K L + + GT G+ APE+
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 206 HSRNNRITVKADVYSFGVMLLEIVCCRK--NVDESLRDDEIVLIDWAHQCYEAGELQNLV 263
T D++S G + ++ R I+L G
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL----------GACSLDC 249
Query: 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQV 298
E L++ + + RP+ K V
Sbjct: 250 LHPEKHEDVIARELIE---KMIAMDPQKRPSAKHV 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-38
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
F +EIG G G V+ G ++A+K + + E +F E +++ ++ H LV L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
C E + LV EFM +G L + L + + L++ EG+ YL + +IH
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 127
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRNNRI 212
D+ N L+ E+ K+SDFG+++ + DQ YT GT+ + +PE +R
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFS--FSRY 182
Query: 213 TVKADVYSFGVMLLEIV 229
+ K+DV+SFGV++ E+
Sbjct: 183 SSKSDVWSFGVLMWEVF 199
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+E+G G G V G G ++AVK + K E EF E + + ++ H LV G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
CS+ +V E++ NG L N L + L S+ + ++ EG+ +L + IH
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRNNRI 212
D+ N L+D K+SDFG+++ + DQ Y GT+ ++APE H +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFH--YFKY 182
Query: 213 TVKADVYSFGVMLLEIV 229
+ K+DV++FG+++ E+
Sbjct: 183 SSKSDVWAFGILMWEVF 199
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-37
Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 14/222 (6%)
Query: 12 SSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCING--GKEIAVKKLIKIV 69
S+ + E L + YE + +G+G G VY G + IA+K++ +
Sbjct: 4 STEEGDCESDLLEYDYE---YDENGDRVVLGKGTYGIVYAG-RDLSNQVRIAIKEIPERD 59
Query: 70 EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSW 129
E+ + + HKN+V +G SE + E + GSL LL L
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 130 SER--RRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTD 186
+E+ +I+EGL YLHD +I+H DIK N+L++ S KISDFG SK L
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176
Query: 187 QTRTYTVLRGTRGYTAPE-LHSRNNRITVKADVYSFGVMLLE 227
T T GT Y APE + AD++S G ++E
Sbjct: 177 NPCTETF-TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 50/236 (21%), Positives = 101/236 (42%), Gaps = 29/236 (12%)
Query: 12 SSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVK--KLIKIV 69
+ F+ + ++ Y + ++IG GGS +V++ + A+K L +
Sbjct: 15 TENLYFQSMSVKGRIYSIL--------KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 66
Query: 70 EEGESEFRNEMKIIGRIHHKNL--VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRL 127
+ +RNE+ + ++ + + L + +V E N L + L + ++ +
Sbjct: 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSI 124
Query: 128 SWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187
ER+ ++E +H +H I+H D+KP N L+ + K+ DFG++ ++ D
Sbjct: 125 DPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180
Query: 188 TRTY-TVLRGTRGYTAPEL----------HSRNNRITVKADVYSFGVMLLEIVCCR 232
T GT Y PE ++I+ K+DV+S G +L + +
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-37
Identities = 61/231 (26%), Positives = 112/231 (48%), Gaps = 23/231 (9%)
Query: 11 VSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGC-----INGGKEIAVKKL 65
VS E+ F + ++G G G+V N G+++AVK L
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKR-----IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL 58
Query: 66 IKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR--LLVYEFMRNGSLGNLLFR 122
++ + E++I+ ++H+N+V G C+E L+ EF+ +GSL L +
Sbjct: 59 KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK 118
Query: 123 AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182
+ +++ ++ + A++I +G+ YL + +H D+ N+L++ + KI DFGL+K
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
Query: 183 LKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
++TD+ YTV + APE + +DV+SFGV L E++
Sbjct: 176 IETDKE-YYTVKDDRDSPVFWYAPE--CLMQSKFYIASDVWSFGVTLHELL 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 66/198 (33%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 37 FKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
K ++G G G VY+G +AVK L + E E EF E ++ I H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 282
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRI 154
G C+ ++ EFM G+L + L Q +S +A +I + YL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNR 211
IH ++ N L+ E+ K++DFGLS+L+ D YT G + +TAPE N+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL-AYNK 395
Query: 212 ITVKADVYSFGVMLLEIV 229
++K+DV++FGV+L EI
Sbjct: 396 FSIKSDVWAFGVLLWEIA 413
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-36
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 37 FKEEIGRGGSGRVYKGCING-----GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL 91
F +++G+G G V + G+ +AVKKL EE +F E++I+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 92 VDLVGFCSEGSNR--LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
V G C R L+ E++ GSL + L + ++R+ + + +I +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 131
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPE-L 205
R IH D+ NIL++ + KI DFGL+K+L D+ + V + APE L
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-FFKVKEPGESPIFWYAPESL 189
Query: 206 HSRNNRITVKADVYSFGVMLLEIV 229
+ +V +DV+SFGV+L E+
Sbjct: 190 TES--KFSVASDVWSFGVVLYELF 211
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKE-----IAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL 91
+ ++G+G G V + + +AVK+L + + +F+ E++I+ +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 92 VDLVGFCSEGSNR--LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
V G + LV E++ +G L + L R RL S + +I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-- 144
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPELH 206
R +H D+ NIL++ KI+DFGL+KLL D+ Y V + + APE
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVREPGQSPIFWYAPE-- 200
Query: 207 SRNNRI-TVKADVYSFGVMLLEIV 229
S ++ I + ++DV+SFGV+L E+
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELF 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 37 FKEEIGRGGSGRVYKGCING-----GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL 91
F +++G+G G V + G+ +AVKKL EE +F E++I+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 92 VDLVGFCSEGSNR--LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
V G C R L+ E++ GSL + L + ++R+ + + +I +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPE-L 205
R IH D+ NIL++ + KI DFGL+K+L D+ Y V + APE L
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-YYKVKEPGESPIFWYAPESL 220
Query: 206 HSRNNRITVKADVYSFGVMLLEIV 229
+ +V +DV+SFGV+L E+
Sbjct: 221 TES--KFSVASDVWSFGVVLYELF 242
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVK--KLIKIVEEGESEFRNEMKIIGRIHHKNL--VDL 94
++IG GGS +V++ + A+K L + + +RNE+ + ++ + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ +V E N L + L + ++ + ER+ ++E +H +H I
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQH---GI 129
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY-TVLRGTRGYTAPEL-------- 205
+H D+KP N L+ + K+ DFG++ ++ D T GT Y PE
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 206 --HSRNNRITVKADVYSFGVMLLEIVCCR 232
++I+ K+DV+S G +L + +
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 51/240 (21%), Positives = 100/240 (41%), Gaps = 29/240 (12%)
Query: 8 SRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVK--KL 65
+S E I ++ Y + ++IG GGS +V++ + A+K L
Sbjct: 39 DDDKASSSANECISVKGRIYSIL--------KQIGSGGSSKVFQVLNEKKQIYAIKYVNL 90
Query: 66 IKIVEEGESEFRNEMKIIGRIHHKNL--VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRA 123
+ + +RNE+ + ++ + + L + +V E N L + L +
Sbjct: 91 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KK 148
Query: 124 EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183
++ + ER+ ++E +H +H I+H D+KP N L+ + K+ DFG++ +
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQM 204
Query: 184 KTDQTRTY-TVLRGTRGYTAPEL----------HSRNNRITVKADVYSFGVMLLEIVCCR 232
+ D T G Y PE ++I+ K+DV+S G +L + +
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-36
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
+G+G G+V K + A+KK I+ EE S +E+ ++ ++H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 96 GFCSEGSNRL-------------LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
E N + + E+ NG+L +L+ E R+ +I+E
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR------- 195
L Y+H + IIH D+KP NI +DES KI DFGL+K + +
Sbjct: 129 LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 196 ------GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230
GT Y A E+ K D+YS G++ E++
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
++++G G G V+ N ++AVK + E F E ++ + H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA 250
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
++ ++ EFM GSL + L + + + +I EG+ ++ + I
Sbjct: 251 VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG---YTAPELHSRNNRI 212
H D++ NIL+ S KI+DFGL+++++ ++ YT G + +TAPE
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAI-NFGSF 362
Query: 213 TVKADVYSFGVMLLEIV 229
T+K+DV+SFG++L+EIV
Sbjct: 363 TIKSDVWSFGILLMEIV 379
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-36
Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 13/197 (6%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+ ++G+G G V+ G NG +A+K L E F E +++ ++ H+ LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 329
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
SE +V E+M GSL + L + L + +A +I G+ Y+ +
Sbjct: 330 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI 212
H D++ NIL+ E+ K++DFGL++L++ ++ YT +G + +TAPE R
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAA-LYGRF 441
Query: 213 TVKADVYSFGVMLLEIV 229
T+K+DV+SFG++L E+
Sbjct: 442 TIKSDVWSFGILLTELT 458
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-36
Identities = 61/229 (26%), Positives = 117/229 (51%), Gaps = 15/229 (6%)
Query: 7 ISRQVSSPDVFEEIKLRSFSYEQIVLASENFK--EEIGRGGSGRVYKGCINGGKEIAVKK 64
+ ++++ + + + + + + E+ + ++G+G G V+ G NG +A+K
Sbjct: 156 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT 215
Query: 65 LIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-FRA 123
L E F E +++ ++ H+ LV L SE +V E+M GSL + L
Sbjct: 216 LKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET 273
Query: 124 EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183
+ L + +A +I G+ Y+ +H D++ NIL+ E+ K++DFGL++L+
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 184 KTDQTRTYTVLRGTR---GYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
+ ++ YT +G + +TAPE R T+K+DV+SFG++L E+
Sbjct: 331 EDNE---YTARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELT 375
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKE-----IAVKKLIK-IVEEGESEFRNEMKIIGRIHHKN 90
++ IG G G VYKG + +A+K L E+ +F E I+G+ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
++ L G S+ +++ E+M NG+L L + S + + I G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--- 164
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRG------YTAPE 204
+H D+ NIL++ + K+SDFGLS++L+ D TYT T G +TAPE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRWTAPE 220
Query: 205 -LHSRNNRITVKADVYSFGVMLLEIV 229
+ R + T +DV+SFG+++ E++
Sbjct: 221 AISYR--KFTSASDVWSFGIVMWEVM 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 37 FKEEIGRGGSGRVYKGC--INGGKEI--AVKKLIKIV-EEGESEFRNEMKIIGRIHHKNL 91
++ IG G SG V G + G +++ A+K L E +F +E I+G+ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
+ L G + G ++V E+M NGSL L + + + + + + G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---D 169
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHS 207
+H D+ N+L+D + K+SDFGLS++L+ D G + +TAPE +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
R + +DV+SFGV++ E++
Sbjct: 229 R--TFSSASDVWSFGVVMWEVL 248
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-35
Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 37 FKEEIGRGGSGRVYKGCINGGK-EIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
K ++G G G VY+G +AVK L K EF E ++ I H NLV L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRI 154
G C+ ++ EFM G+L + L Q +S +A +I + YL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRNN 210
IH D+ N L+ E+ K++DFGLS+L+ D YT G + +TAPE L N
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLA--YN 187
Query: 211 RITVKADVYSFGVMLLEIV 229
+ ++K+DV++FGV+L EI
Sbjct: 188 KFSIKSDVWAFGVLLWEIA 206
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-35
Identities = 69/304 (22%), Positives = 121/304 (39%), Gaps = 49/304 (16%)
Query: 26 SYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGR 85
++EQ + ++ +G G SG V G+ +AVK+++ + E+K++
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTE 64
Query: 86 I-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSL------GNLLFRAEQRLSWSERRRIALE 138
H N++ + + E N +L N+ + + +
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 139 IMEGLHYLHDECETRIIHCDIKPHNILMD-------------ESWKAKISDFGLSKLLKT 185
I G+ +LH +IIH D+KP NIL+ E+ + ISDFGL K L +
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 186 DQTRTYTVLR---GTRGYTAPEL------HSRNNRITVKADVYSFGVMLLEIVCCRKN-- 234
Q+ T L GT G+ APEL R+T D++S G + I+ K+
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 235 VDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT 294
D+ R+ I+ + L + + I E +L+ ++ + RPT
Sbjct: 241 GDKYSRESNIIRGIF--------SLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPT 289
Query: 295 MKQV 298
+V
Sbjct: 290 AMKV 293
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 15/198 (7%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
E +G G G V+ G NG ++AVK L K F E ++ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
++ ++ E+M NGSL + L + +L+ ++ +A +I EG+ ++ + I
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRNNR 211
H D++ NIL+ ++ KI+DFGL++L++ ++ YT G + +TAPE ++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAIN--YGT 186
Query: 212 ITVKADVYSFGVMLLEIV 229
T+K+DV+SFG++L EIV
Sbjct: 187 FTIKSDVWSFGILLTEIV 204
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-35
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 37 FKEEIGRGGSGRVYKGCIN--GGKEI--AVKKLIK-IVEEGESEFRNEMKIIGRIHHKNL 91
+ +G G G V G + KEI A+K L E+ +F E I+G+ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
+ L G ++ ++V E+M NGSL + L + + + + + + I G+ YL D
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM-- 166
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHS 207
+H D+ NIL++ + K+SDFGL ++L+ D RG + +T+PE +
Sbjct: 167 -GYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
R + T +DV+S+G++L E++
Sbjct: 225 R--KFTSASDVWSYGIVLWEVM 244
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 57/230 (24%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 13 SPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKG----CINGGKEIAVKKLIKI 68
+ E+K +E++V + IG+G G VY G + A+K L +I
Sbjct: 4 DSALLAEVKDVLIPHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 69 VEEGE-SEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL-VYEFMRNGSLGNLLFRAEQR 126
E + F E ++ ++H N++ L+G + +M +G L + ++
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
+ + L++ G+ YL E + +H D+ N ++DES+ K++DFGL++ +
Sbjct: 121 PTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177
Query: 187 QTRTYTVLRGTRG------YTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
+ Y ++ R +TA E S T K+DV+SFGV+L E++
Sbjct: 178 E---YYSVQQHRHARLPVKWTALE--SLQTYRFTTKSDVWSFGVLLWELL 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 16/196 (8%)
Query: 38 KEEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+ +GRG G V++ G + AVKK +++ E E+ + +V L G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKK-VRL----EVFRVEELVACAGLSSPRIVPLYG 117
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
EG + E + GSLG L+ + L + +EGL YLH RI+H
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTR---RILH 173
Query: 157 CDIKPHNILMDES-WKAKISDFGLSKLLKTDQTRTYTV----LRGTRGYTAPELHSRNNR 211
D+K N+L+ +A + DFG + L+ D + + GT + APE+
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV-VMGKP 232
Query: 212 ITVKADVYSFGVMLLE 227
K D++S M+L
Sbjct: 233 CDAKVDIWSSCCMMLH 248
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKE-----IAVKKLIKIV-EEGESEFRNEMKIIGRIHHKN 90
++G G G+V C + + +AVK L + S ++ E+ I+ ++H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 91 LVDLVGFCSEGSNR--LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
++ G C + LV E++ GSL + L R + ++ A +I EG+ YLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLH- 151
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPEL 205
IH D+ N+L+D KI DFGL+K + Y V + APE
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPE- 207
Query: 206 HSRNNRI-TVKADVYSFGVMLLEIV 229
+DV+SFGV L E++
Sbjct: 208 -CLKEYKFYYASDVWSFGVTLYELL 231
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-34
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 38 KEEIGRGGSGRVYKGCINGGKE---IAVKKLIK-IVEEGESEFRNEMKIIGRIHHKNLVD 93
E+G G G V +G K+ +A+K L + + E E +I+ ++ + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L+G C +LV E G L L + + S + ++ G+ YL E
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRN 209
+H D+ N+L+ AKISDFGLSK L D + YT + + APE ++ R
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFR- 188
Query: 210 NRITVKADVYSFGVMLLEIV 229
+ + ++DV+S+GV + E +
Sbjct: 189 -KFSSRSDVWSYGVTMWEAL 207
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-34
Identities = 63/229 (27%), Positives = 112/229 (48%), Gaps = 22/229 (9%)
Query: 13 SPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE----IAVKKLIKI 68
+P++ + ++ +++ +F E IGRG G VY G + AVK L +I
Sbjct: 8 NPELVQAVQHVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 64
Query: 69 VEEGE-SEFRNEMKIIGRIHHKNLVDLVGFCSEGSN-RLLVYEFMRNGSLGNLLFRAEQR 126
+ GE S+F E I+ H N++ L+G C L+V +M++G L N +
Sbjct: 65 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 124
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
+ + L++ +G+ YL + +H D+ N ++DE + K++DFGL++ +
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181
Query: 187 QTRTYTVLRGTRG-----YTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
+ Y+V T + A E S + T K+DV+SFGV+L E++
Sbjct: 182 E--YYSVHNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELM 226
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 51/199 (25%), Positives = 78/199 (39%), Gaps = 12/199 (6%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRI-HHKNLVDL 94
+G G G V+K G+ AVK+ + + + E+ ++ H V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
EG L E SL L ++ + + L +LH + +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GL 178
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
+H D+KP NI + + K+ DFGL L T V G Y APEL
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDPRYMAPELL--QGSYGT 234
Query: 215 KADVYSFGVMLLEIVCCRK 233
ADV+S G+ +LE+ C +
Sbjct: 235 AADVFSLGLTILEVACNME 253
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFR---NEMKIIGRIHHKNLVDL 94
++IG G G+ G++ +K+ I I E E+ ++ + H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERR--RIALEIMEGLHYLHDECET 152
E + +V ++ G L + A++ + + E + ++I L ++HD
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR--- 144
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
+I+H DIK NI + + ++ DFG++++L + + GT Y +PE+ N
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEI-CENKPY 202
Query: 213 TVKADVYSFGVMLLEIVCCR 232
K+D+++ G +L E+ +
Sbjct: 203 NNKSDIWALGCVLYELCTLK 222
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFR----NEMKIIGRIHHKNLVD 93
++IGRG VY+ C+ G +A+KK ++I + +++ R E+ ++ +++H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKK-VQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSER--RRIALEIMEGLHYLHDEC 150
E + +V E G L ++ +Q+ ER + +++ L ++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
R++H DIKP N+ + + K+ D GL + + T ++++ GT Y +PE N
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER-IHEN 211
Query: 211 RITVKADVYSFGVMLLEIVCCR 232
K+D++S G +L E+ +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQ 233
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 67/246 (27%), Positives = 108/246 (43%), Gaps = 42/246 (17%)
Query: 11 VSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVKK 64
+ +P F + + IVL K E+G G G+V+ + +AVK
Sbjct: 24 IENPQYFSDACVHHIKRRDIVL-----KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA 78
Query: 65 LIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL---- 120
L + E +F+ E +++ + H+++V G C+EG L+V+E+MR+G L L
Sbjct: 79 LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 121 ----------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170
A L + +A ++ G+ YL +H D+ N L+ +
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGL 195
Query: 171 KAKISDFGLSKLL-KTDQTRTYTVLRGTRG-----YTAPELHSRNNRI-TVKADVYSFGV 223
KI DFG+S+ + TD R G R + PE S R T ++DV+SFGV
Sbjct: 196 VVKIGDFGMSRDIYSTDYYR-----VGGRTMLPIRWMPPE--SILYRKFTTESDVWSFGV 248
Query: 224 MLLEIV 229
+L EI
Sbjct: 249 VLWEIF 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGES-----EFRNEMKIIGRIHHKNL 91
IG G G V++G + A+ IK + S +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
V L+G +E + ++ E G L + L + L + A ++ L YL
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHS 207
R +H DI N+L+ + K+ DFGLS+ ++ TY + + APE ++
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINF 191
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
R R T +DV+ FGV + EI+
Sbjct: 192 R--RFTSASDVWMFGVCMWEIL 211
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 18/227 (7%)
Query: 13 SPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE----IAVKKLIKI 68
+P++ + ++ +++ +F E IGRG G VY G + AVK L +I
Sbjct: 72 NPELVQAVQHVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128
Query: 69 VEEGE-SEFRNEMKIIGRIHHKNLVDLVGFCSEGSN-RLLVYEFMRNGSLGNLLFRAEQR 126
+ GE S+F E I+ H N++ L+G C L+V +M++G L N +
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 188
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
+ + L++ +G+ +L + +H D+ N ++DE + K++DFGL++ +
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245
Query: 187 QTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
+ + G + + A E S + T K+DV+SFGV+L E++
Sbjct: 246 EFDSVHNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELM 290
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG--ESEFRNEMKIIGRIHHKNLVDL 94
+ IG+G G V G G ++AVK + + F E ++ ++ H NLV L
Sbjct: 197 LLQTIGKGEFGDVMLGDYRG-NKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 95 VGFCSEGSNRL-LVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+G E L +V E+M GSL + L R L + +L++ E + YL
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 308
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRN 209
+H D+ N+L+ E AK+SDFGL+K + + +TAPE R
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-------SSTQDTGKLPVKWTAPEAL-RE 360
Query: 210 NRITVKADVYSFGVMLLEIV 229
+ + K+DV+SFG++L EI
Sbjct: 361 KKFSTKSDVWSFGILLWEIY 380
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-33
Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 23/199 (11%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFR---NEMKIIGRIHHKNLVDLV 95
E+G G G V+K + +KLI +E + E++++ + +V
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 96 G-FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
G F S+G + E M GSL +L + R+ ++++ +++GL YL ++ +I
Sbjct: 98 GAFYSDG-EISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREKH--KI 153
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI-- 212
+H D+KP NIL++ + K+ DFG+S L ++ GTR Y +PE R+
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPE------RLQG 204
Query: 213 ---TVKADVYSFGVMLLEI 228
+V++D++S G+ L+E+
Sbjct: 205 THYSVQSDIWSMGLSLVEM 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-33
Identities = 57/308 (18%), Positives = 116/308 (37%), Gaps = 44/308 (14%)
Query: 29 QIVLASENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGR 85
+++ ++++ +++G GG V ++ G A+K+++ ++ E + E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 86 IHHKNLVDLVGFCSEGSNR----LLVYEFMRNGSLGNLLFRAEQ---RLSWSERRRIALE 138
+H N++ LV +C L+ F + G+L N + R + L+ + + L
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 139 IMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR--- 195
I GL +H H D+KP NIL+ + + + D G + L
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 196 -----GTRGYTAPEL--HSRNNRITVKADVYSFGVMLLEIVCCRKN--VDESLRDDEIVL 246
T Y APEL + I + DV+S G +L + + + D + L
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM-MFGEGPYDMVFQKGDSVAL 258
Query: 247 IDWAHQCYEAGELQNLVSDQEDVNI-EEFENLVKIGLWCVECELNLRPTMKQVI---WMM 302
+QN +S + L+ + + + RP + ++ +
Sbjct: 259 A-----------VQNQLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEAL 304
Query: 303 EGIVPPHQ 310
+ P
Sbjct: 305 QPPAPGQH 312
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-33
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV----- 92
E IG GG G+V+K GK IK V+ + E+K + ++ H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYV----IKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 93 -----------DLVGFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIM 140
S+ + EF G+L + R ++L + +I
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
+G+ Y+H + ++I+ D+KP NI + ++ + KI DFGL LK D RT + GT Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLRY 187
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIVCCRK 233
+PE + + D+Y+ G++L E++
Sbjct: 188 MSPEQ-ISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-33
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG-----ESEFRNEMKIIGRIHHKNL 91
+G G G VY+G K + +K ++ + +F +E I+ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
V L+G E ++ E G LG+ L R + L +L+I + + YL
Sbjct: 76 VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 131
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHS 207
+H DI NIL+ K+ DFGLS+ ++ + Y TR + +PE ++
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESINF 188
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
R R T +DV+ F V + EI+
Sbjct: 189 R--RFTTASDVWMFAVCMWEIL 208
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 21 KLRSFSYEQIVLASENFKEEIGRGGSGRVYKG-----CINGGKEIAVKKLIKIVEEGE-S 74
LR + + +G G G VYKG +A+K+L +
Sbjct: 8 LLRILKETEFKK-----IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK 62
Query: 75 EFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRR 134
E +E ++ + + ++ L+G C S L+ + M G L + + + +
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 135 IALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL 194
++I +G++YL + R++H D+ N+L+ KI+DFGL+KLL ++
Sbjct: 122 WCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHA 176
Query: 195 RGTR---GYTAPE-LHSRNNRITVKADVYSFGVMLLEIV 229
G + + A E + R T ++DV+S+GV + E++
Sbjct: 177 EGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELM 213
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 37 FKEEIGRGGSGRVYKGCINGGK--------EIAVKKLIKIVEEGESEFRNEMKIIGRIHH 88
F E +G+G +++KG E+ +K L K F ++ ++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
K+LV G C G +LV EF++ GSL L + + ++ + +A ++ +H+L +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 149 ECETRIIHCDIKPHNILMDESWK--------AKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
+IH ++ NIL+ K+SD G+S + R +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER-IP-W 183
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIV 229
PE + + D +SFG L EI
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 37 FKEEIGRGGSGRVYKGCIN--GGKEIAVK-----KLIKIVEEGESEFRNEMKIIGRIHHK 89
E IG+G V + CIN G++ AVK K + + E I + H
Sbjct: 28 LCEVIGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGN-LLFRAEQRLSWSER--RRIALEIMEGLHYL 146
++V+L+ S +V+EFM L ++ RA+ +SE +I+E L Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 147 HDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
HD IIH D+KPH +L+ + S K+ FG++ L + GT + AP
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 204 ELHSRNNRITVKADVYSFGVML 225
E+ + DV+ GV+L
Sbjct: 203 EV-VKREPYGKPVDVWGCGVIL 223
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 22/212 (10%)
Query: 36 NFKEEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNLVD 93
+ +G+G + V++G G A+K I + E +++ +++HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 94 LVGFCSEGSNRL--LVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDE 149
L E + R L+ EF GSL +L E + +++ G+++L +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 150 CETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
I+H +IKP NI+ D K++DFG ++ L+ D+ L GT Y P++
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHPDM 186
Query: 206 HSRNNRI-------TVKADVYSFGVMLLEIVC 230
+ R D++S GV
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 11/196 (5%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKL-IKIVEEGE--SEFRNEMKIIGRIHHKNLVDL 94
+++G GG VY ++A+K + I E+ E F E+ ++ H+N+V +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ E LV E++ +L + + LS +I++G+ + H + RI
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLL-KTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
+H DIKP NIL+D + KI DFG++K L +T T+T VL GT Y +PE ++
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPE-QAKGEATD 190
Query: 214 VKADVYSFGVMLLEIV 229
D+YS G++L E++
Sbjct: 191 ECTDIYSIGIVLYEML 206
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 26/230 (11%), Positives = 58/230 (25%), Gaps = 43/230 (18%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE---FRNEMKIIGRIHHKNLV 92
E + G V+ + ++ A+K E SE R+ ++
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 93 DLVGFC--------------------------SEGSNRLLVYEFMR--NGSLGNLLFR-- 122
+ +N LL+ L + L
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185
Query: 123 -AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181
+ +++ L + ++H P N+ + + + D
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 182 LLKTDQTRTYTVLRGTRGYTAPE-LHSRNNRITVKADVYSFGVMLLEIVC 230
+ T Y E L++ T + + G+ + + C
Sbjct: 243 KVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 10/194 (5%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEG-ESEFRNEMKIIGRIHHKNLVDLVG 96
+G+GG + ++ + + A K + K +++ + E+ I + H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
F + +V E R SL L + + L+ E R +I+ G YLH R+IH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIH 164
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKA 216
D+K N+ ++E + KI DFGL+ ++ D R + GT Y APE+ S+ + +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH-SFEV 222
Query: 217 DVYSFGVMLLEIVC 230
DV+S G ++ ++
Sbjct: 223 DVWSIGCIMYTLLV 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 25/201 (12%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEG--ESEFRNEMKIIGRIHHKNLVDL 94
+ IG+G G V G G ++AVK + + F E ++ ++ H NLV L
Sbjct: 25 LLQTIGKGEFGDVMLGDYRG-NKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 95 VGFCSEGSNRL-LVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+G E L +V E+M GSL + L R L + +L++ E + YL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSR 208
+H D+ N+L+ E AK+SDFGL+K + + +TAPE L +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-------SSTQDTGKLPVKWTAPEALREK 189
Query: 209 NNRITVKADVYSFGVMLLEIV 229
+ + K+DV+SFG++L EI
Sbjct: 190 --KFSTKSDVWSFGILLWEIY 208
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 49/246 (19%)
Query: 12 SSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVKKL 65
S V IVL K E+G G G+V+ +AVK L
Sbjct: 5 SGIHVQH------IKRRDIVL-----KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL 53
Query: 66 IKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL----- 120
+F+ E +++ + H+++V G C +G ++V+E+M++G L L
Sbjct: 54 KDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGP 113
Query: 121 ----------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170
+A+ L S+ IA +I G+ YL +H D+ N L+ +
Sbjct: 114 DAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL 170
Query: 171 KAKISDFGLSKLL-KTDQTRTYTVLRGTRG-----YTAPE-LHSRNNRITVKADVYSFGV 223
KI DFG+S+ + TD R G + PE + + T ++DV+SFGV
Sbjct: 171 LVKIGDFGMSRDVYSTDYYR-----VGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGV 223
Query: 224 MLLEIV 229
+L EI
Sbjct: 224 ILWEIF 229
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 10/194 (5%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEG-ESEFRNEMKIIGRIHHKNLVDLVG 96
+G+GG + ++ + + A K + K +++ + E+ I + H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
F + +V E R SL L + + L+ E R +I+ G YLH R+IH
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIH 138
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKA 216
D+K N+ ++E + KI DFGL+ ++ D R + GT Y APE+ S+ + +
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGH-SFEV 196
Query: 217 DVYSFGVMLLEIVC 230
DV+S G ++ ++
Sbjct: 197 DVWSIGCIMYTLLV 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRN---EMKIIGR-IHHKNLVDL 94
E+G G G+V+K + K ++ + E + ++ ++ + +V
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
G ++ + E M L R + + ++ + I++ L+YL ++ +
Sbjct: 90 FGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGV 146
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE----LHSRNN 210
IH D+KP NIL+DE + K+ DFG+S L D+ + + G Y APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKP 204
Query: 211 RITVKADVYSFGVMLLEI 228
++ADV+S G+ L+E+
Sbjct: 205 DYDIRADVWSLGISLVEL 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 30/209 (14%)
Query: 37 FKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIK---------IVEEGESEFRNEMKIIGR 85
KE +GRG S V + CI+ KE AVK + V+E E+ I+ +
Sbjct: 21 PKEILGRGVSSVVRR-CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 86 I-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIME 141
+ H N++ L + LV++ M+ G L F ++++ SE+ R+I ++E
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLE 135
Query: 142 GLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYT 201
+ LH I+H D+KP NIL+D+ K++DFG S L + GT Y
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYL 190
Query: 202 APE-----LHSRNNRITVKADVYSFGVML 225
APE ++ + + D++S GV++
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-32
Identities = 57/194 (29%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEG-ESEFRNEMKIIGRIHHKNLVDLVG 96
+G+G VY+ I+ G E+A+K + K + + G +NE+KI ++ H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ + + LV E NG + L + S +E R +I+ G+ YLH I+H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKA 216
D+ N+L+ + KI+DFGL+ LK + YT+ GT Y +PE+ +R+ +++
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAH-GLES 193
Query: 217 DVYSFGVMLLEIVC 230
DV+S G M ++
Sbjct: 194 DVWSLGCMFYTLLI 207
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKE-----IAVKKL-IKIVEEGESEFRNEMKIIGRIHHKN 90
+ +G G G V+KG E + +K + K + + M IG + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V L+G C S+ LV +++ GSL + + + L ++I +G++YL
Sbjct: 77 IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHS 207
E ++H ++ N+L+ + +++DFG++ LL D + + + A E S
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD--KQLLYSEAKTPIKWMALE--S 188
Query: 208 RNNRI-TVKADVYSFGVMLLEIV 229
+ T ++DV+S+GV + E++
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELM 211
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 40 EIGRGGSGRVYKGCINGGK---EIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDL 94
E+G G G V KG K +AVK L + E E ++ ++ + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+G C + +LV E G L L + + + + ++ G+ YL E+
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---ESNF 138
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRNN 210
+H D+ N+L+ AKISDFGLSK L+ D+ Y + + APE ++
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYY-- 195
Query: 211 RITVKADVYSFGVMLLEIV 229
+ + K+DV+SFGV++ E
Sbjct: 196 KFSSKSDVWSFGVLMWEAF 214
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 36 NFKEEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNLVD 93
+ +G+G + V++G G A+K I + E +++ +++HKN+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 94 LVGFCSEGSNRL--LVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDE 149
L E + R L+ EF GSL +L E + +++ G+++L +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 150 CETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
I+H +IKP NI+ D K++DFG ++ L+ D+ ++ GT Y P++
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-SLY-GTEEYLHPDM 186
Query: 206 HSRNNRI-------TVKADVYSFGVMLLEIVC 230
+ R D++S GV
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 47/199 (23%), Positives = 80/199 (40%), Gaps = 22/199 (11%)
Query: 39 EEIGRGGSGRVYKG--CINGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNLVDLV 95
I GG G +Y G+ + +K L+ + E + + + H ++V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 96 GFCSEGSNRL-----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
F +V E++ SL Q+L +E LEI+ L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLH--- 199
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
+++ D+KP NI++ E + K+ D G + + GT G+ APE+
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY-GTPGFQAPEIVR--T 251
Query: 211 RITVKADVYSFGVMLLEIV 229
TV D+Y+ G L +
Sbjct: 252 GPTVATDIYTVGRTLAALT 270
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGES-------EFRNEMKIIGRIHHK 89
E++G G G V +G + V +K ++ +F E+ + + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
NL+ L G +V E GSL + L + + R A+++ EG+ YL
Sbjct: 82 NLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE-- 138
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-L 205
R IH D+ N+L+ KI DFGL + L + Y + + + APE L
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPESL 196
Query: 206 HSRNNRITVKADVYSFGVMLLEIV 229
+R + +D + FGV L E+
Sbjct: 197 KTR--TFSHASDTWMFGVTLWEMF 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-32
Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 12/194 (6%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEG-ESEFRNEMKIIGRIHHKNLVDLVG 96
+G+G G VY +A+K L K + + G E + R E++I + H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ + + L+ E+ G++ L + + E+ L Y H R+IH
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCH---SKRVIH 132
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKA 216
DIKP N+L+ + + KI+DFG S + + L GT Y PE+ K
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD---LCGTLDYLPPEMIEGRMH-DEKV 188
Query: 217 DVYSFGVMLLEIVC 230
D++S GV+ E +
Sbjct: 189 DLWSLGVLCYEFLV 202
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKK--LIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
IG G GR K + GK + K+ + E + +E+ ++ + H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 96 G-FCSEGSNRL-LVYEFMRNGSLGNLLFRA-EQRLSWSERR--RIALEIMEGLHYLHDEC 150
+ L +V E+ G L +++ + ++R E R+ ++ L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 151 ET--RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
+ ++H D+KP N+ +D K+ DFGL+++L D + T + GT Y +PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQM-N 189
Query: 209 NNRITVKADVYSFGVMLLEIVC 230
K+D++S G +L E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCA 211
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 46/219 (21%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+ +GRGG G V++ A+K++ + E + E+K + ++ H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 97 FCSEGSNRL------------LVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEG 142
E + + + R +L + + I L+I E
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR------- 195
+ +LH + ++H D+KP NI K+ DFGL + D+ +
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 196 ----GTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230
GT+ Y +PE N + K D++S G++L E++
Sbjct: 188 TGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFELLY 225
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 38 KEEIGRGGSGRVYKGCINGGKE---IAVKKL-IKIVEEGESEFRNEMKIIGRIHHKNLVD 93
E+G G G V +G K+ +A+K L + E E +I+ ++ + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L+G C +LV E G L L + + S + ++ G+ YL E
Sbjct: 401 LIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHSRN 209
+H ++ N+L+ AKISDFGLSK L D + YT + + APE ++ R
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFR- 514
Query: 210 NRITVKADVYSFGVMLLEIV 229
+ + ++DV+S+GV + E +
Sbjct: 515 -KFSSRSDVWSYGVTMWEAL 533
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E+G G G+VYK G A K + EE ++ E++I+ H +V L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
++ EF G++ ++ ++ L+ + + + +++E L++LH + RIIH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHR 141
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL----HSRNNRIT 213
D+K N+LM +++DFG+S + + + GT + APE+ ++
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYD 200
Query: 214 VKADVYSFGVMLLE 227
KAD++S G+ L+E
Sbjct: 201 YKADIWSLGITLIE 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 52/192 (27%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 39 EEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
+IG G +G V G+++AVK + ++ NE+ I+ H N+V++
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
G ++ EF++ G+L +++ ++ RL+ + + +++ L YLH + +IH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHR 165
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
DIK +IL+ + K+SDFG + D + +++ GT + APE+ SR + + D
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR-SLYATEVD 223
Query: 218 VYSFGVMLLEIV 229
++S G+M++E+V
Sbjct: 224 IWSLGIMVIEMV 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 67/243 (27%), Positives = 114/243 (46%), Gaps = 44/243 (18%)
Query: 10 QVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVK 63
V PD +E + E+I + E+G+G G VY+G G + +A+K
Sbjct: 13 DVYVPDEWE------VAREKITM-----SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 64 KLIKIVEEGE-SEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-- 120
+ + E EF NE ++ + ++V L+G S+G L++ E M G L + L
Sbjct: 62 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 121 -------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAK 173
S S+ ++A EI +G+ YL+ + +H D+ N ++ E + K
Sbjct: 122 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 178
Query: 174 ISDFGLSKLL-KTDQTRTYTVLRGTRGY-----TAPELHSRNNRI-TVKADVYSFGVMLL 226
I DFG+++ + +TD R +G +G +PE S + + T +DV+SFGV+L
Sbjct: 179 IGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLW 231
Query: 227 EIV 229
EI
Sbjct: 232 EIA 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 54/238 (22%), Positives = 95/238 (39%), Gaps = 33/238 (13%)
Query: 13 SPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE----IAVKKLIK- 67
S ++ E+++ +Q L +G+G G V + + +AVK L
Sbjct: 8 SDELKEKLEDVLIPEQQFTL-----GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62
Query: 68 -IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR------LLVYEFMRNGSLGNLL 120
I EF E + H ++ LVG + +++ FM++G L L
Sbjct: 63 IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
Query: 121 -----FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175
L R ++I G+ YL IH D+ N ++ E ++
Sbjct: 123 LASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 176 DFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
DFGLS+ + + Y ++ + A E S + + TV +DV++FGV + EI+
Sbjct: 180 DFGLSRKIYSGD--YYRQGCASKLPVKWLALE--SLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 36 NFKEEIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
F E +G G V+ GK A+K + K +S NE+ ++ +I H+N+V
Sbjct: 12 IFMEVLGSGAFSEVFL-VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLHYLHDEC 150
L ++ LV + + G LF R +R ++E+ + +++ + YLH+
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHEN- 125
Query: 151 ETRIIHCDIKPHNIL---MDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
I+H D+KP N+L +E+ K I+DFGLSK+ + T GT GY APE+ +
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST---ACGTPGYVAPEVLA 180
Query: 208 RNNRITVKADVYSFGVML 225
+ + D +S GV+
Sbjct: 181 QKPY-SKAVDCWSIGVIT 197
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 50/202 (24%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKL-IKIVEEGE--SEFRNEMKIIGRIHHKNLVDL 94
E +G GG V+ + +++AVK L + + FR E + ++H +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 95 --VGFCSEGSNRL--LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
G + L +V E++ +L +++ E ++ + + + L++ H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH--- 133
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ---TRTYTVLRGTRGYTAPELHS 207
+ IIH D+KP NI++ + K+ DFG+++ + T+T V+ GT Y +PE +
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE-QA 191
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
R + + ++DVYS G +L E++
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVL 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 66/248 (26%), Positives = 101/248 (40%), Gaps = 42/248 (16%)
Query: 4 YKIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGK----- 58
Y + S D+ E + I L +G G G VY+G ++G
Sbjct: 12 YCFAGKTSSISDLKE------VPRKNITL-----IRGLGHGAFGEVYEGQVSGMPNDPSP 60
Query: 59 -EIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116
++AVK L ++ E+ E +F E II + +H+N+V +G + R ++ E M G L
Sbjct: 61 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120
Query: 117 GNLL------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170
+ L L+ + +A +I G YL E IH DI N L+
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 177
Query: 171 K---AKISDFGLSKLL-KTDQTRTYTVLRGTRGY-----TAPELHSRNNRITVKADVYSF 221
AKI DFG+++ + + R +G PE T K D +SF
Sbjct: 178 PGRVAKIGDFGMARDIYRASYYR-----KGGCAMLPVKWMPPEAF-MEGIFTSKTDTWSF 231
Query: 222 GVMLLEIV 229
GV+L EI
Sbjct: 232 GVLLWEIF 239
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 52/192 (27%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E+IG+G SG VY + G+E+A++++ + + NE+ ++ + N+V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
G +V E++ GSL +++ E + + + E ++ L +LH ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
DIK NIL+ K++DFG + +Q++ T++ GT + APE+ +R K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR-KAYGPKVD 198
Query: 218 VYSFGVMLLEIV 229
++S G+M +E++
Sbjct: 199 IWSLGIMAIEMI 210
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 37 FKEEIGRGGSGRVYKG-----CINGGKEIAVKKLIKIVEEGE-SEFRNEMKIIGRIHHKN 90
+ +G G G VYKG +A+K+L + E +E ++ + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+ L+G C S L+ + M G L + + + + ++I +G++YL
Sbjct: 79 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LH 206
+ R++H D+ N+L+ KI+DFGL+KLL ++ G + + A E +
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWMALESIL 192
Query: 207 SRNNRITVKADVYSFGVMLLEIV 229
R T ++DV+S+GV + E++
Sbjct: 193 HR--IYTHQSDVWSYGVTVWELM 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 8/190 (4%)
Query: 39 EEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E++G G G VYK G+ +A+K++ VE E E+ I+ + ++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
+ ++ +V E+ GS+ +++ + L+ E I ++GL YLH R IH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHR 149
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
DIK NIL++ AK++DFG++ L + TV+ GT + APE+ + AD
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV-IQEIGYNCVAD 207
Query: 218 VYSFGVMLLE 227
++S G+ +E
Sbjct: 208 IWSLGITAIE 217
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 29/208 (13%)
Query: 37 FKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIK--------IVEEGESEFRNEMKIIGRI 86
K+ IGRG S V + C++ G E AVK + +EE R E I+ ++
Sbjct: 98 PKDVIGRGVSSVVRR-CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 87 H-HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEG 142
H +++ L+ S LV++ MR G L F ++++ SE+ R I ++E
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEA 212
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
+ +LH I+H D+KP NIL+D++ + ++SDFG S L+ + + + GT GY A
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELC-GTPGYLA 267
Query: 203 PE-----LHSRNNRITVKADVYSFGVML 225
PE + + + D+++ GV+L
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-31
Identities = 54/237 (22%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 21 KLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVKKLIKIVEEGE- 73
KL+ S + EE+G G+VYKG + G +A+K L E
Sbjct: 2 KLKEISLSAVRF-----MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR 56
Query: 74 SEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL------------- 120
EFR+E + R+ H N+V L+G ++ +++ + +G L L
Sbjct: 57 EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 116
Query: 121 --FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFG 178
+ L + + +I G+ YL ++H D+ N+L+ + KISD G
Sbjct: 117 DDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLG 173
Query: 179 LSKLLKTDQTRTYTVLRGTRG-----YTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
L + + Y + + APE + ++ +D++S+GV+L E+
Sbjct: 174 LFREVYAAD--YYKL--LGNSLLPIRWMAPE--AIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE----IAVK--KLIKIVEEGESEFRN 78
++L + +G G G V +G + +AVK KL + EF +
Sbjct: 31 IDRNLLIL-----GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 79 EMKIIGRIHHKNLVDLVGFCSEGSNR-----LLVYEFMRNGSLGNLLFRA-----EQRLS 128
E + H N++ L+G C E S++ +++ FM+ G L L + + +
Sbjct: 86 EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 129 WSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188
+ ++I G+ YL +H D+ N ++ + ++DFGLSK + +
Sbjct: 146 LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD- 201
Query: 189 RTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
Y R + + A E S +R+ T K+DV++FGV + EI
Sbjct: 202 -YYRQGRIAKMPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 61/246 (24%), Positives = 92/246 (37%), Gaps = 56/246 (22%)
Query: 37 FKEEIGRGGSGRVYKGCIN--GGKEIAVK-----KLIKIVEEGESEFRNEMKIIGRIHHK 89
K IG+G G V I A+K K+ +I + + E++++ ++HH
Sbjct: 30 LKGAIGQGSYGVVRV-AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSL--------------------------------- 116
N+ L + LV E G L
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 117 ----GNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDECETRIIHCDIKPHNILM--DE 168
FR E+ I +I LHYLH++ I H DIKP N L ++
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 169 SWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPE-LHSRNNRITVKADVYSFGVM 224
S++ K+ DFGLSK Y + GT + APE L++ N K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 225 LLEIVC 230
L ++
Sbjct: 266 LHLLLM 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNL 91
+ KEE+G+G V + C++ G E A K + + + E +I ++ H N+
Sbjct: 9 DVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDE 149
V L E S LV++ + G L R +SE +I+E + Y H
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 150 CETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELH 206
I+H ++KP N+L+ + K++DFGL+ + + GT GY +PE+
Sbjct: 125 ---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV- 178
Query: 207 SRNNRITVKADVYSFGVML 225
+ + + D+++ GV+L
Sbjct: 179 LKKDPYSKPVDIWACGVIL 197
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
+G+G G VY +A+K L K + +EG R E++I + H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ + L+ EF G L L + R E+ + LHY H E ++IH
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH---ERKVIH 137
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKA 216
DIKP N+LM + KI+DFG S R T + GT Y PE+ K
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT-MCGTLDYLPPEMIE-GKTHDEKV 193
Query: 217 DVYSFGVMLLEIVC 230
D++ GV+ E +
Sbjct: 194 DLWCAGVLCYEFLV 207
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 29/237 (12%)
Query: 5 KIISRQVSSPDVFEEIKLRSFS--YEQIVLASENFKEEIGRGGSGRVYKG-CINGGKEIA 61
++ ++P +F + FS Y+ + +G+G G V G+E A
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFSDRYK--------GQRVLGKGSFGEVILCKDKITGQECA 55
Query: 62 VKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGN 118
VK + K + + E++++ ++ H N++ L F + LV E G G
Sbjct: 56 VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT-G--GE 112
Query: 119 LLFRAEQRLSWSER--RRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWKAK 173
L R +SE RI +++ G+ Y+H +I+H D+KP N+L+ + +
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIR 169
Query: 174 ISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230
I DFGLS + + + GT Y APE+ K DV+S GV+L ++
Sbjct: 170 IIDFGLSTHFEASKKMKDKI--GTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLS 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 41/234 (17%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVKKLIKIVEEGE-SEFR 77
F ++ + +G G G+V + G + +AVK L E
Sbjct: 20 FPRNRLSF-----GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 78 NEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL---------------- 120
+E+K++ + +H N+V+L+G C+ G L++ E+ G L N L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 121 -FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
E L + + ++ +G+ +L IH D+ NIL+ KI DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 180 SKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
++ +K D Y V R + APE S N + T ++DV+S+G+ L E+
Sbjct: 192 ARDIKNDS--NYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELF 241
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
+ EE+G G G V++ C+ G+ K + + +NE+ I+ ++HH L++
Sbjct: 54 DILEELGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L + +L+ EF+ G L + + + ++S +E + EGL ++H+
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---S 169
Query: 154 IIHCDIKPHNILM--DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
I+H DIKP NI+ ++ KI DFGL+ L D+ V T + APE+ R
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREP- 226
Query: 212 ITVKADVYSFGVML 225
+ D+++ GV+
Sbjct: 227 VGFYTDMWAIGVLG 240
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGES-----EFRNEMKIIGRIHHKNL 91
IG G G V++G + A+ IK + S +F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
V L+G +E + ++ E G L + L + L + A ++ L YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPE-LHS 207
R +H DI N+L+ + K+ DFGLS+ ++ TY + + APE ++
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINF 566
Query: 208 RNNRITVKADVYSFGVMLLEIV 229
R R T +DV+ FGV + EI+
Sbjct: 567 R--RFTSASDVWMFGVCMWEIL 586
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 67/249 (26%), Positives = 103/249 (41%), Gaps = 44/249 (17%)
Query: 4 YKIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGK----- 58
Y + S D+ E + I L +G G G VY+G ++G
Sbjct: 53 YCFAGKTSSISDLKE------VPRKNITL-----IRGLGHGAFGEVYEGQVSGMPNDPSP 101
Query: 59 -EIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116
++AVK L ++ E+ E +F E II + +H+N+V +G + R ++ E M G L
Sbjct: 102 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161
Query: 117 GNLL------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170
+ L L+ + +A +I G YL E IH DI N L+
Sbjct: 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 218
Query: 171 K---AKISDFGLSKLL-KTDQTRTYTVLRGTRGY-----TAPELHSRNNRI-TVKADVYS 220
AKI DFG+++ + + R +G PE + I T K D +S
Sbjct: 219 PGRVAKIGDFGMARDIYRAGYYR-----KGGCAMLPVKWMPPE--AFMEGIFTSKTDTWS 271
Query: 221 FGVMLLEIV 229
FGV+L EI
Sbjct: 272 FGVLLWEIF 280
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 28/232 (12%), Positives = 68/232 (29%), Gaps = 43/232 (18%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESE---FRNEMKIIGRI-------- 86
+G+ + G+ V + + E+ + +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 87 -----------------HHKNLVDLVGFCSEGS--NRLLVYEFMR--NGSLGNLLF---R 122
K ++ + + +R +Y M+ + G +L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 123 AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182
+ L R ++ L+++ L LH ++H ++P +I++D+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 183 LKTDQTRTYTVLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVC 230
TA + +T D ++ G+ + I C
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 18/201 (8%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFR---NEMKIIGR-IHHKNLVDL 94
E+GRG G V K +I K I+ E + ++ I R + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLL---FRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
G + + E M + SL Q + +IA+ I++ L +LH +
Sbjct: 72 YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-- 128
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLS-KLLKTDQTRTYTVLRGTRGYTAPE---LHS 207
+IH D+KP N+L++ + K+ DFG+S L+ G + Y APE
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPEL 185
Query: 208 RNNRITVKADVYSFGVMLLEI 228
+VK+D++S G+ ++E+
Sbjct: 186 NQKGYSVKSDIWSLGITMIEL 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 30/239 (12%)
Query: 3 SYKIISRQVSSPDVFEEIKLRSFS--YEQIVLASENFKEEIGRGGSGRVYKGCIN--GGK 58
+ ++P +F K S Y+ +++G G G V C +
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQ--------RVKKLGSGAYGEVLL-CRDKVTHV 63
Query: 59 EIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL 116
E A+K + K + S+ E+ ++ + H N++ L F + N LV E + G
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK-G-- 120
Query: 117 GNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWK 171
G L R+ ++E I +++ G+ YLH I+H D+KP N+L+ ++
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDAL 177
Query: 172 AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230
KI DFGLS + + + + GT Y APE+ + K DV+S GV+L ++
Sbjct: 178 IKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLA 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 3e-30
Identities = 32/238 (13%), Positives = 75/238 (31%), Gaps = 54/238 (22%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVK---KLIKIVEEGESEFRNEMKIIGRI-------- 86
+G+ + G+ V + + + E+ + +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 87 -----------------HHKNLVDLVGFCSEGS--NRLLVYEFMR--NGSLGNLLF---R 122
K ++ + + +R +Y M+ + G +L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 123 AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182
+ L R ++ L+++ L LH ++H ++P +I++D+ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 183 LKTDQTRTYTVLRGTRGYTAPEL----------HSRNNRITVKADVYSFGVMLLEIVC 230
+RG+ PEL R +T D ++ G+++ I C
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 37 FKEEIGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVD 93
EE+G+G V + + G+E A + + + E +I + H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDECE 151
L SE + L+++ + G G L R +SE +I+E + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVT-G--GELFEDIVAREYYSEADASHCIQQILEAVLHCHQM-- 129
Query: 152 TRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
++H ++KP N+L+ + K++DFGL+ ++ +Q + GT GY +PE+ +
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRK 187
Query: 209 NNRITVKADVYSFGVML 225
+ D+++ GV+L
Sbjct: 188 -DPYGKPVDLWACGVIL 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 18/197 (9%)
Query: 36 NFKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDL 94
+ IGRG G V A KK+ K E F+ E++I+ + H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLHYLHDECE 151
+ ++ LV E G LF R + + E RI +++ + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL-- 125
Query: 152 TRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
+ H D+KP N L K+ DFGL+ K + V GT Y +P++
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLEG 182
Query: 209 NNRITVKADVYSFGVML 225
+ D +S GVM+
Sbjct: 183 LY--GPECDEWSAGVMM 197
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFR---NEMKIIGR-IHHKNLVDL 94
EIGRG G V K +I K I+ E E + ++ ++ R +V
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRA----EQRLSWSERRRIALEIMEGLHYLHDEC 150
G + + E M + S + + +I L ++ L++L +
Sbjct: 87 YGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN- 144
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE---LHS 207
+IIH DIKP NIL+D S K+ DFG+S L +T G R Y APE +
Sbjct: 145 -LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSA 201
Query: 208 RNNRITVKADVYSFGVMLLEI 228
V++DV+S G+ L E+
Sbjct: 202 SRQGYDVRSDVWSLGITLYEL 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 46/194 (23%), Positives = 87/194 (44%), Gaps = 12/194 (6%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
E++GRG G V++ C+ K K +K+ + + E+ I+ H+N++
Sbjct: 8 MIAEDLGRGEFGIVHR-CVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L ++++EF+ + + + L+ E ++ E L +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---N 122
Query: 154 IIHCDIKPHNILM--DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
I H DI+P NI+ S KI +FG ++ LK + +L Y APE+H +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDV- 179
Query: 212 ITVKADVYSFGVML 225
++ D++S G ++
Sbjct: 180 VSTATDMWSLGTLV 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 37 FKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLV 92
KEE+G+G V + C++ G E A K + + + E +I ++ H N+V
Sbjct: 33 VKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDEC 150
L E S LV++ + G L R +SE +I+E + Y H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTG---GELFEDIVAREFYSEADASHCIQQILESIAYCHSN- 147
Query: 151 ETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
I+H ++KP N+L+ + K++DFGL+ + + GT GY +PE+
Sbjct: 148 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVLK 203
Query: 208 RNNRITVKADVYSFGVML 225
+ + + D+++ GV+L
Sbjct: 204 K-DPYSKPVDIWACGVIL 220
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 34 SENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHK 89
++++ E IG G + V C +++A+K++ ++ + E E++ + + HH
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWS----ERRRIAL---EIMEG 142
N+V LV + + GS+ +++ + + IA E++EG
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR----GTR 198
L YLH IH D+K NIL+ E +I+DFG+S L T T +R GT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 199 GYTAPELHSRNNRITVKADVYSFGVMLLEI 228
+ APE+ + KAD++SFG+ +E+
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
+ EE+G G G V++ G A K ++ E + R E++ + + H LV+
Sbjct: 160 DIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L + + +++YEFM G L + ++S E ++ +GL ++H+
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 154 IIHCDIKPHNILM--DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
+H D+KP NI+ S + K+ DFGL+ L Q + V GT + APE+
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKP- 332
Query: 212 ITVKADVYSFGVML 225
+ D++S GV+
Sbjct: 333 VGYYTDMWSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIK-------------IVEEGESEFRNEMKI 82
++G G G V NG E A+K + K +E+ E NE+ +
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 83 IGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIM 140
+ + H N++ L + LV EF G G L + R + E I +I+
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYE-G--GELFEQIINRHKFDECDAANIMKQIL 156
Query: 141 EGLHYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGT 197
G+ YLH I+H DIKP NIL+ + KI DFGLS D + GT
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GT 211
Query: 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230
Y APE+ + K DV+S GV++ ++C
Sbjct: 212 AYYIAPEVLKKK--YNEKCDVWSCGVIMYILLC 242
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 11/196 (5%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGES---EFRNEMKIIGRIHHKNLVDL 94
+GRGG G VY+ + +A+K + + + + E + GR+ ++V +
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
F + + L +L R + L+ I +I L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGA 155
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLK-TDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
H D+KP NIL+ A + DFG++ T+ + GT Y APE + T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPE-RFSESHAT 213
Query: 214 VKADVYSFGVMLLEIV 229
+AD+Y+ +L E +
Sbjct: 214 YRADIYALTCVLYECL 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVK-----KLIKIVEEGESE-FRNEMKIIGRIH 87
+ EE+G G V K C G E A K + E E+ I+ ++
Sbjct: 15 DIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLH 144
H N++ L ++ +L+ E + G LF Q+ S SE +I++G++
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 145 YLHDECETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
YLH + +I H D+KP NI++ K+ DFGL+ ++ + + GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEF 184
Query: 201 TAPELHSRNNRITVKADVYSFGVML 225
APE+ + + ++AD++S GV+
Sbjct: 185 VAPEIVNY-EPLGLEADMWSIGVIT 208
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 46/246 (18%), Positives = 89/246 (36%), Gaps = 32/246 (13%)
Query: 12 SSPDVFEE-IKLRSFSYE-QIVLASENF--KEEIGRGGSGRVYKGCINGGKEIAVKKL-- 65
S P+ FE KL + + + L S+ +G G +VY+ + K+
Sbjct: 40 SYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFV 99
Query: 66 IKIVE-EGESEF---RNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL- 120
+K+ + EF M+ + + + +LV E G+L N +
Sbjct: 100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAIN 159
Query: 121 ---FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM----------- 166
E+ + A+ ++ + +H + IIH DIKP N ++
Sbjct: 160 LYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED 216
Query: 167 DESWKAKISDFGLSKLLKT-DQTRTYTVLRGTRGYTAPELHSRNNRI-TVKADVYSFGVM 224
D S + D G S +K + +T T G+ E+ +N+ + D +
Sbjct: 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM--LSNKPWNYQIDYFGVAAT 274
Query: 225 LLEIVC 230
+ ++
Sbjct: 275 VYCMLF 280
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 55/192 (28%), Positives = 101/192 (52%), Gaps = 9/192 (4%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
E+IG+G G V+KG K +A+K + ++ E+ + + E+ ++ + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ + ++ E++ GS +LL L ++ I EI++GL YLH E + IH
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSE---KKIH 142
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKA 216
DIK N+L+ E + K++DFG++ L Q + T + GT + APE+ + + KA
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV-IKQSAYDSKA 200
Query: 217 DVYSFGVMLLEI 228
D++S G+ +E+
Sbjct: 201 DIWSLGITAIEL 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVK-----KLIKIVEEGESE-FRNEMKIIGRIH 87
EE+G G V K C GKE A K +L E E+ I+ I
Sbjct: 8 EMGEELGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLH 144
H N++ L ++ +L+ E + G LF ++ S +E + +I++G+H
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 145 YLHDECETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
YLH + RI H D+KP NI++ + + K+ DFG++ ++ + + GT +
Sbjct: 123 YLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEF 177
Query: 201 TAPELHSRNNRITVKADVYSFGVML 225
APE+ + + ++AD++S GV+
Sbjct: 178 VAPEIVNY-EPLGLEADMWSIGVIT 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 38 KEEIGRGGSGRVYKGCIN--GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRI-HHKNLV 92
+E+GRG V + CI+ G+E A K L K ++ +E +E+ ++ ++
Sbjct: 34 SKELGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDEC 150
+L S +L+ E+ G + +L E SE R+ +I+EG++YLH
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLH--- 148
Query: 151 ETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
+ I+H D+KP NIL+ KI DFG+S+ + + GT Y APE+ +
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILN 206
Query: 208 RNNRITVKADVYSFGVML 225
+ IT D+++ G++
Sbjct: 207 Y-DPITTATDMWNIGIIA 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIK-----------------IVEEGESEFRNEMKII 83
+ +G ++ C K A+KK K ++ +F+NE++II
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 84 GRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSL-------GNLLFRAEQRLSWSERRRIA 136
I ++ + G + ++YE+M N S+ L + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 137 LEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG 196
++ Y+H+E I H D+KP NILMD++ + K+SDFG S+ + + + RG
Sbjct: 158 KSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG---SRG 212
Query: 197 TRGYTAPE-LHSRNNRITVKADVYSFGVMLLEIVC 230
T + PE + ++ K D++S G+ L +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNL 91
N +G+G G V K C + +E AVK + K + S E++++ ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLHYLHD 148
+ L + S+ +V E G LF +R +SE RI ++ G+ Y+H
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 149 ECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE- 204
I+H D+KP NIL+ ++ KI DFGLS + + + GT Y APE
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 205 LHSRNNRITVKADVYSFGVML 225
L + K DV+S GV+L
Sbjct: 195 LRGTYDE---KCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNL 91
N +G+G G V K C + +E AVK + K + S E++++ ++ H N+
Sbjct: 25 NIVCMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDE 149
+ L + S+ +V E G G L +R +SE RI ++ G+ Y+H
Sbjct: 84 MKLFEILEDSSSFYIVGELYT-G--GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 150 CETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELH 206
I+H D+KP NIL+ ++ KI DFGLS + + + GT Y APE+
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL 195
Query: 207 SRNNRITVKADVYSFGVMLLEIVC 230
K DV+S GV+L ++
Sbjct: 196 RGT--YDEKCDVWSAGVILYILLS 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 62/245 (25%), Positives = 106/245 (43%), Gaps = 43/245 (17%)
Query: 10 QVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVK 63
Q+ + +E F + + +G G G+V + G + +AVK
Sbjct: 34 QLPYNEKWE------FPRNNLQF-----GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 64 KLIKIVEEGE-SEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL- 120
L E +E+KI+ + H+N+V+L+G C+ G L++ E+ G L N L
Sbjct: 83 MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
Query: 121 ------------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE 168
A S + + ++ +G+ +L IH D+ N+L+
Sbjct: 143 RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTN 199
Query: 169 SWKAKISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVM 224
AKI DFGL++ + D Y V R + APE S + + TV++DV+S+G++
Sbjct: 200 GHVAKIGDFGLARDIMNDS--NYIVKGNARLPVKWMAPE--SIFDCVYTVQSDVWSYGIL 255
Query: 225 LLEIV 229
L EI
Sbjct: 256 LWEIF 260
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 38 KEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDL 94
++ +G G RV CIN +E AVK + K S E++++ + H+N+++L
Sbjct: 18 EDVLGEGAHARVQT-CINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDECET 152
+ F E LV+E MR GS +L +R ++E + ++ L +LH++
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGS---ILSHIHKRRHFNELEASVVVQDVASALDFLHNK--- 130
Query: 153 RIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLR------GTRGYTAP 203
I H D+KP NIL ++ KI DF L +K + + G+ Y AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 204 E-LHSRNNRITV---KADVYSFGVML 225
E + + + ++ + D++S GV+L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 36 NFKEEIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGESEFRNEMKIIGR-IHHKNLV 92
KE+IG G + CI+ E AVK I+++ + + E++I+ R H N++
Sbjct: 25 EVKEDIGVGSYSVCKR-CIHKATNMEFAVK----IIDKSKRDPTEEIEILLRYGQHPNII 79
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLHYLHDE 149
L +G +V E M+ G L + ++ +SER + I + + YLH +
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 150 CETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
++H D+KP NIL +I DFG +K L+ + T T + APE+
Sbjct: 136 ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEV 191
Query: 206 HSRNNRITVKADVYSFGVML 225
R D++S GV+L
Sbjct: 192 LER-QGYDAACDIWSLGVLL 210
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 20/196 (10%)
Query: 38 KEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDL 94
+ +G G K C++ + AVK + K E+ + E+ + H N+V L
Sbjct: 16 DKPLGEGSFSICRK-CVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKL 71
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDECET 152
+ + LV E + G L R +++ +SE I +++ + ++HD
Sbjct: 72 HEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETEASYIMRKLVSAVSHMHDV--- 125
Query: 153 RIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
++H D+KP N+L +++ + KI DFG ++L D T T Y APEL ++
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQ- 183
Query: 210 NRITVKADVYSFGVML 225
N D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 37 FKEEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNLVDL 94
KE +G GG G V + + G+++A+K+ + + E + E++I+ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 95 V------GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSER--RRIALEIMEGLHYL 146
+ LL E+ G L L + E E R + +I L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 147 HDECETRIIHCDIKPHNILMDESWKA---KISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
H+ RIIH D+KP NI++ + KI D G +K L + T V GT Y AP
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAP 192
Query: 204 ELHSRNNRITVKADVYSFGVMLLEIVC 230
EL + TV D +SFG + E +
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECIT 218
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVK-----KLIKIVEEGESE-FRNEMKIIGRIH 87
+ EE+G G V K C G E A K + E E+ I+ ++
Sbjct: 15 DIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLH 144
H N++ L ++ +L+ E + G LF Q+ S SE +I++G++
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 145 YLHDECETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
YLH +I H D+KP NI++ K+ DFGL+ ++ + + GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEF 184
Query: 201 TAPELHSRNNRITVKADVYSFGVML 225
APE+ + + ++AD++S GV+
Sbjct: 185 VAPEIVNY-EPLGLEADMWSIGVIT 208
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 46/239 (19%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVKKLIKIVEEGE-SEFR 77
F + +VL + +G G G+V K K +AVK L + E +
Sbjct: 20 FPRKNLVL-----GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 78 NEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL----------------- 120
+E ++ +++H +++ L G CS+ LL+ E+ + GSL L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 121 ------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKI 174
E+ L+ + A +I +G+ YL E +++H D+ NIL+ E K KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKI 191
Query: 175 SDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
SDFGLS+ + + +Y R + A E S + I T ++DV+SFGV+L EIV
Sbjct: 192 SDFGLSRDVYEED--SYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 44/240 (18%)
Query: 14 PDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE---IAVKKLIKIVE 70
P ++ + + I ++ IG G G+V K I A+K++ +
Sbjct: 16 PTIYPVLD-----WNDIKF-----QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 71 EGE-SEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-------- 120
+ + +F E++++ ++ HH N+++L+G C L E+ +G+L + L
Sbjct: 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 121 -------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAK 173
LS + A ++ G+ YL + + IH D+ NIL+ E++ AK
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 182
Query: 174 ISDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
I+DFGLS+ + Y R + A E S N + T +DV+S+GV+L EIV
Sbjct: 183 IADFGLSR--GQE---VYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 52/192 (27%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 38 KEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
E +G G G+V+K C G ++A K + + + E +NE+ ++ ++ H NL+ L
Sbjct: 94 TEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
++ +LV E++ G L + + L+ + +I EG+ ++H I+
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YIL 209
Query: 156 HCDIKPHNILM--DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
H D+KP NIL ++ + KI DFGL++ K + V GT + APE+ + + ++
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNY-DFVS 266
Query: 214 VKADVYSFGVML 225
D++S GV+
Sbjct: 267 FPTDMWSVGVIA 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 36 NFKEEIGRGGSGRVYKGC-INGGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVD 93
FK ++G G G V+ + G E +K + K + + E++++ + H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 94 LVGFCSEGSNRLLVYEFMRNGSL-GNLLFRAEQRLSWSER--RRIALEIMEGLHYLHDEC 150
+ + N +V E G L ++ + + SE + ++M L Y H +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 151 ETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
++H D+KP NIL KI DFGL++L K+D+ T GT Y APE+
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVFK 199
Query: 208 RNNRITVKADVYSFGVML 225
R+ +T K D++S GV++
Sbjct: 200 RD--VTFKCDIWSAGVVM 215
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVD--- 93
E +G G G+VYKG + G+ A+K + + + E E + E+ ++ + HH+N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 94 --LVGFCSEGSNRL-LVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDE 149
+ ++L LV EF GS+ +L+ L I EI+ GL +LH
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
++IH DIK N+L+ E+ + K+ DFG+S L R T + GT + APE+ + +
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 204
Query: 210 NRITV----KADVYSFGVMLLEI 228
K+D++S G+ +E+
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEM 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 39/203 (19%), Positives = 77/203 (37%), Gaps = 16/203 (7%)
Query: 39 EEIGRGGS--GRVYKG-CINGGKEIAVKK--LIKIVEEGESEFRNEMKIIGRIHHKNLVD 93
IG+G V G+ + V++ L E + + E+ + +H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+ +V FM GS +L+ ++ I +++ L Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM--- 147
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYT------APELH 206
+H +K +IL+ K +S + + + R V + +PE+
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 207 SRNNRI-TVKADVYSFGVMLLEI 228
+N + K+D+YS G+ E+
Sbjct: 208 QQNLQGYDAKSDIYSVGITACEL 230
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 19/196 (9%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
+ E+GRG + VY+ K A+K L K + R E+ ++ R+ H N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLHYLHDECET 152
+ LV E + G LF R ++ +SER +I+E + YLH+
Sbjct: 115 EIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQILEAVAYLHEN--- 167
Query: 153 RIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
I+H D+KP N+L KI+DFGLSK+++ GT GY APE+
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEILRGC 225
Query: 210 NRITVKADVYSFGVML 225
+ D++S G++
Sbjct: 226 A-YGPEVDMWSVGIIT 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 57/234 (24%), Positives = 108/234 (46%), Gaps = 41/234 (17%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE--------IAVKKLIKIVEEGE-SE 75
F +++ L + +G G G+V G + +AVK L E + S+
Sbjct: 32 FPRDKLTL-----GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 86
Query: 76 FRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-------------- 120
+EM+++ I HKN+++L+G C++ ++ E+ G+L L
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 121 -FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
E+++++ + ++ G+ YL + IH D+ N+L+ E+ KI+DFGL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 180 SKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
++ + Y R + APE + +R+ T ++DV+SFGV++ EI
Sbjct: 204 ARDINNID--YYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 47/230 (20%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKE------IAVKKLIKIVEEGE-SEFRNEMKIIGRIHHK 89
+ +IG G GRV++ G +AVK L + ++F+ E ++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-----------------------FRAEQR 126
N+V L+G C+ G L++E+M G L L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS-KLLKT 185
LS +E+ IA ++ G+ YL E + +H D+ N L+ E+ KI+DFGLS +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 186 DQTRTYTVLRGTRGY-----TAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
D Y PE S T ++DV+++GV+L EI
Sbjct: 228 D---YYKA--DGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 36 NFKEEIGRGGSGRVYKGC-INGGKEIAVKKLIK--------IVEEGESEFRNEMKIIGRI 86
+ +G G G V K++A++ + K + E++I+ ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGL 143
+H ++ + F + + +V E M G L F + E + +++ +
Sbjct: 198 NHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 144 HYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
YLH+ IIH D+KP N+L+ +E KI+DFG SK+L + + T+ GT Y
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTY 307
Query: 201 TAPE--LHSRNNRITVKADVYSFGVML 225
APE + D +S GV+L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 36 NFKEEIGRGGSGRVYKGC-INGGKEIAVK----KLIKIVEEGESE----FRNEMKIIGRI 86
+ +G G G V K++A+K + I E++ E++I+ ++
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGL 143
+H ++ + F + + +V E M G L F + E + +++ +
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 144 HYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
YLH+ IIH D+KP N+L+ +E KI+DFG SK+L + + T+ GT Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTY 182
Query: 201 TAPE--LHSRNNRITVKADVYSFGVML 225
APE + D +S GV+L
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 47/221 (21%), Positives = 83/221 (37%), Gaps = 36/221 (16%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE---FRNEMKIIGRI-HHKNLVD 93
E+IG G G V+K G A+K+ K G + E+ + H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLL---FRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+E + L+ E+ GSL + + +R +E + + L++ GL Y+H
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM- 134
Query: 151 ETRIIHCDIKPHNILMDES-------------------WKAKISDFGLSKLLKTDQTRTY 191
++H DIKP NI + + KI D G + + Q
Sbjct: 135 --SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV--- 189
Query: 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
G + A E+ N KAD+++ + ++
Sbjct: 190 --EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 41/234 (17%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGK--------EIAVKKLIKIVEEGE-SE 75
+++VL + +G G G+V G ++AVK L E + S+
Sbjct: 66 LPRDRLVL-----GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD 120
Query: 76 FRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSL---------------GNL 119
+EM+++ I HKN+++L+G C++ ++ E+ G+L N
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 120 LFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
E++LS + A ++ G+ YL + IH D+ N+L+ E KI+DFGL
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGL 237
Query: 180 SKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
++ + Y R + APE + +RI T ++DV+SFGV+L EI
Sbjct: 238 ARDIHHID--YYKKTTNGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 36 NFKEEIGRGGSGRVYKGCIN--GGKEIAVK-----KLIKIVEEGESE-FRNEMKIIGRIH 87
+ EE+G G V K C G + A K + E E+ I+ I
Sbjct: 14 DTGEELGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSER--RRIALEIMEGLH 144
H N++ L ++ +L+ E + G LF ++ S +E +I+ G++
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 145 YLHDECETRIIHCDIKPHNILM----DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
YLH +I H D+KP NI++ + KI DFGL+ + + + GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEF 183
Query: 201 TAPELHSRNNRITVKADVYSFGVML 225
APE+ + ++AD++S GV+
Sbjct: 184 VAPEI-VNYEPLGLEADMWSIGVIT 207
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 46/239 (19%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVKKLIKIVEEGE-SEFR 77
F E + + +G G G+V G + +AVK L + + E
Sbjct: 42 FPRENLEF-----GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 96
Query: 78 NEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL---------------- 120
+E+K++ ++ H+N+V+L+G C+ L++E+ G L N L
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 121 ------FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKI 174
L++ + A ++ +G+ +L +H D+ N+L+ KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI 213
Query: 175 SDFGLSKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
DFGL++ + +D Y V R + APE S I T+K+DV+S+G++L EI
Sbjct: 214 CDFGLARDIMSDS--NYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 41/234 (17%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKG---CINGGKE-----IAVKKLIKIVEEGE-SE 75
F +++ L + +G G G+V I+ K +AVK L E + S+
Sbjct: 78 FPRDKLTL-----GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 76 FRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-------------- 120
+EM+++ I HKN+++L+G C++ ++ E+ G+L L
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 121 -FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
E+++++ + ++ G+ YL + IH D+ N+L+ E+ KI+DFGL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 180 SKLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
++ + Y R + APE + +R+ T ++DV+SFGV++ EI
Sbjct: 250 ARDINNID--YYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 40/233 (17%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKE------IAVKKLIKIVEEGE-SEFR 77
F +++ L + +GRG G+V + G + +AVK L + E
Sbjct: 24 FPRDRLKL-----GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 78 NEMKIIGRI-HHKNLVDLVGFCS-EGSNRLLVYEFMRNGSLGNLL--------------- 120
+E+KI+ I HH N+V+L+G C+ G +++ EF + G+L L
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 121 FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180
+ L+ + ++ +G+ +L + IH D+ NIL+ E KI DFGL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 181 KLLKTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
+ + D Y R + APE + +R+ T+++DV+SFGV+L EI
Sbjct: 196 RDIYKDP--DYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-27
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 25/217 (11%)
Query: 38 KEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLV 95
+ + GG VY+ + G+E A+K+L+ EE E+ + ++ H N+V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 96 GFCS-------EGSNRLLVYEFMRNGSLGNLLFRAEQ--RLSWSERRRIALEIMEGLHYL 146
S G L+ + G L L + E LS +I + + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 147 HDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVL-----------R 195
H + IIH D+K N+L+ K+ DFG + + +++
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 196 GTRGYTAPEL--HSRNNRITVKADVYSFGVMLLEIVC 230
T Y PE+ N I K D+++ G +L +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKL---IKIVEEGESEFRNEMKIIGRIHHKNLVDL 94
EIG G G VY + + +A+KK+ K E + E++ + ++ H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
G LV E+ GS +LL ++ L E + ++GL YLH +
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 175
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT- 213
IH D+K NIL+ E K+ DFG + ++ + + GT + APE+ +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMDEGQY 230
Query: 214 -VKADVYSFGVMLLEI 228
K DV+S G+ +E+
Sbjct: 231 DGKVDVWSLGITCIEL 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK---IVEEGESEFRNEMKIIGRIHHKN---LVD 93
IGRGG G VY ++ A+K L K +++GE+ NE ++ + + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 94 LVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+ + ++L + + M G L L + S ++ R A EI+ GL ++H+
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR--- 311
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
+++ D+KP NIL+DE +ISD GL+ + GT GY APE+ +
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY 368
Query: 213 TVKADVYSFGVMLLEIVC 230
AD +S G ML +++
Sbjct: 369 DSSADWFSLGCMLFKLLR 386
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 24 SFSYEQIVLASENFKEEIGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGESEFRNEM 80
S + EQ + + + IG+G +V I G+E+A+K + K + + E+
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV 65
Query: 81 KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIM 140
+I+ ++H N+V L L+ E+ G + + L A R+ E R +I+
Sbjct: 66 RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQIV 124
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GT 197
+ Y H + I+H D+K N+L+D KI+DFG S L G
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-----LDAFCGA 176
Query: 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEIVC 230
Y APEL + DV+S GV+L +V
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 46/206 (22%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIH 87
+ ++ E+IG G G V+K + +A+K+ +++ ++ E S R E+ ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKR-VRLDDDDEGVPSSALR-EICLLKELK 59
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
HKN+V L LV+EF + L L + ++++GL + H
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
++H D+KP N+L++ + + K+++FGL++ R Y+ T Y P++
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 208 RNNRITVKADVYSFGVMLLEIVCCRK 233
+ D++S G + E+ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 68/252 (26%), Positives = 113/252 (44%), Gaps = 35/252 (13%)
Query: 4 YKIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEI-AV 62
+K + Q D F + ++ +GRGG G V+ + ++ A
Sbjct: 174 WKWLEAQPMGEDWFLDFRV------------------LGRGGFGEVFACQMKATGKLYAC 215
Query: 63 KKLIK--IVEEGESEF-RNEMKIIGRIHHKNLVDLVGFCSEGSNRL-LVYEFMRNGSLGN 118
KKL K + + + E KI+ ++H + +V L + E L LV M G +
Sbjct: 216 KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRY 274
Query: 119 LLFRAEQRLS-WSERRRI--ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175
++ ++ + E R I +I+ GL +LH II+ D+KP N+L+D+ +IS
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRIS 331
Query: 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR--- 232
D GL+ LK QT+T GT G+ APEL D ++ GV L E++ R
Sbjct: 332 DLGLAVELKAGQTKTKG-YAGTPGFMAPEL-LLGEEYDFSVDYFALGVTLYEMIAARGPF 389
Query: 233 KNVDESLRDDEI 244
+ E + + E+
Sbjct: 390 RARGEKVENKEL 401
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.9 bits (250), Expect = 1e-24
Identities = 57/177 (32%), Positives = 90/177 (50%), Gaps = 13/177 (7%)
Query: 35 ENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIHH 88
E + E+IG G G VYK N G+ A+KK I++ +E E + R E+ I+ + H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIR-EISILKELKH 59
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
N+V L +LV+E + + L LL E L + L+++ G+ Y HD
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
R++H D+KP N+L++ + KI+DFGL++ R YT T Y AP++
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPDV 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 13/177 (7%)
Query: 35 ENFK--EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIHH 88
E ++ E++G G G VYK + G+ +A+K+ I++ E E + R E+ ++ +HH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIR-EISLLKELHH 78
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
N+V L+ LV+EFM L +L + L S+ + +++ G+ + H
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
RI+H D+KP N+L++ K++DFGL++ R+YT T Y AP++
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVVTLWYRAPDV 190
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 47/242 (19%), Positives = 90/242 (37%), Gaps = 26/242 (10%)
Query: 5 KIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKK 64
++ +R+++ V E+K + L K + +
Sbjct: 40 RLPNRELAREKVMREVKALA------KLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDE 93
Query: 65 LIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY---EFMRNGSLGNLLF 121
S I R+ + + VG S ++ +Y + R +L + +
Sbjct: 94 STDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN 153
Query: 122 R--AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
R + + I ++I E + +LH + ++H D+KP NI K+ DFGL
Sbjct: 154 RRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 210
Query: 180 SKLLKTDQ-----------TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
+ D+ T+T GT+ Y +PE N + K D++S G++L E+
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ-IHGNNYSHKVDIFSLGLILFEL 269
Query: 229 VC 230
+
Sbjct: 270 LY 271
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
IGRG G V + ++ A+K L K +++ E+ FR E ++ K + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+ + N L LV ++ G L LL + E RL R E++ + +H + +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYV 197
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL----HSRNNR 211
H DIKP NILMD + +++DFG L D T +V GT Y +PE+ R
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 212 ITVKADVYSFGVMLLEIVC 230
+ D +S GV + E++
Sbjct: 258 YGPECDWWSLGVCMYEMLY 276
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 48/178 (26%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIH 87
E ++ +IG G G V+K + G+ +A+KK E+ R E++++ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKK-FLESEDDPVIKKIALR-EIRMLKQLK 60
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
H NLV+L+ LV+E+ + ++ + L R ++ + + I + ++ +++ H
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
IH D+KP NIL+ + K+ DFG ++LL T + Y TR Y +PEL
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPEL 173
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 15/201 (7%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
IGRG V + ++ A+K + K +++ GE FR E ++ + + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
F + N L LV E+ G L LL + +R+ R EI+ + +H +
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYV 184
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL------HSRN 209
H DIKP NIL+D +++DFG L+ D T V GT Y +PE+
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 210 NRITVKADVYSFGVMLLEIVC 230
+ D ++ GV E+
Sbjct: 245 GSYGPECDWWALGVFAYEMFY 265
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-24
Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 18/180 (10%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE------FRNEMKIIGR 85
E ++ +G G G V K + G+ +A+KK +E + + R E+K++ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK---FLESDDDKMVKKIAMR-EIKLLKQ 80
Query: 86 IHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY 145
+ H+NLV+L+ C + LV+EF+ + ++ + L L + ++ +I+ G+ +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
H IIH DIKP NIL+ +S K+ DFG ++ L Y TR Y APEL
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPEL 195
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 29/205 (14%)
Query: 35 ENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNL 91
+ + +G G +G+V + N ++ A+K L + R E+++ R ++
Sbjct: 64 KVTSQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHI 117
Query: 92 VDLVGFC----SEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSER--RRIALEIMEGL 143
V +V + L+V E + G L R + R +++ER I I E +
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 144 HYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
YLH I H D+KP N+L + K++DFG +K + + T T Y
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYY 229
Query: 201 TAPELHSRNNRITVKADVYSFGVML 225
APE+ D++S GV++
Sbjct: 230 VAPEVLGPEK-YDKSCDMWSLGVIM 253
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 8e-24
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVK----KLIKIVEEGESEFRNEMKIIGRIHHKNLVDL- 94
+G G G+V + AVK K ++ + GE+ + E++++ R+ HKN++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 95 -VGFCSEGSNRLLVYEFMRNGSLGNLLFR--AEQRLSWSERRRIALEIMEGLHYLHDECE 151
V + E +V E+ G + E+R + ++++GL YLH +
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ-- 128
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPELHSR 208
I+H DIKP N+L+ KIS G+++ L R G+ + PE+ +
Sbjct: 129 -GIVHKDIKPGNLLLTTGGTLKISALGVAEAL--HPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 209 NNRIT-VKADVYSFGVMLLEIVC 230
+ + K D++S GV L I
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITT 208
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 69/254 (27%), Positives = 119/254 (46%), Gaps = 42/254 (16%)
Query: 4 YKIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEI-AV 62
+K + RQ + + F + ++ +G+GG G V + ++ A
Sbjct: 173 WKWLERQPVTKNTFRQYRV------------------LGKGGFGEVCACQVRATGKMYAC 214
Query: 63 KKLIK--IVEEGESEF-RNEMKIIGRIHHKNLVDLVGFCSEGSNRL-LVYEFMRNGSLGN 118
KKL K I + NE +I+ +++ + +V L + E + L LV M NG G+
Sbjct: 215 KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLM-NG--GD 270
Query: 119 LLFRAEQ--RLSWSERRRI--ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKI 174
L F + + E R + A EI GL LH E RI++ D+KP NIL+D+ +I
Sbjct: 271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRI 327
Query: 175 SDFGLSK-LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR- 232
SD GL+ + + + GT GY APE+ +N R T D ++ G +L E++ +
Sbjct: 328 SDLGLAVHVPEGQTIKGRV---GTVGYMAPEV-VKNERYTFSPDWWALGCLLYEMIAGQS 383
Query: 233 --KNVDESLRDDEI 244
+ + ++ +E+
Sbjct: 384 PFQQRKKKIKREEV 397
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 47/177 (26%), Positives = 90/177 (50%), Gaps = 13/177 (7%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKI-VEEGE--SEFRNEMKIIGRIHH 88
E + +++G G VYKG +A+K+ I++ EEG + R E+ ++ + H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKE-IRLEHEEGAPCTAIR-EVSLLKDLKH 59
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
N+V L + LV+E++ + L L ++ + +++ GL Y H
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
+ +++H D+KP N+L++E + K++DFGL++ K+ T+TY T Y P++
Sbjct: 119 Q---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDI 171
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 32/203 (15%)
Query: 38 KEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDL 94
K+ +G G +G+V + C + G++ A+K L + R E+ + ++V +
Sbjct: 34 KQVLGLGVNGKVLE-CFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCI 87
Query: 95 VGFCSEGSNR----LLVYEFMRNGSLGNLLF-----RAEQRLSWSERRRIALEIMEGLHY 145
+ + L++ E M G L F R +Q + E I +I + +
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 146 LHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
LH I H D+KP N+L ++ K++DFG +K + +T T Y A
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-PC--YTPYYVA 197
Query: 203 PELHSRNNRITVKADVYSFGVML 225
PE+ D++S GV++
Sbjct: 198 PEVLGPEK-YDKSCDMWSLGVIM 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 37/224 (16%)
Query: 38 KEEIGRGGSGRVYKGC-INGGKEIAVK-----KLIKIVEEGESEF--------------- 76
K+EIG+G G V N A+K KLI+
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 77 ------RNEMKIIGRIHHKNLVDL--VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLS 128
E+ I+ ++ H N+V L V + +V+E + G + + + LS
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLS 135
Query: 129 WSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188
+ R ++++G+ YLH +IIH DIKP N+L+ E KI+DFG+S K
Sbjct: 136 EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 189 RTYTVLRGTRGYTAPELHSRNNRI--TVKADVYSFGVMLLEIVC 230
GT + APE S +I DV++ GV L V
Sbjct: 193 LLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-23
Identities = 58/182 (31%), Positives = 94/182 (51%), Gaps = 17/182 (9%)
Query: 34 SENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE-------FRNEMKII 83
++ ++ + +G G VYK N + +A+KK IK+ E++ R E+K++
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKK-IKLGHRSEAKDGINRTALR-EIKLL 66
Query: 84 GRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGL 143
+ H N++ L+ SN LV++FM L ++ L+ S + L ++GL
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 144 HYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
YLH I+H D+KP+N+L+DE+ K++DFGL+K R YT TR Y AP
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAP 181
Query: 204 EL 205
EL
Sbjct: 182 EL 183
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-23
Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESEFRN------EMKIIGRIHHK 89
+G G G V+ KE+ VK + K ++E+ E E+ I+ R+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNL--LFRAEQRLSWSERRRIALEIMEGLHYLH 147
N++ ++ LV E +G +L RL I +++ + YL
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
+ IIH DIK NI++ E + K+ DFG + L+ + GT Y APE+
Sbjct: 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPEVLM 202
Query: 208 RNNRITVKADVYSFGVMLLEIVC 230
N + +++S GV L +V
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVF 225
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-23
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 36 NFKEEIGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGESEF-RNEMKIIGRIHHKNL 91
F + +G G V + +E A+K L K I++E + + E ++ R+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
V L + + +NG L + R + R EI+ L YLH +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGK-- 149
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLK--TDQTRTYTVLRGTRGYTAPELHSRN 209
IIH D+KP NIL++E +I+DFG +K+L + Q R + GT Y +PEL
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSPEL-LTE 206
Query: 210 NRITVKADVYSFGVMLLEIVC 230
+D+++ G ++ ++V
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-23
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 44/285 (15%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEFRN------EMKIIGRIHHK-- 89
+G GG G VY G ++ +A+K + K E N E+ ++ ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL--FRAEQRLSWSERRRIALEIMEGLHYLH 147
++ L+ + + +L+ E +L L R +++E + + H
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 148 DECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELH 206
+ ++H DIK NIL+D + K+ DFG LLK + GTR Y+ PE
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWI 220
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266
+ A V+S G++L ++VC + D+EI+ + + E Q+L+
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRVSSECQHLIR-- 275
Query: 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI---WMMEGIVPP 308
WC+ + RPT +++ WM + ++P
Sbjct: 276 ----------------WCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-23
Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
+G G G+V G G ++AVK L + I + E++ + H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
S ++ +V E++ G L + + R+ E RR+ +I+ + Y H ++H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILSAVDYCHRH---MVVH 134
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPELHSRNNRIT 213
D+KP N+L+D AKI+DFGLS ++ + LR G+ Y APE+ S
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGE-----FLRTSCGSPNYAAPEVISGRLYAG 189
Query: 214 VKADVYSFGVMLLEIVC 230
+ D++S GV+L ++C
Sbjct: 190 PEVDIWSCGVILYALLC 206
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 8e-23
Identities = 54/179 (30%), Positives = 92/179 (51%), Gaps = 15/179 (8%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIH 87
ENF+ E+IG G G VYK G+ +A+KK I++ E E + R E+ ++ ++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIR-EISLLKELN 60
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-FRAEQRLSWSERRRIALEIMEGLHYL 146
H N+V L+ + LV+EF+ + L + A + + ++++GL +
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 147 HDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
H R++H D+KP N+L++ K++DFGL++ RTYT T Y APE+
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPEI 174
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-23
Identities = 50/184 (27%), Positives = 93/184 (50%), Gaps = 18/184 (9%)
Query: 33 ASENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKI-VEEG--ESEFRNEMKIIGRI 86
+S FK E++G G VYKG G +A+K+ +K+ EEG + R E+ ++ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKE-VKLDSEEGTPSTAIR-EISLMKEL 60
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLL-----FRAEQRLSWSERRRIALEIME 141
H+N+V L + LV+EFM + L + + L + + ++++
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 142 GLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYT 201
GL + H+ +I+H D+KP N+L+++ + K+ DFGL++ T++ T Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVVTLWYR 175
Query: 202 APEL 205
AP++
Sbjct: 176 APDV 179
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKL--IKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
+G G G V + +AVK + + V+ E+ + E+ I ++H+N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYGH 73
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
EG+ + L E+ G L + + + + +R ++M G+ YLH I H
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPELHSRNNRITV 214
DIKP N+L+DE KISDFGL+ + + +L GT Y APEL R
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR--YNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 215 KADVYSFGVMLLEIVC 230
DV+S G++L ++
Sbjct: 188 PVDVWSCGIVLTAMLA 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGESEFRNE-------MKIIGRIH- 87
+G+GG G V+ G + ++A+K + + ++ + +G
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF---RAEQRLSWSERRRIALEIMEGLH 144
H ++ L+ + +LV E LF + L R +++ +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 145 YLHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAP 203
+ H ++H DIK NIL+D AK+ DFG LL + YT GTR Y+ P
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPP 207
Query: 204 ELHSRNNRITVKADVYSFGVMLLEIVC 230
E SR+ + A V+S G++L ++VC
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVC 234
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 60/239 (25%), Positives = 107/239 (44%), Gaps = 33/239 (13%)
Query: 5 KIISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKK 64
K+I S E+ ++ Y + IG G G V++ + E+A+KK
Sbjct: 23 KVIKVLASDGKTGEQREIA---YTNC--------KVIGNGSFGVVFQAKLVESDEVAIKK 71
Query: 65 LIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG-FCSEGSNRL-----LVYEFMRNGSLGN 118
++++ + R E++I+ + H N+VDL F S G + LV E++ ++
Sbjct: 72 ---VLQDKRFKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYR 126
Query: 119 LL---FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKI 174
+ +Q + + +++ L Y+H I H DIKP N+L+D S K+
Sbjct: 127 ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL 183
Query: 175 SDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
DFG +K+L + Y +R Y APEL T D++S G ++ E++ +
Sbjct: 184 IDFGSAKILIAGEPNVSYIC---SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG- 96
+ IG G G VY+ + G+ +A+KK ++++ + R E++I+ ++ H N+V L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNR-ELQIMRKLDHCNIVRLRYF 115
Query: 97 FCSEGSNRL-----LVYEFMRNGSLGNLL---FRAEQRLSWSERRRIALEIMEGLHYLHD 148
F S G + LV +++ ++ + RA+Q L + ++ L Y+H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 173
Query: 149 ECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELH 206
I H DIKP N+L+D ++ K+ DFG +K L + Y +R Y APEL
Sbjct: 174 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRAPELI 228
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCR 232
T DV+S G +L E++ +
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
+G G GRV A+K L K +V+ + E NE +I+ ++ LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ SN +V E++ G + + L R R S R A +I+ YLH +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIY 164
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKA 216
D+KP N+L+D+ +++DFG + K + RT+T L GT APE+ +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWT-LCGTPEALAPEI-ILSKGYNKAV 219
Query: 217 DVYSFGVMLLEIVC 230
D ++ GV++ E+
Sbjct: 220 DWWALGVLIYEMAA 233
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-22
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKL--IKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
+G G G V + +AVK + + V+ E+ + E+ I ++H+N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYGH 73
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
EG+ + L E+ G L + + + + +R ++M G+ YLH I H
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPELHSRNNRITV 214
DIKP N+L+DE KISDFGL+ + + +L GT Y APEL R
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFR--YNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 215 KADVYSFGVMLLEIVC 230
DV+S G++L ++
Sbjct: 188 PVDVWSCGIVLTAMLA 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-22
Identities = 19/195 (9%), Positives = 51/195 (26%), Gaps = 39/195 (20%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKL---IKIVEEGESEFRNEMKIIGRIHHKNLVDL 94
G + ++ +++A+ + + ++ E + + RI + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ + L+V E++R GSL + + S R + H +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RAGV 150
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
P + + ++
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA--------NP 181
Query: 215 KADVYSFGVMLLEIV 229
+ D+ G L ++
Sbjct: 182 QDDIRGIGASLYALL 196
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 42/183 (22%), Positives = 83/183 (45%), Gaps = 20/183 (10%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE----SEFRNEMKIIGRIH 87
+ ++ ++G G G VYK + +A+K+ I++ E E + R E+ ++ +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKR-IRLEHEEEGVPGTAIR-EVSLLKELQ 91
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
H+N+++L L++E+ L + +S + +++ G+++ H
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 148 DECETRIIHCDIKPHNILMDESWKA-----KISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
R +H D+KP N+L+ S + KI DFGL++ R +T T Y
Sbjct: 150 SR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEIITLWYRP 205
Query: 203 PEL 205
PE+
Sbjct: 206 PEI 208
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRIHHKNLVDLVG 96
+G+G G+V A+K L K I+ + E E +++ H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHDECETR 153
+ + +RL V E+ NG G L F + ++E R R EI+ L YLH
Sbjct: 72 YAFQTHDRLCFVMEYA-NG--GELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRD 125
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
+++ DIK N+++D+ KI+DFGL K +D T GT Y APE+ N+
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY-G 183
Query: 214 VKADVYSFGVMLLEIVCCR 232
D + GV++ E++C R
Sbjct: 184 RAVDWWGLGVVMYEMMCGR 202
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRIHHKNLVDLVG 96
IG+G G+V N K++ A+K + K VE E E++I+ + H LV+L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 97 -FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
F E + +V + + G L L + + E++ L YL RII
Sbjct: 83 SFQDE-EDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQ---NQRII 137
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI--T 213
H D+KP NIL+DE I+DF ++ +L +T+ T+ GT+ Y APE+ S +
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITTMA-GTKPYMAPEMFSSRKGAGYS 195
Query: 214 VKADVYSFGVMLLEIVC 230
D +S GV E++
Sbjct: 196 FAVDWWSLGVTAYELLR 212
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 41 IGRGGSGRVY---KGCINGGKEI-AVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDL 94
+G+G G+V+ K + +++ A+K L K + + E I+ ++H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 95 VGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHDECE 151
+ + +L L+ +F+ G G+L R + + ++E + E+ L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFL-RG--GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-----H 206
II+ D+KP NIL+DE K++DFGLSK + + Y+ GT Y APE+ H
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGH 203
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCR-----KNVDE 237
+++ AD +SFGV++ E++ K+ E
Sbjct: 204 TQS------ADWWSFGVLMFEMLTGTLPFQGKDRKE 233
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV-G 96
G+G G V G + G +A+KK+I+ E + M+ + +HH N+V L
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSY 87
Query: 97 FCSEGSNRL------LVYEFMRNGSLGNLL---FRAEQRLSWSERRRIALEIMEGLHYLH 147
F + G +V E++ +L +R + + +++ + LH
Sbjct: 88 FYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 148 DECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPEL 205
+ H DIKPHN+L++E+ K+ DFG +K L + Y +R Y APEL
Sbjct: 147 LPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC---SRYYRAPEL 202
Query: 206 HSRNNRITVKADVYSFGVMLLEIV 229
N T D++S G + E++
Sbjct: 203 IFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
IGRG G V +++ A+K L K +++ +S F E I+ + +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+ + L +V E+M G L NL+ + + R E++ L +H I
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMGFI 190
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL---HSRNNRI 212
H D+KP N+L+D+S K++DFG + + GT Y +PE+ +
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250
Query: 213 TVKADVYSFGVMLLEIVC 230
+ D +S GV L E++
Sbjct: 251 GRECDWWSVGVFLYEMLV 268
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-21
Identities = 54/183 (29%), Positives = 92/183 (50%), Gaps = 22/183 (12%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN----EMKIIGRIHHKNLVD 93
+IG+G G V+K G+++A+KK + + E E F E+KI+ + H+N+V+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKK-VLMENEKEG-FPITALREIKILQLLKHENVVN 80
Query: 94 LVGFCSEGSNRL--------LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHY 145
L+ C ++ LV++F + L LL + + SE +R+ ++ GL+Y
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 146 LHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL---KTDQTRTYTVLRGTRGYTA 202
+H +I+H D+K N+L+ K++DFGL++ K Q YT T Y
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196
Query: 203 PEL 205
PEL
Sbjct: 197 PEL 199
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 6e-21
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
+G G G+V G G ++AVK L + I R E++ + H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
S S+ +V E++ G L + + RL E RR+ +I+ G+ Y H ++H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRH---MVVH 139
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPELHSRNNRIT 213
D+KP N+L+D AKI+DFGLS ++ + LR G+ Y APE+ S
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGE-----FLRTSCGSPNYAAPEVISGRLYAG 194
Query: 214 VKADVYSFGVMLLEIVC 230
+ D++S GV+L ++C
Sbjct: 195 PEVDIWSSGVILYALLC 211
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 54/198 (27%), Positives = 80/198 (40%), Gaps = 16/198 (8%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEG---ESEFRNEMKIIGRIHHKNLVDLVG 96
IG G G + +A +K +E G + + E+ + H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVA----VKYIERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
++ ++ E+ G L + A R S E R +++ G+ Y H +I H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSM---QICH 139
Query: 157 CDIKPHNILMDESWKA--KISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
D+K N L+D S KI DFG SK TV GT Y APE+ R
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEYDGK 197
Query: 215 KADVYSFGVMLLEIVCCR 232
ADV+S GV L ++
Sbjct: 198 IADVWSCGVTLYVMLVGA 215
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVG 96
++GRG V++ I +++ VK +K V++ + + E+KI+ + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKI-LKPVKK--KKIKREIKILENLRGGPNIITLAD 98
Query: 97 -FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
S LV+E + N L Q L+ + R EI++ L Y H I
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGI 151
Query: 155 IHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
+H D+KPHN+++D E K ++ D+GL++ + Y V +R + PEL
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPELLVDYQMYD 209
Query: 214 VKADVYSFGVMLLEIV 229
D++S G ML ++
Sbjct: 210 YSLDMWSLGCMLASMI 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 25/190 (13%)
Query: 35 ENFKEEIGRGGSGRVYKGC---INGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL 91
E ++GRG G VYK K+ A+K+ I+ S R E+ ++ + H N+
Sbjct: 23 EYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ-IEGTGISMSACR-EIALLRELKHPNV 80
Query: 92 VDLVG-FCSEGSNRL-LVYEFMR-------NGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
+ L F S ++ L++++ + + +L + + +I++G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKA----KISDFGLSKLLKTDQTRTYTVLRG-- 196
+HYLH ++H D+KP NIL+ KI+D G ++L + L
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVV 196
Query: 197 -TRGYTAPEL 205
T Y APEL
Sbjct: 197 VTFWYRAPEL 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRIHHKNLVDLVG 96
+G+G G+V A+K L K IV + E E +++ H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHDECETR 153
+ + +RL V E+ NG G L F + +SE R R EI+ L YLH E
Sbjct: 215 YSFQTHDRLCFVMEYA-NG--GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-- 269
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
+++ D+K N+++D+ KI+DFGL K D T GT Y APE+ N+
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDY-G 327
Query: 214 VKADVYSFGVMLLEIVCCR 232
D + GV++ E++C R
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 46/197 (23%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 41 IGRGGSGRVYKGC-INGGKEIAVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
+G G G+V +++A+K + + + + E+ + + H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ ++ ++V E+ G L + + ++R++ E RR +I+ + Y H +I+H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIV-EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVH 131
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPELHSRNNRIT 213
D+KP N+L+D++ KI+DFGLS ++ L+ G+ Y APE+ +
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTDGN-----FLKTSCGSPNYAAPEVINGKLYAG 186
Query: 214 VKADVYSFGVMLLEIVC 230
+ DV+S G++L ++
Sbjct: 187 PEVDVWSCGIVLYVMLV 203
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-20
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESE--FRN---------EMKIIGRIH 87
I G G V G + G +A+K++ V +G + + E++++ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 88 HKNLVDLVG-FCSEGSNRL----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
H N++ L F + LV E MR L ++ +S + I+ G
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
LH LH+ ++H D+ P NIL+ ++ I DF L++ D +T+ V R Y A
Sbjct: 147 LHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV--THRWYRA 201
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PEL + T D++S G ++ E+
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-20
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 25/200 (12%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
+G G GRV+ A+K L K +V + E +E ++ + H ++ + G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRI-ALEIMEGLHYLHDECETRII 155
+ ++ +++ G L +LL R QR + + A E+ L YLH + II
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLL-RKSQRFP-NPVAKFYAAEVCLALEYLHSK---DII 128
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-----HSRNN 210
+ D+KP NIL+D++ KI+DFG +K + TYT L GT Y APE+ ++++
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYT-LCGTPDYIAPEVVSTKPYNKS- 183
Query: 211 RITVKADVYSFGVMLLEIVC 230
D +SFG+++ E++
Sbjct: 184 -----IDWWSFGILIYEMLA 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 27/192 (14%)
Query: 33 ASENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIV--EEGESEF-----RNEMKI 82
A+ ++ EIG G G VYK + G +A+K +++ G R E+ +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKS-VRVPNGGGGGGGLPISTVR-EVAL 64
Query: 83 IGRIH---HKNLVDL----VGFCSEGSNRL-LVYEFMRNGSLGNLL-FRAEQRLSWSERR 133
+ R+ H N+V L ++ ++ LV+E + + L L L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 123
Query: 134 RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193
+ + + GL +LH I+H D+KP NIL+ K++DFGL+++ T V
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 194 LRGTRGYTAPEL 205
+ T Y APE+
Sbjct: 181 V--TLWYRAPEV 190
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 32/248 (12%)
Query: 8 SRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEI-AVKKLI 66
+ P ++I L S + +F + IG+G G+V + AVK L
Sbjct: 13 ANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ 72
Query: 67 K--IVEEGESEF-RNEMKIIGR-IHHKNLVDLVGFCSEGSNRL-LVYEFMRNGSLGNLLF 121
K I+++ E + +E ++ + + H LV L F + +++L V +++ NG G L +
Sbjct: 73 KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYI-NG--GELFY 128
Query: 122 RAEQRLSWSERR-RI-ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179
++ + E R R A EI L YLH I++ D+KP NIL+D ++DFGL
Sbjct: 129 HLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL 185
Query: 180 SKLLKTDQTRTYTVLRGTRGYTAPEL-----HSRNNRITVKADVYSFGVMLLEIVCCR-- 232
K + T T GT Y APE+ + R D + G +L E++
Sbjct: 186 CKENIEHNSTTSTFC-GTPEYLAPEVLHKQPYDRT------VDWWCLGAVLYEMLYGLPP 238
Query: 233 ---KNVDE 237
+N E
Sbjct: 239 FYSRNTAE 246
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 41 IGRGGSGRVY---KGCINGGKEI-AVKKLIK--IVEEGESEF--RNEMKIIGRIHHKNLV 92
+G+GG G+V+ K +I A+K L K IV + + E I+ + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 93 DLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHDE 149
DL+ + + +L L+ E++ +G G L + E+ + E EI L +LH +
Sbjct: 85 DLI-YAFQTGGKLYLILEYL-SG--GELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL---- 205
II+ D+KP NI+++ K++DFGL K D T T+T GT Y APE+
Sbjct: 141 ---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILMRS 196
Query: 206 -HSRNNRITVKADVYSFGVMLLEIVCCR-----KNVDE 237
H+R D +S G ++ +++ +N +
Sbjct: 197 GHNRA------VDWWSLGALMYDMLTGAPPFTGENRKK 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 51/188 (27%), Positives = 94/188 (50%), Gaps = 25/188 (13%)
Query: 35 ENFK--EEIGRGGSGRVYKG--CINGGKEIAVKKLIKIVEEGE----SEFRNEMKI---I 83
+ ++ EIG G G+V+K NGG+ +A+K+ +++ E S R E+ + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR-VRVQTGEEGMPLSTIR-EVAVLRHL 68
Query: 84 GRIHHKNLVDL----VGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQR-LSWSERRRIAL 137
H N+V L ++ +L LV+E + + L L + + + + +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGT 197
+++ GL +LH R++H D+KP NIL+ S + K++DFGL+++ T V+ T
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--T 182
Query: 198 RGYTAPEL 205
Y APE+
Sbjct: 183 LWYRAPEV 190
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRI-HHKNLVDLV 95
IGRG +V + I A+K + K + ++ + ++ + E + + +H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHDECET 152
C + +RL V E++ NG G+L+F +++ E R + EI L+YLH E
Sbjct: 77 -SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ER 129
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-----HS 207
II+ D+K N+L+D K++D+G+ K T T GT Y APE+ +
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYG 188
Query: 208 RNNRITVKADVYSFGVMLLEIVCCR 232
+ D ++ GV++ E++ R
Sbjct: 189 FS------VDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-19
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRI-HHKNLVDLV 95
+G+G G+V G E+ AVK L K ++++ + E E +++ L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHDECET 152
C + +RL V E++ NG G+L++ +Q + E A EI GL +L +
Sbjct: 88 -SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK--- 140
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
II+ D+K N+++D KI+DFG+ K D T T GT Y APE+
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEI-IAYQPY 198
Query: 213 TVKADVYSFGVMLLEIVCCR 232
D ++FGV+L E++ +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ 218
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-19
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 41 IGRGGSGRVY---KGCINGGKEI-AVKKLIK--IVEEGESEF--RNEMKIIGRI-HHKNL 91
+G G G+V+ K + ++ A+K L K IV++ ++ R E +++ I L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 92 VDLVGFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHD 148
V L + + +L L+ +++ NG G L QR ++E +I EI+ L +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYI-NG--GELFTHLSQRERFTEHEVQIYVGEIVLALEHLH- 176
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKL-LKTDQTRTYTVLRGTRGYTAPELHS 207
+ II+ DIK NIL+D + ++DFGLSK + + R Y GT Y AP++
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVR 233
Query: 208 RNNRITVKA-DVYSFGVMLLEIVCCR 232
+ KA D +S GV++ E++
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 27/205 (13%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRI-HHKNLVDLV 95
+G+G G+V + ++ AVK L K I+++ + E E +I+ +H L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHDECET 152
C + +RL V EF+ NG G+L+F ++ + E R R A EI+ L +LH +
Sbjct: 91 -CCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DK 143
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-----HS 207
II+ D+K N+L+D K++DFG+ K + T T GT Y APE+ +
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEMLYG 202
Query: 208 RNNRITVKADVYSFGVMLLEIVCCR 232
D ++ GV+L E++C
Sbjct: 203 PA------VDWWAMGVLLYEMLCGH 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 33/207 (15%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIHH 88
+ +G G G V G ++A+KKL + F++ E++++ + H
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRH 83
Query: 89 KNLVDLVG-FCSEGSNRL-----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
+N++ L+ F + + LV FM LG L+ ++L + + ++++G
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM--KHEKLGEDRIQFLVYQMLKG 140
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
L Y+H IIH D+KP N+ ++E + KI DFGL++ ++ T Y V TR Y A
Sbjct: 141 LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-GYVV---TRWYRA 193
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PE+ R T D++S G ++ E++
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-18
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRI-HHKNLVDLV 95
IGRG +V + I A++ + K + ++ + ++ + E + + +H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERR-RI-ALEIMEGLHYLHDECET 152
C + +RL V E++ NG G+L+F +++ E R + EI L+YLH+
Sbjct: 120 -SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER--- 172
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL-----HS 207
II+ D+K N+L+D K++D+G+ K T T GT Y APE+ +
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYG 231
Query: 208 RNNRITVKADVYSFGVMLLEIVCCR 232
+ D ++ GV++ E++ R
Sbjct: 232 FS------VDWWALGVLMFEMMAGR 250
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 34/207 (16%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIHH 88
+G G G V G+++A+KKL + F++ E+ ++ + H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQH 82
Query: 89 KNLVDLVG-FCSEGSNRL-----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
+N++ L+ F S R LV FM L ++ + S + + + ++++G
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM---GLKFSEEKIQYLVYQMLKG 138
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
L Y+H ++H D+KP N+ ++E + KI DFGL++ + T Y V TR Y A
Sbjct: 139 LKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-GYVV---TRWYRA 191
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PE+ D++S G ++ E++
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESE-FRNEMKIIGR-IHHKNLVDLV 95
+G+G G+V+ + A+K L K ++ + + E E +++ H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECET 152
+ L V E++ NG G+L++ + + R A EI+ GL +LH
Sbjct: 85 -CTFQTKENLFFVMEYL-NG--GDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SK 137
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
I++ D+K NIL+D+ KI+DFG+ K +T T GT Y APE+ +
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEI-LLGQKY 195
Query: 213 TVKADVYSFGVMLLEIVCCR 232
D +SFGV+L E++ +
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQ 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 41 IGRGGSGRVYKGCINGGKEI-AVKKLIK--IVEEGESEF-RNEMKIIGRI-HHKNLVDLV 95
+G+G G+V G E+ AVK L K ++++ + E E +++ L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 96 GFCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRI--ALEIMEGLHYLHDECET 152
C + +RL V E++ NG G+L++ +Q + E + A EI GL +L +
Sbjct: 409 -SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK--- 461
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
II+ D+K N+++D KI+DFG+ K D T T GT Y APE+
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEI-IAYQPY 519
Query: 213 TVKADVYSFGVMLLEIVCCR 232
D ++FGV+L E++ +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ 539
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 41 IGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIHHKN 90
IG G G V + +A+KKL + F+N E+ ++ ++HKN
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKN 85
Query: 91 LVDLVG-FCSEGSNRL-----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLH 144
++ L+ F + S +V E M + +L ++ + L + +++ G+
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI---QMELDHERMSYLLYQMLCGIK 141
Query: 145 YLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE 204
+LH IIH D+KP NI++ KI DFGL++ T T V TR Y APE
Sbjct: 142 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPE 196
Query: 205 LHSRNNRITVKADVYSFGVMLLEIV 229
+ D++S G ++ E++
Sbjct: 197 VIL-GMGYKENVDIWSVGCIMGEMI 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 33/207 (15%)
Query: 39 EEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIHH 88
+ IG G G V + +A+KKL + F+N E+ ++ ++H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNH 120
Query: 89 KNLVDLVG-FCSEGSNRL-----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
KN++ L+ F + + LV E M + +L ++ + L + +++ G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI---QMELDHERMSYLLYQMLCG 176
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
+ +LH IIH D+KP NI++ KI DFGL++ T T V TR Y A
Sbjct: 177 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRA 231
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PE+ D++S G ++ E+V
Sbjct: 232 PEV-ILGMGYKENVDIWSVGCIMGEMV 257
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 50/205 (24%)
Query: 35 ENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNL 91
+ + +G G +G+V + N ++ A+K L + R E+++ R ++
Sbjct: 20 KVTSQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHI 73
Query: 92 VDLVGFC----SEGSNRLLVYEFMRNGSLGNLLFRAEQR--LSWSER--RRIALEIMEGL 143
V +V + L+V E + G G L R + R +++ER I I E +
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLD-G--GELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 144 HYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY 200
YLH I H D+KP N+L + K++DFG +K Y
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----------ETTG--EKY 175
Query: 201 TAPELHSRNNRITVKADVYSFGVML 225
D++S GV++
Sbjct: 176 DK------------SCDMWSLGVIM 188
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 33/207 (15%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIHH 88
+G G G V G +AVKKL + F++ E++++ + H
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKH 87
Query: 89 KNLVDLVG-FCSEGSNRL-----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
+N++ L+ F S LV M L N++ Q+L+ + + +I+ G
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV--KCQKLTDDHVQFLIYQILRG 144
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
L Y+H IIH D+KP N+ ++E + KI DFGL++ + T Y TR Y A
Sbjct: 145 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT-GYVA---TRWYRA 197
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIV 229
PE+ D++S G ++ E++
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELL 224
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 48/234 (20%), Positives = 85/234 (36%), Gaps = 53/234 (22%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV-G 96
+ +G G G V + I GK A+KK ++++ + R E+ I+ + H N++ LV
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKNR-ELDIMKVLDHVNIIKLVDY 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRR--------IALEIME------- 141
F + G + + + S + +E +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 142 ------------------------GLHYLHDECETRIIHCDIKPHNILMD-ESWKAKISD 176
+ ++H I H DIKP N+L++ + K+ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 177 FGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
FG +K L + Y +R Y APEL T D++S G + E++
Sbjct: 186 FGSAKKLIPSEPSVAYIC---SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 39/211 (18%)
Query: 39 EEIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIH 87
IG G G V + +A+KK+ S F + E+KI+ R
Sbjct: 33 SYIGEGAYGMVCS-AYDNLNKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFR 83
Query: 88 HKNLVDLVG-FCSEGSNRL----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
H+N++ + + ++ +V + M L LL Q LS +I+ G
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQHLSNDHICYFLYQILRG 140
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT-----YTVLRGT 197
L Y+H ++H D+KP N+L++ + KI DFGL+++ D T Y T
Sbjct: 141 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA---T 194
Query: 198 RGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
R Y APE+ + T D++S G +L E+
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 52/240 (21%), Positives = 95/240 (39%), Gaps = 48/240 (20%)
Query: 38 KEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIH 87
K IGRG G VY N K +A+KK+ ++ F + E+ I+ R+
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLK 83
Query: 88 HKNLVDLVG-FCSEGSNRL----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
++ L + + +V E + L L + L+ + I ++ G
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLF-KTPIFLTEEHIKTILYNLLLG 141
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG------ 196
+++H E+ IIH D+KP N L+++ K+ DFGL++ + +++
Sbjct: 142 ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 197 ---------------TRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241
TR Y APEL T D++S G + E++ ++ +
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 48/224 (21%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIHH 88
+ +G GG+G V+ + K +A+KK++ + E+KII R+ H
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDH 67
Query: 89 KNLVDLVGFCSEGSNRL--------------LVYEFMRNGSLGNLLFRAEQRLSWSERRR 134
N+V + ++L +V E+M L N+L + L R
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLLEEHARL 124
Query: 135 IALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRT--- 190
+++ GL Y+H ++H D+KP N+ ++ E KI DFGL++++ +
Sbjct: 125 FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 191 --YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
V T+ Y +P L N T D+++ G + E++ +
Sbjct: 182 SEGLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 8e-15
Identities = 49/233 (21%), Positives = 92/233 (39%), Gaps = 53/233 (22%)
Query: 38 KEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRIH 87
+ IG G G V + + +A+KK++++ F + E+ I+ R++
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIAILNRLN 110
Query: 88 HKNLVDLVG-FCSEGSNRL----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
H ++V ++ + + +V E S LFR L+ + + ++ G
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG------ 196
+ Y+H I+H D+KP N L+++ K+ DFGL++ + + +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 197 --------------------TRGYTAPELHSRNNRITVKADVYSFGVMLLEIV 229
TR Y APEL T DV+S G + E++
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 44/220 (20%)
Query: 39 EEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
++G G V+ + +A+K +++ + +E+K++ R+ N D
Sbjct: 25 RKLGWGHFSTVWL-AKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRV---NDADNTK 79
Query: 97 FCSEGSNRL------------------LVYEFMRNGSLGNLLFR-AEQRLSWSERRRIAL 137
S G+N + +V+E + +L L+ + + + ++I+
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISK 138
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA------KISDFGLSKLLKTDQTRTY 191
+++ GL Y+H C IIH DIKP N+LM+ KI+D G + Y
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHY 192
Query: 192 TVLRGTRGYTAPE--LHSRNNRITVKADVYSFGVMLLEIV 229
T TR Y +PE L AD++S ++ E++
Sbjct: 193 TNSIQTREYRSPEVLL---GAPWGCGADIWSTACLIFELI 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 38/216 (17%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRN---------EMKIIGRI 86
K +G G G V G+ +A+KK+ F E+KI+
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIKILKHF 66
Query: 87 HHKNLVDLVG-FCSEGSNRL----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIME 141
H+N++ + + ++ E M L ++ + Q LS + + +
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI--STQMLSDDHIQYFIYQTLR 123
Query: 142 GLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG----- 196
+ LH + +IH D+KP N+L++ + K+ DFGL++++
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 197 ----TRGYTAPELHSRNNRITVKADVYSFGVMLLEI 228
TR Y APE+ + + + DV+S G +L E+
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 27/179 (15%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE---FRNEMKIIGRIHH-KNLVD 93
++IG G G + G + + +A+K +E +S E + ++ +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 94 LVGFCSEGSNRLLVYEFMRNG-SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+ F G +V E + G SL +L ++ S IA++++ + Y+H +
Sbjct: 70 VYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN-- 125
Query: 153 RIIHCDIKPHNILMDESWKAK-----ISDFGLSKLLKTDQT------RTYTVLRGTRGY 200
+I+ D+KP N L+ I DF L+K +T R + L GT Y
Sbjct: 126 -LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 44/210 (20%), Positives = 86/210 (40%), Gaps = 36/210 (17%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESE---FRNEMKIIGRIHHKNLV-D 93
IG G G +++G + +++A+K E S+ R+E + + + +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYKLLAGCTGIPN 70
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
+ F EG + +LV + + SL +LL ++ S A +++ + +H++
Sbjct: 71 VYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 126
Query: 154 IIHCDIKPHNILMDESWKAK-----ISDFGLSKLLKTDQT------RTYTVLRGTRGYTA 202
+++ DIKP N L+ + DFG+ K + T R L GT Y +
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 203 PELH-----SRNNRITVKADVYSFGVMLLE 227
H SR + D+ + G + +
Sbjct: 187 INTHLGREQSR------RDDLEALGHVFMY 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 41/225 (18%), Positives = 81/225 (36%), Gaps = 46/225 (20%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKL--IKIVEEGESEFRNEMKI---------IGRIHHK 89
IG+GG G +Y +N + + +K+ E+K I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 90 NLVDLVGFCS----------EGSNRLLVYEFMRNG-SLGNLLFRAEQRLSWSERRRIALE 138
+ +G S R ++ + G L + +R S +++L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 139 IMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKI--SDFGLSKLLKTDQT------RT 190
I++ L Y+H E +H DIK N+L++ ++ D+GL+ +
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217
Query: 191 YTVLRGTRGYTAPELH-----SRNNRITVKADVYSFGVMLLEIVC 230
GT +T+ + H SR + D+ G +++ +
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSR------RGDLEILGYCMIQWLT 256
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 48/214 (22%)
Query: 39 EEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI---------- 86
+ IG+G G+V K + + +A+K +++ + + E++I+ +
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 87 --------HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALE 138
+N + + F N +YE ++ Q S R+ A
Sbjct: 161 VIHMLENFTFRNHICMT-FELLSMN---LYELIKKNKF--------QGFSLPLVRKFAHS 208
Query: 139 IMEGLHYLHDECETRIIHCDIKPHNILMDESWKA--KISDFGLSKLLKTDQTRTYTVLRG 196
I++ L LH RIIHCD+KP NIL+ + ++ K+ DFG S + R YT ++
Sbjct: 209 ILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQ- 261
Query: 197 TRGYTAPE--LHSRNNRITVKADVYSFGVMLLEI 228
+R Y APE L R + D++S G +L E+
Sbjct: 262 SRFYRAPEVIL---GARYGMPIDMWSLGCILAEL 292
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 57/230 (24%), Positives = 108/230 (46%), Gaps = 48/230 (20%)
Query: 37 FKEEIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEGESEFRN---------EMKIIGR 85
+++G+G G V+K I+ G+ +AVKK+ F+N E+ I+
Sbjct: 13 LVKKLGKGAYGIVWK-SIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILTE 64
Query: 86 IH-HKNLVDLVG-FCSEGSNRL-LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142
+ H+N+V+L+ ++ + LV+++M L ++ RA L ++ + ++++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI-RA-NILEPVHKQYVVYQLIKV 121
Query: 143 LHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRG------ 196
+ YLH ++H D+KP NIL++ K++DFGLS+ + T +
Sbjct: 122 IKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 197 --------------TRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
TR Y APE+ + + T D++S G +L EI+C +
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 45/223 (20%)
Query: 41 IGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKI---------IGRIHHKNL 91
IG GG G +Y E + ++K+ + +E+K I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 92 VDLVGF----------CSEGSNRLLVYEFMRNG-SLGNLLFRAEQRLSWSERRRIALEIM 140
+D +G S R +V E + G L + S ++ + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKI-SGQNGTFKKSTVLQLGIRML 161
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMDESWKAKI--SDFGLSKLLKTDQT------RTYT 192
+ L Y+H E +H DIK N+L+ ++ +D+GLS +
Sbjct: 162 DVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218
Query: 193 VLRGTRGYTAPELH-----SRNNRITVKADVYSFGVMLLEIVC 230
GT +T+ + H SR ++DV G +L +C
Sbjct: 219 GHNGTIEFTSLDAHKGVALSR------RSDVEILGYCMLRWLC 255
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 124 EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183
+ L+ + ++ +G+ +L + IH D+ NIL+ E KI DFGL++ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 184 KTDQTRTYTVLRGTR---GYTAPELHSRNNRI-TVKADVYSFGVMLLEIV 229
D Y R + APE + +R+ T+++DV+SFGV+L EI
Sbjct: 244 YKDP--DYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 42/192 (21%), Positives = 72/192 (37%), Gaps = 22/192 (11%)
Query: 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCING--GKEIAVKKLIKIVEEG-----ESEFR 77
F +++ L + +GRG G+V + G +K+++EG
Sbjct: 19 FPRDRLKL-----GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 73
Query: 78 NEMKIIGRI-HHKNLVDLVGFCSEGSNRLLV-YEFMRNGSLGNLLFRAEQRLSWSERRRI 135
+E+KI+ I HH N+V+L+G C++ L+V EF + G+L L S+R
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEF 125
Query: 136 ALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR 195
+G + + I D+K + S + S F K L +
Sbjct: 126 VPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185
Query: 196 GTRGYTAPELHS 207
T L
Sbjct: 186 YKDFLTLEHLIC 197
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 36/209 (17%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEF---RNEMKIIGRIHHKNLV-D 93
+IG G G +Y G I +E+A+K E +++ E KI + + +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKIYRILQGGTGIPN 67
Query: 94 LVGFCSEGSNRLLVYEFMRNG-SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+ F EG +LV + + G SL +L ++LS +A +++ + ++H +
Sbjct: 68 VRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 153 RIIHCDIKPHNILMDESWKAK---ISDFGLSKLLKTDQT------RTYTVLRGTRGYTAP 203
+H DIKP N LM +A I DFGL+K + T R L GT Y +
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182
Query: 204 ELH-----SRNNRITVKADVYSFGVMLLE 227
H SR + D+ S G +L+
Sbjct: 183 NTHLGIEQSR------RDDLESLGYVLMY 205
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 39 EEIGRGGSGRVYKGC-INGGKEIAVKKLIKIVEEGESEF---RNEMKIIGRIHHKNLV-D 93
+IG G G +Y G I G+E+A+K E +++ E KI + +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 94 LVGFCSEGSNRLLVYEFMRNG-SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+ +EG ++V E + G SL +L ++ S +A +++ + Y+H
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 124
Query: 153 RIIHCDIKPHNILMDESWKAK---ISDFGLSKLLKTDQT------RTYTVLRGTRGYTAP 203
IH D+KP N LM K I DFGL+K + +T R L GT Y +
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 204 ELH-----SRNNRITVKADVYSFGVMLLE 227
H SR + D+ S G +L+
Sbjct: 185 NTHLGIEQSR------RDDLESLGYVLMY 207
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 54/217 (24%)
Query: 39 EEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI---------- 86
IG+G G+V K + + +A+K +IK + ++ + E++++ +
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 87 --------HHKNLVDLVGFCSEGSNRLLVYEFMR-NGSLGNLLFRAEQRLSWSERRRIAL 137
+N + LV F N +Y+ +R G +S + R+ A
Sbjct: 118 IVHLKRHFMFRNHLCLV-FEMLSYN---LYDLLRNTNFRG---------VSLNLTRKFAQ 164
Query: 138 EIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA--KISDFGLSKLLKTDQTRTYTVLR 195
++ L +L E IIHCD+KP NIL+ ++ KI DFG S + Y
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQYIQ-- 220
Query: 196 GTRGYTAPELHSRNNRI-----TVKADVYSFGVMLLE 227
+R Y +PE+ + + D++S G +L+E
Sbjct: 221 -SRFYRSPEV------LLGMPYDLAIDMWSLGCILVE 250
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 36/233 (15%), Positives = 77/233 (33%), Gaps = 62/233 (26%)
Query: 41 IGRGGSGRVYKGC---------INGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHK-- 89
R G +Y+ ++ ++K ++ + NE R
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKDGRLFNEQNFFQRAAKPLQ 104
Query: 90 -------NLVDLVGF-------CSEGSNRLLVYEFMRNGSLG-NL--LFRAEQRLSWSER 132
L+ + R LV LG +L + SER
Sbjct: 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-----LGRSLQSALDVSPKHVLSER 159
Query: 133 R--RIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKI--SDFGLSKLLKTDQT 188
++A +++ L +LH E +H ++ NI +D ++++ + +G +
Sbjct: 160 SVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 189 ------RTYTVLRGTRGYTAPELH-----SRNNRITVKADVYSFGVMLLEIVC 230
+ + G + + +LH SR ++D+ S G +L+ +
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPSR------RSDLQSLGYCMLKWLY 263
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 5e-10
Identities = 33/237 (13%), Positives = 62/237 (26%), Gaps = 64/237 (27%)
Query: 32 LASENFK--EEIGRGGSGRVYKGCINGGKEIAVKKL------------IKIVEEGESEFR 77
L +E + E+IG G G V++ I +A+K + K EE E
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 78 -----NEMKIIGRIHHKNLVDLVGFC------------------------------SEGS 102
+ + + + L +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162
+V EF G L + S + + I ++ L H D+
Sbjct: 136 QLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191
Query: 163 NILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVY 219
N+L+ ++ K+ K + G + +R+ V
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST----------IPSCGLQVSIIDYTLSRLERDGIVV 238
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 33/145 (22%), Positives = 54/145 (37%), Gaps = 45/145 (31%)
Query: 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166
+EF++ + Q R +A ++ L +LH+ ++ H D+KP NIL
Sbjct: 108 TFEFLKENN--------FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILF 156
Query: 167 DESWKA-------------------KISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
S +++DFG + D T++ TR Y PE+
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDHEHHTTIVA-TRHYRPPEV-- 210
Query: 208 RNNRI-----TVKADVYSFGVMLLE 227
I DV+S G +L E
Sbjct: 211 ----ILELGWAQPCDVWSIGCILFE 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 42/195 (21%), Positives = 72/195 (36%), Gaps = 63/195 (32%)
Query: 106 LVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNI 164
+V+E + + L + ++ Q L ++I ++++GL YLH +C RIIH DIKP NI
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENI 178
Query: 165 LM-------------------------------------------------DESWKAKIS 175
L+ E K KI+
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR--- 232
D G + + T + TR Y + E+ + AD++S M E+
Sbjct: 239 DLGNACW--VHKHFTEDI--QTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLF 293
Query: 233 --KNVDESLRDDEIV 245
+ +E RD++ +
Sbjct: 294 EPHSGEEYTRDEDHI 308
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 31/142 (21%), Positives = 57/142 (40%), Gaps = 39/142 (27%)
Query: 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166
Y+F++ R++A +I + +++LH ++ H D+KP NIL
Sbjct: 103 TYDFIKENG--------FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILF 151
Query: 167 DESWKAKISDFGLSKLLKT----------------DQTRTYTVLRGTRGYTAPELHSRNN 210
+S + + + + +T D T++ TR Y APE+
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVS-TRHYRAPEV----- 205
Query: 211 RI-----TVKADVYSFGVMLLE 227
I + DV+S G +L+E
Sbjct: 206 -ILALGWSQPCDVWSIGCILIE 226
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 34/152 (22%), Positives = 60/152 (39%), Gaps = 53/152 (34%)
Query: 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166
+YE + + + + +EI++ L+YL + H D+KP NIL+
Sbjct: 122 LYEIITRNN--------YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILL 170
Query: 167 DESWKA-------------------------KISDFGLSKLLKTDQTRT-YTVLRGTRGY 200
D+ + K+ DFG + T ++ +++ TR Y
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TFKSDYHGSIIN-TRQY 225
Query: 201 TAPELHSRNNRI-----TVKADVYSFGVMLLE 227
APE+ I V +D++SFG +L E
Sbjct: 226 RAPEV------ILNLGWDVSSDMWSFGCVLAE 251
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.77 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.66 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.32 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.11 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.4 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.83 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.95 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=390.43 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=214.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
|..++|.+.++||+|+||.||+|++. ++..||||++........+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 44567889999999999999999874 367899999987666667789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK 171 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~ 171 (325)
.+|||||+++|+|.+++...+ ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999995432 4699999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHH
Q 047716 172 AKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDW 249 (325)
Q Consensus 172 vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 249 (325)
+||+|||+++........ ......+|+.|+|||.+ ....++.++|||||||++|||+| |+.||......+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~----- 240 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----- 240 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence 999999999765433322 11223478999999999 56678999999999999999998 89999876433211
Q ss_pred HHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 250 AHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
..+..+.. .+.+..++.++.++|.+||+.||++|||++||++.|+.+....
T Consensus 241 --~~i~~~~~-------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 241 --ECITQGRV-------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp --HHHHHTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred --HHHHcCCC-------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11222221 1122234467999999999999999999999999999887443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=391.63 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=211.3
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..|++.++||+|+||.||+|++. .++.||+|++..........+.+|+.+|+.++|||||++++++.+++.++|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 35889999999999999999987 68999999997665556667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++|+|.+++.+ +++++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 99999999843 5799999999999999999999999 999999999999999999999999999987654332 22
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
...+||+.|+|||++ ....|+.++|||||||++|+|++|++||.+....+... .+.... ........
T Consensus 228 ~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-------~i~~~~-----~~~~~~~~ 294 (346)
T 4fih_A 228 KSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIRDNL-----PPRLKNLH 294 (346)
T ss_dssp CCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSS-----CCCCSCGG
T ss_pred cccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------HHHcCC-----CCCCCccc
Confidence 334599999999998 56678999999999999999999999998654322211 111111 11111222
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
..+.++.+||.+||+.||++|||++|+++ ++.+..
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 33467999999999999999999999994 455443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=387.66 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=208.6
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
...++.+.++||+|+||.||+|++. ++..||||++........+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467788899999999999999874 3678999999876666677899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcc--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC
Q 047716 105 LLVYEFMRNGSLGNLLFRAE--------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW 170 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~ 170 (325)
+|||||+++|+|.+++.... +.+++..+..++.|++.|+.|||++ +|+||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence 99999999999999985432 3589999999999999999999999 999999999999999999
Q ss_pred cEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHH
Q 047716 171 KAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLID 248 (325)
Q Consensus 171 ~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 248 (325)
.+||+|||+++....... .......+|+.|+|||.+ ....++.++|||||||++|||+| |+.||......+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~---- 270 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI---- 270 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH----
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhh-cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH----
Confidence 999999999986543322 222334589999999999 56778999999999999999998 89999876433221
Q ss_pred HHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 249 WAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
..+..+. ..+.+..++.++.++|.+||+.||++|||++||++.|+.+...
T Consensus 271 ---~~i~~g~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 ---DCITQGR-------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HHHHHTC-------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HHHHcCC-------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111 1112223446799999999999999999999999999998743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-56 Score=384.51 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=207.7
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|++.+.||+|+||.||+|++. .++.+|+|++.+. .......+.+|+.+|+.++|||||++++++.+++.+++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999987 7889999999753 2344567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++|+|.+++.+ .+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 112 Ey~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999954 46899999999999999999999999 999999999999999999999999999987654322
Q ss_pred -cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 -RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
......+||+.|+|||++ .+..++.++|||||||++|+|++|++||.+....+.. .......+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-------~~i~~~~~-------- 251 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF-------AKIIKLEY-------- 251 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHH-HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCC--------
T ss_pred cccccCcccCcccCCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCC--------
Confidence 233445699999999999 5667899999999999999999999999865432211 11111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..+...+.++.+||.+||+.||.+|||++|++
T Consensus 252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12222345799999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=389.45 Aligned_cols=249 Identities=19% Similarity=0.309 Sum_probs=201.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++|+++++||+|+||.||+|++. .++.||+|++... .......+.+|+.+|+.++|||||++++++.+++.++||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 47999999999999999999987 6899999998653 23445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++|+|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||++........
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999999544 34578999999999999999999999 999999999999999999999999999986643221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
......||+.|+|||++ .+..++.++|||||||++|+|++|++||.+....+... . ...+... .
T Consensus 181 -~~~~~~GT~~YmAPE~l-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~-i~~~~~~-------~ 244 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEIC-ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------K-IISGSFP-------P 244 (350)
T ss_dssp -HHHHHHSCCTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------H-HHHTCCC-------C
T ss_pred -cccccCCCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------H-HHcCCCC-------C
Confidence 12234599999999999 56778999999999999999999999998754332211 1 1122211 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+...+.++.+||.+||+.||++|||++|+++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22233467999999999999999999999983
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=384.55 Aligned_cols=252 Identities=23% Similarity=0.242 Sum_probs=205.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..|++.++||+|+||.||+|++. .+..||+|++..... ..+|+.+++.++|||||++++++.+++.++|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45788899999999999999987 689999999865322 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeeccccccccCCCcc-
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFGLSKLLKTDQTR- 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~~~~~~~~- 189 (325)
++|+|.+++.+ .+.+++..++.++.|++.||.|||++ +|+||||||+|||++.+| .+||+|||++.........
T Consensus 133 ~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999954 46799999999999999999999999 999999999999999887 6999999999876543221
Q ss_pred ---ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 190 ---TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 190 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.....+||+.|+|||++ .+..++.++|||||||++|+|++|++||......+....+. .... +.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-------~~~~-----~~ 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVV-MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA-------SEPP-----PI 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-------HSCC-----GG
T ss_pred ceecCCccccCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-------cCCC-----Cc
Confidence 12234599999999999 56778999999999999999999999998765544332211 1110 00
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+.++..+..+.++|.+||+.||.+|||+.||++.|....
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1223334567999999999999999999999998776654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=375.33 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=192.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999987 68999999986532 233557889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+ +|+|.+++. ..+++++..++.++.|++.|+.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 93 Ey~-~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 93 EYA-GNELFDYIV-QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp ECC-CEEHHHHHH-HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 999 679999884 456899999999999999999999999 999999999999999999999999999976543322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....||+.|+|||.+.+..+++.++|||||||++|+|++|+.||......... .....+.. .
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~-------~~i~~~~~--------~ 230 (275)
T 3hyh_A 168 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF-------KNISNGVY--------T 230 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCC--------C
T ss_pred --cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCC--------C
Confidence 223459999999999965556678999999999999999999999865332111 11111111 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+...+.++.+++.+||+.||++|||++|+++
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11223456899999999999999999999994
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=380.38 Aligned_cols=264 Identities=27% Similarity=0.395 Sum_probs=208.3
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
+|..+++++.++||+|+||.||+|++++ .+|||++... .....+.+.+|+.++++++|||||++++++.+ +.++|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4555678899999999999999998764 5899988642 33445678999999999999999999998865 56899
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+++|+|.+++......+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999999976667899999999999999999999999 9999999999999999999999999999765432
Q ss_pred Cc-cceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 187 QT-RTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 187 ~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.. .......||+.|+|||.+.. ...++.++|||||||++|||+||+.||.+........ .....+.....
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~~~~~~p~- 258 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVGRGYASPD- 258 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHTTCCCCC-
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCCCCC-
Confidence 22 22334469999999999853 3458899999999999999999999998654322211 11111111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.......++..+.++|.+||+.||++|||+.||++.|+.+..
T Consensus 259 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 259 --LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp --STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred --cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 112233445679999999999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=385.54 Aligned_cols=264 Identities=21% Similarity=0.336 Sum_probs=214.2
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEe
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFC 98 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (325)
++.++..+++++.++||+|+||.||+|.+. .+..||||++.... ....+.+.+|+.++++++|||||++++++
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 334455677889999999999999999863 46789999986533 33456799999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRA---------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
.+++..++||||+++|+|.+++... ...+++..+..++.|++.|+.|||++ +|+||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccc
Confidence 9999999999999999999998532 24589999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
||+++++.+||+|||+++....... .......||+.|+|||.+ ....++.++||||||+++|||+| |+.||.+....
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI-MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHH-hCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999976543322 222334588999999998 56678999999999999999998 89999876433
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
+.. ..+..+... +.+..++..+.++|.+||+.||++|||++||++.|+.+.+
T Consensus 255 ~~~-------~~i~~~~~~-------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 255 DVV-------EMIRNRQVL-------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp HHH-------HHHHTTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred HHH-------HHHHcCCCC-------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 211 122222211 1223345679999999999999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=392.45 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=211.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..|++.++||+|+||.||+|++. .|+.||+|++..........+.+|+.+|+.++|||||++++++.+++.++||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 45999999999999999999987 68999999997655555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++|+|.+++. .+++++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||++......... .
T Consensus 231 ~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 304 (423)
T 4fie_A 231 EGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 304 (423)
T ss_dssp TTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-B
T ss_pred CCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-c
Confidence 9999999984 35699999999999999999999999 9999999999999999999999999999876543322 2
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
...+||+.|+|||++ ....|+.++|||||||++|+|++|++||.+....+... .+.... ........
T Consensus 305 ~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~-------~i~~~~-----~~~~~~~~ 371 (423)
T 4fie_A 305 KSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-------MIRDNL-----PPRLKNLH 371 (423)
T ss_dssp CCCEECTTTCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSC-----CCCCSCTT
T ss_pred cccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------HHHcCC-----CCCCcccc
Confidence 334599999999998 56778999999999999999999999998654322211 111111 11111122
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
..+.++.+||.+||+.||.+|||++|+++ +|.+..
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 23457999999999999999999999994 455443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=367.06 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=196.9
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeec----CCceEEE
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE----GSNRLLV 107 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 107 (325)
|++.++||+|+||.||+|.+. .+..||+|++... .......+.+|+.+++.++|||||++++++.+ ...++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999987 6889999998653 23345668899999999999999999998864 3457999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeeccCCCCceEEcC-CCcEEEeecccccccc
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR--IIHCDIKPHNILMDE-SWKAKISDFGLSKLLK 184 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nilv~~-~~~vkl~Dfg~~~~~~ 184 (325)
|||+++|+|.+++.+ .+.+++..++.++.|++.||.|||++ + |+||||||+|||++. ++.+||+|||++....
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999954 56899999999999999999999998 7 999999999999974 7899999999997543
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.. ......||+.|+|||.+. + .++.++|||||||++|+|++|++||......... ......+....
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~-~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~------~~~i~~~~~~~--- 249 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPA--- 249 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCG---
T ss_pred CC---ccCCcccCccccCHHHcC-C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH------HHHHHcCCCCC---
Confidence 32 233456999999999984 3 5899999999999999999999999765432211 11121111110
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+...+.++.++|.+||+.||++|||++|+++
T Consensus 250 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112346899999999999999999999984
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=375.09 Aligned_cols=246 Identities=23% Similarity=0.254 Sum_probs=196.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
++|++++.||+|+||.||+|++. .++.||+|++.... ......+.+|+.+|+.++|||||++++++.+++.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999873 46789999986532 2233457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+++|+|.+++.+ .+.+++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||++......
T Consensus 104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999954 46799999999999999999999999 9999999999999999999999999999765332
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. .....+||+.|+|||.+ .+..++.++|||||||++|+|++|++||.+....+... ......
T Consensus 180 ~~-~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-------~i~~~~-------- 242 (304)
T 3ubd_A 180 EK-KAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT-------MILKAK-------- 242 (304)
T ss_dssp -C-CCCSCCCCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC--------
T ss_pred Cc-cccccccCcccCCHHHh-ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH-------HHHcCC--------
Confidence 22 22334599999999999 56778999999999999999999999998754332211 111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCH-----hHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTM-----KQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell 299 (325)
...+...+.++.++|.+||+.||++|||+ +|++
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil 280 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK 280 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHH
Confidence 11222234679999999999999999984 6777
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=373.06 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=212.3
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCC-CCcceeeEEee
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHH-KNLVDLVGFCS 99 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~ 99 (325)
++|..++|++.++||+|+||.||+|.+.+ ++.||+|++.... ....+.+.+|+.+|.+++| ||||++++++.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 45678899999999999999999998753 3578999987543 3345678899999999975 89999999986
Q ss_pred c-CCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 100 E-GSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 100 ~-~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
+ ++.++||||||++|+|.+++.... ..+++..+..++.|++.|+.|||++ +|+||||||+|
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~N 215 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 215 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccc
Confidence 5 457899999999999999995432 3488999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
||++.++.+||+|||+++....... .......+|+.|+|||.+ .+..++.++|||||||++|||+| |+.||.+....
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l-~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH-hcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986644332 222334578999999999 56778999999999999999998 89999876543
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
+... ..+..+.- ...+..++.++.++|.+||+.||++|||+.||++.|+.+..
T Consensus 295 ~~~~------~~i~~g~~-------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 EEFC------RRLKEGTR-------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp HHHH------HHHHHTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH------HHHHcCCC-------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 3211 12222211 11222234579999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=356.17 Aligned_cols=254 Identities=21% Similarity=0.300 Sum_probs=190.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC-------
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------- 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 102 (325)
.++|++++.||+|+||.||+|++. ++..||+|++.... ......+.+|+.+|+.++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999987 78899999986533 334456889999999999999999999886543
Q ss_pred -----ceEEEEeecCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEe
Q 047716 103 -----NRLLVYEFMRNGSLGNLLFRAE--QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175 (325)
Q Consensus 103 -----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~ 175 (325)
.+++||||+++++|.+++.... ...+...++.++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999995432 2355677889999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCcc-----------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh
Q 047716 176 DFGLSKLLKTDQTR-----------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI 244 (325)
Q Consensus 176 Dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 244 (325)
|||++......... ......||+.|+|||.+ .+..++.++|||||||++|+|++ ||...... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI-HGNSYSHKVDIFSLGLILFELLY---PFSTQMER--V 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHH-cCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--H
Confidence 99999876543221 11224599999999999 56778999999999999999996 77532110 0
Q ss_pred hHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhcc
Q 047716 245 VLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGI 305 (325)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~ 305 (325)
. .......... +.........+.++|.+||+.||.+|||+.|+++ .++++
T Consensus 235 ---~-~~~~~~~~~~-------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 235 ---R-TLTDVRNLKF-------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp ---H-HHHHHHTTCC-------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred ---H-HHHHHhcCCC-------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 0 0011111111 1112233456789999999999999999999995 55554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=358.81 Aligned_cols=271 Identities=22% Similarity=0.254 Sum_probs=202.0
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCC----ceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS----NRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 108 (325)
.+|.+.++||+|+||.||+|+++ |..||||++..... .......|+..+..++|||||++++++.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46788899999999999999985 78999999865332 2223345677777889999999999987643 579999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC-----ETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~-----~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
||+++|+|.+++.. .++++..+..++.|++.|++|||+++ ..+|+||||||+|||++.++.+||+|||++...
T Consensus 81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999953 46899999999999999999999752 238999999999999999999999999999765
Q ss_pred cCCCcc---ceeeecCCCCcCCccccccCC-----CCCccccchhHHHHHHHHHhCCCCCCCccccchhh--------HH
Q 047716 184 KTDQTR---TYTVLRGTRGYTAPELHSRNN-----RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV--------LI 247 (325)
Q Consensus 184 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~--------~~ 247 (325)
...... ......||+.|+|||.+.+.. .++.++|||||||++|||+||++||.......... ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 443221 122345899999999985432 35679999999999999999988775433211100 01
Q ss_pred HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
...........++.-+... ....+....+.++|.+||+.||++|||+.||++.|+.+...
T Consensus 239 ~~~~~~~~~~~~rp~~p~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccCCCCCCcc-ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1112222222222111111 12335567899999999999999999999999999988643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=366.04 Aligned_cols=266 Identities=22% Similarity=0.317 Sum_probs=206.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeec------CCc
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE------GSN 103 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 103 (325)
++|++++.||+|+||.||+|.+. .|+.||||++.... ......+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46999999999999999999987 78999999986532 2334567889999999999999999998753 367
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
++|||||++ |+|.+++. ..+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++...
T Consensus 134 ~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999995 67988884 456899999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCC---ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 184 KTDQ---TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 184 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
.... ........||+.|+|||++.+..+++.++|||||||++++|++|++||.+....+....+. .........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~---~~~g~p~~~ 285 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM---MVLGTPSPA 285 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH---HHHCCCCGG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH---HhcCCCChH
Confidence 4322 1222335699999999998666788999999999999999999999998765444332221 111111000
Q ss_pred c-----------c---ccCCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 261 N-----------L---VSDQEDV-----NIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 261 ~-----------~---~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
. . ....... .+....++.+||.+||+.||.+|||++|+++ .++++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0 0 0000000 1112356899999999999999999999993 566554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=353.44 Aligned_cols=200 Identities=23% Similarity=0.375 Sum_probs=170.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 106 (325)
.++|++.++||+|+||.||+|+++ .++.||+|++... .....+.+|+.+|+.+ +||||+++++++.+.+.+++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 357999999999999999999864 4678999988653 3445678899999988 59999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-CcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vkl~Dfg~~~~~~~ 185 (325)
||||+++++|.+++ +.+++..++.++.|++.||.|||++ ||+||||||+|||++.+ +.+||+|||++.....
T Consensus 98 vmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 98 AMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999998 3589999999999999999999999 99999999999999876 7999999999975433
Q ss_pred CCc---------------------------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 047716 186 DQT---------------------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDES 238 (325)
Q Consensus 186 ~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 238 (325)
... .......||+.|+|||.+.+...++.++||||+||++++|++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 11122458999999999866677899999999999999999999999655
Q ss_pred cc
Q 047716 239 LR 240 (325)
Q Consensus 239 ~~ 240 (325)
.+
T Consensus 251 ~~ 252 (361)
T 4f9c_A 251 SD 252 (361)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=373.53 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=210.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
++|++.+.||+|+||.||+|.+. .++.+|+|++..........+.+|+.+|+.++||||+++++++.+.+.+++||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999987 78999999997766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC--CcEEEeeccccccccCCCcc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES--WKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~--~~vkl~Dfg~~~~~~~~~~~ 189 (325)
++|+|.+++....+.+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++........
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~- 312 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 312 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE-
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc-
Confidence 99999999966667899999999999999999999999 99999999999999854 7999999999987654332
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
....+||+.|+|||++ .+..++.++|||||||++|+|++|.+||.+....+... .+....+. .....
T Consensus 313 -~~~~~GT~~y~APEv~-~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~-------~i~~~~~~----~~~~~ 379 (573)
T 3uto_A 313 -VKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-------NVKSCDWN----MDDSA 379 (573)
T ss_dssp -EEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHTTCCC----CCSGG
T ss_pred -eeeeEECccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------HHHhCCCC----CCccc
Confidence 3345699999999999 56678999999999999999999999998765432211 11111111 01111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+.++.+||.+||+.||.+|||++|+++
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1123456899999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=368.18 Aligned_cols=248 Identities=24% Similarity=0.275 Sum_probs=202.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHH---HHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFR---NEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
++|++++.||+|+||.||+|++. .++.+|+|++.+.. ......+. .++.+++.++|||||++++.+.+.+.++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56999999999999999999987 68999999986532 12222233 3467778889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++.....
T Consensus 269 lVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999954 46799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
... ...+||+.|+|||++.++..++.++|+|||||++|+|++|++||.+....+..... ..... .
T Consensus 345 ~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~i~~--------~ 409 (689)
T 3v5w_A 345 KKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT--------M 409 (689)
T ss_dssp CCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HHHHH--------C
T ss_pred CCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhhcC--------C
Confidence 332 33469999999999965677899999999999999999999999865443322111 11111 1
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPT-----MKQVI 299 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell 299 (325)
....+...+.++.+||.+||+.||.+|++ ++||+
T Consensus 410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 410 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 11222233467999999999999999998 68887
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=336.19 Aligned_cols=272 Identities=35% Similarity=0.659 Sum_probs=232.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.++|++.+.||+|+||.||+|.+.++..+|+|++..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred HhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 36789999999999999999998889999999987766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 112 RNGSLGNLLFRAE---QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 112 ~~~~L~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
++++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999985432 3589999999999999999999999 999999999999999999999999999876443222
Q ss_pred -cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC-
Q 047716 189 -RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ- 266 (325)
Q Consensus 189 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 266 (325)
.......+++.|+|||.+ ....++.++||||||+++++|++|+.||......+......|.......+.+...+++.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCBCCCEEETTTCCHHHH-HHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred cccccccCCCccccCHHHh-cCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 122223478999999998 45678899999999999999999999998877666666666666666666666665544
Q ss_pred -CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 267 -EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 267 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
....+.....+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 34577888999999999999999999999999999998763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=336.31 Aligned_cols=285 Identities=39% Similarity=0.685 Sum_probs=230.8
Q ss_pred cccccHHHH--HHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEe
Q 047716 22 LRSFSYEQI--VLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFC 98 (325)
Q Consensus 22 ~~~~~~~~~--~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (325)
...|++.++ ...+|++.+.||+|+||.||+|.+.++..+|+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 444555554 4788999999999999999999988899999999875432 2233688999999999999999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEe
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAE---QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKIS 175 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~ 175 (325)
...+..++||||+.+++|.+++.... ..+++..++.++.|++.|+.|||+++..|++|+||+|+||+++.++.++|+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999985432 348999999999999999999999766699999999999999999999999
Q ss_pred eccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcc--ccchhhHHHHHHHH
Q 047716 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESL--RDDEIVLIDWAHQC 253 (325)
Q Consensus 176 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--~~~~~~~~~~~~~~ 253 (325)
|||++...............+++.|+|||.+ ....++.++||||||+++++|++|+.||+... .........|....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHH-HHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHh-ccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987655444444445589999999998 45567899999999999999999999996322 12222334444444
Q ss_pred HHhCcccccccCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 254 YEAGELQNLVSDQ--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 254 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.....+....+.. ..........+.+++.+||+.||.+|||+.||++.|++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 4444444444433 34567788899999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=327.58 Aligned_cols=259 Identities=24% Similarity=0.417 Sum_probs=212.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
.++|++.+.||+|+||.||+|.+. ++..+++|++..........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467889999999999999999987 6888999988776667778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999977677899999999999999999999999 99999999999999999999999999997654332211
Q ss_pred e-------------eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 191 Y-------------TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 191 ~-------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
. ....|++.|+|||.+ .+..++.++||||||+++++|++|..|+............. ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~~~~ 243 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFLDRY 243 (310)
T ss_dssp --------------CCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHHHHT
T ss_pred cccccccccccccccccCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhcccccc
Confidence 1 133488999999998 56778999999999999999999999987654332211000 00111100
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 244 -----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 244 -----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01112245899999999999999999999999999887
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=334.61 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=205.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
..+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 457999999999999999999985 78999999986542 344556889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++........
T Consensus 94 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 94 EYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp CCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred ECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999999999844 46799999999999999999999999 999999999999999999999999999876543322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....+++.|+|||.+.+....+.++||||||+++++|++|+.||.+....+.. .....+.. .
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~--------~ 232 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-------ERVLRGKY--------R 232 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC--------C
T ss_pred --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC--------C
Confidence 223458999999999965555568999999999999999999999876432211 11111111 1
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+...+..+.+++.+||+.||.+|||++|+++
T Consensus 233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 12223456899999999999999999999993
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=328.42 Aligned_cols=256 Identities=21% Similarity=0.333 Sum_probs=210.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.||+|+||.||+|.+. .+..+|+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 467999999999999999999976 7889999999876666777889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+.+++|.+++.. ..+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 99 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp CTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 999999999844 4689999999999999999999999 9999999999999999999999999998765543322
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....+++.|+|||.+ .+..++.++||||||+++++|++|+.||........... ...... .....+
T Consensus 173 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~~------~~~~~~ 239 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT------PELQNP 239 (297)
T ss_dssp BCCCCSCGGGCCHHHH-HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHCS------CCCSCG
T ss_pred cCCccCCcCccChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCC------CCCCCc
Confidence 2233489999999998 566789999999999999999999999976543222111 111111 011112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
......+.+++.+||+.||.+|||++|+++ .++...
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 223456899999999999999999999994 444433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=323.12 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=213.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..++|++.+.||+|+||.||+|.+.++..+|+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 457899999999999999999999888889999986533 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 999999999976666799999999999999999999999 99999999999999999999999999998665443333
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....+++.|+|||.+ ....++.++||||||+++++|++ |+.||.......... ....... ...
T Consensus 162 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~~~-------~~~ 226 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVF-HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-------KVSQGHR-------LYR 226 (268)
T ss_dssp CCSCCCCGGGCCHHHH-HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-------HHHTTCC-------CCC
T ss_pred ccCCCcCcccCCHHHH-hccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-------HHHcCCC-------CCC
Confidence 2333356679999998 55667889999999999999999 999997654432211 1111110 011
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
+...+..+.+++.+||+.+|.+|||+.|+++.|+.+.+.
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111235699999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=328.60 Aligned_cols=263 Identities=28% Similarity=0.429 Sum_probs=203.8
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+...+|++.+.||+|+||.||+|.+ .+..+|+|++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 4467899999999999999999987 47889999986543 33345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 108 YEFMRNGSLGNLLFRAE--QRLSWSERRRIALEIMEGLHYLHDECETR--IIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
|||+++++|.+++.... ..+++..++.++.|++.|+.|||++ | ++|+||||+||+++.++.++|+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999985432 2389999999999999999999999 9 999999999999999999999999998754
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
..... ......+++.|+|||.+ .+..++.++||||||+++++|++|+.||......+... ......
T Consensus 190 ~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------~~~~~~------ 255 (309)
T 3p86_A 190 ASTFL-SSKSAAGTPEWMAPEVL-RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------AVGFKC------ 255 (309)
T ss_dssp -------------CCTTSCHHHH-TTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHHSC------
T ss_pred ccccc-ccccCCCCccccChhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcC------
Confidence 33221 12223489999999998 56677899999999999999999999998654322111 110011
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQN 311 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 311 (325)
.....+......+.++|.+||+.+|.+|||+.++++.|+.+.....+
T Consensus 256 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 256 -KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred -CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 11122223345699999999999999999999999999999865433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=327.30 Aligned_cols=268 Identities=21% Similarity=0.320 Sum_probs=209.0
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
..++|++.++||+|+||.||+|.+.+++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4478999999999999999999998899999999865332 22456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++ +|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++........
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99974 78888766667799999999999999999999999 999999999999999999999999999986643322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc------
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL------ 262 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 262 (325)
. .....+++.|+|||.+.+...++.++||||||+++++|++|+.||......+....+ ............
T Consensus 175 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 175 S-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI---FSILGTPNPREWPQVQEL 250 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH---HHHHCCCCTTTSGGGTTS
T ss_pred c-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHHCCCChHHhhhhhcc
Confidence 1 222347999999999866677899999999999999999999999876655433221 111111110000
Q ss_pred ----------ccCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 263 ----------VSDQ--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 263 ----------~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
.... ....+....++.+++.+||+.||.+|||++|+++ .++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 0000 0011122356899999999999999999999994 555544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=322.49 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=211.8
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.++|++.+.||+|+||.||+|.+.++..+|+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46899999999999999999999888899999986543 34467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++...........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999976667799999999999999999999999 999999999999999999999999999876543332222
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
....++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. ...... .. ...+
T Consensus 165 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~-------~~~~~~-~~------~~~~ 229 (269)
T 4hcu_A 165 TGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTG-FR------LYKP 229 (269)
T ss_dssp TSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTT-CC------CCCC
T ss_pred cCcccccccCCHHHh-cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhcC-cc------CCCC
Confidence 223356789999998 55678999999999999999999 99999865433211 111111 00 1111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
......+.+++.+||+.+|.+|||+.|+++.|+++..
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1223569999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=323.77 Aligned_cols=266 Identities=24% Similarity=0.349 Sum_probs=209.8
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
++..++|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 345678999999999999999999987 68899999885433 23345688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++....
T Consensus 87 ~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999999954 45799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
...........+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... ..... ......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~-~~~~~~-- 232 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQA-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQ-DSVPNV-- 232 (294)
T ss_dssp ------------CCSSCCHHHH-HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHS-SCCCCH--
T ss_pred cccccccCccccCccccCHhHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhh-ccCCCc--
Confidence 4443333344589999999998 5667789999999999999999999999875432211 11111 111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHhHHHHHHhccCCCC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRP-TMKQVIWMMEGIVPPH 309 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~L~~~~~~~ 309 (325)
........+..+.+++.+||+.||.+|| +++++.+.|+.+....
T Consensus 233 -~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 -TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0111222345699999999999999998 9999999999987433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=329.56 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=211.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
+...+|++.+.||+|+||.||+|.+. .+..+|+|++... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 45678999999999999999999985 3445999998754 334456788999999999999999999999998999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++....+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++....
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999976667899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccce--eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 185 TDQTRTY--TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 185 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
....... ....++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. .......
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~--- 271 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAI-AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-------SSVEEGY--- 271 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-------HHHHTTC---
T ss_pred cCccceeeccCCCCcccccCHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHcCC---
Confidence 4322211 112246689999998 55678899999999999999999 99999765433211 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
....+...+..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 272 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 ----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1112223346799999999999999999999999999998843
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=320.19 Aligned_cols=264 Identities=17% Similarity=0.254 Sum_probs=214.3
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 107 (325)
+..++|++.+.||+|++|.||+|.+. ++..+|+|++.... ....+.+|+..++.+ +|+|++.+++++......++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 44678999999999999999999975 78899999886533 233577899999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc-----EEEeecccccc
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK-----AKISDFGLSKL 182 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~-----vkl~Dfg~~~~ 182 (325)
|||+ +++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++. ++|+|||++..
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 9999999976666799999999999999999999999 9999999999999987765 99999999986
Q ss_pred ccCCCcc------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 183 LKTDQTR------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 183 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
....... ......+++.|+|||.+ .+..++.++||||||+++++|++|+.||.....................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 6543221 12334589999999998 5667899999999999999999999999886554443333222222222
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
........ ..+..+.+++.+||+.+|.+|||+++|++.|+++..
T Consensus 240 ~~~~~~~~-------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 240 TPLRELCA-------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp SCHHHHTT-------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHHHh-------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 22221111 123579999999999999999999999999998874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=320.22 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=210.5
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++..++|++.+.||+|+||.||+|.+.++..+++|++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 35568999999999999999999999988899999987543 33467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999976667899999999999999999999999 999999999999999999999999999876543322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......+++.|+|||.+ ....++.++||||||+++++|++ |+.||......... ....... . .
T Consensus 176 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~-~------~ 240 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQGL-R------L 240 (283)
T ss_dssp HSTTSTTSCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHTTC-C------C
T ss_pred ccccCCccCcccCCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-------HHHhccc-C------C
Confidence 222222356789999998 45568899999999999999998 99999865433211 1111111 0 0
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
..+......+.+++.+||+.+|.+|||++|+++.|+.+.+
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1111123569999999999999999999999999988753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=324.06 Aligned_cols=247 Identities=23% Similarity=0.283 Sum_probs=204.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.++|++.+.||+|+||.||+|++. .++.+|+|++.+. .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999987 6889999998753 234456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999999998843 46799999999999999999999999 99999999999999999999999999987543222
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
. ......||+.|+|||.+ .+..++.++|+||||+++++|++|+.||......... ....... .
T Consensus 160 ~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~--------~ 222 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEE--------I 222 (337)
T ss_dssp C-CBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC--------C
T ss_pred C-cccccccChhhCChhhh-cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC--------C
Confidence 1 22234589999999998 5667899999999999999999999999765432211 1111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
..+.....++.++|.+||+.||.+|| +++|++
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~ 259 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHH
Confidence 11222346799999999999999999 899998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=320.93 Aligned_cols=269 Identities=25% Similarity=0.383 Sum_probs=209.3
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEe----C-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec--
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCI----N-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-- 100 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~----~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 100 (325)
.++...+|++.++||+|+||.||+|++ . .+..+|+|++..........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 345668899999999999999999984 2 688899999887666666788999999999999999999999854
Q ss_pred CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
....++||||+++++|.+++......+++..++.++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 3568999999999999999977666799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc---------hhhHHHH
Q 047716 181 KLLKTDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD---------EIVLIDW 249 (325)
Q Consensus 181 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---------~~~~~~~ 249 (325)
......... ......++..|+|||.+ .+..++.++||||||+++++|++|..|+....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHh-cCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 765433221 11122356679999998 45678999999999999999999999986532110 0000111
Q ss_pred HHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 250 AHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
......... ....+...+.++.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 241 ~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNG-------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTC-------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccC-------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111111111 111222344679999999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=325.68 Aligned_cols=245 Identities=21% Similarity=0.346 Sum_probs=202.8
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 78899999986532 223456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+ +++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++........
T Consensus 89 E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 89 EYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred ECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 999 6788888743 46799999999999999999999999 999999999999999999999999999876544332
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....+++.|+|||.+.+....+.++||||||+++++|++|+.||........ ...+......
T Consensus 164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~~~~ 226 (336)
T 3h4j_B 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSCVYV 226 (336)
T ss_dssp --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSSCCC
T ss_pred --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcCCCC
Confidence 22334899999999996555557899999999999999999999976543221 1111111222
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.+...+..+.+++.+||+.||.+|||++|++
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil 257 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIR 257 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHT
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 2333446789999999999999999999999
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=320.51 Aligned_cols=260 Identities=26% Similarity=0.327 Sum_probs=202.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++|++.+.||+|+||.||+|.+..++.+|+|++.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 3688999999999999999999889999999986433 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++ +|.+++....+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 965 89998866667899999999999999999999999 999999999999999999999999999876543221 1
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc---c------
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ---N------ 261 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~------ 261 (325)
.....+++.|+|||.+.+...++.++||||||+++++|++|++||......+.... ........... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHHCCCChhhchhhhcccc
Confidence 12234789999999986566789999999999999999999999987543322211 11111111000 0
Q ss_pred ---cccCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 ---LVSDQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ---~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..... ..........+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0011123456899999999999999999999983
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=328.55 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=208.8
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC--------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN--------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~--------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
...+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3578999999999999999999863 34569999986543 33456788999999999 89999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceE
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNIL 165 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil 165 (325)
.+..++||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||||+||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 999999999999999999986543 3478999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccch
Q 047716 166 MDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDE 243 (325)
Q Consensus 166 v~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~ 243 (325)
++.++.+||+|||++........ .......+++.|+|||.+ .+..++.++||||||+++|+|++ |+.||......+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999976543222 111222356789999998 56778999999999999999999 9999987544332
Q ss_pred hhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 244 IVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.. ....+. ....+......+.++|.+||+.+|.+|||+.|+++.|+.+.
T Consensus 315 ~~-------~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 315 FK-------LLKEGH-------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HH-------HHHTTC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-------HHhcCC-------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 111111 11122234467999999999999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=328.07 Aligned_cols=259 Identities=23% Similarity=0.384 Sum_probs=207.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC-C-------cEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING-G-------KEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-~-------~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
+..++|++.+.||+|+||.||+|.+.. + ..+++|++..........+.+|+.+++.++||||+++++++...
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 445789999999999999999998763 3 46999998777667778899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc--------EE
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK--------AK 173 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~--------vk 173 (325)
+..++||||+++++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++. ++
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999976666699999999999999999999999 9999999999999988877 99
Q ss_pred EeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHH
Q 047716 174 ISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 253 (325)
|+|||++....... ...++..|+|||.+.+...++.++||||||+++++|++|+.|+.......... . ..
T Consensus 162 l~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--~---~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--Q---FY 231 (289)
T ss_dssp ECCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--H---HH
T ss_pred eccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH--H---Hh
Confidence 99999986543221 12368899999998554778999999999999999999665554333221111 0 00
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCCC
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQN 311 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 311 (325)
.....+. ......+.+++.+||+.||.+|||++|+++.|+.+..+...
T Consensus 232 ~~~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 232 EDRHQLP----------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HTTCCCC----------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred hccCCCC----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 1111111 11124588999999999999999999999999999964443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=327.26 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=203.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh------cHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE------GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
...|++.+.||+|+||.||+|.+. ++..+|+|++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457999999999999999999987 6889999998764322 356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC----cEEEeecccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW----KAKISDFGLS 180 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~----~vkl~Dfg~~ 180 (325)
++||||+++++|.+++. ..+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHT-TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999994 346799999999999999999999999 999999999999998776 7999999999
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
........ .....|++.|+|||.+ ....++.++||||||+++|+|++|.+||.+....+.. .......+.
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~-------~~i~~~~~~ 236 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANITAVSYD 236 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTTCCC
T ss_pred eEcCCCCc--cccCCCCccEECchHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCCC
Confidence 86654322 2234489999999998 5667889999999999999999999999875432211 111111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.........+..+.++|.+||+.||.+|||+.|++
T Consensus 237 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 237 ----FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp ----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ----CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000011235699999999999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=320.26 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=204.3
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
|+..++||+|+||.||+|.+. +++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 667789999999999999987 7899999999776666677889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
++|.+++. ...+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 127 ~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 200 (321)
T 2c30_A 127 GALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 200 (321)
T ss_dssp CBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCC
T ss_pred CCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-ccc
Confidence 99999984 35699999999999999999999999 9999999999999999999999999998765543222 223
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (325)
..+++.|+|||.+ ....++.++||||||+++++|++|+.||......... ....... .+........
T Consensus 201 ~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-------~~~~~~~-----~~~~~~~~~~ 267 (321)
T 2c30_A 201 LVGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-------KRLRDSP-----PPKLKNSHKV 267 (321)
T ss_dssp CCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSS-----CCCCTTGGGS
T ss_pred ccCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCC-----CCCcCccccC
Confidence 3489999999998 5667889999999999999999999999765432211 1111111 1111111223
Q ss_pred HHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 274 FENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 274 ~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...+.+++.+||+.||.+|||++|+++
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 356899999999999999999999994
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=324.49 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=204.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
++|++.+.||+|+||.||+|.+. ++..+++|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 57899999999999999999987 5778888887643 344566889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC--CCcEEEeeccccccccCCCcc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE--SWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~--~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
++++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++. ++.++|+|||++........
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence 99999999966566799999999999999999999999 9999999999999987 78999999999987654332
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....+++.|+|||.+ .+..++.++||||||+++++|++|..||......+.. .......... ....
T Consensus 160 -~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~----~~~~ 226 (321)
T 1tki_A 160 -FRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-------ENIMNAEYTF----DEEA 226 (321)
T ss_dssp -EEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCCCC----CHHH
T ss_pred -cccccCChhhcCcHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH-------HHHHcCCCCC----Chhh
Confidence 2334589999999998 4566789999999999999999999999875432211 1111111110 0000
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+.++.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0112356999999999999999999999993
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=328.80 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=207.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.||+|+||.||+|.+. .+..+|+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357999999999999999999987 6888999988766555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC--CCcEEEeeccccccccCCCc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE--SWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~--~~~vkl~Dfg~~~~~~~~~~ 188 (325)
+.+++|.+++......+++..++.++.|++.||.|||++ |++|+||||+||+++. ++.++|+|||++........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 999999999966566799999999999999999999999 9999999999999974 46799999999987654332
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....+++.|+|||.+ ....++.++||||||+++++|++|..||......+.. .......+. ....
T Consensus 207 --~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~i~~~~~~----~~~~ 272 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRCDWE----FDED 272 (387)
T ss_dssp --EEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHHCCCC----CCSS
T ss_pred --eeeeccCCCccCchhc-cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC----CCcc
Confidence 2233589999999998 5667889999999999999999999999865432211 111111111 0111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......++.++|.+||+.||.+|||+.|+++
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11223456999999999999999999999994
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=321.94 Aligned_cols=252 Identities=22% Similarity=0.321 Sum_probs=204.9
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh------cHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE------GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
....|++.+.||+|+||.||+|.+. .+..+|+|++...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4578999999999999999999987 6889999998753321 35678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC----cEEEeeccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW----KAKISDFGL 179 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~----~vkl~Dfg~ 179 (325)
.++||||+++++|.+++. ....+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++ .++|+|||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999999994 346799999999999999999999999 999999999999998887 799999999
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
+........ .....+++.|+|||.+ ....++.++||||||+++++|++|..||......+... .......
T Consensus 165 a~~~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~~~~~~~ 234 (326)
T 2y0a_A 165 AHKIDFGNE--FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAVNY 234 (326)
T ss_dssp CEECCTTSC--CCCCCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHHTCC
T ss_pred CeECCCCCc--cccccCCcCcCCceee-cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHHhcCC
Confidence 986643322 2223489999999998 56678899999999999999999999997654322111 1111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 260 QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. . ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~-~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E-F---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-C---CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-c---CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0 00000112356899999999999999999999994
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=320.01 Aligned_cols=267 Identities=20% Similarity=0.315 Sum_probs=193.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
.++|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999987 68899999986543 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 110 FMRNGSLGNLLFRAE-----QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
|++ ++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 58988885432 4589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc------
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE------ 258 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 258 (325)
..... .....+++.|+|||.+.+...++.++||||||+++++|++|+.||......+.... .........
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL---IFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCTTTCGG
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCChhHhhh
Confidence 32221 12234789999999986556789999999999999999999999987654332211 111111000
Q ss_pred ------ccccccCC----------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 259 ------LQNLVSDQ----------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 259 ------~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
+...+... ..........+.+++.+||+.||.+|||++|++ ..+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 00000000 000011235699999999999999999999999 3555554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.81 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=204.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
....+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35688999999999999999999987 68889999886532 3445668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc---CCCcEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD---ESWKAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~---~~~~vkl~Dfg~~~~~ 183 (325)
||||+.+++|.+.+.. .+.+++..+..++.|++.|+.|||++ ||+|+||||+||+++ .++.+||+|||++...
T Consensus 88 v~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999998844 46799999999999999999999999 999999999999998 4678999999999766
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...... .....|++.|+|||.+ ....++.++||||||+++++|++|.+||......... .....+....
T Consensus 164 ~~~~~~-~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~~-- 232 (444)
T 3soa_A 164 EGEQQA-WFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-------QQIKAGAYDF-- 232 (444)
T ss_dssp CTTCCB-CCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTCCCC--
T ss_pred cCCCce-eecccCCcccCCHHHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-------HHHHhCCCCC--
Confidence 543322 2234489999999998 5667889999999999999999999999765432211 1122222111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 --~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 --PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111123356999999999999999999999994
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=312.90 Aligned_cols=281 Identities=36% Similarity=0.608 Sum_probs=222.3
Q ss_pred cccccccccHHHHHHHHHhhh--------hhcCcCCceeEEEEEeCCCcEEEEEEeeccc----hhcHHHHHHHHHHHhc
Q 047716 18 EEIKLRSFSYEQIVLASENFK--------EEIGRGGSGRVYKGCINGGKEIAVKKLIKIV----EEGESEFRNEMKIIGR 85 (325)
Q Consensus 18 ~~~~~~~~~~~~~~~~~y~~~--------~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~ 85 (325)
+..++..|++.++....-++. +.||+|+||.||+|.+ .+..+++|++.... ......+.+|+.+++.
T Consensus 8 ~~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp ---CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 344667889999887665544 5699999999999987 57889999886532 2345678899999999
Q ss_pred cCCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 86 IHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRA--EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 86 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
++||||+++++++.+.+..+++|||+++++|.+++... ...+++..++.++.|++.|+.+||++ |++|+||+|+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 99999999999999999999999999999999998543 34589999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD 242 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 242 (325)
|+++.++.++|+|||++......... ......+++.|+|||.+. ..++.++||||||+++++|++|.+||.......
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999998765433221 122234789999999883 347889999999999999999999998765443
Q ss_pred hhhHHHHHHHHHH-hCcccccccCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 243 EIVLIDWAHQCYE-AGELQNLVSDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 243 ~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
....+ ...... ...+...+... ..........+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 242 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 LLLDI--KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BTTHH--HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHH--HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 32221 111111 11222333322 3456777889999999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=322.93 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=201.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57999999999999999999987 78899999986433 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-c
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT-R 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~-~ 189 (325)
+++++|.+++. ....+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........ .
T Consensus 87 ~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 87 CSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999984 445799999999999999999999999 999999999999999999999999999976543222 2
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
......+++.|+|||.+.+....+.++||||||+++++|++|+.||.......... ..+ ..... ... .
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~-----~~~~~--~~~----~ 230 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW-----KEKKT--YLN----P 230 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHH-----HTTCT--TST----T
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHH-----hcccc--cCC----c
Confidence 22234589999999998655556889999999999999999999998765433221 111 11100 000 0
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......+.+++.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1122356889999999999999999999983
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=314.52 Aligned_cols=268 Identities=21% Similarity=0.259 Sum_probs=212.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC--ceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS--NRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 107 (325)
..+|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 457999999999999999999988 58899999987543 344566789999999999999999999987654 77999
Q ss_pred EeecCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE----cCCCcEEEeeccccc
Q 047716 108 YEFMRNGSLGNLLFRAEQ--RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM----DESWKAKISDFGLSK 181 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv----~~~~~vkl~Dfg~~~ 181 (325)
|||+++++|.+++..... .+++..++.++.|++.|+.|||++ |++|+||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999965432 399999999999999999999999 99999999999999 777889999999998
Q ss_pred cccCCCccceeeecCCCCcCCcccccc-------CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSR-------NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
........ ....+++.|+|||.+.. ...++.++||||||+++++|++|+.||............ .....
T Consensus 165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYKII 240 (319)
T ss_dssp ECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH--HHHHH
T ss_pred ecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH--HHHHh
Confidence 66543322 22348999999998742 467789999999999999999999999754433222111 11112
Q ss_pred HhCc----------------ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 255 EAGE----------------LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 255 ~~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.... +.................+.+++.+||+.||++|||++|+++......
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111 011112223445677788999999999999999999999998776544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.34 Aligned_cols=255 Identities=24% Similarity=0.244 Sum_probs=205.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.++|++.++||+|+||.||+|++. .++.+|+|++.+... .....+.+|..++..++||||+++++++.+.+.+++|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 467899999999999999999988 578889999865321 2223378899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++....+.+++..++.++.|++.|+.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999966567899999999999999999999999 99999999999999999999999999997665444
Q ss_pred ccceeeecCCCCcCCccccc----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 188 TRTYTVLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
........||+.|+|||.+. +...++.++||||||+++++|++|++||......+....+. .......+...
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~~~~~p~~- 305 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---NHKERFQFPTQ- 305 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---THHHHCCCCSS-
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh---hccccccCCcc-
Confidence 33333456899999999985 24568899999999999999999999998764433222111 00000111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHhHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNL--RPTMKQVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~ell 299 (325)
....+..+.++|.+||+.+|+. ||+++|++
T Consensus 306 ------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil 337 (437)
T 4aw2_A 306 ------VTDVSENAKDLIRRLICSREHRLGQNGIEDFK 337 (437)
T ss_dssp ------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHH
T ss_pred ------cccCCHHHHHHHHHHhcccccccCCCCHHHHh
Confidence 1112356999999999888888 99999999
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=319.81 Aligned_cols=260 Identities=17% Similarity=0.210 Sum_probs=210.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
..+|++.+.||+|+||.||+|.+. .+..+|+|++..... ...+..|+.+++.+ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 467999999999999999999985 788999998865332 23578899999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc-----EEEeecccccccc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK-----AKISDFGLSKLLK 184 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~-----vkl~Dfg~~~~~~ 184 (325)
|+ +++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++. ++|+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 9999999976667899999999999999999999999 9999999999999998887 9999999998654
Q ss_pred CCCcc------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 185 TDQTR------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 185 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
..... ......|++.|+|||.+ .+..++.++||||||+++++|++|+.||......+................
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTH-LGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHH-cCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 33221 12334589999999998 567789999999999999999999999988655444332222222111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..... . ..+ ++.+++..||+.+|.+||++++|.+.|+.+.
T Consensus 241 ~~~~~----~---~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 241 IEVLC----E---NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHHHT----T---TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHh----c---cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 11000 0 012 6999999999999999999999999998765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=332.62 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=209.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+...+|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 44578899999999999999999997 78899999987543 22334578899999999999999999999988899999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++......++...++.++.|++.|+.|||++ |++|+||+|+||+++.++.+||+|||++.......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999999976666799999999999999999999999 99999999999999999999999999987543322
Q ss_pred ccce-eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 188 TRTY-TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 188 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
.... ....++..|+|||.+ ....++.++||||||+++|+|++ |..||......+.. .....+..
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~------ 333 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEAL-NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEKGGR------ 333 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHTTCC------
T ss_pred eeecCCCCCCCcCcCCHhHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC------
Confidence 1111 111135679999998 45667899999999999999998 99999865432211 11111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+..++..+.++|.+||+.||.+|||++++++.|+.+.
T Consensus 334 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 334 -LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1112223457999999999999999999999999998875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=316.36 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=198.3
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
+...+|++.+.||+|+||.||+|.+.. +..+++|++... .......+.+|+.+++.++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345789999999999999999998753 446888887653 2334556889999999999999999999984 4678
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 999999999999999976666799999999999999999999999 99999999999999999999999999997665
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...........+++.|+|||.+ ....++.++||||||+++++|++ |..||......+... .......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~-------~i~~~~~---- 235 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-------RIENGER---- 235 (281)
T ss_dssp -----------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTCC----
T ss_pred cccccccccCCCcccccChhhc-ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH-------HHHcCCC----
Confidence 4333222233367789999998 45678899999999999999996 999998765443221 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122233467999999999999999999999999998875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=316.51 Aligned_cols=270 Identities=23% Similarity=0.256 Sum_probs=210.1
Q ss_pred cccccCCCccccccccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHH
Q 047716 7 ISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKII 83 (325)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l 83 (325)
.+.+-.....+...++.+...+++..++|++.++||+|+||+||+|.+. ++..+|+|++.... .........|+..+
T Consensus 31 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~ 110 (311)
T 3p1a_A 31 VSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110 (311)
T ss_dssp CCSSCCSCSSCCCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHH
T ss_pred eeccCCCCcccCCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHH
Confidence 3334444555666677777788889999999999999999999999997 78999999876432 22233344455555
Q ss_pred hcc-CCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 84 GRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 84 ~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
..+ +||||+++++++.+.+..++||||+ +++|.+++......+++..++.++.|++.|+.|||++ +++|+||||+
T Consensus 111 ~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 186 (311)
T 3p1a_A 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred HHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHH
Confidence 444 8999999999999999999999999 6799998877677899999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD 242 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 242 (325)
||+++.++.+||+|||++........ .....+++.|+|||.+. + .++.++||||||+++++|++|..|+......
T Consensus 187 NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~- 261 (311)
T 3p1a_A 187 NIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELLQ-G-SYGTAADVFSLGLTILEVACNMELPHGGEGW- 261 (311)
T ss_dssp GEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGG-T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-
T ss_pred HEEECCCCCEEEccceeeeecccCCC--CcccCCCccccCHhHhc-C-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-
Confidence 99999999999999999876543322 22334899999999984 3 6889999999999999999998776543211
Q ss_pred hhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 243 EIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......... .........+.+++.+||+.||.+|||++|+++
T Consensus 262 ---------~~~~~~~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 262 ---------QQLRQGYLPP------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---------HHHTTTCCCH------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---------HHHhccCCCc------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111111110 011112367999999999999999999999994
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=314.78 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=210.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.++|++.+.||+|+||.||+|.+.++..+++|++.... .....+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46899999999999999999999888899999987643 33467889999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++...........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 99999999976667799999999999999999999999 999999999999999999999999999876543222111
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
....++..|+|||.+ ....++.++||||||+++++|++ |+.||......... .....+. . ...+
T Consensus 163 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~i~~~~-~------~~~~ 227 (267)
T 3t9t_A 163 TGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTGF-R------LYKP 227 (267)
T ss_dssp TSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTC-C------CCCC
T ss_pred ccccccccccChhhh-cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH-------HHHhcCC-c------CCCC
Confidence 222356789999998 45667899999999999999999 89999765432211 1111111 0 1111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
......+.+++.+||+.+|.+|||++++++.|+++..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1223569999999999999999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.11 Aligned_cols=261 Identities=18% Similarity=0.260 Sum_probs=202.3
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++|++.++||+|+||.||+|.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 36899999999999999999987 68889999986533 2334667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++ ++.+.+....+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9965 66666655567899999999999999999999999 999999999999999999999999999976543322
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc---c----
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN---L---- 262 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 262 (325)
......+++.|+|||.+.+...++.++||||||+++++|++|+.||......... ............... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhcccc
Confidence 1222347899999999866666899999999999999999988886544332211 111111111111000 0
Q ss_pred ----------ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 263 ----------VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 263 ----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+.....+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00001112234467899999999999999999999994
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=313.13 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=206.0
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhc-------HHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG-------ESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
+..++|++.+.||+|+||.||+|.+. +++.+|+|++....... ...+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44578999999999999999999986 78899999986533221 15688999999999999999999998665
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeeccCCCCceEEcCCCc-----EEE
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR--IIHCDIKPHNILMDESWK-----AKI 174 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nilv~~~~~-----vkl 174 (325)
. ++||||+++++|.+++......+++..++.++.|++.|+.|||++ | ++|+||||+||+++.++. ++|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 4 699999999999998866677899999999999999999999999 8 999999999999988776 999
Q ss_pred eeccccccccCCCccceeeecCCCCcCCcccccc-CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHH
Q 047716 175 SDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR-NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253 (325)
Q Consensus 175 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 253 (325)
+|||++...... .....+++.|+|||.+.. ...++.++||||||+++++|++|+.||........... ..
T Consensus 171 ~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-----~~ 241 (287)
T 4f0f_A 171 ADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-----NM 241 (287)
T ss_dssp CCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-----HH
T ss_pred CCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-----HH
Confidence 999998754332 223348999999998842 34568899999999999999999999986654432211 11
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
........ ..+...+..+.+++.+||+.||.+|||++|+++.|+++
T Consensus 242 ~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREEGLRP------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSCCCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HhccCCCC------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111111 11223346799999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=329.72 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=200.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
+...+|++.+.||+|+||.||+|++. .+..+|+|++... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34568999999999999999999875 4677999998654 233456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++....
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999976666799999999999999999999999 99999999999999999999999999987664
Q ss_pred CCCccce--eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 185 TDQTRTY--TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 185 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
....... ....++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. .....+. .
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-------~~i~~~~-~- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-------KAVDEGY-R- 268 (373)
T ss_dssp ---------------CTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-------HHHHTTE-E-
T ss_pred cCCccceeccCCCcCCCccChhhh-ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-C-
Confidence 4322111 111246789999998 56678999999999999999998 99999765432211 1111111 0
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..........+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1112233467999999999999999999999999999886
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=323.25 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=204.8
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
.....+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 355789999999999999999999987 68899999986532 334466889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---cEEEeecccccc
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---KAKISDFGLSKL 182 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---~vkl~Dfg~~~~ 182 (325)
+||||+.+++|.+.+. ....+++..++.++.|++.|+.|||++ ||+|+||||+||+++.++ .+||+|||++..
T Consensus 105 lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EEECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999999884 345799999999999999999999999 999999999999997654 599999999976
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
...... .....+++.|+|||.+ ....++.++||||||+++|+|++|.+||......... .....+....
T Consensus 181 ~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------~~i~~~~~~~- 249 (362)
T 2bdw_A 181 VNDSEA--WHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-------AQIKAGAYDY- 249 (362)
T ss_dssp CTTCCS--CCCSCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCC-
T ss_pred ecCCcc--cccCCCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCCC-
Confidence 653322 2233489999999998 5667889999999999999999999999765432111 1111221110
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...........+.++|.+||+.||.+|||+.|++
T Consensus 250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0011112235689999999999999999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=320.21 Aligned_cols=253 Identities=21% Similarity=0.237 Sum_probs=202.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-----hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-----EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+....|++.+.||+|+||.||+|.+. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45789999999999999999999987 68899999986432 1245678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc---EEEeec
Q 047716 104 RLLVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK---AKISDF 177 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~---vkl~Df 177 (325)
.++||||+++++|.+.+... ...+++..++.++.|++.|+.|||++ |++|+||||+||+++.++. ++|+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998877443 23589999999999999999999999 9999999999999986654 999999
Q ss_pred cccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 178 GLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
|++........ ......+++.|+|||.+ ....++.++||||||+++++|++|+.||..... . ........
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~-----~~~~i~~~ 247 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---R-----LFEGIIKG 247 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---H-----HHHHHHHT
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHH-cCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---H-----HHHHHHcC
Confidence 99977654322 12223489999999998 456678999999999999999999999986421 1 11111111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
....... .....+..+.++|.+||+.||.+|||+.|++
T Consensus 248 ~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 285 (351)
T 3c0i_A 248 KYKMNPR----QWSHISESAKDLVRRMLMLDPAERITVYEAL 285 (351)
T ss_dssp CCCCCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1110000 0011235799999999999999999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=317.67 Aligned_cols=244 Identities=24% Similarity=0.320 Sum_probs=203.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.++|++.+.||+|+||.||+|++. +++.+|+|++.... ......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999987 68899999987532 23456678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160 (318)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence 999999999999954 46799999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
....|++.|+|||.+ .+..++.++|+||||+++++|++|+.||......... ....... .
T Consensus 161 ----~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~--------~ 220 (318)
T 1fot_A 161 ----YTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------EKILNAE--------L 220 (318)
T ss_dssp ----CCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHCC--------C
T ss_pred ----ccccCCccccCHhHh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC--------C
Confidence 233589999999998 5667889999999999999999999999765432211 1111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
..+.....++.+++.+||+.||.+|| +++|++
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 12222346799999999999999999 899998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=324.33 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=205.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
..++|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3478999999999999999999987 67889999986532 3445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+.+++|.+++. ....+++..++.++.|++.|+.|||++ ||+|+||||+||+++.++.++|+|||++......
T Consensus 93 v~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EECCCTTEEHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999984 456799999999999999999999999 9999999999999999999999999999865433
Q ss_pred CccceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 187 QTRTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.. .....||+.|+|||.+.. +..++.++|||||||++|+|++|+.||............. .....
T Consensus 169 ~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~----~~~~~------- 235 (384)
T 4fr4_A 169 TQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH----TFETT------- 235 (384)
T ss_dssp CC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH----HHHHC-------
T ss_pred Cc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhhc-------
Confidence 22 233458999999999853 3457889999999999999999999998655443322111 11111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HhHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPT-MKQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell 299 (325)
....+......+.++|.+||+.||.+||+ +++++
T Consensus 236 -~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 -VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 11112223467999999999999999998 77777
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=326.98 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=200.4
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCC
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGS 102 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 102 (325)
..+..++|++.+.||+|+||.||+|++. .++.+|+|++... .......+..|..+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 3466788999999999999999999987 6889999998753 233455677899999988 6999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999999844 46799999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
..... ......+||+.|+|||.+ .+..++.++|+||||+++|+|++|+.||......+.. ......
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~----- 239 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILND----- 239 (353)
T ss_dssp SCC----------CCGGGCCHHHH-HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC-----
T ss_pred cccCC-ccccccCCCcCeEChhhc-CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH-------HHHHcC-----
Confidence 33222 222334589999999998 5566889999999999999999999999876433221 111111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCH------hHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTM------KQVI 299 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~ell 299 (325)
....+......+.+++.+||+.||.+||++ +|++
T Consensus 240 ---~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il 279 (353)
T 3txo_A 240 ---EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL 279 (353)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHh
Confidence 111222234569999999999999999999 7787
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=334.65 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=213.2
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.++...+|++.+.||+|+||.||+|.+..+..+|+|++.... .....+.+|+.+++.++||||+++++++. ....++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 356678899999999999999999999888899999987543 45677899999999999999999999986 5678999
Q ss_pred EeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|||+.+++|.+++.... ..++...++.++.|++.|+.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999995432 3689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
.........++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. ..+..+..
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~~------ 403 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERGYR------ 403 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------HHHHHTCC------
T ss_pred ceeccCCCcccccccCHHHh-ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC------
Confidence 22222222356789999998 45678999999999999999999 99999865432211 11111110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
...+..++..+.++|.+||+.||.+|||+++|++.|+.+....
T Consensus 404 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 404 -MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1112233467999999999999999999999999999997543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=330.26 Aligned_cols=257 Identities=22% Similarity=0.269 Sum_probs=202.1
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh---cHHHHHHHHHHHhcc-CCCCcceeeEEeecCCc
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE---GESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 103 (325)
.+..++|++.+.||+|+||.||+|++. .++.+|+|++.+.... ....+..|..++..+ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 344578999999999999999999987 5778999998764322 223477889998877 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999998854 46799999999999999999999999 9999999999999999999999999998753
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh--hHHHHHHHHHHhCcccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI--VLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 261 (325)
.... ......+||+.|+|||.+ .+..++.++|+||||+++++|++|++||......+.. .............
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l-~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---- 277 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---- 277 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----
T ss_pred ccCC-CccccccCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----
Confidence 2221 222334589999999999 5667899999999999999999999999754322110 0011111222221
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCH------hHHH
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTM------KQVI 299 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~ell 299 (325)
....+......+.++|.+||+.||.+||++ +|++
T Consensus 278 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~ 317 (396)
T 4dc2_A 278 ----QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 317 (396)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHH
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHh
Confidence 122222334679999999999999999996 5776
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=321.33 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=194.8
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCc----EEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGK----EIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+...+|++.+.||+|+||.||+|.+..+. .+|+|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 45678999999999999999999887432 7899988654 33445678899999999999999999999877655
Q ss_pred e------EEEEeecCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 104 R------LLVYEFMRNGSLGNLLFRAE-----QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 104 ~------~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
. +++|||+.+++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 4 99999999999999985432 2589999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHH
Q 047716 173 KISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWA 250 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 250 (325)
+|+|||++........ .......+++.|+|||.+ .+..++.++||||||+++++|++ |+.||......+...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----- 250 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN----- 250 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-----
T ss_pred EEeeccccccccccccccccccccCcccccCchhh-cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH-----
Confidence 9999999976543322 112223357789999998 56678999999999999999999 999998765433221
Q ss_pred HHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 251 HQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...... ........+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 251 --~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 251 --YLIGGN-------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp --HHHTTC-------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHhcCC-------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111 11122233457999999999999999999999999999887
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=317.10 Aligned_cols=266 Identities=22% Similarity=0.304 Sum_probs=201.1
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhc--cCCCCcceeeEEeec----C
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGR--IHHKNLVDLVGFCSE----G 101 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~ 101 (325)
..+..++|++.+.||+|+||.||+|++ .+..+|+|++... ....+..|.+++.. ++||||+++++++.. .
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 345567899999999999999999988 5888999998653 23444555555555 789999999998643 3
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhh--------ccCCCCeeeccCCCCceEEcCCCcEE
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH--------DECETRIIHCDIKPHNILMDESWKAK 173 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--------~~~~~~i~h~di~p~nilv~~~~~vk 173 (325)
...++||||+++++|.+++. ...+++..++.++.|++.|+.||| +. +++|+||||+||+++.++.+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 45799999999999999994 357999999999999999999999 87 999999999999999999999
Q ss_pred EeeccccccccCCCccc---eeeecCCCCcCCccccccCC-----CCCccccchhHHHHHHHHHhC----------CCCC
Q 047716 174 ISDFGLSKLLKTDQTRT---YTVLRGTRGYTAPELHSRNN-----RITVKADVYSFGVMLLEIVCC----------RKNV 235 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g----------~~p~ 235 (325)
|+|||++.......... .....+++.|+|||.+.+.. .++.++||||||+++++|++| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999987554333221 11234899999999985433 334689999999999999999 8888
Q ss_pred CCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 236 DESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
............ .............+ +...........+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 234 ~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFED--MRKVVCVDQQRPNI-PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHH--HHHHHTTSCCCCCC-CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhh--hhHHHhccCCCCCC-ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 655443322111 11111111111111 11112234567899999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=319.36 Aligned_cols=267 Identities=24% Similarity=0.311 Sum_probs=211.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEe-----CCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEee--cCCce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCI-----NGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS--EGSNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 104 (325)
..+|++.+.||+|+||.||+|.+ ..+..+++|++..........+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 57899999999999999999984 268889999998766666777999999999999999999999876 45678
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 999999999999999976667799999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh--------hHHHHHHHHH
Q 047716 185 TDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI--------VLIDWAHQCY 254 (325)
Q Consensus 185 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--------~~~~~~~~~~ 254 (325)
..... ......++..|+|||.+ .+..++.++||||||+++++|++|+.||......... ..........
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHh-ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 33321 11223367779999998 4566788999999999999999999998754321100 0000111111
Q ss_pred HhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 255 EAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
..+. ....+...+..+.+++.+||+.||.+|||++|+++.|+.+....
T Consensus 258 ~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEGQ-------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hccc-------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111 11122334467999999999999999999999999999998433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=309.93 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=208.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
..++|++.+.||+|+||.||+|.+. .+..+++|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4678999999999999999999987 577899999987766777889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE---cCCCcEEEeeccccccccCC
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv---~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|+++++|.+++.. ...+++..++.++.|++.|+.+||++ |++|+||+|+||++ +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999998844 45799999999999999999999999 99999999999999 78889999999998766543
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. .....+++.|+|||.+. ..++.++||||||+++++|++|+.||......+.. .............
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~-- 229 (277)
T 3f3z_A 163 KM--MRTKVGTPYYVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-------LKIREGTFTFPEK-- 229 (277)
T ss_dssp SC--BCCCCSCTTTCCHHHHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCCCHH--
T ss_pred cc--hhccCCCCCccChHHhc--ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhCCCCCCch--
Confidence 32 22234899999999983 34889999999999999999999999875432211 1111111110000
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
........+.+++.+||+.||.+|||+.|++ ..+++..
T Consensus 230 --~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 230 --DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp --HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred --hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 0001235699999999999999999999999 3444433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=329.83 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=208.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
..+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999987 78999999987532 23345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++. ..+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 99999999999984 456799999999999999999999999 99999999999999999999999999998664432
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
. .....+++.|+|||.+.+....+.++||||||+++++|++|+.||......... .....+..
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~-------- 233 (476)
T 2y94_A 171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF-------KKICDGIF-------- 233 (476)
T ss_dssp C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH-------HHHHTTCC--------
T ss_pred c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHhcCCc--------
Confidence 2 223358999999999965555678999999999999999999999865432211 11111111
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
..+......+.+++.+||+.||.+|||++|+++ .++...
T Consensus 234 ~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 111122356899999999999999999999993 555443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=326.84 Aligned_cols=254 Identities=22% Similarity=0.211 Sum_probs=204.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.++|++.+.||+|+||.||+|++. .++.+|+|++.+.. ......+.+|..++..++||||+++++++.+.+.+++|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 467999999999999999999987 68999999986532 12233477899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++.+.+..+++..++.++.|++.|+.|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 999999999999976666899999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeeecCCCCcCCcccccc------CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 188 TRTYTVLRGTRGYTAPELHSR------NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
........||+.|+|||.+.. ...++.++|+||||+++|+|++|+.||......+....+....... .+
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---~~-- 291 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL---SL-- 291 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---CC--
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc---CC--
Confidence 322333458999999999852 3567899999999999999999999998754432221111000000 00
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCC---CCHhHHH
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLR---PTMKQVI 299 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~ell 299 (325)
+......+.++.++|.+||+ +|.+| |+++|++
T Consensus 292 -----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~ 326 (412)
T 2vd5_A 292 -----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR 326 (412)
T ss_dssp -----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred -----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 00111233579999999999 99998 6999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=333.14 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=208.2
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++...+|++.++||+|+||.||+|.+.++..+|+|++.... .....+.+|+.+++.++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 45668899999999999999999999988889999987543 345678999999999999999999999876 6789999
Q ss_pred eecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+++++|.+++... ...+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.+||+|||++.......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999999643 34689999999999999999999999 99999999999999999999999999997654433
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
........++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. .....+. .
T Consensus 335 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~-------~ 399 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY-------R 399 (452)
T ss_dssp --------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC-------C
T ss_pred eecccCCcccccccCHhHH-hcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-------C
Confidence 2222223357789999998 45678999999999999999999 99999765432211 1111111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
...+..++..+.++|.+||+.+|.+|||+++|++.|+.+....
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1122234467999999999999999999999999999998543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=310.20 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=186.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|++.+.||+|+||.||+|.+. .+..+++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 57999999999999999999985 78899999986532 223467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 99999999999976667899999999999999999999999 999999999999999999999999999876543222
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
. .....+++.|+|||.+ ....++.++||||||+++++|++|+.||......... .........
T Consensus 168 ~-~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~ 230 (278)
T 3cok_A 168 K-HYTLCGTPNYISPEIA-TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADYE 230 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCCC
T ss_pred c-ceeccCCCCcCCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhcccC
Confidence 1 1223478999999998 5667788999999999999999999999765432211 111111112
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+......+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 22233457899999999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=320.44 Aligned_cols=252 Identities=21% Similarity=0.227 Sum_probs=192.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.||+|+||.||+|++. .++.+|+|++..... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999987 788999999865433 335678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc--EEEeeccccccccCCCc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK--AKISDFGLSKLLKTDQT 188 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~--vkl~Dfg~~~~~~~~~~ 188 (325)
+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++. +||+|||++........
T Consensus 98 ~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 98 ASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp CCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 999999999844 45799999999999999999999999 9999999999999987765 99999999864322221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....+++.|+|||.+.+....+.++||||||+++++|++|+.||........... ..... ...... ..
T Consensus 174 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~~~~-~~~~~~--~~---- 242 (361)
T 3uc3_A 174 --PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TIQRI-LSVKYS--IP---- 242 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HHHHH-HTTCCC--CC----
T ss_pred --CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HHHHH-hcCCCC--CC----
Confidence 22234899999999985444445559999999999999999999987554332211 11111 111110 00
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
........+.++|.+||+.||.+|||+.|++
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell 273 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIK 273 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 0111235689999999999999999999999
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=322.27 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=201.4
Q ss_pred HHHhh--hhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENF--KEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~--~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
..|++ .+.||+|+||.||+|.+. ++..+|+|++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34555 467999999999999986 688999999877665666789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE--cCCCcEEEeeccccccccCCC
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM--DESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv--~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|+++++|.+++......+++..++.++.|++.||.|||+. |++|+||||+||++ +.++.++|+|||++.......
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999998866666799999999999999999999999 99999999999999 567789999999998765433
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.. ....+++.|+|||.+ ....++.++||||||+++++|++|+.||......+... ... ...+. ...
T Consensus 244 ~~--~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i~-~~~~~----~~~ 309 (373)
T 2x4f_A 244 KL--KVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN------NIL-ACRWD----LED 309 (373)
T ss_dssp BC--CCCCSSCTTCCHHHH-TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH-HTCCC----SCS
T ss_pred cc--ccccCCCcEeChhhc-cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH-hccCC----CCh
Confidence 22 223489999999998 56778899999999999999999999998764322111 111 11111 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhc
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEG 304 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~ 304 (325)
........++.++|.+||+.||.+|||+.|+++ .+..
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 111123357999999999999999999999994 4443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=311.38 Aligned_cols=251 Identities=29% Similarity=0.417 Sum_probs=194.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccch----hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE----EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
..+|++.+.||+|+||.||+|.+. +..+++|++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999986 78899999865332 2346688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC---eeeccCCCCceEEcC--------CCcEEEee
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR---IIHCDIKPHNILMDE--------SWKAKISD 176 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~---i~h~di~p~nilv~~--------~~~vkl~D 176 (325)
|||+++++|.+++. ...+++..++.++.|++.|+.+||++ | ++|+||+|+||+++. ++.++|+|
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999983 45799999999999999999999998 8 999999999999985 67899999
Q ss_pred ccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 177 FGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 177 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
||++......... ...+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... .....
T Consensus 160 fg~~~~~~~~~~~---~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~ 228 (271)
T 3dtc_A 160 FGLAREWHRTTKM---SAAGAYAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-------YGVAM 228 (271)
T ss_dssp CCC----------------CCGGGSCHHHH-HHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-------HHHHT
T ss_pred CCccccccccccc---CCCCccceeCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------Hhhhc
Confidence 9998765433222 23478999999998 4567889999999999999999999999865432211 11111
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.... ...+......+.+++.+||+.+|.+|||+.|+++.|+.+
T Consensus 229 ~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 NKLA------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp SCCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCC------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111 111222345799999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=310.20 Aligned_cols=264 Identities=20% Similarity=0.287 Sum_probs=205.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEe-ecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFC-SEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 107 (325)
...++|++.+.||+|+||.||+|.+. .++.+|+|++..... ...+..|+.+++.++|++++..+..+ ......+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 45688999999999999999999985 788899998654332 23477899999999988877766655 667788999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE---cCCCcEEEeecccccccc
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLK 184 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv---~~~~~vkl~Dfg~~~~~~ 184 (325)
|||+ +++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||++ +.++.++|+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 9999999976677899999999999999999999999 99999999999999 788899999999998665
Q ss_pred CCCc------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 185 TDQT------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 185 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
.... .......+++.|+|||.+ .+..++.++||||||+++++|++|+.||.......................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHh-cCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 4332 112234589999999998 566789999999999999999999999987655443332222222211111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
...... ..+..+.+++.+||+.+|.+|||++++++.|+.+..
T Consensus 239 ~~~~~~-------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 239 IEVLCK-------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHHHTT-------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhhhhc-------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 111111 112569999999999999999999999999998874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=317.53 Aligned_cols=270 Identities=23% Similarity=0.308 Sum_probs=206.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCC----ceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS----NRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 107 (325)
..+|++.+.||+|+||.||+|++. +..||+|++.... ........|+.+++.++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 368999999999999999999886 7889999986533 33344566899999999999999999987643 36999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC-------CCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC-------ETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~-------~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
|||+++++|.+++.. ..+++..++.++.|++.|+.|||+.+ +.+++|+||||+||+++.++.+||+|||++
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999999944 45999999999999999999999742 228999999999999999999999999999
Q ss_pred ccccCCCcc-ceeeecCCCCcCCccccccC----CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHH-------
Q 047716 181 KLLKTDQTR-TYTVLRGTRGYTAPELHSRN----NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLID------- 248 (325)
Q Consensus 181 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~------- 248 (325)
......... ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.||.............
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 765433321 12223489999999998543 344567899999999999999999998654432211110
Q ss_pred --HHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 249 --WAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 249 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..............+... .........+.++|.+||+.||.+|||+.|+++.|+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDY-WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCcccc-ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011111111111111111 112345567999999999999999999999999998875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=319.80 Aligned_cols=244 Identities=24% Similarity=0.257 Sum_probs=203.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
..+|++.+.||+|+||.||+|++. ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999987 68899999986532 23456688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++.......
T Consensus 120 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 999999999999854 45799999999999999999999999 99999999999999999999999999998654332
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
....|++.|+|||.+ .+..++.++|+||||+++++|++|++||......+.. ..+..+. .
T Consensus 196 ----~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~--------~ 255 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------EKIVSGK--------V 255 (350)
T ss_dssp ----CCCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC--------C
T ss_pred ----ccccCCccccCHHHh-cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-------HHHHcCC--------C
Confidence 223489999999998 4667889999999999999999999999865432211 1111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPT-----MKQVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell 299 (325)
..+......+.++|.+||+.||.+||+ ++|++
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~ 292 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH
Confidence 112223467999999999999999998 89998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=312.00 Aligned_cols=266 Identities=23% Similarity=0.371 Sum_probs=207.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEe-----CCCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCI-----NGGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-- 101 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 101 (325)
+....|++.+.||+|+||.||+|.+ ..+..+|+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3456799999999999999999983 368899999987533 34456788999999999999999999998776
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...++||||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 668999999999999999977777899999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc--------chhhHHHHHH
Q 047716 182 LLKTDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD--------DEIVLIDWAH 251 (325)
Q Consensus 182 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--------~~~~~~~~~~ 251 (325)
....... .......++..|+|||.+ .+..++.++||||||+++++|++|+.|+...... ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECL-MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeee-cCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 6654332 112223367779999998 4566788999999999999999999986533210 0001111111
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
........ ...+...+..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus 254 ~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEGKR-------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTTCC-------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhccCC-------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111 1122233467999999999999999999999999998764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=321.95 Aligned_cols=266 Identities=19% Similarity=0.296 Sum_probs=201.0
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhc-HHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG-ESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++|++.+.||+|+||.||+|.+. ++..+|+|++....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 36889999999999999999987 78899999886433221 11345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++ ++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 96 589888876667799999999999999999999999 999999999999999999999999999875543222 1
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc---ccccccC--
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE---LQNLVSD-- 265 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 265 (325)
.....+++.|+|||.+.+...++.++||||||+++++|++|+.||......+.... ......... +......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHhchhhhcchh
Confidence 22234789999999986667789999999999999999999999987654332221 111111110 1100000
Q ss_pred -------C------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 266 -------Q------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 266 -------~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
. ....+.....+.+++.+||+.||.+|||++|+++ .+.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0 0011122356899999999999999999999993 566555
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=315.14 Aligned_cols=265 Identities=18% Similarity=0.220 Sum_probs=201.3
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhc---HHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG---ESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
....++|++.+.||+|+||.||+|.+. .++.+++|++....... ...+.+|+.+++.++||||+++++++..++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 344578999999999999999999987 68889999987543322 36688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++|||+++++|.+++.. .+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999999854 45799999999999999999999999 99999999999999999999999999987665
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
...........+++.|+|||.+ .+..++.++||||||+++++|++|+.||....... ....... ...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~-~~~---- 252 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERF-SESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQ-AIP---- 252 (309)
T ss_dssp -----------CCGGGCCGGGT-CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHS-CCC----
T ss_pred ccccccccccCCCcCccCHHHH-cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhcc-CCC----
Confidence 4433333334488999999998 56678899999999999999999999998653221 1111111 111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHhHHHHHHhccCCCCC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRP-TMKQVIWMMEGIVPPHQ 310 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~L~~~~~~~~ 310 (325)
.........+..+.+++.+||+.||.+|| |++++++.|+.......
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 11111223335699999999999999999 99999999998875443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=319.78 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=201.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 106 (325)
.++|++.+.||+|+||.||+|++. .++.+|+|++.... ......+..|..+++.+ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999987 68889999987643 23345577899999887 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.+||+|||++......
T Consensus 88 v~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999999999854 46799999999999999999999999 9999999999999999999999999998753322
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh--hHHHHHHHHHHhCccccccc
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI--VLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 264 (325)
. .......|++.|+|||.+ .+..++.++|+|||||++++|++|+.||......+.. ..............
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 235 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred C-CcccccCCCccccCcccc-CCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence 2 122334589999999998 4567789999999999999999999999753221110 00111112222211
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCH------hHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTM------KQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~ell 299 (325)
...+......+.+++.+||+.||.+||++ +|++
T Consensus 236 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~ 274 (345)
T 3a8x_A 236 --IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 274 (345)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHh
Confidence 11222334679999999999999999996 6777
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.47 Aligned_cols=262 Identities=24% Similarity=0.352 Sum_probs=209.6
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEee
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCS 99 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (325)
+.++...+|++.+.||+|+||.||+|.+. .+..+|+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34566789999999999999999999853 4668999998653 3344556888999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRAE------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW--- 170 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~--- 170 (325)
.....++||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ ||+||||||+||+++.++
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence 9999999999999999999996543 3589999999999999999999999 999999999999998554
Q ss_pred cEEEeeccccccccCC-CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHH
Q 047716 171 KAKISDFGLSKLLKTD-QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLID 248 (325)
Q Consensus 171 ~vkl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 248 (325)
.+||+|||++...... .........+++.|+|||.+ .+..++.++||||||+++++|++ |..||......+..
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---- 296 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF-MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---- 296 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence 5999999998754221 11222223468899999998 45678999999999999999998 99999875432211
Q ss_pred HHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 249 WAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.....+.. ...+......+.+++.+||+.+|.+|||+.+|++.|+.+.
T Consensus 297 ---~~i~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 297 ---EFVTSGGR-------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ---HHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHcCCC-------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11111111 1112223356999999999999999999999999998887
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=319.18 Aligned_cols=244 Identities=22% Similarity=0.269 Sum_probs=202.0
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--------hcHHHHHHHHHHHhccCCCCcceeeEEeec
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--------EGESEFRNEMKIIGRIHHKNLVDLVGFCSE 100 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (325)
-...+|++.+.||+|+||.||+|.+. ++..+|+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45789999999999999999999986 688899998875321 122346679999999999999999999999
Q ss_pred CCceEEEEeecCCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 101 GSNRLLVYEFMRNG-SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 101 ~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
.+..++||||+..+ +|.+++. ....+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 99999999998766 9999884 445799999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
+........ .....+++.|+|||.+.+....+.++||||||+++++|++|+.||...... .
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~ 237 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------V 237 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------T
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------H
Confidence 986654332 223448999999999865555688999999999999999999999753221 0
Q ss_pred cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 260 QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...... +......+.+++.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 238 EAAIHP----PYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp TTCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCC----CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 1113356999999999999999999999995
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=320.98 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=210.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS 102 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (325)
+..++|++.+.||+|+||.||+|++.+ +..+|+|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 345789999999999999999999853 3789999987543 334567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccC
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAE-----------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDI 159 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di 159 (325)
..++||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9999999999999999986532 5689999999999999999999999 9999999
Q ss_pred CCCceEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 047716 160 KPHNILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDE 237 (325)
Q Consensus 160 ~p~nilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~ 237 (325)
||+||+++.++.++|+|||++........ .......+++.|+|||.+ ....++.++||||||+++++|++ |..||..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh-ccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999876533221 122223367889999998 45668899999999999999999 9999976
Q ss_pred ccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCC
Q 047716 238 SLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQ 310 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 310 (325)
....+.. .....+.... .+......+.+++.+||+.+|.+|||+.++++.|+.+.....
T Consensus 280 ~~~~~~~-------~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 280 MAHEEVI-------YYVRDGNILA-------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp SCHHHHH-------HHHHTTCCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CChHHHH-------HHHhCCCcCC-------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 5432211 1122222211 112233569999999999999999999999999999986443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=326.52 Aligned_cols=252 Identities=21% Similarity=0.226 Sum_probs=202.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
..+|++.+.||+|+||.||+|++. .+..+|+|++.+.. ......+.+|..+++.++||||+++++++.+...+++|
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 357888999999999999999987 58889999986522 22233477899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++.. ..+++..++.++.|++.|+.|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 148 ~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp ECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 999999999999843 4689999999999999999999999 99999999999999999999999999998765443
Q ss_pred ccceeeecCCCCcCCccccccCC---CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNN---RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
........||+.|+|||.+.... .++.++|+||||+++|+|++|++||...........+......+ .+.
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---~~p---- 295 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL---TFP---- 295 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---CCC----
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc---cCC----
Confidence 33333456899999999985432 26789999999999999999999998654332221111000000 000
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCC--CCCHhHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNL--RPTMKQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~ell 299 (325)
. ....+.++.++|.+||+.+|.+ ||+++||+
T Consensus 296 ~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 296 D----DNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp T----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred C----cccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 0 0112356999999999999988 99999999
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=311.11 Aligned_cols=257 Identities=24% Similarity=0.327 Sum_probs=204.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
..++|++.+.||+|+||.||+|.+.. +..+++|.+... .......+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35789999999999999999998653 235889988754 23445678899999999999999999999865 4678
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 99999999999999977667799999999999999999999999 999999999999999999999999999886654
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..........++..|+|||.+ ....++.++||||||+++++|++ |+.||......+... ........
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-------~~~~~~~~---- 233 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-------VLEKGDRL---- 233 (281)
T ss_dssp -------CCCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-------HHHHTCCC----
T ss_pred ccccccccCCCCcceeCchhh-ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-------HHhcCCCC----
Confidence 333233333467789999998 56678899999999999999998 999997654433221 11111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..+......+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 234 ---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 111123356999999999999999999999999998775
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=316.62 Aligned_cols=269 Identities=25% Similarity=0.402 Sum_probs=202.4
Q ss_pred cccHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 24 SFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 24 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
.+...++...+|++.++||+|+||.||+|.+.. .+++|++.... ......+.+|+.+++.++||||++++++. ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 355557778899999999999999999998754 58999886432 33446688999999999999999999965 45
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...++||||+.+++|.+++......+++..++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecc
Confidence 678999999999999999976677899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCC-ccceeeecCCCCcCCccccc--cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 182 LLKTDQ-TRTYTVLRGTRGYTAPELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 182 ~~~~~~-~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
...... ........+++.|+|||.+. ....++.++||||||+++++|++|+.||......+.. ......+.
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~ 242 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IEMVGRGS 242 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH------HHHHHHTS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH------HHHhcccc
Confidence 554322 12222344899999999884 2456788999999999999999999999865443221 12222222
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
..... .......+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus 243 ~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPDL---SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCCT---TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcch---hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 21111 11222334679999999999999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=314.86 Aligned_cols=262 Identities=20% Similarity=0.255 Sum_probs=186.6
Q ss_pred HHHHhhh---hhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEE
Q 047716 32 LASENFK---EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~---~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 106 (325)
..+|++. +.||+|+||.||+|.+. .+..+|+|++... ....+.+|+.+++.+. ||||+++++++.+....++
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 4567775 67999999999999987 6889999998653 3456778999999997 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---cEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---KAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---~vkl~Dfg~~~~~ 183 (325)
||||+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++ .++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 84 VMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999954 46799999999999999999999999 999999999999997765 7999999999765
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
..... ......+++.|+|||.+ ....++.++||||||+++++|++|+.||.....................+...
T Consensus 160 ~~~~~-~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--- 234 (325)
T 3kn6_A 160 PPDNQ-PLKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--- 234 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC---
T ss_pred CCCCC-cccccCCCcCccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC---
Confidence 43322 12233478999999998 56678999999999999999999999998654321111111111222222111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
.........+.++.+++.+||+.||.+|||++|++ ..+++..
T Consensus 235 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 235 -FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp -CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred -CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 00111112346799999999999999999999998 4454443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=324.21 Aligned_cols=260 Identities=26% Similarity=0.354 Sum_probs=210.7
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC--------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEe
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN--------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFC 98 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 98 (325)
++...+|++.++||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 556689999999999999999999863 23578999886543 33446788999999999 899999999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
...+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ |++|+||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 99999999999999999999996543 3589999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
|+++.++.+||+|||++........ .......+++.|+|||.+ .+..++.++||||||+++++|++ |+.||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999976543322 112222357789999998 56778999999999999999999 99999765432
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
+. .......... ..+......+.+++.+||+.+|.+|||++|+++.|+.+.
T Consensus 301 ~~-------~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 301 EL-------FKLLKEGHRM-------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HH-------HHHHHTTCCC-------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-------HHHHHcCCCC-------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21 1112211111 111223356999999999999999999999999999887
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=314.19 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=204.8
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh------cHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE------GESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
...+|++.+.||+|+||.||+|.+. ++..+|+|++...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4678999999999999999999987 6889999998754322 35678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC----cEEEeeccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW----KAKISDFGL 179 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~----~vkl~Dfg~ 179 (325)
.++||||+++++|.+++. ....+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++ .++|+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999994 346789999999999999999999999 999999999999999887 799999999
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
+........ .....+++.|+|||.+ ....++.++||||||+++++|++|+.||......+... .......
T Consensus 166 ~~~~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~i~~~~~ 235 (321)
T 2a2a_A 166 AHEIEDGVE--FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NITSVSY 235 (321)
T ss_dssp CEECCTTCC--CCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHTTCC
T ss_pred ceecCcccc--ccccCCCCCccCcccc-cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHhccc
Confidence 976654322 1223489999999998 56678899999999999999999999997654322111 1111110
Q ss_pred cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 260 QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
. ............+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 D----FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C----CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c----cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000000112356899999999999999999999994
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=335.09 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=215.0
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeCC-CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
..++...+|++.++||+|+||.||+|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++......+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345567889999999999999999999884 7889999986543 34667899999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 106 LVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+||||+++++|.+++... ...+++..++.++.|++.|+.|||++ +|+|+||||+|||++.++.+||+|||++....
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999653 35689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...........++..|+|||.+ ....++.++||||||+++++|++ |..||......+.. ..+..+.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~----- 436 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDY----- 436 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTC-----
T ss_pred CCceeecCCCcCCcceeCHhHH-hcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-----
Confidence 4332222222356789999998 45668899999999999999999 99999876543321 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
....+..++..+.++|.+||+.||.+|||+.+|++.|+.+...
T Consensus 437 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred --CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1111223346799999999999999999999999999998743
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=319.95 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=202.2
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcE----EEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKE----IAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~----~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
...+|++.+.||+|+||.||+|.+. .+.. +++|.+... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SE
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence 3567999999999999999999976 3333 577776442 234556788999999999999999999999875 47
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++++++.+++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++....
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 899999999999999977677899999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 185 TDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 185 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
..... ......++..|+|||.+ .+..++.++||||||+++++|++ |+.||.......... ......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~~---- 236 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGE---- 236 (327)
T ss_dssp TTCC-------CCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTC----
T ss_pred CCcccccccCCCccccccChHHh-ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH-------HHHcCC----
Confidence 33321 11222357789999998 56778999999999999999999 999998765433221 111111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
....+......+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11112223456999999999999999999999999998876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=319.32 Aligned_cols=268 Identities=16% Similarity=0.196 Sum_probs=203.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccchhcH-----------HHHHHHHHHHhccCCCCcc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVEEGE-----------SEFRNEMKIIGRIHHKNLV 92 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv 92 (325)
+..++|++.+.||+|+||.||+|.+.. ++.+|+|++........ .....|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 344589999999999999999998864 47899999865432111 1233466677888999999
Q ss_pred eeeEEeecC----CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc-
Q 047716 93 DLVGFCSEG----SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD- 167 (325)
Q Consensus 93 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~- 167 (325)
++++++... ...++||||+ +++|.+++....+.+++..++.++.|++.||.|||++ ||+|+||||+||+++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 999988654 4579999999 9999999977667899999999999999999999999 999999999999998
Q ss_pred -CCCcEEEeeccccccccCCCcc------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccc
Q 047716 168 -ESWKAKISDFGLSKLLKTDQTR------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLR 240 (325)
Q Consensus 168 -~~~~vkl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 240 (325)
.++.++|+|||++......... ......+|+.|+|||.+ .+..++.++||||||+++++|++|+.||.....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH-NGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999765432211 11223489999999998 566689999999999999999999999986544
Q ss_pred cchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 241 DDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...... ....... ..+..+++.... ....+.++.+++..||+.+|.+||++++|++.|+.+.
T Consensus 267 ~~~~~~--~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 DPKYVR--DSKIRYR-ENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CHHHHH--HHHHHHH-HCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHHHH--HHHHHhh-hhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 332221 1111111 111222111100 0112356999999999999999999999999988876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=321.59 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=202.8
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCc
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 103 (325)
.+...+|++.+.||+|+||.||+|++. .++.+|+|++.... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 355678999999999999999999987 68889999987632 34455677889998877 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999999999999854 46799999999999999999999999 9999999999999999999999999998754
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
..... ......|++.|+|||.+ .+..++.++|+||||+++++|++|+.||......+.. .......
T Consensus 169 ~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~----- 234 (345)
T 1xjd_A 169 MLGDA-KTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMDN----- 234 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC-----
T ss_pred ccCCC-cccCCCCCcccCChhhh-cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHhCC-----
Confidence 32221 12334589999999998 4567889999999999999999999999865432211 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHh-HHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMK-QVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell 299 (325)
...+......+.++|.+||+.||.+||++. +++
T Consensus 235 ---~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111122346799999999999999999998 776
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=314.85 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=209.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS 102 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (325)
+...+|++.+.||+|+||.||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 44688999999999999999999872 45789999986533 344567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccC
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAE-----------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDI 159 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di 159 (325)
..++||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 9999999999999999986532 2388999999999999999999999 9999999
Q ss_pred CCCceEEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 047716 160 KPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDE 237 (325)
Q Consensus 160 ~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~ 237 (325)
||+||+++.++.++|+|||++......... ......+++.|+|||.+ .+..++.++||||||+++++|++ |+.||..
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh-cCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998765433221 11222356789999998 45667899999999999999999 9999987
Q ss_pred ccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 238 SLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
....... ........ ...+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 256 ~~~~~~~-------~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 256 IPPERLF-------NLLKTGHR-------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CCGGGHH-------HHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHH-------HHhhcCCc-------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6543321 11111111 1112233467999999999999999999999999998875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=312.65 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=194.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh--------------------------cHHHHHHHHHHHh
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE--------------------------GESEFRNEMKIIG 84 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~--------------------------~~~~~~~e~~~l~ 84 (325)
.++|++.+.||+|+||.||+|.+. ++..+|+|++...... ....+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999987 6888999998653211 1245788999999
Q ss_pred ccCCCCcceeeEEeec--CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 85 RIHHKNLVDLVGFCSE--GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 85 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
.++||||+++++++.+ ....++||||+++++|.++. ....+++..++.++.|++.|+.|||++ |++|+||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999999876 56789999999999998875 345799999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCC--CCccccchhHHHHHHHHHhCCCCCCCccc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR--ITVKADVYSFGVMLLEIVCCRKNVDESLR 240 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~p~~~~~~ 240 (325)
||+++.++.++|+|||++......... .....+++.|+|||.+..... .+.++||||||+++++|++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999766543221 222348999999999854332 47789999999999999999999976432
Q ss_pred cchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 241 DDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
... .......... . .........+.+++.+||+.||.+|||+.|++
T Consensus 246 ~~~-------~~~~~~~~~~-~-----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 246 MCL-------HSKIKSQALE-F-----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp HHH-------HHHHHHCCCC-C-----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred HHH-------HHHHhcccCC-C-----CCccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 111 1111111111 0 01112235699999999999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=311.56 Aligned_cols=269 Identities=22% Similarity=0.308 Sum_probs=204.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++|++.++||+|+||.||+|.+. .+..+|+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999987 588999998865332 234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++ .....+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~~l~~~~-~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 83 YCDHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp CCSEEHHHHHH-HTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHH-hhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999998887 3456799999999999999999999999 9999999999999999999999999999765432221
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHHHhCcccc
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCYEAGELQN 261 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 261 (325)
.....++..|+|||.+.+...++.++||||||+++++|++|++||......+....+... ...........
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 122347899999999866677899999999999999999999999876554332222110 01111111100
Q ss_pred cc---cCCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 262 LV---SDQEDV-----NIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 262 ~~---~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
.. ...... .+.....+.+++.+||+.||.+|||++|++ ..++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 00 000000 012345689999999999999999999999 3455544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=314.02 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=196.1
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-----hcHHHHHHHHHHHhcc---CCCCcceeeEE
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-----EGESEFRNEMKIIGRI---HHKNLVDLVGF 97 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~iv~~~~~ 97 (325)
++++..++|++.++||+|+||.||+|.+. .++.+|+|++..... .....+.+|+.+++.+ +||||++++++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 46778899999999999999999999986 788999999864321 1123455677776666 49999999999
Q ss_pred eecCC-----ceEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc
Q 047716 98 CSEGS-----NRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK 171 (325)
Q Consensus 98 ~~~~~-----~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~ 171 (325)
+.... ..+++||++. ++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 87654 4799999996 59999885543 3499999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH
Q 047716 172 AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 172 vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 251 (325)
++|+|||++......... ....+++.|+|||.+ ....++.++||||||+++++|++|++||......+.... ..
T Consensus 159 ~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~ 232 (308)
T 3g33_A 159 VKLADFGLARIYSYQMAL--TPVVVTLWYRAPEVL-LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---IF 232 (308)
T ss_dssp EEECSCSCTTTSTTCCCS--GGGGCCCSSCCHHHH-HTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH---HH
T ss_pred EEEeeCccccccCCCccc--CCccccccccCchHH-cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH
Confidence 999999999765433222 223479999999998 466689999999999999999999999987654332211 11
Q ss_pred HHHHhCcccccc----------cCCC-----CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 252 QCYEAGELQNLV----------SDQE-----DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 252 ~~~~~~~~~~~~----------~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
............ .... ...+.....+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111111100000 0000 001123467899999999999999999999983
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=314.15 Aligned_cols=260 Identities=26% Similarity=0.356 Sum_probs=214.0
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
.++...+|++.+.||+|+||.||+|.+. .+..+++|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3456788999999999999999999988 4788999988653 3445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||||+++++|.+++... ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999653 34589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..........+++.|+|||.+ ....++.++||||||+++++|++ |..||.......... ......
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-------~~~~~~------ 229 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEKDY------ 229 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHHTTC------
T ss_pred CccccccCCccccCcCChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhccC------
Confidence 443333333467789999998 55678899999999999999999 999998765433211 111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
....+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 01111223357999999999999999999999999998876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=320.40 Aligned_cols=262 Identities=25% Similarity=0.362 Sum_probs=208.5
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++...+|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 356789999999999999999999842 46789999987633 33446688999999999 78999999999877
Q ss_pred CC-ceEEEEeecCCCCHHHHHhhccC------------------------------------------------------
Q 047716 101 GS-NRLLVYEFMRNGSLGNLLFRAEQ------------------------------------------------------ 125 (325)
Q Consensus 101 ~~-~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------ 125 (325)
.+ ..++||||+++++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 54 48999999999999999855422
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-cceee
Q 047716 126 -----------RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT-RTYTV 193 (325)
Q Consensus 126 -----------~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~ 193 (325)
.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++........ .....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence 188999999999999999999999 999999999999999999999999999976543322 12222
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHH
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (325)
..+++.|+|||.+ .+..++.++||||||+++++|++ |+.||......+... .....+.... .+..
T Consensus 255 ~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~~~~~~~-------~~~~ 320 (359)
T 3vhe_A 255 ARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLKEGTRMR-------APDY 320 (359)
T ss_dssp CEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH------HHHHHTCCCC-------CCTT
T ss_pred cCCCceeEChhhh-cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH------HHHHcCCCCC-------CCCC
Confidence 3467889999998 46678899999999999999998 999998765433211 1111111111 1112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 273 EFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 273 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
....+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 321 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 23569999999999999999999999999998763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=307.39 Aligned_cols=263 Identities=20% Similarity=0.278 Sum_probs=207.8
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEe-ecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFC-SEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 109 (325)
.++|++.+.||+|+||.||+|.+. .++.+|+|++..... ...+.+|+.+++.++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 467999999999999999999985 788999998765332 23578899999999988877666655 56678899999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE---cCCCcEEEeeccccccccCC
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv---~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|+ +++|.+++......+++..++.++.|++.|+.|||++ |++|+||+|+||++ +.++.++|+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 8999999976667899999999999999999999999 99999999999999 47889999999999866543
Q ss_pred Ccc------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 187 QTR------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 187 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
... ......+++.|+|||.+ .+..++.++||||||+++++|++|+.||.........................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccccccccCChhhh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 321 12234589999999998 56668999999999999999999999998755433322222222211111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
... ...+..+.+++.+||+.||.+|||++++++.|+.+...
T Consensus 241 ~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 241 VLC-------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHT-------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH-------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 111 11225699999999999999999999999999988743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=314.68 Aligned_cols=269 Identities=21% Similarity=0.323 Sum_probs=202.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
....+|++.+.||+|+||.||+|.+. ++..+++|++... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34568999999999999999999986 7889999998642 2334556889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 106 LVYEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
+||||+++++|.+++.. ....+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998854 245689999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
....... .....++..|+|||.+ ....++.++||||||+++++|++|+.||......... .............
T Consensus 186 ~~~~~~~-~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 186 FSSKTTA-AHSLVGTPYYMSPERI-HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEQCDYPPL 258 (310)
T ss_dssp --------------CCSSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-----HHHHHHTTCSCCC
T ss_pred ecCCCcc-ccccCCCeeEeChHHh-CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-----HHHHhhcccCCCC
Confidence 5433221 1223478999999998 5667889999999999999999999999764332111 1111222222111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCCCCCC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQNMLT 314 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~~ 314 (325)
. .......+.+++.+||+.||.+|||+.++++.|+.+.+....+++
T Consensus 259 ~------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 259 P------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp C------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred c------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 1 112335699999999999999999999999999999865555544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=307.72 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=202.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.++|++.+.||+|+||.||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 367999999999999999999987 57789999986532 23356688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++.. ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 999999999999844 46799999999999999999999999 99999999999999999999999999886543322
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
. ....+++.|+|||.+ .+..++.++||||||+++++|++|+.||......+... ...... .
T Consensus 164 ~---~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~--------~ 224 (279)
T 3fdn_A 164 R---TDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RISRVE--------F 224 (279)
T ss_dssp -------CCCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTC--------C
T ss_pred c---cccCCCCCccCHhHh-ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-------HHHhCC--------C
Confidence 1 223478999999998 56677899999999999999999999998654322111 111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhcc
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGI 305 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~ 305 (325)
..+......+.+++.+||+.+|.+|||++|++ ..+...
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 11112335689999999999999999999999 444443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=315.56 Aligned_cols=269 Identities=22% Similarity=0.302 Sum_probs=209.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEee----cCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS----EGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~ 104 (325)
+..++|++.+.||+|+||.||+|.+. .+..+|+|++..........+.+|+.+++.++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 34578999999999999999999985 78999999987766666778899999999999999999999886 23477
Q ss_pred EEEEeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 105 LLVYEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
++||||+.+++|.+++.. ....+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999998855 346799999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCCcc--------ceeeecCCCCcCCccccccCC--CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH
Q 047716 182 LLKTDQTR--------TYTVLRGTRGYTAPELHSRNN--RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 182 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 251 (325)
........ ......+++.|+|||.+.... .++.++||||||+++++|++|+.||...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----- 257 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA----- 257 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-----
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-----
Confidence 54321110 011123688999999984332 368899999999999999999999965322211111
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCCCCC
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQNML 313 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~ 313 (325)
..... .. ...........+.+++.+||+.||.+|||++++++.|+.+.++.+.+.
T Consensus 258 ~~~~~-~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 258 LAVQN-QL------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp HHHHC-C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred HHhhc-cC------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 01111 00 011112233569999999999999999999999999999987666543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=310.03 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=208.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+..++|++.+.||+|+||.||+|.+.++..+++|++.... .....+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 3457899999999999999999999888899999986533 345678899999999999999999999864 56899999
Q ss_pred ecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++++|.+++.... ..+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999985432 3699999999999999999999999 999999999999999999999999999987654332
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. .....+. . .
T Consensus 165 ~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~~-~------~ 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------QNLERGY-R------M 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC-C------C
T ss_pred ccccCCCCccCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-------HHHhccc-C------C
Confidence 222223356789999998 45667889999999999999999 89999765432211 1111111 0 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..+......+.+++.+||+.+|.+|||++++++.|+++.
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 111223357999999999999999999999999999886
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=318.54 Aligned_cols=276 Identities=23% Similarity=0.370 Sum_probs=217.0
Q ss_pred ccccccccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccC
Q 047716 15 DVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIH 87 (325)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~ 87 (325)
+.++..+.......++...+|++.+.||+|+||.||+|.+. .+..+++|.+.... ......+.+|+.+++.++
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~ 86 (322)
T 1p4o_A 7 EYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 86 (322)
T ss_dssp CSSBCCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC
T ss_pred hhcccccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC
Confidence 33444444444445567789999999999999999999865 36789999986533 234456889999999999
Q ss_pred CCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeecc
Q 047716 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE---------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158 (325)
Q Consensus 88 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~d 158 (325)
||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.|++.|+.+||++ |++|+|
T Consensus 87 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~d 163 (322)
T 1p4o_A 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRD 163 (322)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred CCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCC
Confidence 9999999999999899999999999999999985432 4578999999999999999999999 999999
Q ss_pred CCCCceEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 047716 159 IKPHNILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVD 236 (325)
Q Consensus 159 i~p~nilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~ 236 (325)
|+|+||+++.++.++|+|||++........ .......+++.|+|||.+ .+..++.++||||||+++++|++ |+.||.
T Consensus 164 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 164 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp CSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred CccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhh-ccCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence 999999999999999999999875543221 111122257789999998 45668899999999999999999 889987
Q ss_pred CccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 237 ESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
.....+.. .....+... ......+..+.+++.+||+.+|.+|||+.|+++.|+++...
T Consensus 243 ~~~~~~~~-------~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 243 GLSNEQVL-------RFVMEGGLL-------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TSCHHHHH-------HHHHTTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred cCCHHHHH-------HHHHcCCcC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 65432211 112222211 11222345699999999999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=304.65 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=199.5
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
-..++|.+.++||+|+||.||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 35579999999999999999999987 68899999887643 34567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE---cCCCcEEEeeccccc
Q 047716 108 YEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSK 181 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv---~~~~~vkl~Dfg~~~ 181 (325)
|||+++++|.+++... ...+++..++.++.|++.|+.+||++ |++|+||+|+||++ +.++.++|+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999988443 36799999999999999999999999 99999999999999 456789999999997
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
....... .....+++.|+|||.+. ..++.++||||||+++++|++|+.||......+.... .........
T Consensus 176 ~~~~~~~--~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~-----~~~~~~~~~- 245 (285)
T 3is5_A 176 LFKSDEH--STNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK-----ATYKEPNYA- 245 (285)
T ss_dssp C------------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCCCCC-
T ss_pred ecCCccc--CcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh-----hccCCcccc-
Confidence 6544322 22234889999999983 4678999999999999999999999987543221110 011111110
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..... ....+.+++.+||+.||.+|||+.|+++
T Consensus 246 --~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 --VECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --C--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --cccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011 2356889999999999999999999983
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.75 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=206.5
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
...++|++.+.||+|+||.||+|++. +++.+++|++..........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 35689999999999999999999987 78899999987655555567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE---cCCCcEEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv---~~~~~vkl~Dfg~~~~~~~ 185 (325)
||+++++|.+++.. .+.+++..++.++.|++.|+.+||+. |++|+||+|+||++ +.++.++|+|||++.....
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999998844 45799999999999999999999999 99999999999999 7788999999999865433
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
... ....+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... .....+... .
T Consensus 162 ~~~---~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~~~----~ 226 (304)
T 2jam_A 162 GIM---STACGTPGYVAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF-------EKIKEGYYE----F 226 (304)
T ss_dssp BTT---HHHHSCCCBCCTTTB-SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHCCCC----C
T ss_pred Ccc---ccccCCCCccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCCC----C
Confidence 221 223479999999998 5667889999999999999999999999765432211 111111111 0
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
........+..+.+++.+||+.||.+|||++|++ ..+++..+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 1111122335699999999999999999999999 35655443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=326.97 Aligned_cols=253 Identities=28% Similarity=0.388 Sum_probs=206.5
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCC-ceEEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS-NRLLVY 108 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 108 (325)
+...+|++.+.||+|+||.||+|.+. +..+|+|++.... ....+.+|+.+++.++||||+++++++.... ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34578899999999999999999886 6789999987543 4567889999999999999999999976654 789999
Q ss_pred eecCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRAEQ-RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+++++|.+++..... .++...++.++.|++.|+.|||++ +++|+||+|+||+++.++.+||+|||++.......
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999999965543 379999999999999999999999 99999999999999999999999999987543221
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
. ...++..|+|||.+ ....++.++||||||+++++|++ |+.||......+... ....+. .
T Consensus 344 ~----~~~~~~~y~aPE~~-~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~~~~-------~ 404 (450)
T 1k9a_A 344 D----TGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKGY-------K 404 (450)
T ss_dssp -------CCCTTTSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-------HHHTTC-------C
T ss_pred c----CCCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCC-------C
Confidence 1 12367889999998 56778999999999999999998 999998765433221 111111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
...+..++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11222344679999999999999999999999999998763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=319.96 Aligned_cols=270 Identities=16% Similarity=0.184 Sum_probs=205.6
Q ss_pred HHHHhhhhhcCcC--CceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 32 LASENFKEEIGRG--GSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~~~lg~g--~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
..+|++.++||+| +||.||+|++. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999998 68999999987543 3344668889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||||+++++|.+++... ...+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999998544 35699999999999999999999999 999999999999999999999999998764322
Q ss_pred CCc------cceeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH---
Q 047716 186 DQT------RTYTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE--- 255 (325)
Q Consensus 186 ~~~------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--- 255 (325)
... .......++..|+|||.+.+. ..++.++|||||||++++|++|+.||............. .....
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh--cCCCCccc
Confidence 111 111112478889999998543 568899999999999999999999998755443221110 00000
Q ss_pred -------------------hCcccccc-----------cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHh
Q 047716 256 -------------------AGELQNLV-----------SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMME 303 (325)
Q Consensus 256 -------------------~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~ 303 (325)
...+.... .............+.+||.+||+.||.+|||++|++ ..++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 00000000 000011222346799999999999999999999999 3455
Q ss_pred ccC
Q 047716 304 GIV 306 (325)
Q Consensus 304 ~~~ 306 (325)
++.
T Consensus 339 ~~~ 341 (389)
T 3gni_B 339 QIK 341 (389)
T ss_dssp GC-
T ss_pred HHh
Confidence 554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=309.07 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=207.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
+..++|++.+.||+|++|.||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 33467999999999999999999987 57789999886532 233467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+++++|.+++.. .+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999999854 45799999999999999999999999 999999999999999999999999999865543
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
... ....+++.|+|||.+ .+..++.++||||||+++++|++|+.||......+.. .......
T Consensus 167 ~~~---~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~------- 228 (284)
T 2vgo_A 167 LRR---RTMCGTLDYLPPEMI-EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-------RRIVNVD------- 228 (284)
T ss_dssp SCB---CCCCSCGGGCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC-------
T ss_pred ccc---ccccCCCCcCCHHHh-ccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-------HHHhccc-------
Confidence 222 223478999999998 4566789999999999999999999999765432211 1111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
...+......+.+++.+||+.||.+|||++|++ ..++....
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 111222345689999999999999999999999 35555443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=316.32 Aligned_cols=250 Identities=24% Similarity=0.290 Sum_probs=195.0
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEe----CCCcEEEEEEeeccc----hhcHHHHHHHHHHHhccCCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCI----NGGKEIAVKKLIKIV----EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~----~~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (325)
.+...+|++.+.||+|+||.||+|++ ..++.+|+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 34567899999999999999999987 368899999987532 2234457789999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
.+..++||||+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999999843 45789999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
........ ......+++.|+|||.+ ....++.++||||||+++++|++|+.||......... .. ....
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~-i~~~--- 236 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DK-ILKC--- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HH-HHHT---
T ss_pred cccccCCc-cccccCCCcCccCHhhC-cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HH-HHhC---
Confidence 65432211 12223489999999998 5567789999999999999999999999865432211 11 1111
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
....+......+.+++.+||+.||.+|| ++.|++
T Consensus 237 -----~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l 275 (327)
T 3a62_A 237 -----KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275 (327)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence 1112222346799999999999999999 788888
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=319.22 Aligned_cols=250 Identities=23% Similarity=0.246 Sum_probs=202.4
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCc
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 103 (325)
.+...+|++.+.||+|+||.||+|++. .++.+|+|++.... ......+..|..++..+ +||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 345678999999999999999999987 47889999987532 34456678899999988 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.++|+|||++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999999854 45799999999999999999999999 9999999999999999999999999998754
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
..... ......|++.|+|||.+ ....++.++|+||||+++++|++|++||......+.. ..+....
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~~----- 237 (353)
T 2i0e_A 172 IWDGV-TTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------QSIMEHN----- 237 (353)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC-----
T ss_pred ccCCc-ccccccCCccccChhhh-cCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH-------HHHHhCC-----
Confidence 32221 22334589999999998 5667789999999999999999999999865432211 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPT-----MKQVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell 299 (325)
...+...+.++.++|.+||+.||.+||+ +++++
T Consensus 238 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~ 275 (353)
T 2i0e_A 238 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 275 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1122233467999999999999999995 57777
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=315.22 Aligned_cols=263 Identities=22% Similarity=0.349 Sum_probs=208.6
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++...+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 456789999999999999999999862 45679999986532 23345688999999999 89999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhccC----------------------CCCHHHHHHHHHHHHHHHHHhhccCCCCeeecc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAEQ----------------------RLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~d 158 (325)
.+..++||||+++++|.+++..... .+++..++.++.|++.|+.|||++ |++|+|
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 9999999999999999999965432 378999999999999999999999 999999
Q ss_pred CCCCceEEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 047716 159 IKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVD 236 (325)
Q Consensus 159 i~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~ 236 (325)
|+|+||+++.++.++|+|||++......... ......+++.|+|||.+ ....++.++||||||+++++|++ |..||.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh-ccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999765433321 12223367789999998 45678899999999999999998 999998
Q ss_pred CccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 237 ESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
......... .....+. . ...+......+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 277 ~~~~~~~~~------~~~~~~~-~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDANFY------KLIQNGF-K------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSHHHH------HHHHTTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHHHHH------HHHhcCC-C------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 765432211 1111111 1 111122345799999999999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.58 Aligned_cols=267 Identities=24% Similarity=0.295 Sum_probs=201.9
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhc-----HHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG-----ESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
...+|++.+.||+|+||.||+|.+. ++..+|+|++....... ...+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999987 68899999986532211 23577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+.+ +|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999975 88888866666799999999999999999999999 99999999999999999999999999997664
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc---ccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE---LQN 261 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 261 (325)
.... ......+++.|+|||.+.+...++.++||||||+++++|++|.+||......+.... ......... +..
T Consensus 164 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~---i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSS
T ss_pred CCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHcCCCChhhhhh
Confidence 3322 122234799999999986556688999999999999999999999987644322211 111111111 100
Q ss_pred ccc--------CCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhcc
Q 047716 262 LVS--------DQEDVN-----IEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGI 305 (325)
Q Consensus 262 ~~~--------~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~ 305 (325)
... .....+ ......+.++|.+||+.||.+|||++|+++ .+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 000 000111 122367999999999999999999999994 45444
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=314.18 Aligned_cols=270 Identities=16% Similarity=0.191 Sum_probs=200.9
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccchh-----------cHHHHHHHHHHHhccCCCCcce
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIVEE-----------GESEFRNEMKIIGRIHHKNLVD 93 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~ 93 (325)
++..++|++.+.||+|+||.||+|.+. .+..+++|++...... ....+.+|+..++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 345678999999999999999999986 5778899988654321 1123557888899999999999
Q ss_pred eeEEeec----CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC
Q 047716 94 LVGFCSE----GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 94 ~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~ 169 (325)
+++++.. ....++||||+ +++|.+++... +.+++..++.++.|++.|+.|||++ |++|+||||+||+++.+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9999877 67889999999 99999998544 4899999999999999999999999 99999999999999887
Q ss_pred C--cEEEeeccccccccCCCc------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc
Q 047716 170 W--KAKISDFGLSKLLKTDQT------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241 (325)
Q Consensus 170 ~--~vkl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 241 (325)
+ .++|+|||++........ .......+++.|+|||.+ .+..++.++||||||+++++|++|+.||......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH-KGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 7 999999999976543211 111223489999999998 5667899999999999999999999999754333
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
..... .......... ...+.... .....+..+.+++.+||+.+|.+|||+++|++.|+.+...
T Consensus 267 ~~~~~--~~~~~~~~~~-~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 267 PVAVQ--TAKTNLLDEL-PQSVLKWA-PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HHHHH--HHHHHHHHTT-THHHHHHS-CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred cHHHH--HHHHhhcccc-cHHHHhhc-cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 22211 1111111111 11000000 0002235699999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=317.75 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=201.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcE----EEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKE----IAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~----~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
..+|++.+.||+|+||.||+|.+. .+.. +++|.+... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 567999999999999999999976 4444 466665432 344567789999999999999999999999875 478
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
++++++.+++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 99999999999999977777899999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 186 DQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 186 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.... ......++..|+|||.+ .+..++.++||||||+++++|++ |+.||.......... ......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~~----- 236 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGE----- 236 (327)
T ss_dssp ----------CCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTC-----
T ss_pred ccccccccCCCccccccCHHHH-cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCC-----
Confidence 3221 11222356789999998 46678899999999999999999 999998765443221 111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
....+......+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 237 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 --RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111122234569999999999999999999999999998874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=318.10 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=189.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
...+|++.+.||+|+||.||+|.+. .++.+|+|++.... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999997 57889999987533 34567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCcEEEeeccccccccCC
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~vkl~Dfg~~~~~~~~ 186 (325)
|+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++. ++.++|+|||++......
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999843 45699999999999999999999999 9999999999999975 789999999998765432
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. .....+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... ........... .
T Consensus 205 ~~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~i~~~~~~~----~ 271 (349)
T 2w4o_A 205 VL--MKTVCGTPGYCAPEIL-RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM------FRRILNCEYYF----I 271 (349)
T ss_dssp ----------CGGGSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH------HHHHHTTCCCC----C
T ss_pred cc--cccccCCCCccCHHHh-cCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH------HHHHHhCCCcc----C
Confidence 21 1223489999999998 5667899999999999999999999999765433211 11111111110 0
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..........+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111223456999999999999999999999995
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=305.81 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=205.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.++|++.+.||+|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999987 68899999986533 334466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc---EEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK---AKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~---vkl~Dfg~~~~~~~ 185 (325)
||+.+++|.+.+.. ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++. ++|+|||++.....
T Consensus 85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999888844 46799999999999999999999999 9999999999999976655 99999999976554
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
... .....+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... ...........
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~--- 227 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-------AQIKAGAYDYP--- 227 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCCC---
T ss_pred Ccc--ccCCCCCcCCcCchhh-cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH-------HHHHhccccCC---
Confidence 332 1223489999999998 5667789999999999999999999999765432211 11111211111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
..........+.+++.+||+.||.+|||+.|+++ .+++..
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 228 -SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp -TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred -chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 1111122356899999999999999999999993 454443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=318.99 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=202.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcE----EEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKE----IAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~----~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
..+|++.+.||+|+||.||+|.+. .+.. +++|.+.... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 457889999999999999999986 3444 6677664322 222345668999999999999999999986 45789
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+.+++|.+++....+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999966667899999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 186 DQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 186 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.... ......++..|+|||.+ ....++.++||||||+++++|++ |+.||.......... ........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~~--- 236 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESI-HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-------LLEKGERL--- 236 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-------HHHTTCBC---
T ss_pred ccccccccCCCCcccccChHHh-ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-------HHHcCCCC---
Confidence 3322 22233467799999998 55668999999999999999999 999998765433211 11111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
..+......+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 ----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111122358899999999999999999999999998863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=320.16 Aligned_cols=270 Identities=22% Similarity=0.349 Sum_probs=197.8
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccC-CCCcceeeEEeecC--
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEG-- 101 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-- 101 (325)
++....+|++.+.||+|+||.||+|.+. .++.||+|++... .......+.+|+.+++.+. ||||+++++++...
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 3456789999999999999999999987 7889999998543 3344556778999999997 99999999998654
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...++||||++ ++|.+++.. +.+++..+..++.|++.|+.|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 37899999996 588888843 5799999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCC--------------------ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc
Q 047716 182 LLKTDQ--------------------TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241 (325)
Q Consensus 182 ~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 241 (325)
...... ........+|+.|+|||.+.+...++.++|||||||++++|++|++||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 543210 111222458999999999866678899999999999999999999999876543
Q ss_pred chhhHHHHHHHHHHhCcccccc---------------------c-CCCC-------------CCHHHHHHHHHHHhhccc
Q 047716 242 DEIVLIDWAHQCYEAGELQNLV---------------------S-DQED-------------VNIEEFENLVKIGLWCVE 286 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~---------------------~-~~~~-------------~~~~~~~~l~~li~~~l~ 286 (325)
+....+. .....+....+. . .... ........+.+++.+||+
T Consensus 238 ~~~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQLERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 3322211 111100000000 0 0000 000123568999999999
Q ss_pred CCCCCCCCHhHHHHH--HhccC
Q 047716 287 CELNLRPTMKQVIWM--MEGIV 306 (325)
Q Consensus 287 ~~p~~Rps~~ell~~--L~~~~ 306 (325)
.||.+|||++|+++. ++.+.
T Consensus 315 ~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 315 FNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp SSGGGSCCHHHHTTSTTTTTTC
T ss_pred cCcccCCCHHHHhCCHHHHHhc
Confidence 999999999999943 55444
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=313.25 Aligned_cols=248 Identities=24% Similarity=0.286 Sum_probs=201.8
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
....|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 3567999999999999999999985 78889999986432 2334568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+. ++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++......
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 999996 688888766667899999999999999999999999 9999999999999999999999999998765432
Q ss_pred CccceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 187 QTRTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
. ...+++.|+|||.+.. ...++.++||||||+++++|++|++||......... .... .......
T Consensus 208 ~-----~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~-~~~~~~~-- 273 (348)
T 1u5q_A 208 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA-QNESPAL-- 273 (348)
T ss_dssp C-----CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH-HSCCCCC--
T ss_pred C-----cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHH-hcCCCCC--
Confidence 2 2348999999998742 456788999999999999999999999765432211 1111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+.+++.+||+.+|.+|||++++++
T Consensus 274 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 274 ----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11122356899999999999999999999983
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.33 Aligned_cols=254 Identities=24% Similarity=0.279 Sum_probs=197.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
..++|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999987 68899999987532 2334457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+ . ||+|+||||+||+++.++.+||+|||++.....
T Consensus 226 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999998844 4679999999999999999999998 8 999999999999999999999999999875332
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
... ......||+.|+|||.+ .+..++.++||||||+++++|++|+.||.......... ......
T Consensus 302 ~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------~i~~~~------- 365 (446)
T 4ejn_A 302 DGA-TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILMEE------- 365 (446)
T ss_dssp ------CCSSSCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC-------
T ss_pred CCc-ccccccCCccccCHhhc-CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH-------HHHhCC-------
Confidence 221 22234589999999998 56778999999999999999999999997654322111 111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHHH--HHhcc
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRP-----TMKQVIW--MMEGI 305 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~--~L~~~ 305 (325)
...+......+.++|.+||+.||.+|| |++|+++ .++++
T Consensus 366 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 366 -IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 111222335699999999999999999 9999993 44443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=316.84 Aligned_cols=263 Identities=23% Similarity=0.238 Sum_probs=203.3
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-----chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-----VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
-..++|++.+.||+|+||.||+|.+. .+..+|+|++... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 35688999999999999999999987 6788999988653 23445678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhc---------------------------------------cCCCCHHHHHHHHHHHHHHHH
Q 047716 104 RLLVYEFMRNGSLGNLLFRA---------------------------------------EQRLSWSERRRIALEIMEGLH 144 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~---------------------------------------~~~~~~~~~~~~~~ql~~~l~ 144 (325)
.++||||+++++|.+++... ...+++..++.++.|++.|+.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999988421 112357788899999999999
Q ss_pred HhhccCCCCeeeccCCCCceEEcCCC--cEEEeeccccccccCCCc---cceeeecCCCCcCCcccccc-CCCCCccccc
Q 047716 145 YLHDECETRIIHCDIKPHNILMDESW--KAKISDFGLSKLLKTDQT---RTYTVLRGTRGYTAPELHSR-NNRITVKADV 218 (325)
Q Consensus 145 ~lh~~~~~~i~h~di~p~nilv~~~~--~vkl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di 218 (325)
|||++ +++|+||+|+||+++.++ .++|+|||++........ .......+++.|+|||.+.. ...++.++||
T Consensus 183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999 999999999999998776 899999999976543221 12233458999999999853 3678899999
Q ss_pred hhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHH
Q 047716 219 YSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQV 298 (325)
Q Consensus 219 wslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 298 (325)
||||+++++|++|+.||......+.. ..... .... ............+.+++.+||+.+|.+|||+.|+
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~------~~~~~-~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTI------SQVLN-KKLC----FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-CCCC----TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHH------HHHHh-cccc----cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99999999999999999866443221 11111 1111 0001111123569999999999999999999999
Q ss_pred HH--HHhccC
Q 047716 299 IW--MMEGIV 306 (325)
Q Consensus 299 l~--~L~~~~ 306 (325)
++ .++++.
T Consensus 329 l~hp~~~~~~ 338 (345)
T 3hko_A 329 LQHPWISQFS 338 (345)
T ss_dssp HHSHHHHTTS
T ss_pred hcChhhccCh
Confidence 94 555544
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=300.71 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=205.2
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
..++|++.+.||+|++|.||+|.+. ++..+++|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999987 68899999986533 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++++|.+++. ....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 85 EYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp ECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999999884 345799999999999999999999999 999999999999999999999999999876543221
Q ss_pred -cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 -RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......+++.|+|||.+......+.++||||||+++++|++|+.||.......... .. ...... ...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~-----~~~~~~--~~~--- 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD-----WKEKKT--YLN--- 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-HH-----HHTTCT--TST---
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-HH-----hhhccc--ccC---
Confidence 112233478999999998555555789999999999999999999998765433221 11 111110 000
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+.+++.+||+.||.+|||++|+++
T Consensus 230 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 -PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01122356899999999999999999999984
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.40 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=208.1
Q ss_pred HHHHhhhh-hcCcCCceeEEEEEeC---CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 32 LASENFKE-EIGRGGSGRVYKGCIN---GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 32 ~~~y~~~~-~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
..+|.+.+ .||+|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677777 8999999999999864 57789999987632 34456788999999999999999999999 4567899
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+++++|.+++......+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999966667799999999999999999999999 9999999999999999999999999999866433
Q ss_pred Cccc--eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 187 QTRT--YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 187 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.... .....+++.|+|||.+ ....++.++||||||+++++|++ |+.||......+.. .....+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~i~~~~~---- 231 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGKR---- 231 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTCC----
T ss_pred cceeeccccccccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHhcCCc----
Confidence 2211 1122357889999998 45667889999999999999998 99999765432211 11111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
...+...+..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 232 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11222344679999999999999999999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=309.92 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=210.7
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEe------CCCcEEEEEEeeccch-hcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCI------NGGKEIAVKKLIKIVE-EGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~------~~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++..++|++.+.||+|+||.||+|++ ..+..+++|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34567899999999999999999985 2467899999875432 3456788999999999 89999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhccC-----------------CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAEQ-----------------RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~-----------------~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
.+..++||||+++++|.+++..... .+++..++.++.|++.|+.+||++ |++|+||+|+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 9999999999999999999865432 489999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCccc-eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 241 (325)
|+++.++.++|+|||++.......... .....+++.|+|||.+ ....++.++||||||+++++|++ |+.||......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999998665433211 1122356789999988 45678899999999999999999 99999776543
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.... ...... ... ......+..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 255 ~~~~------~~~~~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 SKFY------KMIKEG-FRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHH------HHHHHT-CCC------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHH------HHhccC-CCC------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 2211 111111 110 1111233569999999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=305.86 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=205.8
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch------hcHHHHHHHHHHHhccCCCCcceeeEEeecCC
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE------EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS 102 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (325)
+...+|++.+.||+|+||.||+|.+. .+..+++|++..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 45688999999999999999999987 688999998865322 13567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC----cEEEeecc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW----KAKISDFG 178 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~----~vkl~Dfg 178 (325)
..++||||+++++|.+++.. ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++ .++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999999844 45799999999999999999999999 999999999999998877 79999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
++........ .....+++.|+|||.+ ....++.++||||||+++++|++|+.||......+.. .......
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------TNISAVN 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC
T ss_pred cceeccCCCc--ccccCCCcCccCccee-cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-------HHhHhcc
Confidence 9876543322 1223478999999998 5667889999999999999999999999865432211 1111111
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
.. ............+.+++.+||+.||.+|||+.|+++ .++.+.
T Consensus 228 ~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 228 YD----FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CC----CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cC----CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 00 000000112356899999999999999999999994 555554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=312.62 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=200.6
Q ss_pred HHHHhhh-hhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEE
Q 047716 32 LASENFK-EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 32 ~~~y~~~-~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
...|++. +.||+|+||.||+|.+. .+..+|+|++..........+.+|+.++..+ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578885 78999999999999976 7889999999776666677888999999885 7999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc---EEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK---AKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~---vkl~Dfg~~~~~~~ 185 (325)
||+++++|.+++.. ...+++..++.++.|++.|+.|||++ |++|+||||+||+++.++. ++|+|||++.....
T Consensus 91 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 91 EKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999854 45799999999999999999999999 9999999999999988766 99999999875432
Q ss_pred CCc------cceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhH--------H
Q 047716 186 DQT------RTYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVL--------I 247 (325)
Q Consensus 186 ~~~------~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~--------~ 247 (325)
... .......+++.|+|||.+.. ...++.++||||||+++++|++|+.||......+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 11122348899999999843 14578899999999999999999999987654321000 0
Q ss_pred HHHHHHHHhCcccccccCCCCCCH----HHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNI----EEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
............ ..+. .....+.+++.+||+.||.+|||+.|+++ .+++..
T Consensus 247 ~~~~~~i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 247 NMLFESIQEGKY--------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHCCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHhccCc--------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 001111111111 1111 12356999999999999999999999995 455443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=302.64 Aligned_cols=254 Identities=21% Similarity=0.310 Sum_probs=203.7
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--CceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 106 (325)
..++|++.+.||+|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++||||+++++++.+. ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3468899999999999999999986 7889999986532 34456788999999999999999999999876 78899
Q ss_pred EEeecCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHhhccCCCC--eeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLFRAEQ-RLSWSERRRIALEIMEGLHYLHDECETR--IIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
||||+++++|.+++..... .+++..++.++.|++.|+.|||++ + ++|+||+|+||+++.++.+++.|||+....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999965433 589999999999999999999998 8 999999999999999999999988876543
Q ss_pred cCCCccceeeecCCCCcCCccccccCC--CCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNN--RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
.... ..+++.|+|||.+.+.. .++.++||||||+++++|++|+.||......... ...... ...
T Consensus 164 ~~~~------~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~-~~~- 229 (271)
T 3kmu_A 164 QSPG------RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALE-GLR- 229 (271)
T ss_dssp SCTT------CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHS-CCC-
T ss_pred cccC------ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhc-CCC-
Confidence 2211 23789999999985432 2234799999999999999999999865432211 111111 111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
...+...+..+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 -----PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11122234579999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=315.91 Aligned_cols=259 Identities=19% Similarity=0.257 Sum_probs=196.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCCc----
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN---- 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 103 (325)
.++|++.+.||+|+||.||+|.+. .+..+|+|++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999986 788999999876432 233467899999999999999999998866543
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 3999999999999999854 45799999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 184 KTDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
..... .......+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... ..........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~- 238 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP- 238 (311)
T ss_dssp ---------------CCTTCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC-
T ss_pred cccccccccccccCcCcccCCHHHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCCC-
Confidence 43322 122223479999999998 5667899999999999999999999999765432211 1111111100
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH-HHHhccC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI-WMMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell-~~L~~~~ 306 (325)
........+..+.+++.+||+.||.+||++.+++ ..+..+.
T Consensus 239 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0000111235699999999999999999766655 4554443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=320.30 Aligned_cols=246 Identities=23% Similarity=0.241 Sum_probs=192.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHH-HhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKI-IGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
+..++|++.+.||+|+||.||+|++. .+..+|+|++.+... .....+..|..+ ++.++||||+++++.+.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 44578999999999999999999987 578899999876432 223345566666 5778999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++.+ .+.+++..++.++.|++.||.|||++ ||+||||||+||+++.+|.+||+|||++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999999844 46799999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
... .......||+.|+|||.+ .+..++.++|+||||+++|+|++|..||......+.. .......
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~-------~~i~~~~------ 255 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-------DNILNKP------ 255 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH-------HHHHHSC------
T ss_pred cCC-CccccccCCccccCHHHh-CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHhcc------
Confidence 222 122334589999999998 5667899999999999999999999999765432211 1111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHh
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMK 296 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 296 (325)
...+......+.++|.+||+.||.+||++.
T Consensus 256 --~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 256 --LQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp --CCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred --cCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 111222345699999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=309.45 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=201.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEe-ecCCceEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFC-SEGSNRLL 106 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~l 106 (325)
.+|++.+.||+|+||.||+|.+.. ...+++|.+.... ......+.+|+.+++.++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999998752 2257888876533 33446688999999999999999999985 45568899
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+++++|.+++......++...++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999976667799999999999999999999999 9999999999999999999999999999765433
Q ss_pred Cc---cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 187 QT---RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 187 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
.. .......+++.|+|||.+ .+..++.++||||||+++++|++ |.+||......+... ........
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-------~~~~~~~~-- 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------YLLQGRRL-- 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH-------HHHTTCCC--
T ss_pred chhccccccCCCCCccccChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH-------HHhcCCCC--
Confidence 22 111223356789999998 56678899999999999999999 556665544333211 11111110
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
..+...+..+.+++.+||+.+|.+|||++|+++.|+.+..
T Consensus 252 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111123569999999999999999999999999998874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=310.56 Aligned_cols=275 Identities=21% Similarity=0.263 Sum_probs=212.7
Q ss_pred CccccccccccccHHHHHHHHHhhh-hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccC-C
Q 047716 14 PDVFEEIKLRSFSYEQIVLASENFK-EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIH-H 88 (325)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~y~~~-~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~-h 88 (325)
+++-.++.--.|+-.+...+.|.+. +.||+|+||.||+|.+. +++.+|+|++.... ......+.+|+.+++.+. |
T Consensus 9 ~~~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 88 (327)
T 3lm5_A 9 SGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC 88 (327)
T ss_dssp -------CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTC
T ss_pred ccccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCC
Confidence 3444455555678888899999998 89999999999999987 68899999887533 234567889999999995 6
Q ss_pred CCcceeeEEeecCCceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc
Q 047716 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD 167 (325)
Q Consensus 89 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~ 167 (325)
|||+++++++.+.+..++||||+.+++|.+++... ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++
T Consensus 89 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLS 165 (327)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEES
T ss_pred CCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEe
Confidence 99999999999999999999999999999988433 46799999999999999999999999 999999999999998
Q ss_pred C---CCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh
Q 047716 168 E---SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI 244 (325)
Q Consensus 168 ~---~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 244 (325)
. ++.++|+|||++........ .....+++.|+|||.+ ....++.++||||||+++++|++|+.||......+..
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeee-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 7 78999999999986643322 2223489999999998 5667889999999999999999999999775433221
Q ss_pred hHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhcc
Q 047716 245 VLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGI 305 (325)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~ 305 (325)
.. ...... .............+.+++.+||+.||.+|||++|++ ..++++
T Consensus 243 ~~-------i~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 243 LN-------ISQVNV----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HH-------HHHTCC----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HH-------HHhccc----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 11 111111 111111222345699999999999999999999999 345544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=305.45 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=207.9
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec----
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE---- 100 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 100 (325)
+.+.....+|++.+.||+|+||.||+|.+. +++.+++|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 445678899999999999999999999987 78999999986543 245689999999999999999998753
Q ss_pred ------------CCceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc
Q 047716 101 ------------GSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD 167 (325)
Q Consensus 101 ------------~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~ 167 (325)
....++||||+++++|.+++... ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 34579999999999999999644 35799999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHH
Q 047716 168 ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI 247 (325)
Q Consensus 168 ~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 247 (325)
.++.++|+|||++......... ....+++.|+|||.+ .+..++.++||||||+++++|++|..|+.....
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------- 226 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELLHVCDTAFETSK------- 226 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSCC--CCCCSCCTTSCHHHH-HCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------
T ss_pred CCCCEEECcchhheeccccccc--cccCCcccccChhhh-ccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-------
Confidence 9999999999998766443221 223478999999998 566788999999999999999999988753211
Q ss_pred HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
.........+.. .....+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 227 --~~~~~~~~~~~~----------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 227 --FFTDLRDGIISD----------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --HHHHHHTTCCCT----------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --HHHHhhcccccc----------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111122222211 1224688999999999999999999999999988743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=315.72 Aligned_cols=263 Identities=17% Similarity=0.270 Sum_probs=195.4
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
.....+|++.++||+|+||.||+|.+. .+..+|+|++..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999987 788899999865332 22345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc-----CCCcEEEeecccc
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-----ESWKAKISDFGLS 180 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~-----~~~~vkl~Dfg~~ 180 (325)
+||||++ ++|.+++.. ...+++..++.++.|++.|+.|||++ |++|+||||+||+++ ..+.++|+|||++
T Consensus 110 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999996 599998843 45799999999999999999999999 999999999999994 4556999999999
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc--
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE-- 258 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 258 (325)
........ ......+++.|+|||.+.+...++.++||||||+++++|++|++||......+....+ ........
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI---FEVLGLPDDT 260 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH---HHHhCCCchh
Confidence 76543222 1222347899999999866567899999999999999999999999876443222111 11111000
Q ss_pred -c---------cccccCCCCCCH------HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 -L---------QNLVSDQEDVNI------EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 -~---------~~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+ ............ ....++.+++.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 000000000000 02356899999999999999999999994
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=310.26 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=196.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.++|++.+.||+|+||.||+|.+. ++.+++|++.. ......+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 467899999999999999999886 67899999864 2345678899999999999999999998763 579999999
Q ss_pred CCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc-EEEeeccccccccCCCc
Q 047716 112 RNGSLGNLLFRAEQ--RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK-AKISDFGLSKLLKTDQT 188 (325)
Q Consensus 112 ~~~~L~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~-vkl~Dfg~~~~~~~~~~ 188 (325)
++++|.+++..... .++...++.++.|++.|+.|||+....|++|+||||+||+++.++. +||+|||++........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~ 161 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT 161 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccc
Confidence 99999999954432 4788999999999999999999921129999999999999988876 79999999875433221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
...+++.|+|||.+ .+..++.++||||||+++++|++|+.||......... ..+ .........
T Consensus 162 ----~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~---~~~~~~~~~------- 224 (307)
T 2eva_A 162 ----NNKGSAAWMAPEVF-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMW---AVHNGTRPP------- 224 (307)
T ss_dssp -------CCTTSSCHHHH-TCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHH---HHHTTCCCC-------
T ss_pred ----cCCCCCceEChhhh-CCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHH---HHhcCCCCC-------
Confidence 22379999999998 5667899999999999999999999999765432211 111 111111111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.....+..+.+++.+||+.||.+|||++++++.|+.+..
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111223568999999999999999999999999998873
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=311.62 Aligned_cols=279 Identities=22% Similarity=0.295 Sum_probs=216.3
Q ss_pred ccccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhc--cCCCCcceeeE
Q 047716 19 EIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGR--IHHKNLVDLVG 96 (325)
Q Consensus 19 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~ 96 (325)
.....++...+....+|++.+.||+|+||.||+|.+. ++.+|+|++... ....+..|.+++.. ++||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 28 SGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp CCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred CCCCCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 4446677788899999999999999999999999885 889999998643 34556678888877 78999999999
Q ss_pred EeecCC----ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhh--------ccCCCCeeeccCCCCce
Q 047716 97 FCSEGS----NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH--------DECETRIIHCDIKPHNI 164 (325)
Q Consensus 97 ~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--------~~~~~~i~h~di~p~ni 164 (325)
++.... ..++||||+++++|.+++.. ..+++..++.++.|++.|+.||| +. +++|+||||+||
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 997765 78999999999999999953 46899999999999999999999 77 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCcc---ceeeecCCCCcCCccccccCCC-----CCccccchhHHHHHHHHHhC-----
Q 047716 165 LMDESWKAKISDFGLSKLLKTDQTR---TYTVLRGTRGYTAPELHSRNNR-----ITVKADVYSFGVMLLEIVCC----- 231 (325)
Q Consensus 165 lv~~~~~vkl~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----- 231 (325)
+++.++.++|+|||++......... ......+++.|+|||.+..... ++.++||||||+++++|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999998765443321 1122348899999999854322 23689999999999999999
Q ss_pred -----CCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 232 -----RKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 232 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..||.......... .. .........+...+... .........+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus 259 ~~~~~~~p~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSV-EE-MRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCH-HH-HHHHHTTSCCCCCCCGG-GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccccCccccCcCcccH-HH-HHHHHHHHHhCCCCccc-ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 67876554322211 11 11112122221111110 123456678999999999999999999999999999887
Q ss_pred CCC
Q 047716 307 PPH 309 (325)
Q Consensus 307 ~~~ 309 (325)
...
T Consensus 336 ~~~ 338 (342)
T 1b6c_B 336 QQE 338 (342)
T ss_dssp HTT
T ss_pred HHh
Confidence 543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=312.89 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=203.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC-----CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING-----GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
+...+|++.+.||+|+||.||+|.+.. +..+++|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 445678888999999999999998753 2358999886533 3344568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999976667899999999999999999999999 9999999999999999999999999999765
Q ss_pred cCCCccc--eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 184 KTDQTRT--YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 184 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
....... .....++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. .....+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~-- 267 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-------KAINDGF-- 267 (333)
T ss_dssp -------------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTC--
T ss_pred ccccccccccCCCCccccccCchhc-ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHCCC--
Confidence 4332211 1112246789999998 56678899999999999999998 99999765432211 1111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
....+......+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 268 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112233457999999999999999999999999999877
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=319.33 Aligned_cols=269 Identities=20% Similarity=0.258 Sum_probs=212.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC--ceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS--NRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 107 (325)
..+|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457899999999999999999987 58899999987543 344566789999999999999999999987654 67999
Q ss_pred EeecCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE----cCCCcEEEeeccccc
Q 047716 108 YEFMRNGSLGNLLFRAEQ--RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM----DESWKAKISDFGLSK 181 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv----~~~~~vkl~Dfg~~~ 181 (325)
|||+++++|.+++..... .+++..++.++.|++.|+.|||++ |++|+||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999855432 399999999999999999999999 99999999999999 777789999999997
Q ss_pred cccCCCccceeeecCCCCcCCccccccC-------CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRN-------NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
....... .....+++.|+|||.+... ..++.++||||||+++|+|++|+.||........... ......
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~--~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE--VMYKII 240 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH--HHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH--HHHHHh
Confidence 6544322 2223489999999987431 4567899999999999999999999975443222111 111222
Q ss_pred HhCc----------------ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 255 EAGE----------------LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 255 ~~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.... +...+.............+.+++.+||+.||++|||++|+++.++.+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1111 0111112233456777889999999999999999999999998888774
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=313.88 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=200.8
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeec--------C
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSE--------G 101 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~ 101 (325)
++|++.+.||+|+||.||+|.+. +++.+|+|++..... .....+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 68999999999999999999986 788999998865332 234467789999999999999999999866 3
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
+..++||||+.+ +|.+.+......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999965 77777766667899999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCc---cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 182 LLKTDQT---RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 182 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
....... .......+++.|+|||.+.+...++.++||||||+++++|++|++||...........+...........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 6542221 2222334789999999986667789999999999999999999999987654333222211110000000
Q ss_pred cccc-----------ccCCCCCCHH------HHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 259 LQNL-----------VSDQEDVNIE------EFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 259 ~~~~-----------~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
+... .......... ....+.+++.+||+.||.+|||++|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 0000 0000000000 124588999999999999999999999
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=309.28 Aligned_cols=255 Identities=23% Similarity=0.304 Sum_probs=199.2
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
.+.+....+|++.+.||+|+||.||+|.+. ++..+++|.+... .....+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp --------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 445667889999999999999999999987 5889999998653 2345688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++......+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 999999999999999965667899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
..... .....+++.|+|||.+ ....++.++||||||+++++|++|+.||.......... . ......
T Consensus 177 ~~~~~-~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~~~~~----- 242 (314)
T 3com_A 177 DTMAK-RNTVIGTPFWMAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------M-IPTNPP----- 242 (314)
T ss_dssp TTBSC-BCCCCSCGGGCCHHHH-SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------H-HHHSCC-----
T ss_pred hhccc-cCccCCCCCccChhhc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------H-HhcCCC-----
Confidence 33221 1223478999999998 55678899999999999999999999997654322111 1 111110
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
............+.+++.+||+.||.+|||+.+++
T Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll 277 (314)
T 3com_A 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLL 277 (314)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 00111112235699999999999999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=327.58 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=207.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
-...+|++.++||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 45689999999999999999999987 78899999986532 3456778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc---CCCcEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD---ESWKAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~---~~~~vkl~Dfg~~~~~ 183 (325)
||||+.+++|.+.+.. .+.+++..++.++.|++.|+.|||++ ||+|+||||+||+++ .++.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999998844 46799999999999999999999999 999999999999995 4567999999999765
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
..... .....+++.|+|||.+.+ .++.++||||||+++++|++|++||......+.. .....+.+....
T Consensus 175 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~~~ 243 (486)
T 3mwu_A 175 QQNTK--MKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-------KRVETGKYAFDL 243 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCSCS
T ss_pred CCCCc--cCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCCCC
Confidence 43322 223348999999999843 4889999999999999999999999875432211 111222211111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
+.....+..+.++|.+||+.+|.+|||+.|+++ .++...
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 244 ----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp ----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred ----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 111123356899999999999999999999994 455554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=326.28 Aligned_cols=269 Identities=19% Similarity=0.268 Sum_probs=189.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeec-----CCce
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-----GSNR 104 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 104 (325)
.+|++.+.||+|+||.||+|.+. .++.||+|++... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67999999999999999999987 7889999998653 23345668899999999999999999999843 3578
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++|||++ +++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 133 ~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999998 578888884 456799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc--------------------------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh--------
Q 047716 185 TDQT--------------------------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-------- 230 (325)
Q Consensus 185 ~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-------- 230 (325)
.... .......+|+.|+|||.+.....++.++|||||||++++|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2211 112223479999999987567779999999999999999999
Q ss_pred ---CCCCCCCccccch-----------------hhHHHHHHHHHHhCcc--------------ccccc-----CCCCCCH
Q 047716 231 ---CRKNVDESLRDDE-----------------IVLIDWAHQCYEAGEL--------------QNLVS-----DQEDVNI 271 (325)
Q Consensus 231 ---g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~--------------~~~~~-----~~~~~~~ 271 (325)
|+++|.+...... ...+......+..... ..... ......+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6666755431100 0000000010100000 00000 0011112
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
.....+.+|+.+||+.||.+|||++|+++ .++++.
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 22466899999999999999999999993 565553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=316.07 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=209.6
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC--------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEE
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN--------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGF 97 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 97 (325)
.++...+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3456789999999999999999999874 46679999987543 33456688999999999 89999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCC
Q 047716 98 CSEGSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPH 162 (325)
Q Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 162 (325)
+...+..++||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 999999999999999999999986543 2489999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccc
Q 047716 163 NILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLR 240 (325)
Q Consensus 163 nilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 240 (325)
||+++.++.++|+|||++......... ......+++.|+|||.+ .+..++.++||||||+++++|++ |+.||.....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh-cCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999999765443221 11222356789999998 45667899999999999999999 9999976543
Q ss_pred cchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 241 DDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.+.. ......... ..+......+.+++.+||+.+|.+|||+.|+++.|+.+..
T Consensus 266 ~~~~-------~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 EELF-------KLLKEGHRM-------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHH-------HHHHHTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-------HHHhcCCCC-------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2211 111111111 1122234569999999999999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=310.18 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=209.0
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEe-----CCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC--C
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCI-----NGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--S 102 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 102 (325)
+...+|++.+.||+|+||.||+|.+ ..+..+|+|++..........+.+|+.+++.++||||+++++++... .
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 3456799999999999999999984 26888999998776666667899999999999999999999988654 3
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 78999999999999999976667799999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCccc--eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc---------chhhHHHHHH
Q 047716 183 LKTDQTRT--YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD---------DEIVLIDWAH 251 (325)
Q Consensus 183 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---------~~~~~~~~~~ 251 (325)
........ .....++..|+|||.+ .+..++.++||||||+++++|++|..|+...... ..........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESL-TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhh-cCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 65433211 1112356679999998 4556788999999999999999999998643110 0000011111
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
........ ...+...+..+.++|.+||+.||.+|||+.|+++.|+.+.
T Consensus 274 ~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 274 ELLKNNGR-------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHTTCC-------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhcCCC-------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111110 1112233467999999999999999999999999998874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=309.79 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=196.1
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC------
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------ 102 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 102 (325)
...+|++.+.||+|+||.||+|++. ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4578999999999999999999997 78999999986533 334567889999999999999999999875543
Q ss_pred ---------------------------------------------------ceEEEEeecCCCCHHHHHhhcc--CCCCH
Q 047716 103 ---------------------------------------------------NRLLVYEFMRNGSLGNLLFRAE--QRLSW 129 (325)
Q Consensus 103 ---------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~--~~~~~ 129 (325)
..++||||+++++|.+++.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 2799999999999999995542 23566
Q ss_pred HHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc-----------ceeeecCCC
Q 047716 130 SERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-----------TYTVLRGTR 198 (325)
Q Consensus 130 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-----------~~~~~~~~~ 198 (325)
..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++......... ......+++
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 67899999999999999999 9999999999999999999999999999876543211 112234899
Q ss_pred CcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHH
Q 047716 199 GYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLV 278 (325)
Q Consensus 199 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 278 (325)
.|+|||.+ .+..++.++||||||+++++|++|..|+..... .......... +.........+.
T Consensus 241 ~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---------~~~~~~~~~~-------~~~~~~~~~~~~ 303 (332)
T 3qd2_B 241 LYMSPEQI-HGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---------IITDVRNLKF-------PLLFTQKYPQEH 303 (332)
T ss_dssp GGSCHHHH-HCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---------HHHHHHTTCC-------CHHHHHHCHHHH
T ss_pred CccChHHh-cCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---------HHHHhhccCC-------CcccccCChhHH
Confidence 99999998 566789999999999999999998776532110 0111111111 111223345689
Q ss_pred HHHhhcccCCCCCCCCHhHHHH
Q 047716 279 KIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 279 ~li~~~l~~~p~~Rps~~ell~ 300 (325)
+++.+||+.||.+|||++|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999995
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=303.74 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=205.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
..+|++.+.||+|+||.||+|.+. .++.+++|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357899999999999999999987 57788999886542 23445688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++. ..+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999884 346799999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.. .....+++.|+|||.+ .+..++.++||||||+++++|++|+.||......+.. ....... .
T Consensus 170 ~~-~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~--------~ 232 (294)
T 2rku_A 170 ER-KKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNE--------Y 232 (294)
T ss_dssp CC-BCCCCSCCSSCCHHHH-TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC--------C
T ss_pred cc-cccccCCCCcCCcchh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhhcc--------C
Confidence 21 2223478999999998 5666789999999999999999999999865432211 1111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhcc
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGI 305 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~ 305 (325)
..+......+.+++.+||+.||.+|||++|+++ .+...
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 111122356899999999999999999999993 44433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=327.89 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=199.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
-...+|++.++||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35678999999999999999999987 68889999987533 3345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC---CcEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES---WKAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~---~~vkl~Dfg~~~~~ 183 (325)
||||+.+++|.+.+.. ...+++..++.++.|++.|+.|||++ |++|+||||+||+++.. +.+||+|||++...
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999998843 46799999999999999999999999 99999999999999764 45999999998766
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
..... .....+++.|+|||.+. ..++.++||||||+++++|++|.+||......+.. .....+.....
T Consensus 190 ~~~~~--~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~~- 257 (494)
T 3lij_A 190 ENQKK--MKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL-------RKVEKGKYTFD- 257 (494)
T ss_dssp BTTBC--BCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCCCC-
T ss_pred CCCcc--ccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCCCC-
Confidence 54322 22334899999999983 45889999999999999999999999876443221 11222211110
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.......+..+.+++.+||+.+|.+|||+.|++
T Consensus 258 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 290 (494)
T 3lij_A 258 ---SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290 (494)
T ss_dssp ---SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ---chhcccCCHHHHHHHHHHCCCChhhCccHHHHh
Confidence 000112235689999999999999999999999
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.12 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=204.6
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcE--EEEEEeecc-chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKE--IAVKKLIKI-VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~--~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 104 (325)
+..++|++.+.||+|+||.||+|++. ++.. +++|.+... .......+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 44578899999999999999999986 4554 488887643 233445688999999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC
Q 047716 105 LLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES 169 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~ 169 (325)
++||||+++++|.+++.... ..+++..++.++.|++.|+.+||++ |++|+||+|+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999985432 4699999999999999999999999 99999999999999999
Q ss_pred CcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHH
Q 047716 170 WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLID 248 (325)
Q Consensus 170 ~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 248 (325)
+.++|+|||++........ .....+++.|+|||.+ ....++.++||||||+++++|++ |+.||......+..
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---- 251 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---- 251 (327)
T ss_dssp GCEEECCTTCEESSCEECC--C----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----
T ss_pred CeEEEcccCcCcccccccc--ccCCCCCccccChhhh-ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH----
Confidence 9999999999864332211 1122357889999998 55667899999999999999998 99999765432211
Q ss_pred HHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 249 WAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
.....+. ....+......+.+++.+||+.+|.+|||++|+++.|+.+....
T Consensus 252 ---~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 252 ---EKLPQGY-------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ---HHGGGTC-------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---HHhhcCC-------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111110 11112223456999999999999999999999999999887443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=309.88 Aligned_cols=283 Identities=22% Similarity=0.282 Sum_probs=210.1
Q ss_pred cccccccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhcc--CCCCcce
Q 047716 16 VFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI--HHKNLVD 93 (325)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~ 93 (325)
........+....+...++|++.+.||+|+||.||+|++. +..+|+|++.... ......|.+++..+ +||||++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~ 95 (337)
T 3mdy_A 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILG 95 (337)
T ss_dssp HHCSCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred cCCCCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeee
Confidence 3344455567778888999999999999999999999886 8899999985432 23344455555554 8999999
Q ss_pred eeEEeecC----CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCeeeccCCCCce
Q 047716 94 LVGFCSEG----SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC-----ETRIIHCDIKPHNI 164 (325)
Q Consensus 94 ~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~-----~~~i~h~di~p~ni 164 (325)
+++++... ...++||||+++++|.+++.. ..+++..++.++.|++.|+.|||+++ ..|++|+||||+||
T Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni 173 (337)
T 3mdy_A 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173 (337)
T ss_dssp EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred EEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence 99998776 678999999999999999943 46899999999999999999999741 23899999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCccc---eeeecCCCCcCCccccccCCCCCc------cccchhHHHHHHHHHhC----
Q 047716 165 LMDESWKAKISDFGLSKLLKTDQTRT---YTVLRGTRGYTAPELHSRNNRITV------KADVYSFGVMLLEIVCC---- 231 (325)
Q Consensus 165 lv~~~~~vkl~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~~DiwslG~il~~ll~g---- 231 (325)
+++.++.+||+|||++.......... .....+++.|+|||.+. ...... ++||||||+++|+|++|
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHT-TCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcc-cccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 99999999999999997654332221 11234899999999984 333333 38999999999999999
Q ss_pred ------CCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 232 ------RKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 232 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
+.||........... ................. ......+...+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYE--DMREIVCIKKLRPSFPN-RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHH--HHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccHhhhcCCCCchh--hhHHHHhhhccCccccc-cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 666655433322111 11111111111111111 111235678899999999999999999999999999988
Q ss_pred CCC
Q 047716 306 VPP 308 (325)
Q Consensus 306 ~~~ 308 (325)
...
T Consensus 330 ~~~ 332 (337)
T 3mdy_A 330 SES 332 (337)
T ss_dssp HHT
T ss_pred Hhh
Confidence 743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=334.34 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=212.1
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++...+|++.++||+|+||.||+|.+.++..||+|++.... .....+.+|+.+++.++||||+++++++.+ ...++||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 45677899999999999999999999988889999987543 345678999999999999999999999866 6789999
Q ss_pred eecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||+|+|||++.++.+||+|||++.......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999643 34589999999999999999999999 99999999999999999999999999997654322
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
........++..|+|||.+ ....++.++||||||+++|+|++ |+.||......+.. ..+..+. .
T Consensus 418 ~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~-------~ 482 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY-------R 482 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-------HHHHTTC-------C
T ss_pred eecccCCcCcccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-------C
Confidence 1111222356789999998 45678999999999999999999 89999865432211 1111111 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
...+..+...+.++|.+||+.||++|||+++|+++|+.+....
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 1112234467999999999999999999999999999998543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=303.70 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=197.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
+..++|++.+.||+|++|.||+|.+. +++.+++|++.... ......+.+|+..++.++||||+++++++...+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 34468999999999999999999987 78899999986532 234557889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+++++|.+++.. .+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999854 45799999999999999999999999 999999999999999999999999999876544
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
... .....+++.|+|||.+.+....+.++||||||+++++|++|+.||........ .........
T Consensus 164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------ 228 (276)
T 2h6d_A 164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-------FKKIRGGVF------ 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC------
T ss_pred Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhhcCcc------
Confidence 322 12234788999999985544557899999999999999999999976532211 111111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+......+.+++.+||+.||.+|||+.|+++
T Consensus 229 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 --YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111122356899999999999999999999994
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.64 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=200.3
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++|++.+.||+|+||.||+|.+. .+..+++|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57999999999999999999987 588999998865332 234557789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.++. .....+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 105 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 105 FVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp CCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 99998888876 3456799999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH--------HHHHHHhCc-cc
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW--------AHQCYEAGE-LQ 260 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~-~~ 260 (325)
......+++.|+|||.+.+...++.++||||||+++++|++|++||......+....+.. ....+.... ..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 122234789999999986556789999999999999999999999987654332221110 000111110 00
Q ss_pred ccccCC-------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 NLVSDQ-------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 ~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
....+. ....+.....+.+++.+||+.||.+|||+.|++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 305 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHh
Confidence 000000 000112346799999999999999999999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=326.49 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=194.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecC------C
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------S 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 102 (325)
..+|++.+.||+|+||.||+|.+. .++.||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999987 6888999998753 334456688999999999999999999998554 4
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+++ ++.+.+. ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 56999999965 4656552 3589999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC-----
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG----- 257 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 257 (325)
...... .....+|+.|+|||.+ .+..++.++|||||||++++|++|++||.+....+....+. ..+..+
T Consensus 214 ~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~---~~lg~p~~~~~ 287 (464)
T 3ttj_A 214 AGTSFM--MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI---EQLGTPCPEFM 287 (464)
T ss_dssp ---CCC--C----CCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCSCCHHHH
T ss_pred cCCCcc--cCCCcccccccCHHHH-cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCCHHHH
Confidence 543322 2233489999999999 45678999999999999999999999998765433222111 100000
Q ss_pred -c----ccccccC--------------------CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 258 -E----LQNLVSD--------------------QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 258 -~----~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
. ....+.. ...........+.+|+.+||+.||.+|||++|++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 354 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0 0000000 0001111256799999999999999999999999
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=311.03 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=201.7
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
...+|++.+.||+|+||.||+|.+. .+..+++|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999997 588899999877666667788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ- 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence 9999999999876667899999999999999999999999 999999999999999999999999998753221111
Q ss_pred ceeeecCCCCcCCccccc----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 190 TYTVLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
......+++.|+|||.+. ....++.++||||||+++++|++|+.||......... ..... .....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~~---- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAK-SDPPT---- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SCCCC----
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhc-cCCcc----
Confidence 111233789999999874 3566788999999999999999999999865432211 11111 11110
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111223356999999999999999999999983
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=315.85 Aligned_cols=263 Identities=17% Similarity=0.218 Sum_probs=204.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCC---------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcce---------
Q 047716 32 LASENFKEEIGRGGSGRVYKGCING---------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVD--------- 93 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~--------- 93 (325)
..+|++.+.||+|+||.||+|.+.. +..+|+|.+... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999874 788999998653 35778999999999999887
Q ss_pred ------eeEEeec-CCceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceE
Q 047716 94 ------LVGFCSE-GSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNIL 165 (325)
Q Consensus 94 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil 165 (325)
+++++.. ++..++||||+ +++|.+++... ...+++..++.++.|++.|+.|||++ |++|+||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 5666655 67889999999 99999999654 36799999999999999999999999 9999999999999
Q ss_pred EcCCC--cEEEeeccccccccCCCcc------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 047716 166 MDESW--KAKISDFGLSKLLKTDQTR------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDE 237 (325)
Q Consensus 166 v~~~~--~vkl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 237 (325)
++.++ .++|+|||++......... ......+++.|+|||.+ .+..++.++||||||+++++|++|+.||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH-KGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 8999999999765432211 11223488999999998 566789999999999999999999999987
Q ss_pred ccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 238 SLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
........ .. ....... ....+..... .....+..+.+++.+||+.||.+|||++++++.|+.+...
T Consensus 271 ~~~~~~~~-~~-~~~~~~~-~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 271 CLPNTEDI-MK-QKQKFVD-KPGPFVGPCG-HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GTTCHHHH-HH-HHHHHHH-SCCCEECTTS-CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCcCHHHH-HH-HHHhccC-Chhhhhhhcc-ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 65332221 11 1111111 1111111110 0001125699999999999999999999999999998743
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=327.22 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=209.4
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
+...+|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56789999999999999999999987 78899999986532 345677899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE---cCCCcEEEeecccccc
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKL 182 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv---~~~~~vkl~Dfg~~~~ 182 (325)
+||||+.+++|.+.+. ..+.+++..++.++.|++.|+.|||++ |++|+||||+||++ +.++.++|+|||++..
T Consensus 103 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 103 LVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EEECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999884 446799999999999999999999999 99999999999999 5678999999999876
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|++||......+.. .....+.+..-
T Consensus 179 ~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~~~~~~ 247 (484)
T 3nyv_A 179 FEASKK--MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-------KKVEKGKYTFE 247 (484)
T ss_dssp BCCCCS--HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCCCC
T ss_pred cccccc--cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCCCCC
Confidence 654332 222348999999999843 5889999999999999999999999875432211 11222221111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
.+.....+..+.++|.+||+.+|.+|||+.|++ ..++...
T Consensus 248 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 248 ----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 111112345699999999999999999999999 4555443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=320.20 Aligned_cols=271 Identities=23% Similarity=0.287 Sum_probs=207.1
Q ss_pred cccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-----CCCcce
Q 047716 20 IKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-----HKNLVD 93 (325)
Q Consensus 20 ~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~ 93 (325)
.....+..+++..++|++.++||+|+||.||+|.+. ++..+|+|++... ......+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 334446666678899999999999999999999986 6888999998642 334456677999999886 999999
Q ss_pred eeEEeecCCceEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC----
Q 047716 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---- 168 (325)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---- 168 (325)
+++++...+..++|||++ +++|.+++.... ..+++..++.++.|++.||.|||++ ||+|+||||+||+++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 999999999999999999 899999986543 4599999999999999999999999 9999999999999975
Q ss_pred ---------------------CCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHH
Q 047716 169 ---------------------SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLE 227 (325)
Q Consensus 169 ---------------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 227 (325)
++.++|+|||++........ ...+++.|+|||.+ .+..++.++|||||||++++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~----~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG----SIINTRQYRAPEVI-LNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC----SCCSCGGGCCHHHH-TTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCCc----CccCcccccCcHHH-cCCCCCCccchHHHHHHHHH
Confidence 78899999999976443222 23479999999998 46678999999999999999
Q ss_pred HHhCCCCCCCccccchhhHHHHHH--------HHHHhCccccccc--------CCCCCCHH---------------HHHH
Q 047716 228 IVCCRKNVDESLRDDEIVLIDWAH--------QCYEAGELQNLVS--------DQEDVNIE---------------EFEN 276 (325)
Q Consensus 228 ll~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~--------~~~~~~~~---------------~~~~ 276 (325)
|++|+.||......+....+.... ............. +....... ....
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 999999998654433221111000 0000000000000 00000000 1156
Q ss_pred HHHHHhhcccCCCCCCCCHhHHHH
Q 047716 277 LVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 277 l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+.+++.+||+.||.+|||+.|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 889999999999999999999983
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=305.79 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=205.0
Q ss_pred HHH-hhhhhcCcCCceeEEEEEeC-----CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC--Cc
Q 047716 33 ASE-NFKEEIGRGGSGRVYKGCIN-----GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG--SN 103 (325)
Q Consensus 33 ~~y-~~~~~lg~g~~g~v~~~~~~-----~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 103 (325)
.+| ++.++||+|+||.||++.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 455 99999999999999988653 57889999987643 33456688999999999999999999999774 57
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++.. ..+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 8999999999999999843 3599999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccc--------hhhHHHHHHHH
Q 047716 184 KTDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDD--------EIVLIDWAHQC 253 (325)
Q Consensus 184 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--------~~~~~~~~~~~ 253 (325)
...... ......++..|+|||.+ .+..++.++||||||+++++|++|+.||....... ...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECL-KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHh-cCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 543321 12223367789999998 45667889999999999999999999997543210 00000111111
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
...... ...+...+..+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 264 ~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 264 LERGER-------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcccC-------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111111 11222334679999999999999999999999999998863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=309.62 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=205.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
...+|++.+.||+|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3467999999999999999999987 57788899886542 2344568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
||||+.+++|.+++.. ...+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999998843 46799999999999999999999999 9999999999999999999999999999765432
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
... .....++..|+|||.+ ....++.++||||||+++++|++|+.||......+... .......
T Consensus 195 ~~~-~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~------- 258 (335)
T 2owb_A 195 GER-KKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------RIKKNEY------- 258 (335)
T ss_dssp TCC-BCCCCSCCSSCCHHHH-HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTCC-------
T ss_pred ccc-ccccCCCccccCHHHh-ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHhcCCC-------
Confidence 221 2223488999999998 56667899999999999999999999997654322111 1111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhc
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEG 304 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~ 304 (325)
..+......+.+++.+||+.||.+|||++|+++ .+..
T Consensus 259 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 259 -SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 111122356899999999999999999999993 4444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.87 Aligned_cols=245 Identities=20% Similarity=0.281 Sum_probs=199.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 105 (325)
-...+|++.+.||+|+||.||+|.+. ++..+++|++.... ......+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35689999999999999999999987 78999999987532 33455677899999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-------------
Q 047716 106 LVYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES------------- 169 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~------------- 169 (325)
+||||+++++|.+++... ...+++..++.++.|++.|+.|||++ |++|+||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999998543 25689999999999999999999999 99999999999999844
Q ss_pred ------CcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccch
Q 047716 170 ------WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDE 243 (325)
Q Consensus 170 ------~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 243 (325)
..++|+|||.+........ ..+++.|+|||.+.+...++.++||||||+++++|++|.+++.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred cccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 4799999999876654332 23789999999986555677899999999999999999987754321
Q ss_pred hhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 244 IVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...........+ +......+.+++.+||+.||.+|||+.|++
T Consensus 237 -------~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 237 -------WHEIRQGRLPRI-------PQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp -------HHHHHTTCCCCC-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -------HHHHHcCCCCCC-------CcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 111222222211 112235699999999999999999999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.25 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=199.0
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
...+|++.+.||+|+||.||+|.+. .+..+|+|++...... ..+|+.++..+ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4678999999999999999999987 6888999998664332 34577888887 7999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC----CcEEEeecccccccc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES----WKAKISDFGLSKLLK 184 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~----~~vkl~Dfg~~~~~~ 184 (325)
||+++++|.+++. ..+.+++..++.++.|++.|+.|||++ |++|+||||+||++... +.+||+|||++....
T Consensus 96 E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 96 ELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred eCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999884 346799999999999999999999999 99999999999998543 359999999998654
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.... ......+++.|+|||.+ .+..++.++||||||+++++|++|..||............ ..+..+.+..
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~~--- 242 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFSL--- 242 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHH-HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCCC---
T ss_pred CCCC-ceeccCCCccccCHHHh-cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCccc---
Confidence 4322 12233479999999998 4455788999999999999999999999865433222211 1222222211
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
........+..+.+++.+||+.||.+|||+.|++
T Consensus 243 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il 276 (342)
T 2qr7_A 243 -SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276 (342)
T ss_dssp -CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred -CccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1111122345799999999999999999999999
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.69 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=199.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecC------C
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------S 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 102 (325)
..+|++.+.||+|+||.||+|.+. .+..||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999986 6899999998543 233345688999999999999999999998765 3
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+ +++|.+++.. ..+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 8899999854 5799999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC-----
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG----- 257 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 257 (325)
..... ....+++.|+|||.+.+...++.++|||||||++++|++|++||.+....+....+. ......
T Consensus 178 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~---~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM---KVTGTPPAEFV 250 (367)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCCCCHHHH
T ss_pred ccccc----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCCHHHH
Confidence 54322 223478999999998665788999999999999999999999998765433222111 000000
Q ss_pred -------------cccccccCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCC
Q 047716 258 -------------ELQNLVSDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVP 307 (325)
Q Consensus 258 -------------~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~ 307 (325)
.+....... ....+.....+.+++.+||+.||.+|||++|+++ .++.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 000000000 1111223456999999999999999999999995 5666653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=306.18 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=202.8
Q ss_pred HHHHhhhh-hcCcCCceeEEEEEeC---CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 32 LASENFKE-EIGRGGSGRVYKGCIN---GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 32 ~~~y~~~~-~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
..+|++.+ .||+|+||.||+|.+. .+..+++|++..... .....+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 9999999999999653 467899999865432 2346688999999999999999999999 556789
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+++++|.+++.. ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 99999999999999954 45699999999999999999999999 999999999999999999999999999876644
Q ss_pred CCccc--eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 186 DQTRT--YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 186 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
..... .....++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. ........
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~--- 238 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGER--- 238 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCC---
T ss_pred CCCcccccccCCCCceeeChHHh-ccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCC---
Confidence 33221 1112256789999998 45567889999999999999999 99999875432211 11111111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122233467999999999999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=304.94 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=200.3
Q ss_pred HHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCce-EEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR-LLV 107 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv 107 (325)
.|++.+.||+|+||.||+|.+.. +..+++|++..... .....+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35556899999999999998642 22688888865332 3446688999999999999999999999766554 999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+.+++|.+++......+++..++.++.|++.|+.+||++ |++|+||||+||+++.++.++|+|||++.......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999976667899999999999999999999999 99999999999999999999999999997554322
Q ss_pred c---cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 188 T---RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 188 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
. .......++..|+|||.+ .+..++.++||||||+++++|++|+.|+.......... ........
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~------~~~~~~~~----- 246 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESL-QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT------HFLAQGRR----- 246 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHH-TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH------HHHHTTCC-----
T ss_pred ccccccCcCCCCCccccChhhh-ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH------HHhhcCCC-----
Confidence 1 111223367889999998 56678899999999999999999655544332222111 11111110
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
...+......+.+++.+||+.+|.+|||++++++.|+++..
T Consensus 247 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 247 --LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11112233569999999999999999999999999988863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=305.37 Aligned_cols=251 Identities=28% Similarity=0.395 Sum_probs=198.4
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC-CceEEEEe
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-SNRLLVYE 109 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 109 (325)
..++|++.+.||+|++|.||+|.+. +..+++|++... ...+.+.+|+.+++.++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3578999999999999999999885 788999998653 2456788999999999999999999986544 57899999
Q ss_pred ecCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRAEQ-RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++++|.+++..... .+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 9999999999854432 389999999999999999999999 999999999999999999999999999875443221
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
...++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. .....+. ..
T Consensus 173 ----~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~~~~-------~~ 233 (278)
T 1byg_A 173 ----TGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGY-------KM 233 (278)
T ss_dssp -------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHTTTC-------CC
T ss_pred ----CCCccccccCHHHh-CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCC-------CC
Confidence 12367889999998 55678899999999999999998 99999765433221 1111111 11
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 122233467999999999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.91 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=202.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEe----CCCcEEEEEEeeccc----hhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCC
Q 047716 32 LASENFKEEIGRGGSGRVYKGCI----NGGKEIAVKKLIKIV----EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGS 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~----~~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 102 (325)
..+|++.+.||+|+||.||+|++ ..++.+|+|++.... ......+..|+.+++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999998 368899999986432 22334566789999999 6999999999999999
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999854 45799999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCccceeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
.............+++.|+|||.+.+. ..++.++||||||+++++|++|+.||...........+ ......
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~------ 280 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILK------ 280 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHH------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhc------
Confidence 544333333344589999999998542 45788999999999999999999999765433322111 111111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
.....+......+.++|.+||+.||.+|| |++|+++
T Consensus 281 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 281 ---SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 11112223345689999999999999999 9999983
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.31 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=203.9
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--------hcHHHHHHHHHHHhcc-CCCCcceeeEE
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--------EGESEFRNEMKIIGRI-HHKNLVDLVGF 97 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 97 (325)
......+|++.+.||+|++|.||+|.+. +|..||||++..... .....+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999987 789999999865331 1234577899999999 79999999999
Q ss_pred eecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeec
Q 047716 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDF 177 (325)
Q Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Df 177 (325)
+...+..++||||+++++|.+++.. ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.++|+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEec
Confidence 9999999999999999999999853 46799999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCccceeeecCCCCcCCcccccc-----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHH
Q 047716 178 GLSKLLKTDQTRTYTVLRGTRGYTAPELHSR-----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQ 252 (325)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 252 (325)
|++........ .....+++.|+|||.+.+ ...++.++||||||+++++|++|+.||......... .
T Consensus 245 G~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-------~ 315 (365)
T 2y7j_A 245 GFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML-------R 315 (365)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------H
T ss_pred CcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH-------H
Confidence 99876654322 223448999999998743 235788999999999999999999999764322111 1
Q ss_pred HHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 253 CYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
............. .......+.+++.+||+.||.+|||+.|+++
T Consensus 316 ~i~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQYQFSSPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTCCCCCHHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCCCCCCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111100000 0012346899999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.55 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=195.1
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--------hcHHHHHHHHHHHhccCCCCcceeeEEe
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--------EGESEFRNEMKIIGRIHHKNLVDLVGFC 98 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (325)
.....++|++.+.||+|+||.||+|.+. .++.+|+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3566789999999999999999999987 678999999875321 1122477899999999999999999998
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---cEEEe
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---KAKIS 175 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---~vkl~ 175 (325)
.. ...++||||+++++|.+++. ..+.+++..++.++.|++.|+.|||++ +++|+||||+||+++.++ .+||+
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred ec-CceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 54 56899999999999999884 446799999999999999999999999 999999999999997554 49999
Q ss_pred eccccccccCCCccceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHH
Q 047716 176 DFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253 (325)
Q Consensus 176 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 253 (325)
|||++........ .....+++.|+|||.+.. ...++.++||||||+++++|++|++||.......... ..
T Consensus 285 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~------~~ 356 (419)
T 3i6u_A 285 DFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK------DQ 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH------HH
T ss_pred ecccceecCCCcc--ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH------HH
Confidence 9999987643322 223448999999999743 4567889999999999999999999997654332211 11
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......... .........+.+++.+||+.||.+|||++|+++
T Consensus 357 i~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCc----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111111100 000112356999999999999999999999994
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=316.35 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=194.9
Q ss_pred HHhhhhhcCcCCceeEEEEEeC--CC--cEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEee-cCCceEEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN--GG--KEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCS-EGSNRLLV 107 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~--~~--~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv 107 (325)
.|++.+.||+|+||.||+|++. ++ ..+++|.+.... ......+.+|+.+++.++||||+++++++. .++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999874 22 357888876432 344567889999999999999999999864 45678999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++.......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999976667789999999999999999999999 99999999999999999999999999997553322
Q ss_pred cc---ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 188 TR---TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 188 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.. ......++..|+|||.+ ....++.++||||||+++|+|++ |.+||......+... ....+..
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-------~~~~~~~---- 314 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------YLLQGRR---- 314 (373)
T ss_dssp -----------CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-------HHHTTCC----
T ss_pred cccccccCCCCCcccccChHHh-cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-------HHHcCCC----
Confidence 11 11222356789999998 56678899999999999999999 677777654433221 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
...+...+..+.+++.+||+.+|.+|||++|+++.|+.+..
T Consensus 315 ---~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 315 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11112233569999999999999999999999999998873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=318.54 Aligned_cols=283 Identities=20% Similarity=0.272 Sum_probs=211.5
Q ss_pred cccCCCccccccccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC
Q 047716 9 RQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH 87 (325)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~ 87 (325)
...+..+.+...++..+..+++...+|++.++||+|+||.||+|++. ++..+|+|++... ......+.+|+.+++.++
T Consensus 13 ~~~e~~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~ 91 (397)
T 1wak_A 13 DEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVR 91 (397)
T ss_dssp ---------CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHH
T ss_pred ccccccccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHh
Confidence 34566777888888899999999999999999999999999999986 6788999998643 334556788999999985
Q ss_pred --------CCCcceeeEEee----cCCceEEEEeecCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 047716 88 --------HKNLVDLVGFCS----EGSNRLLVYEFMRNGSLGNLLFR-AEQRLSWSERRRIALEIMEGLHYLHDECETRI 154 (325)
Q Consensus 88 --------h~~iv~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i 154 (325)
|+||+++++.+. .....++||||+ ++++.+.+.. ....+++..++.++.|++.||.|||+++ ||
T Consensus 92 ~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--gi 168 (397)
T 1wak_A 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RI 168 (397)
T ss_dssp HSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CE
T ss_pred hcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CE
Confidence 788999999886 456789999999 5555555533 3467999999999999999999999852 89
Q ss_pred eeccCCCCceEEcCCC-------------------------------------------------cEEEeeccccccccC
Q 047716 155 IHCDIKPHNILMDESW-------------------------------------------------KAKISDFGLSKLLKT 185 (325)
Q Consensus 155 ~h~di~p~nilv~~~~-------------------------------------------------~vkl~Dfg~~~~~~~ 185 (325)
+|+||||+|||++.++ .++|+|||++.....
T Consensus 169 vHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~ 248 (397)
T 1wak_A 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248 (397)
T ss_dssp ECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB
T ss_pred ecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc
Confidence 9999999999998775 799999999976543
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHH---HHHHHHHHh------
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI---DWAHQCYEA------ 256 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~---~~~~~~~~~------ 256 (325)
... ...+++.|+|||.+ .+..++.++|||||||++++|++|+.||......+..... .........
T Consensus 249 ~~~----~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 323 (397)
T 1wak_A 249 HFT----EDIQTRQYRSLEVL-IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323 (397)
T ss_dssp CSC----SCCSCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred cCc----cCCCCCcccCChhh-cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence 322 22479999999998 4566889999999999999999999999866543321111 111111110
Q ss_pred --Cccc----------------------ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 257 --GELQ----------------------NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 257 --~~~~----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.... ..+.............+.+|+.+||+.||.+|||+.|+++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000 0111122345677788999999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=297.50 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=196.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeec----CCceEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE----GSNRLL 106 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 106 (325)
.|++.+.||+|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4788889999999999999987 67788899886532 3445668899999999999999999998764 356899
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeeccCCCCceEEc-CCCcEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR--IIHCDIKPHNILMD-ESWKAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nilv~-~~~~vkl~Dfg~~~~~ 183 (325)
||||+++++|.+++.. ...+++..++.++.|++.|+.|||++ + ++|+||+|+||+++ .++.++|+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999944 46799999999999999999999998 8 99999999999997 7889999999998754
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
..... ....+++.|+|||.+. ..++.++||||||+++++|++|+.||.......... ...........
T Consensus 183 ~~~~~---~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~~~- 250 (290)
T 1t4h_A 183 RASFA---KAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY------RRVTSGVKPAS- 250 (290)
T ss_dssp CTTSB---EESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH------HHHTTTCCCGG-
T ss_pred ccccc---ccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH------HHHhccCCccc-
Confidence 43322 2334899999999884 358899999999999999999999997654322211 11111111110
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........+.+++.+||+.||.+|||++|+++
T Consensus 251 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 -----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111246999999999999999999999984
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=308.25 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=194.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCC--CCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHH--KNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 107 (325)
..+|++.+.||+|+||.||+|.+.++..+|+|++.... ......+.+|+.+++.++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45689999999999999999999889999999986432 3334668899999999986 9999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+ .+++|.+++.. .+.+++..++.++.|++.||.|||++ ||+|+||||+||+++ ++.+||+|||++.......
T Consensus 88 ~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp ECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 995 57899999854 56799999999999999999999999 999999999999997 5689999999998664433
Q ss_pred cc-ceeeecCCCCcCCcccccc----------CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 188 TR-TYTVLRGTRGYTAPELHSR----------NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 188 ~~-~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
.. ......+++.|+|||.+.. ...++.++||||||+++++|++|+.||........ .......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~- 235 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAIID- 235 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHHHC-
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HHHHHhc-
Confidence 21 2223458999999999843 25678899999999999999999999976433211 1111111
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.... ...+......+.+++.+||+.||.+|||+.|++
T Consensus 236 ~~~~------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 272 (343)
T 3dbq_A 236 PNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272 (343)
T ss_dssp TTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCcc------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH
Confidence 1111 111111225689999999999999999999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=303.09 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=202.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEee--cCCceEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCS--EGSNRLLV 107 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 107 (325)
++|++.+.||+|+||.||+|.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++. .....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 57999999999999999999987 68889999986532 334566889999999999999999999874 35688999
Q ss_pred EeecCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHhhccCCCC-----eeeccCCCCceEEcCCCcEEEeeccc
Q 047716 108 YEFMRNGSLGNLLFRAE---QRLSWSERRRIALEIMEGLHYLHDECETR-----IIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~-----i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
|||+++++|.+++.... ..+++..++.++.|++.|+.+||+. + ++|+||+|+||+++.++.++|+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999985432 3499999999999999999999998 8 99999999999999999999999999
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
+......... .....++..|+|||.+ ....++.++||||||+++++|++|+.||......+. ......+..
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~~ 233 (279)
T 2w5a_A 163 ARILNHDTSF-AKTFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKF 233 (279)
T ss_dssp HHHC---CHH-HHHHHSCCTTCCHHHH-HCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC
T ss_pred heeecccccc-ccccCCCccccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-------HHHHhhccc
Confidence 8765433221 1123478999999998 456788999999999999999999999986543211 112222222
Q ss_pred cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 260 QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..+ +......+.+++.+||+.+|.+|||++|+++.+..-.
T Consensus 234 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 234 RRI-------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ccC-------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 211 1223467999999999999999999999997665444
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=306.51 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=208.1
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEe------CCCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCI------NGGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~------~~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++...+|++.+.||+|+||.||+|.+ ..++.+++|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 34578999999999999999999985 246789999987543 33445688999999999 69999999999876
Q ss_pred C-CceEEEEeecCCCCHHHHHhhccCC---------------CCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCce
Q 047716 101 G-SNRLLVYEFMRNGSLGNLLFRAEQR---------------LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNI 164 (325)
Q Consensus 101 ~-~~~~lv~e~~~~~~L~~~~~~~~~~---------------~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ni 164 (325)
. ...++||||+++++|.+++...... +++..++.++.|++.|+.+||++ |++|+||+|+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Ni 179 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 179 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceE
Confidence 5 4589999999999999999654322 78999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccc
Q 047716 165 LMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDD 242 (325)
Q Consensus 165 lv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~ 242 (325)
+++.++.++|+|||++......... ......+++.|+|||.+ .+..++.++||||||+++++|++ |..||.......
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh-ccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 9999999999999999765433221 12223367889999998 45678899999999999999998 999997655432
Q ss_pred hhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 243 EIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
... .....+... ..+......+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 259 ~~~------~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 259 EFC------RRLKEGTRM-------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHH------HHHHHTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH------HHhccCccC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 211 111111111 1111223569999999999999999999999999998763
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=321.11 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=166.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----Cc
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-----SN 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 103 (325)
..+|++.+.||+|+||.||+|.+. .++.||+|++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999987 6788999998653 233456788999999999999999999998665 57
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++|||++. ++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999995 59999884 456799999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCcc---------------------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCC
Q 047716 184 KTDQTR---------------------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV 235 (325)
Q Consensus 184 ~~~~~~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 235 (325)
...... ......+|++|+|||.+.....++.++|||||||++++|++|..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 433211 1233458999999998756778999999999999999999854433
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=327.10 Aligned_cols=251 Identities=26% Similarity=0.314 Sum_probs=204.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.++|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888999999999999999987 68999999986532 33455678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.+||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999885443 3499999999999999999999999 9999999999999999999999999999766433
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. .....||+.|+|||.+ .+..++.++|+||||+++|+|++|++||...........+ ........
T Consensus 340 ~~--~~~~~GT~~Y~APEvl-~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~~-------- 405 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVP-------- 405 (576)
T ss_dssp CC--EECCCSCGGGCCHHHH-TTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHCC--------
T ss_pred cc--ccccCCCccccCHHHH-cCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhccc--------
Confidence 22 2233589999999998 4566889999999999999999999999876433221111 11111111
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRP-----TMKQVI 299 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell 299 (325)
...+...+..+.++|.+||+.||.+|| +++|++
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil 443 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK 443 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence 111222346799999999999999999 789998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=317.32 Aligned_cols=261 Identities=20% Similarity=0.273 Sum_probs=209.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCC-CCcceeeEEeecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHH-KNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 109 (325)
.++|++.++||+|+||.||+|.+. .+..||+|++..... ...+..|+.+++.++| +++..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 467999999999999999999986 688999998765332 2347789999999987 555566666677788899999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE---cCCCcEEEeeccccccccCC
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM---DESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv---~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|+ +++|.+++......+++..++.++.||+.||.|||++ ||+|+||||+|||| +.++.++|+|||++......
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 9999999976677899999999999999999999999 99999999999999 57889999999999866543
Q ss_pred Ccc------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 187 QTR------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 187 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
... ......++..|+|||.+ .+..++.++||||||+++|+|++|+.||...........+.............
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccCCCccccCHHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 321 12234589999999998 56678999999999999999999999998876655444333333332222222
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+... ...++.+++..||+.+|.+||++++|+++|+.+.
T Consensus 239 ~l~~~-------~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 239 ALCRG-------YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHTT-------SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHhcC-------CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 22221 1257999999999999999999999999998874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=308.56 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=197.4
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCC--
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS-- 102 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 102 (325)
..++|++.+.||+|+||.||+|.+.. +..+|+|++... .......+.+|+.+++.++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999998752 347999988643 2334466889999999999999999999987654
Q ss_pred ---ceEEEEeecCCCCHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEE
Q 047716 103 ---NRLLVYEFMRNGSLGNLLFR-----AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKI 174 (325)
Q Consensus 103 ---~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl 174 (325)
..++||||+.+++|.+++.. ....+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 35999999999999998842 235699999999999999999999999 9999999999999999999999
Q ss_pred eeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHH
Q 047716 175 SDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQ 252 (325)
Q Consensus 175 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 252 (325)
+|||++........ .......+++.|+|||.+ ....++.++||||||+++++|++ |..||..........
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------- 260 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD------- 260 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHH-HSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------
T ss_pred eecCcceecccccccCcccccCCCccccCchhh-cCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-------
Confidence 99999876543321 112223367789999998 56778999999999999999999 889997664433211
Q ss_pred HHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 253 CYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
....+.. ...+...+..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 261 ~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 261 YLLHGHR-------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHTTCC-------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCC-------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 11112233569999999999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=326.16 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=203.6
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-------------hcHHHHHHHHHHHhccCCCCcceeeE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-------------EGESEFRNEMKIIGRIHHKNLVDLVG 96 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 96 (325)
...+|++.++||+|+||.||+|.+. .+..+|+|++..... .....+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999987 678899999865321 23466889999999999999999999
Q ss_pred EeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC---cEE
Q 047716 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW---KAK 173 (325)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~---~vk 173 (325)
++.+....++||||+++++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||||+||+++.++ .++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999998844 46799999999999999999999999 999999999999998776 699
Q ss_pred EeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHH
Q 047716 174 ISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 253 (325)
|+|||++........ .....+++.|+|||.+. ..++.++||||||+++++|++|.+||......+.. ..
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~ 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII-------KK 258 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HH
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH
Confidence 999999986654322 22234899999999984 45789999999999999999999999875443221 11
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
...+.+..-... ....+..+.+++.+||+.||.+|||++|++ ..+++..
T Consensus 259 i~~~~~~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 259 VEKGKYYFDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHCCCCCCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHcCCCCCCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 111111100000 011235699999999999999999999999 4455443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=309.59 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=203.0
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
++...+|++.+.||+|+||.||+|.+. .+..+|+|++... .......+.+|+.+++.++||||+++++++..++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 344678999999999999999999987 6888999988654 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||||+++++|.+++.. .+.+++..+..++.|++.|+.|||+ . |++|+||+|+||+++.++.++|+|||++.....
T Consensus 109 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999954 4579999999999999999999998 5 899999999999999999999999999865432
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH----------------
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW---------------- 249 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---------------- 249 (325)
.. .....+++.|+|||.+ .+..++.++||||||+++++|++|+.||......+.......
T Consensus 185 ~~---~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 SM---ANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HC-------CCCCTTCCHHHH-TTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred cc---ccCCCCCCCeECHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 21 1223489999999998 566789999999999999999999999986543322111000
Q ss_pred -------------------HHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 250 -------------------AHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 250 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
........... ..........+.+++.+||+.||.+|||++|++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 323 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPP------KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCC------CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCC------CCCcccccHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 00000000000 000111235699999999999999999999999
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=309.08 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=207.7
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCC------CcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++..++|++.+.||+|+||.||+|.+.. ...+++|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4556889999999999999999999753 2478999886543 23456688999999999 89999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhc-------------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRA-------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD 167 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~ 167 (325)
.+..++||||+++++|.+++... ...+++..++.++.|++.|+.|||++ |++|+||+|+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 99999999999999999998543 23579999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhh
Q 047716 168 ESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIV 245 (325)
Q Consensus 168 ~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 245 (325)
.++.++|+|||++......... ......+++.|+|||.+ .+..++.++||||||+++++|++ |..||..........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI-FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHh-ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999765433221 11122356789999998 45678899999999999999998 999998654432211
Q ss_pred HHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 246 LIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
....... . ...+...+..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 278 ------~~~~~~~-~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 278 ------KLVKDGY-Q------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ------HHHHHTC-C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHhcCC-C------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1111111 0 0011112356899999999999999999999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.15 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=199.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeec--CCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSE--GSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 107 (325)
..+|++.+.||+|+||.||+|.+. ++..+|+|++.. .....+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 578999999999999999999886 788999999864 33467889999999997 9999999999987 5678999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~~~~~ 186 (325)
|||+.+++|.+++ ..+++..++.++.|++.|+.|||++ |++|+||||+||+++.++ .++|+|||++......
T Consensus 112 ~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999999987 3489999999999999999999999 999999999999999776 8999999999765443
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc-------
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL------- 259 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 259 (325)
.. .....++..|+|||.+.+...++.++||||||+++++|++|+.||.......... .. .........+
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l-~~-~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VR-IAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-HH-HHHHHCHHHHHHHHHHT
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH-HH-HHHhcCCchhhhHHHHh
Confidence 32 2223478899999998655778999999999999999999999996543322111 11 0010000000
Q ss_pred --------------------cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 260 --------------------QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 260 --------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..... ..........+.++|.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVH--SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCC--TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhcc--ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0011113467999999999999999999999994
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=305.37 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=198.6
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--------hcHHHHHHHHHHHhccCCCCcceeeEEee
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--------EGESEFRNEMKIIGRIHHKNLVDLVGFCS 99 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (325)
....++|++.+.||+|+||.||+|.+. .++.+|+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 456789999999999999999999987 578899998864321 12234778999999999999999999987
Q ss_pred cCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc---EEEee
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK---AKISD 176 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~---vkl~D 176 (325)
... .++||||+++++|.+++. ....+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++. ++|+|
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred CCc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 654 899999999999999884 446799999999999999999999999 9999999999999987654 99999
Q ss_pred ccccccccCCCccceeeecCCCCcCCccccc--cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH
Q 047716 177 FGLSKLLKTDQTRTYTVLRGTRGYTAPELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 177 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
||++........ .....+++.|+|||.+. ....++.++||||||+++++|++|..||.......... ...
T Consensus 161 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~ 232 (322)
T 2ycf_A 161 FGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK------DQI 232 (322)
T ss_dssp CTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH------HHH
T ss_pred Cccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH------HHH
Confidence 999876543321 12234799999999873 35667899999999999999999999997654432211 111
Q ss_pred HhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 255 EAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..+...... .........+.+++.+||+.||.+|||+.|++
T Consensus 233 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 233 TSGKYNFIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp HHTCCCCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HhCccccCc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 111111000 00011235699999999999999999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.40 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=203.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..|++.+.||+|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56899999999999999999986 68899999986543 34457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+++++|.+++. .+.+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|||++.........
T Consensus 102 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 175 (303)
T 3a7i_A 102 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175 (303)
T ss_dssp CTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence 99999999984 35799999999999999999999999 9999999999999999999999999998765443321
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....+++.|+|||.+ ....++.++||||||+++++|++|+.||.......... ........ ...
T Consensus 176 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~-------~~~ 240 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVI-KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-------LIPKNNPP-------TLE 240 (303)
T ss_dssp BCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHSCCC-------CCC
T ss_pred cCccCCCcCccCHHHH-hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-------HhhcCCCC-------CCc
Confidence 1223478899999998 56677889999999999999999999997654322111 11111111 111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
......+.+++.+||+.+|.+|||+.|+++
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 222356999999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=315.01 Aligned_cols=269 Identities=22% Similarity=0.288 Sum_probs=200.7
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchh-----------cHHHHHHHHHHHhccCCCCcceeeEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEE-----------GESEFRNEMKIIGRIHHKNLVDLVGF 97 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (325)
....++|++.+.||+|+||.||+|.+..+..+|+|++...... ....+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 3446889999999999999999999988999999998653221 23678899999999999999999998
Q ss_pred eec-----CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 98 CSE-----GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 98 ~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
+.. ....++||||+. ++|.+++......+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCE
Confidence 843 346799999996 688888766666799999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHH
Q 047716 173 KISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQ 252 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 252 (325)
+|+|||++........ .....+++.|+|||.+.+...++.++||||||+++++|++|+.||......+....+ ..
T Consensus 174 kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---~~ 248 (362)
T 3pg1_A 174 TICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI---VE 248 (362)
T ss_dssp EECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH
T ss_pred EEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HH
Confidence 9999999875433222 122347889999999865577899999999999999999999999875433221111 11
Q ss_pred HHHh-------------------CcccccccCC-CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 253 CYEA-------------------GELQNLVSDQ-EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 253 ~~~~-------------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
.... .......... ....+.....+.+++.+||+.||.+|||+.|++ ..++.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 1110 0111110000 001112235689999999999999999999999 4566554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.41 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=204.5
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeec
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE 100 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (325)
.++...+|++.+.||+|+||.||+|.+. .+..+|+|.+... .......+.+|+.+++.++||||+++++++.+
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 3466789999999999999999999842 5678999998643 33445578899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWK 171 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~ 171 (325)
....++||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||+|+||+++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcce
Confidence 889999999999999999996543 3489999999999999999999999 9999999999999984 446
Q ss_pred EEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHH
Q 047716 172 AKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDW 249 (325)
Q Consensus 172 vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 249 (325)
++|+|||++........ .......+++.|+|||.+ ....++.++||||||+++++|++ |..||......+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----- 255 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF-MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----- 255 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH-----
Confidence 99999999875432221 112223367899999998 45678899999999999999998 99999765432111
Q ss_pred HHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 250 AHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
........ ..........+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 256 --~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 --EFVTSGGR-------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp --HHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHhcCCC-------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11111111 1111223356999999999999999999999999999886
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=322.91 Aligned_cols=251 Identities=25% Similarity=0.287 Sum_probs=203.3
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|++.+.||+|+||.||+|++. .++.+|+|++.... ......+..|+.+++.++||||+++++++.+...+++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56788889999999999999987 68999999986532 233466888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 109 EFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 109 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||+++++|.+++... ...+++..++.++.|++.|+.|||++ ||+|+||||+||+++.+|.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999988543 34699999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
.... .....||+.|+|||.+ .+..++.++|+|||||++|+|++|++||.......... ... ......
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l-~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~-~~i~~~-------- 408 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELK-QRVLEQ-------- 408 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHH-HHHHHC--------
T ss_pred CCcc-cccccCCccccChhhh-cCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHH-HHHhhc--------
Confidence 3322 2223589999999999 55678999999999999999999999998754322111 111 111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCH-----hHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTM-----KQVI 299 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell 299 (325)
....+...+..+.++|.+||+.||.+||++ ++++
T Consensus 409 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 111222334679999999999999999975 6776
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=304.69 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=198.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC--CCc--EEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN--GGK--EIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~--~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
..++|++.+.||+|+||.||+|.+. ++. .+++|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 3578999999999999999999864 233 57899876532 234567889999999999999999999997754
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++|+||+.+++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 8999999999999999976667799999999999999999999999 9999999999999999999999999998766
Q ss_pred cCCCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 184 KTDQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 184 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
...... ......++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~- 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-------HKIDKEGE- 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTSCC-
T ss_pred cccccchhhhccCCCCceeeCchhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH-------HHHHccCC-
Confidence 443321 11223367789999998 45567889999999999999999 99999765432211 11111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
........+..+.+++.+||+.+|.+|||+.++++.|+++.+..
T Consensus 243 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 243 -----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred -----CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11112233467999999999999999999999999999988643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=309.16 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=188.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEee--------cC
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCS--------EG 101 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~ 101 (325)
..+|++.+.||+|+||.||+|.+. .++.+|+|++..........+.+|+.+++.+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999986 68899999987766666777889999999996 999999999883 33
Q ss_pred CceEEEEeecCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeeccCCCCceEEcCCCcEEEeec
Q 047716 102 SNRLLVYEFMRNGSLGNLLFR--AEQRLSWSERRRIALEIMEGLHYLHDECETR--IIHCDIKPHNILMDESWKAKISDF 177 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nilv~~~~~vkl~Df 177 (325)
...+++|||+. ++|.+++.. ..+.+++..++.++.|++.|+.|||++ + ++|+||||+||+++.++.++|+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 45799999995 688888754 345699999999999999999999998 8 999999999999999999999999
Q ss_pred cccccccCCCccc-----------eeeecCCCCcCCccccc--cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh
Q 047716 178 GLSKLLKTDQTRT-----------YTVLRGTRGYTAPELHS--RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI 244 (325)
Q Consensus 178 g~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 244 (325)
|++.......... .....+++.|+|||.+. ....++.++||||||+++++|++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 9998665432211 11234788999999874 345678899999999999999999999975432111
Q ss_pred hHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 245 VLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
....... .........+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 262 ----------~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 ----------VNGKYSI------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp --------------CCC------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------hcCcccC------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0001000 001111234889999999999999999999999999887
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=309.34 Aligned_cols=265 Identities=23% Similarity=0.294 Sum_probs=204.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----CceE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-----SNRL 105 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 105 (325)
.+|++.+.||+|+||.||+|.+. ++..+|+|++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 58999999999999999999987 67889999986533 33346688999999999999999999998654 4689
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+|||++. ++|.+++.. ..+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++.....
T Consensus 107 iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 9999996 589888843 4699999999999999999999999 999999999999999999999999999976543
Q ss_pred CCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc---
Q 047716 186 DQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ--- 260 (325)
Q Consensus 186 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 260 (325)
.... ......+++.|+|||.+.+...++.++||||||+++++|++|++||......+....+. .........
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHHHHH
Confidence 3221 12233589999999987666778999999999999999999999998765544332221 111000000
Q ss_pred -----------ccccCCCC-----CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 261 -----------NLVSDQED-----VNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 261 -----------~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
........ ..+.....+.+++.+||+.||.+|||+.|++ ..++...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00000000 0112235689999999999999999999999 4555554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=311.88 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=203.7
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcH-----------------HHHHHHHHHHhccCCCCcce
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGE-----------------SEFRNEMKIIGRIHHKNLVD 93 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~-----------------~~~~~e~~~l~~l~h~~iv~ 93 (325)
..++|++.+.||+|+||.||+|.+ ++..+|+|++........ ..+.+|+.+++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 356899999999999999999999 899999999875432211 67889999999999999999
Q ss_pred eeEEeecCCceEEEEeecCCCCHHHH------Hhhc-cCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceE
Q 047716 94 LVGFCSEGSNRLLVYEFMRNGSLGNL------LFRA-EQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNIL 165 (325)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nil 165 (325)
+++++.+.+..++||||+++++|.++ +... ...+++..++.++.|++.|+.+||+ + |++|+||+|+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 99999999999999999999999998 5332 4679999999999999999999999 8 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCc-cccchhHHHHHHHHHhCCCCCCCccccchh
Q 047716 166 MDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV-KADVYSFGVMLLEIVCCRKNVDESLRDDEI 244 (325)
Q Consensus 166 v~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 244 (325)
++.++.++|+|||++...... ......++..|+|||.+.+...++. ++||||||+++++|++|+.||.........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999998765433 2223347899999999855435555 999999999999999999999876542211
Q ss_pred hHHHHHHHHHHhCcccccccCC------------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 245 VLIDWAHQCYEAGELQNLVSDQ------------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......... ..... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 262 ------~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 ------FNNIRTKNIE-YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ------HHHHTSCCCC-CCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHHhccCcC-CccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111111 11000 0000233467999999999999999999999994
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=316.09 Aligned_cols=256 Identities=20% Similarity=0.266 Sum_probs=195.2
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec---------
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--------- 100 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 100 (325)
...+|++.+.||+|+||.||+|.+. +++.+|+|++...... ..+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4468999999999999999999986 7899999998654322 2369999999999999999998843
Q ss_pred -----------------------------CCceEEEEeecCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHhhc
Q 047716 101 -----------------------------GSNRLLVYEFMRNGSLGNLLF---RAEQRLSWSERRRIALEIMEGLHYLHD 148 (325)
Q Consensus 101 -----------------------------~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lh~ 148 (325)
....++||||++ ++|.+.+. .....+++..++.++.|++.|+.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 234789999997 57776664 235679999999999999999999999
Q ss_pred cCCCCeeeccCCCCceEEc-CCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHH
Q 047716 149 ECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLE 227 (325)
Q Consensus 149 ~~~~~i~h~di~p~nilv~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 227 (325)
+ |++|+||||+||+++ .++.++|+|||++.......... ...+++.|+|||.+.+...++.++|||||||++++
T Consensus 160 ~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 L---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV--AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp T---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC--CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred C---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc--CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 9 999999999999997 67899999999998654433222 23378999999998666678999999999999999
Q ss_pred HHhCCCCCCCccccchhhHHHHHHHHHHh----------CcccccccCC-------CCCCHHHHHHHHHHHhhcccCCCC
Q 047716 228 IVCCRKNVDESLRDDEIVLIDWAHQCYEA----------GELQNLVSDQ-------EDVNIEEFENLVKIGLWCVECELN 290 (325)
Q Consensus 228 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~ 290 (325)
|++|++||.+....+....+. ..... ..+....-+. ...+...+..+.+++.+||+.||.
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~---~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRII---QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHH---HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChHHHHHHHH---HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999998765443322211 11000 0111100000 001112345699999999999999
Q ss_pred CCCCHhHHH
Q 047716 291 LRPTMKQVI 299 (325)
Q Consensus 291 ~Rps~~ell 299 (325)
+|||+.|++
T Consensus 312 ~R~t~~e~l 320 (383)
T 3eb0_A 312 LRINPYEAM 320 (383)
T ss_dssp GSCCHHHHH
T ss_pred hCCCHHHHh
Confidence 999999999
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.38 Aligned_cols=261 Identities=24% Similarity=0.324 Sum_probs=188.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecC------Cc
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------SN 103 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 103 (325)
.+|++.+.||+|+||.||+|.+. .+..||+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 68999999999999999999986 6889999998653 233456678999999999999999999998643 56
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++++++ +++|.+++.. +.+++..++.++.|++.|+.|||+. |++|+||||+||+++.++.+||+|||++...
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 79999999 7899888843 5799999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc---cc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE---LQ 260 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 260 (325)
... .....+++.|+|||.+.+...++.++|||||||++++|++|++||.+....+....+. .....+. +.
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~---~~~g~p~~~~~~ 255 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGAELLK 255 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCCHHHHT
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCCCHHHHH
Confidence 432 1223479999999998665788999999999999999999999998765433222111 1110000 00
Q ss_pred -----------ccccCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 261 -----------NLVSDQEDVN-----IEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 261 -----------~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
..+....... +.....+.+|+.+||+.||.+|||+.|++ ..++.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0000001111 11235689999999999999999999999 3555554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=310.23 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=194.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeecc--chhcHHHHHHHHHHHhccC--CCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIH--HKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|++.+.||+|+||.||+|.+..+..+|+|++... .......+.+|+.+++.++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 459999999999999999999888999999998653 2334567889999999997 599999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
| +.+++|.+++.. ...+++..++.++.|++.||.|||++ +|+|+||||+||+++ ++.+||+|||++........
T Consensus 136 E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 558899999854 45789999999999999999999999 999999999999996 46899999999986643322
Q ss_pred c-ceeeecCCCCcCCcccccc----------CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 189 R-TYTVLRGTRGYTAPELHSR----------NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 189 ~-~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
. ......+++.|+|||.+.. ...++.++||||||+++++|++|+.||........ ...... ..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~~~~-~~ 283 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAII-DP 283 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHH-CT
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HHHHHh-Cc
Confidence 1 1223458999999999843 24688899999999999999999999976432111 111111 11
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.... ..+......+.++|.+||+.||.+|||+.|++
T Consensus 284 ~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 284 NHEI------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp TSCC------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccC------CCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 1110 01111135689999999999999999999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=312.16 Aligned_cols=250 Identities=21% Similarity=0.240 Sum_probs=189.1
Q ss_pred HHHhhh-hhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHh-ccCCCCcceeeEEeec----CCceE
Q 047716 33 ASENFK-EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIG-RIHHKNLVDLVGFCSE----GSNRL 105 (325)
Q Consensus 33 ~~y~~~-~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~~ 105 (325)
.+|.+. +.||.|+||.||+|.+. .+..+|+|++.. ...+.+|+.++. ..+||||+++++++.. ...++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456666 68999999999999987 688899999853 234567887764 4579999999998865 56789
Q ss_pred EEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCcEEEeeccccc
Q 047716 106 LVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWKAKISDFGLSK 181 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~vkl~Dfg~~~ 181 (325)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ ||+|+||||+||+++. ++.+||+|||++.
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999996543 4699999999999999999999999 9999999999999987 7889999999997
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
....... .....+++.|+|||.+ ....++.++||||||+++|+|++|+.||........... .......+.+..
T Consensus 213 ~~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~~ 286 (400)
T 1nxk_A 213 ETTSHNS--LTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEF 286 (400)
T ss_dssp ECC-------------CTTCCGGGS-CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCCC
T ss_pred ccCCCCc--cccCCCCCCccCHhhc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCcccC
Confidence 6543222 2234479999999998 567789999999999999999999999976543321100 011111121110
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..........++.++|.+||+.||.+|||+.|+++
T Consensus 287 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 287 ----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp ----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00011123456999999999999999999999994
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=309.52 Aligned_cols=273 Identities=24% Similarity=0.290 Sum_probs=199.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec-----CCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-----GSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 104 (325)
+...+|++.+.||+|+||.||+|++ .+..+|+|++...... ......++..+..++||||+++++.+.. ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3456899999999999999999977 5789999998653322 1122334444556899999999975432 2356
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC------CCCeeeccCCCCceEEcCCCcEEEeecc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC------ETRIIHCDIKPHNILMDESWKAKISDFG 178 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~------~~~i~h~di~p~nilv~~~~~vkl~Dfg 178 (325)
++||||+++++|.+++.. ...++..++.++.|++.||.|||+.+ ..|++|+||||+||+++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 899999999999999944 34588999999999999999999852 2289999999999999999999999999
Q ss_pred ccccccCCCc-------cceeeecCCCCcCCccccccC------CCCCccccchhHHHHHHHHHhCCCCCCCccccchhh
Q 047716 179 LSKLLKTDQT-------RTYTVLRGTRGYTAPELHSRN------NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245 (325)
Q Consensus 179 ~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 245 (325)
++........ .......+++.|+|||.+.+. ..++.++||||||+++++|++|+.||..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9976543221 111223488999999998432 345578999999999999999987765433221110
Q ss_pred -H----------HHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 246 -L----------IDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 246 -~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
. ................+.............+.++|.+||+.||.+|||++|+++.|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 0 001111122222222222333334456778999999999999999999999999999988
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=301.06 Aligned_cols=252 Identities=24% Similarity=0.303 Sum_probs=202.8
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---------hhcHHHHHHHHHHHhccC-CCCcceeeEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---------EEGESEFRNEMKIIGRIH-HKNLVDLVGFCSE 100 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 100 (325)
..+|++.+.||+|++|.||+|.+. .++.+++|++.... ......+.+|+.+++.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999987 68889999986432 122355778999999996 9999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLS 180 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~ 180 (325)
.+..++||||+++++|.+++.. ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999999854 46799999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCccceeeecCCCCcCCccccc-----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHS-----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
........ .....+++.|+|||.+. ....++.++||||||+++++|++|+.||......... ....
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~ 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMIM 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH-------HHHh
Confidence 76543322 22234789999999874 2455788999999999999999999999765332111 1111
Q ss_pred hCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 256 AGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...... ...........+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQF----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCCC----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCccc----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 221111 01111223456999999999999999999999983
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.23 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=202.0
Q ss_pred Hhhhh-hcCcCCceeEEEEEeC---CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 35 ENFKE-EIGRGGSGRVYKGCIN---GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 35 y~~~~-~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
+.+.+ +||+|+||.||+|.+. .+..||+|++.... ......+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 34444 7999999999999874 45679999987643 3456778999999999999999999999876 56899999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+.+++|.+++......+++..++.++.|++.|+.|||++ +|+|+||||+|||++.++.+||+|||++.........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 492 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence 9999999999976667799999999999999999999999 9999999999999999999999999999865433221
Q ss_pred --ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 190 --TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 190 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
......++..|+|||.+ ....++.++||||||+++|+|++ |+.||......+.. ..+..+. .
T Consensus 493 ~~~~~~~~~~~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~-------~ 557 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK-------R 557 (613)
T ss_dssp ---------CCTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-------HHHHTTC-------C
T ss_pred eeeccCCCCccceeCHhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCC-------C
Confidence 11112245789999998 56678999999999999999998 99999876543221 1122211 1
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+..++..+.++|.+||+.+|.+|||+.+|++.|+.+.
T Consensus 558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1222234467999999999999999999999999999876
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.15 Aligned_cols=266 Identities=22% Similarity=0.248 Sum_probs=199.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCC------ceE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------NRL 105 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~ 105 (325)
..+|++.+.||+|+||.||+|++..+..+|+|++...... ..+|+.+++.++||||+++++++...+ ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999987777999988654322 236899999999999999999985433 278
Q ss_pred EEEeecCCCCHHHHH--hhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc-CCCcEEEeecccccc
Q 047716 106 LVYEFMRNGSLGNLL--FRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKL 182 (325)
Q Consensus 106 lv~e~~~~~~L~~~~--~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~-~~~~vkl~Dfg~~~~ 182 (325)
+||||++++.+.... ......+++..++.++.|++.|+.|||++ ||+|+||||+||+++ .++.+||+|||++..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999999765443332 12356799999999999999999999999 999999999999998 789999999999976
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH-------HHHH
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH-------QCYE 255 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-------~~~~ 255 (325)
........ ...+++.|+|||.+.+...++.++|||||||++++|++|++||.+....+....+.... -...
T Consensus 192 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGEPNV--SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTCCCC--SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCCCCc--ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 54333222 23378999999998666778999999999999999999999998765443322211100 0000
Q ss_pred hCcccccccCC-CC------CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 256 AGELQNLVSDQ-ED------VNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 256 ~~~~~~~~~~~-~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
...+.....+. .. .......++.+++.+||+.||.+|||+.|+++ .++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00110000000 00 11123457999999999999999999999993 566655
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=300.17 Aligned_cols=257 Identities=24% Similarity=0.321 Sum_probs=200.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc----hhcHHHHHHHHHHHhccCCCCcceeeEEe--ecCCce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV----EEGESEFRNEMKIIGRIHHKNLVDLVGFC--SEGSNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~~~ 104 (325)
.++|++.+.||+|+||.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 457999999999999999999986 67899999986532 23456788999999999999999999998 445688
Q ss_pred EEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
++||||+.++ |.+++... ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999776 66666433 45799999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCc-cceeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 184 KTDQT-RTYTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
..... .......+++.|+|||.+.+. ...+.++||||||+++++|++|+.||......... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~~-- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-------ENIGKGSY-- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHCCC--
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------HHHhcCCC--
Confidence 43222 222234478999999998432 23477999999999999999999999865322111 11112111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVP 307 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~ 307 (325)
..+......+.+++.+||+.||.+|||++|++ ..++...+
T Consensus 231 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 231 ------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 11122335689999999999999999999999 45666554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=306.52 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=187.7
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
.+...+|++.+.||+|++|.||+|.+. .+..+++|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999876 68899999886432 3344567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh-------ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 107 VYEFMRNGSLGNLLFR-------AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
||||+++++|.+++.. ..+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999853 245689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCc----cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH
Q 047716 180 SKLLKTDQT----RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 180 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
+........ .......+++.|+|||.+.....++.++||||||+++++|++|+.||.......... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhc
Confidence 875543211 111223478999999998544568899999999999999999999998765433221 1111
Q ss_pred hCccccccc--CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 256 AGELQNLVS--DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 256 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........ ............+.+++.+||+.||.+|||+.|+++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 -NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11100000 001111122356899999999999999999999994
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=299.95 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=195.1
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec---------
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--------- 100 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 100 (325)
..++|++.+.||+|+||.||+|.+. ++..+++|++.. .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3578999999999999999999986 788999999854 33445678899999999999999999998754
Q ss_pred ----CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEee
Q 047716 101 ----GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISD 176 (325)
Q Consensus 101 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~D 176 (325)
.+..++||||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 3567999999999999999976666788999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCC-------------ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccch
Q 047716 177 FGLSKLLKTDQ-------------TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDE 243 (325)
Q Consensus 177 fg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 243 (325)
||++....... ........+++.|+|||.+.+...++.++||||||+++++|++ ||.......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~- 235 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV- 235 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH-
Confidence 99987654221 1111223478899999998655678999999999999999998 544321111
Q ss_pred hhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 244 IVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
... ....... ..............+.+++.+||+.||.+|||+.++++
T Consensus 236 ----~~~-~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 ----NIL-KKLRSVS----IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ----HHH-HHHHSTT----CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHH-Hhccccc----cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111 1111111 01112223334456899999999999999999999995
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=298.16 Aligned_cols=248 Identities=26% Similarity=0.317 Sum_probs=195.3
Q ss_pred hhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCCC
Q 047716 36 NFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
.....||+|+||.||+|.+. ++..+++|.+..........+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 33448999999999999986 67889999987766566677899999999999999999999999999999999999999
Q ss_pred CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-CCcEEEeeccccccccCCCccce
Q 047716 115 SLGNLLFRAEQ--RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 115 ~L~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
+|.+++....+ .+++..++.++.|++.|+.+||++ |++|+||+|+||+++. ++.++|+|||++......... .
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-~ 180 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-T 180 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc-c
Confidence 99999865432 467889999999999999999999 9999999999999987 889999999998765432221 1
Q ss_pred eeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
....+++.|+|||.+... ..++.++||||||+++++|++|+.||.......... . ...... .....+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~-~~~~~~-------~~~~~~ 248 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM----F-KVGMFK-------VHPEIP 248 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH----H-HHHHHC-------CCCCCC
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH----H-hhcccc-------cccccc
Confidence 223478999999998543 347889999999999999999999997543322111 0 000000 111122
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
......+.+++.+||+.||.+|||+.|++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 23345799999999999999999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=304.63 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=197.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEee-----------
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS----------- 99 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----------- 99 (325)
.++|++.+.||+|+||.||+|.+. .++.+|+|++..........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999988 58899999987666666677889999999999999999999873
Q ss_pred ---cCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc-CCCcEEEe
Q 047716 100 ---EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKIS 175 (325)
Q Consensus 100 ---~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~-~~~~vkl~ 175 (325)
+....++||||+. ++|.+++. .+.+++..++.++.|++.|+.+||++ |++|+||+|+||+++ .++.++|+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 69999884 35789999999999999999999999 999999999999997 56799999
Q ss_pred eccccccccCCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH---
Q 047716 176 DFGLSKLLKTDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--- 250 (325)
Q Consensus 176 Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--- 250 (325)
|||++........ .......++..|+|||.+.....++.++||||||+++++|++|+.||......+....+...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999876543221 11122336889999998866677899999999999999999999999876543221111000
Q ss_pred -----HHHHHh-------CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 251 -----HQCYEA-------GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 251 -----~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
...... ..............+.....+.+++.+||+.||.+|||++|++ ..++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 000000 0000000000001112346799999999999999999999999 4566544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=308.30 Aligned_cols=265 Identities=20% Similarity=0.243 Sum_probs=193.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCC------
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------ 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 102 (325)
..+|++.+.||+|+||.||+|.+. .+..+|+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999987 6888999998653 2334456789999999999999999999986654
Q ss_pred ceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
..++||||+++ +|.+.+. ..+++..+..++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 67999999964 7777773 4589999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHH--------------
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLID-------------- 248 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~-------------- 248 (325)
...... .....+++.|+|||.+ .+..++.++||||||+++++|++|+.||.+....+....+.
T Consensus 177 ~~~~~~--~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGTSFM--MTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ---------------CTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccc--cCCceecCCccCHHHh-cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 543221 1223478999999998 45678899999999999999999999998754322211100
Q ss_pred --HHHHHHHh-Cccc---------ccccC-CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 249 --WAHQCYEA-GELQ---------NLVSD-QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 249 --~~~~~~~~-~~~~---------~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
........ ..+. ....+ ...........+.+++.+||+.||.+|||++|++ ..++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00000000 0000 00000 0001122356799999999999999999999999 4555433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=330.56 Aligned_cols=249 Identities=23% Similarity=0.242 Sum_probs=203.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 104 (325)
+...+|++.+.||+|+||.||+|.+. .++.+|+|++... .......+..|..++..+ +||+|+.+++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44567999999999999999999987 5788999998753 233445677899999988 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999954 46799999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.... ......||+.|+|||.+ ....++.++|+||||+++|+|++|++||......+.. ..+..
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l-~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~-------- 556 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------QSIME-------- 556 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHH-TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHS--------
T ss_pred cCCc-ccccccCCCcccCHhhh-cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH-------HHHHh--------
Confidence 2222 22334589999999999 5667899999999999999999999999875432211 11111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCH-----hHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTM-----KQVI 299 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~ell 299 (325)
.....+.....++.+||.+||+.||.+||++ +||+
T Consensus 557 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 557 HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp SCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 1222223344679999999999999999998 7887
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=294.20 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=208.1
Q ss_pred ccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 25 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
...+.....+|++.+.||+|++|.||+|.+. .++.+++|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 3445677899999999999999999999987 68899999986533 34566788999999999999999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC---CcEEEeecc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES---WKAKISDFG 178 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~---~~vkl~Dfg 178 (325)
+..++|||++.+++|.+++.. ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.+ +.++|+|||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred CeEEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999999988844 45799999999999999999999999 99999999999999754 469999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
++......... ....+++.|+|||.+.+ .++.++||||||+++++|++|+.||......+.. .....+.
T Consensus 170 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~ 238 (287)
T 2wei_A 170 LSTCFQQNTKM--KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-------KRVETGK 238 (287)
T ss_dssp GGGTBCCCSSC--SCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC
T ss_pred cceeecCCCcc--ccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC
Confidence 98765433221 12236788999999843 4789999999999999999999999865432211 1122222
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhcc
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGI 305 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~ 305 (325)
....... ....+..+.+++.+||+.+|.+|||+.|+++ .+++.
T Consensus 239 ~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 239 YAFDLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp CCCCSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred CCCCchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1111110 1122356899999999999999999999995 44443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=298.56 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=187.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
+..++|++.+.||+|+||.||+|.+. .++.+|+|++.... ......+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34578999999999999999999986 78889999986542 2223334556666888999999999999999999999
Q ss_pred EEeecCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLFR---AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
||||++ ++|.+++.. ....+++..++.++.|++.|+.|||++ .|++|+||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999996 488777643 356799999999999999999999984 28999999999999999999999999998765
Q ss_pred cCCCccceeeecCCCCcCCccccc---cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHS---RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
...... ....+++.|+|||.+. ....++.++||||||+++++|++|+.||......... ......... .
T Consensus 161 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~-~ 232 (290)
T 3fme_A 161 VDDVAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----LKQVVEEPS-P 232 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-----HHHHHHSCC-C
T ss_pred cccccc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-----HHHHhccCC-C
Confidence 443322 2224889999999962 4566789999999999999999999999764332111 111111111 1
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
... ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 QLP------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCC------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ccc------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111 1122356999999999999999999999984
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=308.21 Aligned_cols=276 Identities=20% Similarity=0.243 Sum_probs=194.4
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc-
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN- 103 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 103 (325)
.......++|++.+.||+|+||.||+|.+. .+..+|+|++..... ......+++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566789999999999999999999987 688999998865432 23345677888888999999999999865333
Q ss_pred ------eEEEEeecCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHhh--ccCCCCeeeccCCCCceEEcC-CCc
Q 047716 104 ------RLLVYEFMRNGSLGNLLF---RAEQRLSWSERRRIALEIMEGLHYLH--DECETRIIHCDIKPHNILMDE-SWK 171 (325)
Q Consensus 104 ------~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~~i~h~di~p~nilv~~-~~~ 171 (325)
.++||||+++ +|.+.+. .....+++..++.++.|++.|+.+|| ++ |++|+||||+||+++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999976 4444332 24567899999999999999999999 88 9999999999999996 889
Q ss_pred EEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH-
Q 047716 172 AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA- 250 (325)
Q Consensus 172 vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~- 250 (325)
++|+|||++......... ....+++.|+|||.+.+...++.++||||||+++++|++|+.||...........+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EEECCCTTCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 999999999866543322 22347899999999866667899999999999999999999999876543322111100
Q ss_pred -------HHHHHhCccc-ccccC--------CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccCCC
Q 047716 251 -------HQCYEAGELQ-NLVSD--------QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIVPP 308 (325)
Q Consensus 251 -------~~~~~~~~~~-~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~~~ 308 (325)
.......... ..... ...........+.+++.+||+.||.+|||+.|++ ..++++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 0000000000 00000 0111122456799999999999999999999999 456666543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=316.76 Aligned_cols=239 Identities=14% Similarity=0.177 Sum_probs=185.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHH---HHHhccCCCCcceee-------EEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEM---KIIGRIHHKNLVDLV-------GFC 98 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~ 98 (325)
.+|++.+.||+|+||.||+|++. ++..+|+|++... .......+.+|+ ..++.++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 56888999999999999999975 6899999998742 334456788999 555555799999988 666
Q ss_pred ecCC-----------------ceEEEEeecCCCCHHHHHhhccCCCC-------HHHHHHHHHHHHHHHHHhhccCCCCe
Q 047716 99 SEGS-----------------NRLLVYEFMRNGSLGNLLFRAEQRLS-------WSERRRIALEIMEGLHYLHDECETRI 154 (325)
Q Consensus 99 ~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~~~~ql~~~l~~lh~~~~~~i 154 (325)
...+ ..+++|||+ +|+|.+++... +.++ +..++.++.|++.||.|||++ ||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 5543 278999999 67999998543 2333 478888999999999999999 99
Q ss_pred eeccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccC----------CCCCccccchhHHHH
Q 047716 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN----------NRITVKADVYSFGVM 224 (325)
Q Consensus 155 ~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~i 224 (325)
+|+||||+|||++.++.+||+|||++..... ......+ +.|+|||.+... ..++.++||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999875332 2223346 999999998433 278999999999999
Q ss_pred HHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 225 LLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 225 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+++|++|+.||........ ...+...... .+..+.++|.+||+.||.+|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~---------------~~~~~~~~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---------------SEWIFRSCKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC---------------SGGGGSSCCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc---------------hhhhhhhccC----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999976543221 1111111111 2356999999999999999999999993
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=313.31 Aligned_cols=263 Identities=24% Similarity=0.266 Sum_probs=196.5
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC------CceEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------SNRLL 106 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~l 106 (325)
+|++.+.||+|+||.||+|++. .+..||+|++..... ...+|+.+++.++||||+++++++... ..+++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 6899999999999999999997 689999999865332 234699999999999999999987432 23679
Q ss_pred EEeecCCCCHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-CcEEEeecccccc
Q 047716 107 VYEFMRNGSLGNLLF---RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-WKAKISDFGLSKL 182 (325)
Q Consensus 107 v~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-~~vkl~Dfg~~~~ 182 (325)
||||+++ ++.+.+. .....+++..++.++.|++.||.|||++ ||+|+||||+|||++.+ +.+||+|||++..
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999965 5655543 2356799999999999999999999999 99999999999999955 5789999999986
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHH-----HHH--H
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH-----QCY--E 255 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-----~~~--~ 255 (325)
....... ....+++.|+|||.+.+...++.++|||||||++++|++|++||.+....+....+.... ..+ .
T Consensus 207 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTCCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCCCc--eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 5433222 223479999999998666678999999999999999999999998765433222111000 000 0
Q ss_pred hCcccccccCCCC-------CCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 256 AGELQNLVSDQED-------VNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 256 ~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
...+..+..+... .......++.+|+.+||+.||.+|||+.|++ ..++++.
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1111111111100 1122346799999999999999999999999 4555554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=310.53 Aligned_cols=263 Identities=20% Similarity=0.289 Sum_probs=182.8
Q ss_pred HHHHHhh-hhhcCcCCceeEEEEEeC---CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEee--cCCce
Q 047716 31 VLASENF-KEEIGRGGSGRVYKGCIN---GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCS--EGSNR 104 (325)
Q Consensus 31 ~~~~y~~-~~~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 104 (325)
....|++ .++||+|+||.||+|.+. .+..+|+|++.... ....+.+|+.+++.++||||+++++++. .....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3456777 457999999999999965 57889999986532 2345778999999999999999999984 46788
Q ss_pred EEEEeecCCCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE----cCCCcE
Q 047716 105 LLVYEFMRNGSLGNLLFRA--------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM----DESWKA 172 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv----~~~~~v 172 (325)
++||||+. ++|.+++... ...+++..++.++.|++.||.|||++ ||+|+||||+||++ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 5777776322 12489999999999999999999999 99999999999999 677899
Q ss_pred EEeeccccccccCCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccch------h
Q 047716 173 KISDFGLSKLLKTDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDE------I 244 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~------~ 244 (325)
||+|||++........ .......+++.|+|||.+.+...++.++|||||||++++|++|++||........ .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999999986643221 2223345899999999986656789999999999999999999999976543210 0
Q ss_pred hHHHHHHHHHHhCc---ccccccC-------------C-CC---------CCHHHHHHHHHHHhhcccCCCCCCCCHhHH
Q 047716 245 VLIDWAHQCYEAGE---LQNLVSD-------------Q-ED---------VNIEEFENLVKIGLWCVECELNLRPTMKQV 298 (325)
Q Consensus 245 ~~~~~~~~~~~~~~---~~~~~~~-------------~-~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~el 298 (325)
..+......+.... +..+... . .. ........+.+||.+||+.||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00111111111100 0000000 0 00 000013468899999999999999999999
Q ss_pred H
Q 047716 299 I 299 (325)
Q Consensus 299 l 299 (325)
+
T Consensus 332 L 332 (405)
T 3rgf_A 332 M 332 (405)
T ss_dssp H
T ss_pred h
Confidence 9
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=307.73 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=199.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce----
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR---- 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---- 104 (325)
.++|.+.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368999999999999999999987 68899999987532 23346688999999999999999999999776654
Q ss_pred --EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 105 --LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 105 --~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
++||||+. ++|.+++ ...+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.++|+|||++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 6787776 34599999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc----
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE---- 258 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 258 (325)
..... ....+++.|+|||.+.+...++.++||||||+++++|++|+.||......+....+ ........
T Consensus 194 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~ 266 (371)
T 4exu_A 194 ADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVTGVPGTEFV 266 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHHHH
T ss_pred cccCc----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCcHHHH
Confidence 54322 22347899999999865578899999999999999999999999876433222111 00000000
Q ss_pred -----------ccccccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 259 -----------LQNLVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 259 -----------~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
........ ....+.....+.+++.+||+.||.+|||+.|++ ..++.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 00000000 001112246799999999999999999999999 4565554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=309.32 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=202.5
Q ss_pred ccccccccccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh------cHHHHHHHHHHHhccC
Q 047716 15 DVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE------GESEFRNEMKIIGRIH 87 (325)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~ 87 (325)
+.+......+....+...++|++.+.||+|+||.||+|.+. ++..+|+|++...... ....+..|+.+++.++
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (320)
T 3a99_A 25 NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104 (320)
T ss_dssp ---------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC
T ss_pred HHhhhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhc
Confidence 34444555556666777889999999999999999999986 6888999998654321 1234567899999996
Q ss_pred --CCCcceeeEEeecCCceEEEEeecCC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCce
Q 047716 88 --HKNLVDLVGFCSEGSNRLLVYEFMRN-GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNI 164 (325)
Q Consensus 88 --h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ni 164 (325)
||||+++++++...+..++++|++.+ ++|.+++.. .+.+++..++.++.|++.||.|||++ |++|+||+|+||
T Consensus 105 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 180 (320)
T 3a99_A 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENI 180 (320)
T ss_dssp SSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred cCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHE
Confidence 59999999999999999999999976 899999854 46799999999999999999999999 999999999999
Q ss_pred EEc-CCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccch
Q 047716 165 LMD-ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDE 243 (325)
Q Consensus 165 lv~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 243 (325)
+++ .++.+||+|||++........ ....+++.|+|||.+......+.++||||||+++++|++|+.||.....
T Consensus 181 ll~~~~~~~kL~Dfg~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 254 (320)
T 3a99_A 181 LIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 254 (320)
T ss_dssp EEETTTTEEEECCCTTCEECCSSCB---CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---
T ss_pred EEeCCCCCEEEeeCccccccccccc---cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---
Confidence 998 778999999999876654322 2234889999999986555667889999999999999999999975321
Q ss_pred hhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 244 IVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
...... .........+.+++.+||+.||.+|||++|+++ .++...
T Consensus 255 ----------~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 255 ----------IIRGQV--------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ----------HHHCCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----------hhcccc--------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 011110 011122356899999999999999999999994 455444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=328.67 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=205.1
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
+...+|++.+.||+|+||.||+|.+.. +..+++|++... .......+.+|+.+++.++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 446789999999999999999998752 456888887653 2333467889999999999999999999985 4578
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++......+++..++.++.|++.|+.|||++ |++|+||||+||+++.++.+||+|||++....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 999999999999999976666799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...........+++.|+|||.+ ....++.++||||||+++++|++ |..||......+... ....+..
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~-------~i~~~~~---- 610 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-------RIENGER---- 610 (656)
T ss_dssp C----------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HHHHTCC----
T ss_pred CCcceeccCCCCCcceeCHHHh-cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHHcCCC----
Confidence 4433222333367789999998 45678999999999999999997 999998654332211 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 611 ---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 611 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1122233467999999999999999999999999998875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.93 Aligned_cols=252 Identities=15% Similarity=0.173 Sum_probs=202.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEE------eCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC---CCCcceeeEEeec
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGC------INGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH---HKNLVDLVGFCSE 100 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~------~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 100 (325)
+...+|++.+.||+|+||.||+|. ...++.+|+|++... ....+..|..+++.++ |+||+.+++.+..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 335789999999999999999994 336889999998653 3445667777777776 9999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC--------
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFR----AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-------- 168 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-------- 168 (325)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999954 345699999999999999999999999 9999999999999988
Q ss_pred ---CCcEEEeeccccccccCC-CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchh
Q 047716 169 ---SWKAKISDFGLSKLLKTD-QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI 244 (325)
Q Consensus 169 ---~~~vkl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 244 (325)
++.+||+|||++...... .........||+.|+|||.+ .+..++.++||||||+++|+|++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML-SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH-TTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh-cCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 889999999999754322 22233334589999999999 455689999999999999999999999965433211
Q ss_pred hHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCC-CCHhHHHHHHhccCC
Q 047716 245 VLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLR-PTMKQVIWMMEGIVP 307 (325)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~ell~~L~~~~~ 307 (325)
......... ...+.+.+++..|++.+|.+| |+++++.+.|+.+.+
T Consensus 294 -------------~~~~~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 -------------KPEGLFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -------------EECSCCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -------------eechhcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 011111111 123568889999999999999 788888888887764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=326.32 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=197.5
Q ss_pred hhcCcCCceeEEEEEeC---CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN---GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
++||+|+||.||+|.+. .+..+|+|++..... .....+.+|+.+++.++||||+++++++.. ...++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 37999999999999653 467899999875432 335778999999999999999999999865 568899999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc--cce
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT--RTY 191 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~--~~~ 191 (325)
++|.+++. ....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++.+||+|||++........ ...
T Consensus 454 g~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999994 456799999999999999999999999 999999999999999999999999999976643322 111
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
....++..|+|||.+ ....++.++||||||+++++|++ |+.||......+.. ..+..+... ..+
T Consensus 530 ~~~~~t~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~~~-------~~p 594 (635)
T 4fl3_A 530 THGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGERM-------GCP 594 (635)
T ss_dssp -----CGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCCC-------CCC
T ss_pred cCCCCceeeeChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCCC-------CCC
Confidence 222356789999999 56678999999999999999998 99999876443211 112222111 112
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
..++.++.++|.+||+.||.+|||+.+|++.|+.+.
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 233467999999999999999999999999998764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=310.10 Aligned_cols=249 Identities=10% Similarity=0.031 Sum_probs=179.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHH---HHHhccCCCCcceee-------EEee
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEM---KIIGRIHHKNLVDLV-------GFCS 99 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~~~ 99 (325)
+|++.+.||+|+||.||+|.+. ++..+|+|++.... ......+.+|+ ..|+. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 4888999999999999999987 78899999987643 23345567774 45555 699988755 4443
Q ss_pred cC-----------------CceEEEEeecCCCCHHHHHhhccCCCCHHHH------HHHHHHHHHHHHHhhccCCCCeee
Q 047716 100 EG-----------------SNRLLVYEFMRNGSLGNLLFRAEQRLSWSER------RRIALEIMEGLHYLHDECETRIIH 156 (325)
Q Consensus 100 ~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~------~~~~~ql~~~l~~lh~~~~~~i~h 156 (325)
.. ...++||||++ ++|.+++......+....+ ..++.|++.|+.|||++ ||+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 32 23799999998 8999999665555555556 67889999999999999 9999
Q ss_pred ccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCcccccc-CCCCCccccchhHHHHHHHHHhCCCCC
Q 047716 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR-NNRITVKADVYSFGVMLLEIVCCRKNV 235 (325)
Q Consensus 157 ~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~ 235 (325)
+||||+|||++.++.+||+|||++........ ...+++.|+|||.+.+ ...++.++||||||+++++|++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986543221 2236799999999843 157899999999999999999999999
Q ss_pred CCccccchhhHHHHHHHHHHhCcccccccCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 236 DESLRDDEIVLIDWAHQCYEAGELQNLVSDQ--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.......... ............. .......+..+.++|.+||+.||.+|||+.|++
T Consensus 294 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 294 GLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp TBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 8764321110 0000000000001 111123346799999999999999999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=305.03 Aligned_cols=268 Identities=21% Similarity=0.286 Sum_probs=203.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC-----Cce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG-----SNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 104 (325)
.++|++.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 367999999999999999999987 68889999986432 33345677899999999999999999987653 678
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++|||+. ++|.+++.. +.+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999996 689888843 5799999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCcc---------ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHH
Q 047716 185 TDQTR---------TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255 (325)
Q Consensus 185 ~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (325)
..... ......+++.|+|||.+.....++.++||||||+++++|++|++||...........+ .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHhC
Confidence 32211 1112347889999998756678899999999999999999999999876533221111 11111
Q ss_pred hCccc----------------ccccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCCC
Q 047716 256 AGELQ----------------NLVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVPP 308 (325)
Q Consensus 256 ~~~~~----------------~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~ 308 (325)
..... ...... ....+.....+.+++.+||+.||.+|||+.|+++ .++.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 00000 000000 0001123456899999999999999999999994 67666543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=301.98 Aligned_cols=265 Identities=22% Similarity=0.315 Sum_probs=200.2
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC--CCcEEEEEEeeccchh--cHHHHHHHHHHHhcc---CCCCcceeeEEee-----
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEE--GESEFRNEMKIIGRI---HHKNLVDLVGFCS----- 99 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~~~vk~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~----- 99 (325)
..+|++.+.||+|+||.||+|.+. ++..+|+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 367999999999999999999984 6788999988653321 122455677666666 8999999999886
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecc
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFG 178 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg 178 (325)
.....++||||+. ++|.+++.... ..+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence 4567899999997 69999885543 4589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
++....... ......++..|+|||.+ ....++.++||||||+++++|++|+.||......+.... .........
T Consensus 166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~ 239 (326)
T 1blx_A 166 LARIYSFQM--ALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPG 239 (326)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCC
T ss_pred ccccccCCC--CccccccccceeCHHHH-hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCC
Confidence 987654322 12223478999999998 456688999999999999999999999987644322111 111111110
Q ss_pred ccccc---------------cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 259 LQNLV---------------SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 259 ~~~~~---------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
..... .............+.+++.+||+.||.+|||+.|++ ..++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 00000 000111122346789999999999999999999999 4566655
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=303.97 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=190.4
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh------cHHHHHHHHHHHhcc----CCCCcceee
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE------GESEFRNEMKIIGRI----HHKNLVDLV 95 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv~~~ 95 (325)
..+...++|++.+.||+|+||.||+|.+. ++..+++|++...... ....+..|+.++..+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44667889999999999999999999886 6889999998653321 222355688888888 899999999
Q ss_pred EEeecCCceEEEEee-cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc-CCCcEE
Q 047716 96 GFCSEGSNRLLVYEF-MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAK 173 (325)
Q Consensus 96 ~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~-~~~~vk 173 (325)
+++...+..++|+|+ +.+++|.+++.. .+.+++..++.++.|++.|+.|||++ |++|+||+|+||+++ .++.++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 999988899999999 788999999854 45799999999999999999999999 999999999999998 888999
Q ss_pred EeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHH
Q 047716 174 ISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQC 253 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 253 (325)
|+|||++........ ....++..|+|||.+......+.++||||||+++++|++|+.||.....
T Consensus 181 l~dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------- 244 (312)
T 2iwi_A 181 LIDFGSGALLHDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------- 244 (312)
T ss_dssp ECCCSSCEECCSSCB---CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred EEEcchhhhcccCcc---cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------------
Confidence 999999876654322 2234789999999985555556689999999999999999999975311
Q ss_pred HHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 254 YEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..... ..........+.+++.+||+.+|.+|||++|+++
T Consensus 245 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ILEAE--------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHTC--------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred Hhhhc--------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111 1111223356899999999999999999999995
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=298.16 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=195.3
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeec------CC
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE------GS 102 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~ 102 (325)
...+|++.+.||+|+||.||+|.+. .+..+++|++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3578999999999999999999986 68889999886533 3446788999999999 79999999999866 46
Q ss_pred ceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 103 NRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
..++||||+++++|.+++... ...+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 789999999999999998654 35699999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCccceeeecCCCCcCCcccccc----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSR----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
........ .....+++.|+|||.+.. ...++.++||||||+++++|++|+.||.......... . ....
T Consensus 178 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~-~~~~ 249 (326)
T 2x7f_A 178 QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------L-IPRN 249 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------H-HHHS
T ss_pred ecCcCccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------H-hhcC
Confidence 65432211 122347899999999842 4567889999999999999999999997654322111 1 1111
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
...... .......+.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPRLK------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCCS------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCC------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 1112356999999999999999999999994
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=299.25 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=199.2
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc------
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN------ 103 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------ 103 (325)
.+|.+.+.||+|+||.||+|.+. .+..+|+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57999999999999999999987 68899999986532 2334567899999999999999999999977654
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++|||+. ++|.+++ ...+++..++.++.|++.|+.|||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 104 ~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999996 5887776 24599999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC------
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG------ 257 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 257 (325)
.... ....+++.|+|||.+.+...++.++||||||+++++|++|+.||......+....+ .......
T Consensus 177 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~ 249 (353)
T 3coi_A 177 DAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVTGVPGTEFVQ 249 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH---HHHHCBCCHHHHT
T ss_pred CCCc----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHHH
Confidence 3321 22347899999999865577899999999999999999999999876533221111 1100000
Q ss_pred ------------ccccccc-CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 258 ------------ELQNLVS-DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 258 ------------~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
.+..... ......+.....+.+++.+||+.||.+|||+.|++ ..++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0000000 00111223456799999999999999999999999 4566554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=300.95 Aligned_cols=268 Identities=18% Similarity=0.277 Sum_probs=201.5
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-----------CCCcceeeEEe
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-----------HKNLVDLVGFC 98 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~ 98 (325)
...+|++.+.||+|+||.||+|.+. .+..+|+|++... ......+.+|+.+++.++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 4578999999999999999999986 6888999998643 233456778999988886 79999999998
Q ss_pred ecCC----ceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc------
Q 047716 99 SEGS----NRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD------ 167 (325)
Q Consensus 99 ~~~~----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~------ 167 (325)
...+ ..+++||++ +++|.+++... ...+++..++.++.|++.||.|||+++ |++|+||||+||+++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 7543 789999999 88999998653 345999999999999999999999942 899999999999994
Q ss_pred CCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhh--
Q 047716 168 ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV-- 245 (325)
Q Consensus 168 ~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-- 245 (325)
..+.++|+|||++........ ...+++.|+|||.+ .+..++.++||||||+++++|++|+.||..........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~~----~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHYT----NSIQTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBCCC----SCCSCGGGCCHHHH-HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCCCC----CCCCCccccCcHHH-hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 444799999999876543322 22479999999998 45668999999999999999999999998654321111
Q ss_pred -HHHHHHHHHHh--------Cc----------------------ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC
Q 047716 246 -LIDWAHQCYEA--------GE----------------------LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT 294 (325)
Q Consensus 246 -~~~~~~~~~~~--------~~----------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 294 (325)
.+......... .. +..........+......+.++|.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 01101110000 00 011112223455677889999999999999999999
Q ss_pred HhHHHH--HHhccCC
Q 047716 295 MKQVIW--MMEGIVP 307 (325)
Q Consensus 295 ~~ell~--~L~~~~~ 307 (325)
++|+++ .+++...
T Consensus 328 ~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHHHTCGGGTTCTT
T ss_pred HHHHhhChhhhcccC
Confidence 999994 6666553
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.57 Aligned_cols=262 Identities=19% Similarity=0.316 Sum_probs=203.8
Q ss_pred ccHHHHHHHHHhhhhhcCcCCceeEEEEEeC--CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCC------CcceeeE
Q 047716 25 FSYEQIVLASENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHK------NLVDLVG 96 (325)
Q Consensus 25 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~ 96 (325)
+..+++..++|++.+.||+|+||.||+|.+. ++..+|+|++... ......+.+|+.+++.++|+ +++++++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 3445566789999999999999999999873 6788999988643 33455678899999888655 4999999
Q ss_pred EeecCCceEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-------
Q 047716 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE------- 168 (325)
Q Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~------- 168 (325)
++...+..++||||+ +++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||||+||+++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEE
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccccc
Confidence 999999999999999 889999885543 3689999999999999999999999 9999999999999987
Q ss_pred ------------CCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCC
Q 047716 169 ------------SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVD 236 (325)
Q Consensus 169 ------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 236 (325)
++.++|+|||++....... ....+++.|+|||.+ .+..++.++||||||+++++|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVI-LALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHH-TTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHh-hCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 6689999999987644322 123478999999998 56678999999999999999999999998
Q ss_pred CccccchhhHHHHHHHHHHhC--------ccc------------------------ccccCCCCCCHHHHHHHHHHHhhc
Q 047716 237 ESLRDDEIVLIDWAHQCYEAG--------ELQ------------------------NLVSDQEDVNIEEFENLVKIGLWC 284 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~--------~~~------------------------~~~~~~~~~~~~~~~~l~~li~~~ 284 (325)
.....+....+. ...... ... ................+.+++.+|
T Consensus 236 ~~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 236 THDSKEHLAMME---RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp CSCHHHHHHHHH---HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCChHHHHHHHH---HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 764433221111 111000 000 000011122334567899999999
Q ss_pred ccCCCCCCCCHhHHH
Q 047716 285 VECELNLRPTMKQVI 299 (325)
Q Consensus 285 l~~~p~~Rps~~ell 299 (325)
|+.||.+|||+.|++
T Consensus 313 L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 313 LEYDPAKRITLREAL 327 (339)
T ss_dssp TCSSTTTSCCHHHHT
T ss_pred hCcCcccccCHHHHh
Confidence 999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=301.38 Aligned_cols=266 Identities=25% Similarity=0.369 Sum_probs=202.0
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
..++..++|++.+.||+|+||.||+|.+.. .+++|++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 334556789999999999999999998864 48899886432 22234567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++|||+++++|.+++......+++..++.++.|++.|+.+||++ |++|+||+|+||+++ ++.++|+|||++....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999999966666799999999999999999999999 999999999999998 5699999999876543
Q ss_pred CCC----ccceeeecCCCCcCCcccccc--------CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHH
Q 047716 185 TDQ----TRTYTVLRGTRGYTAPELHSR--------NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQ 252 (325)
Q Consensus 185 ~~~----~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 252 (325)
... ........+++.|+|||.+.. ...++.++||||||+++++|++|+.||......... .
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~ 253 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-------W 253 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-------H
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------H
Confidence 211 111222347889999998853 245788999999999999999999999865432211 1
Q ss_pred HHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCCCC
Q 047716 253 CYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQN 311 (325)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 311 (325)
....+....... ......+.+++.+||+.+|.+|||+.+++++|+.+......
T Consensus 254 ~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 254 QMGTGMKPNLSQ------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHTTCCCCCCC------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HhccCCCCCCCc------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111111110 11224589999999999999999999999999999865433
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=299.84 Aligned_cols=272 Identities=18% Similarity=0.274 Sum_probs=206.6
Q ss_pred cccccHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CC-cEEEEEEeeccchhcHHHHHHHHHHHhccCCCC------cce
Q 047716 22 LRSFSYEQIVLASENFKEEIGRGGSGRVYKGCIN-GG-KEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN------LVD 93 (325)
Q Consensus 22 ~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~-~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~ 93 (325)
......++....+|++.+.||+|+||.||+|.+. .+ ..+|+|++... ......+..|+.+++.++|++ ++.
T Consensus 8 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 8 HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred CcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3445566677889999999999999999999986 34 57899988643 334556778999999987655 889
Q ss_pred eeEEeecCCceEEEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE------
Q 047716 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM------ 166 (325)
Q Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv------ 166 (325)
+++++...+..++||||+ ++++.+++... ...+++..++.++.|++.||.|||++ |++|+||||+||++
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccc
Confidence 999999999999999999 55666666443 35799999999999999999999999 99999999999999
Q ss_pred -------------cCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCC
Q 047716 167 -------------DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRK 233 (325)
Q Consensus 167 -------------~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 233 (325)
+.++.++|+|||++....... ....+++.|+|||.+ .+..++.++||||||+++++|++|+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVI-LELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeee-ecCCCCCccchHHHHHHHHHHHhCCC
Confidence 567889999999987643322 223489999999998 46678999999999999999999999
Q ss_pred CCCCccccchhhHHHHHHHHHHhC--------cccc------------------------cccCCCCCCHHHHHHHHHHH
Q 047716 234 NVDESLRDDEIVLIDWAHQCYEAG--------ELQN------------------------LVSDQEDVNIEEFENLVKIG 281 (325)
Q Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~------------------------~~~~~~~~~~~~~~~l~~li 281 (325)
||......+....+. ...... .... ...............+.+++
T Consensus 238 pf~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 238 LFQTHENREHLVMME---KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp SCCCSSHHHHHHHHH---HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHH---HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 998755433221111 111000 0000 00000112233456799999
Q ss_pred hhcccCCCCCCCCHhHHH--HHHhccC
Q 047716 282 LWCVECELNLRPTMKQVI--WMMEGIV 306 (325)
Q Consensus 282 ~~~l~~~p~~Rps~~ell--~~L~~~~ 306 (325)
.+||+.||.+|||+.|++ ..+.++.
T Consensus 315 ~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp HHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred HHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 999999999999999999 4565554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.20 Aligned_cols=206 Identities=24% Similarity=0.309 Sum_probs=171.3
Q ss_pred cHHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CC-----CcceeeEEe
Q 047716 26 SYEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HK-----NLVDLVGFC 98 (325)
Q Consensus 26 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~ 98 (325)
..++...++|++.+.||+|+||.||+|.+. .+..||+|++... ......+..|+.+++.++ |+ +|+.+++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 444555689999999999999999999987 6788999998643 233456677888888885 44 499999999
Q ss_pred ecCCceEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhc--cCCCCeeeccCCCCceEEc--CCCcEE
Q 047716 99 SEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHD--ECETRIIHCDIKPHNILMD--ESWKAK 173 (325)
Q Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~--~~~~~i~h~di~p~nilv~--~~~~vk 173 (325)
...+..++||||+. ++|.+++.... ..+++..++.++.|++.|+.|||+ . ||+|+||||+||+++ .++.+|
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~---~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL---SIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTT---CEECCCCSGGGEEESSTTSCCEE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCC---CEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999995 59999885543 569999999999999999999994 5 999999999999995 477899
Q ss_pred EeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc
Q 047716 174 ISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 241 (325)
|+|||++....... ....+++.|+|||.+ .+..++.++|||||||++++|++|++||......
T Consensus 202 L~DFG~a~~~~~~~----~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 202 IVDFGSSCQLGQRI----YQYIQSRFYRSPEVL-LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp ECCCTTCEETTCCC----CSSCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEeccCceeccccc----ccccCCccccChHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999997664322 123478999999998 4567899999999999999999999999876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=308.71 Aligned_cols=203 Identities=25% Similarity=0.357 Sum_probs=171.2
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhcc------CCCCcceeeEEeecC
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRI------HHKNLVDLVGFCSEG 101 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 101 (325)
+....+|++.+.||+|+||.||+|.+. .+..||+|++... ......+..|+.+++.+ +|+||+.+++.+...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 345567999999999999999999887 5788999988653 23345566788877777 577999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc--EEEeecc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK--AKISDFG 178 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~--vkl~Dfg 178 (325)
+..++|||++. ++|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+||+++.++. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999995 68888885543 4599999999999999999999999 9999999999999999887 9999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCcccc
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRD 241 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 241 (325)
++....... ....+++.|+|||.+ .+..++.++|||||||++++|++|++||......
T Consensus 248 ~a~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 248 SSCYEHQRV----YTYIQSRFYRAPEVI-LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCEETTCCC----CSSCSCGGGCCHHHH-HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecCCcc----cccCCCCCccChHHH-hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 986543322 123478999999998 4666899999999999999999999999876543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=294.78 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=182.8
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.++|++.+.||+|+||.||+|.+. ++..+++|++..... .....+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 478999999999999999999987 688999999875432 22233455566788889999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
||+ ++.+..+.......+++..++.++.|++.|+.|||+ . |++|+||+|+||+++.++.++|+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 666766665556789999999999999999999998 6 89999999999999999999999999987654332
Q ss_pred ccceeeecCCCCcCCccccc----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 188 TRTYTVLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.. ....+++.|+|||.+. ....++.++||||||+++++|++|+.||......... ...... ..... .
T Consensus 180 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~-~~~~~-~ 250 (318)
T 2dyl_A 180 AK--DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-----LTKVLQ-EEPPL-L 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHHH-SCCCC-C
T ss_pred cc--cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-----HHHHhc-cCCCC-C
Confidence 21 2234789999999984 2456788999999999999999999999764332111 111111 11111 1
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.. .......+.+++.+||+.||.+|||++|++
T Consensus 251 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (318)
T 2dyl_A 251 PG----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282 (318)
T ss_dssp CS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred Cc----cCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 11 111235689999999999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=290.19 Aligned_cols=252 Identities=20% Similarity=0.325 Sum_probs=194.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeecc--chhcHHHHHHHHHHHhccC--CCCcceeeEEeecCCceE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIH--HKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~ 105 (325)
+...+|++.+.||+|+||.||+|.+.++..+|+|++... .......+.+|+.+++.++ ||||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 445779999999999999999999988999999998643 2334567889999999997 599999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
++|| +.+++|.+++.. ...+++..++.++.|++.|+.|||++ |++|+||+|+||++++ +.++|+|||++.....
T Consensus 105 lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 9999 558899999854 45799999999999999999999999 9999999999999975 7999999999876543
Q ss_pred CCcc-ceeeecCCCCcCCcccccc----------CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHH
Q 047716 186 DQTR-TYTVLRGTRGYTAPELHSR----------NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCY 254 (325)
Q Consensus 186 ~~~~-~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (325)
.... ......+++.|+|||.+.. ...++.++||||||+++++|++|+.||......... .....
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~ 253 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LHAII 253 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HHHHH
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-----HHHHH
Confidence 3221 1122347999999999843 146788999999999999999999999765332111 11111
Q ss_pred HhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 255 EAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
. .... ...+......+.+++.+||+.||.+|||+.|++
T Consensus 254 ~-~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 254 D-PNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp C-TTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred h-cccc------cCCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 1 1111 011111135689999999999999999999999
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.81 Aligned_cols=258 Identities=19% Similarity=0.217 Sum_probs=175.1
Q ss_pred HHHHHhhhh-hcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec----CCce
Q 047716 31 VLASENFKE-EIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE----GSNR 104 (325)
Q Consensus 31 ~~~~y~~~~-~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 104 (325)
...+|++.+ .||+|+||.||+|.+. +++.+|+|++.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456899965 6999999999999988 68899999985522 222233344667789999999999865 3458
Q ss_pred EEEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC---CcEEEeecccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES---WKAKISDFGLS 180 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~---~~vkl~Dfg~~ 180 (325)
++||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||+|+||+++.+ +.++|+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999996543 4699999999999999999999999 99999999999999764 45999999998
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
........ ....+++.|+|||.+ ....++.++||||||+++++|++|+.||........... ...........
T Consensus 179 ~~~~~~~~---~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~ 251 (336)
T 3fhr_A 179 KETTQNAL---QTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQYG 251 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C
T ss_pred eecccccc---ccCCCCcCccChhhh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhccccc
Confidence 76543221 223478999999998 566778899999999999999999999976543221100 00001000000
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
............+.+++.+||+.||.+|||++|+++ .+.+..
T Consensus 252 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 252 ----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 001111223456999999999999999999999994 555443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=303.28 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=188.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
..+|++.+.||+|+||+|+.....+++.||||++...... .+.+|+.+++.+ +||||+++++++.+....++|||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3468888999999999977655667899999998653322 245799999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-----CCcEEEeeccccccccC
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-----SWKAKISDFGLSKLLKT 185 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-----~~~vkl~Dfg~~~~~~~ 185 (325)
+. ++|.+++...........++.++.|++.|+.|||++ ||+|+||||+||+++. ...++|+|||++.....
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 95 699999866655566667789999999999999999 9999999999999953 23588999999976643
Q ss_pred CCc--cceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 186 DQT--RTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 186 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
... .......+|+.|+|||.+.. ...++.++|||||||++++|++ |..||......... ......
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~--- 245 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGAC--- 245 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCC---
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccC---
Confidence 321 12233458999999999853 3556789999999999999999 88998654322111 111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..............+.++|.+||+.||.+|||++|++
T Consensus 246 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 246 --SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp --CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred --CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 1111222234456689999999999999999999999
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=291.99 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=177.1
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHH-HHhccCCCCcceeeEEeecCCceEEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMK-IIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
...+|++.+.||+|+||.||+|.+. +++.+|+|++.... ......+..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3478899999999999999999987 68899999987543 223334445555 77888999999999999999999999
Q ss_pred EeecCCCCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 108 YEFMRNGSLGNLLFR----AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
|||+.+ +|.+++.. ....+++..+..++.|++.|+.+||++ .|++|+||+|+||+++.++.+||+|||++...
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999975 77777642 256789999999999999999999984 28999999999999999999999999998765
Q ss_pred cCCCccceeeecCCCCcCCccccc---cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHS---RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
...... ....+++.|+|||.+. ....++.++||||||+++++|++|+.||........ .+.
T Consensus 177 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------------~~~ 240 (327)
T 3aln_A 177 VDSIAK--TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------------QLT 240 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------C
T ss_pred cccccc--ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------------HHH
Confidence 433221 1224789999999984 245578899999999999999999999976432110 001
Q ss_pred ccccCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 NLVSDQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 ~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...... ..........+.+++.+||+.||.+|||+.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 284 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHH
Confidence 111110 011112345699999999999999999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=290.08 Aligned_cols=241 Identities=11% Similarity=0.061 Sum_probs=189.7
Q ss_pred ccHHH-HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEee
Q 047716 25 FSYEQ-IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCS 99 (325)
Q Consensus 25 ~~~~~-~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (325)
...++ +...+|++.+.||+|+||.||+|.+. .++.+|+|++..... .....+.+|+..+..++||||+++++++.
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 44455 66788999999999999999999987 588999999876433 23366889999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
+.+..++||||+++++|.+++.. ......+..++.|++.|+.|||++ |++|+||||+||+++.++.++|++++
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred ECCcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-
Confidence 99999999999999999999843 246677889999999999999999 99999999999999999999998543
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
|++ .++.++||||||+++|+|++|+.||......+..... ....
T Consensus 175 --------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~ 218 (286)
T 3uqc_A 175 --------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDT 218 (286)
T ss_dssp --------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCT
T ss_pred --------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHh
Confidence 222 2577899999999999999999999876543211000 0000
Q ss_pred cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCCC
Q 047716 260 QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPH 309 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 309 (325)
..............+..+.+++.+||+.||.+| |+.|+++.|+.+....
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000000001112234679999999999999999 9999999999987433
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.31 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=186.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEEeecC
Q 047716 34 SENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
.|.+.+.||+|+||+||.+...++..||+|++.... ...+.+|+.+++.+ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 455668899999999987766789999999986532 34567899999876 89999999999999999999999995
Q ss_pred CCCHHHHHhhccCC------CCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC-------------CcEE
Q 047716 113 NGSLGNLLFRAEQR------LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES-------------WKAK 173 (325)
Q Consensus 113 ~~~L~~~~~~~~~~------~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~-------------~~vk 173 (325)
++|.+++...... .++..++.++.|++.|+.|||++ ||+|+||||+||+++.+ +.++
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999998543211 12334578999999999999999 99999999999999754 4899
Q ss_pred EeeccccccccCCCcc---ceeeecCCCCcCCcccccc------CCCCCccccchhHHHHHHHHHh-CCCCCCCccccch
Q 047716 174 ISDFGLSKLLKTDQTR---TYTVLRGTRGYTAPELHSR------NNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDE 243 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~ 243 (325)
|+|||++......... ......+++.|+|||.+.+ ...++.++|||||||++++|++ |+.||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999876543321 1223358999999999853 2567899999999999999999 9999975533211
Q ss_pred hhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 244 IVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........ ..............++.+++.+||+.||.+|||+.|+++
T Consensus 249 ---------~i~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 ---------NIIRGIFS-LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---------HHHHTCCC-CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------HHhcCCCC-cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111111 111112224566788999999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=310.76 Aligned_cols=275 Identities=23% Similarity=0.291 Sum_probs=200.3
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeec----
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE---- 100 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 100 (325)
.......+|++.+.||+|+||.||+|.+. ++..+|+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 34445589999999999999999999886 6889999988653 33445668899999999999999999998755
Q ss_pred --CCceEEEEeecCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCc---EE
Q 047716 101 --GSNRLLVYEFMRNGSLGNLLFRAE--QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWK---AK 173 (325)
Q Consensus 101 --~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~---vk 173 (325)
.+..++||||+++++|.+++.... ..+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++. ++
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEE
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEE
Confidence 667899999999999999996533 2589999999999999999999999 9999999999999987765 99
Q ss_pred EeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhH---HHHH
Q 047716 174 ISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVL---IDWA 250 (325)
Q Consensus 174 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~~~ 250 (325)
|+|||++......... ....+++.|+|||.+ .+..++.++||||||+++++|++|+.||........... ....
T Consensus 165 L~DFG~a~~~~~~~~~--~~~~gt~~Y~APE~l-~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 165 IIDLGYAKELDQGELC--TEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp ECSCCCCCBTTSCCCC--CCCCSCCTTCSSCSS-CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred Eccccccccccccccc--ccccCCcccCChHHh-ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9999999876543322 223489999999998 567789999999999999999999999975421100000 0000
Q ss_pred HHHHHhC------cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH-----HHHhccCC
Q 047716 251 HQCYEAG------ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI-----WMMEGIVP 307 (325)
Q Consensus 251 ~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell-----~~L~~~~~ 307 (325)
....... .+.................+.+++.+||+.||.+|||+.|++ +.++.+..
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000 011111112233445677899999999999999999998854 55555553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=275.01 Aligned_cols=231 Identities=21% Similarity=0.258 Sum_probs=179.5
Q ss_pred HHHhhh-hhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHH-hccCCCCcceeeEEeec----CCceE
Q 047716 33 ASENFK-EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKII-GRIHHKNLVDLVGFCSE----GSNRL 105 (325)
Q Consensus 33 ~~y~~~-~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~~ 105 (325)
.+|.+. +.||+|+||.||+|.+. .+..+|+|++.. ...+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 457776 77999999999999986 688999999854 23456788887 56689999999998876 56789
Q ss_pred EEEeecCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCcEEEeeccccc
Q 047716 106 LVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWKAKISDFGLSK 181 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~vkl~Dfg~~~ 181 (325)
+||||+++++|.+++.... ..+++..++.++.|++.|+.|||++ |++|+||+|+||+++. ++.++|+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999996543 4699999999999999999999999 9999999999999998 7889999999875
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
... +..++.++||||||+++++|++|+.||........ .......
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~ 213 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTR 213 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHH
Confidence 321 23456789999999999999999999976433211 0111111
Q ss_pred cccCCCCCCH----HHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 262 LVSDQEDVNI----EEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
+.......+. .....+.+++.+||+.||.+|||+.|+++ .+....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 1111122221 23467999999999999999999999993 454443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=308.87 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=195.0
Q ss_pred HHHHHHHHHhhhhhcCcCCceeEEEEEeC--CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 27 YEQIVLASENFKEEIGRGGSGRVYKGCIN--GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 27 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
.+++..++|++.+.||+|+||.||+|.+. +++.|++|++.... ......+..|+.+++.++||||+++++++...+.
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 44566789999999999999999999986 57889999886532 3344567899999999999999999999977655
Q ss_pred -----eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecc
Q 047716 104 -----RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFG 178 (325)
Q Consensus 104 -----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg 178 (325)
.++||||+++++|.+++. ..+++..++.++.|++.+|.|||++ ||+|+||||+||+++.+ .+||+|||
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp TSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999998773 2799999999999999999999999 99999999999999986 89999999
Q ss_pred ccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 179 LSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
++...... ....+|+.|+|||.+... ++.++||||||+++++|++|.+||........
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------- 284 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------- 284 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccccc---------------
Confidence 99765443 223489999999998433 38899999999999999999998875432110
Q ss_pred ccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCC-HhHHHHHHhcc
Q 047716 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPT-MKQVIWMMEGI 305 (325)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~~L~~~ 305 (325)
. ...........+.++|.+||+.||.+||+ ++++...|.++
T Consensus 285 ----~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ----P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 00011122356899999999999999995 55566655554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=285.64 Aligned_cols=238 Identities=14% Similarity=0.148 Sum_probs=177.7
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCC-CCcc---------eeeE---
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHH-KNLV---------DLVG--- 96 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h-~~iv---------~~~~--- 96 (325)
+|++.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+.+++.++| +|.. ...+
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 3667789999999999999976 68899999887322 2234668899999999976 2211 1111
Q ss_pred ---------Eeec-----CCceEEEEeecCCCCHHHHHh------hccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeee
Q 047716 97 ---------FCSE-----GSNRLLVYEFMRNGSLGNLLF------RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156 (325)
Q Consensus 97 ---------~~~~-----~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h 156 (325)
.+.. ....+++|+.. +++|.+++. .....+++..++.++.|++.||.|||++ ||+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 1111 22456777766 679998883 2234577888899999999999999999 9999
Q ss_pred ccCCCCceEEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccc---------cCCCCCccccchhHHHHHHH
Q 047716 157 CDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS---------RNNRITVKADVYSFGVMLLE 227 (325)
Q Consensus 157 ~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ 227 (325)
|||||+|||++.++.+||+|||++...... .....+ +.|+|||.+. ....++.++|||||||++|+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999999998765433 223346 9999999883 34457789999999999999
Q ss_pred HHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 228 IVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 228 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
|++|+.||........ ...+....... +..+.++|.+||+.||.+|||+.|++
T Consensus 310 lltg~~Pf~~~~~~~~---------------~~~~~~~~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 310 IWCADLPNTDDAALGG---------------SEWIFRSCKNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHSSCCCCTTGGGSC---------------SGGGGSSCCCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHCCCCCCCcchhhh---------------HHHHHhhcccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999976543221 11222222222 25699999999999999999977765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=276.19 Aligned_cols=244 Identities=14% Similarity=0.112 Sum_probs=183.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc--------hhcHHHHHHHHHHHhccC---------CCCcc
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--------EEGESEFRNEMKIIGRIH---------HKNLV 92 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv 92 (325)
+...+|++.+.||+|+||.||+|++ .+..+|+|++.... ......+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 5578999999999999999999998 57999999987542 223367788888888885 77777
Q ss_pred eeeEEe-----------------ec-------------CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHH
Q 047716 93 DLVGFC-----------------SE-------------GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEG 142 (325)
Q Consensus 93 ~~~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~ 142 (325)
.+.+.+ .+ .+..++||||+++|++.+.+.+ +.+++..++.++.|++.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 666653 22 6789999999999866665522 568999999999999999
Q ss_pred HHHhh-ccCCCCeeeccCCCCceEEcCCC--------------------cEEEeeccccccccCCCccceeeecCCCCcC
Q 047716 143 LHYLH-DECETRIIHCDIKPHNILMDESW--------------------KAKISDFGLSKLLKTDQTRTYTVLRGTRGYT 201 (325)
Q Consensus 143 l~~lh-~~~~~~i~h~di~p~nilv~~~~--------------------~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~ 201 (325)
|.||| ++ ||+||||||+|||++.++ .+||+|||++...... ...||+.|+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 88 999999999999999887 8999999999865432 224899999
Q ss_pred CccccccCCCCCccccchhHHHH-HHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHH
Q 047716 202 APELHSRNNRITVKADVYSFGVM-LLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKI 280 (325)
Q Consensus 202 aPE~~~~~~~~~~~~DiwslG~i-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 280 (325)
|||.+.+. . +.++||||||++ .+++++|..||...... .............. ...........+.++.+|
T Consensus 245 aPE~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 245 DEDLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-----HYLTDKMLKQMTFK--TKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CSGGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-----HHHHHHHHHTCCCS--SCCCSHHHHHHHHHHHHH
T ss_pred ChhhhcCC-C-ccceehhhhhCCCCcccccccCCCcchhhh-----hHHHHhhhhhhccC--cccchhhhhhcCHHHHHH
Confidence 99999533 3 889999998777 67788899998532100 00011111111111 111122234567889999
Q ss_pred HhhcccCCCCCCCCHhHHH
Q 047716 281 GLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 281 i~~~l~~~p~~Rps~~ell 299 (325)
|.+||+.| |++|++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=245.27 Aligned_cols=185 Identities=17% Similarity=0.133 Sum_probs=127.3
Q ss_pred cCcCCceeEEEEEeC-CCcEEEEEEeecc----------chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEEE
Q 047716 41 IGRGGSGRVYKGCIN-GGKEIAVKKLIKI----------VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 41 lg~g~~g~v~~~~~~-~~~~~~vk~~~~~----------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+.|+.|....++.. -|..+++|++... .....+.+.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 344444444433322 4778899988643 123345688999999999 5999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||++|++|.+++.. .+.++.. .++.||+.||.|+|++ ||+||||||+|||++.+|.+||+|||+++.......
T Consensus 322 Eyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 99999999999954 4567654 4789999999999999 999999999999999999999999999976544322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV 235 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 235 (325)
......||+.|+|||.+. +.+..++|+|++|++++.|.++..++
T Consensus 395 -~~~t~vGTp~YmAPE~l~--g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 -WPTNLVQSFFVFVNELFA--ENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred -cccCceechhhccHHHhC--CCCCCcccccccccchhhhccccchh
Confidence 222345899999999984 34567899999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=216.67 Aligned_cols=186 Identities=18% Similarity=0.210 Sum_probs=140.7
Q ss_pred hhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccch--------hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE--------EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
...+.||+|+||.||+|.. .+..+++|+...... ...+.+.+|+.+++.++||||+.+..++......++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 467788887643221 1134478999999999999999665555566778999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++++|.+++.. +..++.|++.++.|||++ +|+|+||||+||+++. .+||+|||++.......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999843 568999999999999999 9999999999999998 99999999998765432
Q ss_pred ccc------eeeecCCCCcCCcccccc-CCCCCccccchhHHHHHHHHHhCCCCCC
Q 047716 188 TRT------YTVLRGTRGYTAPELHSR-NNRITVKADVYSFGVMLLEIVCCRKNVD 236 (325)
Q Consensus 188 ~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~ 236 (325)
... .....+|+.|+|||.+.. ...|+...|+|+..+-..+-..++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 123458999999999843 1446778899999888888777776653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-23 Score=181.92 Aligned_cols=141 Identities=16% Similarity=0.127 Sum_probs=113.4
Q ss_pred hhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccch------------------hcHHHHHHHHHHHhccCCCCcceeeEE
Q 047716 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE------------------EGESEFRNEMKIIGRIHHKNLVDLVGF 97 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (325)
.+.+.||+|++|.||+|.+.++..+|+|.+..... .....+.+|+.+++.++ | +++.++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 35589999999999999997789999999854221 13456889999999999 4 555555
Q ss_pred eecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeec
Q 047716 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDF 177 (325)
Q Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Df 177 (325)
+.. +..++||||+++++|.+ +.. .....++.|++.|+.+||+. |++|+||||+||+++ ++.++|+||
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred Eec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 543 56699999999999988 411 23457999999999999999 999999999999999 999999999
Q ss_pred cccccccCCCccceeeecCCCCcCCcccc
Q 047716 178 GLSKLLKTDQTRTYTVLRGTRGYTAPELH 206 (325)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 206 (325)
|++.. +..+.|||.+
T Consensus 237 G~a~~--------------~~~~~a~e~l 251 (282)
T 1zar_A 237 PQSVE--------------VGEEGWREIL 251 (282)
T ss_dssp TTCEE--------------TTSTTHHHHH
T ss_pred CCCeE--------------CCCCCHHHHH
Confidence 99853 3456788877
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=159.53 Aligned_cols=136 Identities=21% Similarity=0.227 Sum_probs=104.9
Q ss_pred HhhhhhcCcCCceeEEEEEe-CCCcE--EEEEEeeccchh------------------------cHHHHHHHHHHHhccC
Q 047716 35 ENFKEEIGRGGSGRVYKGCI-NGGKE--IAVKKLIKIVEE------------------------GESEFRNEMKIIGRIH 87 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~-~~~~~--~~vk~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 87 (325)
|++.+.||+|+||.||+|.+ .+|.. +|+|++...... ....+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45778999999999999998 57888 999986432111 1135788999999998
Q ss_pred CCCc--ceeeEEeecCCceEEEEeecCC-C----CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhh-ccCCCCeeeccC
Q 047716 88 HKNL--VDLVGFCSEGSNRLLVYEFMRN-G----SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH-DECETRIIHCDI 159 (325)
Q Consensus 88 h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh-~~~~~~i~h~di 159 (325)
|+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.|++.++.+|| +. |++|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 8764 334432 356899999942 3 67665422 234567789999999999999 88 9999999
Q ss_pred CCCceEEcCCCcEEEeeccccccc
Q 047716 160 KPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 160 ~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 8999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.8e-17 Score=147.12 Aligned_cols=138 Identities=14% Similarity=0.111 Sum_probs=101.2
Q ss_pred HhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccch--------------hc--------HHHHHHHHHHHhccCCCCcc
Q 047716 35 ENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE--------------EG--------ESEFRNEMKIIGRIHHKNLV 92 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~--------------~~--------~~~~~~e~~~l~~l~h~~iv 92 (325)
|++.++||+|++|.||+|.+.+|+.+|+|++..... .. ......|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 788899999999999999999999999998642110 00 01134567777777555443
Q ss_pred eeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC--
Q 047716 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-- 170 (325)
Q Consensus 93 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-- 170 (325)
...-+.. ...+|||||+++.+|.++.. ......++.|++.++.+||+. |++||||||.|||++.++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCc
Confidence 2221211 13379999999888866541 123456789999999999998 999999999999998776
Q ss_pred --------cEEEeecccccccc
Q 047716 171 --------KAKISDFGLSKLLK 184 (325)
Q Consensus 171 --------~vkl~Dfg~~~~~~ 184 (325)
.+.++||+.+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-12 Score=111.58 Aligned_cols=142 Identities=13% Similarity=0.067 Sum_probs=109.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..|++...++.|+.+.||++... +..+++|............+..|+.+++.+. +..+.+++++....+..++|||++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 46888888999999999998754 6789999876532233345788999999885 567778999888888899999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC-----------------------------------------
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC----------------------------------------- 150 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~----------------------------------------- 150 (325)
+|.+|.+... +......++.+++.++..||+..
T Consensus 93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9999887631 11223467788999999999810
Q ss_pred ---------------CCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 151 ---------------ETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 151 ---------------~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...++|+|++|.||++++++.+.++||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0259999999999999876556799998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.3e-11 Score=104.60 Aligned_cols=135 Identities=13% Similarity=0.134 Sum_probs=95.6
Q ss_pred HhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceeeEEeecCCceEEEEeecC
Q 047716 35 ENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
+.+....+.|..+.||++...++..+++|..... ....+..|+.+++.+.+.+ +.+++++....+..++||||++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 3333333456669999997766778999986543 2234678899998886544 4558888877778899999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC------------------------------------------
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC------------------------------------------ 150 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~------------------------------------------ 150 (325)
|.++. .. ... ...++.+++..+..||+..
T Consensus 99 G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 99 GQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp SEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred CcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 98874 21 112 1245677777777777641
Q ss_pred -------------CCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 151 -------------ETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 151 -------------~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...++|+|++|.||++++++.+.++||+.+.
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877556799999763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=3e-10 Score=101.03 Aligned_cols=141 Identities=18% Similarity=0.256 Sum_probs=103.6
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEee--ccc-hhcHHHHHHHHHHHhccCC--CCcceeeEEeecC---CceEEEEe
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLI--KIV-EEGESEFRNEMKIIGRIHH--KNLVDLVGFCSEG---SNRLLVYE 109 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~--~~~-~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e 109 (325)
.+.++.|.++.+|+.... +..+++|+.. ... ......+..|+.+++.+.. ..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 357899999999998765 4678888765 221 1233467789999999974 4577888887665 45799999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC---------------------------------------
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC--------------------------------------- 150 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--------------------------------------- 150 (325)
|++|..+.+.. ...++......++.+++..+..||+..
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99988775421 234678888889999999999999720
Q ss_pred ----------------CCCeeeccCCCCceEEcCCCc--EEEeecccccc
Q 047716 151 ----------------ETRIIHCDIKPHNILMDESWK--AKISDFGLSKL 182 (325)
Q Consensus 151 ----------------~~~i~h~di~p~nilv~~~~~--vkl~Dfg~~~~ 182 (325)
...++|+|+++.||+++.++. +.++||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 137999999999999987653 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.5e-09 Score=94.16 Aligned_cols=184 Identities=20% Similarity=0.230 Sum_probs=117.7
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCC--cceeeEEeecCC---ceEEEEeecC
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKN--LVDLVGFCSEGS---NRLLVYEFMR 112 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~~ 112 (325)
+.++.|..+.||+.. ..+++|.-.. ......+..|..+++.+. +.. +..++....... ..++||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458889999999863 5688887433 234556888999998884 333 334444443332 3488999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC------------------------------------------
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC------------------------------------------ 150 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~------------------------------------------ 150 (325)
|.++.+... ..++......++.+++..+..||+..
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 988865331 34667777778888888888887510
Q ss_pred -------------CCCeeeccCCCCceEEcC--CCcEEEeeccccccccCCCccceeeecCCCCc---CCcccccc----
Q 047716 151 -------------ETRIIHCDIKPHNILMDE--SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGY---TAPELHSR---- 208 (325)
Q Consensus 151 -------------~~~i~h~di~p~nilv~~--~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~~---- 208 (325)
...++|+|++|.||++++ +..+.++||+.+..-.... ... ..... .+|+....
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~---~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFI---SLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHH---TTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHH---HHHhhccccCHHHHHHHHHH
Confidence 125899999999999998 5567899999875421110 000 00011 12222110
Q ss_pred CCCC---------CccccchhHHHHHHHHHhCCCCCC
Q 047716 209 NNRI---------TVKADVYSFGVMLLEIVCCRKNVD 236 (325)
Q Consensus 209 ~~~~---------~~~~DiwslG~il~~ll~g~~p~~ 236 (325)
.... ....+.|++|.+++.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0000 112589999999999999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=6.6e-07 Score=75.91 Aligned_cols=133 Identities=17% Similarity=0.145 Sum_probs=92.8
Q ss_pred cCcCCce-eEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEeecCCCCHH
Q 047716 41 IGRGGSG-RVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYEFMRNGSLG 117 (325)
Q Consensus 41 lg~g~~g-~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (325)
+..|..| .||+.... ++..+++|.-.. .....+..|...|+.+. +-.+.+++.++.+.+..++||++++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3445544 68987765 466788887543 23456778999988885 223567788888888899999999998887
Q ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC-----------------------------------------------
Q 047716 118 NLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC----------------------------------------------- 150 (325)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~----------------------------------------------- 150 (325)
+..... ......+..++...+..||...
T Consensus 109 ~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 765221 1223345566666666676421
Q ss_pred --------CCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 151 --------ETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 151 --------~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...++|+|+++.||++++++.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999988667799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=7.6e-07 Score=77.13 Aligned_cols=134 Identities=21% Similarity=0.273 Sum_probs=88.1
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCC---CcceeeEEee-cCCceEEEEeecCCC
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHK---NLVDLVGFCS-EGSNRLLVYEFMRNG 114 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~ 114 (325)
+.++.|....||+. +..+++|+-. .......+..|..+|+.+.+. .+.+++.+.. ..+..+++|++++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899987 5678888732 223345688999999999753 3455666653 445678999999998
Q ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhcc---------------------------------------------
Q 047716 115 SLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE--------------------------------------------- 149 (325)
Q Consensus 115 ~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~--------------------------------------------- 149 (325)
++.+... ..++......++.++...+..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 8765321 1223333344444444444444432
Q ss_pred ------------CCCCeeeccCCCCceEEcC---CCc-EEEeeccccc
Q 047716 150 ------------CETRIIHCDIKPHNILMDE---SWK-AKISDFGLSK 181 (325)
Q Consensus 150 ------------~~~~i~h~di~p~nilv~~---~~~-vkl~Dfg~~~ 181 (325)
....++|+|+++.||+++. ++. +.++||+.+.
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1125799999999999987 345 4899998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=7.8e-07 Score=78.72 Aligned_cols=79 Identities=5% Similarity=0.017 Sum_probs=52.2
Q ss_pred hhc-CcCCceeEEEEEeC-------CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccC-C--CCcceeeEEeecC---
Q 047716 39 EEI-GRGGSGRVYKGCIN-------GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIH-H--KNLVDLVGFCSEG--- 101 (325)
Q Consensus 39 ~~l-g~g~~g~v~~~~~~-------~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~--- 101 (325)
+.| +.|..+.+|+.... ++..+++|.-.... ......+..|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 88888999987654 25677887654322 101234677888888875 2 2466777776554
Q ss_pred CceEEEEeecCCCCHH
Q 047716 102 SNRLLVYEFMRNGSLG 117 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~ 117 (325)
+..++|||+++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=7.3e-06 Score=73.60 Aligned_cols=75 Identities=16% Similarity=0.112 Sum_probs=47.7
Q ss_pred hhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch-------hcHHHHHHHHHHHhccCC--CCc-ceeeEEeecCCceEE
Q 047716 38 KEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE-------EGESEFRNEMKIIGRIHH--KNL-VDLVGFCSEGSNRLL 106 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~i-v~~~~~~~~~~~~~l 106 (325)
.+.+|.|..+.||++... ++..+++|....... .....+..|..+++.+.. |.. .+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999765 467899997643211 122345678888887742 333 345544 3345689
Q ss_pred EEeecCCC
Q 047716 107 VYEFMRNG 114 (325)
Q Consensus 107 v~e~~~~~ 114 (325)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.5e-05 Score=69.76 Aligned_cols=30 Identities=20% Similarity=0.232 Sum_probs=26.6
Q ss_pred CCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 152 TRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 152 ~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
..++|+|+++.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 389999999999999877889999998653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00011 Score=63.43 Aligned_cols=74 Identities=16% Similarity=0.136 Sum_probs=57.1
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC---CCCcceeeEEeecCCceEEEEeecCCCC
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH---HKNLVDLVGFCSEGSNRLLVYEFMRNGS 115 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 115 (325)
+.|+.|....+|+... ++..+++|..... ....+..|...|+.+. ...+.+++.+....+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4688899999999875 4677888876432 3556788988888884 3567788888877788999999998875
Q ss_pred H
Q 047716 116 L 116 (325)
Q Consensus 116 L 116 (325)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.77 E-value=9e-05 Score=63.31 Aligned_cols=74 Identities=19% Similarity=0.252 Sum_probs=53.6
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCC---CcceeeEEeecCCceEEEEeecCCC
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHK---NLVDLVGFCSEGSNRLLVYEFMRNG 114 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (325)
.+.+|.|..+.||+.+..+|+.+++|+-..........+..|...|+.+... .+.+++.+. .-+++|||+++.
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 4678999999999999989999999986554434444577899988888522 244455442 347899998765
Q ss_pred C
Q 047716 115 S 115 (325)
Q Consensus 115 ~ 115 (325)
.
T Consensus 96 ~ 96 (288)
T 3f7w_A 96 P 96 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.75 E-value=0.0004 Score=55.96 Aligned_cols=104 Identities=12% Similarity=0.042 Sum_probs=69.5
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccceee
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTV 193 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~~ 193 (325)
.+|.+++...+.++++.++|.++.|.+.++.-+-.+ ..-...=+.|..|++..+|.|-+.+-. .. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~~~-s~------~----- 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAPAA-DD------A----- 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECCC----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccccc-cc------c-----
Confidence 379999988889999999999999999998776221 011223345788999999988887511 10 0
Q ss_pred ecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCC
Q 047716 194 LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNV 235 (325)
Q Consensus 194 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 235 (325)
....+.|||... ...+.+.=|||||+++|.-+--..|-
T Consensus 99 --~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 99 --GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ----------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred --cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 123456888762 34567889999999999988655544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00027 Score=63.78 Aligned_cols=29 Identities=17% Similarity=0.331 Sum_probs=26.2
Q ss_pred CeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 153 RIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 153 ~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
.++|||++|.||+++.++ +.++||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 899999999999999876 99999987754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00026 Score=60.86 Aligned_cols=71 Identities=13% Similarity=0.113 Sum_probs=42.9
Q ss_pred hhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCc-ceeeEEeecCCceEEEEeec-CCCC
Q 047716 38 KEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL-VDLVGFCSEGSNRLLVYEFM-RNGS 115 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~~ 115 (325)
.+.|+.|....+|+. ..+++|+-...... ......|..+++.+...++ .+++.+. ....+++++|+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567888999999998 45777776432111 1123457777777753333 3455443 33457899999 6654
Q ss_pred H
Q 047716 116 L 116 (325)
Q Consensus 116 L 116 (325)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0015 Score=56.82 Aligned_cols=30 Identities=27% Similarity=0.372 Sum_probs=26.2
Q ss_pred CeeeccCCCCceEEcCC----CcEEEeecccccc
Q 047716 153 RIIHCDIKPHNILMDES----WKAKISDFGLSKL 182 (325)
Q Consensus 153 ~i~h~di~p~nilv~~~----~~vkl~Dfg~~~~ 182 (325)
.++|||+++.||+++.+ +.+.++||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 79999999999999874 6799999987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00038 Score=60.29 Aligned_cols=140 Identities=16% Similarity=0.179 Sum_probs=72.7
Q ss_pred hhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC-----CCCcceee-E--EeecCCceEEEEee
Q 047716 39 EEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-----HKNLVDLV-G--FCSEGSNRLLVYEF 110 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~-~--~~~~~~~~~lv~e~ 110 (325)
+.|+.|....+|+....++ .+++|...... ....+..|..+++.+. -|.++... + +....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999876654 67888765421 1223456777776664 23333211 0 11223567899999
Q ss_pred cCCCCHHH-----------HH---hhccCC--------CC---HHHHHH------------HHHHHHHHHHHhhcc----
Q 047716 111 MRNGSLGN-----------LL---FRAEQR--------LS---WSERRR------------IALEIMEGLHYLHDE---- 149 (325)
Q Consensus 111 ~~~~~L~~-----------~~---~~~~~~--------~~---~~~~~~------------~~~ql~~~l~~lh~~---- 149 (325)
++|..+.. .+ ...... .. +..... +...+...+..+...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98754311 01 010000 01 111000 000122333333321
Q ss_pred CCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 150 ~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...+++|+|+++.||++++++.+.++||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12379999999999999987556899998664
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00093 Score=60.48 Aligned_cols=71 Identities=18% Similarity=0.230 Sum_probs=46.6
Q ss_pred hhcCcCCceeEEEEEeCC--------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCc-ceeeEEeecCCceEEEEe
Q 047716 39 EEIGRGGSGRVYKGCING--------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL-VDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~--------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 109 (325)
+.|+.|....+|++...+ +..+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|++
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457888889999998653 467888876331 111345578888888864444 456665532 38999
Q ss_pred ecCCCC
Q 047716 110 FMRNGS 115 (325)
Q Consensus 110 ~~~~~~ 115 (325)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 997643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0015 Score=57.98 Aligned_cols=137 Identities=17% Similarity=0.230 Sum_probs=77.9
Q ss_pred hcCcCCceeEEEEEeC--------CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCc-ceeeEEeecCCceEEEEee
Q 047716 40 EIGRGGSGRVYKGCIN--------GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL-VDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~--------~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~ 110 (325)
.+..|-...+|++... ++..+++++--. .......+.+|..+++.+...++ .++++++.+ .+|+||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 4666888899998764 246788877422 22234556689998888863333 455665543 289999
Q ss_pred cCCCCHHHH--------------Hh---hcc----CCCC--HHHHHHHHHHHHH-------------------HHHHhh-
Q 047716 111 MRNGSLGNL--------------LF---RAE----QRLS--WSERRRIALEIME-------------------GLHYLH- 147 (325)
Q Consensus 111 ~~~~~L~~~--------------~~---~~~----~~~~--~~~~~~~~~ql~~-------------------~l~~lh- 147 (325)
++|.++..- +. ... .... +..+..++.++-. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 987554310 10 000 1112 2344455544322 122221
Q ss_pred ---cc-CCCCeeeccCCCCceEEcCC----CcEEEeeccccc
Q 047716 148 ---DE-CETRIIHCDIKPHNILMDES----WKAKISDFGLSK 181 (325)
Q Consensus 148 ---~~-~~~~i~h~di~p~nilv~~~----~~vkl~Dfg~~~ 181 (325)
.. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 11 12369999999999999876 689999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0038 Score=54.04 Aligned_cols=74 Identities=12% Similarity=0.080 Sum_probs=46.4
Q ss_pred hcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceeeEE-----eecCCceEEEEeecC
Q 047716 40 EIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLVGF-----CSEGSNRLLVYEFMR 112 (325)
Q Consensus 40 ~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~lv~e~~~ 112 (325)
.++ |....||+....+|+.+++|...... .....+..|..+++.+.... +.+++.. ...++..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77889998876667778999875321 23445667787777774222 2333332 122455678999998
Q ss_pred CCC
Q 047716 113 NGS 115 (325)
Q Consensus 113 ~~~ 115 (325)
|..
T Consensus 111 G~~ 113 (328)
T 1zyl_A 111 GRQ 113 (328)
T ss_dssp CEE
T ss_pred CCC
Confidence 743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0014 Score=57.95 Aligned_cols=72 Identities=11% Similarity=0.145 Sum_probs=41.6
Q ss_pred hhcCcCCceeEEEEEeCC---------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCc-ceeeEEeecCCceEEEE
Q 047716 39 EEIGRGGSGRVYKGCING---------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL-VDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~---------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 108 (325)
+.++.|....+|+....+ +..+++|+....... ......|..+++.+...++ .++++.. . -++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467788889999987653 257777765432211 1123567778877753343 3555543 1 36899
Q ss_pred eecCCCC
Q 047716 109 EFMRNGS 115 (325)
Q Consensus 109 e~~~~~~ 115 (325)
+|++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0053 Score=55.89 Aligned_cols=73 Identities=18% Similarity=0.089 Sum_probs=45.0
Q ss_pred hhcCcCCceeEEEEEeCC-CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEeecCCCCH
Q 047716 39 EEIGRGGSGRVYKGCING-GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYEFMRNGSL 116 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~-~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L 116 (325)
+.|+.|-...+|++...+ +..+++|+...... ..-....|..+++.+...++. ++++.+. + .+|++|++|.++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 457788889999988764 46777776533221 111125788888888755554 5666653 2 359999986443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.055 Score=47.04 Aligned_cols=30 Identities=23% Similarity=0.285 Sum_probs=26.5
Q ss_pred CCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 152 TRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 152 ~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
..++|+|+.+.||+++.++.+.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 379999999999999987789999997654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.054 Score=48.70 Aligned_cols=73 Identities=15% Similarity=0.163 Sum_probs=45.2
Q ss_pred hhcCcCCceeEEEEEeCC--------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCc-ceeeEEeecCCceEEEEe
Q 047716 39 EEIGRGGSGRVYKGCING--------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL-VDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~--------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 109 (325)
+.+..|-...+|+....+ +..+++++..... ...-...+|..+++.+...++ .++++.+. -++|++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 457778888999988753 5677887753322 111223567888877753333 34454332 378999
Q ss_pred ecCCCCH
Q 047716 110 FMRNGSL 116 (325)
Q Consensus 110 ~~~~~~L 116 (325)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9987653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.83 E-value=0.67 Score=37.27 Aligned_cols=115 Identities=10% Similarity=0.111 Sum_probs=77.1
Q ss_pred CCCCcceeeEEeecCCceEEEEeecCCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHH-HhhccCCCCeeeccCCCCce
Q 047716 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNG-SLGNLLFRAEQRLSWSERRRIALEIMEGLH-YLHDECETRIIHCDIKPHNI 164 (325)
Q Consensus 87 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~-~lh~~~~~~i~h~di~p~ni 164 (325)
.||++ -..+..+++.+.+.++.-+++ ++.. + .+.+..+.+.++.+++.... ++++ -+|--++|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence 58888 444556667777766654332 3332 2 45789999999999998877 6664 48889999999
Q ss_pred EEcCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 047716 165 LMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDE 237 (325)
Q Consensus 165 lv~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 237 (325)
+++.++.+++.-.|+-.. ++|..+ ++.-=.-+.=|++..++.++..|+.
T Consensus 116 ~f~~~~~p~i~hRGi~~~------------------lpP~e~------~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKES------------------LPPDEW------DDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp EECTTCCEEESCCEETTT------------------BSSCSC------CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EEeCCCcEEEEEcCCccc------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999998775321 233222 1111122455677888888887753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.64 E-value=0.42 Score=38.30 Aligned_cols=118 Identities=10% Similarity=0.106 Sum_probs=78.7
Q ss_pred CCCCcceeeEEeecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEE
Q 047716 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILM 166 (325)
Q Consensus 87 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv 166 (325)
.||+.++. .+...++.+.+.++.- .....+- .-.+.+..+.+.++.+++....++++. +|--++|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD--NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG--GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHH--HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEE
Confidence 58888877 5555556655555543 2233332 124578899999999999988666644 888999999999
Q ss_pred cCCCcEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 047716 167 DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDES 238 (325)
Q Consensus 167 ~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 238 (325)
+.++.+++.=.|+... ++|..+ ++..=.-..=|++..+++++..|+..
T Consensus 113 ~~~~~p~i~~RGik~~------------------l~P~~~------~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV------------------VDPLPV------SEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp CTTSCEEESCCEETTT------------------BSCCCC------CHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred cCCCCEEEEEccCccC------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999997775321 122211 11112234557888899998888643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.95 E-value=0.52 Score=41.87 Aligned_cols=29 Identities=34% Similarity=0.417 Sum_probs=24.5
Q ss_pred CeeeccCCCCceEE------cCCCcEEEeeccccc
Q 047716 153 RIIHCDIKPHNILM------DESWKAKISDFGLSK 181 (325)
Q Consensus 153 ~i~h~di~p~nilv------~~~~~vkl~Dfg~~~ 181 (325)
.++|+|+.+.||++ +.+..+.++||..+.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46899999999999 445679999998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 325 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 5e-68
Identities = 62/272 (22%), Positives = 127/272 (46%), Gaps = 16/272 (5%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+ IG G G VYKG +G + + + + F+NE+ ++ + H N++ +G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
+ + +V ++ SL + L E + + IA + +G+ YLH + IIH
Sbjct: 72 YSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 157 CDIKPHNILMDESWKAKISDFGLSKLL-KTDQTRTYTVLRGTRGYTAPE--LHSRNNRIT 213
D+K +NI + E KI DFGL+ + + + + L G+ + APE N +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 214 VKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273
++DVY+FG++L E++ + ++ +I + Y + +L + S+
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSN-------C 238
Query: 274 FENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
+ + ++ C++ + + RP Q++ +E +
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-62
Identities = 70/271 (25%), Positives = 127/271 (46%), Gaps = 22/271 (8%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
E +G G G V+ G NG ++AVK +K F E ++ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRII 155
++ ++ E+M NGSL + L +L+ ++ +A +I EG+ ++ + I
Sbjct: 76 VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H D++ NIL+ ++ KI+DFGL++L++ ++ + +TAPE T+K
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIK 190
Query: 216 ADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF- 274
+DV+SFG++L EIV + + + E+ +QNL V +
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV--------------IQNLERGYRMVRPDNCP 236
Query: 275 ENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
E L ++ C + RPT + ++E
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-61
Identities = 65/271 (23%), Positives = 119/271 (43%), Gaps = 20/271 (7%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
F +E+G G G V G G ++A+K IK E EF E K++ + H+ LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G C++ ++ E+M NG L N L R + + ++ E + YL + +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FL 122
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H D+ N L+++ K+SDFGLS+ + D+ + + ++ PE+ ++ + K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL-MYSKFSSK 181
Query: 216 ADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF- 274
+D+++FGV++ EI K E + E +++
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSET--------------AEHIAQGLRLYRPHLAS 227
Query: 275 ENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
E + I C + + RPT K ++ + +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-61
Identities = 68/272 (25%), Positives = 127/272 (46%), Gaps = 20/272 (7%)
Query: 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
F +EIG G G V+ G ++A+K I+ E +F E +++ ++ H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
G C E + LV+EFM +G L + L + + L++ EG+ YL + C +I
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H D+ N L+ E+ K+SDFG+++ + DQ + T + + +PE+ +R + K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-SFSRYSSK 182
Query: 216 ADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF- 274
+DV+SFGV++ E+ K E+ + E+ ++++ +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEV--------------VEDISTGFRLYKPRLAS 228
Query: 275 ENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306
++ +I C + RP +++ + I
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-59
Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 32 LASENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEG-ESEFRNEMKIIGRIH 87
L ++F+ E+G G G V+K G +A K + ++ ++ E++++ +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
+V G + E M GSL +L + R+ ++++ +++GL YL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLR 121
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
++ +I+H D+KP NIL++ + K+ DFG+S L ++ GTR Y +PE
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERL- 175
Query: 208 RNNRITVKADVYSFGVMLLEIVCCR 232
+ +V++D++S G+ L+E+ R
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (475), Expect = 4e-58
Identities = 68/303 (22%), Positives = 136/303 (44%), Gaps = 39/303 (12%)
Query: 25 FSYEQIVLASENFKEE-----------IGRGGSGRVYKGCINGGKE----IAVKKLIK-I 68
F++E A F +E IG G G V G + + +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 69 VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLS 128
E+ +F +E I+G+ H N++ L G ++ + +++ EFM NGSL + L + + + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 129 WSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188
+ + I G+ YL D +H D+ NIL++ + K+SDFGLS+ L+ D +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 189 RTYTV----LRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI 244
+ +TAPE + + T +DV+S+G+++ E++ + + + ++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 245 VLIDWAHQCYEAGELQNLVSDQE-DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303
+ + D ++ L ++ L C + + N RP Q++ ++
Sbjct: 243 --------------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 304 GIV 306
++
Sbjct: 289 KMI 291
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-58
Identities = 69/303 (22%), Positives = 136/303 (44%), Gaps = 31/303 (10%)
Query: 13 SPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGGK----EIAVKKLIKI 68
+P++ + ++ +++ +F E IGRG G VY G + AVK L +I
Sbjct: 10 NPELVQAVQHVVIGPSSLIV---HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66
Query: 69 VEEGE-SEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR-LLVYEFMRNGSLGNLLFRAEQR 126
+ GE S+F E I+ H N++ L+G C L+V +M++G L N +
Sbjct: 67 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 126
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL--- 183
+ + L++ +G+ +L + + +H D+ N ++DE + K++DFGL++ +
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183
Query: 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDE 243
+ D T + + A E + + T K+DV+SFGV+L E++ + +
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242
Query: 244 IVLIDWAHQCYEAGELQNLVSDQEDVNIEEF-ENLVKIGLWCVECELNLRPTMKQVIWMM 302
I L+ + + E + L ++ L C + +RP+ +++ +
Sbjct: 243 I--------------TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288
Query: 303 EGI 305
I
Sbjct: 289 SAI 291
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 9e-58
Identities = 68/280 (24%), Positives = 123/280 (43%), Gaps = 26/280 (9%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+ ++G+G G V+ G NG +A+K +K F E +++ ++ H+ LV L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLS-WSERRRIALEIMEGLHYLHDECETRII 155
SE +V E+M GSL + L + + +A +I G+ Y+ +
Sbjct: 80 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 135
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H D++ NIL+ E+ K++DFGL++L++ ++ + +TAPE R T+K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA-LYGRFTIK 194
Query: 216 ADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF- 274
+DV+SFG++L E+ + + + E+ L + E
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV--------------LDQVERGYRMPCPPECP 240
Query: 275 ENLVKIGLWCVECELNLRPTMKQVIWMMEGIV----PPHQ 310
E+L + C E RPT + + +E P +Q
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-57
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 27/271 (9%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVD 93
F EIGRG VYKG E+A +L + + F+ E +++ + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 94 LVGFC----SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
+LV E M +G+L L R + + R +I++GL +LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 150 CETRIIHCDIKPHNILM-DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
IIH D+K NI + + KI D GL+ L + + GT + APE++
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEMY-- 185
Query: 209 NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268
+ DVY+FG+ +LE+ E +I + +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTSGVKPASFDKVAI---- 239
Query: 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
E + +++ C+ + R ++K ++
Sbjct: 240 ---PEVKEIIE---GCIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-56
Identities = 69/285 (24%), Positives = 125/285 (43%), Gaps = 24/285 (8%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
E+G G G+VYK A K + EE ++ E+ I+ H N+V L+
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+N ++ EF G++ ++ E+ L+ S+ + + + ++ L+YLH + +II
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL----HSRNNR 211
H D+K NIL K++DFG+S R + GT + APE+ S++
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRP 191
Query: 212 ITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271
KADV+S G+ L+E+ E + VL+ A + S
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHE--LNPMRVLLKIAKSEPPTLAQPSRWSS------ 243
Query: 272 EEFENLVKIGLWCVECELNLRPTMKQVI---WMMEGIVPPHQNML 313
F++ +K C+E ++ R T Q++ ++ P + ++
Sbjct: 244 -NFKDFLK---KCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-56
Identities = 62/288 (21%), Positives = 118/288 (40%), Gaps = 29/288 (10%)
Query: 28 EQIVLASENFK---EEIGRGGSGRVYKGCI---NGGKEIAVKKLIKIVEEGESE-FRNEM 80
+++ L +N E+G G G V +G ++A+K L + E+ ++E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 81 KIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIM 140
+I+ ++ + +V L+G C + +LV E G L L + + S + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT--RTYTVLRGTR 198
G+ YL ++ +H D+ N+L+ AKISDFGLSK L D + + +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 199 GYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258
+ APE + + ++DV+S+GV + E + + + ++ E+
Sbjct: 177 KWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------------- 221
Query: 259 LQNLVSDQEDVNIEEF-ENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
+ + + E L + C + RP V M
Sbjct: 222 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 4e-56
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 30/273 (10%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+ IG+G G V G G ++AVK + + F E ++ ++ H NLV L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRG-NKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 97 FCSEGSNRL-LVYEFMRNGSLGNLLF-RAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
E L +V E+M GSL + L R L + +L++ E + YL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 124
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
+H D+ N+L+ E AK+SDFGL+K + Q +TAPE R + +
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEAL-REKKFST 179
Query: 215 KADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF 274
K+DV+SFG++L EI + + ++V V ++ +
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---------------PRVEKGYKMDAPDG 224
Query: 275 --ENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
+ ++ C + +RP+ Q+ +E I
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 3e-55
Identities = 66/294 (22%), Positives = 122/294 (41%), Gaps = 30/294 (10%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
+E IG+G G V++G G +E+AVK EE E+ + H+N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRG-EEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 97 FCSEGSNRL----LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC-- 150
++ + LV ++ +GSL + L R ++ ++AL GL +LH E
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 151 ---ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLR---GTRGYTAPE 204
+ I H D+K NIL+ ++ I+D GL+ + GT+ Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 205 L-----HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259
+ + ++ +AD+Y+ G++ EI R ++ D ++ D E+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI-ARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 260 QNLVSDQ--------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
+ +V +Q + E + KI C R T ++ + +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-55
Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 24/279 (8%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKL-IKIVEEGESEFRNEMKIIGRIHHKN 90
E++ + +G G G V + +AVK + +K + + E+ I ++H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V G EG+ + L E+ G L + + + + + +R ++M G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK-TDQTRTYTVLRGTRGYTAPELHSRN 209
I H DIKP N+L+DE KISDFGL+ + + ++ R + GT Y APEL R
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 210 NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269
DV+S G++L ++ D+ D DW + + +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEKKTYLNPWKKI------- 232
Query: 270 NIEEFENLVKIGLWCVECELNLRPTMKQVI---WMMEGI 305
L+ + + R T+ + W + +
Sbjct: 233 -DSAPLALLH---KILVENPSARITIPDIKKDRWYNKPL 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 178 bits (453), Expect = 6e-55
Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 22/287 (7%)
Query: 23 RSFSYEQIVLASENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNE 79
S +Y++ + + ++G G G VY+G +AVK L + E E EF E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 63
Query: 80 MKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALE 138
++ I H NLV L+G C+ ++ EFM G+L + L Q +S +A +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 139 IMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTR 198
I + YL + IH D+ N L+ E+ K++DFGLS+L+ D + +
Sbjct: 124 ISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 199 GYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258
+TAPE N+ ++K+DV++FGV+L EI + + ++ + E E
Sbjct: 181 KWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239
Query: 259 LQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305
E + ++ C + + RP+ ++ E +
Sbjct: 240 -------------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-54
Identities = 56/277 (20%), Positives = 112/277 (40%), Gaps = 28/277 (10%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHK 89
E+++ IG G GR K + GK + K+L + E + +E+ ++ + H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 90 NLVDLVGFCSEGSNRLL--VYEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLH 144
N+V + +N L V E+ G L +++ + Q L R+ ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 145 YLHD--ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTA 202
H + ++H D+KP N+ +D K+ DFGL+++L D + GT Y +
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMS 182
Query: 203 PELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262
PE +R K+D++S G +L E+ + + I +
Sbjct: 183 PEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-----------REGK 230
Query: 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
+E ++ + + RP++++++
Sbjct: 231 FRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEIL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-54
Identities = 67/283 (23%), Positives = 127/283 (44%), Gaps = 29/283 (10%)
Query: 35 ENFKEE--IGRGGSGRVYKGCINGGKE-----IAVKKLIK-IVEEGESEFRNEMKIIGRI 86
+ IG G G VYKG + +A+K L E+ +F E I+G+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYL 146
H N++ L G S+ +++ E+M NG+L L + S + + I G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 147 HDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT--VLRGTRGYTAPE 204
+ +H D+ NIL++ + K+SDFGLS++L+ D TYT + +TAPE
Sbjct: 127 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 205 LHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV-LIDWAHQCYEAGELQNLV 263
+ T +DV+SFG+++ E++ + L + E++ I+
Sbjct: 184 AI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------------ 230
Query: 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306
+ ++ + ++ + C + E RP ++ +++ ++
Sbjct: 231 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (447), Expect = 1e-53
Identities = 62/268 (23%), Positives = 106/268 (39%), Gaps = 30/268 (11%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLVDL 94
EIG G G VY + + +A+KK+ E + E++ + ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
G LV E+ + +LL ++ L E + ++GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPE--LHSRNNRI 212
IH D+K NIL+ E K+ DFG + ++ + GT + APE L +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQY 191
Query: 213 TVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI- 271
K DV+S G+ +E+ + + + I QN + +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----------AQNESPALQSGHWS 240
Query: 272 EEFENLVKIGLWCVECELNLRPTMKQVI 299
E F N V C++ RPT + ++
Sbjct: 241 EYFRNFVD---SCLQKIPQDRPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-53
Identities = 61/271 (22%), Positives = 112/271 (41%), Gaps = 29/271 (10%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHH 88
E+F+ +G+G G VY +A+K L K E + R E++I + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
N++ L G+ + + L+ E+ G++ L + + E+ L Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS 124
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
+ R+IH DIKP N+L+ + + KI+DFG S + + T GT Y PE+
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMI-E 177
Query: 209 NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268
K D++S GV+ E + + + + + I + V+
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----FTFPDFVT---- 228
Query: 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
E +L+ ++ + RP +++V+
Sbjct: 229 ---EGARDLIS---RLLKHNPSQRPMLREVL 253
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (441), Expect = 2e-52
Identities = 63/294 (21%), Positives = 123/294 (41%), Gaps = 23/294 (7%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
EE+G G G V++ G A K ++ E + R E++ + + H LV+L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+ + +++YEFM G L + ++S E ++ +GL ++H+ +
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146
Query: 156 HCDIKPHNILM--DESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
H D+KP NI+ S + K+ DFGL+ L Q+ T GT + APE+ +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA-EGKPVG 203
Query: 214 VKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273
D++S GV+ ++ D+ + + ++ + S ++ E+
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-------KSCDWNMDDSAFSGIS-ED 255
Query: 274 FENLVKIGLWCVECELNLRPTMKQVI---WMMEGIVPPHQNMLTHPTSTNQEKS 324
++ ++ + + N R T+ Q + W+ G P + + T S
Sbjct: 256 GKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-52
Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 30/273 (10%)
Query: 40 EIGRGGSGRVYKGCING---GKEIAVKKLIKIVEEGES--EFRNEMKIIGRIHHKNLVDL 94
E+G G G V KG K +AVK L + E E ++ ++ + +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+G C E + +LV E G L L + + + + ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT--RTYTVLRGTRGYTAPELHSRNNRI 212
+H D+ N+L+ AKISDFGLSK L+ D+ + T + + APE +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-NYYKF 187
Query: 213 TVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272
+ K+DV+SFGV++ E + ++ E+ ++ E +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---------------AMLEKGERMGCP 232
Query: 273 EF--ENLVKIGLWCVECELNLRPTMKQVIWMME 303
+ + C ++ RP V +
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 1e-51
Identities = 65/301 (21%), Positives = 119/301 (39%), Gaps = 48/301 (15%)
Query: 36 NFKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHH 88
+ +IG G GRV++ G +AVK L + + +++F+ E ++ +
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR-----------------------AEQ 125
N+V L+G C+ G L++E+M G L L
Sbjct: 76 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135
Query: 126 RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL-K 184
LS +E+ IA ++ G+ YL E + +H D+ N L+ E+ KI+DFGLS+ +
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEI 244
D + + PE NR T ++DV+++GV+L EI + +E+
Sbjct: 193 ADYYKADGNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 245 VLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEG 304
+ G + + L + C RP+ + +++
Sbjct: 252 I------YYVRDGNILACPEN-------CPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
Query: 305 I 305
+
Sbjct: 299 M 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-51
Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 46/298 (15%)
Query: 37 FKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVEEGESE-FRNEMKIIGRI-HH 88
F + +G G G+V + G +AVK L E E +E+K++ + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR-----------------AEQRLSWSE 131
N+V+L+G C+ G L++ E+ G L N L R E L +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 132 RRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT- 190
+ ++ +G+ +L + IH D+ NIL+ KI DFGL++ +K D
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA 250
R + APE N T ++DV+S+G+ L E+ + + D
Sbjct: 204 KGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------- 255
Query: 251 HQCYEAGELQNLVSDQEDVNIEEF--ENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306
+ ++ + + E + I C + + RPT KQ++ ++E +
Sbjct: 256 -------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-51
Identities = 58/262 (22%), Positives = 120/262 (45%), Gaps = 20/262 (7%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGF 97
E+IG+G SG VY + G+E+A++++ + + NE+ ++ + N+V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHC 157
G +V E++ GSL +++ + + + E ++ L +LH ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 158 DIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKAD 217
DIK NIL+ K++DFG + +Q++ T+ GT + APE K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPE-VVTRKAYGPKVD 198
Query: 218 VYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENL 277
++S G+M +E++ + LI A + + E ++ F +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLI--------ATNGTPELQNPEKLS-AIFRDF 249
Query: 278 VKIGLWCVECELNLRPTMKQVI 299
+ C++ ++ R + K+++
Sbjct: 250 LN---RCLDMDVEKRGSAKELL 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-51
Identities = 70/333 (21%), Positives = 135/333 (40%), Gaps = 54/333 (16%)
Query: 14 PDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKGCINGG---KEIAVKKLIKIV- 69
P ++ + F++ IG G G+V K I + A+K++ +
Sbjct: 1 PTIYPVLDWNDI----------KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 50
Query: 70 EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFR------ 122
++ +F E++++ ++ HH N+++L+G C L E+ +G+L + L +
Sbjct: 51 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 110
Query: 123 ---------AEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAK 173
LS + A ++ G+ YL + + IH D+ NIL+ E++ AK
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 167
Query: 174 ISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRK 233
I+DFGLS+ + +T R + A E + T +DV+S+GV+L EIV
Sbjct: 168 IADFGLSRGQEVYVKKTMG--RLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 234 NVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF-ENLVKIGLWCVECELNLR 292
+ E+ + L + + + C + R
Sbjct: 225 TPYCGMTCAEL--------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 270
Query: 293 PTMKQVIWMMEGIVPPHQNMLTHPTSTNQEKST 325
P+ Q++ + ++ + T+ +T EK T
Sbjct: 271 PSFAQILVSLNRMLEERK---TYVNTTLYEKFT 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 5e-51
Identities = 60/296 (20%), Positives = 125/296 (42%), Gaps = 30/296 (10%)
Query: 29 QIVLASE-NFKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIV-----EEGESEFRNEMK 81
+I+ +E + +G G G VYKG I G+++ + IK + + E +E
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 82 IIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIME 141
++ + + ++ L+G C L+ + M G L + + + + ++I +
Sbjct: 64 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 142 GLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT-VLRGTRGY 200
G++YL D R++H D+ N+L+ KI+DFGL+KLL ++ + + +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 201 TAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260
A E + T ++DV+S+GV + E++ + A E+
Sbjct: 180 MALESI-LHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEIS 223
Query: 261 NLVSDQEDVNIEEF--ENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQNMLT 314
+++ E + ++ I + C + + RP +++I + Q L
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-50
Identities = 61/286 (21%), Positives = 112/286 (39%), Gaps = 32/286 (11%)
Query: 31 VLASENFK--EEIGRGGSGRVYKGCING----GKEIAVKKLIKIV---EEGESEFRNEMK 81
++ ++ + E++G G G V +G + +AVK L V E +F E+
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 82 IIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIME 141
+ + H+NL+ L G ++ V E GSL + L + + R A+++ E
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 142 GLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY--TVLRGTRG 199
G+ YL + IH D+ N+L+ KI DFGL + L + +
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 200 YTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259
+ APE + + +D + FGV L E+ + L +I L
Sbjct: 180 WCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------L 224
Query: 260 QNLVSDQEDVNIEEF--ENLVKIGLWCVECELNLRPTMKQVIWMME 303
+ + E + E +++ + + C + RPT + +
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-50
Identities = 56/275 (20%), Positives = 107/275 (38%), Gaps = 23/275 (8%)
Query: 37 FKEEIGRGGSGRVYKGCI----NGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNL 91
IG G G V++G N +A+K + E F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 92 VDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECE 151
V L+G +E ++ E G L + L + L + A ++ L YL
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 126
Query: 152 TRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNR 211
R +H DI N+L+ + K+ DFGLS+ ++ + + + APE R
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRR 185
Query: 212 ITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271
T +DV+ FGV + EI+ + +++++++ + E +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERLPMPPNCP------- 235
Query: 272 EEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306
+L+ C + + RP ++ + I+
Sbjct: 236 PTLYSLMT---KCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-50
Identities = 62/300 (20%), Positives = 120/300 (40%), Gaps = 51/300 (17%)
Query: 37 FKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVEEGESE-FRNEMKIIGRI-HH 88
F + +G G G+V G ++AVK L + + E E +E+K++ ++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR---------------------- 126
+N+V+L+G C+ L++E+ G L N L ++
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
L++ + A ++ +G+ +L + +H D+ N+L+ KI DFGL++ + +D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 187 QTRT-YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV 245
R + APE T+K+DV+S+G++L EI N + D
Sbjct: 218 SNYVVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA-- 274
Query: 246 LIDWAHQCYEAGELQNLVSDQEDVNIEEF--ENLVKIGLWCVECELNLRPTMKQVIWMME 303
L+ + ++ + E + I C + RP+ + +
Sbjct: 275 ------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (411), Expect = 6e-48
Identities = 55/266 (20%), Positives = 112/266 (42%), Gaps = 20/266 (7%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
EE+G G G V++ G+ K + + +NE+ I+ ++HH L++L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+ +L+ EF+ G L + + + ++S +E + EGL ++H+ I+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 156 HCDIKPHNILMD--ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
H DIKP NI+ + ++ KI DFGL+ L D+ T T + APE+ +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIV-DREPVG 206
Query: 214 VKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273
D+++ GV+ ++ + + + ++ ++ E
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS--------PE 258
Query: 274 FENLVKIGLWCVECELNLRPTMKQVI 299
++ +K ++ E R T+ +
Sbjct: 259 AKDFIK---NLLQKEPRKRLTVHDAL 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-47
Identities = 60/289 (20%), Positives = 110/289 (38%), Gaps = 35/289 (12%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHH 88
E+FK + +G G V + +E A+K L K I E E ++ R+ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
V L + + +NG L + + + R EI+ L YLH
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG 126
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT-YTVLRGTRGYTAPELHS 207
+ IIH D+KP NIL++E +I+DFG +K+L + + GT Y +PEL
Sbjct: 127 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL- 182
Query: 208 RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267
+D+++ G ++ ++V +E ++ Q ++ +
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLI------------FQKIIKLEY 227
Query: 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPPHQNMLTHP 316
D + F + + + R +++ + + HP
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG--------YGPLKAHP 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 2e-47
Identities = 68/289 (23%), Positives = 129/289 (44%), Gaps = 34/289 (11%)
Query: 37 FKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVEEGE-SEFRNEMKIIGRIHHK 89
E+G+G G VY+G G +A+K + + E EF NE ++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR---------LSWSERRRIALEIM 140
++V L+G S+G L++ E M G L + L S S+ ++A EI
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL-KTDQTRTYTVLRGTRG 199
+G+ YL+ + +H D+ N ++ E + KI DFG+++ + +TD R
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 200 YTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259
+ +PE ++ T +DV+SFGV+L EI + + L +++++ + G L
Sbjct: 201 WMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFVMEGGL 253
Query: 260 QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308
+ + D L ++ C + +RP+ ++I ++ + P
Sbjct: 254 LDKPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-46
Identities = 55/282 (19%), Positives = 113/282 (40%), Gaps = 22/282 (7%)
Query: 37 FKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVG 96
E++GRG G V++ K+ + K +K+ + + E+ I+ H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIH 156
++++EF+ + + + L+ E ++ E L +LH I H
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 157 CDIKPHNILMD--ESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITV 214
DI+P NI+ S KI +FG ++ LK + +L Y APE+H +++ ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVH-QHDVVST 182
Query: 215 KADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEF 274
D++S G ++ ++ I I A ++ + + E
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS--------IEA 234
Query: 275 ENLVKIGLWCVECELNLRPTMKQVI---WMMEGIVPPHQNML 313
+ V + E R T + + W+ + I ++
Sbjct: 235 MDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 2e-45
Identities = 56/266 (21%), Positives = 107/266 (40%), Gaps = 17/266 (6%)
Query: 36 NFKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEG-ESEFRNEMKIIGRIHHKNLVD 93
+F++ +G G V K +A+K + K EG E NE+ ++ +I H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 94 LVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR 153
L G + L+ + + G L + + + + + R+ ++++ + YLHD
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 154 IIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRIT 213
+DE K ISDFGLSK+ + GT GY APE+ +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVL-AQKPYS 187
Query: 214 VKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEE 273
D +S GV+ ++C + I A +++ ++ +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS--------DS 239
Query: 274 FENLVKIGLWCVECELNLRPTMKQVI 299
++ ++ +E + R T +Q +
Sbjct: 240 AKDFIR---HLMEKDPEKRFTCEQAL 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-45
Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 43/296 (14%)
Query: 37 FKEEIGRGGSGRVYKG--------CINGGKEIAVKKLIK-IVEEGESEFRNEMKIIGRI- 86
+ +G G G+V N ++AVK L E+ S+ +EM+++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 87 HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLF---------------RAEQRLSWSE 131
HKN+++L+G C++ ++ E+ G+L L E++LS +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 132 RRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191
A ++ G+ YL + + IH D+ N+L+ E KI+DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 192 T-VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA 250
T R + APE + T ++DV+SFGV+L EI + + +E+ +
Sbjct: 194 TTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252
Query: 251 HQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306
+ L + C + RPT KQ++ ++ IV
Sbjct: 253 GHRMDKPS-------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (382), Expect = 2e-44
Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIK---------IVEEGESEFRNEMKI 82
EN++ E +GRG S V + KE AVK + V+E E+ I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 83 IGRIH-HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIME 141
+ ++ H N++ L + LV++ M+ G L + L + LS E R+I ++E
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 142 GLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYT 201
+ LH + I+H D+KP NIL+D+ K++DFG S L + GT Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYL 176
Query: 202 APEL-----HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256
APE+ + + + D++S GV++ ++ + + +I +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-------MS 229
Query: 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
G Q + +D + + ++LV + + R T ++ +
Sbjct: 230 GNYQFGSPEWDDYS-DTVKDLVS---RFLVVQPQKRYTAEEAL 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-43
Identities = 60/309 (19%), Positives = 119/309 (38%), Gaps = 28/309 (9%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE-FRNEMKIIGRIHHKNLVDLVG 96
IG G G V +A+KK+ + + E+KI+ R H+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 97 FCSEGSNRLLVYEFMRNGSLGNLLFR--AEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
+ + ++ +G L++ Q LS +I+ GL Y+H +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 130
Query: 155 IHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR--TYTVLRGTRGYTAPELHSRNNRI 212
+H D+KP N+L++ + KI DFGL+++ D T TR Y APE+ +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 213 TVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272
T D++S G +L E++ R D++ I +L +++ + +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 273 EFENLVKIGL----------------WCVECELNLRPTMKQVI---WMMEGIVPPHQNML 313
+ K+ + + R ++Q + ++ + P + +
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA 310
Query: 314 THPTSTNQE 322
P + E
Sbjct: 311 EAPFKFDME 319
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-43
Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 37 FKEEIGRGGSGRVYKGCING------GKEIAVKKLIKIVEEGE-SEFRNEMKIIGRI-HH 88
+ +GRG G+V + G + +AVK L + E +E+KI+ I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 89 KNLVDLVGFCSEGSNRL-LVYEFMRNGSLGNLLFR---------------AEQRLSWSER 132
N+V+L+G C++ L ++ EF + G+L L + L+
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 133 RRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT-Y 191
+ ++ +G+ +L + IH D+ NIL+ E KI DFGL++ + D
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAH 251
R + APE + T+++DV+SFGV+L EI + ++ DE
Sbjct: 194 GDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------- 244
Query: 252 QCYEAGELQNLVSDQEDVNIEEF--ENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306
E + + + ++ + + L C E + RPT +++ + ++
Sbjct: 245 ------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 9e-43
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 27/300 (9%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKL-----IKIVEEGESEFRNEMKIIGRIHHKNLV 92
+ +G G VYK N + +A+KK+ + + E+K++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
L+ SN LV++FM ++ L+ S + L ++GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
I+H D+KP+N+L+DE+ K++DFGL+K + YT TR Y APEL
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMY 178
Query: 213 TVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272
V D+++ G +L E++ + D++ I + ++ S + V +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 273 EFENLVKIGLW-------------CVECELNLRPTMKQVI---WMMEGIVPPHQNMLTHP 316
F + ++ R T Q + + P L P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (376), Expect = 1e-42
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 26/268 (9%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIK---IVEEGESEFRNE---MKIIGRIHHK 89
IGRGG G VY + GK A+K L K +++GE+ NE + ++
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
+V + + + M G L L + S ++ R A EI+ GL ++H+
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
+++ D+KP NIL+DE +ISD GL+ + GT GY APE+ +
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKG 180
Query: 210 NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269
AD +S G ML +++ + D+ + EL + S
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFS----- 233
Query: 270 NIEEFENLVKIGLWCVECELNLRPTMKQ 297
E +L++ ++ ++N R
Sbjct: 234 --PELRSLLE---GLLQRDVNRRLGCLG 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIK---IVEEGESEFRNEMKIIGR-IH 87
E+F + +G+G G+V+ + A+K L K ++++ E +++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
H L + N V E++ G L + ++ + S A EI+ GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL- 119
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
I++ D+K NIL+D+ KI+DFG+ K +T T GT Y APE+
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEIL- 175
Query: 208 RNNRITVKADVYSFGVMLLEIVCCR 232
+ D +SFGV+L E++ +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 1e-41
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 23/283 (8%)
Query: 35 ENFK--EEIGRGGSGRVYKGCINGGKEIAVKKL--IKIVEEGESEFRNEMKIIGRIHHKN 90
E + E+IG G G VYK N G+ A+KK+ K E S E+ I+ + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 91 LVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+V L +LV+E + L E L + L+++ G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
+ R++H D+KP N+L++ + KI+DFGL++ + + Y AP++ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-WYRAPDVLMGSK 176
Query: 211 RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI----------DWAHQCYEAGELQ 260
+ + D++S G + E+V D+++ I +W +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 261 NLVSDQEDVNIEEFENLVKIGL----WCVECELNLRPTMKQVI 299
N + + L + G+ ++ + N R T KQ +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 2e-41
Identities = 51/277 (18%), Positives = 100/277 (36%), Gaps = 23/277 (8%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
+IG G G +Y G I G+E+A+K + + E KI + + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
+C + ++ + SL +L ++ S +A +++ + Y+H + I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFI 125
Query: 156 HCDIKPHNILM---DESWKAKISDFGLSKLLKTDQTRTY------TVLRGTRGYTAPELH 206
H D+KP N LM + I DFGL+K + +T + L GT Y + H
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266
+ + D+ S G +L+ + + + + ++ L
Sbjct: 186 -LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303
EF + +C + +P + +
Sbjct: 245 P----SEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-41
Identities = 61/284 (21%), Positives = 117/284 (41%), Gaps = 40/284 (14%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESE------FRNEMKIIGRIH-- 87
+G GG G VY G ++ +A+K + K E E+ ++ ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 88 HKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
++ L+ + + +L+ E L R +++E + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 126
Query: 148 DECETRIIHCDIKPHNILMDES-WKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELH 206
++H DIK NIL+D + + K+ DFG LLK + GTR Y+ PE
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWI 181
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266
+ A V+S G++L ++VC + D+EI ++ V +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEI--------------IRGQVFFR 224
Query: 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI---WMMEGIVP 307
+ V+ E ++L++ WC+ + RPT +++ WM + ++P
Sbjct: 225 QRVS-SECQHLIR---WCLALRPSDRPTFEEIQNHPWMQDVLLP 264
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 4e-41
Identities = 64/301 (21%), Positives = 121/301 (40%), Gaps = 27/301 (8%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHK 89
ENF+ E+IG G G VYK G+ +A+KK+ E S E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
N+V L+ + LV+EF+ + A + + ++++GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
++H D+KP N+L++ K++DFGL++ + T Y APE+
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGC 177
Query: 210 NRITVKADVYSFGVMLLEIVCCR-----KNVDESLR---------DDEIVLIDWAHQCYE 255
+ D++S G + E+V R + + L D+ + + Y+
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 256 AGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI---WMMEGIVP-PHQN 311
+ D V E+ + + + N R + K + + + P PH
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
Query: 312 M 312
+
Sbjct: 298 L 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (357), Expect = 1e-40
Identities = 43/280 (15%), Positives = 102/280 (36%), Gaps = 27/280 (9%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDL 94
IG G G +++G + +++A+K + + R+E + + + ++
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 95 VGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRI 154
F EG + +LV + + +LL ++ S A +++ + +H++ +
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SL 122
Query: 155 IHCDIKPHNILMDE-----SWKAKISDFGLSKLLKTDQTRTY------TVLRGTRGYTAP 203
++ DIKP N L+ + + DFG+ K + T+ + L GT Y +
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 204 ELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263
H + + D+ + G + + + + + ++ L+ L
Sbjct: 183 NTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303
+ EEF + + + P + +
Sbjct: 242 AGFP----EEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 141 bits (355), Expect = 1e-40
Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGES---EFRNEMKIIGRIHHKNLV 92
E +G GG V+ + +++AVK L + S FR E + ++H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 93 DLVGFC----SEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
+ G +V E++ +L +++ E ++ + + + L++
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFS-- 127
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR--TYTVLRGTRGYTAPELH 206
+ IIH D+KP NI++ + K+ DFG+++ + + GT Y +PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ- 185
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCR 232
+R + + ++DVYS G +L E++
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-39
Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 28/251 (11%)
Query: 7 ISRQVSSPDVFEEIKLRSFSYEQIVLASENFKEEIGRGGSGRVYKG-CINGGKEIAVKKL 65
++ V++P + + + SY + IG G G VY+ + G+ +A+KK+
Sbjct: 3 VTTVVATPGQGPD-RPQEVSYTDT--------KVIGNGSFGVVYQAKLCDSGELVAIKKV 53
Query: 66 IKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR------LLVYEFMRNGSLGNL 119
++ + E++I+ ++ H N+V L F + LV +++
Sbjct: 54 LQ----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 120 LF--RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKP-HNILMDESWKAKISD 176
RA+Q L + ++ L Y+H I H DIKP + +L ++ K+ D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 177 FGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVD 236
FG +K L + + +R Y APEL T DV+S G +L E++ +
Sbjct: 167 FGSAKQLVRGEPNVSYI--CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224
Query: 237 ESLRDDEIVLI 247
D++V I
Sbjct: 225 GDSGVDQLVEI 235
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-39
Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 18/223 (8%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLV 95
+IG+G G V+K G+++A+KK++ E E+KI+ + H+N+V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 96 GFCSEGSNR--------LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLH 147
C ++ LV++F + G LL + + SE +R+ ++ GL+Y+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYI- 133
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL---KTDQTRTYTVLRGTRGYTAPE 204
+I+H D+K N+L+ K++DFGL++ K Q YT T Y PE
Sbjct: 134 --HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 205 LHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI 247
L D++ G ++ E+ + + ++ LI
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 138 bits (348), Expect = 4e-39
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHH 88
++F+ +G G GRV+ + G+ A+K L K + + +E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
++ + G + ++ +++ G L L R QR + A E+ L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
+ II+ D+KP NIL+D++ KI+DFG +K + L GT Y APE+
Sbjct: 123 KD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVV-S 174
Query: 209 NNRITVKADVYSFGVMLLEIVCCRK 233
D +SFG+++ E++
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 8e-39
Identities = 61/300 (20%), Positives = 121/300 (40%), Gaps = 31/300 (10%)
Query: 38 KEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRI-HHKNLVDLV 95
+ +G G +G+V + ++ A+K L + + R E+++ R ++V +V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 71
Query: 96 GFC----SEGSNRLLVYEFMRNGSLGNLLF-RAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+ L+V E + G L + + R +Q + E I I E + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 151 ETRIIHCDIKPHNILMDESWK---AKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHS 207
I H D+KP N+L K++DFG +K + + T T Y APE+
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVL- 185
Query: 208 RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267
+ D++S GV++ ++C + + + G+ + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVI---WMMEGIVPPHQNMLTHPTSTNQEKS 324
+V+ EE + L++ ++ E R T+ + + W+M+ P + T ++
Sbjct: 243 EVS-EEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-37
Identities = 62/288 (21%), Positives = 110/288 (38%), Gaps = 36/288 (12%)
Query: 39 EEIGRGGSGRVYKG--CINGGKEIAVKKLIKIVEEGESEFR-----NEMKIIGRIHHKNL 91
EIG G G+V+K NGG+ +A+K++ E ++ + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 92 VDLVGFCSEGSNR-----LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYL 146
V L C+ LV+E + L E + + + +++ GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 147 HDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELH 206
H ++H D+KP NIL+ S + K++DFGL+++ T V T Y APE+
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 207 SRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLI----------DWAHQCYEA 256
+ D++S G + E+ + S D++ I DW
Sbjct: 188 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 257 GELQNLVSDQEDVNI-----EEFENLVKIGLWCVECELNLRPTMKQVI 299
+ + S Q E ++L+ C+ R + +
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSAL 291
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-37
Identities = 55/274 (20%), Positives = 110/274 (40%), Gaps = 29/274 (10%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGE------SEFRNEMKIIGRIHHK 89
EE+G G V K + G + A K + K + + E+ I+ I H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 90 NLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
N++ L ++ +L+ E + G L + L ++ L+ E +I+ G++YLH
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL 132
Query: 150 CETRIIHCDIKPHNILMDE----SWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPEL 205
I H D+KP NI++ + + KI DFGL+ + GT + APE+
Sbjct: 133 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187
Query: 206 HSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265
+ ++AD++S GV+ ++ + + + + + +E N
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS-- 244
Query: 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299
++ ++ + + R T++ +
Sbjct: 245 ------ALAKDFIR---RLLVKDPKKRMTIQDSL 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-36
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 10/200 (5%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHHKNLV 92
+ + +G+G G+V G+ A+K L K I ++ + E +++ H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 93 DLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
L V E+ G L L R E+ + R EI+ L YLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
+++ DIK N+++D+ KI+DFGL K +D T GT Y APE+ +N
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL-EDNDY 182
Query: 213 TVKADVYSFGVMLLEIVCCR 232
D + GV++ E++C R
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 53/280 (18%), Positives = 107/280 (38%), Gaps = 27/280 (9%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLV 95
E+IG G G V+K + +A+K++ E S E+ ++ + HKN+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 96 GFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRII 155
LV+EF L + ++++GL + H ++
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLK-KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 156 HCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVK 215
H D+KP N+L++ + + K+++FGL++ R Y+ T Y P++ +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 216 ADVYSFGVMLLEIVCCR------KNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269
D++S G + E+ +VD+ L+ I + + + L +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLK--RIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 270 NIEEFENLVKIG-----------LWCVECELNLRPTMKQV 298
+LV + ++C R + ++
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (323), Expect = 2e-35
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 22/228 (9%)
Query: 15 DVFEEIKLRSFSYEQIVLASEN-----FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKI 68
DV + YE V+ N ++GRG V++ I +++ VK L +
Sbjct: 12 DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 71
Query: 69 VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRL--LVYEFMRNGSLGNLLFRAEQ 125
++ + + E+KI+ + N++ L + +R LV+E + N L Q
Sbjct: 72 KKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----Q 124
Query: 126 RLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLK 184
L+ + R EI++ L Y H I+H D+KPHN+++D E K ++ D+GL++
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR 232
Q V +R + PEL D++S G ML ++ +
Sbjct: 182 PGQEYNVRV--ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-33
Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 29/282 (10%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIK--IVEEGESEFRNEMKIIGRIHHKNLVDLV 95
+ +G G G V G ++A+KKL + E E++++ + H+N++ L+
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 96 GFCSEGSNRLLVYEF---MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECET 152
+ +F M ++L + + ++++GL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG-- 141
Query: 153 RIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRI 212
IIH D+KP N+ ++E + KI DFGL++ + T TR Y APE+ R
Sbjct: 142 -IIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRY 196
Query: 213 TVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIE 272
T D++S G ++ E++ + S D++ I A +Q L SD+ ++
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256
Query: 273 EFENLVKIGL----------------WCVECELNLRPTMKQV 298
L K + + R T +
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (303), Expect = 2e-32
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 35 ENFK--EEIGRGGSGRVYKG-CINGGKEIAVKKLIK---IVEEGESEFRNEMKIIGRIHH 88
+ F + +G G GRV G A+K L K + + NE +I+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD 148
LV L + SN +V E++ G + + L R R S R A +I+ YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 149 ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSR 208
+I+ D+KP N+L+D+ +++DFG +K L GT APE+
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEII-L 211
Query: 209 NNRITVKADVYSFGVMLLEIVCCR 232
+ D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-31
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 16/227 (7%)
Query: 18 EEIKLRSFSYEQIVLASENFK--EEIGRGGSGRVYKG----CINGGKEIAVKKLIKIV-- 69
E++ + + + ENF+ + +G G G+V+ + GK A+K L K
Sbjct: 7 HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 70 --EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQR 126
+ R E +++ I LV L + L+ +++ G L L + +R
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RER 125
Query: 127 LSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186
+ E + EI+ L +LH II+ DIK NIL+D + ++DFGLSK D
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182
Query: 187 QTRTYTVLRGTRGYTAPE-LHSRNNRITVKADVYSFGVMLLEIVCCR 232
+T GT Y AP+ + ++ D +S GV++ E++
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-30
Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 17/260 (6%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGES--EFRNEMKIIGRIHHKNLVDLV 95
+G G G V G +AVKKL + + E++++ + H+N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 96 GFCSEGS-----NRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC 150
+ N + + + L N++ Q+L+ + + +I+ GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNN 210
IIH D+KP N+ ++E + KI DFGL++ + T TR Y APE+
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWM 194
Query: 211 RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270
D++S G ++ E++ R + D++ LI A L+ + S+
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 271 IEEFENLVKIGLWCVECELN 290
I+ + K+ V N
Sbjct: 255 IQSLTQMPKMNFANVFIGAN 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 7e-28
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 39 EEIGRGGSGRVYKG-CINGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLV 95
+ IG G G V + +A+KKL + + E+ ++ ++HKN++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 96 GFCS------EGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDE 149
+ E + LV E M NL + L + +++ G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 150 CETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRN 209
IIH D+KP NI++ KI DFGL++ T T V TR Y APE
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPE-VILG 192
Query: 210 NRITVKADVYSFGVMLLEIVCCR 232
D++S G ++ E+V +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.6 bits (244), Expect = 5e-24
Identities = 43/237 (18%), Positives = 87/237 (36%), Gaps = 22/237 (9%)
Query: 37 FKEEIGRGGSGRVYKG-CINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLV 95
++G G V+ + +A+K ++ + +E+K++ R++ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 96 GFCSEGSNRLLVY---------------EFMRNGSLGNLLFRAEQRLSWSERRRIALEIM 140
+ +LL + E + L + + + ++I+ +++
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 141 EGLHYLHDECETRIIHCDIKPHNILMD-ESWKAKISDFGLSKLLKTDQT-RTYTVLRGTR 198
GL Y+H C IIH DIKP N+LM+ + ++ L YT TR
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 199 GYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYE 255
Y +PE+ AD++S ++ E++ + D Q E
Sbjct: 194 EYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 2e-18
Identities = 36/203 (17%), Positives = 63/203 (31%), Gaps = 31/203 (15%)
Query: 39 EEIGRGGSGRVYKGCINGGKEIAVK----------KLIKIVEEGESEFRNEMKIIGRIHH 88
+ +G G V+ E VK K+ + + G+ F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 89 KNLVDLVGFCSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSW-SERRRIALEIMEGLHYLH 147
+ L L G VY + N L L+ E + I+E + +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 148 DECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT---VLRGTRGYTAPE 204
I+H D+ +N+L+ E I DF S + + R V +
Sbjct: 121 HRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYF---- 172
Query: 205 LHSRNNRITVKADVYSFGVMLLE 227
+ + D+ S +L+
Sbjct: 173 ----SRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.76 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.19 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=372.07 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=208.0
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.+|++.++||+|+||.||+|.+. +|..||+|++........+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999986 68999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
++++|.+++.+ +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......... .
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc-c
Confidence 99999998743 5699999999999999999999999 9999999999999999999999999999876543322 2
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
....||+.|+|||.+ .+..++.++|||||||++|+|++|+.||......+... ........ ....+.
T Consensus 174 ~~~~gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~~------~~~~~~ 240 (293)
T d1yhwa1 174 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTP------ELQNPE 240 (293)
T ss_dssp CCCCSCGGGCCHHHH-SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCSC------CCSSGG
T ss_pred cccccCCCccChhhh-cCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCCC------CCCCcc
Confidence 334589999999999 45677899999999999999999999997654332211 11111110 111122
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+..+.++|.+||+.||.+|||++|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33467999999999999999999999983
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=368.07 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=205.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++|++.+.||+|+||.||+|++. ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999997 68899999986532 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++|+|.+++. ..+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 86 Ey~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999985 446799999999999999999999999 99999999999999999999999999997654332
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....||+.|+|||.+ .+..++.++|||||||++|+|++|+.||......+.. ....... ..
T Consensus 161 --~~~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~--------~~ 222 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRISRVE--------FT 222 (263)
T ss_dssp --CEETTEEGGGCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC--------CC
T ss_pred --ccccCCCCcccCHHHH-cCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC--------CC
Confidence 2334589999999999 4567899999999999999999999999765432211 1111111 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+...++++.+++.+||+.||++|||++|+++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 22223467999999999999999999999984
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=370.42 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=203.8
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++|++.+.||+|+||.||+|.+. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46999999999999999999987 68899999986533 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc-c
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT-R 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~-~ 189 (325)
+++|+|.+++. ..+.+++..++.++.|++.|+.|||++ ||+||||||+|||++.++.+||+|||++........ .
T Consensus 85 ~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999984 456799999999999999999999999 999999999999999999999999999987654332 2
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
......||+.|+|||.+.+...++.++|||||||++|+|++|++||........... ........ ...
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------~~~~~~~~------~~~ 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------DWKEKKTY------LNP 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH------HHHTTCTT------STT
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH------HHhcCCCC------CCc
Confidence 233345899999999996555667889999999999999999999987654332211 11111100 001
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+.++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122356889999999999999999999973
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=368.38 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=200.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
++|++.++||+|+||.||+|.+.++..||||++.... ...+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688999999999999999999888899999986533 445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+|+|.+++......+++..++.++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||++............
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999999876667799999999999999999999999 9999999999999999999999999999876544433333
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhC-CCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCC-RKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
...+|..|+|||.+ ....++.++||||||+++|||+++ .+||......+. .. ....+.- ...+.
T Consensus 161 ~~~gt~~y~aPE~l-~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~----~i~~~~~-------~~~p~ 225 (263)
T d1sm2a_ 161 GTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VE----DISTGFR-------LYKPR 225 (263)
T ss_dssp ----CTTSCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HH----HHHHTCC-------CCCCT
T ss_pred ceecCcccCChHHh-cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHhcCC-------CCCcc
Confidence 34578999999999 566789999999999999999995 555544322111 11 1111110 11112
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.++.++.++|.+||+.||++|||++||++.|+++.
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 23357999999999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=371.90 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=208.0
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
.|++.+.||+|+||.||+|.+. ++..+|+|++........+.+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 5899999999999999999987 688899999877666666778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+|+|.+++.+..+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++........ ...
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 168 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HHT
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-ccc
Confidence 9999999866667899999999999999999999999 999999999999999999999999999875433211 112
Q ss_pred eecCCCCcCCccccc----cCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 193 VLRGTRGYTAPELHS----RNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
...||+.|+|||.+. ....++.++|||||||++|+|++|+.||......+.... ....... ...
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~-------i~~~~~~-----~~~ 236 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK-------IAKSEPP-----TLA 236 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-------HHHSCCC-----CCS
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH-------HHcCCCC-----CCC
Confidence 234899999999874 245578999999999999999999999987654432211 1111111 111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.+...+.++.++|.+||+.||.+|||++|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12233467999999999999999999999984
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=366.31 Aligned_cols=262 Identities=26% Similarity=0.406 Sum_probs=206.3
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
..++|++.+.||+|+||.||+|++++ .||||++... .....+.+.+|+.++++++||||+++++++.+ ...++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 35678899999999999999998753 5999998643 34445678899999999999999999998754 5689999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++|+|.+++......+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999976667899999999999999999999999 999999999999999999999999999976543322
Q ss_pred -cceeeecCCCCcCCccccccC--CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 189 -RTYTVLRGTRGYTAPELHSRN--NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 189 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
.......||+.|+|||.+... ..++.++||||||+++|||++|+.||.......... .....+......
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~~~p~~-- 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------FMVGRGYLSPDL-- 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHHTSCCCCG--
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCCCCCcc--
Confidence 223334589999999998532 347889999999999999999999998754432211 111111111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
......++.++.++|.+||+.||++|||++||++.|+.+..
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223344679999999999999999999999999998763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=359.30 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=213.0
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecC
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMR 112 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 112 (325)
++|+++++||+|+||.||+|+++++..||||++.... .....+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 4688999999999999999999888899999987643 345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcccee
Q 047716 113 NGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTYT 192 (325)
Q Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~~ 192 (325)
+|+|.+++......+++..++.++.|++.|+.|||++ ||+|+||||+||+++.++.+||+|||++............
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9999999866777899999999999999999999999 9999999999999999999999999999766544443333
Q ss_pred eecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCCH
Q 047716 193 VLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNI 271 (325)
Q Consensus 193 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (325)
...++..|+|||.+ ....++.++||||||+++|||+| |+.||......+.. ..+..+.. ...+.
T Consensus 160 ~~~~t~~y~aPE~~-~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-------~~i~~~~~-------~~~p~ 224 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVL-MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQGLR-------LYRPH 224 (258)
T ss_dssp CSCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-------HHHHTTCC-------CCCCT
T ss_pred ccCCCCCcCCcHHh-cCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-------HHHHhCCC-------CCCcc
Confidence 34578899999998 55678999999999999999998 89999876543221 11222111 11112
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 272 EEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 272 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
..++++.++|.+||+.||++|||++|+++.|..+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2335799999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-53 Score=366.71 Aligned_cols=263 Identities=26% Similarity=0.370 Sum_probs=215.6
Q ss_pred HHHHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 28 EQIVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 28 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
.+|..++|++.++||+|+||.||+|.+. .+..||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3456678999999999999999999987 57889999986543 445678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 107 VYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
||||+++|+|.+++... ...+++..++.++.|++.|+.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999998543 45789999999999999999999999 999999999999999999999999999987655
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
..........+++.|+|||.+ ....++.++||||||+++|+|++|+.||......... ......+.
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~-~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~------~~~i~~~~------- 233 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDY------- 233 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------HHHHHTTC-------
T ss_pred CCceeeccccccccccChHHH-cCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH------HHHHhcCC-------
Confidence 444333334478899999998 4567899999999999999999987776544332211 11121111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
..+.+...+.++.+++.+||+.||++|||++||++.|+.+...
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1112223346799999999999999999999999999988653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=360.54 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=193.7
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeec--CCceEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--GSNRLLV 107 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 107 (325)
.+|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+ ++.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999987 68899999986532 3344568899999999999999999998854 4568999
Q ss_pred EeecCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHhhccC--CCCeeeccCCCCceEEcCCCcEEEeecccccc
Q 047716 108 YEFMRNGSLGNLLFRA---EQRLSWSERRRIALEIMEGLHYLHDEC--ETRIIHCDIKPHNILMDESWKAKISDFGLSKL 182 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~ 182 (325)
|||+++|+|.+++.+. ...+++..++.++.|++.|+.|||++. ..+|+||||||+|||++.++.+||+|||++..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 457999999999999999999999970 01399999999999999999999999999987
Q ss_pred ccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 183 LKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
....... .....||+.|+|||.+ .+..++.++|||||||++|+|++|++||......+. ...+..+....+
T Consensus 164 ~~~~~~~-~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------~~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDTSF-AKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKFRRI 234 (269)
T ss_dssp C------------CCCSCCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCCCCC
T ss_pred cccCCCc-cccCCCCcccCCHHHH-cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCCCC
Confidence 6543322 2234589999999999 567789999999999999999999999986543221 112222332222
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+...+.++.+++.+||+.||.+|||++|+++
T Consensus 235 -------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 -------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2223467999999999999999999999984
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-53 Score=366.57 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=202.2
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC-C---cEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING-G---KEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-~---~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
+..++|++.+.||+|+||.||+|.+.. + ..+++|++... .....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 335678889999999999999999862 2 25778887553 334456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++|+|.+++....+.+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999999876667899999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCccc----eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 185 TDQTRT----YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 185 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
...... .....+++.|+|||.+ ....++.++|||||||++|||++ |++||......+.. .....+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~-------~~i~~~~- 250 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI-------NAIEQDY- 250 (299)
T ss_dssp ----------------CGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTC-
T ss_pred CCCCcceeeecccccCCccccCHHHH-hcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-
Confidence 432211 1112368899999998 56778999999999999999998 89999865433211 1111111
Q ss_pred cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 260 QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
..+.+...+..+.++|.+||+.||++|||+.||++.|+.+..
T Consensus 251 ------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 ------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 122233345679999999999999999999999999998763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-52 Score=371.60 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=210.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..|++.+.||+|+||.||+|.+. ++..+|+|++..........+.+|+.+|+.++||||+++++++.+++.+++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46999999999999999999986 68999999987766566677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc--CCCcEEEeeccccccccCCCcc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD--ESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~--~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
++++|.+.+.....++++..++.++.|++.||.|||++ ||+||||||+|||++ .++.+||+|||++........
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 99999998866666799999999999999999999999 999999999999997 568999999999987755433
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....+++.|+|||.+ .+..++.++|||||||++|+|++|++||.+....+.. ......... .....
T Consensus 185 -~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~~~----~~~~~ 251 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRCDWE----FDEDA 251 (352)
T ss_dssp -EEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHHCCCC----CCSST
T ss_pred -eeeccCcccccCHHHH-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC----CCccc
Confidence 3334589999999998 5667899999999999999999999999865443221 111111111 11112
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+.++.+||.+||+.||.+|||++|+++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2233456899999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.2e-53 Score=371.97 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=209.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
++|++.+.||+|+||.||+|++. .|..||+|++..........+.+|+.+|+.++||||+++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999987 68899999997766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC--CCcEEEeeccccccccCCCcc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE--SWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~--~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
++|+|.+++....+.+++..++.++.||+.||.|||++ |++||||||+|||++. ++.+||+|||++........
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence 99999999866667899999999999999999999999 9999999999999954 57899999999987654433
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....||+.|+|||.+ .+..++.++|||||||++|+|++|+.||.+....+... ........ .....
T Consensus 182 -~~~~~gT~~Y~aPEv~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~~~----~~~~~ 248 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-------NVKSCDWN----MDDSA 248 (350)
T ss_dssp -EEEECSCTTTCCHHHH-HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCC----SCCGG
T ss_pred -cceecCcccccCHHHH-cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCCCC----CCccc
Confidence 2334589999999998 56677899999999999999999999998654322211 11111111 01111
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....++++.+||.+||+.||++|||++|+++
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223457999999999999999999999996
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=361.49 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=207.9
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
|..++|++.++||+|+||.||+|.++++..||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 4457899999999999999999999888899999986533 445678999999999999999999998754 56799999
Q ss_pred ecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 110 FMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 110 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
|+++|+|.+++... ..++++..+..++.|++.|+.|||++ +|+||||||+||+|+.++.+||+|||++........
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999999977433 34699999999999999999999999 999999999999999999999999999987655443
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.......+++.|+|||.+ ....++.++||||||+++|||+||+.|+......... . ..+..+. ...
T Consensus 165 ~~~~~~~gt~~y~APE~~-~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~--~----~~i~~~~-------~~~ 230 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--I----QNLERGY-------RMV 230 (272)
T ss_dssp ECCTTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H----HHHHTTC-------CCC
T ss_pred ccccccCCcccccChHHH-hCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHhcC-------CCC
Confidence 333334578899999998 4567889999999999999999976655433322111 1 1111111 111
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+...+.++.+++.+||+.||++|||++||++.|+.+.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 12233457999999999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=365.40 Aligned_cols=247 Identities=22% Similarity=0.273 Sum_probs=203.3
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
.+|++.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999986 6889999998753 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++|+|.+++. ..+.+++..++.++.|++.|+.|||++ ||+||||||+||+++.++.+||+|||++........
T Consensus 88 Ey~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999884 446899999999999999999999999 999999999999999999999999999987653322
Q ss_pred -cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 189 -RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 189 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
.......||+.|+|||.+ .+..++.++|||||||++|+|++|+.||......+.. ....... .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~--------~ 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-------QKIIKLE--------Y 227 (288)
T ss_dssp ------CCCCGGGCCHHHH-HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHTTC--------C
T ss_pred ccccccccCCccccCceee-ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-------HHHHcCC--------C
Confidence 223334589999999999 5667899999999999999999999999865432211 1111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
..+...+.++.++|.+||+.||.+|||++|++
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 12223346799999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=352.74 Aligned_cols=245 Identities=26% Similarity=0.386 Sum_probs=196.1
Q ss_pred HhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeec----CCceEEE
Q 047716 35 ENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE----GSNRLLV 107 (325)
Q Consensus 35 y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 107 (325)
|++.++||+|+||+||+|.+. .+..||+|++.... ......+.+|++++++++||||+++++++.. +..+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367778999999999999987 67889999986532 3345568899999999999999999998854 3467999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeeccCCCCceEEc-CCCcEEEeecccccccc
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETR--IIHCDIKPHNILMD-ESWKAKISDFGLSKLLK 184 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nilv~-~~~~vkl~Dfg~~~~~~ 184 (325)
|||+++++|.+++.+ ...+++..++.++.|++.|+.|||++ + |+||||||+|||++ .++.+||+|||++....
T Consensus 91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999954 46799999999999999999999998 8 99999999999996 47899999999997543
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
... .....||+.|+|||.+. + .++.++|||||||++|+|++|+.||......... .+....+....
T Consensus 167 ~~~---~~~~~GT~~Y~aPE~~~-~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~------~~~i~~~~~~~--- 232 (270)
T d1t4ha_ 167 ASF---AKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPA--- 232 (270)
T ss_dssp TTS---BEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCG---
T ss_pred CCc---cCCcccCccccCHHHhC-C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH------HHHHHcCCCCc---
Confidence 322 23345999999999984 3 4899999999999999999999999765432221 11111111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
..+....+++.++|.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111112346899999999999999999999984
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-52 Score=364.57 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=191.1
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
.+.|++.+.||+|+||.||+|++. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356999999999999999999987 68899999987543 2334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEc---CCCcEEEeeccccccccCC
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMD---ESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~---~~~~vkl~Dfg~~~~~~~~ 186 (325)
|+++++|.+++. ..+.+++..+..++.|++.|+.|||++ ||+||||||+||++. .++.+||+|||++......
T Consensus 88 ~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999994 456799999999999999999999999 999999999999994 5788999999999765433
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCC
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQ 266 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (325)
.. .....||+.|+|||.+ .+..++.++|||||||++|+|++|++||.+....+.. ......... ..
T Consensus 164 ~~--~~~~~GT~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------~~i~~~~~~----~~ 229 (307)
T d1a06a_ 164 SV--LSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-------EQILKAEYE----FD 229 (307)
T ss_dssp -----------CTTSCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHTTCCC----CC
T ss_pred Ce--eeeeeeCccccCcHHH-cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHhccCCC----CC
Confidence 32 2234589999999999 5667899999999999999999999999865433211 111111111 11
Q ss_pred CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 267 EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 267 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.......+.++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1112233457999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=370.94 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=205.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
+..++|+++++||+|+||+||+|.+. ++..+|+|++.... ......+.+|+.+|+.++||||+++++++.+++..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34568999999999999999999987 68889999986542 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
|||+++++|.+++.+ .+.+++..++.++.|++.|+.|||+ + ||+||||||+|||++.++.+||+|||++......
T Consensus 83 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999999954 4679999999999999999999996 6 8999999999999999999999999999865432
Q ss_pred CccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH-HHHHHH----------
Q 047716 187 QTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW-AHQCYE---------- 255 (325)
Q Consensus 187 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~---------- 255 (325)
.. ....||+.|+|||.+ .+..++.++|||||||++++|++|+.||.+............ ......
T Consensus 159 ~~---~~~~GT~~Y~APEvl-~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 MA---NSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp TC------CCSSCCCCHHHH-HCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred cc---ccccCCccccCchHH-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 22 234589999999999 567789999999999999999999999987543322110000 000000
Q ss_pred hCc----------------ccccccCC-CC-CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhc
Q 047716 256 AGE----------------LQNLVSDQ-ED-VNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEG 304 (325)
Q Consensus 256 ~~~----------------~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~ 304 (325)
... ........ +. .....+.++.+++.+||+.||.+|||++|+++ ++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000 00000000 00 00112356899999999999999999999994 4543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-52 Score=360.72 Aligned_cols=247 Identities=23% Similarity=0.269 Sum_probs=202.3
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
...|+++++||+|+||.||+|++. ++..||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 456999999999999999999987 68889999986533 23345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+.+++|..+. ...+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (309)
T d1u5ra_ 94 MEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (309)
T ss_dssp EECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred EEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCCC
Confidence 9999998887665 4456799999999999999999999999 99999999999999999999999999997654332
Q ss_pred ccceeeecCCCCcCCcccccc--CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 188 TRTYTVLRGTRGYTAPELHSR--NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
...||+.|+|||.+.+ ...++.++|||||||++|+|++|+.||......+... ... ........
T Consensus 170 -----~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~-~~~~~~~~-- 235 (309)
T d1u5ra_ 170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIA-QNESPALQ-- 235 (309)
T ss_dssp -----CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHH-HSCCCCCS--
T ss_pred -----ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-hCCCCCCC--
Confidence 2348999999999853 3457889999999999999999999998654322111 111 11111111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....++.+.+||.+||+.||.+|||++|+++
T Consensus 236 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1123457999999999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=356.07 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=206.5
Q ss_pred HHHhhhh-hcCcCCceeEEEEEeC---CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEE
Q 047716 33 ASENFKE-EIGRGGSGRVYKGCIN---GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 33 ~~y~~~~-~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.++.+.+ +||+|+||.||+|.+. ++..||||++.... ......+.+|+.+|++++|||||++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999875 34479999986543 3445678899999999999999999999865 468999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++|+|.+++......+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999866667899999999999999999999999 99999999999999999999999999998765433
Q ss_pred cc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 188 TR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 188 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
.. ......+++.|+|||.+ ....++.++||||||+++|||++ |+.||......+.. ..+..+.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-------~~i~~~~------ 229 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK------ 229 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTC------
T ss_pred cccccccccccCccccChHHH-hCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC------
Confidence 21 12223478899999998 45678999999999999999998 89999876443211 1122221
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.++.+...+.++.++|.+||+.||++|||+.+|++.|+.+.
T Consensus 230 -~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11222334467999999999999999999999999998664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=358.66 Aligned_cols=247 Identities=23% Similarity=0.265 Sum_probs=206.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++|++++.||+|+||.||+|++. +++.+|+|++.+. .......+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999986 7899999998753 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+++|+|.+++. ..+.+++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||++........
T Consensus 85 ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 85 EYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 9999999999984 456799999999999999999999999 999999999999999999999999999986543222
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
.....+||+.|+|||.+ .+..++.++|||||||++|+|++|++||.+....+.. ....... ..
T Consensus 161 -~~~~~~GT~~Y~aPE~~-~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-------~~i~~~~--------~~ 223 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEE--------IR 223 (337)
T ss_dssp -CBCCCEECGGGCCGGGG-SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC--------CC
T ss_pred -ccccceeCHHHhhhhhc-cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-------HHHhcCC--------CC
Confidence 22334589999999999 5667799999999999999999999999876532211 1111111 12
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPT-----MKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell~ 300 (325)
.+...+.++.+||.+||+.||.+||+ ++|+++
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 22234467899999999999999995 888884
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=356.59 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=204.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc------hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV------EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
.++|++.+.||+|+||.||+|.+. +|..+|+|++.... ....+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999986 68899999986432 22356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC----cEEEeecccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW----KAKISDFGLS 180 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~----~vkl~Dfg~~ 180 (325)
++||||+++|+|.+++.. .+.+++..++.++.|++.|+.|||++ +|+||||||+||+++.++ .+|++|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999854 45799999999999999999999999 999999999999998776 4999999999
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
........ .....+++.|+|||.+ .+..++.++|||||||++|+|++|+.||.+....+... ........
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-------~i~~~~~~ 234 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAVNYE 234 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHTTCCC
T ss_pred hhcCCCcc--ccccCCCCcccCHHHH-cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH-------HHHhcCCC
Confidence 87654332 2233488999999999 56678999999999999999999999998654322211 11111111
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
.........+..+.++|.+||+.||++|||++|+++
T Consensus 235 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 ----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011122356899999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=351.19 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=204.7
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.++|++.+.||+|+||.||+|+++++..||||++... ....+.+.+|+.+++.++|||||++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4689999999999999999999998888999998653 3455779999999999999999999999854 5689999999
Q ss_pred CCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 112 RNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 112 ~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
++|+|..++... .+.+++..++.++.|++.|+.|||++ +++|+||||+||||+.++.+||+|||++..........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999887543 35699999999999999999999999 99999999999999999999999999998665444433
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
.....+++.|+|||.+ ....++.++||||||+++|||++|+.|+......... .. ....+. ..+.+
T Consensus 171 ~~~~~gt~~y~aPE~~-~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~--~~----~i~~~~-------~~~~~ 236 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LD----QVERGY-------RMPCP 236 (285)
T ss_dssp -----CCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----HHHTTC-------CCCCC
T ss_pred eccccccccccChHHH-hCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH--HH----HHHhcC-------CCCCC
Confidence 3444588999999999 5677899999999999999999976666544332211 11 111111 11223
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
...++++.++|.+||+.||++|||+++|+++|+.....
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 34456799999999999999999999999999998743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=355.38 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=200.0
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
|..++|++.+.||+|+||.||+|.+.. +..+++|++.... ......+.+|+.+++.++||||+++++++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999998753 3457788875433 333456889999999999999999999986 4678
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||+++++|.+++......+++..++.++.|++.|+.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999998877777899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
...........+|+.|+|||.+ ....++.++||||||+++|||++ |.+||......+... ....+..
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l-~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~-------~i~~~~~---- 227 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-------RIENGER---- 227 (273)
T ss_dssp -----------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTCC----
T ss_pred CCcceeccceecCcccchhhHh-ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCCC----
Confidence 4444333444578999999999 56678899999999999999998 899998765543221 1111111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+.+...+..+.++|.+||+.||++|||++||++.|+.+.
T Consensus 228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1223334467999999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=353.01 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=202.5
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCC-----cEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGG-----KEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
.+.|++.+.||+|+||.||+|.++.+ ..||||++.... ......+.+|+.+++.++|||||++++++.+....+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35678889999999999999987632 368999986533 333456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+.++++.+++......+++..+..++.|++.|+.|||++ +|+||||||+||||+.++.+||+|||++.....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999998877777899999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcc--ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc
Q 047716 186 DQTR--TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV 263 (325)
Q Consensus 186 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (325)
.... ......+|+.|+|||.+ ....++.++||||||+++|||++|+.|+......... . .....+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~--~----~~i~~~~----- 230 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--M----KAINDGF----- 230 (283)
T ss_dssp -----------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--H----HHHHTTC-----
T ss_pred CCccceEeccCCCCccccCHHHH-ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH--H----HHHhccC-----
Confidence 3221 12223478899999998 5678899999999999999999976665543332211 1 1122111
Q ss_pred cCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 264 SDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
..+.+...+.++.++|.+||+.||++|||+.||+++|+.+..
T Consensus 231 --~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 --RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 112222344679999999999999999999999999998763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=358.63 Aligned_cols=258 Identities=23% Similarity=0.378 Sum_probs=205.6
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeCC-C-----cEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCING-G-----KEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~-----~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++..++|++.++||+|+||.||+|++.. + ..||+|++.... ......+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4556789999999999999999998753 2 258888875532 33345688899999998 89999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc----------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeecc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE----------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCD 158 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~d 158 (325)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.|+.|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 999999999999999999985442 2488999999999999999999999 999999
Q ss_pred CCCCceEEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 047716 159 IKPHNILMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVD 236 (325)
Q Consensus 159 i~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~ 236 (325)
|||+||+++.++.+||+|||++......... ......+|+.|+|||.+ ....++.++|||||||++|||++ |++||.
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH-cCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999765543322 22233478999999998 56678999999999999999997 899998
Q ss_pred CccccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHh
Q 047716 237 ESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMME 303 (325)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 303 (325)
+........ .....+ . ..+.+...+.++.++|.+||+.||++|||++||++.|.
T Consensus 269 ~~~~~~~~~------~~~~~~-~------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFY------KLIQNG-F------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHH------HHHHTT-C------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHH------HHHhcC-C------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 765433221 111111 1 11222234467999999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=349.14 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=197.2
Q ss_pred hhcCcCCceeEEEEEeC---CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeecCC
Q 047716 39 EEIGRGGSGRVYKGCIN---GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFMRN 113 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~---~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (325)
++||+|+||.||+|.+. .++.||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999865 34679999986532 2334568899999999999999999999865 467899999999
Q ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc--ce
Q 047716 114 GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR--TY 191 (325)
Q Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~--~~ 191 (325)
|+|.+++. ....+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.+|++|||++......... ..
T Consensus 92 g~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999984 456799999999999999999999999 9999999999999999999999999999866443322 22
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCCC
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDVN 270 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (325)
....+|+.|+|||.+ ....++.++||||||+++|||++ |++||.+....+.. ..+..+. ..+.+
T Consensus 168 ~~~~gt~~y~APE~l-~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-------~~i~~~~-------~~~~p 232 (277)
T d1xbba_ 168 THGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGE-------RMGCP 232 (277)
T ss_dssp ---CCCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC-------CCCCC
T ss_pred cccCCCceecCchhh-cCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-------HHHHcCC-------CCCCC
Confidence 223478899999998 45678899999999999999997 89999875432211 1222221 12222
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 271 IEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 271 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
...+.++.++|.+||+.||++|||+++|+++|+..
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 33446799999999999999999999999988764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-50 Score=354.34 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=204.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc---chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI---VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++|++++.||+|+||.||+|++. ++..+|+|++... .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999986 6899999998753 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+.+++|..++. ....+++..++.++.|++.|+.|||++ ||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 E~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 84 DYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 9999999999884 456789999999999999999999999 99999999999999999999999999998764332
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
....||+.|+|||.+ .+..++.++|||||||++|+|++|+.||.+....+.. ....... ..
T Consensus 159 ---~~~~Gt~~Y~APE~l-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~--------~~ 219 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------EKILNAE--------LR 219 (316)
T ss_dssp ---CCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHCC--------CC
T ss_pred ---ccccCcccccCHHHH-cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-------HHHHcCC--------CC
Confidence 234589999999998 5667889999999999999999999999875432221 1111111 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
.++..+.++.+++.+||+.||.+|+ |++++++
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2223345699999999999999996 9999984
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-50 Score=359.07 Aligned_cols=248 Identities=24% Similarity=0.283 Sum_probs=201.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHH---HHHHHHhccCCCCcceeeEEeecCCceE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFR---NEMKIIGRIHHKNLVDLVGFCSEGSNRL 105 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~---~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (325)
++|++.+.||+|+||.||+|++. .|..||+|++.... ......+. .++.+++.++||||+++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 47999999999999999999987 68999999986422 12222333 3477788889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccC
Q 047716 106 LVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKT 185 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~ 185 (325)
+||||+++++|.+++.+ ...+++..++.++.|++.||.|||++ |++||||||+|||++.+|.+||+|||++.....
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999844 46789999999999999999999999 999999999999999999999999999986654
Q ss_pred CCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccC
Q 047716 186 DQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSD 265 (325)
Q Consensus 186 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (325)
... ....||+.|+|||.+..+..++.++|||||||++|+|++|+.||......+..... .. ....
T Consensus 160 ~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~--------~~~~ 224 (364)
T d1omwa3 160 KKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RM--------TLTM 224 (364)
T ss_dssp SCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HH--------SSSC
T ss_pred Ccc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh--------cccC
Confidence 332 23358999999999866677899999999999999999999999876544332111 11 1111
Q ss_pred CCCCCHHHHHHHHHHHhhcccCCCCCCCC-----HhHHH
Q 047716 266 QEDVNIEEFENLVKIGLWCVECELNLRPT-----MKQVI 299 (325)
Q Consensus 266 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~ell 299 (325)
....+...+.++.++|.+||+.||.+||| ++|++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil 263 (364)
T d1omwa3 225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263 (364)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHH
Confidence 12222233467999999999999999999 68888
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-50 Score=347.13 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=205.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---------hcHHHHHHHHHHHhccC-CCCcceeeEEeecC
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---------EGESEFRNEMKIIGRIH-HKNLVDLVGFCSEG 101 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 101 (325)
.+|++.+.||+|+||+||+|++. +++.+|+|++..... .....+.+|+.+++.++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57999999999999999999986 788999999865321 12235778999999997 99999999999999
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
+..++||||+++++|.+++. ..+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999995 456899999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCccceeeecCCCCcCCcccccc-----CCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHh
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSR-----NNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEA 256 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (325)
........ ....||+.|+|||.+.. ...++.++||||+||++++|++|+.||.+....... .....
T Consensus 159 ~~~~~~~~--~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~~i~~ 229 (277)
T d1phka_ 159 QLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------RMIMS 229 (277)
T ss_dssp ECCTTCCB--CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHH
T ss_pred EccCCCce--eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------HHHHh
Confidence 76543322 23448999999998752 345688999999999999999999999876432211 11222
Q ss_pred CcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 257 GELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
+.... ........++++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQF----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCCC----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCC----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22211 11112234467999999999999999999999984
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=351.51 Aligned_cols=260 Identities=23% Similarity=0.277 Sum_probs=200.1
Q ss_pred hhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhc-----HHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 38 KEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEG-----ESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
+++||+|+||+||+|++. +++.||+|++....... ...+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999987 68899999986533221 235788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccce
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRTY 191 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~~ 191 (325)
.++++..+. .....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~- 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY- 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC-
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcccc-
Confidence 887666555 4566799999999999999999999999 99999999999999999999999999997665433222
Q ss_pred eeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccc--------
Q 047716 192 TVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLV-------- 263 (325)
Q Consensus 192 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 263 (325)
....+|+.|+|||.+.....++.++|||||||++++|++|.+||.+....+....+ .............
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSSTTSSTTC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhccchhccchh
Confidence 22348999999999866777899999999999999999999999876543322211 1111111100000
Q ss_pred ---cCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhcc
Q 047716 264 ---SDQEDVN-----IEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGI 305 (325)
Q Consensus 264 ---~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~ 305 (325)
......+ ....+.+.+|+.+||+.||++|||++|+++ .+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0001111 122467999999999999999999999995 56544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=349.54 Aligned_cols=269 Identities=22% Similarity=0.294 Sum_probs=206.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch--hcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE--EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
.+|+++++||+|+||.||+|.+. .+..||+|++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 37899999999999999999986 688999999865332 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
|+.++.+........+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+|++|||.+.........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 9976544444444566799999999999999999999999 9999999999999999999999999999766443322
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC---cccc-----
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG---ELQN----- 261 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~----- 261 (325)
.....+++.|+|||.+.....++.++||||||+++|+|++|+.||.+....+....+ ....... .+..
T Consensus 159 -~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 159 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI---FRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGGST
T ss_pred -ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH---HHhcCCCchhhcccccccc
Confidence 222348999999999867777889999999999999999999999865433221111 0110000 0000
Q ss_pred ----cccCCCCC-----CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCCC
Q 047716 262 ----LVSDQEDV-----NIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVPP 308 (325)
Q Consensus 262 ----~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~ 308 (325)
........ .+..+.++.+|+.+||+.||.+|||++|+++ +++++-.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 00000000 1122367899999999999999999999995 57766544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=353.60 Aligned_cols=250 Identities=20% Similarity=0.261 Sum_probs=204.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
.+|++.+.||+|+||+||+|.+. ++..+|+|++.... .....+.+|+.+|+.++||||+++++++.+++.+++||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46999999999999999999987 68889999986543 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCC--CcEEEeeccccccccCCCcc
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDES--WKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~--~~vkl~Dfg~~~~~~~~~~~ 189 (325)
++++|.+++......+++..++.++.||+.|+.|||++ ||+||||||+||+++.+ ..++++|||++........
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 99999999966666799999999999999999999999 99999999999999754 4799999999986644332
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQEDV 269 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (325)
.....+++.|+|||.+ .+..++.++|||||||++|+|++|..||......+... ........ .....
T Consensus 160 -~~~~~~t~~y~ape~~-~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~-------~i~~~~~~----~~~~~ 226 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-------NIMNAEYT----FDEEA 226 (321)
T ss_dssp -EEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTCCC----CCHHH
T ss_pred -ccccccccccccchhc-cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCCCC----CChhh
Confidence 2334589999999998 56778899999999999999999999998764432211 11111111 00000
Q ss_pred CHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 270 NIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 270 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
....+.++.+|+.+||+.||.+|||++|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112356899999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-50 Score=354.01 Aligned_cols=244 Identities=23% Similarity=0.246 Sum_probs=203.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 108 (325)
++|++++.||+|+||.||+|.+. +|..+|+|++.... ......+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999987 78999999986532 234456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQT 188 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~ 188 (325)
||+.+++|.+++.+ .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 99999999999844 45799999999999999999999999 999999999999999999999999999987654322
Q ss_pred cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 189 RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
...||+.|+|||.+ .+..++.++|||||||++|+|++|+.||.+....... ....... ..
T Consensus 197 ----~~~Gt~~Y~APE~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~--------~~ 256 (350)
T d1rdqe_ 197 ----TLCGTPEALAPEII-LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-------EKIVSGK--------VR 256 (350)
T ss_dssp ----CCEECGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC--------CC
T ss_pred ----cccCccccCCHHHH-cCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH-------HHHhcCC--------CC
Confidence 23489999999999 4667789999999999999999999999865432211 1111111 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHHH
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRP-----TMKQVIW 300 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~ 300 (325)
.+...+.++.++|.+||+.||.+|+ |++|+++
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1223345699999999999999994 9999984
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-50 Score=346.53 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=200.6
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccch---hcHHHHHHHHHHHhccCCCCcceeeEEeecCC----c
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVE---EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS----N 103 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 103 (325)
.++|++.+.||+|+||.||+|.+. .++.+|+|++..... .....+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 357999999999999999999986 788999999875432 33456889999999999999999999886543 3
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.++||||+++++|.+++. ..+.+++..++.++.|++.|+.|||++ |++||||||+||+++.++.++++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 789999999999999884 446799999999999999999999999 9999999999999999999999999988654
Q ss_pred cCCCc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 184 KTDQT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 184 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
..... .......||+.|+|||.+ .+..++.++|||||||++|+|++|++||......+. .......+...
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~~- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP- 233 (277)
T ss_dssp C----------------TTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC-
T ss_pred ccccccccccccccCcccccCHHHH-cCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCCC-
Confidence 32221 222334589999999998 566789999999999999999999999986543221 11222221111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCC-CHhHHHHHHhccC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRP-TMKQVIWMMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~ell~~L~~~~ 306 (325)
........+.++.++|.+||+.||.+|| |++++++.|..+.
T Consensus 234 ----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111122335699999999999999999 8999998887653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=343.32 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=197.9
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeec-CCceEEEEee
Q 047716 32 LASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-GSNRLLVYEF 110 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 110 (325)
.++|++.++||+|+||.||+|.++ +..||||++... ...+.+.+|+.++++++||||+++++++.+ .+.+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 457889999999999999999985 678999998653 344678899999999999999999998854 4668999999
Q ss_pred cCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 111 MRNGSLGNLLFRAE-QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 111 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
+++|+|.+++.... ..+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++........
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~- 158 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 158 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCc-
Confidence 99999999985443 3589999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
...++..|+|||.+. +..++.++||||||+++|||++ |++||......+.. . .+..+ ..++
T Consensus 159 ---~~~~~~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~----~i~~~-------~~~~ 220 (262)
T d1byga_ 159 ---TGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P----RVEKG-------YKMD 220 (262)
T ss_dssp ------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---H----HHTTT-------CCCC
T ss_pred ---cccccccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHcC-------CCCC
Confidence 223688999999984 5678999999999999999998 67777765433321 1 11111 1122
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
.+...+.++.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 23334467999999999999999999999999998874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=348.98 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=203.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCC-Cc----EEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCING-GK----EIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLL 106 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~-~~----~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 106 (325)
.+|++++.||+|+||.||+|.+.. ++ .||+|++... .....+.+.+|+.+++.++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 358999999999999999998863 33 5788887543 334566789999999999999999999999764 5678
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
+++++.+++|.+++......+++..++.++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 8899999999998877778899999999999999999999999 9999999999999999999999999999876543
Q ss_pred Ccc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCccccccc
Q 047716 187 QTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVS 264 (325)
Q Consensus 187 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (325)
... ......+|+.|+|||.+ .+..++.++||||||+++|||+| |.+||.+....+... ....+.
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l-~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-------~i~~~~------ 230 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESI-LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGE------ 230 (317)
T ss_dssp CC--------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-------HHHHTC------
T ss_pred cccccccccccCccccChHHH-hcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCC------
Confidence 332 22223478999999998 45678999999999999999998 788887765443221 111111
Q ss_pred CCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 265 DQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
....+...+..+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 231 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 231 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 11222234467999999999999999999999998887764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-50 Score=341.75 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=197.4
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeCC----CcEEEEEEeeccc---hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCce
Q 047716 32 LASENFKEEIGRGGSGRVYKGCING----GKEIAVKKLIKIV---EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNR 104 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~vk~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (325)
..+|++.+.||+|+||.||+|++.. ...||+|++.... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999998642 2368899886532 2334578899999999999999999999976 467
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
++||||++++++.+.+....+.+++..++.++.|++.|+.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 899999999999998877777899999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCccc--eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 185 TDQTRT--YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 185 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
...... .....++..|+|||.+ ....++.++||||||+++|||++ |+.||.+....+.. .. .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~------~~-i~~~~~~- 233 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HK-IDKEGER- 233 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HH-HHTSCCC-
T ss_pred cCCCcceecCccccCcccCCHHHH-hCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH------HH-HHhCCCC-
Confidence 433221 1223467889999999 45678899999999999999998 89999765433221 11 1111111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhcc
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGI 305 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 305 (325)
.+.+...+..+.+++.+||+.||++|||++||.++|++.
T Consensus 234 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111222335699999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=350.67 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=200.7
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc---hhcHHHHHHHHHHHh-ccCCCCcceeeEEeecCCceEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV---EEGESEFRNEMKIIG-RIHHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 107 (325)
.+|++.+.||+|+||+||+|++. +++.||+|++.+.. ......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 36899999999999999999987 68899999997532 333445556666654 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCC
Q 047716 108 YEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~ 187 (325)
|||+++|+|.+++. ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 82 mEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999984 456799999999999999999999999 99999999999999999999999999997654333
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCC
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQE 267 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (325)
. ......||+.|+|||.+ .+..++.++|||||||++|+|++|+.||.+....+.. .....+. +
T Consensus 158 ~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------~~i~~~~--------~ 220 (320)
T d1xjda_ 158 A-KTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------HSIRMDN--------P 220 (320)
T ss_dssp C-CBCCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC--------C
T ss_pred c-cccccCCCCCcCCHHHH-cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCC--------C
Confidence 2 22334589999999999 5667889999999999999999999999875433221 1111111 1
Q ss_pred CCCHHHHHHHHHHHhhcccCCCCCCCCHh-HHH
Q 047716 268 DVNIEEFENLVKIGLWCVECELNLRPTMK-QVI 299 (325)
Q Consensus 268 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell 299 (325)
..+...+.++.++|.+||+.||.+|||++ |++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 12222346699999999999999999996 776
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=349.59 Aligned_cols=250 Identities=21% Similarity=0.226 Sum_probs=195.7
Q ss_pred HHHhhhh-hcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhc-cCCCCcceeeEEeec----CCceE
Q 047716 33 ASENFKE-EIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGR-IHHKNLVDLVGFCSE----GSNRL 105 (325)
Q Consensus 33 ~~y~~~~-~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~ 105 (325)
.+|++.+ .||+|+||.||+|++. +++.||+|++.. ...+.+|+.++.+ .+||||+++++++.+ +..++
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4788875 5999999999999986 688999999854 2456788988655 479999999998865 45689
Q ss_pred EEEeecCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCcEEEeeccccc
Q 047716 106 LVYEFMRNGSLGNLLFRA-EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWKAKISDFGLSK 181 (325)
Q Consensus 106 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~vkl~Dfg~~~ 181 (325)
+||||+++|+|.+++.+. ...+++..++.++.|++.|+.|||++ ||+||||||+||+++. .+.+||+|||++.
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence 999999999999999654 34699999999999999999999999 9999999999999975 4579999999998
Q ss_pred cccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 182 LLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
........ ....||+.|+|||.+ .+..++.++|||||||++|+|++|++||.+......... ........
T Consensus 163 ~~~~~~~~--~~~~gt~~y~aPE~~-~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-------~~~~i~~~ 232 (335)
T d2ozaa1 163 ETTSHNSL--TTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIRMG 232 (335)
T ss_dssp ECCCCCCC--CCCSCCCSSCCCCCC-CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSC
T ss_pred eccCCCcc--ccccCCcccCCcHHH-cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-------HHHHHhcC
Confidence 66543332 234589999999998 566789999999999999999999999976544322110 00000000
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
............+.++.+||.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 001111112234567999999999999999999999995
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-49 Score=343.14 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=207.4
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccch-hcHHHHHHHHHHHhccCCCCcceeeEEeecCCc
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIVE-EGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSN 103 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (325)
..++|++.+.||+|+||.||+|++. ++..||||++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3568999999999999999999874 356899999875433 334568999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhcc-----------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCC
Q 047716 104 RLLVYEFMRNGSLGNLLFRAE-----------------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIK 160 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~ 160 (325)
.+++|||+.+++|.+++.... ..+++..++.++.|++.|++|||++ +++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 999999999999999985332 2378899999999999999999999 99999999
Q ss_pred CCceEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCC-CCCCCc
Q 047716 161 PHNILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR-KNVDES 238 (325)
Q Consensus 161 p~nilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~ 238 (325)
|+||+++.++.+||+|||++........ .......+++.|+|||.+ ....++.++||||||+++|||++|. +||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH-ccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999875543322 222234478899999999 5667899999999999999999996 567655
Q ss_pred cccchhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 239 LRDDEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...+.. ..+..+..... +...+.++.+++.+||+.+|++|||+.||+++|+++.
T Consensus 247 ~~~e~~-------~~v~~~~~~~~-------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEEVI-------YYVRDGNILAC-------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHHHH-------HHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHH-------HHHHcCCCCCC-------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 332211 12222222211 2223356999999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=345.46 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=202.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCC-Cc--EEEEEEeecc-chhcHHHHHHHHHHHhcc-CCCCcceeeEEeecCCceEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCING-GK--EIAVKKLIKI-VEEGESEFRNEMKIIGRI-HHKNLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~-~~--~~~vk~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 107 (325)
++|++.++||+|+||.||+|++.+ +. .|+||++... .....+.+.+|+.+|.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999999874 33 4667776543 333455789999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 108 YEFMRNGSLGNLLFRA---------------EQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 108 ~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
|||+++|+|.+++... ...+++..+..++.|++.|+.|||++ +++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999998533 35699999999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCC-CCCCccccchhhHHHHHH
Q 047716 173 KISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRK-NVDESLRDDEIVLIDWAH 251 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-p~~~~~~~~~~~~~~~~~ 251 (325)
||+|||++......... ....++..|+|||.+ ....++.++||||||+++|+|++|.. ||......+..
T Consensus 167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l-~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~------- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------- 236 (309)
T ss_dssp EECCTTCEESSCEECCC------CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------
T ss_pred EEccccccccccccccc--cceecCCcccchHHh-ccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH-------
Confidence 99999998755433222 122378999999999 56678999999999999999999765 56554322211
Q ss_pred HHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 252 QCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
..+..+ ..++.+...+.++.++|.+||+.||++|||++||++.|+.+...
T Consensus 237 ~~i~~~-------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 EKLPQG-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHGGGT-------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHhc-------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111111 11222333456799999999999999999999999999988743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=345.43 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=199.0
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchh------cHHHHHHHHHHHhccC--CCCcceeeEEeecCC
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEE------GESEFRNEMKIIGRIH--HKNLVDLVGFCSEGS 102 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 102 (325)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999987 6889999998653211 1223567999999987 899999999999999
Q ss_pred ceEEEEeecCC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-CCcEEEeecccc
Q 047716 103 NRLLVYEFMRN-GSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-SWKAKISDFGLS 180 (325)
Q Consensus 103 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-~~~vkl~Dfg~~ 180 (325)
..++|||++.+ +++.+++. ..+.+++..++.++.|++.|+.|||++ ||+||||||+||+++. ++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 99999999975 57777774 456799999999999999999999999 9999999999999985 479999999999
Q ss_pred ccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc
Q 047716 181 KLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ 260 (325)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (325)
........ ....||+.|+|||.+.....++.++|||||||++|+|++|+.||..... .....
T Consensus 159 ~~~~~~~~---~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~~-- 220 (273)
T d1xwsa_ 159 ALLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ-- 220 (273)
T ss_dssp EECCSSCB---CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC--
T ss_pred eecccccc---cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhcc--
Confidence 76543322 2344899999999986666667889999999999999999999975321 11111
Q ss_pred ccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhcc
Q 047716 261 NLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGI 305 (325)
Q Consensus 261 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~ 305 (325)
...+...+.++.++|.+||+.||.+|||++|+++ .++++
T Consensus 221 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 ------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111123357999999999999999999999995 45544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.5e-49 Score=342.00 Aligned_cols=259 Identities=25% Similarity=0.304 Sum_probs=202.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 110 (325)
++|+++++||+|+||+||+|++.+++.||+|++.... ......+.+|+.+|+.++||||+++++.+..++..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 3689999999999999999999999999999986532 33356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCccc
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTRT 190 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~~ 190 (325)
+.++.+..+. ...+.+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+|++|||.+..........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9776665555 5567899999999999999999999999 99999999999999999999999999997665433222
Q ss_pred eeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccc----------
Q 047716 191 YTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQ---------- 260 (325)
Q Consensus 191 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 260 (325)
....+++.|+|||.+.+...++.++||||||+++++|++|+.||......+....+ ..........
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 158 -THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---FRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGGSTT
T ss_pred -ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH---HHhhCCCChhhccchhhhhh
Confidence 22237889999999877778899999999999999999999999865443322111 1111111000
Q ss_pred --ccccCC-----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 261 --NLVSDQ-----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 261 --~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
...... .......+..+.+++.+||+.||++|||++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000000 011122335689999999999999999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=342.80 Aligned_cols=259 Identities=26% Similarity=0.351 Sum_probs=203.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeCC--------CcEEEEEEeeccch-hcHHHHHHHHHHHhcc-CCCCcceeeEEee
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCING--------GKEIAVKKLIKIVE-EGESEFRNEMKIIGRI-HHKNLVDLVGFCS 99 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~~--------~~~~~vk~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 99 (325)
|..++|++++.||+|+||.||+|+... +..||+|++..... .....+.+|...+.++ +||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 456789999999999999999998642 24689999876443 3346678888888888 7999999999999
Q ss_pred cCCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCce
Q 047716 100 EGSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNI 164 (325)
Q Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ni 164 (325)
+++..++||||+++|+|.+++.... ..+++..++.++.|++.|+.|||++ +++||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 9999999999999999999985432 3589999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHh-CCCCCCCccccc
Q 047716 165 LMDESWKAKISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVC-CRKNVDESLRDD 242 (325)
Q Consensus 165 lv~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~ 242 (325)
|++.++.+||+|||++......... ......+++.|+|||.+ .+..++.++||||||+++|+|++ |.+||.......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l-~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh-cCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999999866543322 22334478899999998 45678999999999999999998 688887544321
Q ss_pred hhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 243 EIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
. ...+..+.. .+.+...+.++.++|.+||+.||.+|||+.||++.|+++.
T Consensus 246 ~-------~~~i~~~~~-------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 L-------FKLLKEGHR-------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp H-------HHHHHTTCC-------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-------HHHHHcCCC-------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1 122222211 1112223457999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=342.82 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=196.7
Q ss_pred HHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec-
Q 047716 30 IVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE- 100 (325)
Q Consensus 30 ~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~- 100 (325)
+..++|++.++||+|+||.||+|++. .++.||+|++.... ....+.+..|...+.++ +|+||+.+++++..
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 45678999999999999999999864 24579999986533 33445677778877777 58999999998755
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceE
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE---------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNIL 165 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil 165 (325)
+...++||||+++|+|.+++.... ..+++..+..++.|++.|+.|||++ +|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 456899999999999999985432 2488999999999999999999999 9999999999999
Q ss_pred EcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCC-CCCCCccccch
Q 047716 166 MDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR-KNVDESLRDDE 243 (325)
Q Consensus 166 v~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~ 243 (325)
++.++.+||+|||++........ .......||+.|+|||.+ .+..++.++|||||||++|+|++|. +||......+.
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh-hcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999976543322 222234488999999999 4667899999999999999999875 57765543322
Q ss_pred hhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 244 IVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.. .....+... ..+...+.++.++|.+||+.||++|||++|+++.|+.+..
T Consensus 246 ~~------~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 FC------RRLKEGTRM-------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HH------HHHHHTCCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH------HHHhcCCCC-------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 112222111 1112233569999999999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=336.69 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=201.1
Q ss_pred hhhcCcCCceeEEEEEeCCC----cEEEEEEeecc-chhcHHHHHHHHHHHhccCCCCcceeeEEeec-CCceEEEEeec
Q 047716 38 KEEIGRGGSGRVYKGCINGG----KEIAVKKLIKI-VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-GSNRLLVYEFM 111 (325)
Q Consensus 38 ~~~lg~g~~g~v~~~~~~~~----~~~~vk~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 111 (325)
.++||+|+||+||+|++..+ ..+|||++... .......+.+|++++++++||||+++++++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999997632 25789988643 34445679999999999999999999999765 56889999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc--
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR-- 189 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~-- 189 (325)
++++|.+++......+++..++.++.|++.|+.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999976777788999999999999999999999 9999999999999999999999999999865433221
Q ss_pred -ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccccccCCCC
Q 047716 190 -TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNLVSDQED 268 (325)
Q Consensus 190 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (325)
......+++.|+|||.+ ....++.++||||||+++|||++|+.||.......... .....+.. +.
T Consensus 189 ~~~~~~~gt~~y~aPE~~-~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~------~~i~~g~~-------~~ 254 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------VYLLQGRR-------LL 254 (311)
T ss_dssp TCTTCSSCCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH------HHHHTTCC-------CC
T ss_pred eecccccccccccChHHH-hcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH------HHHHcCCC-------CC
Confidence 11223478899999998 45678999999999999999999888876544322111 11111211 11
Q ss_pred CCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 269 VNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 269 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
.+......+.++|.+||+.||++|||++||++.|+.+...
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122335699999999999999999999999999998843
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=337.54 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=208.4
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhcc-CCCCcceeeEEeec
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRI-HHKNLVDLVGFCSE 100 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 100 (325)
++..++|++.++||+|+||.||+|++. .++.||||++.... ......+.+|+.+++.+ +||||+++++++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 355689999999999999999999862 45689999987533 33445688999999999 69999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHhhcc-----------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCc
Q 047716 101 GSNRLLVYEFMRNGSLGNLLFRAE-----------------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHN 163 (325)
Q Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~n 163 (325)
....+++|||+++++|.+++.... ..+++..+..++.|++.|+.|||++ +++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 999999999999999999985432 2589999999999999999999999 99999999999
Q ss_pred eEEcCCCcEEEeeccccccccCCCc-cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCC-CCCCCcccc
Q 047716 164 ILMDESWKAKISDFGLSKLLKTDQT-RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR-KNVDESLRD 241 (325)
Q Consensus 164 ilv~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~ 241 (325)
|+++.++.++++|||.+........ .......+++.|+|||.+ ....++.++||||||+++|+|++++ +||......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh-cCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986654332 222234578999999998 5677899999999999999999955 555444332
Q ss_pred chhhHHHHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 242 DEIVLIDWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
+... .....+. . ...+...+..+.+||.+||+.||++|||++||+++|+++.
T Consensus 255 ~~~~------~~i~~~~-~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 255 SKFY------KMIKEGF-R------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHH------HHHHHTC-C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH------HHHhcCC-C------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 2211 1111111 1 1111123356999999999999999999999999998765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=338.83 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=199.8
Q ss_pred HHHHhhhhhcCcCCceeEEEEEeC-C-CcEEEEEEeeccch--hcHHHHHHHHHHHhcc---CCCCcceeeEEeec----
Q 047716 32 LASENFKEEIGRGGSGRVYKGCIN-G-GKEIAVKKLIKIVE--EGESEFRNEMKIIGRI---HHKNLVDLVGFCSE---- 100 (325)
Q Consensus 32 ~~~y~~~~~lg~g~~g~v~~~~~~-~-~~~~~vk~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---- 100 (325)
.++|+++++||+|+||+||+|.+. . ++.||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 368999999999999999999985 3 56789999865332 2223455677776665 79999999998742
Q ss_pred -CCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccc
Q 047716 101 -GSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGL 179 (325)
Q Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~ 179 (325)
....+++||++.++.+..........+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 3467999999988777666555567799999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcc
Q 047716 180 SKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGEL 259 (325)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (325)
+....... ......||+.|+|||.+ .+..++.++|||||||++++|++|++||.+....+....+. .......-
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~-~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~ 236 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL---DVIGLPGE 236 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCG
T ss_pred hhhhcccc--cCCCcccChhhcCcchh-cCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH---HhhCCCch
Confidence 87554332 22334589999999998 56778999999999999999999999998765433222111 11110000
Q ss_pred ccc---------------ccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccC
Q 047716 260 QNL---------------VSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIV 306 (325)
Q Consensus 260 ~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~ 306 (325)
..+ ............+.+.+|+.+||+.||++|||++|+++ +++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 000 00001112223456899999999999999999999994 455554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=338.83 Aligned_cols=262 Identities=24% Similarity=0.380 Sum_probs=209.8
Q ss_pred HHHHHHHhhhhhcCcCCceeEEEEEeC------CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecC
Q 047716 29 QIVLASENFKEEIGRGGSGRVYKGCIN------GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG 101 (325)
Q Consensus 29 ~~~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (325)
+|..++|++.++||+|+||.||+|.+. .+..||||++.... ......+.+|+.++++++||||+++++++..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 445578999999999999999999874 25689999987533 33345688999999999999999999999998
Q ss_pred CceEEEEeecCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcE
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAE---------QRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKA 172 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~v 172 (325)
...++||||+++|+|.+++.... ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999999885332 2468899999999999999999999 99999999999999999999
Q ss_pred EEeeccccccccCCCcc-ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCC-CCCCCccccchhhHHHHH
Q 047716 173 KISDFGLSKLLKTDQTR-TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCR-KNVDESLRDDEIVLIDWA 250 (325)
Q Consensus 173 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~~~~~~~~~~~ 250 (325)
||+|||++......... ......+++.|+|||.+ ....++.++||||||+++|||++|+ +||......+..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l-~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------ 245 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------ 245 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHH-ccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------
Confidence 99999999765433221 12222478999999998 5667788999999999999999985 667654332211
Q ss_pred HHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCCC
Q 047716 251 HQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVPP 308 (325)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 308 (325)
.....+.. .+.+...+..+.++|.+||+.+|++|||++||+++|++...+
T Consensus 246 -~~i~~~~~-------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 246 -RFVMEGGL-------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp -HHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -HHHHhCCC-------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11222221 112223345799999999999999999999999999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=332.34 Aligned_cols=270 Identities=22% Similarity=0.256 Sum_probs=200.1
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecCC----ceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS----NRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 108 (325)
.+|.+.+.||+|+||.||+|+++ |..||||++..... .......|+..+..++||||+++++++.+.+ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 46778899999999999999874 78999999865322 2222334666667789999999999986543 579999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC-----ETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~-----~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
||+++|+|.+++.+ .++++..++.++.|++.|+.|||+.. ..||+||||||+||||+.++.+||+|||++...
T Consensus 81 Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999999954 46899999999999999999999620 129999999999999999999999999999866
Q ss_pred cCCCcc---ceeeecCCCCcCCccccccCC-----CCCccccchhHHHHHHHHHhCCCCCCCccccchhh--------HH
Q 047716 184 KTDQTR---TYTVLRGTRGYTAPELHSRNN-----RITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV--------LI 247 (325)
Q Consensus 184 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~--------~~ 247 (325)
...... ......||+.|+|||.+.... .++.++|||||||++|||++|.+||.......... ..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 443321 223345899999999985332 24678999999999999999998875433221110 11
Q ss_pred HHHHHHHHhCcccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccCC
Q 047716 248 DWAHQCYEAGELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIVP 307 (325)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 307 (325)
.........+.++.-+.... ...+....+.+++.+||+.||.+|||+.||++.|+++..
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhccccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 12222333333322111111 133455679999999999999999999999999998763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=335.14 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=198.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeecCC------c
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS------N 103 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 103 (325)
++|+++++||+|+||+||+|.+. .++.||+|++... .....+.+.+|+.+|+.++||||+++++++...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 57999999999999999999987 6899999998653 2333456889999999999999999999986544 5
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
+++||||+ +.+|..+.. .+++++..++.++.|++.||.|||++ ||+||||||+|||++.++.++++|||++...
T Consensus 98 ~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence 69999999 667877763 35799999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHH-----HHH---
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQ-----CYE--- 255 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-----~~~--- 255 (325)
..... ...+++.|+|||.+.+...++.++|||||||++++|++|++||.+............... ...
T Consensus 172 ~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 172 DSEMT----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CSSCC----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred CCccc----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 44322 234899999999986667789999999999999999999999987644332211110000 000
Q ss_pred -------hCcccccccC-CCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCC
Q 047716 256 -------AGELQNLVSD-QEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVP 307 (325)
Q Consensus 256 -------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~ 307 (325)
...+...... ...........+.+||.+||+.||++|||++|+++ .++++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 0000000000 01111222356889999999999999999999995 5777653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=333.89 Aligned_cols=260 Identities=23% Similarity=0.323 Sum_probs=196.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeecc--chhcHHHHHHHHHHHhccCCCCcceeeEEeec--------C
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKI--VEEGESEFRNEMKIIGRIHHKNLVDLVGFCSE--------G 101 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~ 101 (325)
++|+++++||+|+||+||+|++. +++.||||++... .......+.+|+.+|+.++||||+++++.+.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68999999999999999999986 7899999998543 23344567899999999999999999998744 3
Q ss_pred CceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 102 SNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
+..+++||++.++.+.... .....+++..++.++.|++.|+.|||++ ||+||||||+|||++.++.+|++|||++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 5689999999766555443 5567899999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCc---cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc
Q 047716 182 LLKTDQT---RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE 258 (325)
Q Consensus 182 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 258 (325)
....... .......+|+.|+|||.+.....++.++|||||||++++|++|+.||.+.........+ ........
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLCGSIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH---HHhcCCCC
Confidence 6543222 12222358999999999866677899999999999999999999999865443322211 11111100
Q ss_pred ---cccc-----------ccCCCCCCH------HHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 259 ---LQNL-----------VSDQEDVNI------EEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 259 ---~~~~-----------~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
.... ......... .....+.+||.+||+.||++|||++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 0000 000000000 1134578999999999999999999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=335.17 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=200.9
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-hhcHHHHHHHHHHHhccCCCCcceeeEEeecCC----ceEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGS----NRLL 106 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l 106 (325)
.+|+++++||+|+||+||+|.+. ++..+|||++.... ......+.+|+.+|+.++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 46999999999999999999986 78999999986533 334556889999999999999999999986543 2344
Q ss_pred EEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCC
Q 047716 107 VYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTD 186 (325)
Q Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~ 186 (325)
+++++.+++|.+++.. .++++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 88 l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 5556679999999843 4799999999999999999999999 9999999999999999999999999999765433
Q ss_pred Cc--cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc------
Q 047716 187 QT--RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE------ 258 (325)
Q Consensus 187 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 258 (325)
.. .......+++.|+|||.+.....++.++||||+||++++|++|+.||......+...... .......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh---hhccCCChhhhhh
Confidence 22 122334488999999998667778899999999999999999999998765432221111 0000000
Q ss_pred ---------ccccccCC----CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCCCC
Q 047716 259 ---------LQNLVSDQ----EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVPPH 309 (325)
Q Consensus 259 ---------~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~~ 309 (325)
........ ....+....++.+|+.+||+.||.+|||++|+++ +|+......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 00000000 0001112346899999999999999999999995 366665433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=337.62 Aligned_cols=266 Identities=23% Similarity=0.270 Sum_probs=199.6
Q ss_pred HHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcceeeEEeecC------CceEE
Q 047716 34 SENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLVDLVGFCSEG------SNRLL 106 (325)
Q Consensus 34 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~l 106 (325)
+|+..++||+|+||+||+|++. .++.||||++..... ...+|+.+|++++||||+++++++... ..+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999997 689999999865432 234699999999999999999988432 34789
Q ss_pred EEeecCCCCHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeeccccccc
Q 047716 107 VYEFMRNGSLGNLLF--RAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFGLSKLL 183 (325)
Q Consensus 107 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~~ 183 (325)
||||++++.+..+.. .....+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999997654433321 2345799999999999999999999999 999999999999998775 8999999999866
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHH--------HHHHH
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWA--------HQCYE 255 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~ 255 (325)
....... ...++..|+|||.+.+...++.++|||||||++++|++|++||......+....+... .....
T Consensus 174 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSCCC--SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcccc--cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 5433322 2348999999998866778999999999999999999999999876543332211100 00000
Q ss_pred h----CcccccccCC--CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCCC
Q 047716 256 A----GELQNLVSDQ--EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVPP 308 (325)
Q Consensus 256 ~----~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~ 308 (325)
. ..+....... ..........+.+|+.+||+.||++|||++|+++ +++++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 0 0000000000 0111223456899999999999999999999994 57776643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-47 Score=327.23 Aligned_cols=268 Identities=18% Similarity=0.229 Sum_probs=208.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeecCCceEEEEe
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 109 (325)
++|+++++||+|+||+||+|++. +++.||||++.... ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 36999999999999999999987 78889999986432 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccccCCCcc
Q 047716 110 FMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLKTDQTR 189 (325)
Q Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~~~~~~ 189 (325)
++.++++..+. ...+.+++..++.++.|++.|++|||++ ||+||||||+||+++.++.+|++|||.+.........
T Consensus 82 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred ecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99888887776 4567899999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc---c-------
Q 047716 190 TYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE---L------- 259 (325)
Q Consensus 190 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~------- 259 (325)
. ....++..|.|||.+.....++.++|||||||++++|++|+.||.......... ........... +
T Consensus 158 ~-~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 158 Y-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp C-CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH--HHHHHHHCCCCTTTCTTGGGST
T ss_pred c-eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH--HHHHhhcCCCChhhhhhhhhcc
Confidence 2 122367889999998666678999999999999999999999976543322211 11111111100 0
Q ss_pred -------cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCC
Q 047716 260 -------QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVP 307 (325)
Q Consensus 260 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~ 307 (325)
...............+.+.+|+.+||+.||.+|||++|+++ .|+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 00001111122233467899999999999999999999995 5665544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-46 Score=324.73 Aligned_cols=262 Identities=18% Similarity=0.256 Sum_probs=210.9
Q ss_pred HHHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCC-CCcceeeEEeecCCceEEEE
Q 047716 31 VLASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHH-KNLVDLVGFCSEGSNRLLVY 108 (325)
Q Consensus 31 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 108 (325)
+.++|+++++||+|+||.||+|++. .++.+|+|++.... ....+.+|++.++.++| +|++.+++++..+...++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 3468999999999999999999987 68889999875532 23356788999999975 89999999999999999999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC-----CCcEEEeeccccccc
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE-----SWKAKISDFGLSKLL 183 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~-----~~~vkl~Dfg~~~~~ 183 (325)
|++ +++|.+++......++...+..++.|++.|+.+||++ ||+||||||+||+++. .+.++++|||++...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 7899999877677899999999999999999999999 9999999999999964 568999999999876
Q ss_pred cCCCc------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhC
Q 047716 184 KTDQT------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAG 257 (325)
Q Consensus 184 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 257 (325)
..... .......||+.|+|||.+ .+..++.++||||||+++++|++|+.||.+....................
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~-~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccCccccceeecccCceEEchhhcCHHHh-cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 43321 122334589999999999 56778999999999999999999999998776655443333222222222
Q ss_pred cccccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 258 ELQNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
...++... .++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 236 ~~~~l~~~-------~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 236 PLRELCAG-------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp CHHHHTTT-------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ChHHhcCC-------CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 22222111 2256899999999999999999999998888765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-46 Score=324.31 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=199.6
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEee
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYEF 110 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~ 110 (325)
++|++.++||+|+||.||+|++. +++.||||++..... ...+..|+++++.++|++++ .+..++.+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46999999999999999999986 688999998765332 23577899999999877655 455566777888999999
Q ss_pred cCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcC---CCcEEEeeccccccccCCC
Q 047716 111 MRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDE---SWKAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 111 ~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~---~~~vkl~Dfg~~~~~~~~~ 187 (325)
+ ++++.+.+......+++..+..++.|++.|+.|||++ ||+||||||+||+++. +..++++|||++.......
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 5677777666677899999999999999999999999 9999999999999854 4569999999998765432
Q ss_pred c------cceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCcccc
Q 047716 188 T------RTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQN 261 (325)
Q Consensus 188 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (325)
. .......||+.|+|||.+ .+..++.++|||||||++++|++|+.||..........................
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHH-TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHH-hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 2 122334589999999998 566789999999999999999999999987665444332222222211111111
Q ss_pred cccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHHHHhccC
Q 047716 262 LVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVIWMMEGIV 306 (325)
Q Consensus 262 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 306 (325)
... ..+.++.+++..||+.+|++||+++++.+.|+.+.
T Consensus 240 ~~~-------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 240 LCK-------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HTT-------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred hcc-------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111 12356999999999999999999999999888764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=330.28 Aligned_cols=258 Identities=22% Similarity=0.243 Sum_probs=206.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC----CCcEEEEEEeeccc----hhcHHHHHHHHHHHhccCC-CCcceeeEEeecCCc
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN----GGKEIAVKKLIKIV----EEGESEFRNEMKIIGRIHH-KNLVDLVGFCSEGSN 103 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~vk~~~~~~----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 103 (325)
++|+++++||+|+||+||+|... .|..+|+|++.... ......+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 66999999999999999999863 47889999886422 2334557789999999976 899999999999999
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
.+++|||+.+++|.+++. ..+.+.+..++.++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++..+
T Consensus 104 ~~~v~e~~~~~~L~~~i~-~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHH-hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999984 445788999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCccceeeecCCCCcCCccccccC-CCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCccccc
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRN-NRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGELQNL 262 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (325)
............+++.|++||.+... ..++.++|||||||++|+|++|+.||......+....+. .... .
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~-~------ 250 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRIL-K------ 250 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHH-H------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhcc-c------
Confidence 55444444445689999999998544 356889999999999999999999998776544332221 1111 1
Q ss_pred ccCCCCCCHHHHHHHHHHHhhcccCCCCCCC-----CHhHHHH--HHhcc
Q 047716 263 VSDQEDVNIEEFENLVKIGLWCVECELNLRP-----TMKQVIW--MMEGI 305 (325)
Q Consensus 263 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~ell~--~L~~~ 305 (325)
.....+...+.++.+++.+||+.||.+|| |++|+++ +++++
T Consensus 251 --~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 251 --SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred --CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 11112223446799999999999999999 4889984 45443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-46 Score=326.12 Aligned_cols=256 Identities=20% Similarity=0.340 Sum_probs=197.7
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeec--CCceEEEE
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSE--GSNRLLVY 108 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~ 108 (325)
++|+++++||+|+||+||+|++. .++.||+|++... ....+.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 58999999999999999999986 6888999998642 3456889999999996 9999999999874 35689999
Q ss_pred eecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCC-cEEEeeccccccccCCC
Q 047716 109 EFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESW-KAKISDFGLSKLLKTDQ 187 (325)
Q Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~-~vkl~Dfg~~~~~~~~~ 187 (325)
||+.+++|.++. +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .++++|||++.......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999987764 5699999999999999999999999 999999999999998654 69999999998665433
Q ss_pred ccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhh-HHHH------HHHHHHhCc--
Q 047716 188 TRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIV-LIDW------AHQCYEAGE-- 258 (325)
Q Consensus 188 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~------~~~~~~~~~-- 258 (325)
. .....+|+.|+|||.+.+...++.++|||||||++++|++|+.||.......... .+.. .........
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2 2233478999999998666778999999999999999999999997654422211 1000 000000000
Q ss_pred ----ccccccCC----------CCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHHH
Q 047716 259 ----LQNLVSDQ----------EDVNIEEFENLVKIGLWCVECELNLRPTMKQVIW 300 (325)
Q Consensus 259 ----~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 300 (325)
........ .........++.+||.+||+.||.+|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 0011223456899999999999999999999994
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=327.24 Aligned_cols=268 Identities=22% Similarity=0.302 Sum_probs=201.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEeec-----CCce
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCSE-----GSNR 104 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 104 (325)
.+|++.++||+|+||+||+|.+. +++.||||++.... ......+.+|+.+|+.++||||+++++++.. +...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 47999999999999999999986 78999999987533 3344568899999999999999999999853 2344
Q ss_pred EEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeecccccccc
Q 047716 105 LLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLLK 184 (325)
Q Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~~ 184 (325)
+++++++.+++|.+++. .+++++..++.++.|++.||.|||++ ||+||||||+||+++.++.++++|||++....
T Consensus 98 ~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 66677788999999983 35799999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHHHHHHHHhCc------
Q 047716 185 TDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDWAHQCYEAGE------ 258 (325)
Q Consensus 185 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 258 (325)
... ....+++.|+|||.+.+...++.++|||||||++++|++|++||.+.........+. .......
T Consensus 173 ~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~---~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 DEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL---RLVGTPGAELLKK 245 (348)
T ss_dssp GGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCHHHHTT
T ss_pred ccc----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChHHhhh
Confidence 322 223378899999987666778999999999999999999999998764332221111 1100000
Q ss_pred --------ccccccCCCCCC-----HHHHHHHHHHHhhcccCCCCCCCCHhHHHH--HHhccCCCCCCC
Q 047716 259 --------LQNLVSDQEDVN-----IEEFENLVKIGLWCVECELNLRPTMKQVIW--MMEGIVPPHQNM 312 (325)
Q Consensus 259 --------~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~--~L~~~~~~~~~~ 312 (325)
............ ......+.+||.+||+.||.+|||++|+++ .+.++......+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~ 314 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCC
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCC
Confidence 000000001111 112356899999999999999999999995 677766444433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=325.49 Aligned_cols=257 Identities=21% Similarity=0.253 Sum_probs=189.4
Q ss_pred HHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccc--hhcHHHHHHHHHHHhccCCCCcceeeEEee------cCCc
Q 047716 33 ASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV--EEGESEFRNEMKIIGRIHHKNLVDLVGFCS------EGSN 103 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~ 103 (325)
++|+++++||+|+||+||+|.+. .+..||||++.... ......+.+|+.+++.++||||+++++++. ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999987 68999999987533 334456889999999999999999999985 3467
Q ss_pred eEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeeccccccc
Q 047716 104 RLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDFGLSKLL 183 (325)
Q Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~~~ 183 (325)
+++||||+.++++..+ ...+++..++.++.|++.|+.|||++ ||+|+||||+||+++.++.++++|||++...
T Consensus 97 ~~iv~Ey~~~~l~~~~----~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHhh----hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence 8999999976555443 35689999999999999999999999 9999999999999999999999999988755
Q ss_pred cCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCccccchhhHHHH--------------
Q 047716 184 KTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDESLRDDEIVLIDW-------------- 249 (325)
Q Consensus 184 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-------------- 249 (325)
...... ....+|+.|+|||.+ .+..+++++||||+||++++|++|++||.+.........+..
T Consensus 170 ~~~~~~--~~~~~t~~y~aPE~l-~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTSFMM--TPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccccc--ccccccccccChhhh-cCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 443322 233479999999998 457789999999999999999999999976543222111100
Q ss_pred --HHHHHHhC-cc----------cccccCCCCCCHHHHHHHHHHHhhcccCCCCCCCCHhHHH
Q 047716 250 --AHQCYEAG-EL----------QNLVSDQEDVNIEEFENLVKIGLWCVECELNLRPTMKQVI 299 (325)
Q Consensus 250 --~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell 299 (325)
........ .. ..............+..+.+|+.+||+.||++|||++|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 00000000 00 0000111112233567899999999999999999999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-41 Score=300.76 Aligned_cols=276 Identities=17% Similarity=0.184 Sum_probs=195.0
Q ss_pred ccccHHHHH-HHHHhhhhhcCcCCceeEEEEEeC-CCcEEEEEEeeccchhcHHHHHHHHHHHhccC-----------CC
Q 047716 23 RSFSYEQIV-LASENFKEEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-----------HK 89 (325)
Q Consensus 23 ~~~~~~~~~-~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-----------h~ 89 (325)
++..++++. +.+|+++++||+|+||+||+|++. +++.||||++..... ....+.+|+.+++.++ |+
T Consensus 2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 344455543 356999999999999999999986 789999999875432 2346678888888775 57
Q ss_pred CcceeeEEeec--CCceEEEEeecCCCCH-HH-HHhhccCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeeccCCCCce
Q 047716 90 NLVDLVGFCSE--GSNRLLVYEFMRNGSL-GN-LLFRAEQRLSWSERRRIALEIMEGLHYLHD-ECETRIIHCDIKPHNI 164 (325)
Q Consensus 90 ~iv~~~~~~~~--~~~~~lv~e~~~~~~L-~~-~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~~i~h~di~p~ni 164 (325)
||+++++++.. ....++++.++..... .. ........+++..++.++.|++.|+.|||+ . ||+||||||+||
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NI 157 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENV 157 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHe
Confidence 89999988754 3455666666544432 22 222345678999999999999999999998 6 999999999999
Q ss_pred EEcCCC------cEEEeeccccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 047716 165 LMDESW------KAKISDFGLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVMLLEIVCCRKNVDES 238 (325)
Q Consensus 165 lv~~~~------~vkl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 238 (325)
|++.++ .++++|||.+....... ....+++.|+|||.+. ...++.++||||+||++++|++|+.||...
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeccCcccccceeeEeeccccccccccc----ccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 997654 39999999987554322 2234899999999884 566789999999999999999999999754
Q ss_pred cccchhhHHHHHH---HHHH--------h----------C------------cccccccCCCCCCHHHHHHHHHHHhhcc
Q 047716 239 LRDDEIVLIDWAH---QCYE--------A----------G------------ELQNLVSDQEDVNIEEFENLVKIGLWCV 285 (325)
Q Consensus 239 ~~~~~~~~~~~~~---~~~~--------~----------~------------~~~~~~~~~~~~~~~~~~~l~~li~~~l 285 (325)
.........+... ..+. . . .+.................+.+|+.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 3321111110000 0000 0 0 0011111123345667788999999999
Q ss_pred cCCCCCCCCHhHHHH--HHhccCC
Q 047716 286 ECELNLRPTMKQVIW--MMEGIVP 307 (325)
Q Consensus 286 ~~~p~~Rps~~ell~--~L~~~~~ 307 (325)
+.||.+|||++|+++ .+++..+
T Consensus 313 ~~dP~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred CCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999995 5766553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=8.9e-24 Score=170.07 Aligned_cols=168 Identities=15% Similarity=0.118 Sum_probs=119.0
Q ss_pred hhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccch------------------hcHHHHHHHHHHHhccCCCCcceeeEE
Q 047716 36 NFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVE------------------EGESEFRNEMKIIGRIHHKNLVDLVGF 97 (325)
Q Consensus 36 ~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (325)
.+.++||+|+||.||+|.+.+|+.+|+|++..... ........|...+..+.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999998899999997642110 112234568889999999999988876
Q ss_pred eecCCceEEEEeecCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeeccCCCCceEEcCCCcEEEeec
Q 047716 98 CSEGSNRLLVYEFMRNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDECETRIIHCDIKPHNILMDESWKAKISDF 177 (325)
Q Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nilv~~~~~vkl~Df 177 (325)
. ..+++||++++..+.+ ++......++.|++.++.+||++ |++|+||||+|||++++ .++++||
T Consensus 83 ~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred c----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence 4 2379999998765433 33444567899999999999999 99999999999999976 5899999
Q ss_pred cccccccCCCccceeeecCCCCcCCccccccCCCCCccccchhHHHH
Q 047716 178 GLSKLLKTDQTRTYTVLRGTRGYTAPELHSRNNRITVKADVYSFGVM 224 (325)
Q Consensus 178 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 224 (325)
|.+............. ..... -.+.+ .+.++.++|+||+.--
T Consensus 147 G~a~~~~~~~~~~~l~--rd~~~-~~~~f--~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWREILE--RDVRN-IITYF--SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHHHHHH--HHHHH-HHHHH--HHHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcHHHHH--HHHHH-HHHHH--cCCCCCcccHHHHHHH
Confidence 9987654332211100 00000 01112 2456778899996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=5.3e-08 Score=80.30 Aligned_cols=142 Identities=13% Similarity=0.072 Sum_probs=94.5
Q ss_pred HHHhhhhhcCcCCceeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccC-CCCcceeeEEeecCCceEEEEeec
Q 047716 33 ASENFKEEIGRGGSGRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIH-HKNLVDLVGFCSEGSNRLLVYEFM 111 (325)
Q Consensus 33 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 111 (325)
..|++.+..+.++.+.||+... +++.+++|+...........+..|...++.+. +=.+.+++.+...++..++||+++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred hceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 3555666555555678998754 56678888876655444555677888887775 223566777777788899999999
Q ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHhhccC-----------------------------------------
Q 047716 112 RNGSLGNLLFRAEQRLSWSERRRIALEIMEGLHYLHDEC----------------------------------------- 150 (325)
Q Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~----------------------------------------- 150 (325)
+|.++.+..... .. ...++.++...++.||+..
T Consensus 93 ~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 93 DGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 988876554211 11 1223444455555555320
Q ss_pred ---------------CCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 151 ---------------ETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 151 ---------------~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
...++|+|+.|.||++++++.+-++||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987656799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=1.3e-05 Score=65.15 Aligned_cols=129 Identities=16% Similarity=0.151 Sum_probs=82.2
Q ss_pred cCcCCc-eeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCC--cceeeEEeecCCceEEEEeecCCCCHH
Q 047716 41 IGRGGS-GRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKN--LVDLVGFCSEGSNRLLVYEFMRNGSLG 117 (325)
Q Consensus 41 lg~g~~-g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (325)
+..|.. +.||+....++..+++|...... ...+..|...++.+.... +.+++.+..+++..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444443 67899888777778888754332 234667788777775333 456777777778889999999876543
Q ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHhhcc------------------------------------------------
Q 047716 118 NLLFRAEQRLSWSERRRIALEIMEGLHYLHDE------------------------------------------------ 149 (325)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~------------------------------------------------ 149 (325)
+.. ..... .+.++...+..||+.
T Consensus 95 ~~~------~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 95 SSH------LAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp TSC------CCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred ccc------ccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 211 11111 122333333333321
Q ss_pred -------CCCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 150 -------CETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 150 -------~~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
....++|+|+.|.||+++++..+-++||+.+.
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 01238999999999999987667799998653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=2.2e-05 Score=68.15 Aligned_cols=75 Identities=15% Similarity=0.078 Sum_probs=47.0
Q ss_pred hhcCcCCceeEEEEEeC-CCcEEEEEEeeccc-------hhcHHHHHHHHHHHhccC--CC-CcceeeEEeecCCceEEE
Q 047716 39 EEIGRGGSGRVYKGCIN-GGKEIAVKKLIKIV-------EEGESEFRNEMKIIGRIH--HK-NLVDLVGFCSEGSNRLLV 107 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~-~~~~~~vk~~~~~~-------~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv 107 (325)
+.+|.|....||+.... +++.+++|.-.... .........|...|+.+. .| .+.+++.+ +.....+|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999876 46788888643211 112234556888887764 23 34445544 34456899
Q ss_pred EeecCCCC
Q 047716 108 YEFMRNGS 115 (325)
Q Consensus 108 ~e~~~~~~ 115 (325)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.85 E-value=0.0047 Score=51.48 Aligned_cols=132 Identities=12% Similarity=0.121 Sum_probs=76.1
Q ss_pred eeEEEEEeCCCcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCc--ceee-----EEeecCCceEEEEeecCCCCHH--
Q 047716 47 GRVYKGCINGGKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNL--VDLV-----GFCSEGSNRLLVYEFMRNGSLG-- 117 (325)
Q Consensus 47 g~v~~~~~~~~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~~L~-- 117 (325)
..||+++..+|..+++|+... .......+..|...+..|...++ +..+ ..+..++..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 579999888899999988644 23345667888888888752222 1111 1224456678899998764221
Q ss_pred ---H------HHh---hc--c------CC-------------------CC---HHHHHHHHHHHHHHHHHhh-ccCCCCe
Q 047716 118 ---N------LLF---RA--E------QR-------------------LS---WSERRRIALEIMEGLHYLH-DECETRI 154 (325)
Q Consensus 118 ---~------~~~---~~--~------~~-------------------~~---~~~~~~~~~ql~~~l~~lh-~~~~~~i 154 (325)
. .+. .. . .. ++ .......+.++...+..+- +....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 010 00 0 00 11 1122333344444333321 1123479
Q ss_pred eeccCCCCceEEcCCCcEEEeeccccc
Q 047716 155 IHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 155 ~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
+|+|+.+.||+++++ ..++||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4589998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.76 E-value=0.0027 Score=54.52 Aligned_cols=72 Identities=19% Similarity=0.232 Sum_probs=47.1
Q ss_pred hhcCcCCceeEEEEEeCC--------CcEEEEEEeeccchhcHHHHHHHHHHHhccCCCCcc-eeeEEeecCCceEEEEe
Q 047716 39 EEIGRGGSGRVYKGCING--------GKEIAVKKLIKIVEEGESEFRNEMKIIGRIHHKNLV-DLVGFCSEGSNRLLVYE 109 (325)
Q Consensus 39 ~~lg~g~~g~v~~~~~~~--------~~~~~vk~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e 109 (325)
+.|+.|-.-.+|++...+ ...+++++.- . ........+|..+++.+...++. ++++++.+ .+|++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 468889999999998653 2345555443 2 22334566788888888644544 66776643 58999
Q ss_pred ecCCCCH
Q 047716 110 FMRNGSL 116 (325)
Q Consensus 110 ~~~~~~L 116 (325)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9976443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.19 E-value=0.02 Score=47.13 Aligned_cols=31 Identities=19% Similarity=0.280 Sum_probs=26.9
Q ss_pred CCCeeeccCCCCceEEcCCCcEEEeeccccc
Q 047716 151 ETRIIHCDIKPHNILMDESWKAKISDFGLSK 181 (325)
Q Consensus 151 ~~~i~h~di~p~nilv~~~~~vkl~Dfg~~~ 181 (325)
..|++|+|+.++||+++++...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3489999999999999988767899999764
|